0001214659-13-001731.txt : 20130329 0001214659-13-001731.hdr.sgml : 20130329 20130329163920 ACCESSION NUMBER: 0001214659-13-001731 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130329 DATE AS OF CHANGE: 20130329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BROADCAST INTERNATIONAL INC CENTRAL INDEX KEY: 0000740726 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 870395567 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-13316 FILM NUMBER: 13728095 BUSINESS ADDRESS: STREET 1: 7050 UNION PARK AVENUE, #600 CITY: SALT LAKE CITY STATE: UT ZIP: 84047 BUSINESS PHONE: 801-562-2252 MAIL ADDRESS: STREET 1: 7050 UNION PARK AVENUE #600 CITY: SALT LAKE CITY STATE: UT ZIP: 84047 FORMER COMPANY: FORMER CONFORMED NAME: LASER CORP DATE OF NAME CHANGE: 19920703 10-K 1 a32213110k.htm FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012. a32213110k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
 
R
Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
For the fiscal year ended December 31, 2012.
 
£
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
For the transition period from __________ to __________.

Commission File Number: 0-13316
BROADCAST INTERNATIONAL, INC.
(Exact Name of Registrant as Specified in its Charter)

Utah
  
87-0395567
(State or Other Jurisdiction of Incorporation or Organization)
  
(I.R.S. Employer Identification No.)

7050 Union Park Avenue, Suite 600, Salt Lake City, UT 84047
(Address of Principal Executive Offices) (Zip Code)

Registrant’s Telephone Number, including Area Code: (801) 562-2252

Securities Registered Pursuant to Section 12(b) of the Exchange Act:  None.
Securities Registered Pursuant to Section 12(g) of the Exchange Act:  Common Stock, Par Value $0.05

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities
Act   Yes £      No R

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15 (d) of the Exchange Act.    Yes £     No R

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes R     No £

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 Yes £     No £

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  £

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

£ Large accelerated filer
£ Accelerated filer
£ Non-accelerated filer (Do not check if a smaller reporting company)
R Smaller reporting company

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)
Yes  £  No  R

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the average bid and asked price of such common equity, as of June 30, 2012 the last business day of the Registrant’s most recently completed second fiscal quarter, was $26,806,955.

As of March 15, 2013 the Registrant had outstanding 107,932,373 shares of its common stock.
 
 
 
 
 
TABLE OF CONTENTS
 
Page No.
 
PART I
3
        ITEM 1.  
BUSINESS
4
  ITEM 1A. 
 RISK FACTORS
12
  ITEM 1B.  
UNRESOLVED STAFF COMMENTS
18
  ITEM 2.  
PROPERTIES
18
  ITEM 3.  
LEGAL PROCEEDINGS
18
  ITEM 4.  
MINE SAFETY DISCLOUSRES
19
PART II
19
  ITEM 5.  
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS  AND ISSUER PURCHASES OF EQUITY SECURITIES
19
  ITEM 6.  
SELECTED FINANCIAL DATA
20
  ITEM 7.  
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
20
  ITEM 7A. 
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
36
  ITEM 8.  
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
36
  ITEM 9.  
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
36
  ITEM 9A(T).   
CONTROLS AND PROCEDURES
36
  ITEM 9B.  
OTHER INFORMATION
37
PART III
38
  ITEM 10.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
38
  ITEM 11.  
EXECUTIVE COMPENSATION
41
  ITEM 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
49
  ITEM 13.  
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
51
  ITEM 14.
PRINCIPAL ACCOUNTANT FEES AND SERVICES
54
PART IV
55
  ITEM 15.
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
55
SIGNATURES
59

 
2
 

PART I
 
Cautionary Note Regarding Forward-Looking Statements
 
This report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended, and Rule 3b-6 promulgated thereunder, that involve inherent risk and uncertainties.  Any statements about our expectations, beliefs, plans, objectives, strategies or future events or performance constitute forward-looking statements.  These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend” and similar words or phrases.  Accordingly, these statements involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed or implied therein.  All forward-looking statements are qualified in their entirety by reference to the factors discussed in this report, including, among others, the following risk factors discussed more fully in Item 1A hereof:
 
 
·
dependence on commercialization of our CodecSys technology;
 
 
·
our need and ability to raise sufficient additional capital;
 
 
·
uncertainty about our ability to repay our outstanding  notes;
 
 
·
our continued losses;
 
 
·
delays in adoption of our CodecSys technology;
 
 
·
concerns of OEMs and customers relating to our financial uncertainty;
 
 
·
restrictions contained in our outstanding convertible notes;
 
 
·
general economic and market conditions;
 
 
·
ineffective internal operational and financial control systems;
 
 
·
rapid technological change;
 
 
·
intense competitive factors;
 
 
·
our ability to hire and retain specialized and key personnel;
 
 
·
dependence on the sales efforts of others;
 
 
·
dependence on significant customers;
 
 
·
uncertainty of intellectual property protection;
 
 
·
potential infringement on the intellectual property rights of others;
 
 
·
factors affecting our common stock as a “penny stock;”
 
 
·
extreme price fluctuations in our common stock;
 
 
·
price decreases due to future sales of our common stock;
 
 
3
 
 
 
·
future shareholder dilution; and
 
 
·
absence of dividends.
 
Because the risk factors referred to above could cause actual results or outcomes to differ materially from those expressed or implied in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statement.  Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of future events or developments.  New factors emerge from time to time, and it is not possible for us to predict which factors will arise.  In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
 
ITEM 1.  BUSINESS
 
Broadcast International, Inc. is a communications services and technology company headquartered in Salt Lake City, Utah.  Broadcast operates two divisions – BI Networks and CodecSys.  Broadcast was incorporated in Utah in 1983 under the name “Laser Corporation,” but did not commence its current business until the year 2000.
 
Overview of BI Networks
 
Through BI Networks, we install, manage and support private communication networks for large organizations that have widely-dispersed locations or operations.  Our enterprise clients use these networks to deliver digital signage solutions, training programs, product announcements, entertainment and other communications to their employees and customers.  We use a variety of delivery technologies, including satellite, Internet streaming and WIFI, depending on the industry standard products and equipment sold by other companies.
 
In July 2009, we entered into a $10.1 million, three-year contract with Bank of America (“BofA”) to provide technology and digital signage services to approximately 2,100 of its more than 6,000 retail and administrative locations throughout North America.  This digital signage network grew to approximately 2,500 retail banking sites.. For the past three years this has been our largest customer, but in December 2012, we were notified that a new vendor would begin servicing the customer.  Although Broadcast may continue providing some services, our revenues from this customer will decrease by approximately 90%. Currently, our contract, which would have expired in August 2012, has been extended to May 31, 2013.  We tested our digital signage product offering with a regional bank through the installation of six test sites at different banking locations.  .  This customer and its affiliated banks have approximately 550 total banking locations.  In addition, we have been selected to be the vendor for a large religious institution that has in excess of 16,000 churches and other places of worship worldwide to provide digital signage software and services.    This religious organization has paid us for development engineering work and we have successfully completed a proof of concept demonstration.  Because we will not continue with our largest customer, we must replace those revenues with new customers or severely scale back our operations.  These new customers may replace a portion of the revenues lost due to losing the largest customer.
   
BI Networks Products and Services
 
Following are some of the ways in which businesses utilize Broadcast’s products and services.
 
 
4
 
 
Internal Business Applications
 
 
·
Deliver briefings from the CEO or other management
 
 
·
Launch new products or services
 
 
·
Present new marketing campaigns
 
 
·
Train employees
 
 
·
Announce significant changes or implement new policies and procedures
 
 
·
Respond to crisis situations
 
External Business Applications
 
 
·
Display advertising in public areas utilizing digital signage
 
 
·
Make promotional presentations to prospective customers or recruits
 
 
·
Provide product/service training to customers
 
 
·
Train and communicate with sales agents, dealers, VARs, franchisees, association members, etc.
 
 
·
Sponsor satellite media tours
 
 
·
Provide video/audio news releases
 
Network-Based Services
 
Broadcast utilizes satellite technology for various business training and communication applications.  The list that follows describes the comprehensive offering of products and services that attracts companies in need of a satellite solution.
 
 
·
Network design and engineering
 
 
·
Equipment and installation
 
 
·
Network management
 
 
·
24/7 help desk services
 
 
·
On-site maintenance and service
 
 
·
Full-time or occasional satellite transponder purchases (broadcast time)
 
 
·
Uplink facilities or remote SNG uplink trucks
 
Streamed Video Hosting Services
 
With the advancement of streaming technologies and the increase of bandwidth, the Internet provides an effective platform for video-based business training and communications.  Broadcast management believes that the Internet will become an increasing means of broadband business video delivery.  Consequently, Broadcast has invested in the infrastructure and personnel needed to be a recognized provider of Internet-based services.  Following are the services Broadcast currently provides:
 
 
·
Dedicated server space
 
 
·
High-speed, redundant Internet connection
 
 
·
Secure access
 
 
·
Seamless links from client's website
 
 
·
Customized link pages and media viewers
 
 
5
 
 
 
·
Testing or self-checks
 
 
·
Interactive discussion threads
 
 
·
Participation/performance reports for managers/administrators
 
 
·
Notification of participants via email
 
 
·
Pay-per-view or other e-commerce applications
 
 
·
Live events
 
 
·
24/7 technical support
 
Production and Content Development Services
 
To support both satellite and Internet-based delivery platforms, we employ professional production and content development teams and operate full service video and audio production studios.  A list of support services follows:
 
 
·
In-studio or on-location video/audio production
 
 
·
Editing/post-production
 
 
·
Instructional design
 
 
·
Video/audio encoding for Internet delivery
 
 
·
Conversion of text or PowerPoint to HTML
 
 
·
Alternative language conversion
 
 
·
Access to “off-the-shelf” video training content
 
Service Revenue
 
We generate revenue by charging fees for the services we provide, and/or by selling equipment and satellite time.  A typical satellite network generates one-time revenues from the sale and installation of satellite receivers and antennas and monthly revenues from network management services.  On-site maintenance/service, production fees, and occasional satellite time are charged as they are used.
 
For Internet-based services, we charge customers monthly fees for hosting content, account management, quality assurance and technical support, if requested.  For delivery of content, we generally charge a fee every time a person listens to or watches a streamed audio or video presentation.  Encoding, production and content creation or customization are billed as these services are performed.  We have also entered into content development partnerships with professional organizations that have access to subject matter experts.  In these cases, we produce web-based training presentations and sell them on a pay-per-view basis, sharing revenues with the respective partner.
 
In the process of creating integrated technology solutions, we have developed proprietary software systems such as its content delivery system, incorporating site, user, media and template controls to provide a powerful mechanism to administer content delivery across multiple platforms and to integrate into any web-based system.  We use our content delivery system to manage networks of thousands of video receiving locations for enterprise clients.
 
The percentages of revenues derived from our different services fluctuate depending on the customer contracts entered into and the level of activity required by such contracts in any given period.  Of our net sales in 2012 and 2011, approximately 90% were derived from network management related services and approximately 10% were derived from product and content development and all other services.
 
 
6
 
 
Our network management and support services are generally provided to customers by our operations personnel located at corporate headquarters.  Our production and content development services are generally provided by personnel from our production studio.  We generally contract with independent service technicians to perform installation and maintenance services at customer locations throughout the United States.
 
Overview of Video Compression
 
Video compression is the process by which video content is converted into a digital data stream for transmission over satellite, cable, Internet or wireless networks.
 
Video compression is generally accomplished by using a single technique or computer formula to create a particular data stream.  As more and more video content is broadcast and streamed to a rapidly expanding based of new video receivers, such as cell phones, tablets, and notebook computers, the need to stream the video content with the highest possible quality and at the lowest possible bandwidth expands exponentially.  At the same time traditional media desires to keep pace with the new media by transmitting higher and higher quality video to enhance the viewing experience of the consumer and we will experience the expansion of “smart televisions”, movies streamed in high definition and 3D, and entertainment streaming services to the home and computer, all of which increase the need to transmit video using the least amount of bandwidth possible without affecting the quality of the experience.
 
CodecSys Technology
 
We have patented our video compression technology and have trademarked it as “CodecSys.”  Initially, we developed this technology for delivering video content for our network customers. However, this proprietary technology has expanded into a much wider application.
 
Video compression is generally accomplished by using a single technique or computer formula to create a particular data stream.  Our patented CodecSys technology is a software-based video operating system that uses multiple techniques or computer formulas to create a particular data stream.  With CodecSys, video content may be transmitted over substantially decreased bandwidth while maintaining media quality.  We believe that our CodecSys technology offers significant efficiencies and cost savings over traditional hardware solutions associated with video content transmission and storage.
 
We have developed a video encoding software product based upon its CodecSys technology that operates on multiple hardware platforms and is easily upgradable. In September 2009, CodecSys video encoding technology was certified by Microsoft as an approved software encoding system for use by IPTV providers that use Microsoft operating platforms.  Microsoft is a leading provider of network control software to the IPTV market.
 
In July 2010, we released CodecSys version 2.0, which has been installed in more than 30 large telecoms and labs for evaluation by potential customers. We continue to make sales presentations and respond to requests for proposals at other large telecoms, cable companies and broadcasting companies.  These presentations have been made with our technology and sales channel partners, which include IBM, HP, Fujitsu and Microsoft, and others which are suppliers of hardware and software for video transmission applications. Because CodecSys is a software encoding and transcoding system, it also supports  “cloud-based” initiatives.  In October 2011, CodecSys was selected as the compression technology to be used by Fujitsu for its NuVolo cloud based product offering.
In today's market, any video content to be distributed via satellite, cable, the Internet and other methods must be encoded into a digital stream using any one of numerous codecs.  The most commonly used codecs are now MPEG2, MPEG4, and H.264.  When new codecs are developed that perform functions better than the current standards, all of the video content previously encoded in the old format must be re-encoded to take advantage of the new codec.  Our CodecSys technology eliminates obsolescence in the video compression marketplace by integrating new codecs into its library.  Using a CodecSys switching system to utilize the particular advantages of each codec, we may utilize any new codec as it becomes available by including it in the application library.  Codec switching can happen on a scene-by-scene or even a frame-by-frame basis.
 
 
7
 
 
We believe the CodecSys technology represents an unprecedented shift from currently used technologies for two important reasons.  First, CodecSys allows a change from using only a single codec to compress video content to using multiple codecs and algorithms in the compression and transmission of content.  The CodecSys system selects dynamically the most suitable codecs available from the various codecs stored in its library and matches the codecs with various video settings to compress a single video stream.  As a video frame, or a number of similar frames (a scene), is compressed, CodecSys applies the optimized codec from the library that best compresses that content and matches the codec with the appropriate setting to then perform the compression.  CodecSys repeats the selection throughout the video encoding process, resulting in the use of numerous codecs on a best performance basis.  The resulting file is typically substantially smaller than when a single codec compression method is used.
 
The second important distinction is that CodecSys is a software encoding system that can be upgraded and improved without changing the hardware on which it is resident, much as a personal computer can have its application software upgraded and changed without replacing the equipment.  In addition, CodecSys software can run equally efficiently on different manufacturers’ equipment.  For example, using the Intel chip currently employed by us, the CodecSys encoding system can run equally as well on IBM equipment and HP equipment, which expands our potential market of customers and opens the possibility of different sales channels as our software can be sold by IBM sales people as well as HP sales people.  In addition, most video encoders currently utilize an application specific integrated circuit (ASIC) chip as the encoding engine and when new developments are made, the customer must purchase new hardware to take advantage of the changes.  Having a software based encoding system means that new changes in technology and encoding algorithms can be downloaded remotely to upgrade the encoding system on the customers already resident hardware.  We believe that having a software based encoding product will slow hardware obsolescence for the customer and be a competitive advantage for CodecSys.
 
CodecSys Products and Services
 
In November 2007, we entered into a two-year license agreement with IBM pursuant to which Broadcast licensed its patented CodecSys technology for use by IBM in selling video encoding solutions using IBM’s Cell-BE processing chip.  The IBM agreement was our first significant license of the CodecSys technology for use in a commercial application.  In connection with this license, Broadcast increased its engineering staff, acquired additional equipment to facilitate the development process, purchased additional codecs for use in its encoding system and engaged outside engineering firms to perform development services.  The initial version of a video encoder running on the IBM platform was completed in a commercially deployable form for sales in 2009, although additional development work was required.
 
After we had completed substantially all of its development work on the IBM Cell-BE processor chip in the first half of 2009, IBM sales efforts using the Cell-BE processor chip were redirected to products not employing the Cell-BE processor chip.  At approximately the same time, Intel released a newly developed operating chip with sufficient processing capacity to perform the multiple functions required by CodecSys to which Broadcast redirected its development efforts.  This chip is based on x86 architecture, which is the standard in the industry acceptable to almost all users, and it is easier to program applications to this architecture.  Although our license agreement with IBM has expired, IBM is making hardware sales presentations utilizing CodecSys technology based upon the Intel chip. The initial version of the CodecSys video encoding system utilizing the Intel chip was first ready for sales presentations and testing in the fourth quarter of 2009, but the CodecSys version 2.0, the first commercial version of the software hardened for sales and deployment was not ready for sales installation until July 1, 2010.  All sales anticipated in the future will be made using the Intel chip.  Notwithstanding the expiration of its license with IBM, we continue to market our CodecSys video encoding software with IBM for use on IBM hardware to prospective customers.
 
 
8
 
 
As described above, we continue to make sales presentations with IBM to IBM customers as Broadcast’s software based encoding system is a part of the IBM media room product offering.  The IBM media room products consist of servers and control and management software used by broadcasters and other distributors of video content over a variety of delivery platforms.  Using CodecSys as an integral part of the product offering gives IBM and other hardware providers an additional product that is sold in the same process as its media room offering.  Currently, IBM has installed CodecSys based software in “proof of concept” systems at customer locations for the customers to test and evaluate the quality, speed, and bandwidth requirements of our software encoding solution.  IBM marketing and sales activities with respect to an encoder utilizing the Intel chip and incorporating CodecSys technology are continuing, and we are increasing the number of its “proof of concept” units at IBM potential customers.
 
Because we now have our CodecSys technology resident on the Intel chip, it is able to market with other manufacturers of computer equipment such as HP.  We have made sales presentations to HP customers in conjunction with HP, which has also selected Broadcast’s video encoding solution as a solution that it will present to its customers.  This has occurred primarily because CodecSys is the only software based encoding system available that will operate on HP hardware platforms and is the only solution that will operate in a cloud computing environment.
 
In September 2009, our CodecSys encoding system was certified by Microsoft as an approved software encoding system for use by IPTV providers, which use Microsoft Media Room software in their delivery and management of their IPTV systems.    The certification has been a source of sales and marketing leads from Microsoft customers desiring encoding solutions for their projects.
 
In October 2011, Fujitsu North America, after fully testing and evaluating CodecSys and its competitors, selected CodecSys as the compression technology to be employed by Fujitsu in its NuVolo cloud based initiative, which has since been discontinued by Fujitsu.  The first sale of CodecSys resident on Fujitsu hardware was completed in November 2011.  The customer is a small cable company that desired to launch an over the top (OTT) network for its cable customers to allow the subscribers to get the cable company content not only through the hardwired cable network, but also through the Internet and wirelessly to cell phones.  The network was launched in December 2011 and is currently operational.  Although, the customer is relatively small and the revenues generated on a monthly basis are not significant, the sale is important for two reasons.  The first is that, although CodecSys has been tested in labs and at potential customers’ locations for two years without material deficiencies being noted by the customers or the channel partners, this is the first time it has been installed and is operational for the benefit of end users.  The second is that the pricing structure put in place as we have gone to market has been validated as a reasonable and cost effective product offering that is competitive with the traditional encoding hardware products currently sold in the video distribution marketplace.
 
In December 2011, IBM introduced its video encoding and transcoding service that is accomplished through the Internet cloud.  The encoding engine for this service is CodecSys.  Broadcast will derive revenue from the service based on the amount of the video encoded by IBM’s customers, although to date we have received no revenue from this new application of its technology.
 
In March 2012, we announced our second OTT customer, which is one of the larger cable and media network companies in Mexico, which is developing its OTT service to deliver content to its subscribers.  The customer will launch a package of both live and file-based programs and services to be streamed over the Internet in support of various screens and mobile devices.  Initially, the offering will include local channels and content.  CodecSys will stream multiple profiles for multi-device consumption enabling the customer to create dynamic bundles for consumers based on content and devices.  The decisive factor in selecting CodecSys was the high level of video quality that the service produces a bandwidth rates that create a cost advantage.  The traditional means of purchasing hardware-based products does not adapt or support the new OTT economy.
 
 
9
 
 
We continue to develop the CodecSys technology for a variety of applications, including Internet streaming, cable and satellite broadcasting, IPTV and transmitting video content to cellular phones and other hand-held electronic devices.  Commercialization and future applications of the CodecSys technology are expected to require additional development capital estimated to be approximately $2.0 million annually.  This estimate may increase or decrease depending on specific opportunities and available funding.
 
Research and Development
 
We have spent substantial amounts in connection with its research and development efforts.  These efforts have been dedicated to the development and commercialization of the CodecSys technology.  Because the majority of the development work for CodecSys has been completed, we have steadily decreased those expenditures from $2,410,249 for the year ended December 31, 2011 to $1,754,163 for the year ended December 31, 2012.  Because of our current liquidity position and capital budgeting plans and the fact that we still expended approximately $300,000 more per month during the year than we received from operating activities, our cash resources may not be sufficient to support future research and development activities unless we raise additional capital, succeed in generating revenues from sales of CodecSys products or restructure.  See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources”.
 
Intellectual Property Protection
 
Because much of our future success and value depends on the CodecSys technology, our patent and intellectual property strategy is of critical importance.  Two provisional patents describing the technology were filed on September 30, 2001.  We have filed for patent protection in the United States and various foreign countries.  Broadcast’s initial U.S. patent related to the CodecSys technology was granted by the U.S. Patent and Trademark Office, or PTO, in August 2007.  Four additional patents have been issued by the PTO.  As of December 31, 2012, we also had eleven patents issued in foreign countries and 20 pending patent applications, including U.S. and foreign counterpart applications and continuations.
 
We have identified additional applications of the technology, which represent potential patents that further define specific applications of the processes that are covered by the original patents.  We intend to continue building our intellectual property portfolio as development continues and resources are available.
 
We have registered the “CodecSys” trademark with the PTO, and seek to protect our know-how, trade secrets and other intellectual property through a variety of means, including confidentiality agreements with our employees, customers, vendors, and others.
 
Major Customers
 
A small number of customers account for a large percentage of our revenue.  For the year ended December 31 2012, 85% of our revenues were from our largest customer compared to 89% from this customer for the year ended December 31, 2011. Our largest customer signed a three year contact which expired in August, 2012 but has been extended to May 31, 2013.  We have been notified that the customer has chosen a competing vendor to provide those services and our revenues from this customer are expected to be substantially reduced during 2013.
 
Any material reduction in revenues generated from this customer could harm our results of operations, financial condition and liquidity.  Our largest customer has elected not to continue to purchase our services, decreasing its level of purchases from us from approximately $6,400,000 in 2012 to approximately $2,300,000 in 2013. This decrease in revenues will materially affect our business unless we can replace that customer with other significant customers.
 
 
10
 
 
Competition
 
The communications industry is extremely competitive.  In the private satellite network market, there are many firms that provide some or all of the services we provide.  Many of these competitors are larger than we are and have significantly greater financial resources.  In the bidding process for potential customers, many of our competitors have a competitive advantage in the satellite delivery of content because many own satellite transponders or otherwise have unused capacity that gives them the ability to submit lower bids than we are able to make.  In the satellite network and services segment, we compete with Convergent Media Systems, Globecast, IBM, Cisco, TeleSat Canada and others.  With respect to video conferencing, we compete with Sony, Polycom, Tandberg and others.
 
There are several additional major market sectors in which we plan to compete with its CodecSys technology, all with active competitors.  These sectors include the basic codec technology market, the corporate enterprise and small business streaming media market, and the video conferencing market.  These are sectors where we may compete by providing direct services.  Competition in these new market areas will also be characterized by intense competition with much larger and more powerful companies, such as Microsoft and Yahoo, which are already in the video compression and transmission business.  Many of these competitors already have an established customer base with industry standard technology, which we must overcome to be successful.
 
The video encoders to be sold by channel partners will compete directly against video encoders manufactured and sold by a number of competitors, including  Erickson/Tandberg, Harmonic Scientific Atlanta, Motorola, and Thomson. None of our channel partners have ever produced a video encoder to compete in this market.  Our marketing partners have not been successful in entering this new market, and we have not derived the amount of licensing revenue originally anticipated by management.
 
On a technology basis, CodecSys competition varies by market sector, with codecs and codec suppliers like Microsoft Windows Media Player, Real Networks’ Real Player, Apple, QuickTime, MPEG2, MPEG4, On2, DivX and many others.  There are several companies, including Akamai, Inktomi, Activate and Loudeye that utilize different codec systems.  These companies specialize in encoding, hosting and streaming content services primarily for news/entertainment clients with large consumer audiences.  We compete directly with the two companies in the broadcast media encoding market that have the largest market share, Erickson/Tandberg and Harmonic. In addition, we compete with Cisco, Harris Corporation, and with many other smaller companies.  Most are larger than us and most have greater financial resources than we have.
 
Competition in the digital signage business is extremely widespread with competitors in almost every pricing strata.  The industry is fragmented with many providers as there is a relatively low cost of entry into the market with many companies developing a new piece of software and immediately there is another competitor. Large companies such as Harris Corporation and Cisco have digital signage offerings among there many other products.  Scala and Fourwinds Interactive are among the many smaller digital signage companies that offer are primarily digital signage software and service to the general business community and with which we most often compete.
 
Employees
 
We currently employ 24 full-time personnel at our executive offices and studio facilities in Salt Lake City, Utah.  We engage independent contractors and employ the services of independent sales representatives as well as voice and production talent on an “as needed” basis at its recording studios.
 
Government Regulation
 
Broadcast has seven licenses issued by the Federal Communications Commission for satellite uplinks, Ethernet, radio connections and other video links between Broadcast facilities and third-party uplinks.  Notwithstanding these licenses, all of our activities could be performed outside these licenses with third-party vendors.  All material business activities are subject to general governmental regulations with the exception of actual transmission of video signals via satellite.
 
 
11
 
 
Properties
 
Our executive offices are located at 7050 Union Park Ave., Suite 600, Salt Lake City, Utah 84047.  We occupy the space at the executive offices under a thirty-nine month term lease, the term of which ends January 31, 2015.  The lease covers approximately 13,880 square feet of office space leased at a rate of $23,049 per month.  Our production studio is located at 6952 South 185 West, Unit C, Salt Lake City, Utah 84047, and consists of approximately 7,500 square feet of space leased under a month to month contract at a rate of $7,000 per month plus utilities.  We have no other properties.
 
Legal Proceedings
 
We have pending legal matters.  We have a judgment rendered against us in a lawsuit, the total amount in dispute in which is approximately $130,000.
 
On July 27, 2012, CTC Resources Inc. dba U.S. Media Capital (“CTC”) filed a lawsuit in the Third Judicial District Court in and for Salt Lake City, State of Utah against ACC Capital Corporation (“ACC”), Loni L. Lowder and the Company (the “CTCD Lawsuit”) asserting claims for relief for breach of contract against ACC, breach of fiduciary duty and fraud against ACC and Mr. Lowder and civil conspiracy against ACC, Mr. Lowder and the Company, and seeking injunctive relief and constructive trust as to all defendants as well as money damages.  On October 9, 2012, we filed our answer as well as a cross claim against ACC seeking declaratory relief as to the price to be paid by us for the leased equipment and specific performance against ACC.  On January 7, 2013 in a hearing relative to a temporary injunction previously granted by the Court, the Court took testimony and heard arguments from the parties on the matter and the Court and the parties agreed that a trial would be unnecessary.  Both parties submitted briefs regarding the law and summarizing the testimony elicited at the hearing.  The Court’s judgment rendered on February 25, 2013 vacated the parties’ joint appraisal and required that the parties jointly secure another appraisal for the equipment, the results of which will be binding on the parties.  We have paid $424,500 toward the purchase price of the equipment, which we believe satisfies our payment obligation, but pursuant to a restraining order we sought to prevent the lessor from contacting our customer as of March 26, 2013 we have escrowed an aggregate of $425,100 with the Court and have a current obligation to continue making monthly escrow payments in the amount of $141,700 pending a decision in the matter.
 
ITEM 1A.  RISK FACTORS
 
You should carefully consider the following risk factors and all other information contained in this report.  Our business and our securities involve a high degree of risk.
 
If we do not successfully commercialize our CodecSys technology, we may never achieve profitability, retire our convertible debt or be able to raise future capital.
 
It is imperative that we successfully commercialize our CodecSys technology. We continue to develop this technology for a variety of applications.  We have never been involved in a development project of the size and breadth that is involved with CodecSys and none of our management has ever been involved with a software development project.  Management may lack the expertise and we may not have the financial resources needed for successful development of this technology.  Furthermore, commercialization and future applications of the CodecSys technology are expected to require additional capital estimated to be approximately $2.0 million annually for the foreseeable future, although we have spent considerably more than that in past years.  This estimate will increase or decrease depending on specific opportunities and available funding.  If we are unsuccessful in our CodecSys development and commercialization efforts, it is highly doubtful we will achieve profitable operations, retire our existing convertible indebtedness or be able to raise additional funding in the future.
 
 
12
 
 
We may need additional capital.  If additional capital is required but is not available, we may have to curtail or cease operations.
 
If we are unable to generate net sales in excess of operating expenses, we will need to obtain additional financing to continue operations.  We believe external funding may be difficult to obtain, particularly given the prevailing financial market conditions.  If sufficient capital is not available to us, we will be required to pursue one or a combination of the following remedies:  significantly reduce development, commercialization or other operating expenses; sell part or all of our assets; or terminate operations.  The existing turbulence and illiquidity in the credit and financial markets are continuing challenges that have generally made potential funding sources more difficult to access, less reliable and more expensive.  These market conditions have made the management of our liquidity significantly more challenging.  A further deterioration in the credit and financial markets or a prolonged period without improvement could adversely affect our ability to raise additional capital.
 
We have sustained and may continue to sustain substantial losses.
 
We have sustained operating losses in each of the last seven years.  Through December 31, 2012, our accumulated deficit was $109,585,041.  We continue to sustain operating losses on a quarterly and annual basis and may continue to do so.
 
Our success depends on adoption of our CodecSys technology by OEMs and end-users.
 
The success of our CodecSys technology depends on the adoption of this technology by original equipment manufacturers, or OEMs, like IBM, Fujitsu and HP, as well as end-users.  The OEM qualification and adoption process is complex, time-consuming and unpredictable.  Furthermore, OEMs may elect to maintain their relationships with incumbent technology providers, even when presented with technology that may be superior to the incumbent technology.  Significant delays in the development or OEM adoption of CodecSys will adversely affect our results of operations, financial condition and prospects.
 
Our continued losses may impact our relationships with OEMs and customers.
 
Our continued losses may impact our relationships with existing and potential OEMs and customers.  OEMs may be reluctant to partner with us or present our technology in conjunction with their product offerings if they believe our financial condition is marginal or in jeopardy.  OEMs and prospective customers may delay adoption of our CodecSys technology and other products if they believe we are not financially sound enough to support our technology or other product offerings.
 
Adverse economic or other market conditions could reduce the purchase of our services by existing and prospective customers, which would harm our business.
 
Our business is impacted from time to time by changes in general economic, business and international conditions and other similar factors.  Adverse economic or other market conditions negatively affect the business spending of existing and prospective customers.  In adverse market times, our network and other services may not be deemed critical for these customers.  Therefore, our services are often viewed as discretionary and may be deferred or eliminated in times of limited business spending, thereby harming its business.
 
The recent recession and market turmoil present considerable risks and challenges.  These risks and challenges have reached unprecedented levels and have significantly diminished overall confidence in the national economy, upon which we are dependent.  Such factors could have an adverse impact on our business and prospects in ways that are not predictable or that we may fail to anticipate.
 
 
13
 
 
Our systems of internal operational and financial controls may not be effective.
 
We establish and maintain systems of internal operational and financial controls that provide us with critical information.  These systems are not foolproof, and are subject to various inherent limitations, including cost, judgments used in decision-making, assumptions about the likelihood of future events, the soundness of our systems, the possibility of human error, and the risk of fraud.  Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions and the risk that the degree of compliance with policies or procedures may deteriorate over time.  Because of these limitations, any system of internal controls or procedures may not be successful in preventing all errors or fraud or in making all material information known in a timely manner to the appropriate levels of management.  We have previously experienced significant deficiencies in our required disclosure controls and procedures regarding the updating of certain accounting pronouncements and the reporting of current information required to be filed with the SEC.  We also experienced a significant deficiency and a material weakness in our required disclosure controls and procedures regarding its accounting entries and financial statements, which resulted in the restatement of one accounting period.  Any future deficiency, weakness, malfunction or inadequacy related to internal operational or financial control systems or procedures could produce inaccurate and unreliable information that may harm our business.
 
We may be unable to respond adequately to rapid changes in technology.
 
The markets for private communication networks and video encoder systems are characterized by rapidly changing technology, evolving industry standards and frequent new product introductions.  The introduction of new technology and products and the emergence of new industry standards not only impacts our ability to compete, but could also render our products, services and CodecSys technology uncompetitive or obsolete.  If we are unable to adequately respond to changes in technology and standards, we will not be able to serve its clients effectively.  Moreover, the cost to modify our services, products or infrastructure in order to adapt to these changes could be substantial and we may not have the financial resources to fund these expenses.
 
We face intense competition that could harm our business.
 
The communications industry is extremely competitive.  We compete with numerous competitors who are much larger than we are and have greater financial and other resources.  In the satellite network and services segment, including digital signage, we compete with Convergent Media Systems, Globecast, IBM, Cisco, Hughes and others.  Our competitors have established distribution channels and significant marketing and sales resources.  Competition results in reduced operating margins for our business and may cause us to lose clients and/or prevent us from gaining new clients critical for our success.
 
There are several additional major market sectors in which we plan to compete with our CodecSys technology, all with active competitors.  These sectors include the basic codec technology market, the corporate enterprise network market and small business streaming media market.  These are sectors where we may compete by providing direct services.  Competition in these new market areas will also be characterized by intense competition with much larger and more powerful companies, such as Microsoft and Yahoo, which are already in the video compression and transmission business.  Many of these competitors already have established customer bases with industry standard technology, which we must overcome to be successful.
 
On a technology basis, CodecSys competition varies by market sector, with codecs and codec suppliers like Microsoft Windows Media Player, Real Networks’ Real Player, Apple QuickTime, MPEG2, MPEG4, On2, DivX and many others.  There are several companies, including Akamai, Inktomi, Activate and Loudeye, which utilize different codec systems.  These companies specialize in encoding, hosting and streaming content services primarily for news/entertainment clients with large consumer audiences.  All are larger and have greater financial resources than we have.  Tandberg/Erickson and Harmonic are two of the largest suppliers of high end video encoders to the broadcast industry and are the incumbent suppliers to many of the customers to which we are selling.
 
 
14
 
 
If we fail to hire additional specialized personnel or retain are key personnel in the future, we will not have the ability to successfully commercialize our technology or manage our business.
 
We still need to hire additional specialized personnel to successfully commercialize our CodecSys technology.  If we are unable to hire or retain qualified software engineers and project managers, our ability to complete further development and commercialization efforts will be significantly impaired.  Our success is also dependent upon the efforts and abilities of its management team.  If we lose the services of certain of our current management team members, we may not be able to find qualified replacements, which would harm the continuation and management of our business.
 
Our revenue is dependent upon the sales efforts of others.
 
We are dependent upon the sales and marketing efforts of IBM, HP, Fujitsu and other third-party businesses in order to derive licensing revenue from its CodecSys technology.  Such businesses may not continue their sales efforts which would adversely affect our potential licensing fees.  We are not able to control the sales and marketing efforts of these third parties.  Limited revenues from our historical sources make it even more dependent upon the sales efforts of others.  Given the current recession and market developments, third-party businesses may scale back on sales efforts which could significantly harm our business and prospects.
 
We rely heavily on a few significant customers and if we lose any of these significant customers, our business may be harmed.
 
A small number of customers account for a large percentage of our revenue.  Our business model relies upon generating new sales to existing and new customers.  In September 2009 Broadcast secured a contract with a large national organization, which has become its largest customer.  We have been informed by this largest customer, that our contract to provide digital signage services to this customer would be extended through May 31, 2013 and will then terminate.  We may continue to provide managed media services to the customer for a 3-year period, but in excess of 90% of our revenues from the customer are for the digital signage service. As a result of this termination, our revenues will decline substantially, which will harm our business, unless we can replace that customer with another similarly large customer or customers.
 
There is significant uncertainty regarding our patent and proprietary technology protection.
 
Our success is dependent upon its CodecSys technology and other intellectual property rights.  If we are unable to protect and enforce these intellectual property rights, competitors will have the ability to introduce competing products that are similar to ours.  If this were to occur, our revenues, market share and operating results would suffer.  To date, we have relied primarily on a combination of patent, copyright, trade secret, and trademark laws, and nondisclosure and other contractual restrictions on copying and distribution to protect its proprietary technology. Our initial U.S. patent related to our CodecSys technology was granted by the PTO in August 2007 and four additional patents related to applications of the technology were subsequently issued by the PTO.  As of December 31, 2012, eleven foreign countries had issued our initial patent.  In addition, we have 20 pending U.S. and foreign patent applications.  If we fail to deter misappropriation of its proprietary information or if we are unable to detect unauthorized use of its proprietary information, then our revenues, market share and operating results will suffer.  The laws of some countries may not protect our intellectual property rights to the same extent as do the laws of the United States.  Furthermore, litigation may be necessary to enforce our intellectual property rights, to protect trade secrets, to determine the validity and scope of the proprietary rights of others, or to defend against claims of infringement or invalidity.  This litigation could result in substantial costs and diversion of resources that would harm our business.
 
 
15
 
 
Our products could infringe on the intellectual property rights of others, which may subject us to future litigation and cause financial harm to its business.
 
To date, we have not been notified that our services, products and technology infringe the proprietary rights of third parties, but there is the risk that third parties may claim infringement by us with respect to current or future operations.  We expect software developers will increasingly be subject to infringement claims as the number of products and competitors in the industry segment grows and the functionality of products in different industry segments overlaps.  Any of these claims, with or without merit, could be time-consuming to defend, result in costly litigation, divert management’s attention and resources, cause product shipment delays, or require us to enter into royalty or licensing agreements.  These royalty or licensing agreements, if required, may not be available on terms acceptable to us.  A successful claim against us of infringement and failure or inability to license the infringed or similar technology on favorable terms would harm its business.
 
Our common stock is considered “penny stock” which may make selling the common stock difficult.
 
Our common stock is considered to be a “penny stock” under the definitions in Rules 15g-2 through 15g-6 promulgated under Section 15(g) of the Securities Exchange Act of 1934, as amended.  Under the rules, stock is considered “penny stock” if: (i) the stock trades at a price less than $5.00 per share; (ii) it is not traded on a “recognized” national exchange; (iii) it is not quoted on the Nasdaq Stock Market, or even if quoted, has a price less than $5.00 per share; or (iv) is issued by a company with net tangible assets less than $2.0 million, if in business more than a continuous three years, or with average revenues at less than $6.0 million for the past three years.  The principal result or effect of being designated a “penny stock” is that securities broker-dealers cannot recommend our stock but must trade it on an unsolicited basis.
 
Section 15(g) of the Exchange Act and Rule 15g-2 promulgated thereunder by the SEC require broker-dealers dealing in penny stocks to provide potential investors with a document disclosing the risks of penny stocks and to obtain a manually signed and dated written receipt of the document before effecting any transaction in a penny stock for the investor’s account.  Potential investors in Broadcast common stock are urged to obtain and read such disclosure carefully before purchasing any shares that are deemed to be “penny stocks.”  Moreover, Rule 15g-9 requires broker-dealers in penny stocks to approve the account of any investor for transactions in such stocks before selling any penny stock to that investor.  This procedure requires the broker-dealer to (i) obtain from the investor information concerning his or her financial situation, investment experience and investment objectives; (ii) reasonably determine, based on that information, that transactions in penny stocks are suitable for the investor and that the investor has sufficient knowledge and experience as to be reasonably capable of evaluating the risks of penny stock transactions; (iii) provide the investor with a written statement setting forth the basis on which the broker-dealer made the determination in (ii) above; and (iv) receive a signed and dated copy of such statement from the investor, confirming that it accurately reflects the investors financial situation, investment experience and investment objectives.  Compliance with these requirements may make it more difficult for holders of our common stock to resell their shares to third parties or to otherwise dispose of them in the market or otherwise.
 
Trading in our securities could be subject to extreme price fluctuations that could cause the value of your investment to decrease.
 
Our stock price has fluctuated significantly in the past and could continue to do so in the future.  Our stock is thinly-traded, which means investors will have limited opportunities to sell their shares of common stock in the open market.  Limited trading of our common stock also contributes to more volatile price fluctuations.  The market price of our common stock is also subject to extreme fluctuations because of the nature of the CodecSys technology and the potential for large-scale acceptance or rejection of our technology in the marketplace.  Given these fluctuations, an investment in our common stock could lose value.  A significant drop in our stock price could expose it to the risk of securities class action lawsuits.  Defending against such lawsuits could result in substantial costs and divert management’s attention and resources, thereby causing an investment in stock to lose additional value.
 
 
16
 
 
Future sales of our common stock could cause our stock price to decrease.
 
Substantial sales of our common stock in the public market, or the perception by the market that such sales could occur, could lower our stock price.  As of March 15, 2013, we had 107,932,373 shares of common stock outstanding.  As of March 15, 2013, stock options, including options granted to our employees, and warrants to purchase an aggregate of 44,246,863 shares of our common stock were issued and outstanding, a substantial portion of which were fully exercisable.  As of March 15, 2013, notes convertible into 17,900,000 shares of our common stock were issued and outstanding.  As of March 15, 2013, we had granted restricted stock units to members of our board of directors and others, which may be settled at various time in the future by the issuance of 3,368,247 shares of common stock.  In connection with  a proposed merger, we would be required to engage in an exchange offer with current warrant holders pursuant to which we expect to issue shares of our common stock in exchange for the termination and cancellation of most of our outstanding options and warrants (other than specified warrants) and all of our outstanding notes.  In addition, we expect to issue shares of our common stock to non-Broadcast stockholders of IDI in a subsidiary merger. The number of shares is not currently determined.  Following the closing of the exchange offers and the subsidiary merger, Broadcast will issue to the proposed merger partner’s stockholders in the merger additional shares of Broadcast common stock that will result in the proposed merger partner’s stockholders owning 54% of our outstanding common stock immediately following the merger (assuming the exercise or conversion of warrants, options and other derivative securities except for certain warrants).  Future sales of our common stock, or the availability of our common stock for sale, may cause the market price of our common stock to decline.
 
Any stock ownership interest may be substantially diluted by future issuances of securities.
 
We may issue shares of our common stock to holders of outstanding convertible notes, stock options and warrants.  The conversion of the convertible notes and the exercise of options and warrants into shares of our common stock will be dilutive to stockholders.  We also expect to continue to offer stock options to our employees and others, and as of March 15, 2013, we had approximately 3,779,508 shares of common stock available for future issuance under our 2004 long-term incentive stock option plan and 88,200 shares of common stock available for future issuance under our 2008 equity incentive plan.  Although we anticipate terminating our 2004 long-term incentive stock option plan and 2008 equity incentive plan in connection with the proposed merger, such that no future grants may be made thereunder, we would assume the merger partner’s stock plan in the merger and expect to grant options and other equity awards under that plan in the future. Following the closing of the exchange offers and the subsidiary merger, Broadcast will issue to merger partner’s stockholders in the merger additional shares of Broadcast common stock that will result in the merger partner’s stockholders owning 54% of our outstanding common stock immediately following the merger (assuming the exercise or conversion of warrants, options and other derivative securities except for certain warrants). To the extent that future stock options are granted and ultimately exercised, there will be further dilution to stockholders.
 
We have never paid dividends and do not anticipate paying any dividends on our common stock in the future, so any return on an investment in our common stock will depend on the market price of the stock.
 
We currently intend to retain any future earnings to finance its operations.  The terms and conditions of its convertible notes restrict and limit payments or distributions in respect of its common stock.  The return on any investment in our common stock will depend on the future market price of such common stock and not on any potential dividends.

Current and future legal proceedings against us could be costly and time consuming to defend.
 
From time to time we are subject to legal proceedings and claims that arise in the ordinary course of business, including claims brought by our customers in connection with commercial disputes, employment-based claims made by our current or former employees, administrative agencies, or government regulators. Litigation, enforcement actions, and other legal proceedings, regardless of their outcome, may result in substantial costs and may divert management’s attention and our resources, which may harm our business, overall financial condition and operating results. In addition, legal claims that have not yet been asserted against us may be asserted in the future.
 
 
17
 
 
On July 27, 2012, CTC Resources Inc. dba U.S. Media Capital (“CTC”) filed a lawsuit in the Third Judicial District Court in and for Salt Lake City, State of Utah against ACC Capital Corporation (“ACC”), Loni L. Lowder and the Company (the “CTCD Lawsuit”) asserting claims for relief for breach of contract against ACC, breach of fiduciary duty and fraud against ACC and Mr. Lowder and civil conspiracy against ACC, Mr. Lowder and the Company, and seeking injunctive relief and constructive trust as to all defendants as well as money damages.  On October 9, 2012, we filed our answer as well as a cross claim against ACC seeking declaratory relief as to the price to be paid by us for the leased equipment and specific performance against ACC.  On January 7, 2013 in a hearing relative to a temporary injunction previously granted by the Court, the Court took testimony and heard arguments from the parties on the matter and the Court and the parties agreed that a trial would be unnecessary.  Both parties submitted briefs regarding the law and summarizing the testimony elicited at the hearing.  The Court’s judgment rendered on February 25, 2013 vacated the parties’ joint appraisal and required that the parties jointly secure another appraisal for the equipment, the results of which appraisal will be binding on the parties.  We have paid $424,500 toward the purchase price of the equipment, which we believe satisfies our payment obligation, but pursuant to a restraining order we sought to prevent the lessor from contacting our customer, we have also escrowed an additional $425,100 with the Court and have a current obligation to continue making monthly escrow payments in the amount of $141,700 pending a decision in the matter.
 
 
ITEM 1B.  UNRESOLVED STAFF COMMENTS
 
None.
 
ITEM 2.  PROPERTIES
 
Our executive offices are located at 7050 Union Park Ave., Suite 600, Salt Lake City, Utah 84047.  We occupy the space at the executive offices under a thirty-nine month term lease, the term of which ends January 31, 2015.  The lease covers approximately 13,880 square feet of office space leased at a rate of $23,049 per month.  Our production studio is located at 6952 South 185 West, Unit C, Salt Lake City, Utah 84047, and consists of approximately 7,500 square feet of space leased under a month to month contract at a rate of $7,000 per month plus utilities.  We have no other properties.
 
ITEM 3.  LEGAL PROCEEDINGS
 
We are parties to legal matters. We are a judgment debtor in a lawsuit, the total amount in dispute in which is approximately $130,000.
 
On July 27, 2012, CTC Resources Inc. dba U.S. Media Capital (“CTC”) filed a lawsuit in the Third Judicial District Court in and for Salt Lake City, State of Utah against ACC Capital Corporation (“ACC”), Loni L. Lowder and the Company (the “CTCD Lawsuit”) asserting claims for relief for breach of contract against ACC, breach of fiduciary duty and fraud against ACC and Mr. Lowder and civil conspiracy against ACC, Mr. Lowder and the Company, and seeking injunctive relief and constructive trust as to all defendants as well as money damages.  On October 9, 2012, we filed our answer as well as a cross claim against ACC seeking declaratory relief as to the price to be paid by us for the leased equipment and specific performance against ACC.  On January 7, 2013 in a hearing relative to a temporary injunction previously granted by the Court, the Court took testimony and heard arguments from the parties on the matter and the Court and the parties agreed that a trial would be unnecessary.  Both parties submitted briefs regarding the law and summarizing the testimony elicited at the hearing.  The Court’s judgment rendered on February 25, 2013 vacated the parties’ joint appraisal and required that the parties jointly secure another appraisal for the equipment, the results of which appraisal will be binding on the parties.  We have paid $424,500 toward the purchase price of the equipment, which we believe satisfies our payment obligation, but pursuant to a restraining order we sought to prevent the lessor from contacting our customer, we have escrowed an additional $425,100 with the Court and have a current obligation to continue making monthly escrow payments in the amount of $141,700 pending a decision in the matter.  Because of the amounts paid and escrowed we have made no further reserves in our financial statements with respect to this litigation.
 
 
18
 
 
To the knowledge of management, no other litigation has been filed or, except for one collection matter, threatened.
 

 
ITEM 4.  MINE SAFETY DISCLOURES
 
Not Applicable.
 
PART II
 
ITEM 5.  MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS
 AND ISSUER PURCHASES OF EQUITY SECURITIES
 
Common Stock Price Range
 
Our common stock is currently traded on the OTC Bulletin Board under the symbol “BCST.”  The following table sets forth, for the periods indicated, the high and low bid quotations, as adjusted for stock splits of our common stock, as reported by the OTC Bulletin Board, and represents prices between dealers, does not include retail markups, markdowns or commissions, and may not represent actual transactions:
 
   
High Bid
    
Low Bid
  
2012
            
First Quarter
   $ .67     $ .31  
Second Quarter
     .50       .18  
Third Quarter
     .25       .10  
Fourth Quarter
     .20       .05  
                 
2011
                
First Quarter
   $ 1.27     $ .73  
Second Quarter
     .84       .51  
Third Quarter
     .58       .23  
Fourth Quarter
     .47       .13  

Holders
 
As of March 15, 2013, we had 107,932,373 shares of our common stock issued and outstanding, and there were approximately 1,400 shareholders of record.
 
Dividends
 
We have never paid or declared any cash dividends.  Future payment of dividends, if any, will be at the discretion of our board of directors and will depend, among other criteria, upon our earnings, capital requirements, and financial condition as well as other relative factors.  Management intends to retain any and all earnings to finance the development of our business, at least in the foreseeable future.  Such a policy is likely to be maintained as long as necessary to provide working capital for our operations.  Moreover, our outstanding convertible notes contain restrictive covenants that prohibit us from declaring or paying dividends.
 
 
19
 
 
Sales of Unregistered Securities
 
On February 21, 2013, we issued restricted stock units that may be settled by the issuance of 200,000 shares of our common stock to each of three of our directors and 86,667 shares to one of our directors for a total of 686,667 shares in consideration of unpaid director fees, which aggregated $51,500 or $.075 per share. The directors are accredited investors and were fully informed regarding their investments.  In the transaction, we relied on the exemption from registration under the Securities Act set forth in Section 4(2) thereof.
 
On February 21, 2013, we issued 200,000 shares of our common stock to one of our former directors in consideration of unpaid director fees, which aggregated $15,000 or $.075 per share. The former director is an accredited investor and was fully informed regarding his investment.  In the transaction, we relied on the exemption from registration under the Securities Act set forth in Section 4(2) thereof.
 
In December 2012 and January 2013, we issued two convertible promissory notes in the aggregate amount of $300,000 to one of our directors in consideration of the payment of $300,000.  The notes bear interest at the rate of 12% per annum. The notes are convertible at the rate of $.25 per share any time prior to their maturity dates, which is July 13, 2013.  In addition, we granted to the director warrants to acquire an additional 600,000 shares at an exercise price of $.25 per share.  The warrants expire five years from the date of issuance.  The director is an accredited investor and was fully informed regarding his investments.  In the transaction, we relied on the exemption from registration under the Securities Act set forth in Section 4(2) thereof.
 
In January 2013, we issued two convertible promissory notes in the principal amount of $375,000 to four individual investors in consideration of the payment of an aggregate amount $375,000.  The notes are convertible at the rate of $.25 per share or 1,500,000 shares any time prior to their maturity dates, which is July 13, 2013.  In addition, we granted to the investors warrants to acquire an additional 750,000 shares at an exercise price of $.25 per share.  The warrants expire five years from the date of issuance.  The investors are accredited investors and were fully informed regarding their investments.  In the transaction, we relied on the exemptions from registration under the Securities Act set forth in Section 4(2) thereof.
 
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
 
We had no purchases of equity securities by the issuer or affiliated purchasers during the fourth quarter of 2012.
 
ITEM 6.  SELECTED FINANCIAL DATA
 
Not applicable.
 
ITEM 7.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
 
The following discussion of our financial condition and results of operations should be read together with our consolidated financial statements and related notes that are included elsewhere in this report.  This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties.  Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under the caption “Risk Factors” or in other parts of this report.  See “Cautionary Note Regarding Forward-Looking Statements.”
 
Critical Accounting Policies
 
Management Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.
 
 
 
20
 
 
Cash and Cash Equivalents
 
We consider all cash on hand and in banks, and highly liquid investments with maturities of three months or less, to be cash equivalents. At December 31, 2012 and 2011, we had bank balances in the excess of amounts insured by the Federal Deposit Insurance Corporation. We have not experienced any losses in such accounts, and believe we are not exposed to any significant credit risk on cash and cash equivalents.
 
Current financial market conditions have had the effect of restricting liquidity of cash management investments and have increased the risk of even the most liquid investments and the viability of some financial institutions.  We do not believe, however, that these conditions will materially affect our business or our ability to meet our obligations or pursue our business plans.
 
Accounts Receivable
 
Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.
 
A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than 90 days. After the receivable becomes past due, it is on non-accrual status and accrual of interest is suspended.
 
Property and Equipment
 
Property and equipment are stated at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the property, generally from three to five years.  Repairs and maintenance costs are expensed as incurred except when such repairs significantly add to the useful life or productive capacity of the asset, in which case the repairs are capitalized.
 

Patents and Intangibles
 
Patents represent initial legal costs incurred to apply for United States and international patents on the CodecSys technology, and are amortized on a straight-line basis over their useful life of approximately 20 years.  We have filed patent applications in the United States and foreign countries. As of December 31, 2012, the U.S. Patent and Trademark Office or PTO had approved six patents and a seventh has been approved awaiting a patent number.  Additionally, eleven foreign countries had issued patents and we had 20 pending patent applications, including U.S. and foreign counterpart applications.  While we are unsure whether we can develop the technology in order to obtain the full benefits of the issued patents, the patents themselves hold value and could be sold to companies with more resources to complete the development. On-going legal expenses incurred for patent follow-up have been expensed from July 2005 forward and in 2011 Broadcast abandoned two foreign patent applications and incurred a charge of $26,180.
 
Long-Lived Assets
 
We review our long-lived assets, including patents, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets held and used is measured by a comparison of the carrying amount of an asset to future un-discounted net cash flows expected to be generated by the asset.  If such assets are considered to be impaired, then the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.  Fair value is determined by using cash flow analyses and other market valuations.
 
 
21
 
 
After our review at December 31, 2012, it was determined that no adjustment was required.
 
Stock-based Compensation
 
Stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.
 
Income Taxes
 
We account for income taxes in accordance with the asset and liability method of accounting for income taxes.  Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income in the years in which those temporary differences are expected to be recovered or settled.
 
Revenue Recognition
 
We recognize revenue when evidence exists that there is an arrangement between us and our customers, delivery of equipment sold or service has occurred, the selling price to our customers is fixed and determinable with required documentation, and collectability is reasonably assured. We recognize as deferred revenue, payments made in advance by customers for services not yet provided.
 
When we enter into a multi-year contract with a customer to provide installation, network management, satellite transponder and help desk, or combination of these services, we recognize this revenue as services are performed and as equipment is sold.  These agreements typically provide for additional fees, as needed, to be charged if on-site visits are required by the customer in order to ensure that each customer location is able to receive network communication. As these on-site visits are performed the associated revenue and cost are recognized in the period the work is completed. If we install, for an additional fee, new or replacement equipment to an immaterial number of new customer locations, and the equipment immediately becomes the property of the customer, the associated revenue and cost are recorded in the period in which the work is completed.

In instances where we have entered into license agreements with a third parties to use our technology within their product offering, we recognize any base or prepaid revenues over the term of the agreement and any per occurrence or periodic usage revenues in the period they are earned.

 
Research and Development
 
Research and development costs are expensed when incurred.  We expensed $1,754,163 in 2012 and $2,410,249 in 2011 of research and development costs.
 
Concentration of Credit Risk
 
Financial instruments, which potentially subject us to concentration of credit risk, consist primarily of trade accounts receivable. In the normal course of business, we provide credit terms to our customers. Accordingly, we perform ongoing credit evaluations of our customers and maintain allowances for possible losses which, when realized, have been within the range of management’s expectations.
 
 
22
 
 
In 2012 and 2011, we had one customer that individually constituted 85% and 89%, respectively of our total revenues, with no other single customer representing more than 5% of total revenues.  Our largest customer signed a three year contract which we began servicing in the second half of 2009, which expired in August 2012, but has been extended to May 31, 2013 after which time we will no longer provide any significant services for the customer.
 
Weighted Average Shares
 
Basic earnings per common share is computed by dividing net income or loss applicable to common shareholders by the weighted average number of shares outstanding during each period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year, plus the dilutive common stock equivalents that would rise from the exercise of stock options, warrants and restricted stock units outstanding during the period, using the treasury stock method and the average market price per share during the period, plus the effect of assuming conversion of the convertible debt. The computation of diluted earnings per share does not assume conversion or exercise of securities that would have an anti-dilutive effect on earnings.

Potentially dilutive securities representing 18,568,963 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2012, because their effect would have been anti-dilutive.

Options and warrants to purchase 20,442,170 shares of common stock and 950,000 restricted stock units were outstanding at December 31, 2011. As we experienced a net loss during the year ended December 31, 2011, no common stock equivalents were included in the diluted earnings per common share calculation as the effect of such common stock equivalents would be anti-dilutive.
 

Advertising Expenses
 
We follow the policy of charging the costs of advertising to expense as incurred.  Advertising expense for the years ended December 31, 2012 and 2011 were $35,168 and $68,703, respectively.
 
Off-Balance Sheet Arrangements
 
We have no off-balance sheet arrangements.
 
Executive Overview
 
The current recession and market conditions have had substantial impacts on the global and national economies and financial markets.  These factors, together with soft credit markets, have slowed business growth and generally made potential funding sources more difficult to access.  We continue to be affected by prevailing economic and market conditions, which present considerable risks and challenges to it.
 
Because we have not been successful in deploying our CodecSys technology with customers sufficient to achieve a breakeven and are finding it difficult to raise additional investment capital, we determined that we should seek an alternative to continuing to commercialize CodecSys by ourselves.  In that connection we sought a merger partner that has compatible video broadcasting products and services, with which we could integrate our CodecSys encoding system.  In that connection, on January 7, 2013, we entered into a Merger Agreement with All Digital, Inc., a Nevada corporation.  The merger is subject among other things to normal due diligence, approval of the shareholders of both companies, and the filing and effectiveness of a registration statement.  The registration statement requires year-end financial statements be included with the proxy statements furnished to the shareholders and will not be effective until at least the second quarter of 2013.  On February 8, 2013, All Digital notified us that we were in breach of certain covenants regarding unencumbered ownership or potential claims against our technology, which gave us 30 days to cure the alleged defects before the merger agreement could be terminated.  On March 8, 2013 All Digital notified us that sufficient progress had been made that the cure period was extended to April 8, 2013 for the remainder of the alleged defects to be cured or waived.
 
 
23
 
 
During 2009, we decreased certain of its development activities and expenses notwithstanding the need to refocus and develop its CodecSys technology on a different platform using a newly announced Intel operating chip.  Even with decreased engineering staff and certain related development employees, we were able to complete its video encoding system utilizing the Intel chip, prepare its CodecSys technology for installation on both the IBM and HP equipment platforms, and become certified by Microsoft as an approved software video encoding system for use by IPTV providers using Microsoft operating platforms.  On July 1, 2010, we released CodecSys 2.0, which has been installed in various large telecoms and labs for evaluation by potential customers. In 2011 we continued development of additional sales channel partners by integrating CodecSys on hardware manufactured and sold by Fujitsu, which has adopted CodecSys as its compression technology for use in its NuVolo cloud initiative and has commenced sales and marketing efforts including CodecSys as an integral part of the products.  We continue to make sales presentations and respond to requests for proposals at other large telecoms, cable companies and broadcasting companies.  These presentations have been made with our technology partners which are suppliers of hardware and software for video transmission applications in media room environments such as IBM, HP Fujitsu and Microsoft. In October 2011, we completed our first sale of CodecSys to a small cable operator in Mexico as part of its OTT product offering operating on Fujitsu hardware.  It is currently in operation and demonstrates that the CodecSys product offering does operate to its operating specifications in a working environment, which we believe will help in its sales and marketing efforts.    Although license revenue from the CodecSys technology has been minimal to date and none of our channel partners have sold any products incorporating CodecSys technology, we believe we have made significant progress and continue to believe that our CodecSys technology holds substantial revenue opportunities for our business.
 
On July 31, 2009, we entered into a $10.1 million, three-year contract with Bank of America, a Fortune 10 financial institution, to provide technology and digital signage services to approximately 2,100 of its more than 6,000 retail and administrative locations throughout North America. For the year ended December 31, 2012, we realized approximately $6,386,903 from this contract, which constituted approximately 85% of our revenues for the period.  For the year ended December 31, 2011, we realized approximately $7,540,025 in revenue from this contract, which contributed approximately 89% of our revenues for the year.  Because the customer has not selected us as its vendor after the contract expires in May 2013, our revenues will be substantially less after the contract terminates unless we can secure contracts which can replace the revenue lost from its largest customer.
 
Our revenues for the year ended December 31, 2012 decreased by approximately $922,458 compared to the year ended December 31, 2011. Even with the decrease in our revenues, we realized an increase of approximately $126,519 in our gross margin for the year ended December 31, 2012 compared to the same period in 2011, but we continued to deplete our available cash and increased our need for future equity and debt financing because we continue to spend more money than we generate from operations. See Note 3 of the Notes to Consolidated Financial Statements appearing elsewhere herein.
 
To fund operations, we engaged our investment banker to raise funds through the issuance of convertible promissory notes.  We anticipate issuing promissory notes with a principal amount of up to $5,000,000 (“2012 Convertible Debt Offering”) due and payable on or before July 13, 2013.  As of December 31, 2012, we had issued notes with an aggregate principal value of $3,050,000 as explained below.  The notes bear interest at 12% per annum and may be convertible to common stock at a $.25 per share conversion price.  We also granted holders of the notes warrants with a five year life to acquire up to 200,000 shares of our common stock for each $100,000 of principal amount of the convertible notes.  The notes are secured by all of our assets with the exception of the equipment and receivables secured by the equipment lessor for equipment used in providing services for our largest customer’s digital signage network.  On July 13, 2012, we entered into a note and warrant purchase and security agreement with individual investors and broke escrow on the initial funding under the 2012 Convertible Debt Offering, the principal amount of which was $1,900,000, which included the conversion of $900,000 of previously issued short term debt (See Bridge Loan described below) to the 2012 Convertible Debt Offering, which extinguished the Bridge Loan.  We realized $923,175 of cash in the initial closing, issued warrants to acquire 3,800,000 shares of our common stock and paid $76,825 in investment banking fees and costs of the offering.  We have continued sales of convertible debt under the 2012 Convertible Debt Offering and as of January 31, 2013 have issued additional short term debt with a principal amount of $1,225,000, from which we realized cash of $1,176,624 after payment of investment banking fees of $48,376.  We have, however, paid no investment banking fees on sales of our 2012 Convertible Debt Offering since August 2012 and do not anticipate paying additional investment banking fees for the 2012 Convertible Debt Offering. We have issued warrants to acquire an additional 2,450,000 shares of our common stock.
 
 
24
 
 
On March 16, 2012, we closed on an equity financing (the “2012 Equity Financing”) as well as a restructuring of our outstanding senior convertible indebtedness (the “2012 Debt Restructuring”) resulting in complete satisfaction our senior indebtedness.

We entered in to an Engagement Agreement, dated October 28, 2011, with MDB Capital Group, LLC(“MDB”), pursuant to which MDB agreed to act as our exclusive agent on a “best efforts” basis with respect to the sale of up to a maximum gross consideration of $6,000,000, subsequently verbally increased to $10,000,000, of our securities, subject to a minimum gross consideration of $3,000,000.  We agreed to pay to MDB a commission of 10% of the gross offering proceeds received by us, to grant to MDB warrants to acquire up to 10% of the shares of our common stock issued in the financing, and to pay the reasonable costs and expenses of MDB related to the offering.
 
Pursuant to the Engagement Agreement, we entered into a Securities Purchase Agreement (“SPA”) dated March 13, 2012 with select institutional and other accredited investors for the private placement of 27,800,000 units of our securities.  The SPA included a purchase price of $0.25 per unit, with each unit consisting of one share of common stock and two forms of Warrant: (1) The “A” Warrant grants the investors the right to purchase an additional share of common stock for each two shares of common stock purchased, for a term of six years and at an exercise price of $.35 per share; and (2) The “B” Warrant, which has now been extinguished as described below, would not have been exercisable unless and until the occurrence of a future issuance of stock at less than $0.25 per share, but, in the event of such issuance, granted the investors the right to acquire additional shares at a price of $0.05 to reduce the impact of the dilution caused by such issuance, but in no event were the number of shares to be issued under the B Warrant to cause us to exceed the number of authorized shares of our common stock.  A majority of the holders of the B Warrants agreed in December 2012 to amend the terms of the B Warrant to reduce the amount of subsequent financing required to extinguish the B Warrants.
    
Proceeds from the 2012 Equity Financing, before deducting the commissions and the legal, printing and other costs and expenses related to the financing, were approximately $6,950,000.  Coincident to the closing of the 2012 Equity Financing, we also closed on the 2012 Debt Restructuring.  In connection therewith, we paid $2.75 million to Castlerigg Master Investment Ltd. (“Castlerigg”), and issued to Castlerigg 2,000,000 shares of common stock valued at $760,000 in full and complete satisfaction of the $5.5 million senior convertible note and all accrued interest then owing.  In accepting the cash and stock tendered, Castlerigg forgave $2,670,712, which included $680,816 in accrued but unpaid interest. In consideration of negotiating the 2012 Debt Restructuring, we paid to one of our placement agents compensation equal to 10% of the savings realized through the 2012 Debt Restructuring, which consisted of paying cash of $275,041 and issuing 586,164 shares of Broadcast common stock valued at $222,742. As a result of the forgoing we recognized a gain on settlement of debt of $2,173,032.
 
 
25
 
 
In December 2011, we entered into a loan with 7 accredited individuals and entities under the terms of which we borrowed $1,300,000 to be used as working capital (“Bridge Loan”).  The Bridge Loan bears an interest rate of 18% per annum and had a maturity date of February 28, 2012, which was subsequently extended to the earlier of the date nine months from the original maturity date or the date we closed on an additional sale of its securities that resulted in gross proceeds to us of $12 million.  In consideration of the Bridge Loan, we granted to lenders of the Bridge Loan warrants with a five year term to purchase 357,500 shares of our common stock at an exercise price of $0.65 per share.  In consideration of the extension of the maturity date of the Bridge Loan, we granted the lenders Bridge Loan warrants with a six year term to purchase 247,500 shares of our common stock at an exercise price of $.35 per share.
 
In connection with the 2012 Equity Financing and under the terms of the SPA, two of the above described bridge lenders converted the principal balance of their portion of the bridge loan in the amount of $400,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing.  In addition, one other entity converted the amount owed by us for equipment purchases in the amount of $500,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing. The proceeds from these conversions were treated as funds raised with respect to the financing.
 
In connection with the 2012 Equity Financing and under the terms of the SPA, we agreed to prepare and file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying certain warrants.  We filed as required and the registration statement was declared effective within 120 days following the date of the filing of the registration statement, with the result that we were not obligated to pay any penalties in connection with the registration statement.

During 2010 Broadcast sold 1,601,666 shares of its common stock to 19 separate investors at a purchase price of $1.00 per share together with a warrant to purchase additional shares of our common stock for $1.50 per share. The warrant expires at the end of three years. The net proceeds from the sale of these shares were used for general working capital purposes. Each of the investors was given the right to adjust their purchase in the event we sold additional equity at a price and on terms different from the terms on which their equity was purchased.  Upon completion of the 2010 Equity Financing described below, each of the investors converted their purchase to the terms contained in the 2010 Equity Financing.  This resulted in the issuance of an additional 2,083,374 shares of common stock and the cancellation of 2,495,075 warrants with an exercise price of $1.50 and the issuance of 2,079,222 warrants with an exercise price of $1.00 and an expiration date of five years from the conversion.
 
On December 24, 2010, we closed on an equity financing (the “2010 Equity Financing”) as well as a restructuring of its outstanding convertible indebtedness (the “2010 Debt Restructuring”).  The 2010 Equity Financing and the 2010 Debt Restructuring are described as follows.
 
We entered into a Placement Agency Agreement, dated December 17, 2010, with Philadelphia Brokerage Corporation (“PBC”), pursuant to which PBC agreed to act as our exclusive agent on a “best efforts” basis with respect to the sale of up to a maximum gross consideration of $15,000,000 of units of our securities, subject to a minimum gross consideration of $10,000,000.  The Units consisted of two shares of our common stock and one warrant to purchase a share of our common stock. We agreed to pay PBC a commission of 8% of the gross offering proceeds received by us, to issue PBC 40,000 shares of our common stock for each $1,000,000 raised, and to pay the reasonable costs and expenses of PBC related to the offering. We also agreed to pay PBC a restructuring fee in the amount of approximately $180,000 upon the closing of the 2010 Equity Financing and the simultaneous 2010 Debt Restructuring.
 
Pursuant to the Placement Agency Agreement, we entered into Subscription Agreements dated December 23, 2010 with select institutional and other accredited investors for the private placement of 12,500,000 units of its securities.  The Subscription Agreements included a purchase price of $1.20 per unit, with each unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock.  The warrants have a term of five years and an exercise price of $1.00 per share.
 
Net proceeds from the 2010 Equity Financing, after deducting the commissions and debt restructuring fees payable to PBC and the estimated legal, printing and other costs and expenses related to the financing, were approximately $13.5 million.  We used a portion of the net proceeds of the 2010 Equity Financing to pay down debt and the remainder was used for working capital.
 
 
26
 
 
On November 29, 2010, we entered into a bridge loan transaction with three accredited investors pursuant to which we issued unsecured notes in the aggregate principal amount of $1.0 million.  Upon the closing of the 2010 Equity Financing, the lenders converted the entire principal amount plus accrued interest into the same units offered in the 2010 Equity Financing and the proceeds from the bridge loan transaction were treated as funds raised with respect to the financing.
 
In connection with the 2010 Equity Financing and under the terms of the Subscription Agreements, we agreed to prepare and file and did file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the certain of the warrants.  The registration statement continues to be effective.
 
On December 24, 2010, we also closed on the 2010 Debt Restructuring.  In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the “Amended and Restated Note”) to Castlerigg Master Investment Ltd. (“Castlerigg”), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents were issued (the “Loan Restructuring Agreement”), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.
 
The Amended and Restated Note, dated December 23, 2010, was a senior, unsecured note that matured in three years from the closing and bore interest at an annual rate of 6.25%, payable semi-annually.  Broadcast paid the first year’s interest of approximately $344,000 at the closing.
 
In connection with the 2010 Debt Restructuring, we amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013.  We also issued 150,000 shares to the holder of this note and a warrant to acquire up to 75,000 shares of our common stock as consideration to extend the term of the note. The warrant is exercisable for $0.90 per share and has a five year life.
 
Results of Operations for the Years Ended December 31, 2012 and December 31, 2011
 
Net Sales
 
We realized net sales of $7,523,624 for the year ended December 31, 2012 compared to net sales of $8,446,082 for the year ended December 31, 2011 which represents a decrease of approximately 11% for the year.  The net decrease in revenues of $922,458 was primarily the result of a decrease of $1,588,227 in system sales and installation revenue, of which $1,514,456 was a decrease in system sales and installation revenue for our largest digital signage network customer, which was partially offset by an increase in license fee revenue of $396,847, principally from our largest customer, and an increase in streaming revenue of $142,388 made up of many smaller customers.
 
 
27
 
 
Cost of Sales
 
The cost of revenues for the year ended December 31, 2012 aggregated $4,819,624 as compared to the cost of sales of $5,868,601 for the year ended December 31, 2011, which represents a decrease in cost of sales of 18%.  The decrease in cost of sales of $1,048,977 was primarily a result of our decreased activity in sales and installation of new digital signage locations for our largest customer.  Costs of sales related to installation activity decreased by $599,285 and costs of employee expenses related to the decreased activity decreased by $111,110.  In addition, our depreciation expense decreased by $332,071, which resulted from the digital signage equipment used for our largest customer being fully depreciated.
 
Operating Expenses
 
We incurred total operating expenses of $8,767,686 for the year ended December 31, 2012 compared to total operating expenses of $10,572,042 for the year ended December 31, 2011.  The decrease of $1,804,356 was primarily due to a decrease in general and administrative expenses of $1,626,182, a decrease of $656,086 in our development expenses and a decrease of $127,043 in depreciation expense.  These decreases were partially offset by an increase of $631,134 sales and marketing expenses.
 
Our general and administrative expenses decreased $1,626,182 from $6,172,794 for the year ended December 31, 2011 to $4,546,612 for the year ended December 31, 2012.  The decrease of $1,857,908 in option and warrant expense accounted for the largest single decrease in expenses due to fewer options being granted consultants, employees and directors. In addition, directors’ fees decreased by $59,500.  These decreases were partially offset by increased expenses for legal services of $144,311, temporary help of $129,661, and consulting fees of $69,683.
 
Our research and development expenses decreased by $656,086 primarily due to a decrease in outside consulting expenses of $340,469, a decrease of $171,626 in travel and tradeshow expenses, a decrease of $117,196 for temporary help, and a decrease of $120,939 in for expenses related to the issuance of options and warrants.  These decreases were partially offset by an increase of $91,363 in licenses, permits and fees and an increase of $90,965 for expenses incurred for addition consulting services.
 
Our sales and marketing expenses for the year ended December 31, 2012 were $1,908,763 compared to sales and marketing expenses of $1,277,629 for the year ended December 31, 2011.  The increase of $631,134 is due primarily to an increase of $319,126 in employee and related expenses, an increase of $166,962 in advertising, promotion and tradeshow expenses, and an increase of $176,100 in other professional services.
 
Interest Expense
 
We recorded an increase in interest expense of $542,352 from interest of $1,000,072 in 2011 to $1,542,424 in 2012. The increase in interest expense resulted primarily from issuance of secured convertible promissory notes during 2012 year of approximately $3,050,000, for which we expensed a total of $650,393, which included accretion of the notes for accounting purposes.  Of the total amount of interest expense incurred in 2012, $1,047,030 was for non cash expenses related to accretion on our unsecured convertible note that was extended in December 2010 to December 31, 2013 and for the secured convertible notes issued in 2012 and other related expenses incident to the notes.
 
Net Income
 
We had net income of $1,602,824 for the year ended December 31, 2012 compared to net income of $1,304,446 for the year ended December 31, 2011.  The increase in net income of $298,378  resulted primarily from recording a gain on extinguishment of debt of our 6.25% Senior Secured Notes of $2,173,033 together with a decrease in our loss from operations of $1,930,876 , all of which was partially offset by a decrease of $2,894,652 in the amount of derivative valuation gain recorded related to our convertible notes and investor warrants, an increase in expense of $619,075 related to issuance of warrants issued during the year and the increase of $542,352 in interest expense as discussed above.
 
 
28
 
 
Contractual Obligations
 
The following table summarizes our contractual obligations as of December 31, 2012:
 
   
Payments Due
  
   
Within
 One
Year
    
One Year to
Three
Years
    
Three
Years
to
 Five
Years
    
After Five
Years
    
Total
  
                               
Long-term debt obligations
   $ --     $ --     $ --     $ --     $ --  
Capital lease obligations
     --       --       --       --       --  
Operating lease obligations
     284,447       301,600       --       --       586,047  
Purchase obligations
     --       --       --       --       --  
Other obligations
     4,050,000       --       --       --       4,050,000  
Total contractual obligations
   $ 4,334,447     $ 301,600     $ --     $ --     $ 4,636,047  
 
Liquidity and Capital Resources
 
At December 31, 2012, we had cash of $394,342, total current assets of $1,753,013, total current liabilities of $7,306,376 and total stockholders' deficit of $4,616,860.  Included in current liabilities is $1,191,269 of liability related to the value of the embedded derivatives for convertible notes and investor warrants and $3,102,006 related to the current portion of notes payable and other debt obligations.
 
Broadcast experienced negative cash flow used in operations during the year of $3,362,785 compared to negative cash flow used in operations for the year ended December 31, 2011 of $5,164,437. Our current monthly excess of cash expenses over income is approximately $300,000 per month. During  2012 the decreased in negative cash flow was realized primarily through a reduction in the number of employees by approximately 40%, with more reductions scheduled, as well as additional  expense reduction actions including reducing sales and general and administrative expenses.  In addition, we have commenced an initiative designed to satisfy accounts payable through the issuance of common stock, which will further decrease our need for cash.  We have to date received verbal and/or written commitments to accept partial payments and/or stock in full satisfaction of at least $600,000 of current payables and indebtedness.

The negative cash flow was met by cash reserves from the completion of the 2012 Equity Financing and the issuance of the 2012 Convertible Debt in the total amount of $3,050,000, which included $900,000 of Bridge Loan indebtedness that was converted to the 2012 Convertible Debt. In addition, we received $400,000 in January, 2013. We have commitments from current debt holders to fund up to an additional $1.550 million of our 2012 Convertible debt to offset future negative cash flow.  We expect to continue to experience negative operating cash flow as long as we continue our current expenditures related primarily to bringing CodecSys products to market, continue our development of CodecSys or until we begin to receive licensing revenue from sales of CodecSys proprietary software or increase sales in our network division by adding new customers. We are actively pursuing potential customers to replace lost revenues when the BofA contract expires.
 
 
29
 
 
The current recession and market conditions have had substantial impacts on the global and national economies and financial markets.  These factors, together with soft credit markets, have slowed business growth and generally made potential funding sources more difficult to access.  We continue to be affected by prevailing economic and market conditions, which present considerable risks and challenges to it.
  
Because we have not been successful in deploying our CodecSys technology with customers sufficient to achieve a breakeven and are finding it difficult to raise additional investment capital, we determined that we should seek an alternative to continuing to commercialize CodecSys by ourselves.  In that connection we sought a merger partner that has compatible video broadcasting products and services, with which we could integrate our CodecSys encoding system.  In that connection, in January 2013 we entered into a Merger Agreement with All Digital, Inc., a Nevada corporation.  The merger is subject among other things to normal due diligence, approval of the shareholders of both companies, and the filing and effectiveness of a registration statement.  The registration statement requires year-end financial statements be included with the proxy statements furnished to the shareholders and will not be effective until at least the second quarter of 2013.  On February 8, 2013, All Digital notified us that we were in breach of certain covenants regarding unencumbered ownership or potential claims against our technology, which gave us 30 days to cure the alleged defects before the merger agreement could be terminated.  On March 8, 2013 All Digital notified us that sufficient progress had been made that the cure period was extended to April 8, 2013 for the remainder of the alleged defects to be cured or waived.
 
To fund operations, we engaged our investment banker to raise funds through the issuance of convertible promissory notes.  We anticipate issuing promissory notes with a principal amount of up to $5,000,000 (“2012 Convertible Debt Offering”) due and payable on or before July 13, 2013.  As of December 31, 2012, we had issued notes with an aggregate principal value of $3,050,000 as explained below.  The notes bear interest at 12% per annum and may be convertible to common stock at a $.25 per share conversion price.  We also granted holders of the notes warrants with a five year life to acquire up to 200,000 shares of our common stock for each $100,000 of principal amount of the convertible notes.  The notes are secured by all of our assets with the exception of the equipment and receivables secured by the equipment lessor for equipment used in providing services for our largest customer’s digital signage network.  On July 13, 2012, we entered into a note and warrant purchase and security agreement with individual investors and broke escrow on the initial funding under the 2012 Convertible Debt Offering, the principal amount of which was $1,900,000, which included the conversion of $900,000 of previously issued short term debt (See Bridge Loan described below) to the 2012 Convertible Debt Offering, which extinguished the Bridge Loan.  We realized $923,175 of cash in the initial closing, issued warrants to acquire 3,800,000 shares of our common stock and paid $76,825 in investment banking fees and costs of the offering.  We have continued sales of convertible debt under the 2012 Convertible Debt Offering and as of January 31, 2013 have issued additional short term debt with a principal amount of $1,575,000, from which we realized cash of $1,526,624 after payment of investment banking fees of $48,376.  We have, however, paid no investment banking fees on sales of our 2012 Convertible Debt Offering since August 2012 and do not anticipate paying additional investment banking fees for the 2012 Convertible Debt Offering. We have issued warrants to acquire an additional 3,150,000 shares of our common stock.
 
On March 16, 2012, we closed on an equity financing (the “2012 Equity Financing”) as well as a restructuring of our outstanding senior convertible indebtedness (the “2012 Debt Restructuring”) resulting in complete satisfaction our senior indebtedness.

We entered in to an Engagement Agreement, dated October 28, 2011, with MDB Capital Group, LLC(“MDB”), pursuant to which MDB agreed to act as our exclusive agent on a “best efforts” basis with respect to the sale of up to a maximum gross consideration of $6,000,000, subsequently verbally increased to $10,000,000, of our securities, subject to a minimum gross consideration of $3,000,000.  We agreed to pay to MDB a commission of 10% of the gross offering proceeds received by us, to grant to MDB warrants to acquire up to 10% of the shares of ours common stock issued in the financing, and to pay the reasonable costs and expenses of MDB related to the offering.
 
Pursuant to the Engagement Agreement, we entered into a Securities Purchase Agreement (“SPA”) dated March 13, 2012 with select institutional and other accredited investors for the private placement of 27,800,000 units of its securities.  The SPA included a purchase price of $0.25 per unit, with each unit consisting of one share of common stock and two forms of Warrant: (1) The “A” Warrant grants the investors the right to purchase an additional share of common stock for each two shares of common stock purchased, for a term of six years and at an exercise price of $.35 per share; and (2) The “B” Warrant, which has now been extinguished as described below, would not have been exercisable unless and until the occurrence of a future issuance of stock at less than $0.25 per share, but, in the event of such issuance, granted the investors the right to acquire additional shares at a price of $0.05 to reduce the impact of the dilution caused by such issuance, but in no event were the number of shares to be issued under the B Warrant to cause us to exceed the number of authorized shares of our common stock.  The holders of the B Warrants agreed in December 2012 to amend the terms of the B Warrant to reduce the amount of subsequent financing required to extinguish the B Warrants with the result that the B Warrants have now been extinguished.
 
 
30
 
 
Proceeds from the 2012 Equity Financing, before deducting the commissions and the legal, printing and other costs and expenses related to the financing, were approximately $6,950,000.  Coincident to the closing of the 2012 Equity Financing, we also closed on the 2012 Debt Restructuring.  In connection therewith, we paid $2.75 million to Castlerigg Master Investment Ltd. (“Castlerigg”), and issued to Castlerigg 2,000,000 shares of common stock valued at $760,000 in full and complete satisfaction of the $5.5 million senior convertible note and all accrued interest then owing.  In accepting the cash and stock tendered, Castlerigg forgave $2,670,712, which included $680,816 in accrued but unpaid interest. In consideration of negotiating the 2012 Debt Restructuring, we paid to one of our placement agents compensation equal to 10% of the savings realized through the 2012 Debt Restructuring, which consisted of paying cash of $275,041 and issuing 586,164 shares of Broadcast common stock valued at $222,742. As a result of the forgoing we recognized a gain on settlement of debt of $2,173,032.

In December 2011, we entered into a loan with 7 accredited individuals and entities under the terms of which we borrowed $1,300,000 to be used as working capital (“Bridge Loan”).  The Bridge Loan bears an interest rate of 18% per annum and had a maturity date of February 28, 2012, which was subsequently extended to the earlier of the date nine months from the original maturity date or the date we closed on an additional sale of its securities that resulted in gross proceeds to us of $12 million.  In consideration of the Bridge Loan, we granted to lenders of the Bridge Loan warrants with a five year term to purchase 357,500 shares of our common stock at an exercise price of $0.65 per share.  In consideration of the extension of the maturity date of the Bridge Loan, we granted the lenders Bridge Loan warrants with a six year term to purchase 247,500 shares of our common stock at an exercise price of $.35 per share.
 
In connection with the 2012 Equity Financing and under the terms of the SPA, two of the above described bridge lenders converted the principal balance of their portion of the bridge loan in the amount of $400,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing.  In addition, one other entity converted the amount owed by us for equipment purchases in the amount of $500,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing. The proceeds from these conversions were treated as funds raised with respect to the financing.
 
During 2010 we sold 1,601,666 shares of its common stock to 19 separate investors at a purchase price of $1.00 per share together with a warrant to purchase additional shares of our common stock for $1.50 per share. The warrant expires at the end of three years. The net proceeds from the sale of these shares were used for general working capital purposes. Each of the investors was given the right to adjust their purchase in the event we sold additional equity at a price and on terms different from the terms on which their equity was purchased.  Upon completion of the 2010 Equity Financing described below, each of the investors converted their purchase to the terms contained in the 2010 Equity Financing.  This resulted in the issuance of an additional 2,083,374 shares of common stock and the cancellation of 2,495,075 warrants with an exercise price of $1.50 and the issuance of 2,079,222 warrants with an exercise price of $1.00 and an expiration date of five years from the conversion.
 
On December 24, 2010, we closed on an equity financing (the “2010 Equity Financing”) as well as a restructuring of its outstanding convertible indebtedness (the “2010 Debt Restructuring”).  The 2010 Equity Financing and the 2010 Debt Restructuring are described as follows.
 
We entered into a Placement Agency Agreement, dated December 17, 2010, with Philadelphia Brokerage Corporation (“PBC”), pursuant to which PBC agreed to act as our exclusive agent on a “best efforts” basis with respect to the sale of up to a maximum gross consideration of $15,000,000 of units of our securities, subject to a minimum gross consideration of $10,000,000.  The Units consisted of two shares of our common stock and one warrant to purchase a share of our common stock. We agreed to pay PBC a commission of 8% of the gross offering proceeds received by us, to issue PBC 40,000 shares of our common stock for each $1,000,000 raised, and to pay the reasonable costs and expenses of PBC related to the offering. We also agreed to pay PBC a restructuring fee in the amount of approximately $180,000 upon the closing of the 2010 Equity Financing and the simultaneous 2010 Debt Restructuring.
 
 
31
 
 
Pursuant to the Placement Agency Agreement, we entered into Subscription Agreements dated December 23, 2010 with select institutional and other accredited investors for the private placement of 12,500,000 units of its securities.  The Subscription Agreements included a purchase price of $1.20 per unit, with each unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock.  The warrants have a term of five years and an exercise price of $1.00 per share.
 
Net proceeds from the 2010 Equity Financing, after deducting the commissions and debt restructuring fees payable to PBC and the estimated legal, printing and other costs and expenses related to the financing, were approximately $13.5 million.  We used a portion of the net proceeds of the 2010 Equity Financing to pay down debt and the remainder was used for working capital.
 
On November 29, 2010, we entered into a bridge loan transaction with three accredited investors pursuant to which we issued unsecured notes in the aggregate principal amount of $1.0 million.  Upon the closing of the 2010 Equity Financing, the lenders converted the entire principal amount plus accrued interest into the same units offered in the 2010 Equity Financing and the proceeds from the bridge loan transaction were treated as funds raised with respect to the financing.
 
On December 24, 2010, we also closed on the 2010 Debt Restructuring.  In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the “Amended and Restated Note”) to Castlerigg Master Investment Ltd. (“Castlerigg”), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents were issued (the “Loan Restructuring Agreement”), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.
 
The Amended and Restated Note, dated December 23, 2010, was a senior, unsecured note that matured in three years from the closing and bore interest at an annual rate of 6.25%, payable semi-annually.  Broadcast paid the first year’s interest of approximately $344,000 at the closing.
 
In connection with the 2010 Debt Restructuring, we amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013.  We also issued 150,000 shares to the holder of this note and a warrant to acquire up to 75,000 shares of our common stock as consideration to extend the term of the note. The warrant is exercisable for $0.90 per share and has a five year life.
 
During 2010, we entered into two Accounts Receivable Purchase Agreements with one individual for an aggregate amount of $775,000. In these agreements, we pledged certain outstanding accounts receivable in exchange for an advance payment and a commitment to remit to the purchaser the amount advanced upon collection from Broadcast’s customer.  Terms of the first agreement under which we were advanced $275,000 include a 3% discount with a 3% interest fee for every 30 days the advances remain outstanding.  Terms of the second agreement under which we were advanced $500,000 include a 10% discount with a 0.5% interest fee for every 30 days the advances remain outstanding.
 
During 2010, we entered into a $500,000 line of credit for equipment financing to purchase equipment for our largest customer’s digital signage network.  The terms of the line of credit include a 3% interest fee for every 30 days the advances on the line of credit remain outstanding.  We received total advances on the line of credit of $500,000 and subsequent to the completion of the Equity Financing repaid the line of credit.  We used the proceeds to purchase and install the equipment at our customer’s locations.
 
 
32
 
 
In August 2009, we entered into a sale and leaseback agreement which financed the purchase and installation of equipment to retrofit our new customer’s approximately 2,100 retail sites with our digital signage product offering.  We received approximately $4,100,000 from the sale of the equipment in exchange for making lease payments over a 36 month period of approximately $144,000 per month.
 
On December 24, 2007, we entered into a securities purchase agreement in connection with its senior secured convertible note financing in which it raised $15,000,000 (less $937,000 of prepaid interest).  We used the proceeds from this financing to support its CodecSys commercialization and development and for general working capital purposes.  The senior secured convertible note has been retired as described above.  During 2010, we capitalized interest of $1,491,161 related to the senior secured convertible note.
 
On November 2, 2006, we closed on a convertible note securities agreement dated October 28, 2006 with an individual that provided we issue to the convertible note holder (i) an unsecured convertible note in the principal amount of $1,000,000 representing the funding received by us from an affiliate of the convertible note holder on September 29, 2006, and (ii) four classes of warrants (A warrants, B warrants, C warrants and D warrants) which gave the convertible note holder the right to purchase a total of 5,500,000 shares of our common stock.  The holder of the note no longer has any warrants to purchase any of our stock.  The unsecured convertible note was due October 16, 2009 and was extended to December 22, 2010 and the annual interest rate was increased to 8%, payable semi-annually in cash or in shares of our common stock if certain conditions are satisfied  The unsecured convertible note was convertible into shares of common stock originally at a conversion price of $1.50 per share, convertible any time during the term of the note, and is subject to standard anti-dilution rights, pursuant to which the note is now convertible at a conversion price of $.25 per share.  The term of the convertible note has been extended and now is due December 31, 2013.  In connection with the extension of the note, Broadcast issued to the holder of the note 150,000 shares of common stock and a five year warrant to acquire up to 75,000 shares of our common stock at an exercise price of $.90 per share to extend the term of the note.  In addition, we committed to pay accrued interest due on the convertible note through the issuance of common stock and warrants on the same terms as the Equity Financing.
 
The conversion feature and the prepayment provision of our $5.5 million Amended and Restated Note and its $1.0 million unsecured convertible note have been accounted for as embedded derivatives and valued on the respective transaction dates using a Black-Scholes pricing model.  The warrants related to the $1.0 million unsecured convertible notes have been accounted for as derivatives and were valued on the respective transaction dates using a Black-Scholes pricing model as well.  At the end of each quarterly reporting date, the values of the embedded derivatives and the warrants are evaluated and adjusted to current market value.  The conversion features of the convertible notes and the warrants may be exercised at any time and, therefore, have been reported as current liabilities.  Prepayment provisions contained in the convertible notes limit Broadcast’s ability to prepay the notes in certain circumstances.  For all periods since the issuance of the senior secured convertible note and the unsecured convertible note, the derivative values of the respective prepayment provisions have been nominal and have not had any offsetting effect on the valuation of the conversion features of the notes.  For a description of the accounting treatment of the senior secured convertible note financing, see Note 7 to the Notes to Condensed Consolidated Financial Statements (Unaudited) included elsewhere herein.
 
On March 21, 2011, we converted $784,292 of our short-term debt into equity through the issuance of common stock and warrants to two lenders at the same unit pricing as the 2010 Equity Financing. In consideration of converting the short- term loans on the basis of $1.20 for two shares of common stock plus one warrant at an exercise price of $1.00, we issued 1,307,153 shares of common stock and warrants to acquire up to 653,576 shares of common stock, which warrants have a five year term and are exercisable at $1.00 per share.  Our objective for converting the short-term debt into equity was to conserve cash.
 
 
33
 
 
Our monthly operating expenses, including its CodecSys technology research and development expenses, exceeded our monthly net sales by approximately $300,000 per month during the year ended December 31, 2012.  The foregoing estimates, expectations and forward-looking statements are subject to change as we make strategic operating decisions from time to time and as our expenses and sales fluctuate from period to period.
 
The amount of our operating deficit could decrease or increase significantly depending on strategic and other operating decisions, thereby affecting our need for additional capital. We expect that our operating expenses will continue to outpace our net sales until we are able to generate additional revenue.  Our business model contemplates that sources of additional revenue include (i) sales from private communication network services, (ii) sales resulting from new customer contracts, and (iii) sales, licensing fees and/or royalties related to commercial applications of CodecSys technology, and (iv) operational efficiencies to be obtained through the merger will All Digital.
 
Our long-term liquidity is dependent upon execution of our business model and the realization of additional revenue and working capital as described above, and upon capital needed for continued commercialization and development of the CodecSys technology.  Commercialization and future applications of the CodecSys technology are expected to require additional capital for the foreseeable future.  The amount required  will be determined based  on specific opportunities and available funding.
  
To date, we have met our working capital needs primarily through funds received from sales of common stock and from convertible debt financings.  Until our operations become profitable, we will continue to rely on proceeds received from external funding.  We expect additional investment capital may come from (i) the exercise of outstanding warrants to purchase capital stock currently held by existing warrant holders; (ii) additional private placements of common stock with existing and new investors; and (iii) the private placement of other securities with institutional investors similar to those institutions that have provided funding in the past.
 
Recent Accounting Pronouncements
 
In August 2012, the FASB issued ASU No 2012-03, Technical Amendments and Corrections to SEC Sections. This Update makes changes to several of the SEC guidance literature sections within the Codification.  The main focus is to update the SEC guidance as per SAB 114 to reference the codification sections rather than the old standards prior to the codification.  The changes were mainly references and were not intended to change guidance. The amendments in this Update are effective immediately.  This guidance didn’t have a significant impact on the Company’s financials since it was an update of SEC referenced guidance and didn’t change existing guidance.

In July 2012, the FASB issued ASU 2012-02, Intangibles - Goodwill and Other (Topic 350) - Testing Indefinite-Lived Intangible Assets for Impairment. The objective of this Update is to simplify how entities test indefinite-lived intangible assets for impairment and to have the testing be in-line with the updated guidance issued in 2011 related to impairment testing for goodwill. This Update allows entities to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative analysis. The more likely than not threshold is defined as having a likelihood of more than 50%.  The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the quantitative impairment test and still be able to resume performing the qualitative assessment in subsequent years. Some examples of circumstances to consider are 1) cost factors that have a negative impact on earnings, 2) financial performance such as negative or declining cash flows, 3) legal, regulatory, contractual, political or business conditions, 4) other relevant entity specific events 5) industry and market conditions, and 6) macroeconomic conditions. The Update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before July 27, 2012 if the financial statements have not been issued.  The Company doesn’t expect this Update to impact the Company’s financials since it currently has no indefinite-lived intangibles other than goodwill, but the Company will plan on utilizing the qualitative assessment options if any are acquired.
 
 
34
 
 
In June 2011, the FASB issued ASU 2011-05, Comprehensive Income (Topic 220) – Presentation of Comprehensive Income. This Update eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity in order to increase the prominence of other comprehensive income items and to facilitate convergence with IFRS. The Update requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements (a statement of income and statement of other comprehensive income).  Additionally, adjustments for items reclassified from other comprehensive income to net income must be presented on the face of the financial statements.  This Update should be applied retrospectively. For public entities, the Update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. For nonpublic entities, the Update is effective for fiscal years ending after December 15, 2012, and interim and annual periods thereafter. Early adoption is permitted, because compliance with the amendments is already permitted. The amendments do not require any transition disclosures. This impacts how items for Other Comprehensive Income are presented and the Company will follow the guidance starting in Q1 2012.

In December 2011, the FASB issued ASU 2011-11, Balance Sheet (Topic 210) – Disclosures about Offsetting Assets and Liabilities. This Update is applicable to all entities that have financial instruments and derivative instruments that are either 1) offset in accordance with current guidance or 2) subject to an enforceable master netting arrangement.  The Update requires an entity with these types of instruments to disclose information about offsetting and related arrangements. Both net and gross information for these assets and liabilities is required to be disclosed. This Update is effective for fiscal years beginning on or after January 1, 2013. The Company doesn’t expect this Update to impact the Company’s financials since it does not currently have any financial instruments or derivative instruments that are offset.

In September 2011, the FASB issued ASU 2011-08, Intangibles - Goodwill and Other  (Topic 350)- Testing Goodwill for Impairment. The objective of this Update is to simplify how entities test goodwill for impairment. This Update now allows entities to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step process of (1) comparing the fair value of the reporting unit to its carrying value and (2) test to measure the amount of the impairment loss if the fair value is less than the carrying value.  The more likely than not threshold is defined as having a likelihood of more than 50%.  The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the first step of the two-step goodwill impairment test. Some examples of circumstances to consider are 1) macroeconomic conditions, 2) industry and market conditions, 3) cost factors that have a negative impact on earnings, 4) overall financial performance such as negative or declining cash flows 5) other relevant entity specific events and 6) sustained decrease in stock price. The Update is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before September 15, 2011 if the financial statements have not been issued.  If necessary, the Company will evaluate whether or not it will utilize the qualitative assessment option prior to performing the first goodwill impairment test in 2012, typically done during the 4th quarter.
 
 
35
 
 
In May 2011, the FASB issued ASU 2011-04, Fair Value Measurement (Topic 820) – Amendments to Achieve Common Fair Value Measurements and Disclosure Requirements in US GAAP and IFRSs. The Amendments in this Update will improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with US GAAP and IFRSs.  The Boards of both organizations worked together to ensure fair value has the same meaning and the measurement and disclosures would be the same other than minor differences in wording. The Amendments explain how to measure fair value and do not require any additional fair value measurements. A couple of the more significant changes are 1) Clarification that quantitative information about unobservable inputs categorized as Level 3 should be disclosed, 2) Specifies that premiums and discounts should be applied in the absence of Level 1 input if market participants would do so, but that premiums or discounts related to size/quantity should not be considered, 3) Additional disclosure requirements for fair value measurements categorized as Level 3, an entity’s us of a nonfinancial asset in a way that differs from the asset’s highest and best use and the categorization by level for items not measured at fair value in the statement of financial position, but for which fair value disclosure is required. The amendments in this Update are to be applied prospectively. The Update is effective during interim and annual periods beginning after December 15, 2011.  The Company doesn’t expect this guidance to have a significant impact on its financials since the amount of items disclosed at fair value is minimal, but will ensure the guidance is followed for items disclosed at fair value.

ITEM 7A.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
Not applicable.
 
ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
 
The following financial statements required by this Item 8 begin on Page F-1 and are located following the signature page.  All information which has been omitted is either inapplicable or not required.
 
Report of Independent Registered Public Accounting Firm for the years ended
December 31, 2012 and 2011
F-1
   
Consolidated Balance Sheets as of December 31, 2012 and December 31, 2011
F-2
   
Consolidated Statements of Operations for the years ended December 31, 2012
and 2011
F-3
   
Consolidated Statements of Stockholders’ Deficit for the years ended
December 31, 2012 and 2011
F-4
   
Consolidated Statements of Cash Flows for the years ended
December 31, 2012 and 2011
F-5
   
Notes to Consolidated Financial Statements
F-6

 
ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE
 
None.
 
ITEM 9A  CONTROLS AND PROCEDURES
 
Disclosure Controls and Procedures
 
Our management is responsible for establishing and maintaining effective disclosure controls and procedures,  as  defined  under  Rules  13a-15(e)  and  15d-15(e)  of  the  Exchange  Act.  As of December 31, 2012, an evaluation was performed, under the supervision and with the participation of management, including our president and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures.  Based on that evaluation, our president officer and chief financial officer concluded that our disclosure controls and procedures, as of December 31, 2012, were effective in ensuring that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and in ensuring that such information is accumulated and communicated to our management, including our president and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
 
 
36
 
 
Management’s Annual Report on Internal Control Over Financial Reporting
 
Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our system of internal control over financial reporting within the meaning of Rules 13a-15(f) and 15d-15(f) of the Exchange Act is designed to provide reasonable assurance to our management and board of directors regarding the preparation and fair presentation of our published financial statements in accordance with U.S. generally accepted accounting principles.
 
Our management, including the president and the chief financial officer, assessed the effectiveness of our system of internal control over financial reporting as of December 31, 2011.  In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework.  Based on our assessment, we believe that, as of December 31, 2012, our system of internal control over financial reporting was effective to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our financial statements for external purposes in accordance with U.S. generally accepted accounting principles.
 
This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting.  Management’s report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management’s report in this annual report.
 
Changes in Internal Control Over Financial Reporting
 
For the year ended December 31, 2012 we made enhancements to our internal controls over financial reporting by strengthening documentation of corporate governance, and journal entries, we also further restricted access to our accounting database.
 
Limitations on Controls and Procedures
 
The effectiveness of our disclosure controls and procedures and our internal control over financial reporting is subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the soundness of our systems, the possibility of human error, and the risk of fraud.  Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions and the risk that the degree of compliance with policies or procedures may deteriorate over time.  Because of these limitations, any system of disclosure controls and procedures or internal control over financial reporting may not be successful in preventing all errors or fraud or in making all material information known in a timely manner to the appropriate levels of management.
 
The foregoing limitations do not qualify the conclusions set forth above by our president and our chief financial officer regarding the effectiveness of our disclosure controls and procedures and our internal control over financial reporting as of December 31, 2012.
 
ITEM 9B.  OTHER INFORMATION
 
None.
 
 
37
 
 
PART III
 
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
 
The following table sets forth the names, ages and positions of our executive officers and directors:
 
Name
Age
  
Position
       
William Boyd
71
  
Chairman of the Board
       
Rodney M. Tiede
52
  
President and Director
       
James E. Solomon
62
  
Chief Financial Officer
and Secretary
       
R. Phil Zobrist
66
  
Director
       
Donald Harris
60
  
Director
       
Steven Ledger
53
  
Director

William Boyd has been a director since November 2007.  Mr. Boyd has served as the Chairman of the Board of Agility Recovery Solutions, a privately held disaster recovery and business continuity company since 2006.  He was CEO of Muzak Corporation from 1996 to 2000 and continued with Muzak in an advisory executive position and on the Board until August 2006.  He became associated with Muzak Corporation in 1968 as a sales representative and continued as a manager and franchise owner until he became CEO in 1996.  Mr. Boyd received a Bachelor of Arts degree in political science in 1963 from Beloit College in Wisconsin.  Mr. Boyd’s CEO level experience with Muzak and his overall experience in satellite networks, management, operations and financing matters are qualities and expertise that were determined to be particularly useful as a member of our Board.
 
Rodney M. Tiede has been our chief executive officer, president and a director since the acquisition of Broadcast International, or BI, in October 2003 until July 16, 2012, at which time he ceased to serve as our chief executive officer.  From August 2000 to July 2012, Mr. Tiede was the president, chief executive officer and a director of BI, a wholly-owned subsidiary and since July 2012 he has continued to serve as the president and a director of BI.  From April 2003 to the present, Mr. Tiede has also been the chief executive officer and a director of Interact Devices, Inc., or IDI, a consolidated subsidiary.  From November 1987 to August 2000, Mr. Tiede was employed as director of sales, vice president and general manager of Broadcast International, Inc., the predecessor of BI.  Mr. Tiede received a Bachelor of Science Degree in Industrial Engineering from the University of Washington in 1983.  Mr. Tiede has been a part of our operations for more than 20 years and as a result has significant knowledge, insight and understanding that he provides as a director.
 
James E. Solomon has served as Chief Financial Officer and Secretary since September 2008.  From 1995 to January 2002, Mr. Solomon was a business consultant primarily for emerging growth companies.  In January 2002, he formed Corporate Development Services, Inc., a business consulting firm, and has served as President since its formation.  From June 1993 to the present, Mr. Solomon has been an adjunct professor at the Graduate School of Business at the University of Utah.  Mr. Solomon served on the Board of Directors of Nevada Chemicals, Inc., a public company, until October 2008, as well as several privately-held companies. Mr. Solomon received a Bachelor of Science Degree in Finance from the University of Utah in 1972.  Mr. Solomon became a Certified Public Accountant in 1974.  Mr. Solomon’s experience in finance, accounting and business consulting, together with his role as our CFO and prior public company directorship, provide Mr. Solomon with expertise enabling critical input to our Board decision-making process.
 
 
38
 
 
R. Phillip Zobrist has been a member of our board of directors since June 2009.  He currently manages his own investments and since 1996 has been President and Chairman of the Board of Valley Property Management, a privately held real estate management company headquartered in Las Vegas, Nevada, which he founded.  He also serves as an independent consultant for Sundance Builders, LLC, a privately held real estate construction company and serves on the board of directors of Greffex, Inc., a start up bio-technology company in Aurora, Colorado.  Mr. Zobrist was the president and CEO of a $150 million enterprise for more than ten years and gained valuable business experience in dealing with financing, employee relations, and sales and marketing that make his advice and counsel valuable for the Company.
 
Donald A. Harris was appointed to Broadcast’s board of directors in June 2012.  He has been President of 1162 Management, the General Partner of 5 Star Partnership, a private equity firm, since June 2006.  Mr. Harris has been President and Chief Executive Officer of UbiquiTel Inc., a telecommunications company organized by Mr. Harris and other investors, since its inception in September, 1999 and also its Chairman since May 2000. Mr. Harris served as the President of Comcast Cellular Communications Inc. from March 1992 to March 1997.  Mr. Harris received a Bachelor of Science degree from the United States Military Academy and an MBA from Columbia University in. Mr. Harris’s experience in the telecommunications industry and his association with private equity funding will be valuable to us.
 
Steven Ledger has been a director since May 2011.  He is the founder and from September 2002 to the present has been the Managing Partner at Tamalpais Partners LLC, a privately held company that acts as a principal investor in, and advisor to, emerging growth companies.  From August 1999 to December 2002 he served as co-founder and managing partner of eCompanies Venture Group, a privately held company that managed an Internet focused, strategic venture capital fund whose investors included Sprint, Disney, Earthlink and Sun America. From January 1994 to December 1999, Mr. Ledger served as the co-founder and managing partner of Storie Partners, L.P., a technology focused investment fund that provided early lead investment capital to Earthlink Networks and SeeBeyond Technologies Corporation (acquired by Sun Microsystems). From September 1989 to October 1993 Mr. Ledger was a managing partner with Kayne Anderson Investment Management. Mr. Ledger graduated from the University of Connecticut in 1982 with a BA in Economics.  Mr. Ledger’s experience with technology companies and their financing was deemed valuable to us.
 
Our directors generally serve until the next annual or special meeting of shareholders held for the purpose of electing directors.  Our officers generally serve at the discretion of the board of directors.  One of our directors, Mr. Tiede, is an employee who serves as our president.  The employment service of Mr. Tiede and Mr. Solomon are governed by the terms of their respective employment contracts.  See “Employment Contracts” in Item 11 below.
 
As noted above, Mr. Tiede has served as an officer and director of BI since August 2000 and as an officer and director of Interact Devices, Inc. (“IDI”) since April 2003.  During 2001 and 2002, BI entered into various licensing agreements with IDI and purchased shares of convertible preferred stock of IDI.  Management of BI determined that the CodecSys technology being developed by IDI represented a significant opportunity for BI and its future business prospects.  By April 2003, the financial condition of IDI had deteriorated significantly and BI provided a line of credit to IDI to sustain its operations.  At such time, BI also assumed operational control of IDI.  By October 2003, management of BI realized that IDI could not survive on its own notwithstanding the financial support provided by BI.  Accordingly, IDI filed for bankruptcy protection under chapter 11 of the federal bankruptcy code on October 23, 2003.  Over the next seven months, IDI continued its limited operations and designed a bankruptcy plan of reorganization which was confirmed on May 18, 2004.  Under the plan of reorganization, we issued shares of our common stock to creditors of IDI and assumed certain liabilities of IDI in exchange for shares of the common stock of IDI representing majority ownership of IDI.  Since confirmation of the plan of reorganization, the operations of IDI have been consolidated with ours.
 
 
39
 
 
Board and Committee Matters
 
We maintain an audit committee of the board and a compensation committee of the board, each of which is discussed below.  We have not established a nominating committee of the board.  Our entire board of directors participates in the selection and nomination of candidates to serve as directors.  Our board has determined that three of our current directors are “independent” under the definition of independence in the Marketplace Rules of the NASDAQ listing standards, but that Mr. Tiede, our chief executive officer and president is not independent and Mr. Ledger, who serves as a consultant to the Company, is also not independent.
 
We do not have a formal policy concerning shareholder recommendations of candidates for board of director membership.  Our board views that such a formal policy is not necessary at the present time given the board’s willingness to consider candidates recommended by shareholders.  Shareholders may recommend candidates by writing to our Secretary at our principal offices: 7050 Union Park Avenue, Suite 600, Salt Lake City, Utah 84047, giving the candidate’s name, contact information, biographical data and qualifications.  A written statement from the candidate consenting to be named as a candidate and, if nominated and elected, to serve as a director should accompany any such recommendation.  Shareholders who wish to nominate a director for election are generally advised to submit a shareholder proposal no later than December 31 for the next year’s annual meeting of shareholders.
 
Audit Committee and Financial Expert
 
Our audit committee currently includes Messrs. Boyd and Zobrist.  Mr. Boyd serves as chairman of the audit committee.  The functions of the audit committee include engaging an independent registered public accounting firm to audit our annual financial statements, reviewing the independence of our auditors, the financial statements and the auditors’ report, and reviewing management’s administration of our system of internal control over financial reporting and disclosure controls and procedures.  The board of directors has adopted a written audit committee charter.  A current copy of the audit committee charter is available to security holders on our website at www.brin.com.  Our board has determined that each of the members of the audit committee is “independent” under the definition of independence in the Marketplace Rules of the NASDAQ listing standards.
 
Our board of directors has determined that Mr. Boyd meets the requirements of an “audit committee financial expert” as defined in applicable SEC regulations.
 
Compensation Committee
 
Our compensation committee currently includes Messrs. Boyd and Zobrist.  Mr. Zobrist serves as chairman of the compensation committee.  The functions of the compensation committee include reviewing and approving corporate goals relevant to compensation for executive officers, evaluating the effectiveness of our compensation practices, evaluating and approving the compensation of our chief executive officer and other executives, recommending compensation for board members, and reviewing and making recommendations regarding incentive compensation and other employee benefit plans.  The board of directors has adopted a written compensation committee charter.  A current copy of the compensation committee charter is available to security holders on our website at www.brin.com.  Our board has determined that each of the members of the compensation committee is “independent” under the definition of independence in the Marketplace Rules of the NASDAQ listing standards.
 
Communication with the Board
 
We have not, to date, developed a formal process for shareholder communications with the board of directors.  We believe our current informal process, in which any communication sent to the board of directors, either generally or in care of the chief executive officer, secretary or other corporate officer or director, is forwarded to all members of the board of directors, has served the board’s and the shareholders’ needs.
 
 
40
 
 
Conflicts of Interests
 
On an annual basis, each director and executive officer is obligated to complete a director and officer questionnaire  that requires disclosure of any transactions with our company, including related person transactions reportable under SEC rules, in which the director or executive officer, or any member of his or her immediate family, have a direct or indirect material interest.  Under our company’s standards of conduct for employees, all employees, including the executive officers, are expected to avoid conflicts of interest.  Pursuant to our code of ethics for the chief executive officer and senior finance officers (as discussed below), such officers are prohibited from engaging in any conflict of interest unless a specific exception has been granted by the board.  All of our directors are subject to general fiduciary standards to act in the best interests of our company and our shareholders.  Conflicts of interest involving an executive officer or a director are generally resolved by the board.
 
Compliance with Section 16(a) of the Exchange Act
 
Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than 10% of our common stock, to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities.  Executive officers, directors and greater than 10% shareholders are required by SEC regulations to furnish us with copies of all Section 16(a) forms they file.
 
To our knowledge, during the year ended December 31, 2012, our directors, executive officers and greater than 10% shareholders complied with all Section 16(a) filing requirements, although on two occasions filings for all of our directors’ filings were late.
 
Code of Ethics
 
We have adopted a code of ethics for our principal executive officer, principal financial officer, controller, or persons performing similar functions.  A copy of the code of ethics is included on our website at www.brin.com.
 
ITEM 11.  EXECUTIVE COMPENSATION
 
Overview of Compensation Program
 
Throughout this section, the individuals who served as our chief executive officer and/or president and chief financial officer during 2012 are collectively referred to as the “named executive officers.”
 
Our compensation committee has overall responsibility to review and approve our compensation structure, policy and programs and to assess whether the compensation structure establishes appropriate incentives for management and employees.  The compensation committee annually reviews and determines the salary and any bonus and equity compensation that may be awarded to our chief executive officer and/or president, or CEO/President and its chief financial officer, or CFO.  The compensation committee oversees the administration of our long-term incentive plan and employee benefit plans.
 
The compensation committee’s chairman regularly reports to our board on compensation committee actions and recommendations.  The compensation committee has authority to retain, at its expense, outside counsel, experts, compensation consultants and other advisors as needed.
 
2012 and 2011 Company Performance.  Because of the stage of our development, the compensation committee looks at various factors in evaluating the progress we have made and the services provided by the named executive officers.  In considering executive compensation, the compensation committee noted certain aspects of our financial performance and accomplishments in 2012 and 2011 including the following:
 
 
41
 
 
 
·
Operations.  Our revenues decreased approximately 11% from $8,446,082 in 2011 to $7,523,624 in 2012, which was principally the result of decreased services provided for our largest customer in 2012.  This customer has more retail locations than all of Broadcast’s other existing customers combined.  We were able to install its proprietary digital signage delivery and management hardware and software, which incorporates portions of our CodecSys software, at approximately 2,500 locations and managed approximately 33,000 screens for this customer as of December 31, 2012. For the first time we did not receive a 100% vendor rating by the client. During the twelve months ended December 31, 2012, our license fees revenue increased by $396,847, revenue from studio and production services increased by $137,606 and revenue from web services and other services increased by $142,388.  However, these increases in revenues were offset by a decrease in system sales and installation revenue of $1,588,277, almost all of which resulted from fewer work orders from our largest customer.
 
 
·
CodecSys Milestones.  Our executive officers also made significant progress on the development of the CodecSys technology.  In 2011, we added Fujitsu North America to its list of technology partners and sales channel partners.  We trained salesmen and sales engineers for Fujitsu as an integral part of Fujitsu’s sales initiative for 2012, which has yielded no significant revenues.  Fujitsu joins IBM, Microsoft, and HP as large companies that have included our video compression technology as a video compression solution and have proceeded with sales presentations and testing with their large video customers, which include large broadcasters, cable companies, and satellite companies.
 
 
·
During 2011 and 2012, we expanded the installed base of test locations of our CodecSys version 2.0 to over 35 locations consisting principally of large international telecommunication companies and have moved toward contract with most of the test sites.
 
 
·
In December 2011, we entered into our first customer agreement with a cable company located in Mexico to utilize CodecSys technology in providing an “over-the-top” product offering to the cable company’s subscribers.  CodecSys was installed at the cable company and is operational in providing the service.  During 2012, we continued our development of this opportunity, and although there have been no material revenues generated from the contract, it is important because it represents the first commercial installation of our CodecSys product.
 
Compensation Philosophy. Our general compensation philosophy is designed to link an employee’s total cash compensation with our performance, the employee’s department goals and individual performance.  Given our stage of operations and limited capital resources, it is subject to various financial restraints in its compensation practices.  As an employee’s level of responsibility increases, there is a more significant level of variability and compensation at risk.  The compensation committee believes linking incentive compensation to our performance creates an environment in which employees are stakeholders in our success and, thus, benefits all stockholders.
 
Executive Compensation Policy.  Our executive compensation policy is designed to establish an appropriate relationship between executive pay and annual performance, long-term growth objectives, individual performance of the executive officer and ability to attract and retain qualified executive officers.  The compensation committee attempts to achieve these goals by integrating competitive annual base salaries with bonuses based on corporate performance and on the achievement of specified performance objectives, and to a lesser extent, awards through our long-term incentive plan.  The compensation committee believes that cash compensation in the form of salary and bonus provides executives with short-term rewards for success in operations.  The compensation committee also believes our executive compensation policy and programs do not promote inappropriate risk-taking behavior by executive officers that could threaten the value of the company.
 
 
42
 
 
Role of Executive Officers in Compensation Decisions
 
The compensation committee makes all compensation decisions for the named executive officers and approves recommendations regarding equity awards to all other senior management personnel. The CEO/President annually reviews the performance of the CFO and other senior management.  The conclusions reached and recommendations based on these reviews, including with respect to salary adjustments and annual award amounts, are presented to the compensation committee.  The compensation committee is charged with the responsibility of ensuring a consistent compensation plan throughout the company and providing an independent evaluation of the proposed adjustments or awards at all levels of management.  As such, the compensation committee has determined that it have the discretion to modify or adjust any proposed awards and changes to management compensation to be able to satisfy these responsibilities.
 
2012 Executive Compensation Components
 
For the fiscal year ended December 31, 2012, the principal components of compensation for the named executive officers were:
 
 
·
base salary; and
 
 
·
performance-based bonus compensation.
 
Base Salary.  The compensation committee determined that the executive officers had been compensated fairly relative to similarly situated executives, and approved decreases in 2012 to the base salary of the CEO/President and CFO.  In determining the base salary of each executive officer, the compensation committee relied on publicly available information gathered by the compensation committee related to salaries paid to executive officers of similarly situated small public companies.
 
Performance-based Incentive Compensation.  Annual incentives for the executive officers are intended to recognize and reward those employees who contribute meaningfully to an increase in shareholder value and move the company toward profitability. No cash bonuses were paid for 2012 due to fiscal restraints and no restricted stock units were issued to executive officers.
 
Long-term Equity Incentive Compensation.  Long-term incentive compensation encourages participants to focus on our long-term performance and provides an opportunity for executive officers and certain designated key employees to increase their stake in the Company through grants of options to purchase our common stock.  No stock options or restricted stock units were granted during 2012 to any of the named executive officers.  The board made awards of stock options to other employees and awards of restricted stock units to each of our non-employee directors under Broadcast’s equity incentive plan.
 
All awards made under our equity incentive plan are made at the market price at the time of the award.  Annual awards of stock options to executives are made at the discretion of the compensation committee at such times throughout the year at it deems most desirable.  Newly hired or promoted executives, other than executive officers, generally receive their award of stock options on the first business day of the month following their hire or promotion.  Grants of stock options to newly hired executive officers who are eligible to receive them are made at the next regularly scheduled compensation committee meeting following their hire date.
 
Perquisites and Other Personal Benefits.  We provide no perquisites to its named executive officers other than matching 401(k) contributions described below and other group benefits offered generally to all salaried employees.
 
 
43
 
 
Retirement and Related Plans.  We maintain a 401(k) profit sharing plan for all non-temporary employees.  Employee contributions are matched by the Company in an amount of 100% of employee contributions up to 3% of employee salaries and 50% of employee contributions up to an additional 2% of their salaries. Participants vest immediately in the company matching contributions.
 
Compensation of Chief Executive Officer/President.  For the fiscal year ended December 31, 2012, we paid Rodney M. Tiede, CEO/President, a salary of $225,690, representing a decrease from a salary of $250,690 paid to Mr. Tiede in the fiscal year ended December 31, 2012. The compensation committee met with Mr. Tiede twice during 2012 to review his performance and individual objectives and goals versus results achieved.  The compensation committee reviewed all components of the CEO’s compensation, including salary, bonus, and equity incentive compensation, and under potential severance and change-in-control scenarios.  Mr. Tiede’s compensation package was determined to be reasonable and not excessive by the compensation committee based on compensation surveys for chief executive officers of small public companies.  The compensation committee also considered the continuing economic recession and market conditions in determining the compensation of the CEO/President or other management personnel.
 
In April 2004, the Company and Mr. Tiede entered into an employment agreement covering Mr. Tiede’s employment for a term commencing upon the execution thereof and continuing until December 31, 2006.  The contract continues for additional terms of one year each until terminated by us.  The agreement calls for payment of a gross annual salary of not less than $120,000, payable in equal bi-weekly installments for the year ended December 31, 2004, subject to such increases as the board of directors may approve.  The employment agreement further provides that Mr. Tiede shall receive a performance bonus on an annual basis equal to up to 100% of his base salary for the fiscal year then ended, the exact percentage to be determined in the sole discretion of the board of directors (or the compensation committee thereof) based upon an evaluation of the performance of Mr. Tiede during the previous fiscal year.  The agreement also provides for participation in our stock option plan, the payment of severance pay, and other standard benefits such as vacation, participation in our other benefit plans and reimbursement for necessary and reasonable business expenses.  In the event of a change in control of the company, defined as the purchase of shares of Broadcast capital stock enabling any person or persons to cast 20% or more of the votes entitled to be voted at any meeting to elect directors, Mr. Tiede shall have the right to terminate the employment agreement and receive severance pay equal to the base salary and a bonus equal to 50% of the salary for the remainder of the employment term or two years, whichever is longer.  In addition, if the change of control event results in our shareholders exchanging their shares for stock or other consideration, Mr. Tiede shall receive an amount equal to the per share price paid to the shareholders less the pre-announcement price multiplied by 50,000.
 
In September 2008, the Company and Mr. Solomon entered into an employment agreement covering Mr. Solomon’s employment for a term commencing upon the execution thereof and continuing until December 31, 2011.  The contract continues for additional terms of one year each until terminated by us.  The agreement calls for payment of a gross annual salary of not less than $225,000, payable in equal bi-weekly installments for the year ended December 31, 2008, subject to such increases as the board of directors may approve.  The employment agreement further provides that Mr. Solomon shall receive a performance bonus on an annual basis equal to up to 100% of his base salary for the fiscal year then ended, the exact percentage to be determined in the sole discretion of the board of directors (or the compensation committee thereof) based upon an evaluation of the performance of Mr. Solomon during the previous fiscal year.  The agreement also provides for participation in our stock option plan, the payment of severance pay, and other standard benefits such as vacation, participation in our other benefit plans and reimbursement for necessary and reasonable business expenses.  In the event of a change in control of the company, defined as the purchase of shares of Broadcast capital stock enabling any person or persons to cast 20% or more of the votes entitled to be voted at any meeting to elect directors, Mr. Solomon shall have the right to terminate the employment agreement and receive severance pay equal to the base salary and a bonus equal to 50% of the salary for the remainder of the employment term or two years, whichever is longer.  In addition, if the change of control event results in our shareholders exchanging their shares for stock or other consideration, Mr. Solomon shall receive an amount equal to the per share price paid to the shareholders less the pre-announcement price multiplied by 50,000.
 
 
44
 
 
On January 6, 2013, we entered into an Amendment and Settlement Agreement with each of Mr. Tiede and Mr. Solomon, modifying their respective existing employment agreements described above as follows:  the salary of each officer is reduced to $180,000 per year, each officer’s employment is terminable at will, each officer is to report to the executive committee of the board of directors, each officer’s termination and change of control benefits are terminated, each officer waives his accrued vacation benefits, each officer and Broadcast grant each other mutual releases, and we agreed to issue to each officer 529,100 shares of Common Stock if such officer remains employed by us for 60 days following January 6, 2013 or if such officer is terminated by at any time following January 6, 2013.
 
Stock Option Plans
 
Under our 2004 Long-term Incentive Plan (the “2004 Plan”), the board of directors may issue incentive stock options to employees and directors and non-qualified stock options to consultants of the company.  Options generally may not be exercised until twelve months after the date granted and expire ten years after being granted. Options granted vest in accordance with the vesting schedule determined by the board of directors, usually ratably over a three-year vesting schedule upon the anniversary date of the grant.  Should an employee’s director’s or consultant’s relationship with the company terminate before the vesting period is completed, the unvested portion of each grant is forfeited.  We continue to maintain and grant awards under the 2004 Plan which will remain in effect until the earlier of its expiration by its terms or its termination as required by the merger agreement. The number of unissued stock options authorized under the 2004 Plan at December 31, 2012 was 3,779,508.

The Broadcast International, Inc. 2008 Equity Incentive Plan (the “2008 Plan”) has become our primary plan for providing stock-based incentive compensation to its eligible employees and non-employee directors and consultants of the Company. The provisions of the 2008 Plan are similar to the 2004 Plan except that the 2008 Plan allows for the grant of share equivalents such as restricted stock awards, stock bonus awards, performance shares and restricted stock units in addition to non-qualified and incentive stock options. The number of unissued shares of common stock reserved for issuance under the 2008 Plan was 774,867 at December 31, 2012.
 
The purpose of our incentive plans is to advance the interests of our stockholders by enhancing our ability to attract, retain and motivate persons who are expected to make important contributions to the company by providing them with both equity ownership opportunities and performance-based incentives intended to align their interests with those of our stockholders.  These plans are designed to provide us with flexibility to select from among various equity-based compensation methods, and to be able to address changing accounting and tax rules and corporate governance practices by optimally utilizing stock options and shares of common stock.
 
Summary Compensation Table
 
The table below summarizes the total compensation paid or earned by each of the named executive officers in their respective capacities for the fiscal years ended December 31, 2012, 2011 and 2010.  When setting total compensation for each of the named executive officers, the compensation committee reviewed tally sheets which show the executive’s current compensation, including equity and non-equity based compensation.  We have omitted in this report certain tables and columns otherwise required to be included because there was no compensation made with respect to such tables and columns, as permitted by applicable SEC regulations. The amounts shown as salary in the following table for 2010 include an amount equal to 10% of total salary for each executive which had been accrued for 2009, but the payment was deferred and paid and included in 2010 compensation shown below.
 
 
45
 
 
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
Name and
Principal Position
Year
Salary
($)
Bonus
($)
Option
Awards
($)
Restricted
 Stock
 Unit
Awards
($)
All Other
Compensation
($)(1)
Total
($)
               
Rodney M. Tiede
President & Chief
Executive Officer*
2012
2011
2010
$225,690
  250,690
  273,078
--
--
--
--
--
--
--
$555,000
--
$4,841
  7,333
  7,333
$230,531
  813,023
  280,411
               
James E. Solomon
Chief Financial
Officer and Secretary
2012
2011
2010
$256,980
  256,980
  283,270
--
--
--
--
--
--
--
$333,000
--
  $9,494
  10,200
  11,331
$266,474
  600,180
  294,601
 
(1)
The amounts shown in column (g) reflect for each named executive officer matching contributions made by Broadcast to its 401(k) employee retirement plan.  The amounts shown in column (g) do not reflect premiums paid by us for any group health or other insurance policies that apply generally to all salaried employees on a nondiscriminatory basis.
*
From and after July 16, 2012, Mr. Tiede served as our president and no officer held the title of chief executive officer.
 
 
Other Compensation
 
We do not have any non-qualified deferred compensation plan.
 
Outstanding Equity Awards at Fiscal Year-End
 
 
Option Awards
Stock Awards
Name
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
Option
Exercise
Price
($)
Option
Expiration
Date
Number
of
Shares
or
Units of
Stock
that
have not
Vested
(#)
Market
Value
of
shares
or
Units of
Stock
that
have
not
Vested
($)
Number
of
Unearned
shares,
units or
other
rights
that
have not
vested
(#)
 
Market or
payout
value
of
unearned
shares,
units
or other
rights that
have not
vested ($)
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
Rodney M.
Tiede
50,000
--
2.25
04/28/2014
--
--
--
--
James E.
Solomon
75,000
25,000
--
--
2.25
1.17
09/15/2015
12/27/2016
--
--
--
--

Potential Payments Upon Termination or Change of Control
 
The amount of compensation payable to the named executive officers upon voluntary termination, retirement, involuntary not-for-cause termination, termination following a change of control and in the event of disability or death of the executive of prior employment agreements is summarized below. The amounts shown assume that such termination was effective as of December 31, 2012, and thus include amounts earned through such time and are estimates of the amounts which would be paid out to the executives upon their termination if it were to occur as of such date. The actual amounts to be paid out can only be determined at the time of such executive’s separation.
 
 
46
 
 
As discussed above, we entered into an Amendment and Settlement Agreement with each of the named executive officers on January 6, 2013 that terminated each officer’s change of control benefits as of such date.
 
Payments Made Upon Termination
 
Regardless of the manner in which a named executive officer’s employment is terminated, he is entitled to receive amounts earned during his term of employment.  Such amounts include:
 
 
·
salary;
 
 
·
grants under Broadcast’s stock option and equity plans, subject to the vesting and other terms applicable to such grants;
 
 
·
amounts contributed and vested under Broadcast’s 401(k) plan; and
 
 
·
unused vacation pay.
 
 
·
In addition to the amounts above, pursuant to the January 6, 2013 Amendment and Settlement Agreement with each of Mr. Tiede and Mr. Solomon, modifying their respective employment agreements, Broadcast agreed to issue each of Mr. Tiede and Mr. Solomon 529,100 shares of common stock at the earlier of such officer’s  termination  at any time following January 6, 2013 or the expiration of 60 days.  All other termination benefits and severance benefits for Mr. Tiede and Mr. Solomon, except for those set forth in this section, were terminated as of January 6, 2013.
 
Payments Made Upon Death or Disability
 
In the event of the death or disability of a named executive officer, in addition to the benefits listed under the heading “Payments Made Upon Termination,” the named executive officers will receive benefits under any group life or disability insurance plan, as appropriate, that we may have in effect from time to time.  Broadcast currently maintains a group term life insurance plan that generally pays a death benefit equal to two times base salary up to a maximum of $300,000.
 
Payments Made Upon a Change of Control
 
As of December 31, 2012, if there is a change of control, which is defined as the purchase of shares of capital stock of the company enabling any person or persons to cast 20% or more of the votes entitled to be voted at any meeting to elect directors, Mr. Tiede and Mr. Solomon may each elect to terminate employment and would receive under the terms of their employment agreements:
 
 
·
a lump sum severance payment  up to the sum of two years of  the base salary ;
 
 
·
any bonus compensation earned, if any; and
 
 
·
If the change of control event results in Broadcast stockholders exchanging their shares for stock, the executive would receive an amount equal to the per share price paid to stockholders, less the pre-announcement share price, multiplied by 50,000.  For example and illustration purposes only, if the share price paid to stockholders were $3.00 and the pre-announcement share price were $1.50, Mr. Tiede and Mr. Solomon would receive an amount equal to $75,000 under this provision.
 
 
47
 
 
In the event of a change in control as defined above, Mr. Tiede would receive a lump sum payment of $500,000 and Mr. Solomon would receive a lump sum payment of $510,000.  In addition, they would be entitled to receive the share price differential, if any, as discussed above.
 
As discussed above, Broadcast entered into an Amendment and Settlement Agreement with each of the named executive officers on January 6, 2013 that terminated each such officer’s termination and change of control benefits as of such date.  As a result, neither Mr. Tiede nor Mr. Solomon will receive any payment upon consummation of a change of control.
 
Non-compete Agreement
 
Included in Mr. Tiede’s and Mr. Solomon’s employment agreements is a two year non-compete agreement, which is no longer effective due to the amendment described above.
 
 
Compensation Committee Interlocks and Insider Participation in Compensation Decisions
 
None of our executive officers served as a member of the compensation committee or as a director of any other company, one of whose executive officers served as a member of our compensation committee of the board or as one of our directors during 2012.
 
Director Compensation
 
We use a combination of cash and stock-based incentive compensation to attract and retain qualified candidates to serve on its board of directors.  In setting director compensation, we consider the significant amount of time that directors expend in fulfilling their duties as well as the skill-level required by our members of the board.
 
Our non-employee directors generally receive fees of $48,000 per year, paid quarterly, and an initial grant of stock options to purchase 100,000 shares (thereafter annual grants of 25,000 options or restricted stock units) of our common stock with an exercise price equal to the fair market value of the stock on the date of grant.  Given our financial condition in 2012, the board approved and the non-employee directors accepted the 2012 compensation set forth in the director summary compensation table below.  In addition, non-employee directors may be entitled to receive special awards of stock options from time to time as determined by the board.  The chairman of the board and the chairman of each of the audit and compensation committees receive no additional fees for serving in such capacities. There is no additional compensation for meeting attendance.  Directors who are employees of Broadcast receive no additional compensation for serving as directors. All stock options granted to outside directors are immediately exercisable and expire ten years from the date of grant.  All restricted stock units granted to outside directors are immediately vested and are settled by the issuance of our common stock upon their respective retirements from the board of directors.  Directors are reimbursed for ordinary expenses incurred in connection with attending board and committee meetings.  The directors voluntarily deferred a significant portion of their 2012 cash compensation and agreed to receive shares of our common stock in 2013 in payment of the accrued directors’ fees.
 
 
48
 
 
Director Summary Compensation Table
 
The table below summarizes the compensation paid by Broadcast to its directors for the fiscal year ended December 31, 2012.
 
(a)
(b)
(c)
(d)
(e)
Name
Fees Earned or
Paid in Cash ($)
(1)
Options/Awards
($)
Restricted
Stock Units ($)
(2)
Total ($)
William Boyd
$27,000
--
$ 7,000
$34,000
Mark F. Spagnolo (3)
  27,000
--
   7,000
  34,000
Rodney M. Tiede (4)
         --
--
--
         --
R. Phil Zobrist
 27,000
--
   7,000
  34,000
Steven Ledger
 27,000
  
   7,000
  34,000
Donald A. Harris (5)
   6,500
--
 37,500
  44,000
         

 
(1)
Of the fees earned, $15,000 was accrued and remained unpaid to each of Messrs. Boyd, Spagnolo, Zobrist and Ledger and $6,500 was accrued and remained unpaid to Mr. Harris at December 31, 2012.
 
(2)
Each of Messrs. Boyd, Spagnolo, Zobrist and Ledger were granted a total of 58,553 restricted stock units with an estimated value of $7,000.  Mr. Harris was granted a total of 155,921 restricted stock units with an estimated value of $37,500, including 100,000 restricted stock units upon his appointment to Broadcast’s board of directors.
 
(3)
Mr. Spagnolo resigned from the board of directors effective February 12, 2013.
 
(4)
Mr. Tiede receives no compensation for serving as a director, but is compensated in his capacity as Broadcast’s President.
 
(5)
Mr. Harris was appointed to Broadcast’s board of directors in June 2012.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
 
The following table sets forth the beneficial ownership of our common stock at February 4, 2013 by each of our directors or executive officer, each person known by us to own beneficially more than 5% of our common stock, and all of our directors and executive officers as a group.
 
Beneficial Owner
Beneficial Ownership
Percent of Class
     
Gem Asset Management LC (1)
100 State Str. #2b
Teaneck, New Jersey 07666
 11,199,999
10.1%
     
Rodney M. Tiede (2)
c/o Broadcast International, Inc.
7050 Union Park Avenue, Suite 600
Salt Lake City, UT  84047                                                  
 3,518,541
3.3%
     
Leon Frenkel (3)
401 City Avenue, Suite 802
Bala Cynwyd, PA  19004                                                  
 6,982,276
6.2%
      
R. Phil Zobrist (4)
 2,079,919
1.9%
Donald Harris (5)
 1,955,921
1.8%
James E. Solomon (6)                                                  
 662,500
*
William Boyd (7)                                                  
 641,553
*
Steven Ledger (8)
 374,553
*
All directors and executive officers
as a group (7persons) (9)                                                  
9,232,722
8.5%

* Represents less than 1% of Broadcast’s common stock outstanding.
 
 
49
 
 
(1)
Includes 7,466,666 shares of common stock and warrants to purchase 3,733,333 shares of common stock. The control person of Gem Asset Management, LC is Daniel Lewis.
 
(2)
Includes 500,000 restricted stock units, which are settled by the issuance of one share of common stock for each unit upon Mr. Tiede’s retirement from Broadcast and presently exercisable options to acquire 50,000 shares of common stock.
 
(3)
Includes 2,643,517 shares of common stock, presently exercisable warrants to purchase a total of 338,759 shares of common stock and an unsecured convertible note that is convertible into 4,000,000 shares of common stock.
 
(4)
Includes 1,607,908 shares, presently exercisable options to acquire 100,000 shares, warrants to purchase 163,458 shares, and restricted stock units that may be settled by the issuance of 208,553 shares of common stock upon Mr. Zobrist’s retirement from the board of directors.
 
(5)
Includes 155,921 restricted stock units, which are settled by the issuance of one share of common stock for each unit upon Mr. Harris’s retirement from the Board of Directors, a secured convertible note convertible into 1,200,000 shares of common stock and warrants to purchase 600,000 shares of common stock.
 
 (6)
Includes 12,500 shares of common stock, presently exercisable options to acquire a total of 100,000 shares of common stock and 550,000 restricted stock units, which are settled by the issuance of one share of common stock for each unit upon Mr. Solomon’s retirement from Broadcast.
 
(7)
147,000 shares of common stock, presently exercisable options to acquire a total of 100,000 shares of common stock, warrants to acquire 36,000 shares of common stock and 358,553 restricted stock units, which are settled by the issuance of one share of common stock for each unit upon Mr. Boyd’s retirement from the board of directors.
 
(8)
Includes 144,000 shares of common stock, warrants to acquire 72,000 shares of common stock and 158,553 restricted stock units, which are settled by the issuance of one share of common stock for each unit upon Mr. Ledger’s retirement from the board of directors.
 
(9)
Includes warrants, presently exercisable options and vested restricted stock units to acquire a total of 4,353,038 shares of common stock held by all of our directors and executive officers.
 
Securities Authorized for Issuance Under Equity Compensation Plans
 
The following table sets forth, as of December 31, 2012, information regarding our equity compensation plans under which shares of common stock are authorized for issuance.
 
 
50
 
 
 
Number of securities to 
be issued upon exercise of 
outstanding options, 
warrants and rights
Weighted-average 
exercise price of 
outstanding options, 
warrants and rights
Number of securities 
remaining available for 
future issuance under 
equity compensation 
plans (excluding 
outstanding securities)
Equity compensation plans
approved by security holders(1)
2,940,133
$1.11
774,867
Equity compensation plans not
approved by security holders (2)
1,933,103
$1.36
3,779,508
Total
4,873,236
$1.21
4,554,375

(1)
Our 2008 Plan provides for the grant of stock options, stock appreciation rights, restricted stock, and restricted stock units to our employees, directors and consultants.  The plan covers a total of 4,000,000 shares of Broadcast common stock.  As of December 31, 2012, restricted stock units covering 285,000 units had been settled through the issuance of common stock and 2,940,133 were outstanding.  The plan is administered by our board of directors or compensation committee of the board.  Awards may be vested on such schedules determined by the plan administrator.  We anticipate that a significant number of the options outstanding under the 2008 Plan will be terminated in exchange for shares of Broadcast common stock in the exchange offers if the All Digital merger is consummated.

(2)
Our 2004 Plan provides for the grant of stock options, stock appreciation rights and restricted stock to our employees, directors and consultants.  The plan covers a total of 6,000,000 shares of Broadcast common stock.  As of December 31, 2012, options to purchase 287,389 shares of common stock had been exercised.  All awards must be granted at fair market value on the date of grant.  The plan is administered by our board of directors or compensation committee of the board.  Awards may be vested on such schedules determined by the plan administrator.  We anticipate that a significant number of the options outstanding under the 2004 Plan will be terminated in exchange for shares of our common stock in the exchange offers if the All Digital merger is consummated.

 
ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS,
AND DIRECTOR INDEPENDENCE
 
In January 2011, we granted options to the holder of our $1.0 million unsecured convertible note to acquire up to 500,000 shares of our common stock for services performed pursuant to a consulting agreement with the holder.  The options were exercisable at $1.00 per share and were exercisable for five years.
 
In April 2011, we issued 293,517 shares of our common stock and granted a warrant to acquire an additional 146,758 shares of our common stock in payment of accrued interest to the holder of our $1.0 million unsecured convertible note.  The warrant was exercisable at $.90 per share and had a life of five years.
 
On November 15, 2010 we entered into an amendment dated November 15, 2010 with the holder of our $1,000,000 unsecured convertible note due December 22, 2010, pursuant to which the maturity date of such note was extended to January 1, 2011.
 
In connection with the Debt Restructuring, the Company amended its note with the holder of its $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013. We issued to the holder of the note 150,000 shares of our common stock and issued a warrant to acquire up to 75,000 shares of common stock at an exercise price of $.90.
 
 
51
 
 
On March 26, 2010, we entered into an amendment and extension agreement with Castlerigg, the holder of our senior secured convertible note in the principal amount of $15.0 million.  Castlerigg was an affiliate of ours due to its beneficial ownership of 9.9% of our outstanding common stock.  Pursuant to the amendment and extension agreement, we extended the maturity date of the senior secured convertible note from December 21, 2010 to December 21, 2011.  This extension of the maturity date was conditioned upon us raising at least $6,000,000 of gross proceeds from the sale of our equity securities by September 30, 2010.  If the additional funding were not completed, the maturity date reverted back to December 21, 2010.  In exchange for extending the maturity date, we issued to Castlerigg 1,000,000 shares of our common stock.  In addition, we agreed to the inclusion of three additional terms and conditions in the note: (i) from and after the additional funding, we would be required to maintain a cash balance of at least $1,250,000 and provide monthly certifications of the cash balance to Castlerigg; (ii) we would not make principal payments on our $1.0 million unsecured convertible note without the written permission of Castlerigg; and (iii) we grant board observation rights to Castlerigg.
 
On July 30, 2010, we amended our 6.25% senior secured convertible promissory note (“Note”) and related warrants. The amendment provided for (i) the change of the maturity date from December 21, 2011 to June 21, 2012; (ii) the requirement to maintain a balance of cash and marketable securities equal to or greater than $950,000 was added as an additional condition of default in the event we completed the required capital raise described below; (iii) in the event of the completion of the required capital raise, the conversion price of the Note would be reduced to $1.80 per share instead of the price at which the new equity is sold; (iv) in the event of the completion of the required capital raise, the exercise price of the Warrants would be reduced to $1.80 per share instead of the price at which new equity were sold; (v) in the event of the completion of the required capital raise the number of warrants were to be increased from 1,875,000 to 5,208,333. The amendment was conditioned upon the Company raising at least $6,000,000 of gross proceeds from the sale of its equity securities by September 30, 2010. If the additional funding were not completed by September 30, 2010, certain provisions of the amendment agreement would have been void in that the maturity date would have reverted back to December 21, 2010, the conversion price would have become the lowest price at which equity securities had been sold, the exercise price would have become the lowest price at which equity securities have been sold, and the number of warrants then outstanding would have be determined by the original purchase documents and the Company would not have had an obligation to maintain a balance of cash and marketable securities equal to $950,000. In exchange for the amendments, the Company issued to the holder 2,000,000 shares of the Company’s common stock, par value $0.05 per share, and committed to issue another 800,000 shares upon completion of the equity financing.
 
On September 24, 2010, the holder of the Note extended the due date for the equity financing required by the July 30, 2010 amendment to the Note to October 31, 2010. If the additional funding were not completed by October 31, 2010, certain provisions of the amendment agreement would have been void in that the maturity date would have reverted back to December 21, 2010, the conversion price of the Note would become the lowest price at which equity securities had been sold, the exercise price of the holder’s warrants would have become the lowest price at which equity securities had been sold, and the number of warrants then outstanding would have been determined by the original purchase documents and we would not have an obligation to maintain a balance of cash and marketable securities equal to $950,000.
 
On October 29, 2010, we entered into an extension and amendment agreement with the holder of the Note, which provided; (i) the definition of a “Qualified Financing Transaction” was amended to mean a capital raise of $8,000,000; (ii) in the event of the completion of the required capital raise, the conversion price of the Note would be reduced to an amount equal to 150% of the lowest price at which Company common stock were sold during calendar year 2010; (iii) paragraph 9 of the 6.25% senior secured convertible promissory note entitled “Company Redemption Right” was deleted in its entirety; (iv) in the event of the completion of the required capital raise, the exercise price of the Warrants was to be reduced to an amount equal to 150% of the lowest price at which Company common stock was sold during calendar year 2010; (v) in the event of the completion of the required capital raise the number of warrants was to be increased as provided in the 6.25% senior secured convertible promissory note; and (vi) the Expiration Date of the warrants was to be amended to December 30, 2013. The amendment was conditioned upon the Company raising at least $8,000,000 of gross proceeds from the sale of its equity securities by December 3, 2010. If the additional funding was not completed by October 31, 2010, certain provisions of the amendment agreement would have been void in that the maturity date would revert back to December 21, 2010, the conversion price of the Note would become the lowest price at which equity securities had been sold in 2010, the exercise price of the holder’s warrants would have become the lowest price at which equity securities had been sold, and the number of warrants then outstanding would have been determined by the original purchase documents and we would not have an obligation to maintain a balance of cash and marketable securities equal to $950,000.
 
 
52
 
 
On November 15, 2010, we entered into a Fifth Amendment and Extension Agreement dated as of November 15, 2010 (the “Fifth Amendment”) with the holder of the Note. The Fifth Amendment provided that the date by which the Company must consummate a Qualified Financing Transaction (as defined in prior amendments to the Note) was extended from December 3, 2010 to December 31, 2010. If a Qualified Financing Transaction occurred by December 31, 2010, the maturity date of the Note was to be extended to June 21, 2012 (as set forth in prior amendments). If a Qualified Financing Transaction was not completed by December 31, 2010, certain provisions of the amendment agreement would have been void in that the maturity date would revert back to December 21, 2010, the conversion price of the Note would become the lowest price at which equity securities had been sold in 2010, the exercise price of the holder’s warrants would have become the lowest price at which equity securities had been sold in 2010, and the number of warrants then outstanding would have been determined by the original purchase documents and we would not have an obligation to maintain a balance of cash and marketable securities equal to $950,000.
 
On December 24, 2010, we closed the Debt Restructuring.  In connection therewith, we (i) issued the Amended and Restated Note in the principal amount of $5.5 million to Castlerigg, (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the Loan Restructuring Agreement, and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010 under the terms of which we agreed to register up to 2,500,000 of Castlerigg’s shares of our common stock.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.
 
The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bears interest at an annual rate of 6.25%, payable semi-annually.  We paid the first year’s interest of approximately $344,000 at the closing.  The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.  The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us.  The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions.  Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.
 
The Investor Rights Agreement provides Castlerigg with certain registration rights with respect to the Company’s securities held by Castlerigg.  These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied.  The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.
 
In January 2011, we granted options to Leon Frankel, the holder of its $1.0 million unsecured convertible note and a greater-than-5% stockholder of Broadcast, to acquire up to 500,000 shares of our common stock for services performed pursuant to a consulting agreement with Mr. Frankel.  The options were exercisable at $1.00 per share and were exercisable for five years.  These options were converted to 250,000 shares of our common stock in January 2012.
 
In April 2011, we issued 293,517 shares of our common stock and granted a warrant to acquire an additional 146,758 shares of its common stock in payment of accrued interest to Leon Frankel, the holder of our $1.0 million unsecured convertible note and a greater-than 5% stockholder of Broadcast.  The warrant is exercisable at $.90 per share and has a life of five years.
 
 
53
 
 
In March and April, 2012, R. Phillip Zobrist, a Broadcast director, invested a total of $50,000 in Broadcast as a part of the 2012 Equity Funding.  In exchange for his investment he received 200,000 shares of common stock and warrants to acquire an additional 100,000 shares of common stock at an exercise price of $.35 per share.  The warrant is currently exercisable and expires six years from the date of issuance.
 
In December, 2012, and January 2013 Donald A. Harris, a Broadcast director, loaned a total of $300,000 to Broadcast pursuant to a written securities purchase agreement and promissory note.  The notes bear interest at the rate of 12% per annum and are due and payable on July 13, 2013.  The notes are convertible to common stock at the rate of $.25 per share.  In addition, the Mr. Harris received warrants to acquire an additional 600,000 shares of common stock at an exercise price of $.25 per share.  The warrant is currently exercisable and expires six years after issuance.
 
On February 21, 2013, we issued restricted stock units that may be settled by the issuance of 200,000 shares of our common stock to each of three of our directors and 86,667 shares to one of our directors for a total of 686,667 shares in consideration of unpaid director fees, which aggregated $51,500 or $.075 per share.
 
  For a description of our policies and procedures related to the review, approval or ratification of related person transactions, see “Conflict of Interest Policy” under Item 10, “Directors, Executive Officers and Corporate Governance.”
 
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
 
Fees for professional services provided by our current independent auditors for each of the last two fiscal years, in each of the following categories, are as follows:
 
   
2012
    
2011
  
Audit fees
   $ 86,500     $ 70,000  
Audit-related fees
     --       --  
Tax fees
     6,800       3,900  
All other fees
     8,800       9,700  
Total
   $ 102,100     $ 83,600  
 
Audit fees included fees associated with the annual audit and reviews of our annual and quarterly reports for 2012 and 2011.  In addition, these fees for 2012 included fees associated with our registration statement under the Securities Act of 1933, as amended, filed with the SEC.  All audit fees incurred during 2012 and 2011 were pre-approved by the audit committee. Tax fees included fees associated with tax compliance and tax consultations.  All tax fees incurred during 2012 and 2011 were pre-approved by the audit committee.
 
All other fees related to reviews of registration statements during each respective year and were pre-approved by the audit committee.
 
Tax fees included fees associated with tax compliance and tax consultations.  All tax fees incurred during 2012 and 2011 were pre-approved by the audit committee.
 
The audit committee has adopted a policy that requires advance approval of all services performed by the independent auditor when fees are expected to exceed $15,000.  The audit committee has delegated to the audit committee chairman, Mr. Boyd, authority to approve services, subject to ratification by the audit committee at its next committee meeting.
 
 
54
 
 
PART IV
 
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
 
(a)(1)  Financial Statements.  See the financial statements included in Item 8 of this report.
 
     (2)  Financial Statement Schedules.  All applicable schedule information is included in our financial statements included in Item 8 of this report. (a)Exhibits
 

 
Exhibit
Number
Description of Document
   
2.1
Agreement and Plan of Merger and Reorganization, dated as of January 6, 2012, by and among Broadcast International, Inc., AllDigital, Inc., and Alta Acquisition Corporation.  (Incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013.
   
3.1
Amended and Restated Articles of Incorporation of Broadcast International.   (Incorporated by reference to Exhibit No. 3.1 of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 filed with the SEC on November 14, 2006.)
   
3.2
Amended and Restated Bylaws of Broadcast International.  (Incorporated by reference to Exhibit No. 3.2 of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 filed with the SEC on November 14, 2006.)
   
4.1
Specimen Stock Certificate of Common Stock of Broadcast International.  (Incorporated by reference to Exhibit No. 4.1 of the Company's Registration Statement on Form SB-2, filed under cover of Form S-3, pre-effective Amendment No. 3 filed with the SEC on October 11, 2005.)
   
10.1*
Employment Agreement of Rodney M. Tiede dated April 28, 2004.  (Incorporated by reference to Exhibit No. 10.1 of the Company's Quarterly Report on Form 10-QSB for the quarter ended March 31, 2004 filed with the SEC on May 12, 2004.)
   
10.2*
Employment Agreement of James E Solomon dated September 19, 2008.  (Incorporated by reference to Exhibit No. 10.2 of the Company's Annual Report on Form 10-K for the year ended December 31, 2009 filed with the SEC on Mach 31, 2010.)
   
10.3*
Broadcast International 2004 Long-Term Incentive Plan.  (Incorporated by reference to Exhibit No. 10.4 of the Company's Annual Report on Form 10-KSB for the year ended December 31, 2003 filed with the SEC on March 30, 2004.)
   
10.4*
Broadcast International 2008 Long-Term Incentive Plan.  (Incorporated by reference to the Company’s  definitive Proxy Statement on Schedule 14A filed with the SEC on April 17, 2009)
   
10.5
Securities Purchase Agreement dated October 28, 2006 between Broadcast International and Leon Frenkel.  (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 6, 2006.)
   
10.6
5% Convertible Note dated October 16, 2006 issued by Broadcast International to Leon Frenkel.  (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on November 6, 2006.)
 
 
55
 
 
10.7
Registration Rights Agreement dated October 28, 2006 between Broadcast International and Leon Frenkel.  (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on November 6, 2006.)
   
10.8
Securities Purchase Agreement dated as of December 21, 2007, by and among Broadcast International and the investors listed on the Schedule of Buyers attached thereto. (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.9
Registration Rights Agreement dated as of December 21, 2007, by and among Broadcast International and the buyers listed therein.  (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.10
6.25% Senior Secured Convertible Promissory Note dated December 21, 2007 issued to the holder listed therein.  (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.11
Warrant to Purchase Common Stock dated December 21, 2007 issued to the holder listed therein.  (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.12
Loan Restructuring Agreement between the Company and Castlerigg Master Investments Ltd., dated December 16, 2010 (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 22, 2010.)
   
10.13
Amendment to 8% Convertible Note Due 2010 between the Company and Leon Frenkel, dated December 22, 2010 (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on December 22, 2010.)
   
10.14
Placement Agency Agreement between the Company and Philadelphia Brokerage Corporation, dated December 17, 2010 (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.15
Form of Subscription Agreement (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.16
Form of Warrant (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.17
Amended and Restated Senior Convertible Note issued by the Company to Castlerigg master Investments Ltd., dated December 23, 2010 (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.18
Investor Rights Agreement between the Company and Castlerigg Master Investments Ltd., dated December 23, 2010 (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.19
Letter between the Company and Castlerigg Master Investments Ltd., dated December 23, 2010 (Incorporated by reference to Exhibit 10.6 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
 
 
56
 
 
10.20
Form of Securities Purchase Agreement dated March 13, 2012.  (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.21
Form of A Warrant.  (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.22
Form of B Warrant.  (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.23
Loan Satisfaction Agreement between the Company and Castlerigg Master Investments Ltd. dated March 13, 2012.  (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.24
Registration Rights Agreement dated March 13, 2012.  (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.25
Form of Placement Agent Warrant.  (Incorporated by reference to Exhibit 10.6 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.26
Form of Note and Warrant Purchase and Security Agreement dated July 16, 2012.  (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2012.)
   
10.27
Form of Promissory Note dated July 16, 2012.  (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2012.)
   
10.28
Form of Warrant.  (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2012.)
   
10.29
Form of Voting Agreement, dated January 6, 2013, by and among AllDigital, Inc. and certain stockholders of Broadcast International, Inc. (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
10.30
Form of Voting Agreement, dated January 6, 2013, by and among Broadcast International, Inc. and certain stockholders of AllDigital, Inc. (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
10.31
Professional Services Agreement, dated January 6, 2013, by and between AllDigital, Inc. and Broadcast International, Inc. (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
10.32*
Amendment and Settlement Agreement, dated January 6, 2013, by and between Broadcast International, Inc. and Rodney Tiede.  (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
10.33*
Amendment and Settlement Agreement, dated January 6, 2013, by and between Broadcast International, Inc. and James E. Solomon. (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
 
 
57
 
 
10.34*
Amendment and Settlement Agreement, dated January 6, 2013, by and between Broadcast International, Inc. and Steve Jones. (Incorporated by reference to Exhibit 10.6 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
14.1
Code of Ethics. (Incorporated by reference to Exhibit No. 14 of the Company’s Annual Report on Form 10-KSB filed with the SEC on March 30, 2004.)
   
21.1
Subsidiaries.  (Incorporated by reference to Exhibit No. 21.1 of the Company’s Annual Report on Form 10-KSB filed with the SEC on April 1, 2005.)
   
23.1
Consent of HJ & Associates, LLC, independent registered public accountant.
   
24.1
Power of Attorney. (Included on page II-15).
   
31.1
Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer.
   
31.2
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.
   
32.1
Principal Executive Officer Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2
Chief Financial Officer Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS
XBRL Instance Document.
   
101.SCH
XBRL Taxonomy Extension Schema Document.
   
101.CAL
Taxonomy Extension Calculation Linkbase Document.
   
101.DEF
Taxonomy Extension Definition Linkbase Document.
   
101.LAB
Extension Labels Linkbase Document.
   
101.PRE
Taxonomy Extension Presentation Linkbase Document.
   
* Management contract or compensatory plan or arrangement.
 
 
58
 
 
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Broadcast International, Inc.
  
     
Date: March 29, 2012
/s/ Rodney M. Tiede
  
     
 
By:  Rodney M. Tiede
  
 
Its:  President
  
     
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
 
Date: March 29, 2013
/s/ Rodney M. Tiede
  
     
 
By:  Rodney M. Tiede
  
 
Its:  President and Director
  
 
(Principal Executive Officer)
  
     
Date: March 29, 2013
/s/ James E. Solomon
  
     
 
Its:  Chief Financial Officer
  
 
(Principal Financial and Accounting Officer)
  
     
Date: March 29, 2013
/s/ R. Phil Zobrist
  
     
 
By: R. Phil Zobrist
  
 
Its: Director
  
     
     
Date: March 29, 2013
/s/ William Boyd
  
     
 
By:  William Boyd
  
 
Its:  Director
 
  
Date: March 29, 2013
/s/ Steven Ledger
  
     
 
By:  Steven Ledger
  
 
Its:  Director
  
     
Date: March 29, 2013
/s/ Donald A. Harris
  
     
 
By:  Donald A. Harris
  
 
Its:  Director
  
 
 
59
 
 
Report of Independent Registered Public Accounting Firm
 

 
To the Board of Directors
Broadcast International, Inc.
Salt Lake City, Utah
 
We have audited the accompanying consolidated balance sheets of Broadcast International, Inc. and subsidiaries as of December 31, 2012 and 2011, and the related consolidated statements of operations, stockholders' equity (deficit), and cash flows for the years then ended. These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
 
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
 
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Broadcast International, Inc. and subsidiaries as of December 31, 2012 and 2011, and the results of their operations and their cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles.
 

 
/s/  HJ & Associates, LLC
HJ & Associates, LLC
Salt Lake City, Utah
March 29, 2013
 
 
F-1
 

 
             BROADCAST INTERNATIONAL, INC.
CONSOLIDATED BALANCE SHEETS
 
             
   
DEC 31,
2011
    
DEC 31,
2012
  
ASSETS:
            
Current Assets
            
     Cash and cash equivalents
   $ 961,265     $ 394,342  
     Restricted cash
     --       140,700  
     Trade accounts receivable, net
     1,239,903       821,608  
     Inventory
     60,851       306,296  
     Prepaid expenses
     203,973       90,067  
     Total current assets
     2,465,992       1,753,013  
Property and equipment, net
     1,417,134       572,107  
Other Assets, non current
                
     Debt offering costs
     123,278       42,176  
     Patents, net
     131,079       120,928  
     Deposits and other assets
     406,004       196,292  
     Total other assets, non current
     660,361       359,396  
                 
     Total assets
   $ 4,543,487     $ 2,684,516  
                 
LIABILITIES AND STOCKHOLDERS DEFICT
                
LIABILITIES:
                
Current Liabilities
                
     Accounts payable
   $ 1,252,538     $ 2,293,470  
     Payroll and related expenses
     390,206       363,568  
     Other accrued expenses
     175,008       299,728  
     Unearned revenue
     10,449       51,335  
     Current portion of notes payable (net of discount of $103,859 and
     $947,994, respectively)
     2,068,016       3,102,006  
     Other current obligations
     1,067,649       --  
     Derivative valuation
     3,760,200       1,191,269  
          Total current liabilities
     8,724,066       7,301,376  
Long-term Liabilities
                
     Long-term portion of notes payable (net of discount of $659,496
     and $0, respectively)
     6,349,445       --  
     Total long-term liabilities
     6,349,445       --  
     Total liabilities
     15,073,511       7,301,376  
Commitments and contingencies
     --       --  
STOCKHOLDERS’ DEFICIT:
                
     Preferred stock, no par value, 20,000,000 shares authorized; none issued
     --       --  
     Common stock, $.05 par value, 180,000,000 shares authorized;
     75,975,656 and 107,473,820 shares issued as of December 31,
     2011 and December 31, 2012, respectively
     3,798,783       5,373,691  
     Additional paid-in capital
     96,859,058       99,594,490  
     Accumulated deficit
     (111,187,865 )     (109,585,041 )
          Total stockholders’ deficit
     (10,530,024 )     (4,616,860 )
                 
          Total liabilities and stockholders’ deficit
   $ 4,543,487     $ 2,684,516  

See accompanying notes to consolidated financial statements
 
 
F-2
 
 
BROADCAST INTERNATIONAL, INC.
CONSOLIDATED STATEMENT OF OPERATIONS

             
   
For the Year Ended
Dec 31, 2011
    
For the Year Ended
Dec 31, 2012
  
             
Net sales
   $ 8,446,082     $ 7,523,624  
Cost of sales
     5,868,601       4,819,624  
Gross profit
     2,577,481       2,704,000  
                 
Operating expenses:
                
     Administrative and general
     6,172,794       4,546,612  
     Selling and marketing
     1,277,629       1,908,763  
     Research and development
     2,410,249       1,754,163  
     Impairment of assets
     26,180       --  
     Depreciation and amortization
     685,191       558,148  
          Total operating expenses
     10,572,043       8,767,686  
          Total operating loss
     (7,994,562 )     (6,063,686 )
                 
Other income (expense):
                
     Interest income
     2,327       --  
     Interest expense
     (1,000,072 )     (1,542,424 )
     Gain on derivative valuation
     11,724,400       8,829,748  
     Note conversion offering expense
     --       (47,348 )
     Retirement of debt offering costs
     --       (53,150 )
     Debt conversion costs
     (476,234 )     (1,095,309 )
     (Loss) gain on extinguishment of debt
     (954,017 )     1,578,914  
     (Loss) gain on sale of assets
     (362 )     512  
     Other income, net
     2,966       (4,433 )
          Total other income
     9,299,008       7,666,510  
                 
Income before income taxes
     1,304,446       1,602,824  
Provision for income taxes
     --       --  
Net income
   $ 1,304,446     $ 1,602,824  
                 
Income per share basic
   $ 0.02     $ 0.2  
Income per share diluted
   $ 0.02     $ 0.2  
                 
Weighted average shares basic
     75,416,916       100,798,223  
Weighted average shares diluted
     78,098,166       106,533,844  

See accompanying notes to consolidated financial statements

 
 
F-3
 
 
BROADCAST INTERNATIONAL, INC.
 
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
 
YEARS ENDED DECEMBER 31, 2012 AND 2011
 
         
Additional
    
Retained
        
   
Common Stock
    
Paid-in
    
Earnings
    
Equity
  
   
Shares
    
Amount
    
Capital
    
(Deficit)
    
(Deficit)
  
Balance, December 31, 2010
     74,078,153     $ 3,703,908     $ 92,867,561     $ (112,492,311 )   $ (15,920,842 )
                                         
Common stock issued on debt conversion,
net of costs
     1,307,153       65,357       1,230,790       --       1,296,147  
                                         
Common stock issued for interest
     135,369       6,768       74,453       --       81,221  
                                         
Common stock issued for option exercises
     55,098       2,755       15,549       --       18,304  
                                         
Common stock issued for warrant exercises
     372,272       18,614       241,386       --       260,000  
                                         
Common stock issued in exchange for IDI
shares
     27,611       1,381       9,379       --       10,760  
                                         
Equity issued for interest
     --       --       157,400       --       157,400  
                                         
Stock based compensation
     --       --       2,262,540       --       2,262,540  
                                         
Net Income
     --       --       --       1,304,446       1,304,446  
                                         
Balance, December 31, 2011
     75,975,656     $ 3,798,783     $ 96,859,058     $ (111,187,865 )   $ (10,530,024 )
                                         
Common stock issued for 2012 equity
financing and debt restructuring, net of
issuance costs
     25,402,164       1,270,108       837,726       --       2,107,834  
                                         
Common stock issued on debt conversion
     5,600,000       280,000       1,380,000       --       1,660,000  
                                         
Common stock issued for services rendered
     496,000       24,800       152,513       --       177,313  
                                         
Amended and restated 6.25% note
conversion feature
     --       --       81,500       --       81,500  
                                         
Stock based compensation
     --       --       283,693       --       283,693  
                                         
Net Income
     --       --       --       1,602,824       1,602,824  
                                         
Balance, December 31, 2012
     107,473,820     $ 5,373,691     $ 99,594,490     $ (109,585,041 )   $ (4,616,860 )

See accompanying notes to consolidated financial statements
 
 
F-4
 
 
BROADCAST INTERNATIONAL, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
   
For the Year
Ended Dec 31,
2011
    
For the Year
Ended Dec 31,
2012
  
Cash flows from operating activities:
            
    Net Income
   $ 1,304,446     $ 1,602,824  
    Adjustments to reconcile net loss to net cash used in operating activities:
                
         Depreciation and amortization
     1,483,868       1,024,754  
         Common stock issued for services
     --       177,313  
         Common stock issued for interest
     19,634       --  
         Common stock issued for in process research and development
     10,760       --  
         Accretion of discount on convertible notes payable
     340,377       941,225  
         Stock based compensation
     2,262,540       283,693  
         Warrants issued for interest
     157,400       --  
         Warrants issued for debt extinguishment costs
     404,000       --  
         Warrants issued and expensed for issuance costs
     --       1,095,309  
         Loss (gain) on extinguishment of debt
     954,017       (1,578,914 )
         Expensed note conversion costs
     --       47,348  
         Gain on derivative liability valuation
     (11,724,400 )     (8,829,748 )
         Loss (gain) on sale of assets
     362       (512 )
         Retirement of debt offering costs
     --       53,150  
         Loss on impairment of assets
     26,180       --  
         Allowance for doubtful accounts
     10,149       31,982  
    Changes in assets
                
         Decrease (increase) in accounts receivable
     (124,997 )     386,313  
         Increase in inventories
     (8,676 )     (245,445 )
         Decrease (increase) in debt offering costs
     (102,978 )     105,805  
         Decrease in prepaid and other assets
     205,498       323,618  
    Changes in liabilities
                
         Increase (decrease) in accounts payable
     (267,452 )     1,040,932  
         Increase in accrued expenses
     13,823       136,682  
         Increase (decrease) in deferred revenues
     (128,988 )     40,886  
    Net cash used in operating activities
     (5,164,437 )     (3,362,785 )
                 
Cash flows from investing activities:
                
    Purchase of equipment
     (472,505 )     (172,825 )
    Proceeds from sale of assets
     1,183       3,761  
    Net cash used by investing activities
     (471,322 )     (169,064 )
                 
Cash flows from financing activities:
                
    Proceeds from the exercise of options and warrants
     18,304       --  
    Proceeds from equity financing
     --       6,150,000  
    Payments on principal on debt
     (1,526,834 )     (4,017,649 )
    Equity issuance costs
     (24,078 )     (776,483 )
    Proceeds from equipment financing
     700,000       --  
    Payments for debt extinguishment costs
     --       (275,041 )
    Increase in restricted cash
     --       (140,700 )
    Proceeds from notes payable
     1,300,000       2,024,799  
    Net cash provided by financing activities
     467,392       2,964,926  
                 
Net decrease in cash and cash equivalents
     (5,168,367 )     (566,923 )
Cash and cash equivalents, beginning of period
     6,129,632       961,265  
                 
Cash and cash equivalents, end of period
   $ 961,265     $ 394,342  
                 
Supplemental disclosure of cash flow information:
                
    Interest paid
   $ 357,246     $ 347,902  
    Income taxes paid
   $ --     $ --  
 
See accompanying notes to consolidated financial statements
 
 
F-5
 
 
BROADCAST INTERNATIONAL, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2012 AND 2011
 
Note 1 – Organization and Basis of Presentation
 
Broadcast International, Inc. (the Company) is the consolidated parent company of BI Acquisitions, Inc. (BI), a wholly-owned subsidiary, and Interact Devices, Inc. (IDI), a 94% owned subsidiary.
 
BI was incorporated in Utah in December 1999 and began operations in January 2000.  It is a communications services and technology company headquartered in Salt Lake City, Utah.  The Company operates two divisions – BI Networks and CodecSys.
 
On October 1, 2003, the Company (formerly known as Laser Corporation) acquired BI by issuing shares of its common stock representing 98% of the total equity ownership in exchange for all of the issued and outstanding BI common stock.  The transaction was accounted for as a reverse acquisition, or recapitalization of BI, with BI being treated as the accounting acquirer. Effective January 13, 2004, the company changed its name from Laser Corporation to Broadcast International, Inc.
 
On May 18, 2004, the Debtor-in-Possession’s Plan of Reorganization for IDI was confirmed by the United States Bankruptcy Court. As a result of this confirmation and subsequent share acquisitions, for the years ended December 31, 2012 and 2011, the Company owned, on a fully diluted basis, approximately 55,897,169 common share equivalents of IDI, representing approximately 94% of the equity of IDI.
 
The audited consolidated financial statements herein include operations from January 1, 2011 to December 31, 2012. IDI produced losses from operations during the period; therefore, 100% of the results from operations have been included in the Company’s consolidated statements.
 
Note 2 - Significant Accounting Policies
 
Management Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.
 
Cash and Cash Equivalents
 
We consider all cash on hand and in banks, and highly liquid investments with maturities of three months or less, to be cash equivalents. At December 31, 2012 and 2011, we had bank balances of $38,847 and $909,182, respectively in excess of amounts insured by the Federal Deposit Insurance Corporation. In addition we have restricted cash of $140,700, which represents a deposit to the Utah District Court, which is held pending the outcome of our litigation with our equipment lessor.  We have not experienced any losses in such accounts, and believe we are not exposed to any significant credit risk on cash and cash equivalents.
 
Current financial market conditions have had the effect of restricting liquidity of cash management investments and have increased the risk of even the most liquid investments and the viability of some financial institutions.  We do not believe, however, that these conditions will materially affect our business or our ability to meet our obligations or pursue our business plans.
 
 
F-6
 
 
Account Receivables
 
Trade account receivables are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.
 
A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than 90 days. After the receivable becomes past due, it is on non-accrual status and accrual of interest is suspended.
 
Inventories
 
Inventories consisting of electrical and computer parts are stated at the lower of cost or market determined using the first-in, first-out method.
 
Property and Equipment
 
Property and equipment are stated at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the property, generally from three to five years.  Repairs and maintenance costs are expensed as incurred except when such repairs significantly add to the useful life or productive capacity of the asset, in which case the repairs are capitalized.
 
Patents and Intangibles
 
Patents represent initial legal costs incurred to apply for United States and international patents on the CodecSys technology, and are amortized on a straight-line basis over their useful life of approximately 20 years.  We have filed several patents in the United States and foreign countries. As of December 31, 2012, the United States Patent and Trademark Office had approved four patents.  Additionally, eleven foreign countries had approved patent rights.  While we are unsure whether we can develop the technology in order to obtain the full benefits, the patents themselves hold value and could be sold to companies with more resources to complete the development. On-going legal expenses incurred for patent follow-up have been expensed from July 2005 forward. For the year ended December 31, 2011 we recorded a $26,180 valuation impairment related to two patent applications for areas outside the United States.
 
Amortization expense recognized on all patents totaled $10,151 for each of the years ended December 31, 2012 and 2011, respectively.
 
Estimated amortization expense, if all patents were issued at the beginning of 2013, for each of the next five years is as follows:
 
Year ending
December 31:
        
2013
     $ 11,343  
2014
       10,121  
2015
       10,121  
2016
       10,121  
2017
       10,121  
 
 
F-7
 
 
Long-Lived Assets
 
We review our long-lived assets, including patents, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets held and used is measured by a comparison of the carrying amount of an asset to future un-discounted net cash flows expected to be generated by the asset.  If such assets are considered to be impaired, then the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.  Fair value is determined by using cash flow analyses and other market valuations. After our review at December 31, 2012 it was determined that no adjustment was required.
 
Stock-based Compensation
 
In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.
 
Income Taxes
 
We account for income taxes in accordance with the asset and liability method of accounting for income taxes prescribed by ASC Topic 740.  Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income in the years in which those temporary differences are expected to be recovered or settled.
 
Revenue Recognition
 
We recognize revenue when evidence exists that there is an arrangement between us and our customers, delivery of equipment sold or service has occurred, the selling price to our customers is fixed and determinable with required documentation, and collectability is reasonably assured. We recognize as deferred revenue, payments made in advance by customers for services not yet provided.

When we enter into a multi-year contract with a customer to provide installation, network management, and satellite transponder and help desk, or combination of these services, we recognize this revenue as services are performed and as equipment is sold.  These agreements typically provide for additional fees, as needed, to be charged if on-site visits are required by the customer in order to ensure that each customer location is able to receive network communication. As these on-site visits are performed the associated revenue and cost are recognized in the period the work is completed. If we install, for an additional fee, new or replacement equipment to an immaterial number of new customer locations, and the equipment immediately becomes the property of the customer, the associated revenue and cost are recorded in the period in which the work is completed.

In instances where we have entered into license agreements with a third parties to use our technology within their product offering, we recognize any base or prepaid revenues over the term of the agreement and any per occurrence or periodic usage revenues in the period they are earned.

Research and Development
 
Research and development costs are expensed when incurred.  We expensed $1,754,163 and $2,410,249 of research and development costs for the years ended December 31, 2012 and 2011, respectively.
 
Concentration of Credit Risk
 
Financial instruments, which potentially subject us to concentration of credit risk, consist primarily of trade accounts receivable. In the normal course of business, we provide credit terms to our customers. Accordingly, we perform ongoing credit evaluations of our customers and maintain allowances for possible losses which, when realized, have been within the range of management’s expectations.
 
 
F-8
 

For the years ended December 31, 2012 and 2011, we had the same customer that individually constituted 85% and 89%, of our total revenues, respectively.  Although the initial contract for this customer has expired, we received a contract extension through May 31, 2013 to continue to provide services. Unless we can replace that customer with another similarly large customer or customers, revenues will decline substantially, which will harm our business.

Weighted Average Shares
 
Basic earnings per common share is computed by dividing net income or loss applicable to common shareholders by the weighted average number of shares outstanding during each period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year, plus the dilutive common stock equivalents that would rise from the exercise of stock options, warrants and restricted stock units outstanding during the period, using the treasury stock method and the average market price per share during the period, plus the effect of assuming conversion of the convertible debt. The computation of diluted earnings per share does not assume conversion or exercise of securities that would have an anti-dilutive effect on earnings.

 
The following table sets forth the computation of basic and diluted earnings per common share for the years ended December 31, 2011 and 2012:

   
For the Year
Ended 2011
    
For the year
Ended 2012
  
Numerator
            
  Net income
   $ 1,304,446     $ 1,602,824  
Denominator
                
  Basic weighted average shares outstanding
     75,416,916       100,978,223  
  Effect of dilutive securities:
                
  Stock options and warrants
     131,250       2,510,488  
  Restricted stock units
     2,550,000       3,225,133  
Diluted weighted average shares outstanding
     78,098,166       106,533,844  
                 
  Net income per common share
                
    Basic
   $ 0.02     $ 0.02  
    Diluted
   $ 0.02     $ 0.02  

Potentially dilutive securities representing 18,568,963 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2012, because their effect would have been anti-dilutive.

Potentially dilutive securities representing 24,597,134 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2011, because their effect would have been anti-dilutive.

Advertising Expenses
 
We follow the policy of charging the costs of advertising to expense as incurred.  Advertising expense for the years ended December 31, 2012 and 2011 were $35,168 and $68,703, respectively.
 
Off-Balance Sheet Arrangements
 
We have no off-balance sheet arrangements.
 
 
F-9
 
 
Recent Accounting Pronouncements
 
In August 2012, the FASB issued ASU No 2012-03, Technical Amendments and Corrections to SEC Sections. This Update makes changes to several of the SEC guidance literature sections within the Codification.  The main focus is to update the SEC guidance as per SAB 114 to reference the codification sections rather than the old standards prior to the codification.  The changes were mainly references and were not intended to change guidance. The amendments in this Update are effective immediately.  This guidance didn’t have a significant impact on the Company’s financials since it was an update of SEC referenced guidance and didn’t change existing guidance.

In July 2012, the FASB issued ASU 2012-02, Intangibles - Goodwill and Other (Topic 350) - Testing Indefinite-Lived Intangible Assets for Impairment. The objective of this Update is to simplify how entities test indefinite-lived intangible assets for impairment and to have the testing be in-line with the updated guidance issued in 2011 related to impairment testing for goodwill. This Update allows entities to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative analysis. The more likely than not threshold is defined as having a likelihood of more than 50%.  The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the quantitative impairment test and still be able to resume performing the qualitative assessment in subsequent years. Some examples of circumstances to consider are 1) cost factors that have a negative impact on earnings, 2) financial performance such as negative or declining cash flows, 3) legal, regulatory, contractual, political or business conditions, 4) other relevant entity specific events 5) industry and market conditions, and 6) macroeconomic conditions. The Update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before July 27, 2012 if the financial statements have not been issued.  The Company doesn’t expect this Update to impact the Company’s financials since it currently has no indefinite-lived intangibles other than goodwill, but the Company will plan on utilizing the qualitative assessment options if any are acquired.

In June 2011, the FASB issued ASU 2011-05, Comprehensive Income (Topic 220) – Presentation of Comprehensive Income. This Update eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity in order to increase the prominence of other comprehensive income items and to facilitate convergence with IFRS. The Update requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements (a statement of income and statement of other comprehensive income).  Additionally, adjustments for items reclassified from other comprehensive income to net income must be presented on the face of the financial statements.  This Update should be applied retrospectively. For public entities, the Update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. For nonpublic entities, the Update is effective for fiscal years ending after December 15, 2012, and interim and annual periods thereafter. Early adoption is permitted, because compliance with the amendments is already permitted. The amendments do not require any transition disclosures. This impacts how items for Other Comprehensive Income are presented and the Company will follow the guidance starting in Q1 2012.

In December 2011, the FASB issued ASU 2011-11, Balance Sheet (Topic 210) – Disclosures about Offsetting Assets and Liabilities. This Update is applicable to all entities that have financial instruments and derivative instruments that are either 1) offset in accordance with current guidance or 2) subject to an enforceable master netting arrangement.  The Update requires an entity with these types of instruments to disclose information about offsetting and related arrangements. Both net and gross information for these assets and liabilities is required to be disclosed. This Update is effective for fiscal years beginning on or after January 1, 2013. The Company doesn’t expect this Update to impact the Company’s financials since it does not currently have any financial instruments or derivative instruments that are offset.
 
 
F-10
 
 
In September 2011, the FASB issued ASU 2011-08, Intangibles - Goodwill and Other  (Topic 350)- Testing Goodwill for Impairment. The objective of this Update is to simplify how entities test goodwill for impairment. This Update now allows entities to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step process of (1) comparing the fair value of the reporting unit to its carrying value and (2) test to measure the amount of the impairment loss if the fair value is less than the carrying value.  The more likely than not threshold is defined as having a likelihood of more than 50%.  The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the first step of the two-step goodwill impairment test. Some examples of circumstances to consider are 1) macroeconomic conditions, 2) industry and market conditions, 3) cost factors that have a negative impact on earnings, 4) overall financial performance such as negative or declining cash flows 5) other relevant entity specific events and 6) sustained decrease in stock price. The Update is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before September 15, 2011 if the financial statements have not been issued.  If necessary, the Company will evaluate whether or not it will utilize the qualitative assessment option prior to performing the first goodwill impairment test in 2012, typically done during the 4th quarter.

In May 2011, the FASB issued ASU 2011-04, Fair Value Measurement (Topic 820) – Amendments to Achieve Common Fair Value Measurements and Disclosure Requirements in US GAAP and IFRSs. The Amendments in this Update will improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with US GAAP and IFRSs.  The Boards of both organizations worked together to ensure fair value has the same meaning and the measurement and disclosures would be the same other than minor differences in wording. The Amendments explain how to measure fair value and do not require any additional fair value measurements. A couple of the more significant changes are 1) Clarification that quantitative information about unobservable inputs categorized as Level 3 should be disclosed, 2) Specifies that premiums and discounts should be applied in the absence of Level 1 input if market participants would do so, but that premiums or discounts related to size/quantity should not be considered, 3) Additional disclosure requirements for fair value measurements categorized as Level 3, an entity’s us of a nonfinancial asset in a way that differs from the asset’s highest and best use and the categorization by level for items not measured at fair value in the statement of financial position, but for which fair value disclosure is required. The amendments in this Update are to be applied prospectively. The Update is effective during interim and annual periods beginning after December 15, 2011.  The Company doesn’t expect this guidance to have a significant impact on its financials since the amount of items disclosed at fair value is minimal, but will ensure the guidance is followed for items disclosed at fair value.

Note 3 – Accounts Receivable
 
Included in our $821,608 and $1,239,903 net accounts receivable for the years ending December 2012 and 2011, respectively, were (i) $856,462 and $1,269,579 for billed trade receivables, respectively; (ii) $44,478 and $23,814 of unbilled trade receivables, respectively; (iii) $1,808 and $0 for employee travel advances and other receivables, respectively; less (iv) $81,140 and $53,490 for allowance for uncollectible accounts, respectively.
 
Included in the numbers above is our single largest customer for each year ended December 31, 2012 and, 2011, which provided 85% and 89% of total revenue and represented 71% and 79% of our trade receivables on December 31, 2012 and 2011, respectively.
 
Our largest customer initially signed a three-year agreement which has now expired, although we did receive a contract extension through May 31, 2013 to continue to provide services. Unless we can replace that customer with another similarly large customer or customers, revenues will decline substantially, which will harm our business.

 
F-11
 
 
Note 4 – Equity Financing and the Debt Restructuring
 
2012 Equity Financing and the Debt Restructuring
 
On March 26, 2012, we closed on an equity financing (the “2012 Equity Financing”) as well as a restructuring of our outstanding senior convertible indebtedness (the “2012 Debt Restructuring”) resulting in complete satisfaction of our senior indebtedness.
 
We entered into an Engagement Agreement, dated October 28, 2011, with MDB Capital Group, LLC (“MDB”), pursuant to which MDB agreed to act as the exclusive agent of the Company on a “best efforts” basis with respect to the sale of up to a maximum gross consideration of $6,000,000, subsequently verbally increased to $10,000,000, of the Company’s securities, subject to a minimum gross consideration of $3,000,000.  The Company agreed to pay to MDB a commission of 10% of the gross offering proceeds received by the Company, to grant to MDB warrants to acquire up to 10% of the shares of our common stock and warrants issued in the financing, and to pay the reasonable costs and expenses of MDB related to the offering.
 
Pursuant to the Engagement Agreement, we entered into a Securities Purchase Agreement (“SPA”) dated March 23, 2012 with select institutional and other accredited investors for the private placement of 27,800,000 units of our securities.  The SPA included a purchase price of $0.25 per unit, with each unit consisting of one share of common stock and two forms of Warrant: (1) The “A” Warrant grants the investors the right to purchase an additional share of common stock for each two shares of common stock purchased, for a term of six years and at an exercise price of $0.35 per share; and (2) The “B” Warrant will not be exercisable unless and until the occurrence of a future issuance of stock at less than $0.25 per share, but, in the event of such issuance, grants the investors the right to acquire additional shares at a price of $0.05 to reduce the impact of the dilution caused by such issuance, but in no event shall the number of shares to be issued under the B Warrant cause us to exceed the number of authorized shares of common stock. The shares in excess of our authorized shares that would have been issuable under the B Warrant shall be “net settled” by payment of cash in an amount equal to the number of shares in excess of the authorized common shares multiplied by the closing price of our common stock as of the trading day immediately prior to the applicable date of the exercise of such B Warrant. The holders of the B Warrants agreed in December 2012 to amend the terms of the B Warrant to reduce the amount of subsequent financing required to extinguish the B Warrants with the result that the B Warrants have now been extinguished.

Net proceeds from the 2012 Equity Financing, after deducting the commissions and the estimated legal, printing and other costs and expenses related to the financing, were approximately $6.1 million.  Coincident to the closing of the 2012 Equity Financing, we also closed on the 2012 Debt Restructuring.  In connection therewith, the Company paid $2,750,000 to Castlerigg Master Investment Ltd. (“Castlerigg”), and issued to Castlerigg 2,000,000 shares of common stock in full and complete satisfaction of the senior convertible note and all accrued interest. In consideration of negotiating the 2012 Debt Restructuring, we issued to one of our placement agents 586,164 shares of our common stock and paid them $275,041.
 
In December 2011, we entered into a loan with 7 accredited individuals and entities under the terms of which we borrowed $1,300,000 to be used as working capital (“Bridge Loan”).  The Bridge Loan bears an interest rate of 18% per annum and had a maturity date of February 28, 2012, which was subsequently extended to the earlier of the date nine months from the original maturity date or the date we close on an additional sale of our securities that results in gross proceeds to us of $12 million.  In consideration of the Bridge Loan we granted to the holders of the Bridge Loan warrants with a five year term to purchase 357,500 shares of our common stock at an exercise price of $0.65 per share.  In consideration of the extension of the maturity date of the Bridge Loan, we granted the holders of the Bridge Loan warrants with a six year term to purchase 247,500 shares of our common stock at an exercise price of $0.35 per share.
 
In connection with the 2012 Equity Financing and under the terms of the SPA, two of the above described bridge lenders converted the principal balance of their portion of the bridge loan in the amount of $400,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing.  In addition, one other entity converted the amount owed by us for equipment purchases in the amount of $500,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing. The proceeds from these conversions were treated as funds raised with respect to the financing.

 
F-12
 
 
In connection with the 2012 Equity Financing and under the terms of the SPA, the Company agreed to prepare and file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the Warrants.  The Company filed the registration statement on April 9, 2012 and it was declared effective on August 1, 2012.
 
On April 5, 2012 we secured an additional $154,000 from 1 company and 4 individuals (three of which are members of our Board of Directors) on the same terms and conditions as the investors of the 2012 Equity Financing. As a result of this funding we issued 616,000 shares of our common stock and A warrants totaling 400,400 of which 308,000 were issued to investors and 92,400 were issued to our investment banker.
 
All warrants listed below were issued with price protection provisions and were accounted for as derivative liabilities. The A Warrants were valued using the Black Scholes pricing model and the B Warrants were valued using the Geometric Brownian Motion methodology with a risk neutral Monte Carlo approach.
 

                               
   
Common
Shares
Issued
    
Number of
A Warrants
    
Value of A
Warrants
    
Value of
B
Warrants
    
Total
Warrant
Value
  
Investors
     24,816,000       12,408,000     $ 469,464     $ 39,387     $ 508,851  
Bridge Loan Conversion
     1,600,000       800,000       30,268       2,539       32,807  
Equipment Finance Conversion
     2,000,000       1,000,000       37,836       3,174       41,010  
Agency
     --       4,262,400       161,270       13,531       174,801  
Total
     28,416,000       18,470,400     $ 698,838     $ 58,631     $ 757,469  

We recorded an aggregate derivative liability of $757,469 as of December 31, 2012, related to the reset feature of the A warrants and the B warrants mentioned above. A derivative valuation gain of $4,365,323 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants issued.  The aggregate derivative liability of $757,469 was calculated as follows: (1) $698,838 for the reset feature of the A warrants using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.72%, (ii) expected life (in years) of 5.2; (iii) expected volatility of 85.49%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08 and (2) $58,631 for the B warrants using the Geometric Brownian Motion methodology with a risk neutral Monte Carlo approach.
 
2010 Equity Financing and the Debt Restructuring
 
On December 24, 2010, we closed on an equity financing (the “Equity Financing”) as well as a restructuring of our then outstanding convertible indebtedness (the “Debt Restructuring”).  The Equity Financing and the Debt Restructuring are described as follows.
 
We entered into a Placement Agency Agreement, dated December 17, 2010, with Philadelphia Brokerage Corporation (“PBC”), pursuant to which PBC agreed to act as the exclusive agent of the Company on a “best efforts” basis with respect to the sale of up to a maximum gross consideration of $15,000,000 of units of the Company’s securities, subject to a minimum gross consideration of $10,000,000.  The units consisted of two shares of our common stock and one warrant to purchase a share of our common stock.  The Company agreed to pay PBC a commission of 8% of the gross offering proceeds received by the Company, to issue PBC 40,000 shares of its common stock for each $1,000,000 raised, and to pay the reasonable costs and expenses of PBC related to the offering.  The Company also agreed to pay PBC a restructuring fee in the amount of approximately $180,000 upon the closing of the Equity Financing and the simultaneous Debt Restructuring.
 
 
F-13
 
 
Pursuant to the Placement Agency Agreement, we entered into Subscription Agreements dated December 23, 2010 with select institutional and other accredited investors for the private placement of 12,500,000 units of our securities.  The Subscription Agreements included a purchase price of $1.20 per unit, with each unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock.  The warrants have a term of five years and had an exercise price of $1.00 per share which was reset to $0.78 pursuant to the 2012 Equity Financing.
 
Net proceeds from the Equity Financing, after deducting the commissions and debt restructuring fees payable to PBC and the estimated legal, printing and other costs and expenses related to the financing, were approximately $13.5 million.  We used a portion of the net proceeds of the Equity Financing to pay down debt and the remainder was used for working capital.
 
On November 29, 2010, we entered into a bridge loan transaction with three accredited investors pursuant to which we issued unsecured notes in the aggregate principal amount of $1.0 million.  Upon the closing of the Equity Financing, the lenders converted the entire principal amount plus accrued interest into the same units offered in the Equity Financing and the proceeds from the bridge loan transaction were treated as funds raised with respect to the financing.
 
In connection with the Equity Financing and under the terms of the Subscription Agreements, the Company agreed to prepare and file, and did file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the warrants.  The registration statement was declared effective June 16, 2011 satisfying the obligation contained in the Subscription Agreements.
 
On December 24, 2010, we also closed on the Debt Restructuring.  In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the “Amended and Restated Note”) to Castlerigg Master Investment Ltd. (“Castlerigg”), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents were issued (the “Loan Restructuring Agreement”), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.
 
The Amended and Restated Note, dated December 23, 2010, was a senior, unsecured note that matured in three years from the closing and bore interest at an annual rate of 6.25%, payable semi-annually.  We paid the first year’s interest of $350,434 at the closing.  The Amended and Restated Note was convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.  The Amended and Restated Note was convertible in whole or in part at any time upon notice by Castlerigg to us.  The Amended and Restated Note also contained various restrictions, acceleration provisions and other standard and customary terms and conditions.  Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.
 
The Investor Rights Agreement provides Castlerigg with certain registration rights with respect to the Company’s securities held by Castlerigg.  These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied.  The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.
 
During the three months ended March 31, 2011, we issued Castlerigg 400,000 warrants pursuant to a waiver agreement dated March 10, 2011 allowing the issuance of shares and warrants for the conversion of the AR Note Payable without adjusting the conversion price of the Amended and Restated Senior 6.25% Convertible Note.  These warrants contain full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model. During the three and six months ended June 30 ,2011 the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock. A valuation gain of $144,000 was recorded to reflect the change in value of the aggregate derivative from the time of issue to the date of conversion.
 
 
F-14
 
 
In connection with the Debt Restructuring, the Company amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013. We also issued 150,000 shares and 75,000 warrants to acquire our common stock at $.90 per share to the holder of this note as consideration to extend the term of the note.
 
On March 26, 2012, we closed on an equity financing (the “2012 Equity Financing”) as well as a restructuring of our outstanding senior convertible indebtedness (the “2012 Debt Restructuring”) resulting in complete satisfaction our senior indebtedness.
 
A portion of the net proceeds from the 2012 Equity Financing was used to close on the 2012 Debt Restructuring therewith. The Company paid $2,750,000 and issued 2,000,000 shares of common stock valued at $760,000 to Castlerigg in satisfaction of the $5,500,000 senior convertible note and $680,816 of accrued interest.
 
Investor warrants totaling 12,499,980 issued under the Subscription  Agreements contain price protection adjustments in the event we issue new common stock or common stock equivalents in certain transactions at a price less than $1.00 per share and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model. The exercise price has been reset to $0.7312 per share due to subsequent financings.

We recorded an aggregate derivative liability of $109,400 and $2,785,000 as of December 31, 2012 and 2011, respectively, related to the reset feature of the warrants issued under the Placement agency Agreement. A derivative valuation gain of $2,765,600 and $7,875,000, respectively, were recorded to reflect the change in value of the aggregate derivative liability since December 31, 2011 and December 31, 2010, respectively.  The aggregate derivative liability of $109,400 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.36%, (ii) expected life (in years) of 3.0; (iii) expected volatility of 85.10%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.
 

Note 5 – Notes Payable
 
The recorded value of our notes payable (net of debt discount) for the years ending December 31, 2012 and 2011 was as follows:

   
December 31,
2011
    
December 31,
2012
  
2012 Secured Convertible Notes
     --       2,428,166  
Unsecured Convertible Note
     340,504       673,840  
Amended and Restated Senior 6.25% Convertible Note
   $ 6,180,816     $ --  
Bridge Loan Note Payable
     1,196,141       --  
Equipment Purchase and Sale Agreement
     700,000       --  
Total
     8,417,461       3,102,006  
Less Current Portion
     (2,068,016 )     (3,102,006 )
Total Long-term
   $ 6,349,445     $ --  
 
 
F-15
 
 
2012 Secured Convertible Notes
 
We engaged Philadelphia Brokerage Corporation to raise funds through the issuance of convertible promissory notes.  We anticipated issuing promissory notes with an aggregate principal amount of up to $5,000,000 (“2012 Convertible Debt Offering”). As of December 31, 2012 we have issued notes having an aggregate principal value of $3,050,000 as explained below.  The notes are due and payable on or before July 13, 2013.  The notes bear interest at 12% per annum and may convertible to common stock at a $.25 per share conversion price.  We also granted holders of the notes warrants with a five year life to acquire up to 200,000 shares of our common stock for each $100,000 of principal amount of the convertible notes.  The notes are secured by all of our assets with the exception of the equipment and receivables secured by the equipment lessor for equipment used in providing services for our largest customer’s digital signage network.
 
In July 2012, we entered into a note and warrant purchase and security agreement with individual investors and broke escrow on the initial funding under the 2012 Convertible Debt Offering, the principal amount of which was $1,900,000, which included the conversion of $900,000 of previously issued short term debt (See Bridge Loan described above) to the 2012 convertible Debt Offering, which extinguished the Bridge Loan.  Of the $1,000,000 non-converted principal amount, we realized $923,175 of cash in the initial closing and issued warrants to acquire 3,800,000 shares of our common stock.  We paid $76,825 in investment banking fees and costs of the offering.
 
In August 2012, we continued sales of convertible debt under the 2012 Convertible Debt Offering by issuing short term debt with a principal amount of $900,000, issued warrants to acquire 1,800,000 shares of our common stock, from which we realized cash of $851,624 after payment of investment banking fees of $48,376.
 
In December 2012, we continued sales of convertible debt under the 2012 Convertible Debt Offering by issuing short term debt with a principal amount of $250,000, issued warrants to acquire 500,000 shares of our common stock to one member of our Board of Directors.
 
The notes and warrants mentioned above were issued with price protection provisions and were accounted for as derivative liabilities and valued on the dates issued using a Black-Scholes pricing model.

We recorded an aggregate derivative liability of $74,500 as of December 31, 2012, related to the conversion feature of the note. A derivative valuation gain of $423,500 was recorded to reflect the change in value of the aggregate derivative liability from the time the notes were issued.  The aggregate derivative liability of $74,500 was calculated as follows using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.11%, (ii) expected life (in years) of 0.50; (iii) expected volatility of 129.08%, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.
 
Additionally, we recorded an aggregate derivative liability of $183,000 as of December 31, 2012, related to the warrant reset provision. A derivative valuation gain of $442,000 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants were issued.  The aggregate derivative liability of $183,000 was calculated as follows using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.63%, (ii) expected life (in years) of 4.50; (iii) expected volatility of 85.75%, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.
 

Unsecured Convertible Note

On September 29, 2006, we entered into a letter of understanding with Triage Capital Management, or Triage, dated September 25, 2006.  The letter of understanding provided that Triage loan $1,000,000 to us in exchange for us entering into, on or prior to October 30, 2006, a convertible note securities agreement.  It was intended that the funding provided by Triage be replaced by a convertible note and accompanying warrants, as described below.  Effective November 2, 2006, we entered into securities purchase agreement, a 5% convertible note, a registration rights agreement, and four classes of warrants to purchase our common stock, all of which were with an individual note holder, the controlling owner of Triage, who caused our agreement with Triage to be assigned to him, which satisfied our agreement with Triage.
 
 
F-16
 
 
Pursuant to the securities purchase agreement, (i) we sold to the convertible note holder a three-year convertible note in the principal amount of $1,000,000 representing the funding received by us on September 29, 2006; (ii) the convertible note bears an annual interest rate of 5%, payable semi-annually in cash or shares of our common stock; (iii) the convertible note is convertible into shares of our common stock at a conversion price of $1.50 per share subject to full-ratchet anti-dilution price protection provisions ; and (iv) we issued to the convertible note holder four classes of warrants (A Warrants, B Warrants, C Warrants and D Warrants), which give the convertible note holder the right to purchase a total of 5,500,000 shares of our common stock as described below.  The A and B Warrants originally expired one year after the effective date of a registration statement filed under the Securities Act of 1933, as amended (the “Securities Act”), to register the subsequent sale of shares received from exercise of the A and B Warrants. The C Warrants and D Warrants originally expired eighteen months and twenty four months, respectively, after the effective date of a registration statement to be filed under the Securities Act.  The A Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.60 per share, the B Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.75 per share, the C Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $2.10 per share, and the D Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $3.00 per share.

During the year ended December 31, 2007, the convertible note holder exercised 454,000 A Warrants. We entered into an exchange agreement dated October 31, 2007 in which the convertible note holder received 650,000 shares of our common stock in exchange for cancellation of the C and the D Warrants.  The expiration date of the A Warrants and the B Warrants was extended from January 11, 2008 to December 3, 2008. During the year ended December 31, 2008, the convertible note holder exercised 64,400 A Warrants. On December 3, 2008, the remaining 231,600 A Warrants and 750,000 B Warrants were unexercised and expired.

On December 23, 2009 we entered into an amendment with the holder of our unsecured convertible note in the principal amount of $1.0 million which (i) extended the note maturity date to December 22, 2010 and (ii) increased the annual rate of interest from 5% to 8% commencing October 16, 2009. All other terms and conditions of the note remain unchanged.

On December 24, 2010 we closed on a Debt Restructuring as mentioned above, In connection with that Debt Restructuring the Company amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013.  We issued 150,000 shares to the holder of this note as consideration to extend the term of the note.
 
During March 2011, we issued 135,369 shares of common stock to the holder of our unsecured convertible note in satisfaction of $81,221 of accrued interest on the unsecured convertible note.  Also in connection with the satisfaction of the accrued interest we granted to the holder a warrant to acquire up to 221,758 additional shares of our common stock at an exercise price of $0.96 per share.  The warrant is exercisable at any time for a five-year period. For the year ended December 31, 2011, the $157,400 value of the warrant was included in interest expense.
 
We recorded an aggregate derivative liability of $46,400 and $300,000 as of December 31, 2012 and 2011, respectively, related to the conversion feature of the note. A derivative valuation gain of $253,600 and $1,101,900, respectively, was recorded to reflect the change in value of the aggregate derivative liability since December 31, 2011 and December 31, 2010, respectively.  The aggregate derivative liability of $46,400 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.16%, (ii) expected life (in years) of 1.0; (iii) expected volatility of 112.04%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.

In connection with the amendment mentioned above, the principal value of the note is being accreted due to the difference in the value of the conversion feature before and after the amendment. The principal value of $1,000,000 of the unsecured convertible note was accreted over the amended term of the obligation, for which $333,336 was included in interest expense for each the years ended December 31, 2012 and 2011. The note bears an 8% annual interest rate payable semi-annually, and for each the years ended December 31, 2011 and 2010, $80,000, was included in interest expense.
 
 
F-17
 
 
Senior Unsecured 6.25% Convertible Note

On December 24, 2007, we entered into a securities purchase agreement in which we raised $15,000,000 (less $937,000 of prepaid interest).  We used the proceeds from this financing to support our CodecSys commercialization and development and for general working capital purposes.  Pursuant to the financing, we issued a senior secured convertible note in the principal amount of $15,000,000 (which principal amount has been increased as discussed below).The senior secured convertible note was originally due December 21, 2010, but was extended to December 21, 2013 and has been subsequently retired. The senior secured convertible note bore interest at 6.25% per annum (which rate has been changed as discussed below) if paid in cash.  Interest for the first year was prepaid at closing.  Interest-only payments thereafter in the amount of $234,375 are due quarterly and commenced in April 2009.  Interest payments may be made through issuance of common stock in certain circumstances or may be capitalized and added to the principal.  The original principal of the note was convertible into 2,752,294 shares of our common stock at a conversion price of $5.45 per share, convertible any time during the term of the note.  We granted a first priority security interest in all of our property and assets and of our subsidiaries to secure our obligations under the note and related transaction agreements. In August 2009 we received a waiver from the note holder releasing their security interest for the equipment purchased under our sale lease back financing.

In connection with the 2007 financing, the senior secured convertible note holder received warrants to acquire 1,875,000 shares of our common stock exercisable at $5.00 per share.  We also issued to the convertible note holder 1,000,000 shares of our common stock valued at $3,750,000 and incurred an additional $1,377,000 for commissions, finder’s fees and other transaction expenses, including the grant of a three-year warrant to purchase 112,500 shares of our common stock to a third party at an exercise price of $3.75 per share, valued at $252,000.  A total of $1,377,000 was included in debt offering costs and is being amortized over the term of the note.
 
From March 26, 2010 through October 29, 2010, we entered into a series of amendments to the senior secured convertible note.  Each of these amendments is described below.
 
On March 26, 2010, we entered into an amendment and extension agreement with the holder of the senior secured convertible note.  The agreement conditionally amended the maturity date of the note to December 21, 2011.  If we are unsuccessful in raising at least $6.0 million in equity financing before September 30, 2010, the maturity date of the note will automatically be restored to its original date of December 21, 2010.  In consideration of entering into the agreement, the note holder was issued 1,000,000 shares of our restricted common stock valued at $990,000.  In addition, we agreed to the inclusion of three additional terms and conditions in the note: (i) from and after the additional funding, we will be required to maintain a cash balance of at least $1,250,000 and provide monthly certifications of the cash balance to the note holder; (ii) we will not make principal payments on our outstanding $1.0 million unsecured convertible note without the written consent of the holder of the senior secured convertible note; and (iii) we will grant board observation rights to the note holder.  Given these additional terms, unless the senior secured convertible note holder provides consent, of which there can be no assurance, we will be precluded from repaying the $1.0 million unsecured convertible note when it becomes due on December 22, 2010.
 
On July 30, 2010, we entered into a further amendment agreement with the holder of the senior secured convertible note regarding the note and warrant reset provisions.  The July 30, 2010 amendment conditionally amended the maturity date of the note to June 21, 2012.  If we are unsuccessful in raising the $6.0 million in equity financing referenced above, the maturity date of the note will automatically be restored to its original date of December 21, 2010.  The holder of the note agreed to a conversion price of the note of $1.80 per share instead of the price at which we sell equity between now and September 30, 2010 and reduced the required cash balance referenced in the March 26, 2010 amendment above from $1,250,000 to $950,000.  In addition, the number of warrants originally granted to the holder pursuant to the 2007 financing increased from 1,875,000 to 5,208,333 and were exercisable at $1.80 per share instead of $5.00 per share.  The warrants continued to be exercisable any time for the five years from the original date of grant.  In consideration of entering into the July 30, 2010 amendment the note holder was issued 2,000,000 shares of common stock and would be issued an additional 800,000 shares of our common stock contingent upon completion of the required equity raise.
 
 
F-18
 
 
On September 27, 2010, we entered into a further amendment agreement with the holder of the senior secured convertible note regarding the note.  Pursuant to this amendment, the due date for the required equity financing was extended to October 31, 2010.
 
On October 29, 2010, we entered into a fourth amendment agreement with the holder of the senior secured convertible note regarding the note and warrant provisions.  The fourth amendment (i) increased the amount of the required equity raise to $8.0 million, approximately $2.5 million of which had been raised or committed by investors at the time of the amendment; (ii) extended the time in which we can complete the equity financing to December 3, 2010; (iii) deleted the provision of the senior secured convertible note that granted the Company the option to redeem the note prior to its maturity date; (iv) changed the conversion price of the note upon successful completion of the required capital raise to an amount equal to 150% of the lowest price at which Company common stock is sold during calendar year 2010; (v) changed the exercised price of the warrants to an amount equal to 150% of the lowest price at which Company common stock is sold during calendar year 2010; (vi) provides that if we are successful in completing the required capital raise the number of warrants will be increased as currently provided in the 6.25% senior secured convertible promissory note; and (vii) extended the expiration date of the warrants to December 31, 2013.
 
If the additional funding was not completed by December 3, 2010, certain provisions of the prior amendments became void in that the maturity date will revert back to December 21, 2010, the conversion price became the lowest price at which equity securities had been sold, the exercise price became the lowest price at which equity securities have been sold, the number of warrants then outstanding would be determined by the original purchase documents, and the Company would not have an obligation to maintain a balance of cash and marketable securities equal to $950,000.
 
On December 24, 2010, we closed on the Debt Restructuring.  In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the “Amended and Restated Note”) to Castlerigg Master Investment Ltd. (“Castlerigg”), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents was issued (the “Loan Restructuring Agreement”), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest. The Debt Restructuring was considered a troubled-debt restructuring and a gain on debt restructuring of $3,062,457 was recorded during the year ended December 31, 2010, which was the difference between the adjusted carrying value of the original note and the carrying value of the Amended and Restated Note.
 
The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bore interest at an annual rate of 6.25%, payable semi-annually.  We paid the first year’s interest of approximately $344,000 at the closing.  The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.  The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us.  The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions.  Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.
 
The Investor Rights Agreement provides Castlerigg with certain registration rights with respect to the Company’s securities held by Castlerigg.  These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions were not satisfied.  The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.
 
 
F-19
 
 
On March 26, 2012, we closed on an equity financing (the “2012 Equity Financing”), as well as a restructuring of our outstanding senior convertible indebtedness (the “2012 Debt Restructuring”), resulting in complete satisfaction of our senior indebtedness under the Amended and Restated Note.
 
A portion of the net proceeds from the 2012 Equity Financing was used to close on the 2012 Debt Restructuring. The Company paid $2,750,000 and issued 2,000,000 shares of common stock valued at $760,000 in satisfaction of the Amended and Restated Note and remaining interest value of $680,816. In consideration of negotiating the 2012 Debt Restructuring and amending our agreement with our placement agent, we paid $275,041 and issued 586,164 shares of our common stock valued at $222,742 to our placement agent, and recognized a $2,173,033 gain on extinguishment of debt as a result of this retirement.
 
With the retirement of the Amended and Restated Note we recorded no aggregate derivative liability at December 31, 2012, however at the date of retirement we recorded a derivative valuation gain of $203,700, related to the conversion feature of the Amended and Restated Note to reflect the change in value of the aggregate derivative from December 31, 2011 to the date of retirement. The derivative value of $81,500 at the date of retirement was recorded as additional paid in capital.
 
We recorded an aggregate derivative liability of $285,200 at December 31, 2011, related to the conversion features of the Amended and Restated Note and the conversion feature and warrants related to the Original Note.  A derivative valuation gain of $2,322,200 was recorded during the year ended December 31, 2011 to reflect the change in value of the aggregate derivative.

The $6,180,816 value of the Amended and Restated Note at December 31, 2011 consists of $5,500,000 for the principal due of the note plus $680,816 for aggregate future interest due of which $171,875 is payable in 2012 and has been included in current debt obligations at December 31, 2011 and was retired pursuant to the 2012 Debt Restructuring noted above.

Accounts Receivable Purchase Agreements

During the year ended December 31, 2010 we entered into two Accounts Receivable Purchase Agreements with one individual for an aggregate amount of $775,000. During the year ended December 31, 2011 we remitted $100,000 of the principal balance plus accrued interest of $8,360 and converted the remaining $675,000 of principal balance plus $109,292 of accrued and unpaid interest into 1,307,153 shares of our common stock and warrants to purchase an additional 653,576 shares of our common stock. The warrants contain anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than $1.00 per share.  The current exercise price has been reset to $0.725 per share due to subsequent financings.

We recorded an aggregate derivative liability of $5,900 and $156,300 as of December 31, 2012 and 2011, respectively, related to the conversion feature of the note. A derivative valuation gain of $253,600 and $293,800, respectively, was recorded to reflect the change in value of the aggregate derivative liability since December 31, 2011 and December 31, 2010, respectively.  The aggregate derivative liability of $5,900 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.36%, (ii) expected life (in years) of 3.20; (iii) expected volatility of 83.16%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.

Bridge Loan

On December 28, 2011 we entered into a Note and Warrant Purchase and Security Agreement with seven individuals for an aggregate of $1,300,000 (“Bridge Loan”) to be used as working capital. The note bears an annual interest rate of 18%, payable monthly in cash.  Additionally, we granted to the holders of the Bridge Loan warrants with a five year term to purchase an aggregate of 357,500 shares of our common stock at an exercise price of $0.65.  The note was due on February 28, 2012, but the term was subsequently extended to the earlier of the date nine months from the original maturity date or the date we closed on an additional sale of our securities that resulted in gross proceeds to us of $12 million.  In consideration of the extension of the maturity date of the Bridge Loan, we granted the holders of the Bridge Loan warrants with a six year term to purchase 247,500 shares of our common stock at an exercise price of $0.35 per share. This note is collateralized by a security interest in all of our accounts receivable
 
 
F-20
 
 
In connection with the Bridge Loan, we paid an $84,500 placement fee and issued warrants to purchase 65,000 shares of our common stock at an exercise price of $0.65 per share and subsequently reset to $0.53, to our investment banker for services in completing the above transaction and paid a $3,000 escrow fee to the Escrow Agent in exchange for holding the funds prior to their disbursement to us.
 
On March 26, 2012, we closed on the 2012 Equity Financing and under the terms of the associated securities purchase agreement, two of the above described bridge lenders converted the principal balance of their portion of the bridge loan in the amount of $400,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing, reducing the outstanding principal balance to $900,000. The warrants issued had a total value of $222,426 which resulted in a loss on extinguishment of debt of $222,426. The aggregate derivative liability and valuation gain or loss for the warrants issued for the converted portion of the principal balance are included in the aggregate of 2012 Equity Financing information.

 
All warrants mentioned above were issued with price protection provisions and were accounted for as derivative liabilities and valued using a Black Scholes pricing model.
 
On July 13, 2012 the $900,000 principal balance was retired and was included as part of the 2012 Convertible Note (as described below) and recorded a (i) $93,661 loss on extinguishment of debt related to the remaining un-accreted portion of the note and (ii) $53,160 expense related to unrecognized offering costs, at the time of retirement.
 
At December 31, 2012 we recorded an aggregate derivative liability of $7,400 related to the reset provision for the original and placement warrants issued. A derivative valuation gain of $136,300 was recorded to reflect the change in value of the aggregate derivative liability from December 31, 2011.  The aggregate derivative liability of $7,400 for the reset provision of the warrants was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.54%, (ii) expected life (in years) of 4.0; (iii) expected volatility of 82.55%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.
 
At December 31, 2012 we recorded an aggregate derivative liability of $7,200 related to the reset provision for the warrants issued for an extension of the maturity date.  A derivative valuation gain of $89,325 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants were issued.  The aggregate derivative liability of $7,200 for the reset provision of the warrants was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.54%, (ii) expected life (in years) of 4.0; (iii) expected volatility of 82.55%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.
 
The principal value of the note was being accreted over the amended term of the obligation, for which $106,723 and 7,041 were included in interest expense for the years ended December 31, 2012 and 2011, respectively.  The note bore an 18% annual interest rate, and for the years ended December 31, 2012 and 2011, $100,899 and $2,564, respectively were included in interest expense.
 

Equipment Purchase and Sale Agreement

In October 2011, we entered into an Equipment Purchase and Sale Agreement with a Utah corporation whereby we use the funds advanced to purchase certain electronic receiving and digital signage equipment along with installation costs.  A 3% fee is due each month the amount remains outstanding.  At December 31, 2011 we had an outstanding amount owed of $700,000 and had accrued two months of fees totaling $42,000 which was included as interest expense for the year ended December 31, 2011.
 
 
F-21
 
 
On March 26, 2012, we closed on the 2012 Equity Financing and under the terms of the associated securities purchase agreement the above described lender converted the principal balance of its portion of the loan in the amount of $500,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing, the remaining $200,000 principal balance plus $105,000 of interest due was paid in cash. The warrants issued had a total value of $278,032 which resulted in a loss on extinguishment of debt of $278,032. The aggregate derivative liability and valuation gain or loss for the warrants issued for the converted portion of the principal balance are included in the aggregate of 2012 Equity Financing information.

The 3% fee mention above was recorded as interest expense and or the years ended December 31 2012 and 2011, $63,000 and $42,000 were included, respectively.

Note 6 – Investment in Interact Devices, Inc (IDI)
 
We began investing in and advancing monies to IDI in 2001.  IDI was developing technology which became an initial part of the CodecSys technology.
 
On October 23, 2003, IDI filed for Chapter 11 Federal Bankruptcy protection. We desired that the underlying patent process proceed and that the development of CodecSys technology continue. Therefore, we participated in IDI’s plan of reorganization, whereby we would satisfy the debts of the creditors and obtained certain licensing rights.  On May 18, 2004, the debtor-in-possession’s plan of reorganization for IDI was confirmed by the United States Bankruptcy Court. As a result of this confirmation, we issued to the creditors of IDI shares of our common stock and cash in exchange for approximately 50,127,218 shares of the common stock of IDI. Since May 18, 2004, we have acquired additional common share equivalents IDI. During the year ended December 31, 2012 we did not acquire any IDI share equivalents. During the year ended December 31, 2011 we acquired 414,172 IDI common share equivalents in exchange for 27,611 shares of our common stock valued at $10,760. As of December 31, 2012, we owned approximately 55,897,169 IDI common share equivalents, representing approximately 94% of the total outstanding IDI share equivalents
 
Since May 18, 2004, we have advanced additional cash to IDI for the payment of operating expenses, which continues development and marketing of the CodecSys technology. As of December 31, 2012 and 2011, we have advanced an aggregate amount of $3,347,255 and $3,126,772 respectively, pursuant to a promissory note that is secured by assets and technology of IDI.
 
Note 7 – Operating Leases
 
Our executive offices are located at 7050 Union Park Avenue, Suite 600, Salt Lake City, Utah 84047.  We occupy the space at the executive offices under a 39-month lease, the term of which ends January 31, 2015.  The lease covers approximately 13,880 square feet of office space leased at a rate of $23,049 per month.  We occupy a production studio located at 6952 South 185 West, Unit C, Salt Lake City, Utah 84047, which consists of approximately 7,500 square feet on a month to month basis, at the rate of $7,000 per month plus utilities. We have no other properties.  We recognized rent expense of approximately $352,789 and $463,694, in 2012 and 2011, respectively.
 
We also lease copy machines on multi-year leases that expire in March 2014 at a minimum rate of $655 per month.
 
 
F-22
 
 
Future minimum payments under non-cancelable operating leases at December 31, 2012 are as follow:

 
2013
   $ 284,447  
2014
     278,552  
2015
     23,049  
    $ 586,048  
 
Note 8 – Income Taxes
 
Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
 
Net deferred tax liabilities consist of the following components as of December 31, 2011 and 2012:
 
   
2011
    
2012
  
Deferred tax assets
            
NOL carry-forward                                                             
   $ 23,862,500     $ 25,881,900  
General business credit carry-forwards                                                                      
     1,147,000       1,158,900  
Deferred compensation                                                             
     83,500       78,500  
Allowance for doubtful accounts                                                             
     21,000       31,600  
Deferred tax liabilities
                
Depreciation                                                             
     (173,000 )     61,700  
                 
Valuation allowance                                                                   
     (24,941,000 )     (27,212,600 )
Net deferred tax asset                                                                   
   $ -     $ -  
 
The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, 2010 and 2011 due to the following:
 
   
2011
    
2012
  
             
Federal income tax (expense) benefit at statutory rates
   $ 1,902,500     $ 1,831,600  
State income tax (expense) benefit at statutory rates
     280,000       269,300  
Change in valuation allowance                                                                      
     (2,182,500 )     (2,100,900 )
    $ -     $ -  

At December 31, 2012, the Company had net operating loss carry-forwards of approximately $66,364,000 that may be offset against future taxable income from the year 2013 through 2032.  No tax benefit has been reported in the December 31, 2011 and 2012 consolidated financial statements since the potential tax benefit is offset by a valuation allowance of the same amount.
 
 
F-23
 
 
Due to change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations.  Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years.
 
Note 9 – Preferred and Common Stock
 
We have authorized two classes of stock, 20,000,000 shares of preferred stock with no par value and 180,000,000 shares of common stock with a $0.05 par value. No preferred stock has been issued, while 107,473,820 shares of common stock were issued and outstanding at December 31, 2012. Holders of shares of common stock are entitled to receive dividends if and when declared and are entitled to one vote for each share on all matters submitted to a vote of the shareholders.
 
During the year ended December 31, 2012, we issued 31,498,164 shares of our common stock as follows: (i) 24,816,000 related to our 2012 Equity Financing and Debt Restructuring, (ii) 5,600,000 for debt conversions and (iii) 1,082,164 for services rendered by consultants.
 
During the year ended December 31, 2011, we issued 1,897,503 shares of our common stock as follows: (i) 1,307,153 for debt to equity conversions, (ii) 372,272 for warrant exercises, (iii) 135,369 for interest instead of cash, (iv) 55,098 for employee option exercises and (v) 27,611 shares for conversion of IDI share equivalents.
 
Note 10 – Stock-based Compensation
 
In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.
 
Stock Incentive Plans
 
Under the Broadcast International, Inc. 2004 Long-term Incentive Plan (the “2004 Plan”), the board of directors may issue incentive stock options to employees and directors and non-qualified stock options to consultants of the company.  Options generally may not be exercised until twelve months after the date granted and expire ten years after being granted. Options granted vest in accordance with the vesting schedule determined by the board of directors, usually ratably over a three-year vesting schedule upon anniversary date of the grant.  Should an employee terminate before the vesting period is completed, the unvested portion of each grant is forfeited. We have used the Black-Scholes valuation model to estimate fair value of our stock-based awards, which requires various judgmental assumptions including estimated stock price volatility, forfeiture rates, and expected life.  Our computation of expected volatility is based on a combination of historical and market-based implied volatility.  The number of unissued stock options authorized under the 2004 Plan at December 31, 2012 was 3,779,508.

The Broadcast International, Inc. 2008 Equity Incentive Plan (the “2008 Plan”) has become our primary plan for providing stock-based incentive compensation to our eligible employees and non-employee directors and consultants of the company. The provisions of the 2008 Plan are similar to the 2004 Plan except that the 2008 Plan allows for the grant of share equivalents such as restricted stock awards, stock bonus awards, performance shares and restricted stock units in addition to non-qualified and incentive stock options. We continue to maintain and grant awards under our 2004 Plan which will remain in effect until it expires by its terms. The number of unissued shares of common stock reserved for issuance under the 2008 Plan was 774,867 at December 31, 2012.
 
 
F-24
 
 
Stock Options
 
We estimate the fair value of stock option awards granted beginning January 1, 2006 using the Black-Scholes option-pricing model. We then amortize the fair value of awards expected to vest on a straight-line basis over the requisite service periods of the awards, which is generally the period from the grant date to the end of the vesting period. The Black-Scholes valuation model requires various judgmental assumptions including the estimated volatility, risk-free interest rate and expected option term.  Our computation of expected volatility is based on a combination of historical and market-based implied volatility.  The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the stock option award was granted with a maturity equal to the expected term of the stock option award. The expected option term is derived from an analysis of historical experience of similar awards combined with expected future exercise patterns based on several factors including the strike price in relation to the current and expected stock price, the minimum vest period and the remaining contractual period.
 
The fair values for the options granted in 2012 and 2011 were estimated at the date of grant using the Black Scholes option-pricing model with the following weighted average assumptions:
 
 
Year Ended December 31,
 
2012
2011
Risk free interest rate
1.65%
1.91%
Expected life (in years)
10.0
6.2
Expected volatility
78.97%
80.89%
Expected dividend yield
0.00%
0.00%

The weighted average fair value of options granted during the years ended December 31, 2012 and 2011, was $0.27 and $0.61, respectively.
 
Warrants
 
We estimate the fair value of issued warrants on the date of issuance as determined using a Black-Scholes pricing model. We amortize the fair value of issued warrants using a vesting schedule based on the terms and conditions of each associated underling contract, as earned. The Black-Scholes valuation model requires various judgmental assumptions including the estimated volatility, risk-free interest rate and warrant expected exercise term.  Our computation of expected volatility is based on a combination of historical and market-based implied volatility.  The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the warrant was issued with a maturity equal to the expected term of the warrant.
 
The fair values for the warrants granted in 2012 and 2011 were estimated at the date of grant using the Black Scholes option-pricing model with the following weighted average assumptions:
 
 
Year Ended December 31,
 
2012
2011
Risk free interest rate
1.16%
2.07%
Expected life (in years)
5.7
5.0
Expected volatility
82.79%
85.37%
Expected dividend yield
0.00%
0.00%

The weighted average fair value of warrants granted during the years ended December 31, 2012 and 2011, was $0.23 and $0.67, respectively.
 

Results of operations for the years ended December 31, 2012 and 2011 includes $283,692 and $2,262,540, respectively, of non-cash stock-based compensation expense. Restricted stock units and options issued to directors vest immediately. All other restricted stock units, options and warrants are subject to applicable vesting schedules. Expense is recognized proportionally as each award or grant vests.

For the year ended December 31, 2012 we recognized $283,692 of stock based compensation as follows: (i) $65,500 for 390,133 restricted stock units issued to 5 members of the board of directors, (ii) $833 for 50,000 options granted to 4 employees and (iii) $217,359 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2012.
 
 
F-25
 

 
For the year ended December 31, 2011 we recognized $2,262,540 of stock based compensation expense as follows: (i) $1,544,000 for 1,400,000 restricted stock units issued to all 5 members of the board of directors, (ii) $124,000 for 200,000 restricted stock units issued to one employee, (iii) $364,000 for 600,000 options issued to one individual and one corporation for consulting services, (iv) $96,489 for 909,200 options granted to 43 employees, (v) $15,000 for 50,000 options granted to one member of our advisory board, (vi) $4,263 for 8,700 options granted to 15 of our non-employee installation technicians and (vi) $114,788 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2011.  Additionally, we issued (i) 221,758 warrants to our unsecured convertible note holder, (ii) 653,576 warrants related to our accounts receivable purchase agreements, (iii) 422,500 warrants related to our Bridge Loan. See Note 5. There were 400,000 warrants exercised in the year ending December 31, 2011.

The following table summarizes option and warrant activity during the years ended December 31, 2012 and 2011.

 
   
Options
and
Warrants
Outstanding
    
Weighted
Average
Exercise
Price
  
             
Outstanding at December 31, 2010
     20,442,170       1.13  
Options granted                                                        
     1,567,900       0.91  
Warrants issued                                                        
     1,697,834       0.68  
Expired                                                        
     (302,054 )     18.67  
Forfeited                                                        
     (2,510,201 )     0.08  
Exercised                                                        
     (455,098 )     -  
                 
Outstanding at December 31, 2011
     20,440,551       1.10  
Options granted                                                        
     50,000       0.37  
Warrants issued                                                        
     24,817,900       0.33  
Expired                                                        
     (252,669 )     1.31  
Forfeited                                                        
     (1,658,919 )     1.31  
Exercised                                                        
     -       -  
                 
Outstanding at December 31, 2012
     43,396,863     $ 0.54  

 
The following table summarizes information about stock options and warrants outstanding at December 31, 2012.
 
     
Outstanding
    
Exercisable
  
           
Weighted
Average
Remaining
    
Weighted
Average
          
Weighted
Average
  
Range of
Exercise Prices
    
Number
Outstanding
    
Contractual
Life (years)
    
Exercise
Price
    
Number
Exercisable
    
Exercise
Price
  
$ 0.17-0.95     39,583,684     4.36     $ 0.47     39,207,017     $ 0.47  
  1.00-1.59       3,306,679     3.20       1.04       3,248,146       1.04  
  2.25-4.00          506,500     3.34       2.62          506,500       2.62  
$ 0.17-4.00     43,396,863     4.26     $ 0.54     42,961,663     $ 0.54  
 
 
F-26
 
 
There were no options exercised in the year ended December 31, 2012 and 55,098 options were exercised in the year ended December 31, 2011. There was no intrinsic value of options and warrants available and exercisable for the years ended December 31, 2012 or 2011.

 
Restricted Stock Units
 
For the years ended December 31, 2012 and 2011, 390,133 and 1,600,000 restricted stock units were awarded, respectively. The cost of restricted stock units is determined using the fair value of our common stock on the date of the grant and compensation expense is recognized in accordance with the vesting schedule.  All of the restricted stock units vested during the year they were awarded.

 
The following is a summary of restricted stock unit activity for the years ended December 31, 2012 and 2011:
 
   
Restricted
Stock Units
    
Weighted
Average
Grant
Date Fair
Value
  
             
Outstanding at December 31, 2010
     950,000       1.61  
Awarded at fair value
     1,600,000       1.04  
Canceled/Forfeited
     --       --  
Settled by issuance of stock
     --       --  
Outstanding at December 31, 2011
     2,550,000       1.25  
Awarded at fair value
     390,133       0.17  
Canceled/Forfeited
     --       --  
Settled by issuance of stock
     --       --  
Outstanding at December 31, 2012
     2,940,133     $ 1.11  
Vested at December 31, 2012
     2,940,133     $ 1.11  

Included in stock based compensation for the year ended December 31, 2012, was $65,500 for 390,133 restricted stock units issued to all 5 members of the board of directors, all of which were recorded in general and administrative expense.

Included in stock based compensation for the year ended December 31, 2011, was $1,668,000 as follows; (i) $1,544,000 for 1,400,000 restricted stock units issued to all 5 members of the board of directors, (ii) $124,000 for 200,000 restricted stock units issued to one employee, all of which were recorded in general and administrative expense.

The impact on our results of operations for recording stock-based compensation for the years ended December 31, 2012 and 2011 is as follows:

   
For the years ended
  
   
December 31,
  
   
2012
    
2011
  
General and administrative
   $ 185,478     $ 2,043,386  
Research and development
     98,214       219,154  
                 
Total
   $ 283,692     $ 2,262,540  
 

 
 
F-27
 
Total unrecognized stock-based compensation was $180,732 at December 31, 2012, which we expect to recognize over the next three years in accordance with vesting provisions as follows:
 
2013
   $ 118,127  
2014
     62,038  
2015
     567  
Total
   $ 180,732  

Note 11 – Equipment Financing
 
On August 27, 2009, we completed an equipment lease financing transaction with a financial institution.  Pursuant to the financing, we entered into various material agreements with the financial institution. These agreements are identified and summarized below.

We entered into a Master Lease Agreement dated as of July 28, 2009 with the financial institution pursuant to which we sold to the financing institution certain telecommunications equipment to be installed at 1,981 (subsequent additional locations have increased the customer’s network to an aggregate of approximately 2,100 locations) of our customer’s retail locations in exchange for a one-time payment of $4,100,670 by the financial institution. We paid to the financial institution 36 monthly lease payments of approximately $144,000 plus applicable sales taxes. We had the right to terminate the lease after making 33 payments for a termination fee of the higher of approximately 10% of the original equipment value (approximately $410,000) or the then “in-place fair market value” after which payment we would own all of the equipment. We gave timely notice of exercise of this option. We are currently a party to a lawsuit to determine if the “in-place fair market value” exceeds the 10% of the original lease value and by what amount.  We contend that the three payments made subsequent to the notice exercising our right to purchase constitute full payment for the equipment. The equipment broker contends that we owe an additional amount.  Our accounting records reflect that the capital lease has been retired and the equipment has been fully depreciated.

We also entered into a security agreement with the financial institution pursuant to which we granted a first priority security interest in the equipment, whether now owned or hereafter acquired, and in our customer service agreement and service payments thereunder during the term of the equipment lease.

During 2012 we had made lease payments totaling approximately $1,125,588 of which $1,067,649 was applied toward the outstanding lease and $57,939 was included in interest expense. Included in the $1,125,588 is approximately $422,100 paid toward the in place fair market value. Additionally during the year ended December 31, 2012 we made payments of $140,700 into an escrow account held by the court pending resolution of our dispute. For the year ending December 31, 2012, we expensed the final $33,512 of our lease acquisition fee of $150,792 which was being recognized over the life of the lease included in interest expense.
 
During 2011 we had made lease payments totaling approximately $1,688,382 of which $1,423,528 was applied toward the outstanding lease and $264,854 was included in interest expense. Additionally, we expensed $50,268 of our lease acquisition fee of $150,792 which is being recognized over the life of the lease included in interest expense for the year ended December 31, 2011.
 
Note 12 – Fair Value Measurements
 
We adopted ASC Topic 820 as of January 1, 2008 for financial instruments measured at fair value on a recurring basis.  ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.
 
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).  These tiers include:
 
 
F-28
 
 
 
·
Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
 
 
·
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
 
·
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
 
We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2012:
 
               
Significant
        
         
Quoted Prices in
    
Other
    
Significant
  
         
Active Markets for
    
Observable
    
Unobservable
  
         
Identical Assets
    
Inputs
    
Inputs
  
   
Total
    
(Level 1)
    
(Level 2)
    
(Level 3)
  
Assets
                        
None
     --       --       --       --  
Total assets measured at fair value
   $ --     $ --     $ --     $ --  
                                 
Liabilities
                                
Derivative valuation (1)
   $ 1,191,269     $ --     $ --     $ 1,191,269  
Total liabilities measured at fair value
   $ 1,191,269     $ --     $ --     $ 1,191,269  
 
 
(1)
See Notes 4 & 5 for additional discussion.
 
The table below presents our assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at December 31, 2012.  We classify financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model.
 
   
Derivative
  
   
Valuation
  
   
Liability
  
Balance at December 31, 2011
   $ (3,760,200 )
Total gains or losses (realized and unrealized)
        
Included in net income
     8,829,748  
Valuation adjustment
     --  
Purchases, issuances, and settlements, net
     (6,260,817 )
Transfers to Level 3
     --  
Balance at December 31, 2012
   $ (1,191,269 )
 
 
F-29
 
 
Money Market Funds and Treasury Securities

The money market funds and treasury cash reserve securities balances are classified as cash and cash equivalents on our consolidated balance sheet.

Fair Value of Other Financial Instruments
 
The carrying amounts of our accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their immediate or short-term maturities.  The aggregate carrying amount of the notes payable approximates fair value as the individual notes bear interest at market interest rates and there hasn’t been a significant change in our operations and risk profile.
 
Note 13 – Retirement Plan
 
We have implemented a 401(k) employee retirement plan. Under the terms of the plan, participants may elect to contribute a portion of their compensation, generally up to 60%, to the plan, subject to IRS Code Section 415 limitations. We match contributions up to 100% of the first 3% of a participant’s compensation contributed to the plan and 50% of the next 2%. Employees are eligible to participate in the plan after three months of service as defined by the plan. For the years ended December 31, 2012 and 2011, we made matching contributions totaling $99,761 and $90,453, respectively.
 
 
F-30
 
 
Note 14 – Legal Proceedings
 
We have pending legal matters.  We have a judgment rendered against us in a lawsuit, the total amount in dispute in which is approximately $130,000.
 
On July 27, 2012, CTC Resources Inc. dba U.S. Media Capital (“CTC”) filed a lawsuit in the Third Judicial District Court in and for Salt Lake City, State of Utah against ACC Capital Corporation (“ACC”), Loni L. Lowder and the Company (the “CTCD Lawsuit”) asserting claims for relief for breach of contract against ACC, breach of fiduciary duty and fraud against ACC and Mr. Lowder and civil conspiracy against ACC, Mr. Lowder and the Company, and seeking injunctive relief and constructive trust as to all defendants as well as money damages.  On October 9, 2012, we filed our answer as well as a cross claim against ACC seeking declaratory relief as to the price to be paid by us for the leased equipment and specific performance against ACC.  On January 7, 2013 in a hearing relative to a temporary injunction previously granted by the Court, the Court took testimony and heard arguments from the parties on the matter and the Court and the parties agreed that a trial would be unnecessary.  Both parties submitted briefs regarding the law and summarizing the testimony elicited at the hearing.  The Court’s judgment rendered on February 25, 2013 vacated the parties’ joint appraisal and required that the parties jointly secure another appraisal for the equipment, the results of which will be binding on the parties.  We have paid $424,500 toward the purchase price of the equipment, which we believe satisfies our payment obligation, but pursuant to a restraining order we sought to prevent the lessor from contacting our customer as of March 26, 2013 we have escrowed an aggregate of $425,100 with the Court and have a current obligation to continue making monthly escrow payments in the amount of $141,700 pending a decision in the matter.
 
Note 15 – Liquidity
 
Broadcast experienced negative cash flow used in operations during the year of $3,362,785 compared to negative cash flow used in operations for the year ended December 31, 2011 of $5,164,437. Our current monthly excess of cash expenses over income is approximately $300,000 per month. During  2012 the decreased in negative cash flow was realized primarily through a reduction in the number of employees by approximately 40%, with more reductions scheduled, as well as additional  expense reduction actions including reducing sales and general and administrative expenses.  In addition, we have commenced an initiative designed to satisfy accounts payable through the issuance of common stock, which will further decrease our need for cash.  We have to date received verbal and/or written commitments to accept partial payments and/or stock in full satisfaction of at least $600,000 of current payables and indebtedness.

The negative cash flow was met by cash reserves from the completion of the 2012 Equity Financing and the issuance of the 2012 Convertible Debt in the total amount of $3,050,000, which included $900,000 of Bridge Loan indebtedness that was converted to the 2012 Convertible Debt. In addition, we received $400,000 in January, 2013. We have commitments from current debt holders to fund up to an additional $1.550 million of our 2012 Convertible debt to offset future negative cash flow.  We expect to continue to experience negative operating cash flow as long as we continue our current expenditures related primarily to bringing CodecSys products to market, continue our development of CodecSys or until we begin to receive licensing revenue from sales of CodecSys proprietary software or increase sales in our network division by adding new customers.  We are actively pursuing potential customers to replace lost revenues when the BofA contract expires.

Note 16 – Supplemental Cash Flow Information
 
2012
 
 
·
During the year ended December 31, 2012 we issued 586,164 shares our common stock, valued at $222,742 to a placement agency for services rendered related to our 2012 Equity Financing and Debt Restructuring agreement
 
 
·
During the year ended December 31, 2012, we issued 496,000 shares of our common stock valued at $177,313 to two consultants and one corporation of which (i) 250,000 shares was in consideration for cancellation of a warrant issued for consulting services rendered and (ii) 246,000 was for consulting services rendered.
 
 
F-31
 
 
 
·
During the year ended December 31, 2012, we recognized $1,024,754 in depreciation and amortization expense from the following: (i) $466,606 related to cost of sales for equipment used directly by or for customers, (ii) $547,997 related to equipment other property and equipment, and (iii) $10,151 for patent amortization.
 
 
·
For the year ended December 31, 2012, an aggregate non-cash expense of $941,225 was recorded for the accretion of our convertible notes of which (i) $501,166 was for the accretion of our 2012 Secured Convertible Note (ii) $333,336 was related to our unsecured convertible note and (iii) $106,723 was for our bridge loan.
 
2011
 
 
·
During the year ended December 31, 2011, we granted options to acquire up to 600,000 shares of our common stock valued at $389,000 to two consultants in consideration of consulting services to be rendered by the consultants over a one-year period pursuant to a written consulting agreement. For the year ended December 31, 2011, the value of options is being recognized over the contract period and $364,000 was included in stock based compensation.
 
 
·
During the year ended December 31, 2011 we issued 135,369 shares our common stock to an individual for interest owed on a debt obligation, valued at $81,221 which was accrued at December 31, 2010.
 
 
·
During the year ended December 31, 2011 we acquired 414,172 IDI common share equivalents in exchange for 27,611 shares of our common stock valued at $10,760 which was expensed to research and development.
 
 
·
During the year ended December 31, 2011, we recognized $1,483,868 in depreciation and amortization expense from the following: (i) $798,677 related to cost of sales for equipment used directly by or for customers, (ii) $675,040 related to equipment other property and equipment, and (iii) $10,151 for patent amortization.
 
 
·
For the year ended December 31, 2011, an aggregate non-cash expense of $340,377 was recorded for the accretion of our convertible notes of which (i) $333,336 was related to our unsecured convertible note and (ii) $7,041 was for our bridge loan.
 
 
·
On March 21, 2011, the Company, converted $784,292 of its short-term debt into equity through the issuance of common stock and warrants to two lenders at the same unit pricing as the Equity Financing. In consideration of converting the short- term loans on the basis of $1.20 for two shares of common stock plus one warrant at an exercise price of $1.00, the Company issued 1,307,153 shares of common stock and warrants to acquire up to 653,576 shares of common stock, which warrants have a five year term and are exercisable at $1.00 per share. The $784,292 above is net of expense and includes $109,292 of interest of which $89,658 was accrued in the year ended December 31, 2010 and $19,634 which was included as interest expense for the year ended December 31, 2011. The Company’s objective for converting the short-term debt into equity is to conserve cash for further market development.
 
 
·
In March 2011, we granted to the holder of our senior unsecured convertible note a warrant to acquire 400,000 shares of our common stock at an exercise price of $.05 per share in consideration of a waiver of the holder’s reset provision that allowed us to convert certain short terms loans to equity without causing an adjustment in the conversion price of our senior note.  The warrants had a 5-year life from the date of grant, contained full-ratchet anti-dilution price protection provisions and were valued at $404,000 using a Black Scholes pricing model on the date of grant. During the year ended December 31, 2011, the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock
 
We paid no cash for income taxes during the years ended December 31 2012 and 2011.
 
 
F-32
 
 
Note 17 – Subsequent Events
 
           During January 2013, we sold additional convertible promissory notes in the principal amount of $425,000 on our 2012 Convertible Note offering due on July 13, 2013.  The notes are convertible at $.25 per share and are secured by all of our assets.  In addition, we issued warrants to acquire up to 850,000 shares of our common stock to the holders of the notes.  The warrants have a five year life and are exercisable at $.25 per share.

In March 2013 we issued 258,553 shares of common stock to a former director in settlement of his Restricted Stock Units.  In addition, we issued to him 200,000 shares of common stock in satisfaction of unpaid director’s fees of $15,000.

In March 2013 we granted Restricted Stock Units to four of our directors in satisfaction of unpaid director’s fees of $51,500.  The Restricted Stock Units may be settled by the issuance of 686,667 shares of our common stock at the time the directors retire from the board.

On January 7, 2013 we entered into a Merger Agreement with AllDigital, Inc., a Nevada corporation.  The merger is subject among other things to normal due diligence, approval of the shareholders of both companies, and the filing and effectiveness of a registration statement.  The registration statement requires year-end financial statements be included with the proxy statements furnished to the shareholders and will not be effective until at least the second quarter of 2013.  On February 8, 2013, All Digital notified us that we were in breach of certain covenants regarding unencumbered ownership or potential claims against our technology and intellectual property, which gave us 30 days to cure the alleged defects before the merger agreement could be terminated.  On March 8, 2013 All Digital notified us that sufficient progress had been made that the cure period was extended to April 8, 2013 for the remainder of the alleged defects to be cured or waived
 
Pursuant to the January 6, 2013 Amendment and Settlement Agreement with each of Mr. Tiede and Mr. Solomon, their respective employment agreements were modified and we agreed to issue each of Mr. Tiede and Mr. Solomon 529,100 shares of common stock if they were terminated by us at any time following January 6, 2013.  All other termination benefits and severance benefits for Mr. Tiede and Mr. Solomon, were terminated as of January 6, 2013. We had an obligation as of March 6, 2013 to issue to each of them 529,100 shares of common stock.
 
 
F-33
 
 
Exhibit Index
 
(a)           Exhibits
 
Exhibit
Number
Description of Document
   
2.1
Agreement and Plan of Merger and Reorganization, dated as of January 6, 2012, by and among Broadcast International, Inc., AllDigital, Inc., and Alta Acquisition Corporation.  (Incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013.
   
3.1
Amended and Restated Articles of Incorporation of Broadcast International.   (Incorporated by reference to Exhibit No. 3.1 of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 filed with the SEC on November 14, 2006.)
   
3.2
Amended and Restated Bylaws of Broadcast International.  (Incorporated by reference to Exhibit No. 3.2 of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 filed with the SEC on November 14, 2006.)
   
4.1
Specimen Stock Certificate of Common Stock of Broadcast International.  (Incorporated by reference to Exhibit No. 4.1 of the Company's Registration Statement on Form SB-2, filed under cover of Form S-3, pre-effective Amendment No. 3 filed with the SEC on October 11, 2005.)
   
10.1*
Employment Agreement of Rodney M. Tiede dated April 28, 2004.  (Incorporated by reference to Exhibit No. 10.1 of the Company's Quarterly Report on Form 10-QSB for the quarter ended March 31, 2004 filed with the SEC on May 12, 2004.)
   
10.2*
Employment Agreement of James E Solomon dated September 19, 2008.  (Incorporated by reference to Exhibit No. 10.2 of the Company's Annual Report on Form 10-K for the year ended December 31, 2009 filed with the SEC on Mach 31, 2010.)
   
10.3*
Broadcast International 2004 Long-Term Incentive Plan.  (Incorporated by reference to Exhibit No. 10.4 of the Company's Annual Report on Form 10-KSB for the year ended December 31, 2003 filed with the SEC on March 30, 2004.)
   
10.4*
Broadcast International 2008 Long-Term Incentive Plan.  (Incorporated by reference to the Company’s  definitive Proxy Statement on Schedule 14A filed with the SEC on April 17, 2009)
   
10.5
Securities Purchase Agreement dated October 28, 2006 between Broadcast International and Leon Frenkel.  (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 6, 2006.)
   
10.6
5% Convertible Note dated October 16, 2006 issued by Broadcast International to Leon Frenkel.  (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on November 6, 2006.)
   
10.7
Registration Rights Agreement dated October 28, 2006 between Broadcast International and Leon Frenkel.  (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on November 6, 2006.)
   
10.8
Securities Purchase Agreement dated as of December 21, 2007, by and among Broadcast International and the investors listed on the Schedule of Buyers attached thereto. (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
 
 
 
 

10.9
Registration Rights Agreement dated as of December 21, 2007, by and among Broadcast International and the buyers listed therein.  (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.10
6.25% Senior Secured Convertible Promissory Note dated December 21, 2007 issued to the holder listed therein.  (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.11
Warrant to Purchase Common Stock dated December 21, 2007 issued to the holder listed therein.  (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.12
Loan Restructuring Agreement between the Company and Castlerigg Master Investments Ltd., dated December 16, 2010 (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 22, 2010.)
   
10.13
Amendment to 8% Convertible Note Due 2010 between the Company and Leon Frenkel, dated December 22, 2010 (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on December 22, 2010.)
   
10.14
Placement Agency Agreement between the Company and Philadelphia Brokerage Corporation, dated December 17, 2010 (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.15
Form of Subscription Agreement (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.16
Form of Warrant (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.17
Amended and Restated Senior Convertible Note issued by the Company to Castlerigg master Investments Ltd., dated December 23, 2010 (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.18
Investor Rights Agreement between the Company and Castlerigg Master Investments Ltd., dated December 23, 2010 (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.19
Letter between the Company and Castlerigg Master Investments Ltd., dated December 23, 2010 (Incorporated by reference to Exhibit 10.6 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.20
Form of Securities Purchase Agreement dated March 13, 2012.  (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.21
Form of A Warrant.  (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.22
Form of B Warrant.  (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
 
 
 
 
 
10.23
Loan Satisfaction Agreement between the Company and Castlerigg Master Investments Ltd. dated March 13, 2012.  (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.24
Registration Rights Agreement dated March 13, 2012.  (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.25
Form of Placement Agent Warrant.  (Incorporated by reference to Exhibit 10.6 of the Company’s Current Report on Form 8-K filed with the SEC on March 13, 2012.)
   
10.26
Form of Note and Warrant Purchase and Security Agreement dated July 16, 2012.  (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2012.)
   
10.27
Form of Promissory Note dated July 16, 2012.  (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2012.)
   
10.28
Form of Warrant.  (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2012.)
   
10.29
Form of Voting Agreement, dated January 6, 2013, by and among AllDigital, Inc. and certain stockholders of Broadcast International, Inc. (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
10.30
Form of Voting Agreement, dated January 6, 2013, by and among Broadcast International, Inc. and certain stockholders of AllDigital, Inc. (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
10.31
Professional Services Agreement, dated January 6, 2013, by and between AllDigital, Inc. and Broadcast International, Inc. (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
10.32*
Amendment and Settlement Agreement, dated January 6, 2013, by and between Broadcast International, Inc. and Rodney Tiede.  (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
10.33*
Amendment and Settlement Agreement, dated January 6, 2013, by and between Broadcast International, Inc. and James E. Solomon. (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
10.34*
Amendment and Settlement Agreement, dated January 6, 2013, by and between Broadcast International, Inc. and Steve Jones. (Incorporated by reference to Exhibit 10.6 of the Company’s Current Report on Form 8-K filed with the SEC on January 7, 2013).
   
14.1
Code of Ethics. (Incorporated by reference to Exhibit No. 14 of the Company’s Annual Report on Form 10-KSB filed with the SEC on March 30, 2004.)
   
21.1
Subsidiaries.  (Incorporated by reference to Exhibit No. 21.1 of the Company’s Annual Report on Form 10-KSB filed with the SEC on April 1, 2005.)
   
23.1
Consent of HJ & Associates, LLC, independent registered public accountant.
   
24.1
Power of Attorney. (Included on page II-15).
   
31.1
Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer.
 
 
 
 
 
31.2
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.
   
32.1
Principal Executive Officer Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2
Chief Financial Officer Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS
XBRL Instance Document.
   
101.SCH
XBRL Taxonomy Extension Schema Document.
   
101.CAL
Taxonomy Extension Calculation Linkbase Document.
   
101.DEF
Taxonomy Extension Definition Linkbase Document.
   
101.LAB
Extension Labels Linkbase Document.
   
101.PRE
Taxonomy Extension Presentation Linkbase Document.
 
* Management contract or compensatory plan or arrangement.
 
 
 
 
 
 
 EX-31.1 2 ex31_1.htm EXHIBIT 31.1 ex31_1.htm
Exhibit 31.1
Broadcast International, Inc. & Subsidiaries
Certification Of Chief Executive Officer
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Rodney M. Tiede, certify that:
 
1.           I have reviewed this annual report on Form 10-K of Broadcast International, Inc.;
 
2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.           The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a.           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b.           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
 
c.           Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d.           Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.           The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a.           All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b.           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date:       March 29, 2013
 
 /s/  Rodney M. Tiede
  
Rodney M. Tiede, President
  
 
 
 
 EX-31.2 3 ex31_2.htm EXHIBIT 31.2 ex31_2.htm
Exhibit 31.2
Broadcast International, Inc. & Subsidiaries
Certification Of Chief Financial Officer
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, James E. Solomon, certify that:
 
1.           I have reviewed this annual report on Form 10-K of Broadcast International, Inc.;
 
2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.           The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a.           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b.           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
 
c.           Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d.           Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.           The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a.           All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b.           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date:       March 29, 2013
 
 /s/  James E. Solomon
  
James E. Solomon, Chief Financial Officer
  
 
 
 
 EX-32.1 4 ex32_1.htm EXHIBIT 32.1 ex32_1.htm
Chief Financial Officer Exhibit 32.1
Broadcast International, Inc. & Subsidiaries
Certification Of Chief Executive Officer
Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To
Section 906 Of The Sarbanes-Oxley Act Of 2002
 
In connection with the annual report of Broadcast International, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2012, Rodney M. Tiede hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)           The annual report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)           The information contained in the annual report fairly presents, in all material respects, the financial condition and results  of operations of the Company for the periods presented therein.
 
Date:       March 29, 2013
 
 /s/  Rodney M. Tiede
  
Rodney M. Tiede, President
  
 
 
 
 
 
 
 
 EX-32.2 5 ex32_2.htm EXHIBIT 32.2 ex32_2.htm
Exhibit 32.2
Broadcast International, Inc. & Subsidiaries
Certification Of Chief Financial Officer
Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To
Section 906 Of The Sarbanes-Oxley Act Of 2002
 
In connection with the annual report of Broadcast International, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2012, James E. Solomon hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)           The annual report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)           The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.
 
Date:       March 29, 2013
 
 /s/  James E. Solomon
  
James E. Solomon
Chief Financial Officer
  
 
 
 
 
 
 
 
 EX-101.INS 6 bcst-20121231.xml EXHIBIT 101.INS 157400 157400 33512 50268 1550000 0.25 5208333 5208333 P5Y P3Y P5Y P6Y P5Y P5Y P5Y P6Y P6Y P5Y P5Y P5Y P5Y P5Y P1Y P1Y P18M P24M 1.0 2500000 6000000 6000000 8000000 0.03 947994 103859 0 659496 1 0.5 0.6 118127 567 62038 0.1 0.08 10000000 3000000 6000000 15000000 10000000 0.1 27800000 0.5 0.5 0.25 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="96%"> <tr> <td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Common</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Issued</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> A Warrants</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Value of A</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> B</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrant</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Value</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Investors</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">24,816,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">12,408,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">469,464</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">39,387</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">508,851</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Bridge Loan Conversion</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,600,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">800,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30,268</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,539</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">32,807</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Equipment Finance Conversion</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">37,836</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,174</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">41,010</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Agency</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4,262,400</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">161,270</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">13,531</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">174,801</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">28,416,000</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">18,470,400</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">698,838</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">58,631</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">757,469</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 4 - Equity Financing and the Debt Restructuring</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2012 Equity Financing and the Debt Restructuring</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> On March 26, 2012, we closed on an equity financing (the "2012 Equity Financing") as well as a restructuring of our outstanding senior convertible indebtedness (the "2012 Debt Restructuring") resulting in complete satisfaction of our senior indebtedness.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We entered into an Engagement Agreement, dated October 28, 2011, with MDB Capital Group, LLC ("MDB"), pursuant to which MDB agreed to act as the exclusive agent of the Company on a "best efforts" basis with respect to the sale of up to a maximum gross consideration of $6,000,000, subsequently verbally increased to $10,000,000, of the Company&#39;s securities, subject to a minimum gross consideration of $3,000,000. The Company agreed to pay to MDB a commission of 10% of the gross offering proceeds received by the Company, to grant to MDB warrants to acquire up to 10% of the shares of our common stock and warrants issued in the financing, and to pay the reasonable costs and expenses of MDB related to the offering.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Pursuant to the Engagement Agreement, we entered into a Securities Purchase Agreement ("SPA") dated March 23, 2012 with select institutional and other accredited investors for the private placement of 27,800,000 units of our securities. The SPA included a purchase price of $0.25 per unit, with each unit consisting of one share of common stock and two forms of Warrant: (1) The "A" Warrant grants the investors the right to purchase an additional share of common stock for each two shares of common stock purchased, for a term of six years and at an exercise price of $0.35 per share; and (2) The "B" Warrant will not be exercisable unless and until the occurrence of a future issuance of stock at less than $0.25 per share, but, in the event of such issuance, grants the investors the right to acquire additional shares at a price of $0.05 to reduce the impact of the dilution caused by such issuance, but in no event shall the number of shares to be issued under the B Warrant cause us to exceed the number of authorized shares of common stock. The shares in excess of our authorized shares that would have been issuable under the B Warrant shall be "net settled" by payment of cash in an amount equal to the number of shares in excess of the authorized common shares multiplied by the closing price of our common stock as of the trading day immediately prior to the applicable date of the exercise of such B Warrant. The holders of the B Warrants agreed in December 2012 to amend the terms of the B Warrant to reduce the amount of subsequent financing required to extinguish the B Warrants with the result that the B Warrants have now been extinguished.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> Net proceeds from the 2012 Equity Financing, after deducting the commissions and the estimated legal, printing and other costs and expenses related to the financing, were approximately $6.1 million. Coincident to the closing of the 2012 Equity Financing, we also closed on the 2012 Debt Restructuring. In connection therewith, the Company paid $2,750,000 to Castlerigg Master Investment Ltd. ("Castlerigg"), and issued to Castlerigg 2,000,000 shares of common stock in full and complete satisfaction of the senior convertible note and all accrued interest. In consideration of negotiating the 2012 Debt Restructuring, we issued to one of our placement agents 586,164 shares of our common stock and paid them $275,041.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In December 2011, we entered into a loan with 7 accredited individuals and entities under the terms of which we borrowed $1,300,000 to be used as working capital ("Bridge Loan"). The Bridge Loan bears an interest rate of 18% per annum and had a maturity date of February 28, 2012, which was subsequently extended to the earlier of the date nine months from the original maturity date or the date we close on an additional sale of our securities that results in gross proceeds to us of $12 million. In consideration of the Bridge Loan we granted to the holders of the Bridge Loan warrants with a five year term to purchase 357,500 shares of our common stock at an exercise price of $0.65 per share. In consideration of the extension of the maturity date of the Bridge Loan, we granted the holders of the Bridge Loan warrants with a six year term to purchase 247,500 shares of our common stock at an exercise price of $0.35 per share.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> In connection with the 2012 Equity Financing and under the terms of the SPA, two of the above described bridge lenders converted the principal balance of their portion of the bridge loan in the amount of $400,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing. In addition, one other entity converted the amount owed by us for equipment purchases in the amount of $500,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing. The proceeds from these conversions were treated as funds raised with respect to the financing.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> In connection with the 2012 Equity Financing and under the terms of the SPA, the Company agreed to prepare and file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the Warrants. The Company filed the registration statement on April 9, 2012 and it was declared effective on August 1, 2012.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> On April 5, 2012 we secured an additional $154,000 from 1 company and 4 individuals (three of which are members of our Board of Directors) on the same terms and conditions as the investors of the 2012 Equity Financing. As a result of this funding we issued 616,000 shares of our common stock and A warrants totaling 400,400 of which 308,000 were issued to investors and 92,400 were issued to our investment banker.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> All warrants listed below were issued with price protection provisions and were accounted for as derivative liabilities. The A Warrants were valued using the Black Scholes pricing model and the B Warrants were valued using the Geometric Brownian Motion methodology with a risk neutral Monte Carlo approach.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="96%"> <tr> <td valign="bottom" width="40%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="40%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Common</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Issued</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> A Warrants</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Value of A</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> B</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrant</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Value</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Investors</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">24,816,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">12,408,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">469,464</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">39,387</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">508,851</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Bridge Loan Conversion</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,600,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">800,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30,268</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,539</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">32,807</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Equipment Finance Conversion</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,000,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,000,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">37,836</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,174</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">41,010</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Agency</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4,262,400</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">161,270</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">13,531</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">174,801</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">28,416,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">18,470,400</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">698,838</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">58,631</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">757,469</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We recorded an aggregate derivative liability of $757,469 as of December 31, 2012, related to the reset feature of the A warrants and the B warrants mentioned above. A derivative valuation gain of $4,365,323 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants issued. The aggregate derivative liability of $757,469 was calculated as follows: (1) $698,838 for the reset feature of the A warrants using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.72%, (ii) expected life (in years) of 5.2; (iii) expected volatility of 85.49%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08 and (2) $58,631 for the B warrants using the Geometric Brownian Motion methodology with a risk neutral Monte Carlo approach.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2010 Equity Financing and the Debt Restructuring</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On December 24, 2010, we closed on an equity financing (the "Equity Financing") as well as a restructuring of our then outstanding convertible indebtedness (the "Debt Restructuring"). The Equity Financing and the Debt Restructuring are described as follows.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We entered into a Placement Agency Agreement, dated December 17, 2010, with Philadelphia Brokerage Corporation ("PBC"), pursuant to which PBC agreed to act as the exclusive agent of the Company on a "best efforts" basis with respect to the sale of up to a maximum gross consideration of $15,000,000 of units of the Company&#39;s securities, subject to a minimum gross consideration of $10,000,000. The units consisted of two shares of our common stock and one warrant to purchase a share of our common stock. The Company agreed to pay PBC a commission of 8% of the gross offering proceeds received by the Company, to issue PBC 40,000 shares of its common stock for each $1,000,000 raised, and to pay the reasonable costs and expenses of PBC related to the offering. The Company also agreed to pay PBC a restructuring fee in the amount of approximately $180,000 upon the closing of the Equity Financing and the simultaneous Debt Restructuring.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Pursuant to the Placement Agency Agreement, we entered into Subscription Agreements dated December 23, 2010 with select institutional and other accredited investors for the private placement of 12,500,000 units of our securities. The Subscription Agreements included a purchase price of $1.20 per unit, with each unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock. The warrants have a term of five years and had an exercise price of $1.00 per share which was reset to $0.78 pursuant to the 2012 Equity Financing.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Net proceeds from the Equity Financing, after deducting the commissions and debt restructuring fees payable to PBC and the estimated legal, printing and other costs and expenses related to the financing, were approximately $13.5 million. We used a portion of the net proceeds of the Equity Financing to pay down debt and the remainder was used for working capital.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On November 29, 2010, we entered into a bridge loan transaction with three accredited investors pursuant to which we issued unsecured notes in the aggregate principal amount of $1.0 million. Upon the closing of the Equity Financing, the lenders converted the entire principal amount plus accrued interest into the same units offered in the Equity Financing and the proceeds from the bridge loan transaction were treated as funds raised with respect to the financing.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In connection with the Equity Financing and under the terms of the Subscription Agreements, the Company agreed to prepare and file, and did file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the warrants. The registration statement was declared effective June 16, 2011 satisfying the obligation contained in the Subscription Agreements.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On December 24, 2010, we also closed on the Debt Restructuring. In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the "Amended and Restated Note") to Castlerigg Master Investment Ltd. ("Castlerigg"), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents were issued (the "Loan Restructuring Agreement"), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010. As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The Amended and Restated Note, dated December 23, 2010, was a senior, unsecured note that matured in three years from the closing and bore interest at an annual rate of 6.25%, payable semi-annually. We paid the first year&#39;s interest of $350,434 at the closing. The Amended and Restated Note was convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment. The Amended and Restated Note was convertible in whole or in part at any time upon notice by Castlerigg to us. The Amended and Restated Note also contained various restrictions, acceleration provisions and other standard and customary terms and conditions. <font style="DISPLAY: inline">Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.</font></div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> <font style="DISPLAY: inline">The Investor Rights Agreement</font> provides Castlerigg with certain registration rights with respect to the Company&#39;s securities held by Castlerigg. These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied. The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> During the three months ended March 31, 2011, we issued Castlerigg 400,000 warrants pursuant to a waiver agreement dated March 10, 2011 allowing the issuance of shares and warrants for the conversion of the AR Note Payable without adjusting the conversion price of the Amended and Restated Senior 6.25% Convertible Note. These warrants contain full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model. During the three and six months ended June 30 ,2011 the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock. A valuation gain of $144,000 was recorded to reflect the change in value of the aggregate derivative from the time of issue to the date of conversion.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In connection with the Debt Restructuring, the Company <font style="DISPLAY: inline">amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013. We also issued 150,000 shares and 75,000 warrants to acquire our common stock at $.90 per share to the holder of this note as consideration to extend the term of the note.</font></div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> On March 26, 2012, we closed on an equity financing (the "2012 Equity Financing") as well as a restructuring of our outstanding senior convertible indebtedness (the "2012 Debt Restructuring") resulting in complete satisfaction our senior indebtedness.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> A portion of the net proceeds from the 2012 Equity Financing was used to close on the 2012 Debt Restructuring therewith. The Company paid $2,750,000 and issued 2,000,000 shares of common stock valued at $760,000 to Castlerigg in satisfaction of the $5,500,000 senior convertible note and $680,816 of accrued interest.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Investor warrants totaling 12,499,980 issued under the Subscription Agreements contain price protection adjustments in the event we issue new common stock or common stock equivalents in certain transactions at a price less than $1.00 per share and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model. The exercise price has been reset to $0.7312 per share due to subsequent financings.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We recorded an aggregate derivative liability of $109,400 and $2,785,000 as of December 31, 2012 and 2011, respectively, related to the reset feature of the warrants issued under the Placement agency Agreement. A derivative valuation gain of $2,765,600 and $7,875,000, respectively, were recorded to reflect the change in value of the aggregate derivative liability since December 31, 2011 and December 31, 2010, respectively. The aggregate derivative liability of $109,400 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.36%, (ii) expected life (in years) of 3.0; (iii) expected volatility of 85.10%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.</div> <!--EndFragment--></div> </div> 12500000 1.2 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 15 - Liquidity</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Broadcast experienced negative cash flow used in operations during the year of $3,362,785 compared to negative cash flow used in operations for the year ended December 31, 2011 of $5,164,437. Our current monthly excess of cash expenses over income is approximately $300,000 per month. During 2012 the decreased in negative cash flow was realized primarily through a reduction in the number of employees by approximately 40%, with more reductions scheduled, as well as additional expense reduction actions including reducing sales and general and administrative expenses. In addition, we have commenced an initiative designed to satisfy accounts payable through the issuance of common stock, which will further decrease our need for cash. We have to date received verbal and/or written commitments to accept partial payments and/or stock in full satisfaction of at least $600,000 of current payables and indebtedness.</div> <div style="DISPLAY: block; FONT-WEIGHT: bold; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The negative cash flow was met by cash reserves from the completion of the 2012 Equity Financing and the issuance of the 2012 Convertible Debt in the total amount of $3,050,000, which included $900,000 of Bridge Loan indebtedness that was converted to the 2012 Convertible Debt. In addition, we received $400,000 in January, 2013. We have commitments from current debt holders to fund up to an additional $1.550 million of our 2012 Convertible debt to offset future negative cash flow. We expect to continue to experience negative operating cash flow as long as we continue our current expenditures related primarily to bringing CodecSys products to market, continue our development of CodecSys or until we begin to receive licensing revenue from sales of CodecSys proprietary software or increase sales in our network division by adding new customers. We are actively pursuing potential customers to replace lost revenues when the BofA contract expires.</div> <!--EndFragment--></div> </div> 105805 -102978 P39M 800000 300000 2100 1981 357500 247500 65000 400000 400400 308000 23049 7000 655 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 7 - Operating Leases</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Our executive offices are located at 7050 Union Park Avenue, Suite 600, Salt Lake City, Utah 84047. We occupy the space at the executive offices under a 39-month lease, the term of which ends January 31, 2015. The lease covers approximately 13,880 square feet of office space leased at a rate of $23,049 per month. We occupy a production studio located at 6952 South 185 West, Unit C, Salt Lake City, Utah 84047, which consists of approximately 7,500 square feet on a month to month basis, at the rate of $7,000 per month plus utilities. We have no other properties. We recognized rent expense of approximately $352,789 and $463,694, in 2012 and 2011, respectively.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We also lease copy machines on multi-year leases that expire in March 2014 at a minimum rate of $655 per month.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Future minimum payments under non-cancelable operating leases at December 31, 2012 are as follow:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="30%"> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left" valign="bottom" width="60%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="33%">284,447</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left" valign="bottom" width="60%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="33%">278,552</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="60%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> 2015</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="33%">23,049</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="60%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="33%">586,048</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> </div> <!--EndFragment--></div> </div> 33 36 410000 0.1 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="30%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="67%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="30%">118,127</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="67%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="30%">62,038</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="67%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2015</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="30%">567</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="67%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="30%">180,732</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> 2940133 1.11 P10Y 1 5 5 4 43 1 1 15 3500000 3500000 414172 50127218 414172 586164 2000000 800000 800000 800000 135369 135369 135369 372272 372272 222742 760000 150000 6768 74453 81221 18614 260000 241386 1000000 12000000 5000000 0.5 500000 1095309 0.4 false --12-31 FY 2012 2012-12-31 10-K 0000740726 107932373 Yes Smaller Reporting Company 26806955 BROADCAST INTERNATIONAL INC No No 2293470 1252538 821608 1239903 99594490 96859058 404000 81500 81500 283693 2262540 283693 2262540 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Advertising Expenses</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We follow the policy of charging the costs of advertising to expense as incurred. Advertising expense for the years ended December 31, 2012 and 2011 were $35,168 and $68,703, respectively.</div> <!--EndFragment--></div> </div> 35168 68703 185478 2043386 98214 219154 283692 2262540 81140 53490 941225 340377 106723 7041 53160 501166 333336 333336 10151 10151 18568963 24597134 13880 7500 26180 2684516 4543487 1753013 2465992 856462 1269579 0.98 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 1 - Organization and Basis of Presentation</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Broadcast International, Inc. (the Company) is the consolidated parent company of BI Acquisitions, Inc. (BI), a wholly-owned subsidiary, and Interact Devices, Inc. (IDI), a 94% owned subsidiary.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> BI was incorporated in Utah in December 1999 and began operations in January 2000. It is a communications services and technology company headquartered in Salt Lake City, Utah. The Company operates two divisions - BI Networks and CodecSys.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On October 1, 2003, the Company (formerly known as Laser Corporation) acquired BI by issuing shares of its common stock representing 98% of the total equity ownership in exchange for all of the issued and outstanding BI common stock. The transaction was accounted for as a reverse acquisition, or recapitalization of BI, with BI being treated as the accounting acquirer. Effective January 13, 2004, the company changed its name from Laser Corporation to Broadcast International, Inc.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On May 18, 2004, the Debtor-in-Possession&#39;s Plan of Reorganization for IDI was confirmed by the United States Bankruptcy Court. As a result of this confirmation and subsequent share acquisitions, for the years ended December 31, 2012 and 2011, the Company owned, on a fully diluted basis, approximately 55,897,169 common share equivalents of IDI, representing approximately 94% of the equity of IDI.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The audited consolidated financial statements herein include operations from January 1, 2011 to December 31, 2012. IDI produced losses from operations during the period; therefore, 100% of the results from operations have been included in the Company&#39;s consolidated statements.</div> <!--EndFragment--></div> </div> 57939 264854 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 11 - Equipment Financing</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On August 27, 2009, we completed an equipment lease financing transaction with a financial institution. Pursuant to the financing, we entered into various material agreements with the financial institution. These agreements are identified and summarized below.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We entered into a Master Lease Agreement dated as of July 28, 2009 with the financial institution pursuant to which we sold to the financing institution certain telecommunications equipment to be installed at 1,981 (subsequent additional locations have increased the customer&#39;s network to an aggregate of approximately 2,100 locations) of our customer&#39;s retail locations in exchange for a one-time payment of $4,100,670 by the financial institution. We paid to the financial institution 36 monthly lease payments of approximately $144,000 plus applicable sales taxes. We had the right to terminate the lease after making 33 payments for a termination fee of the higher of approximately 10% of the original equipment value (approximately $410,000) or the then "in-place fair market value" after which payment we would own all of the equipment. We gave timely notice of exercise of this option. We are currently a party to a lawsuit to determine if the "in-place fair market value" exceeds the 10% of the original lease value and by what amount. We contend that the three payments made subsequent to the notice exercising our right to purchase constitute full payment for the equipment. The equipment broker contends that we owe an additional amount. Our accounting records reflect that the capital lease has been retired and the equipment has been fully depreciated.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We also entered into a security agreement with the financial institution pursuant to which we granted a first priority security interest in the equipment, whether now owned or hereafter acquired, and in our customer service agreement and service payments thereunder during the term of the equipment lease.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> During 2012 we had made lease payments totaling approximately $1,125,588 of which $1,067,649 was applied toward the outstanding lease and $57,939 was included in interest expense. Included in the $1,125,588 is approximately $422,100 paid toward the in place fair market value. Additionally during the year ended December 31, 2012 we made payments of $140,700 into an escrow account held by the court pending resolution of our dispute. For the year ending December 31, 2012, we expensed the final $33,512 of our lease acquisition fee of $150,792 which was being recognized over the life of the lease included in interest expense.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> During 2011 we had made lease payments totaling approximately $1,688,382 of which $1,423,528 was applied toward the outstanding lease and $264,854 was included in interest expense. Additionally, we expensed $50,268 of our lease acquisition fee of $150,792 which is being recognized over the life of the lease included in interest expense for the year ended December 31, 2011.</div> <!--EndFragment--></div> </div> 394342 961265 6129632 -566923 -5168367 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Cash and Cash Equivalents</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We consider all cash on hand and in banks, and highly liquid investments with maturities of three months or less, to be cash equivalents. At December 31, 2012 and 2011, we had bank balances of $38,847 and $909,182, respectively in excess of amounts insured by the Federal Deposit Insurance Corporation. In addition we have restricted cash of $140,700, which represents a deposit to the Utah District Court, which is held pending the outcome of our litigation with our equipment lessor. We have not experienced any losses in such accounts, and believe we are not exposed to any significant credit risk on cash and cash equivalents.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Current financial market conditions have had the effect of restricting liquidity of cash management investments and have increased the risk of even the most liquid investments and the viability of some financial institutions. We do not believe, however, that these conditions will materially affect our business or our ability to meet our obligations or pursue our business plans.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 16 - Supplemental Cash Flow Information</div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2012</div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> During the year ended December 31, 2012 we issued 586,164 shares our common stock, valued at $222,742 to a placement agency for services rendered related to our 2012 Equity Financing and Debt Restructuring agreement</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> During the year ended December 31, 2012, we issued 496,000 shares of our common stock valued at $177,313 to two consultants and one corporation of which (i) 250,000 shares was in consideration for cancellation of a warrant issued for consulting services rendered and (ii) 246,000 was for consulting services rendered.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> During the year ended December 31, 2012, we recognized $1,024,754 in depreciation and amortization expense from the following: (i) $466,606 related to cost of sales for equipment used directly by or for customers, (ii) $547,997 related to equipment other property and equipment, and (iii) $10,151 for patent amortization.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> For the year ended December 31, 2012, an aggregate non-cash expense of $941,225 was recorded for the accretion of our convertible notes of which (i) $501,166 was for the accretion of our 2012 Secured Convertible Note (ii) $333,336 was related to our unsecured convertible note and (iii) $106,723 was for our bridge loan.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2011</div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> During the year ended December 31, 2011, we granted options to acquire up to 600,000 shares of our common stock valued at $389,000 to two consultants in consideration of consulting services to be rendered by the consultants over a one-year period pursuant to a written consulting agreement. For the year ended December 31, 2011, the value of options is being recognized over the contract period and $364,000 was included in stock based compensation.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> During the year ended December 31, 2011 we issued 135,369 shares our common stock to an individual for interest owed on a debt obligation, valued at $81,221 which was accrued at December 31, 2010.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> During the year ended December 31, 2011 we acquired 414,172 IDI common share equivalents in exchange for 27,611 shares of our common stock valued at $10,760 which was expensed to research and development.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> During the year ended December 31, 2011, we recognized $1,483,868 in depreciation and amortization expense from the following: (i) $798,677 related to cost of sales for equipment used directly by or for customers, (ii) $675,040 related to equipment other property and equipment, and (iii) $10,151 for patent amortization.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> For the year ended December 31, 2011, an aggregate non-cash expense of $340,377 was recorded for the accretion of our convertible notes of which (i) $333,336 was related to our unsecured convertible note and (ii) $7,041 was for our bridge loan.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> On March 21, 2011, the Company, converted $784,292 of its short-term debt into equity through the issuance of common stock and warrants to two lenders at the same unit pricing as the Equity Financing. In consideration of converting the short- term loans on the basis of $1.20 for two shares of common stock plus one warrant at an exercise price of $1.00, the Company issued 1,307,153 shares of common stock and warrants to acquire up to 653,576 shares of common stock, which warrants have a five year term and are exercisable at $1.00 per share. The $784,292 above is net of expense and includes $109,292 of interest of which $89,658 was accrued in the year ended December 31, 2010 and $19,634 which was included as interest expense for the year ended December 31, 2011. The Company&#39;s objective for converting the short-term debt into equity is to conserve cash for further market development.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.999pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> In March 2011, we granted to the holder of our senior unsecured convertible note a warrant to acquire 400,000 shares of our common stock at an exercise price of $.05 per share in consideration of a waiver of the holder&#39;s reset provision that allowed us to convert certain short terms loans to equity without causing an adjustment in the conversion price of our senior note. The warrants had a 5-year life from the date of grant, contained full-ratchet anti-dilution price protection provisions and were valued at $404,000 using a Black Scholes pricing model on the date of grant. During the year ended December 31, 2011, the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We paid no cash for income taxes during the years ended December 31 2012 and 2011.</div> <!--EndFragment--></div> </div> 38847 909182 0.7312 0.725 0.53 0.65 5.0 1.8 3.75 0.65 0.35 1.0 0.05 0.35 0.05 0.65 0.25 0.35 0.78 0.9 1.0 0.96 0.9 1.6 1.75 2.1 3.0 1875000 5208333 112500 653576 247500 357500 200000 500000 3800000 1800000 221758 75000 750000 750000 2000000 2000000 5500000 850000 18470400 800000 1000000 400000 12499980 75000 12408000 4262400 774867 0.05 0.05 180000000 180000000 107473820 75975656 107473820 75975656 74078153 107473820 5373691 3798783 950000 1250000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Concentration of Credit Risk</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Financial instruments, which potentially subject us to concentration of credit risk, consist primarily of trade accounts receivable. In the normal course of business, we provide credit terms to our customers. Accordingly, we perform ongoing credit evaluations of our customers and maintain allowances for possible losses which, when realized, have been within the range of management&#39;s expectations.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> For the years ended December 31, 2012 and 2011, we had the same customer that individually constituted 85% and 89%, of our total revenues, respectively. Although the initial contract for this customer has expired, we received a contract extension through May 31, 2013 to continue to provide services. Unless we can replace that customer with another similarly large customer or customers, revenues will decline substantially, which will harm our business.</div> <!--EndFragment--></div> </div> 0.71 0.79 372272 466606 798677 4819624 5868601 28416000 1600000 2000000 1307153 1307153 24816000 653576 500000 675000 784292 400000 500000 900000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 5 - Notes Payable</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The recorded value of our notes payable (net of debt discount) for the years ending December 31, 2012 and 2011 was as follows:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31,</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31,</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2012 Secured Convertible Notes</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,428,166</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Unsecured Convertible Note</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">340,504</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">673,840</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Amended and Restated Senior 6.25% Convertible Note</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,180,816</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Bridge Loan Note Payable</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,196,141</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Equipment Purchase and Sale Agreement</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">700,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">8,417,461</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,102,006</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Less Current Portion</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(2,068,016</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(3,102,006</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total Long-term</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,349,445</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2012 Secured Convertible Notes</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We engaged Philadelphia Brokerage Corporation to raise funds through the issuance of convertible promissory notes. We anticipated issuing promissory notes with an aggregate principal amount of up to $5,000,000 ("2012 Convertible Debt Offering"). As of December 31, 2012 we have issued notes having an aggregate principal value of $3,050,000 as explained below. The notes are due and payable on or before July 13, 2013. The notes bear interest at 12% per annum and may convertible to common stock at a $.25 per share conversion price. We also granted holders of the notes warrants with a five year life to acquire up to 200,000 shares of our common stock for each $100,000 of principal amount of the convertible notes. The notes are secured by all of our assets with the exception of the equipment and receivables secured by the equipment lessor for equipment used in providing services for our largest customer&#39;s digital signage network.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In July 2012, we entered into a note and warrant purchase and security agreement with individual investors and broke escrow on the initial funding under the 2012 Convertible Debt Offering, the principal amount of which was $1,900,000, which included the conversion of $900,000 of previously issued short term debt (See Bridge Loan described above) to the 2012 convertible Debt Offering, which extinguished the Bridge Loan. Of the $1,000,000 non-converted principal amount, we realized $923,175 of cash in the initial closing and issued warrants to acquire 3,800,000 shares of our common stock. We paid $76,825 in investment banking fees and costs of the offering.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In August 2012, we continued sales of convertible debt under the 2012 Convertible Debt Offering by issuing short term debt with a principal amount of $900,000, issued warrants to acquire 1,800,000 shares of our common stock, from which we realized cash of $851,624 after payment of investment banking fees of $48,376.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In December 2012, we continued sales of convertible debt under the 2012 Convertible Debt Offering by issuing short term debt with a principal amount of $250,000, issued warrants to acquire 500,000 shares of our common stock to one member of our Board of Directors.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> The notes and warrants mentioned above were issued with price protection provisions and were accounted for as derivative liabilities and valued on the dates issued using a Black-Scholes pricing model.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We recorded an aggregate derivative liability of $74,500 as of December 31, 2012, related to the conversion feature of the note. A derivative valuation gain of $423,500 was recorded to reflect the change in value of the aggregate derivative liability from the time the notes were issued. The aggregate derivative liability of $74,500 was calculated as follows using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.11%, (ii) expected life (in years) of 0.50; (iii) expected volatility of 129.08%, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Additionally, we recorded an aggregate derivative liability of $183,000 as of December 31, 2012, related to the warrant reset provision. A derivative valuation gain of $442,000 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants were issued. The aggregate derivative liability of $183,000 was calculated as follows using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.63%, (ii) expected life (in years) of 4.50; (iii) expected volatility of 85.75%, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Unsecured Convertible Note</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On September 29, 2006, we entered into a letter of understanding with Triage Capital Management, or Triage, dated September 25, 2006. The letter of understanding provided that Triage loan $1,000,000 to us in exchange for us entering into, on or prior to October 30, 2006, a convertible note securities agreement. It was intended that the funding provided by Triage be replaced by a convertible note and accompanying warrants, as described below. Effective November 2, 2006, we entered into securities purchase agreement, a 5% convertible note, a registration rights agreement, and four classes of warrants to purchase our common stock, all of which were with an individual note holder, the controlling owner of Triage, who caused our agreement with Triage to be assigned to him, which satisfied our agreement with Triage.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Pursuant to the securities purchase agreement, (i) we sold to the convertible note holder a three-year convertible note in the principal amount of $1,000,000 representing the funding received by us on September 29, 2006; (ii) the convertible note bears an annual interest rate of 5%, payable semi-annually in cash or shares of our common stock; (iii) the convertible note is convertible into shares of our common stock at a conversion price of $1.50 per share subject to full-ratchet anti-dilution price protection provisions ; and (iv) we issued to the convertible note holder four classes of warrants (A Warrants, B Warrants, C Warrants and D Warrants), which give the convertible note holder the right to purchase a total of 5,500,000 shares of our common stock as described below. The A and B Warrants originally expired one year after the effective date of a registration statement filed under the Securities Act of 1933, as amended (the "Securities Act"), to register the subsequent sale of shares received from exercise of the A and B Warrants. The C Warrants and D Warrants originally expired eighteen months and twenty four months, respectively, after the effective date of a registration statement to be filed under the Securities Act. The A Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.60 per share, the B Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.75 per share, the C Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $2.10 per share, and the D Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $3.00 per share.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> During the year ended December 31, 2007, the convertible note holder exercised 454,000 A Warrants. We entered into an exchange agreement dated October 31, 2007 in which the convertible note holder received 650,000 shares of our common stock in exchange for cancellation of the C and the D Warrants. The expiration date of the A Warrants and the B Warrants was extended from January 11, 2008 to December 3, 2008. During the year ended December 31, 2008, the convertible note holder exercised 64,400 A Warrants. On December 3, 2008, the remaining 231,600 A Warrants and 750,000 B Warrants were unexercised and expired.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On December 23, 2009 we entered into an amendment with the holder of our unsecured convertible note in the principal amount of $1.0 million which (i) extended the note maturity date to December 22, 2010 and (ii) increased the annual rate of interest from 5% to 8% commencing October 16, 2009. All other terms and conditions of the note remain unchanged.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On December 24, 2010 we closed on a Debt Restructuring as mentioned above, In connection with that Debt Restructuring the Company <font style="DISPLAY: inline">amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013. We issued 150,000 shares to the holder of this note as consideration to extend the term of the note.</font></div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> During March 2011, we issued 135,369 shares of common stock to the holder of our unsecured convertible note in satisfaction of $81,221 of accrued interest on the unsecured convertible note. Also in connection with the satisfaction of the accrued interest we granted to the holder a warrant to acquire up to 221,758 additional shares of our common stock at an exercise price of $0.96 per share. The warrant is exercisable at any time for a five-year period. For the year ended December 31, 2011, the $157,400 value of the warrant was included in interest expense.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We recorded an aggregate derivative liability of $46,400 and $300,000 as of December 31, 2012 and 2011, respectively, related to the conversion feature of the note. A derivative valuation gain of $253,600 and $1,101,900, respectively, was recorded to reflect the change in value of the aggregate derivative liability since December 31, 2011 and December 31, 2010, respectively. The aggregate derivative liability of $46,400 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.16%, (ii) expected life (in years) of 1.0; (iii) expected volatility of 112.04%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In connection with the amendment mentioned above, the principal value of the note is being accreted due to the difference in the value of the conversion feature before and after the amendment. The principal value of $1,000,000 of the unsecured convertible note was accreted over the amended term of the obligation, for which $333,336 was included in interest expense for each the years ended December 31, 2012 and 2011. The note bears an 8% annual interest rate payable semi-annually, and for each the years ended December 31, 2011 and 2010, $80,000, was included in interest expense.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Senior Unsecured 6.25% Convertible Note</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On December 24, 2007, we entered into a securities purchase agreement in which we raised $15,000,000 (less $937,000 of prepaid interest). We used the proceeds from this financing to support our CodecSys commercialization and development and for general working capital purposes. Pursuant to the financing, we issued a senior secured convertible note in the principal amount of $15,000,000 (which principal amount has been increased as discussed below).The senior secured convertible note was originally due December 21, 2010, but was extended to December 21, 2013 and has been subsequently retired. The senior secured convertible note bore interest at 6.25% per annum (which rate has been changed as discussed below) if paid in cash. Interest for the first year was prepaid at closing. Interest-only payments thereafter in the amount of $234,375 are due quarterly and commenced in April 2009. Interest payments may be made through issuance of common stock in certain circumstances or may be capitalized and added to the principal. The original principal of the note was convertible into 2,752,294 shares of our common stock at a conversion price of $5.45 per share, convertible any time during the term of the note. We granted a first priority security interest in all of our property and assets and of our subsidiaries to secure our obligations under the note and related transaction agreements. In August 2009 we received a waiver from the note holder releasing their security interest for the equipment purchased under our sale lease back financing.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In connection with the 2007 financing, the senior secured convertible note holder received warrants to acquire 1,875,000 shares of our common stock exercisable at $5.00 per share. We also issued to the convertible note holder 1,000,000 shares of our common stock valued at $3,750,000 and incurred an additional $1,377,000 for commissions, finder&#39;s fees and other transaction expenses, including the grant of a three-year warrant to purchase 112,500 shares of our common stock to a third party at an exercise price of $3.75 per share, valued at $252,000. A total of $1,377,000 was included in debt offering costs and is being amortized over the term of the note.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> From March 26, 2010 through October 29, 2010, we entered into a series of amendments to the senior secured convertible note. Each of these amendments is described below.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On March 26, 2010, we entered into an amendment and extension agreement with the holder of the senior secured convertible note. The agreement conditionally amended the maturity date of the note to December 21, 2011. If we are unsuccessful in raising at least $6.0 million in equity financing before September 30, 2010, the maturity date of the note will automatically be restored to its original date of December 21, 2010. In consideration of entering into the agreement, the note holder was issued 1,000,000 shares of our restricted common stock valued at $990,000. In addition, we agreed to the inclusion of three additional terms and conditions in the note: (i) from and after the additional funding, we will be required to maintain a cash balance of at least $1,250,000 and provide monthly certifications of the cash balance to the note holder; (ii) we will not make principal payments on our outstanding $1.0 million unsecured convertible note without the written consent of the holder of the senior secured convertible note; and (iii) we will grant board observation rights to the note holder. Given these additional terms, unless the senior secured convertible note holder provides consent, of which there can be no assurance, we will be precluded from repaying the $1.0 million unsecured convertible note when it becomes due on December 22, 2010.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On July 30, 2010, we entered into a further amendment agreement with the holder of the senior secured convertible note regarding the note and warrant reset provisions. The July 30, 2010 amendment conditionally amended the maturity date of the note to June 21, 2012. If we are unsuccessful in raising the $6.0 million in equity financing referenced above, the maturity date of the note will automatically be restored to its original date of December 21, 2010. The holder of the note agreed to a conversion price of the note of $1.80 per share instead of the price at which we sell equity between now and September 30, 2010 and reduced the required cash balance referenced in the March 26, 2010 amendment above from $1,250,000 to $950,000. In addition, the number of warrants originally granted to the holder pursuant to the 2007 financing increased from 1,875,000 to 5,208,333 and were exercisable at $1.80 per share instead of $5.00 per share. The warrants continued to be exercisable any time for the five years from the original date of grant. In consideration of entering into the July 30, 2010 amendment the note holder was issued 2,000,000 shares of common stock and would be issued an additional 800,000 shares of our common stock contingent upon completion of the required equity raise.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On September 27, 2010, we entered into a further amendment agreement with the holder of the senior secured convertible note regarding the note. Pursuant to this amendment, the due date for the required equity financing was extended to October 31, 2010.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On October 29, 2010, we entered into a fourth amendment agreement with the holder of the senior secured convertible note regarding the note and warrant provisions. The fourth amendment (i) increased the amount of the required equity raise to $8.0 million, approximately $2.5 million of which had been raised or committed by investors at the time of the amendment; (ii) extended the time in which we can complete the equity financing to December 3, 2010; (iii) deleted the provision of the senior secured convertible note that granted the Company the option to redeem the note prior to its maturity date; (iv) changed the conversion price of the note upon successful <font style="DISPLAY: inline">completion of the required capital raise to an amount equal to 150% of the lowest price at which Company common stock is sold during calendar year 2010</font>; (v) changed the exercised price of the warrants to an amount equ<font style="DISPLAY: inline">al to 150% of the lowest price at which Company common stock is sold during calendar year 2010; (vi) provides that if we are successful in completing the required capital raise the number of warrants will be increased as currently provided in the 6.25% senior secured convertible promissory note; and (vii) extended the expiration date of the warrants to December 31, 2013.</font></div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> If the additional funding was not completed by December 3, 2010, certain provisions of the prior amendments became void in that the maturity date will revert back to December 21, 2010, the conversion price became the lowest price at which equity securities had been sold, the exercise price became the lowest price at which equity securities have been sold, the number of warrants then outstanding would be determined by the original purchase documents, and the Company would not have an obligation to maintain a balance of cash and marketable securities equal to $950,000.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On December 24, 2010, we closed on the Debt Restructuring. In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the "Amended and Restated Note") to Castlerigg Master Investment Ltd. ("Castlerigg"), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents was issued (the "Loan Restructuring Agreement"), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010. As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest. The Debt Restructuring was considered a troubled-debt restructuring and a gain on debt restructuring of $3,062,457 was recorded during the year ended December 31, 2010, which was the difference between the adjusted carrying value of the original note and the carrying value of the Amended and Restated Note.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bore interest at an annual rate of 6.25%, payable semi-annually. We paid the first year&#39;s interest of approximately $344,000 at the closing. The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment. The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us. The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions. <font style="DISPLAY: inline">Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.</font></div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> <font style="DISPLAY: inline">The Investor Rights Agreement</font> provides Castlerigg with certain registration rights with respect to the Company&#39;s securities held by Castlerigg. These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions were not satisfied. The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> On March 26, 2012, we closed on an equity financing (the "2012 Equity Financing"), as well as a restructuring of our outstanding senior convertible indebtedness (the "2012 Debt Restructuring"), resulting in complete satisfaction of our senior indebtedness under the Amended and Restated Note.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> A portion of the net proceeds from the 2012 Equity Financing was used to close on the 2012 Debt Restructuring. The Company paid $2,750,000 and issued 2,000,000 shares of common stock valued at $760,000 in satisfaction of the Amended and Restated Note and remaining interest value of $680,816. In consideration of negotiating the 2012 Debt Restructuring and amending our agreement with our placement agent, we paid $275,041 and issued 586,164 shares of our common stock valued at $222,742 to our placement agent, and recognized a $2,173,033 gain on extinguishment of debt as a result of this retirement.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> With the retirement of the Amended and Restated Note we recorded no aggregate derivative liability at December 31, 2012, however at the date of retirement we recorded a derivative valuation gain of $203,700, related to the conversion feature of the Amended and Restated Note to reflect the change in value of the aggregate derivative from December 31, 2011 to the date of retirement. The derivative value of $81,500 at the date of retirement was recorded as additional paid in capital.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We recorded an aggregate derivative liability of $285,200 at December 31, 2011, related to the conversion features of the Amended and Restated Note and the conversion feature and warrants related to the Original Note. A derivative valuation gain of $2,322,200 was recorded during the year ended December 31, 2011 to reflect the change in value of the aggregate derivative.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The $6,180,816 value of the Amended and Restated Note at December 31, 2011 consists of $5,500,000 for the principal due of the note plus $680,816 for aggregate future interest due of which $171,875 is payable in 2012 and has been included in current debt obligations at December 31, 2011 and was retired pursuant to the 2012 Debt Restructuring noted above.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accounts Receivable Purchase Agreements</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> During the year ended December 31, 2010 we entered into two Accounts Receivable Purchase Agreements with one individual for an aggregate amount of $775,000. During the year ended December 31, 2011 we remitted $100,000 of the principal balance plus accrued interest of $8,360 and converted the remaining $675,000 of principal balance plus $109,292 of accrued and unpaid interest into 1,307,153 shares of our common stock and warrants to purchase an additional 653,576 shares of our common stock. The warrants contain anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than $1.00 per share. The current exercise price has been reset to $0.725 per share due to subsequent financings.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We recorded an aggregate derivative liability of $5,900 and $156,300 as of December 31, 2012 and 2011, respectively, related to the conversion feature of the note. A derivative valuation gain of $253,600 and $293,800, respectively, was recorded to reflect the change in value of the aggregate derivative liability since December 31, 2011 and December 31, 2010, respectively. The aggregate derivative liability of $5,900 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.36%, (ii) expected life (in years) of 3.20; (iii) expected volatility of 83.16%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Bridge Loan</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> <font style="DISPLAY: inline">On December 28, 2011 we entered into a Note and Warrant Purchase and Security Agreement with seven individuals for an aggregate of $1,300,000</font> ("Bridge Loan") to be used as working capital<font style="DISPLAY: inline">. The note bears an annual interest rate of 18%, payable monthly in cash. Additionally, we</font> granted to the holders of the Bridge Loan warrants with a five year term to purchase an aggregate of 357,500 shares of our common stock at an exercise price of $0.65. <font style="DISPLAY: inline">The note was due on February 28, 2012, but the term</font> was subsequently extended to the earlier of the date nine months from the original maturity date or the date we closed on an additional sale of our securities that resulted in gross proceeds to us of $12 million. In consideration of the extension of the maturity date of the Bridge Loan, we granted the holders of the Bridge Loan warrants with a six year term to purchase 247,500 shares of our common stock at an exercise price of $0.35 per share. <font style="DISPLAY: inline">This note is collateralized by a security interest in all of our accounts receivable</font></div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> <font style="DISPLAY: inline">In connection with the Bridge Loan, we paid an $84,500 placement fee and issued warrants to purchase 65,000 shares of our common stock at an exercise price of $0.65 per share and</font> subsequently reset to $0.53, <font style="DISPLAY: inline">to our investment banker for services in completing the above transaction and paid a $3,000 escrow fee to the Escrow Agent in exchange for holding the funds prior to their disbursement to us.</font></div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> On March 26, 2012, we closed on the 2012 Equity Financing and under the terms of the associated securities purchase agreement, two of the above described bridge lenders converted the principal balance of their portion of the bridge loan in the amount of $400,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing, reducing the outstanding principal balance to $900,000. The warrants issued had a total value of $222,426 which resulted in a loss on extinguishment of debt of $222,426. The aggregate derivative liability and valuation gain or loss for the warrants issued for the converted portion of the principal balance are included in the aggregate of 2012 Equity Financing information.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> All warrants mentioned above were issued with price protection provisions and were accounted for as derivative liabilities and valued using a Black Scholes pricing model.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On July 13, 2012 the $900,000 principal balance was retired and was included as part of the 2012 Convertible Note (as described below) and recorded a (i) $93,661 loss on extinguishment of debt related to the remaining un-accreted portion of the note and (ii) $53,160 expense related to unrecognized offering costs, at the time of retirement.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> At December 31, 2012 we recorded an aggregate derivative liability of $7,400 related to the reset provision for the original and placement warrants issued. A derivative valuation gain of $136,300 was recorded to reflect the change in value of the aggregate derivative liability from December 31, 2011. The aggregate derivative liability of $7,400 for the reset provision of the warrants was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.54%, (ii) expected life (in years) of 4.0; (iii) expected volatility of 82.55%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> At December 31, 2012 we recorded an aggregate derivative liability of $7,200 related to the reset provision for the warrants issued for an extension of the maturity date. A derivative valuation gain of $89,325 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants were issued. The aggregate derivative liability of $7,200 for the reset provision of the warrants was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.54%, (ii) expected life (in years) of 4.0; (iii) expected volatility of 82.55%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The principal value of the note was being accreted over the amended term of the obligation, for which $106,723 and 7,041 were included in interest expense for the years ended December 31, 2012 and 2011, respectively. The note bore an 18% annual interest rate, and for the years ended December 31, 2012 and 2011, $100,899 and $2,564, respectively were included in interest expense.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Equipment Purchase and Sale Agreement</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In October 2011, we entered into an Equipment Purchase and Sale Agreement with a Utah corporation whereby we use the funds advanced to purchase certain electronic receiving and digital signage equipment along with installation costs. A 3% fee is due each month the amount remains outstanding. At December 31, 2011 we had an outstanding amount owed of $700,000 and had accrued two months of fees totaling $42,000 which was included as interest expense for the year ended December 31, 2011.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> On March 26, 2012, we closed on the 2012 Equity Financing and under the terms of the associated securities purchase agreement the above described lender converted the principal balance of its portion of the loan in the amount of $500,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing, the remaining $200,000 principal balance plus $105,000 of interest due was paid in cash. The warrants issued had a total value of $278,032 which resulted in a loss on extinguishment of debt of $278,032. The aggregate derivative liability and valuation gain or loss for the warrants issued for the converted portion of the principal balance are included in the aggregate of 2012 Equity Financing information.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> The 3% fee mention above was recorded as interest expense and or the years ended December 31 2012 and 2011, $63,000 and $42,000 were included, respectively.</div> <!--EndFragment--></div> </div> 1.35 5.45 1.8 0.25 1.5 1.2 0.25 0.25 80000 80000 2752294 7200000 7200000 5500000 15000000 15000000 1300000 1000000 1000000 3050000 5000000 425000 1900000 900000 1000000 0.0625 0.0625 0.18 0.08 0.05 0.08 0.12 2010-12-21 2011-12-21 2012-06-21 2012-02-28 2013-07-13 2013-12-31 2010-12-22 2013-07-13 234375 1067649 1423528 150792 150792 47348 15000 51500 1 year 686667 529100 200000 42176 123278 51335 10449 25881900 23862500 1158900 1147000 78500 83500 31600 21000 27212600 24941000 61700 173000 99761 90453 0.03 0.02 558148 685191 1024754 1483868 547997 675040 1191269 1191269 1191269 3760200 757469 5900 156300 58631 698838 7400 7200 109400 2785000 46400 300000 285200 81500 74500 183000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 10 - Stock-based Compensation</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Stock Incentive Plans</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> <font style="DISPLAY: inline">Under the Broadcast International, Inc. 2004 Long-term Incentive Plan (the "2004 Plan"), the board of directors may issue incentive stock options to employees and directors and non-qualified stock options to consultants of the company.</font> Options generally may not be exercised until twelve months after the date granted and expire ten years after being granted. Options granted vest in accordance with the vesting schedule determined by the board of directors, usually ratably over a three-year vesting schedule upon anniversary date of the grant. Should an employee terminate before the vesting period is completed, the unvested portion of each grant is forfeited. We have used the Black-Scholes valuation model to estimate fair value of our stock-based awards, which requires various judgmental assumptions including estimated stock price volatility, forfeiture rates, and expected life. Our computation of expected volatility is based on a combination of historical and market-based implied volatility. The number of unissued stock options authorized under the 2004 Plan at December 31, 2012 was 3,779,508.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The Broadcast International, Inc. 2008 Equity Incentive Plan (the "2008 Plan") has become our primary plan for providing stock-based incentive compensation to our eligible employees and non-employee directors and consultants of the company. The provisions of the 2008 Plan are similar to the 2004 Plan except that the 2008 Plan allows for the grant of share equivalents such as restricted stock awards, stock bonus awards, performance shares and restricted stock units in addition to non-qualified and incentive stock options. We continue to maintain and grant awards under our 2004 Plan which will remain in effect until it expires by its terms. The number of unissued shares of common stock reserved for issuance under the 2008 Plan was 774,867 at December 31, 2012.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Stock Options</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> <font style="DISPLAY: inline">We estimate the fair value of stock option awards granted beginning January 1, 2006 using the Black-Scholes option-pricing model. We then amortize the fair value of awards expected to vest on a straight-line basis over the requisite service periods of the awards, which is generally the period from the grant date to the end of the vesting period. The Black-Scholes valuation model</font> requires various judgmental assumptions including the estimated volatility, risk-free interest rate and expected option term. Our computation of expected volatility is based on a combination of historical and market-based implied volatility. <font style="DISPLAY: inline">The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the stock option award was granted with a maturity equal to the expected term of the stock option award. The expected option term is derived from an analysis of historical experience of similar awards combined with expected future exercise patterns based on several factors including the strike price in relation to the current and expected stock price, the minimum vest period and the remaining contractual period.</font></div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The fair values for the options granted in 2012 and 2011 were estimated at the date of grant using the Black Scholes option-pricing model with the following weighted average assumptions:</div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="70%"> <tr> <td valign="top" width="28%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="top" width="32%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year Ended December 31,</div> </td> </tr> <tr> <td valign="top" width="28%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Risk free interest rate</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1.65%</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1.91%</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected life (in years)</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 10.0</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 6.2</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected volatility</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 78.97%</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 80.89%</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected dividend yield</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 0.00%</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 0.00%</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The weighted average fair value of options granted during the years ended December 31, 2012 and 2011, was $0.27 and $0.61, respectively.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Warrants</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We <font style="DISPLAY: inline">estimate the fair value of issued warrants on the date of issuance as determined using a Black-Scholes pricing model. We amortize the fair value of issued warrants using a vesting schedule based on the terms and conditions of each associated underling contract, as earned. The Black-Scholes valuation model</font> requires various judgmental assumptions including the estimated volatility, risk-free interest rate and warrant expected exercise term. Our computation of expected volatility is based on a combination of historical and market-based implied volatility. <font style="DISPLAY: inline">The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the warrant was issued with a maturity equal to the expected term of the warrant.</font></div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The fair values for the warrants granted in 2012 and 2011 were estimated at the date of grant using the Black Scholes option-pricing model with the following weighted average assumptions:</div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="70%"> <tr> <td valign="top" width="28%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="top" width="30%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year Ended December 31,</div> </td> </tr> <tr> <td valign="top" width="28%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Risk free interest rate</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 1.16%</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 2.07%</div> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Expected life (in years)</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 5.7</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 5.0</div> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Expected volatility</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 82.79%</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 85.37%</div> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Expected dividend yield</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 0.00%</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 0.00%</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The weighted average fair value of warrants granted during the years ended December 31, 2012 and 2011, was $0.23 and $0.67, respectively.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Results of operations for the years ended December 31, 2012 and 2011 includes $283,692 and $2,262,540, respectively, of non-cash stock-based compensation expense. Restricted stock units and options issued to directors vest immediately. All other restricted stock units, options and warrants are subject to applicable vesting schedules. Expense is recognized proportionally as each award or grant vests.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> For the year ended December 31, 2012 we recognized $283,692 of stock based compensation as follows: (i) $65,500 for 390,133 restricted stock units issued to 5 members of the board of directors, (ii) $833 for 50,000 options granted to 4 employees and (iii) $217,359 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2012.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> For the year ended December 31, 2011 we recognized $2,262,540 of stock based compensation expense as follows: (i) $1,544,000 for 1,400,000 restricted stock units issued to all 5 members of the board of directors, (ii) $124,000 for 200,000 restricted stock units issued to one employee, (iii) $364,000 for 600,000 options issued to one individual and one corporation for consulting services, (iv) $96,489 for 909,200 options granted to 43 employees, (v) $15,000 for 50,000 options granted to one member of our advisory board, (vi) $4,263 for 8,700 options granted to 15 of our non-employee installation technicians and (vi) $114,788 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2011. Additionally, we issued (i) 221,758 warrants to our unsecured convertible note holder, (ii) 653,576 warrants related to our accounts receivable purchase agreements, (iii) 422,500 warrants related to our Bridge Loan. See Note 5. There were 400,000 warrants exercised in the year ending December 31, 2011.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The following table summarizes option and warrant activity during the years ended December 31, 2012 and 2011.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="MARGIN-LEFT: 45pt; text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="70%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Options</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> and</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" width="70%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="13%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="13%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2010</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">20,442,170</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.13</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Options granted</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1,567,900</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.91</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Warrants issued</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1,697,834</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.68</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Expired</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(302,054</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">18.67</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Forfeited</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(2,510,201</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.08</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Exercised</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(455,098</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">-</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2011</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">20,440,551</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.10</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Options granted</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">50,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.37</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Warrants issued</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">24,817,900</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.33</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Expired</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(252,669</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.31</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Forfeited</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(1,658,919</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.31</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Exercised</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">-</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">-</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2012</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">43,396,863</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.54</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The following table summarizes information about stock options and warrants outstanding at December 31, 2012.</div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#ffffff"> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" colspan="2" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="8" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="5" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercisable</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#ffffff"> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Remaining</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#ffffff"> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Range of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise Prices</div> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Contractual</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Life (years)</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercisable</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.17-0.95</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">39,583,684</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">4.36</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.47</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">39,207,017</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.47</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">1.00-1.59</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">3,306,679</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">3.20</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">1.04</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">3,248,146</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">1.04</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">2.25-4.00</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">506,500</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">3.34</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">2.62</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">506,500</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">2.62</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.17-4.00</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">43,396,863</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">4.26</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.54</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">42,961,663</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.54</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> There were no options exercised in the year ended December 31, 2012 and 55,098 options were exercised in the year ended December 31, 2011. There was no intrinsic value of options and warrants available and exercisable for the years ended December 31, 2012 or 2011.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Restricted Stock Units</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> For the years ended December 31, 2012 and 2011, 390,133 and 1,600,000 restricted stock units were awarded, respectively. The cost of restricted stock units is determined using the fair value of our common stock on the date of the grant and compensation expense is recognized in accordance with the vesting schedule. All of the restricted stock units vested during the year they were awarded.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The following is a summary of restricted stock unit activity for the years ended December 31, 2012 and 2011<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">:</font></div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="96%"> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="76%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Restricted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Stock Units</div> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Grant</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Date Fair</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Value</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" width="76%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2010</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">950,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.61</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Awarded at fair value</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,600,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.04</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Canceled/Forfeited</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Settled by issuance of stock</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2011</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,550,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.25</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Awarded at fair value</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">390,133</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.17</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Canceled/Forfeited</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Settled by issuance of stock</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2012</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,940,133</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.11</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Vested at December 31, 2012</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,940,133</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.11</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Included in stock based compensation for the year ended December 31, 2012, was $65,500 for 390,133 restricted stock units issued to all 5 members of the board of directors, all of which were recorded in general and administrative expense.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Included in stock based compensation for the year ended December 31, 2011, was $1,668,000 as follows; (i) $1,544,000 for 1,400,000 restricted stock units issued to all 5 members of the board of directors, (ii) $124,000 for 200,000 restricted stock units issued to one employee, all of which were recorded in general and administrative expense.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The impact on our results of operations for recording stock-based compensation for the years ended December 31, 2012 and 2011 is as follows:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="MARGIN-LEFT: 36pt; text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="94%"> <tr> <td valign="bottom" width="76%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</td> <td valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the years ended</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" width="76%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</td> <td valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31,</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="76%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> General and administrative</div> </td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">185,478</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,043,386</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Research and development</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">98,214</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">219,154</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">283,692</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,262,540</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Total unrecognized stock-based compensation was $180,732 at December 31, 2012, which we expect to recognize over the next three years in accordance with vesting provisions as follows:</div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="30%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="67%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="30%">118,127</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="67%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="30%">62,038</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="67%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2015</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="30%">567</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="67%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="30%">180,732</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <!--EndFragment--></div> </div> 3347255 3126772 1808 0 2750000 2750000 2750000 2750000 0.02 0.02 0.02 0.02 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Weighted Average Shares</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Basic earnings per common share is computed by dividing net income or loss applicable to common shareholders by the weighted average number of shares outstanding during each period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year, plus the dilutive common stock equivalents that would rise from the exercise of stock options, warrants and restricted stock units outstanding during the period, using the treasury stock method and the average market price per share during the period, plus the effect of assuming conversion of the convertible debt. The computation of diluted earnings per share does not assume conversion or exercise of securities that would have an anti-dilutive effect on earnings.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The following table sets forth the computation of basic and diluted earnings per common share for the years ended December 31, 2011 and 2012:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="64%">&nbsp;</td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 0.5pt solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Year</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Ended 2011</div> </td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 0.5pt solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the year</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Ended 2012</div> </td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Numerator</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,304,446</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,602,824</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Denominator</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Basic weighted average shares outstanding</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">75,416,916</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">100,978,223</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Effect of dilutive securities:</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Stock options and warrants</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">131,250</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,510,488</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Restricted stock units</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,550,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,225,133</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Diluted weighted average shares outstanding</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">78,098,166</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">106,533,844</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income per common share</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Basic</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Diluted</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Potentially dilutive securities representing 18,568,963 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2012, because their effect would have been anti-dilutive.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Potentially dilutive securities representing 24,597,134 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2011, because their effect would have been anti-dilutive.</div> <!--EndFragment--></div> </div> 363568 390206 180732 P3Y 0.85 0.89 425100 400000 900000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: left"> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Significant</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Quoted Prices in</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Other</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Significant</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Active Markets for</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Observable</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Unobservable</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Identical Assets</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Inputs</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Inputs</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Total</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (Level 1)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (Level 2)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (Level 3)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Assets</div> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 3%" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> None</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total assets measured at fair value</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Liabilities</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 3%" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Derivative valuation (1)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,191,269</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,191,269</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total liabilities measured at fair value</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,191,269</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,191,269</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 9pt">&nbsp;</td> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> (1)</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> See Notes 4 &amp; 5 for additional discussion.</div> </td> </tr> </table> </div> </div> </div> <!--EndFragment--></div> </div> 0 0 0 0 0 0 0 0 P3Y2M12D P5Y2M12D P4Y0M P4Y0M P3Y0M P1Y0M P6M P4Y6M 0.8316 0.8549 0.8255 0.8255 0.851 1.1204 1.2908 0.8575 0.0036 0.0072 0.0054 0.0054 0.0036 0.0016 0.0011 0.0063 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 12 - Fair Value Measurements</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We adopted ASC Topic 820 as of January 1, 2008 for financial instruments measured at fair value on a recurring basis. ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:</div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</div> </td> </tr> </table> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</div> </td> </tr> </table> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2012:</div> <div style="text-align: left"> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Significant</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Quoted Prices in</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Other</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Significant</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Active Markets for</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Observable</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Unobservable</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Identical Assets</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Inputs</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Inputs</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Total</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (Level 1)</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (Level 2)</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (Level 3)</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Assets</div> </td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 3%" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> None</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total assets measured at fair value</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Liabilities</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 3%" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Derivative valuation (1)</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,191,269</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,191,269</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total liabilities measured at fair value</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,191,269</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,191,269</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 9pt">&nbsp;</td> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> (1)</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> See Notes 4 &amp; 5 for additional discussion.</div> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The table below presents our assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at December 31, 2012. We classify financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model.</div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="80%"> <tr> <td valign="bottom" width="85%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="13%" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Derivative</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" width="85%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="13%" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Valuation</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="85%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Liability</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at December 31, 2011</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(3,760,200</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total gains or losses (realized and unrealized)</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-LEFT: 1%" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Included in net income</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">8,829,748</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-LEFT: 1%" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Valuation adjustment</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Purchases, issuances, and settlements, net</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(6,260,817</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Transfers to Level 3</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">--</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at December 31, 2012</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(1,191,269</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Money Market Funds and Treasury Securities</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The money market funds and treasury cash reserve securities balances are classified as cash and cash equivalents on our consolidated balance sheet.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Fair Value of Other Financial Instruments</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The carrying amounts of our accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their immediate or short-term maturities. The aggregate carrying amount of the notes payable approximates fair value as the individual notes bear interest at market interest rates and there hasn&#39;t been a significant change in our operations and risk profile.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="80%"> <tr> <td valign="bottom" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="13%" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Derivative</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="13%" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Valuation</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Liability</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at December 31, 2011</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(3,760,200</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total gains or losses (realized and unrealized)</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-LEFT: 1%" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Included in net income</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">8,829,748</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-LEFT: 1%" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Valuation adjustment</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Purchases, issuances, and settlements, net</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(6,260,817</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Transfers to Level 3</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at December 31, 2012</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(1,191,269</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> </table> </div> <!--EndFragment--></div> </div> 8829748 -6260817 1191269 3760200 11343 10121 10121 10121 10121 120928 131079 P20Y 8829748 11724400 253600 293800 4365323 136300 89325 2765600 7875000 144000 253600 1101900 203700 2322200 423500 442000 512 -362 1578914 -954017 2173033 -222426 -93661 -278032 4546612 6172794 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Patents and Intangibles</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Patents represent initial legal costs incurred to apply for United States and international patents on the CodecSys technology, and are amortized on a straight-line basis over their useful life of approximately 20 years. We have filed several patents in the United States and foreign countries. As of December 31, 2012, the United States Patent and Trademark Office had approved four patents. Additionally, eleven foreign countries had approved patent rights. While we are unsure whether we can develop the technology in order to obtain the full benefits, the patents themselves hold value and could be sold to companies with more resources to complete the development. On-going legal expenses incurred for patent follow-up have been expensed from July 2005 forward. For the year ended December 31, 2011 we recorded a $26,180 valuation impairment related to two patent applications for areas outside the United States.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Amortization expense recognized on all patents totaled $10,151 for each of the years ended December 31, 2012 and 2011, respectively.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Estimated amortization expense, if all patents were issued at the beginning of 2013, for each of the next five years is as follows:</div> <div style="MARGIN-LEFT: 63pt; text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="40%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ending</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31:</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="7%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="16%" colspan="2" nowrap="nowrap"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="7%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">11,343</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="7%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2015</div> </td> <td valign="bottom" width="7%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2016</div> </td> <td valign="bottom" width="7%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2017</div> </td> <td valign="bottom" width="7%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <!--EndFragment--></div> </div> 2704000 2577481 26180 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Long-Lived Assets</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We review our long-lived assets, including patents, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by a comparison of the carrying amount of an asset to future un-discounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, then the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. Fair value is determined by using cash flow analyses and other market valuations. After our review at December 31, 2012 it was determined that no adjustment was required.</div> <!--EndFragment--></div> </div> 1602824 1304446 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 8 - Income Taxes</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Net deferred tax liabilities consist of the following components as of December 31, 2011 and 2012:</div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Deferred tax assets</div> </td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOL carry-forward</div> </td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23,862,500</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">25,881,900</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> General business credit carry-forwards</div> </td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,147,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,158,900</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Deferred compensation</div> </td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">83,500</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">78,500</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Allowance for doubtful accounts</div> </td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">21,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">31,600</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Deferred tax liabilities</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Depreciation</div> </td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(173,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">61,700</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Valuation allowance</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(24,941,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(27,212,600</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net deferred tax asset</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, 2010 and 2011 due to the following:</div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> <td valign="bottom" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Federal income tax (expense) benefit at statutory rates</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,902,500</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,831,600</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> State income tax (expense) benefit at statutory rates</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">280,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">269,300</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Change in valuation allowance</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(2,182,500</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(2,100,900</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="76%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> At December 31, 2012, the Company had net operating loss carry-forwards of approximately $66,364,000 that may be offset against future taxable income from the year 2013 through 2032. No tax benefit has been reported in the December 31, 2011 and 2012 consolidated financial statements since the potential tax benefit is offset by a valuation allowance of the same amount.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Due to change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Income Taxes</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We account for income taxes in accordance with the asset and liability method of accounting for income taxes prescribed by ASC Topic 740. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income in the years in which those temporary differences are expected to be recovered or settled.</div> <!--EndFragment--></div> </div> -2100900 -2182500 1831600 1902500 269300 280000 1040932 -267452 -386313 124997 136682 13823 40886 -128988 245445 8676 -323618 -205498 -140700 2510488 131250 3225133 2550000 1095309 476234 1542424 1000072 100899 2564 63000 42000 89658 347902 357246 680816 350434 937000 8360 105000 680816 171875 680816 680816 42000 19634 306296 60851 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Inventories</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Inventories consisting of electrical and computer parts are stated at the lower of cost or market determined using the first-in, first-out method.</div> <!--EndFragment--></div> </div> 2327 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 6 - Investment in Interact Devices, Inc (IDI)</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We began investing in and advancing monies to IDI in 2001. IDI was developing technology which became an initial part of the CodecSys technology.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On October 23, 2003, IDI filed for Chapter 11 Federal Bankruptcy protection. We desired that the underlying patent process proceed and that the development of CodecSys technology continue. Therefore, we participated in IDI&#39;s plan of reorganization, whereby we would satisfy the debts of the creditors and obtained certain licensing rights. On May 18, 2004, the debtor-in-possession&#39;s plan of reorganization for IDI was confirmed by the United States Bankruptcy Court. As a result of this confirmation, we issued to the creditors of IDI shares of our common stock and cash in exchange for approximately 50,127,218 shares of the common stock of IDI. Since May 18, 2004, we have acquired additional common share equivalents IDI. During the year ended December 31, 2012 we did not acquire any IDI share equivalents. During the year ended December 31, 2011 we acquired 414,172 IDI common share equivalents in exchange for 27,611 shares of our common stock valued at $10,760. As of December 31, 2012, we owned approximately 55,897,169 IDI common share equivalents, representing approximately 94% of the total outstanding IDI share equivalents</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Since May 18, 2004, we have advanced additional cash to IDI for the payment of operating expenses, which continues development and marketing of the CodecSys technology. As of December 31, 2012 and 2011, we have advanced an aggregate amount of $3,347,255 and $3,126,772 respectively, pursuant to a promissory note that is secured by assets and technology of IDI.</div> <!--EndFragment--></div> </div> 157400 2015-01-31 2014-03-31 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 14 - Legal Proceedings</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We have pending legal matters. We have a judgment rendered against us in a lawsuit, the total amount in dispute in which is approximately $130,000.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On July 27, 2012, CTC Resources Inc. dba U.S. Media Capital ("CTC") filed a lawsuit in the Third Judicial District Court in and for Salt Lake City, State of Utah against ACC Capital Corporation ("ACC"), Loni L. Lowder and the Company (the "CTCD Lawsuit") asserting claims for relief for breach of contract against ACC, breach of fiduciary duty and fraud against ACC and Mr. Lowder and civil conspiracy against ACC, Mr. Lowder and the Company, and seeking injunctive relief and constructive trust as to all defendants as well as money damages. On October 9, 2012, we filed our answer as well as a cross claim against ACC seeking declaratory relief as to the price to be paid by us for the leased equipment and specific performance against ACC. On January 7, 2013 in a hearing relative to a temporary injunction previously granted by the Court, the Court took testimony and heard arguments from the parties on the matter and the Court and the parties agreed that a trial would be unnecessary. Both parties submitted briefs regarding the law and summarizing the testimony elicited at the hearing. The Court&#39;s judgment rendered on February 25, 2013 vacated the parties&#39; joint appraisal and required that the parties jointly secure another appraisal for the equipment, the results of which will be binding on the parties. We have paid $424,500 toward the purchase price of the equipment, which we believe satisfies our payment obligation, but pursuant to a restraining order we sought to prevent the lessor from contacting our customer as of March 26, 2013 we have escrowed an aggregate of $425,100 with the Court and have a current obligation to continue making monthly escrow payments in the amount of $141,700 pending a decision in the matter.</div> <!--EndFragment--></div> </div> 7301376 15073511 2684516 4543487 7301376 8724066 1191269 1191269 6349445 2006-10-30 2006-09-25 1000000 1000000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 3 - Accounts Receivable</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Included in our $821,608 and $1,239,903 net accounts receivable for the years ending December 2012 and 2011, respectively, were (i) $856,462 and $1,269,579 for billed trade receivables, respectively; (ii) $44,478 and $23,814 of unbilled trade receivables, respectively; (iii) $1,808 and $0 for employee travel advances and other receivables, respectively; less (iv) $81,140 and $53,490 for allowance for uncollectible accounts, respectively.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Included in the numbers above is our single largest customer for each year ended December 31, 2012 and, 2011, which provided 85% and 89% of total revenue and represented 71% and 79% of our trade receivables on December 31, 2012 and 2011, respectively.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Our largest customer initially signed a three-year agreement which has now expired, although we did receive a contract extension through May 31, 2013 to continue to provide services. Unless we can replace that customer with another similarly large customer or customers, revenues will decline substantially, which will harm our business.</div> <!--EndFragment--></div> </div> 6180816 700000 6349445 141700 130000 0.94 0.94 2964926 467392 -169064 -471322 -3362785 -5164437 1602824 1304446 1602824 1304446 1602824 1304446 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Recent Accounting Pronouncements</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In August 2012, the FASB issued ASU No 2012-03, <font style="FONT-STYLE: italic; DISPLAY: inline">Technical Amendments and Corrections to SEC Sections.</font> This Update makes changes to several of the SEC guidance literature sections within the Codification. The main focus is to update the SEC guidance as per SAB 114 to reference the codification sections rather than the old standards prior to the codification. The changes were mainly references and were not intended to change guidance. The amendments in this Update are effective immediately. This guidance didn&#39;t have a significant impact on the Company&#39;s financials since it was an update of SEC referenced guidance and didn&#39;t change existing guidance.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In July 2012, the FASB issued ASU 2012-02, <font style="FONT-STYLE: italic; DISPLAY: inline">Intangibles - Goodwill and Other (Topic 350) - Testing Indefinite-Lived Intangible Assets for Impairment.</font> The objective of this Update is to simplify how entities test indefinite-lived intangible assets for impairment and to have the testing be in-line with the updated guidance issued in 2011 related to impairment testing for goodwill. This Update allows entities to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative analysis. The more likely than not threshold is defined as having a likelihood of more than 50%. The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the quantitative impairment test and still be able to resume performing the qualitative assessment in subsequent years. Some examples of circumstances to consider are 1) cost factors that have a negative impact on earnings, 2) financial performance such as negative or declining cash flows, 3) legal, regulatory, contractual, political or business conditions, 4) other relevant entity specific events 5) industry and market conditions, and 6) macroeconomic conditions. The Update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before July 27, 2012 if the financial statements have not been issued. The Company doesn&#39;t expect this Update to impact the Company&#39;s financials since it currently has no indefinite-lived intangibles other than goodwill, but the Company will plan on utilizing the qualitative assessment options if any are acquired.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In June 2011, the FASB issued ASU 2011-05, <font style="FONT-STYLE: italic; DISPLAY: inline">Comprehensive Income (Topic 220) - Presentation of Comprehensive Income.</font> This Update eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders&#39; equity in order to increase the prominence of other comprehensive income items and to facilitate convergence with IFRS. The Update requires that all non-owner changes in stockholders&#39; equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements (a statement of income and statement of other comprehensive income). Additionally, adjustments for items reclassified from other comprehensive income to net income must be presented on the face of the financial statements. This Update should be applied retrospectively. For public entities, the Update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. For nonpublic entities, the Update is effective for fiscal years ending after December 15, 2012, and interim and annual periods thereafter. Early adoption is permitted, because compliance with the amendments is already permitted. The amendments do not require any transition disclosures. This impacts how items for Other Comprehensive Income are presented and the Company will follow the guidance starting in Q1 2012.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In December 2011, the FASB issued ASU 2011-11, <font style="FONT-STYLE: italic; DISPLAY: inline">Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities.</font> This Update is applicable to all entities that have financial instruments and derivative instruments that are either 1) offset in accordance with current guidance or 2) subject to an enforceable master netting arrangement. The Update requires an entity with these types of instruments to disclose information about offsetting and related arrangements. Both net and gross information for these assets and liabilities is required to be disclosed. This Update is effective for fiscal years beginning on or after January 1, 2013. The Company doesn&#39;t expect this Update to impact the Company&#39;s financials since it does not currently have any financial instruments or derivative instruments that are offset.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In September 2011, the FASB issued ASU 2011-08, <font style="FONT-STYLE: italic; DISPLAY: inline">Intangibles - Goodwill and Other (Topic 350)- Testing Goodwill for Impairment.</font> The objective of this Update is to simplify how entities test goodwill for impairment. This Update now allows entities to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step process of (1) comparing the fair value of the reporting unit to its carrying value and (2) test to measure the amount of the impairment loss if the fair value is less than the carrying value. The more likely than not threshold is defined as having a likelihood of more than 50%. The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the first step of the two-step goodwill impairment test. Some examples of circumstances to consider are 1) macroeconomic conditions, 2) industry and market conditions, 3) cost factors that have a negative impact on earnings, 4) overall financial performance such as negative or declining cash flows 5) other relevant entity specific events and 6) sustained decrease in stock price. The Update is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before September 15, 2011 if the financial statements have not been issued. If necessary, the Company will evaluate whether or not it will utilize the qualitative assessment option prior to performing the first goodwill impairment test in 2012, typically done during the 4<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> quarter.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In May 2011, the FASB issued ASU 2011-04, <font style="FONT-STYLE: italic; DISPLAY: inline">Fair Value Measurement (Topic 820) - Amendments to Achieve Common Fair Value Measurements and Disclosure Requirements in US GAAP and IFRSs.</font> The Amendments in this Update will improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with US GAAP and IFRSs. The Boards of both organizations worked together to ensure fair value has the same meaning and the measurement and disclosures would be the same other than minor differences in wording. The Amendments explain how to measure fair value and do not require any additional fair value measurements. A couple of the more significant changes are 1) Clarification that quantitative information about unobservable inputs categorized as Level 3 should be disclosed, 2) Specifies that premiums and discounts should be applied in the absence of Level 1 input if market participants would do so, but that premiums or discounts related to size/quantity should not be considered, 3) Additional disclosure requirements for fair value measurements categorized as Level 3, an entity&#39;s us of a nonfinancial asset in a way that differs from the asset&#39;s highest and best use and the categorization by level for items not measured at fair value in the statement of financial position, but for which fair value disclosure is required. The amendments in this Update are to be applied prospectively. The Update is effective during interim and annual periods beginning after December 15, 2011. The Company doesn&#39;t expect this guidance to have a significant impact on its financials since the amount of items disclosed at fair value is minimal, but will ensure the guidance is followed for items disclosed at fair value.</div> <!--EndFragment--></div> </div> 7666510 9299008 2428166 673840 340504 6180816 1196141 700000 3102006 8417461 3102006 2068016 600000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Off-Balance Sheet Arrangements</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We have no off-balance sheet arrangements.</div> <!--EndFragment--></div> </div> 8767686 10572043 -6063686 -7994562 586048 284447 23049 278552 352789 463694 66364000 2013 through 2032 299728 175008 359396 660361 1067649 10760 -4433 2966 177313 19634 109292 157400 81221 109292 76825 48376 422100 275041 84500 180000 275041 1377000 3000 776483 24078 172825 472505 424500 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 13 - Retirement Plan</div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We have implemented a 401(k) employee retirement plan. Under the terms of the plan, participants may elect to contribute a portion of their compensation, generally up to 60%, to the plan, subject to IRS Code Section 415 limitations. We match contributions up to 100% of the first 3% of a participant&#39;s compensation contributed to the plan and 50% of the next 2%. Employees are eligible to participate in the plan after three months of service as defined by the plan. For the years ended December 31, 2012 and 2011, we made matching contributions totaling $99,761 and $90,453, respectively.</div> <!--EndFragment--></div> </div> 20000000 20000000 0 0 196292 406004 90067 203973 923175 851624 250000 3050000 400000 6150000 154000 13500000 18304 2024799 1300000 700000 -140700 3761 1183 900000 572107 1417134 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Property and equipment are stated at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the property, generally from three to five years. Repairs and maintenance costs are expensed as incurred except when such repairs significantly add to the useful life or productive capacity of the asset, in which case the repairs are capitalized.</div> <!--EndFragment--></div> </div> P3Y P5Y 31982 10149 2500000 4017649 1526834 200000 1125588 1688382 100000 1754163 2410249 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Research and Development</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Research and development costs are expensed when incurred. We expensed $1,754,163 and $2,410,249 of research and development costs for the years ended December 31, 2012 and 2011, respectively.</div> <!--EndFragment--></div> </div> 140700 -109585041 -111187865 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We recognize revenue when evidence exists that there is an arrangement between us and our customers, delivery of equipment sold or service has occurred, the selling price to our customers is fixed and determinable with required documentation, and collectability is reasonably assured. We recognize as deferred revenue, payments made in advance by customers for services not yet provided.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> When we enter into a multi-year contract with a customer to provide installation, network management, and satellite transponder and help desk, or combination of these services, we recognize this revenue as services are performed and as equipment is sold. These agreements typically provide for additional fees, as needed, to be charged if on-site visits are required by the customer in order to ensure that each customer location is able to receive network communication. As these on-site visits are performed the associated revenue and cost are recognized in the period the work is completed. If we install, for an additional fee, new or replacement equipment to an immaterial number of new customer locations, and the equipment immediately becomes the property of the customer, the associated revenue and cost are recorded in the period in which the work is completed.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In instances where we have entered into license agreements with a third parties to use our technology within their product offering, we recognize any base or prepaid revenues over the term of the agreement and any per occurrence or periodic usage revenues in the period they are earned.</div> <!--EndFragment--></div> </div> 7523624 8446082 4100670 144000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31,</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31,</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2012 Secured Convertible Notes</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,428,166</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Unsecured Convertible Note</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">340,504</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">673,840</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Amended and Restated Senior 6.25% Convertible Note</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,180,816</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Bridge Loan Note Payable</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,196,141</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Equipment Purchase and Sale Agreement</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">700,000</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">8,417,461</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,102,006</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Less Current Portion</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(2,068,016</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(3,102,006</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total Long-term</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,349,445</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Deferred tax assets</div> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOL carry-forward&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23,862,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">25,881,900</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> General business credit carry-forwards&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,147,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,158,900</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Deferred compensation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">83,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">78,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Allowance for doubtful accounts&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">21,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">31,600</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Deferred tax liabilities</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Depreciation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(173,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">61,700</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Valuation allowance&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(24,941,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(27,212,600</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net deferred tax asset&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="64%">&nbsp;</td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 0.5pt solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Year</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Ended 2011</div> </td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 0.5pt solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the year</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Ended 2012</div> </td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Numerator</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,304,446</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,602,824</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Denominator</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Basic weighted average shares outstanding</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">75,416,916</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">100,798,223</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Effect of dilutive securities:</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Stock options and warrants</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">131,250</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,510,488</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Restricted stock units</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,550,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,225,133</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Diluted weighted average shares outstanding</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">78,098,166</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">106,533,844</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income per common share</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Basic</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Diluted</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Federal income tax (expense) benefit at statutory rates</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,902,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,831,600</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> State income tax (expense) benefit at statutory rates</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">280,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">269,300</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Change in valuation allowance&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(2,182,500</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(2,100,900</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="MARGIN-LEFT: 36pt; text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="94%"> <tr> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the years ended</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31,</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> General and administrative</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">185,478</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,043,386</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Research and development</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">98,214</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">219,154</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">283,692</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,262,540</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="MARGIN-LEFT: 63pt; text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="40%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ending</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31:</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="16%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">11,343</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2015</div> </td> <td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2016</div> </td> <td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2017</div> </td> <td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <!--StartFragment--> <div style="text-align: center"> <table style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="30%"> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left" valign="bottom" width="60%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="33%">284,447</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left" valign="bottom" width="60%"> &nbsp;</td> <td valign="bottom" width="1%" align="right">&nbsp;</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="TEXT-ALIGN: right" valign="bottom" width="33%"> &nbsp;</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left" valign="bottom" width="60%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="33%">278,552</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="60%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> 2015</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="33%">23,049</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="33%">586,048</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="96%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Restricted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Stock Units</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Grant</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Date Fair</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Value</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2010</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">950,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.61</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Awarded at fair value</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,600,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.04</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Canceled/Forfeited</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Settled by issuance of stock</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2011</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,550,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Awarded at fair value</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">390,133</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.17</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Canceled/Forfeited</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Settled by issuance of stock</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2012</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,940,133</td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.11</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Vested at December 31, 2012</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,940,133</td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.11</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#ffffff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="8" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="5" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercisable</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#ffffff"> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Remaining</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#ffffff"> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Range of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise Prices</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Contractual</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Life (years)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercisable</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.17-0.95</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">39,583,684</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">4.36</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.47</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">39,207,017</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.47</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">1.00-1.59</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">&nbsp; 3,306,679</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">3.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">1.04</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">&nbsp; 3,248,146</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">1.04</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">2.25-4.00</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">&nbsp; &nbsp;&nbsp; 506,500</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">3.34</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">2.62</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">&nbsp;&nbsp;&nbsp;&nbsp; 506,500</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">2.62</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.17-4.00</td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">43,396,863</td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">4.26</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.54</td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">42,961,663</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="9%">0.54</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="MARGIN-LEFT: 45pt; text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Options</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> and</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="13%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="13%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2010</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">20,442,170</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.13</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Options granted&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1,567,900</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.91</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Warrants issued&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1,697,834</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.68</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Expired&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(302,054</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">18.67</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Forfeited&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(2,510,201</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.08</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Exercised&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(455,098</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2011</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">20,440,551</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.10</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Options granted&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">50,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.37</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Warrants issued&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">24,817,900</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.33</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Expired&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(252,669</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.31</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Forfeited&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(1,658,919</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.31</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Exercised&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2012</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">43,396,863</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.54</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="70%"> <tr> <td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="top" width="32%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year Ended December 31,</div> </td> </tr> <tr> <td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Risk free interest rate</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1.65%</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1.91%</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected life (in years)</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 10.0</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 6.2</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected volatility</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 78.97%</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 80.89%</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected dividend yield</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 0.00%</div> </td> <td valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 0.00%</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="70%"> <tr> <td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="top" width="30%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year Ended December 31,</div> </td> </tr> <tr> <td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Risk free interest rate</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 1.16%</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 2.07%</div> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Expected life (in years)</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 5.7</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 5.0</div> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Expected volatility</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 82.79%</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 85.37%</div> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Expected dividend yield</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="16%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 0.00%</div> </td> <td style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="top" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 0.00%</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div> 1908763 1277629 283693 2262540 364000 15000 65500 1668000 65500 1544000 833 96489 124000 364000 4263 217359 114788 P3Y 390133 1600000 390133 1400000 200000 0.17 1.04 2940133 2550000 950000 1.11 1.25 1.61 0 0 0 0 P10Y P6Y2M12D P5Y8M12D P5Y0M 0.7897 0.8089 0.8279 0.8537 0.0165 0.0191 0.0116 0.0207 3779508 252669 302054 650000 750000 650000 1658919 2510201 50000 50000 909200 600000 8700 221758 653576 422500 50000 1567900 24817900 1697834 600000 0.27 0.61 0.23 0.67 389000 43396863 20440551 20442170 0.54 1.1 1.13 258553 1.31 18.67 1.31 0.08 0.37 0.91 0.33 0.68 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Stock-based Compensation</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.</div> <!--EndFragment--></div> </div> 0.47 1.04 2.62 0.54 0.17 1.0 2.25 0.17 39207017 3248146 506500 42961663 39583684 3306679 506500 43396863 0.47 1.04 2.62 0.54 P4Y4M10D P3Y2M12D P3Y4M2D P4Y3M4D 0.95 1.59 4.0 4.0 222742 177313 586164 92400 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 2 - Significant Accounting Policies</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Management Estimates</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Cash and Cash Equivalents</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We consider all cash on hand and in banks, and highly liquid investments with maturities of three months or less, to be cash equivalents. At December 31, 2012 and 2011, we had bank balances of $38,847 and $909,182, respectively in excess of amounts insured by the Federal Deposit Insurance Corporation. In addition we have restricted cash of $140,700, which represents a deposit to the Utah District Court, which is held pending the outcome of our litigation with our equipment lessor. We have not experienced any losses in such accounts, and believe we are not exposed to any significant credit risk on cash and cash equivalents.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Current financial market conditions have had the effect of restricting liquidity of cash management investments and have increased the risk of even the most liquid investments and the viability of some financial institutions. We do not believe, however, that these conditions will materially affect our business or our ability to meet our obligations or pursue our business plans.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Account Receivables</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Trade account receivables are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than 90 days. After the receivable becomes past due, it is on non-accrual status and accrual of interest is suspended.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Inventories</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Inventories consisting of electrical and computer parts are stated at the lower of cost or market determined using the first-in, first-out method.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Property and equipment are stated at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the property, generally from three to five years. Repairs and maintenance costs are expensed as incurred except when such repairs significantly add to the useful life or productive capacity of the asset, in which case the repairs are capitalized.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Patents and Intangibles</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Patents represent initial legal costs incurred to apply for United States and international patents on the CodecSys technology, and are amortized on a straight-line basis over their useful life of approximately 20 years. We have filed several patents in the United States and foreign countries. As of December 31, 2012, the United States Patent and Trademark Office had approved four patents. Additionally, eleven foreign countries had approved patent rights. While we are unsure whether we can develop the technology in order to obtain the full benefits, the patents themselves hold value and could be sold to companies with more resources to complete the development. On-going legal expenses incurred for patent follow-up have been expensed from July 2005 forward. For the year ended December 31, 2011 we recorded a $26,180 valuation impairment related to two patent applications for areas outside the United States.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Amortization expense recognized on all patents totaled $10,151 for each of the years ended December 31, 2012 and 2011, respectively.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Estimated amortization expense, if all patents were issued at the beginning of 2013, for each of the next five years is as follows:</div> <div style="MARGIN-LEFT: 63pt; text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="40%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ending</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31:</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="7%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="16%" colspan="2" nowrap="nowrap"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="7%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">11,343</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="7%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2015</div> </td> <td valign="bottom" width="7%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2016</div> </td> <td valign="bottom" width="7%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="75%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2017</div> </td> <td valign="bottom" width="7%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" align="left" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">10,121</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Long-Lived Assets</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We review our long-lived assets, including patents, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by a comparison of the carrying amount of an asset to future un-discounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, then the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. Fair value is determined by using cash flow analyses and other market valuations. After our review at December 31, 2012 it was determined that no adjustment was required.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Stock-based Compensation</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Income Taxes</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We account for income taxes in accordance with the asset and liability method of accounting for income taxes prescribed by ASC Topic 740. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income in the years in which those temporary differences are expected to be recovered or settled.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We recognize revenue when evidence exists that there is an arrangement between us and our customers, delivery of equipment sold or service has occurred, the selling price to our customers is fixed and determinable with required documentation, and collectability is reasonably assured. We recognize as deferred revenue, payments made in advance by customers for services not yet provided.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> When we enter into a multi-year contract with a customer to provide installation, network management, and satellite transponder and help desk, or combination of these services, we recognize this revenue as services are performed and as equipment is sold. These agreements typically provide for additional fees, as needed, to be charged if on-site visits are required by the customer in order to ensure that each customer location is able to receive network communication. As these on-site visits are performed the associated revenue and cost are recognized in the period the work is completed. If we install, for an additional fee, new or replacement equipment to an immaterial number of new customer locations, and the equipment immediately becomes the property of the customer, the associated revenue and cost are recorded in the period in which the work is completed.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In instances where we have entered into license agreements with a third parties to use our technology within their product offering, we recognize any base or prepaid revenues over the term of the agreement and any per occurrence or periodic usage revenues in the period they are earned.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Research and Development</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Research and development costs are expensed when incurred. We expensed $1,754,163 and $2,410,249 of research and development costs for the years ended December 31, 2012 and 2011, respectively.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Concentration of Credit Risk</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Financial instruments, which potentially subject us to concentration of credit risk, consist primarily of trade accounts receivable. In the normal course of business, we provide credit terms to our customers. Accordingly, we perform ongoing credit evaluations of our customers and maintain allowances for possible losses which, when realized, have been within the range of management&#39;s expectations.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> For the years ended December 31, 2012 and 2011, we had the same customer that individually constituted 85% and 89%, of our total revenues, respectively. Although the initial contract for this customer has expired, we received a contract extension through May 31, 2013 to continue to provide services. Unless we can replace that customer with another similarly large customer or customers, revenues will decline substantially, which will harm our business.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Weighted Average Shares</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Basic earnings per common share is computed by dividing net income or loss applicable to common shareholders by the weighted average number of shares outstanding during each period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year, plus the dilutive common stock equivalents that would rise from the exercise of stock options, warrants and restricted stock units outstanding during the period, using the treasury stock method and the average market price per share during the period, plus the effect of assuming conversion of the convertible debt. The computation of diluted earnings per share does not assume conversion or exercise of securities that would have an anti-dilutive effect on earnings.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The following table sets forth the computation of basic and diluted earnings per common share for the years ended December 31, 2011 and 2012:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="64%">&nbsp;</td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 0.5pt solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Year</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Ended 2011</div> </td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 0.5pt solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the year</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Ended 2012</div> </td> <td style="BORDER-TOP: black 0.5pt solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Numerator</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,304,446</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,602,824</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Denominator</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Basic weighted average shares outstanding</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">75,416,916</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">100,978,223</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Effect of dilutive securities:</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Stock options and warrants</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">131,250</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,510,488</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Restricted stock units</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,550,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,225,133</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Diluted weighted average shares outstanding</div> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">78,098,166</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">106,533,844</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income per common share</div> </td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Basic</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Diluted</div> </td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Potentially dilutive securities representing 18,568,963 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2012, because their effect would have been anti-dilutive.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Potentially dilutive securities representing 24,597,134 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2011, because their effect would have been anti-dilutive.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Advertising Expenses</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We follow the policy of charging the costs of advertising to expense as incurred. Advertising expense for the years ended December 31, 2012 and 2011 were $35,168 and $68,703, respectively.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Off-Balance Sheet Arrangements</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We have no off-balance sheet arrangements.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Recent Accounting Pronouncements</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In August 2012, the FASB issued ASU No 2012-03, <font style="FONT-STYLE: italic; DISPLAY: inline">Technical Amendments and Corrections to SEC Sections.</font> This Update makes changes to several of the SEC guidance literature sections within the Codification. The main focus is to update the SEC guidance as per SAB 114 to reference the codification sections rather than the old standards prior to the codification. The changes were mainly references and were not intended to change guidance. The amendments in this Update are effective immediately. This guidance didn&#39;t have a significant impact on the Company&#39;s financials since it was an update of SEC referenced guidance and didn&#39;t change existing guidance.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In July 2012, the FASB issued ASU 2012-02, <font style="FONT-STYLE: italic; DISPLAY: inline">Intangibles - Goodwill and Other (Topic 350) - Testing Indefinite-Lived Intangible Assets for Impairment.</font> The objective of this Update is to simplify how entities test indefinite-lived intangible assets for impairment and to have the testing be in-line with the updated guidance issued in 2011 related to impairment testing for goodwill. This Update allows entities to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative analysis. The more likely than not threshold is defined as having a likelihood of more than 50%. The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the quantitative impairment test and still be able to resume performing the qualitative assessment in subsequent years. Some examples of circumstances to consider are 1) cost factors that have a negative impact on earnings, 2) financial performance such as negative or declining cash flows, 3) legal, regulatory, contractual, political or business conditions, 4) other relevant entity specific events 5) industry and market conditions, and 6) macroeconomic conditions. The Update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before July 27, 2012 if the financial statements have not been issued. The Company doesn&#39;t expect this Update to impact the Company&#39;s financials since it currently has no indefinite-lived intangibles other than goodwill, but the Company will plan on utilizing the qualitative assessment options if any are acquired.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In June 2011, the FASB issued ASU 2011-05, <font style="FONT-STYLE: italic; DISPLAY: inline">Comprehensive Income (Topic 220) - Presentation of Comprehensive Income.</font> This Update eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders&#39; equity in order to increase the prominence of other comprehensive income items and to facilitate convergence with IFRS. The Update requires that all non-owner changes in stockholders&#39; equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements (a statement of income and statement of other comprehensive income). Additionally, adjustments for items reclassified from other comprehensive income to net income must be presented on the face of the financial statements. This Update should be applied retrospectively. For public entities, the Update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. For nonpublic entities, the Update is effective for fiscal years ending after December 15, 2012, and interim and annual periods thereafter. Early adoption is permitted, because compliance with the amendments is already permitted. The amendments do not require any transition disclosures. This impacts how items for Other Comprehensive Income are presented and the Company will follow the guidance starting in Q1 2012.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In December 2011, the FASB issued ASU 2011-11, <font style="FONT-STYLE: italic; DISPLAY: inline">Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities.</font> This Update is applicable to all entities that have financial instruments and derivative instruments that are either 1) offset in accordance with current guidance or 2) subject to an enforceable master netting arrangement. The Update requires an entity with these types of instruments to disclose information about offsetting and related arrangements. Both net and gross information for these assets and liabilities is required to be disclosed. This Update is effective for fiscal years beginning on or after January 1, 2013. The Company doesn&#39;t expect this Update to impact the Company&#39;s financials since it does not currently have any financial instruments or derivative instruments that are offset.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In September 2011, the FASB issued ASU 2011-08, <font style="FONT-STYLE: italic; DISPLAY: inline">Intangibles - Goodwill and Other (Topic 350)- Testing Goodwill for Impairment.</font> The objective of this Update is to simplify how entities test goodwill for impairment. This Update now allows entities to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step process of (1) comparing the fair value of the reporting unit to its carrying value and (2) test to measure the amount of the impairment loss if the fair value is less than the carrying value. The more likely than not threshold is defined as having a likelihood of more than 50%. The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the first step of the two-step goodwill impairment test. Some examples of circumstances to consider are 1) macroeconomic conditions, 2) industry and market conditions, 3) cost factors that have a negative impact on earnings, 4) overall financial performance such as negative or declining cash flows 5) other relevant entity specific events and 6) sustained decrease in stock price. The Update is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before September 15, 2011 if the financial statements have not been issued. If necessary, the Company will evaluate whether or not it will utilize the qualitative assessment option prior to performing the first goodwill impairment test in 2012, typically done during the 4<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> quarter.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> In May 2011, the FASB issued ASU 2011-04, <font style="FONT-STYLE: italic; DISPLAY: inline">Fair Value Measurement (Topic 820) - Amendments to Achieve Common Fair Value Measurements and Disclosure Requirements in US GAAP and IFRSs.</font> The Amendments in this Update will improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with US GAAP and IFRSs. The Boards of both organizations worked together to ensure fair value has the same meaning and the measurement and disclosures would be the same other than minor differences in wording. The Amendments explain how to measure fair value and do not require any additional fair value measurements. A couple of the more significant changes are 1) Clarification that quantitative information about unobservable inputs categorized as Level 3 should be disclosed, 2) Specifies that premiums and discounts should be applied in the absence of Level 1 input if market participants would do so, but that premiums or discounts related to size/quantity should not be considered, 3) Additional disclosure requirements for fair value measurements categorized as Level 3, an entity&#39;s us of a nonfinancial asset in a way that differs from the asset&#39;s highest and best use and the categorization by level for items not measured at fair value in the statement of financial position, but for which fair value disclosure is required. The amendments in this Update are to be applied prospectively. The Update is effective during interim and annual periods beginning after December 15, 2011. The Company doesn&#39;t expect this guidance to have a significant impact on its financials since the amount of items disclosed at fair value is minimal, but will ensure the guidance is followed for items disclosed at fair value.</div> <!--EndFragment--></div> </div> -4616860 -10530024 -15920842 5373691 3798783 3703908 99594490 96859058 92867561 -109585041 -111187865 -112492311 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 9 - Preferred and Common Stock</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> We have authorized two classes of stock, 20,000,000 shares of preferred stock with no par value and 180,000,000 shares of common stock with a $0.05 par value. No preferred stock has been issued, while 107,473,820 shares of common stock were issued and outstanding at December 31, 2012. Holders of shares of common stock are entitled to receive dividends if and when declared and are entitled to one vote for each share on all matters submitted to a vote of the shareholders.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> During the year ended December 31, 2012, we issued 31,498,164 shares of our common stock as follows: (i) 24,816,000 related to our 2012 Equity Financing and Debt Restructuring, (ii) 5,600,000 for debt conversions and (iii) 1,082,164 for services rendered by consultants.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> During the year ended December 31, 2011, we issued 1,897,503 shares of our common stock as follows: (i) 1,307,153 for debt to equity conversions, (ii) 372,272 for warrant exercises, (iii) 135,369 for interest instead of cash, (iv) 55,098 for employee option exercises and (v) 27,611 shares for conversion of IDI share equivalents.</div> <!--EndFragment--></div> </div> 27611 27611 27611 27611 5600000 1307153 5600000 1307153 496000 1082164 25402164 24816000 616000 150000 2000000 1000000 1000000 2000000 40000 31498164 1897503 246000 250000 496000 55098 455098 55098 400000 55098 372272 454000 64400 231600 1381 9379 10760 10760 280000 65357 1380000 1230790 1660000 1296147 24800 152513 177313 1270108 837726 2107834 3750000 990000 2755 15549 18304 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 17 - Subsequent Events</div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During January 2013, we sold additional convertible promissory notes in the principal amount of $425,000 on our 2012 Convertible Note offering due on July 13, 2013. The notes are convertible at $.25 per share and are secured by all of our assets. In addition, we issued warrants to acquire up to 850,000 shares of our common stock to the holders of the notes. The warrants have a five year life and are exercisable at $.25 per share.</div> <div style="DISPLAY: block; FONT-WEIGHT: bold; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In March 2013 we issued 258,553 shares of common stock to a former director in settlement of his Restricted Stock Units. In addition, we issued to him 200,000 shares of common stock in satisfaction of unpaid director&#39;s fees of $15,000.</div> <div style="DISPLAY: block; FONT-WEIGHT: bold; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In March 2013 we granted Restricted Stock Units to four of our directors in satisfaction of unpaid director&#39;s fees of $51,500. The Restricted Stock Units may be settled by the issuance of 686,667 shares of our common stock at the time the directors retire from the board.</div> <div style="DISPLAY: block; FONT-WEIGHT: bold; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> On January 7, 2013 we entered into a Merger Agreement with AllDigital, Inc., a Nevada corporation. The merger is subject among other things to normal due diligence, approval of the shareholders of both companies, and the filing and effectiveness of a registration statement. The registration statement requires year-end financial statements be included with the proxy statements furnished to the shareholders and will not be effective until at least the second quarter of 2013. On February 8, 2013, All Digital notified us that we were in breach of certain covenants regarding unencumbered ownership or potential claims against our technology and intellectual property, which gave us 30 days to cure the alleged defects before the merger agreement could be terminated. On March 8, 2013 All Digital notified us that sufficient progress had been made that the cure period was extended to April 8, 2013 for the remainder of the alleged defects to be cured or waived</div> <div style="DISPLAY: block; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Pursuant to the January 6, 2013 Amendment and Settlement Agreement with each of Mr. Tiede and Mr. Solomon, their respective employment agreements were modified and we agreed to issue each of Mr. Tiede and Mr. Solomon 529,100 shares of common stock if they were terminated by us at any time following January 6, 2013. All other termination benefits and severance benefits for Mr. Tiede and Mr. Solomon, were terminated as of January 6, 2013. We had an obligation as of March 6, 2013 to issue to each of them 529,100 shares of common stock.</div> <!--EndFragment--></div> </div> 55897169 55897169 0.94 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Account Receivables</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> Trade account receivables are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than 90 days. After the receivable becomes past due, it is on non-accrual status and accrual of interest is suspended.</div> <!--EndFragment--></div> </div> 775000 3062457 44478 23814 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Management Estimates</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 36pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</div> <!--EndFragment--></div> </div> 698838 58631 30268 37836 2539 3174 32807 41010 757469 3750000 252000 404000 469464 39387 161270 13531 508851 174801 106533844 78098166 100798223 75416916 53150 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure iso4217:USD bcst:warrants utr:sqft 0000740726 bcst:FormerDirectorMember us-gaap:SubsequentEventMember 2013-03-01 2013-03-29 0000740726 us-gaap:DirectorMember us-gaap:SubsequentEventMember 2013-03-01 2013-03-29 0000740726 bcst:WarrantsIssuedSubsequentToBalanceSheetDateMember us-gaap:SubsequentEventMember 2013-01-01 2013-01-31 0000740726 bcst:TwentyTwelveConvertibleNotesMember us-gaap:SubsequentEventMember 2013-01-01 2013-01-31 0000740726 2013-01-01 2013-01-31 0000740726 bcst:TwentyTwelveConvertibleNotesMember 2012-12-01 2012-12-31 0000740726 bcst:TwentyTwelveConvertibleNotesMember 2012-08-01 2012-08-31 0000740726 bcst:NewlyIssuedDebtMember 2012-07-01 2012-07-31 0000740726 bcst:TwentyTwelveConvertibleNotesMember 2012-07-01 2012-07-31 0000740726 bcst:BridgeLoanNotePayableMember 2012-07-01 2012-07-31 0000740726 bcst:TwoThousandTwelvePlanMember 2012-04-04 2012-04-05 0000740726 bcst:ConversionOfEquipmentPurchaseAndSaleAgreementToCommonStockAndWarrantsMember 2012-03-25 2012-03-26 0000740726 bcst:TwoThousandTwelvePlanMember bcst:BridgeLoanConversionMember bcst:BridgeLoanNotePayableMember 2012-03-25 2012-03-26 0000740726 bcst:TwoThousandTwelvePlanMember us-gaap:MinimumMember 2012-03-25 2012-03-26 0000740726 bcst:TwoThousandTwelvePlanMember us-gaap:MaximumMember 2012-03-25 2012-03-26 0000740726 bcst:TwoThousandTwelvePlanMember 2012-03-25 2012-03-26 0000740726 bcst:BridgeLoanConversionMember 2012-03-25 2012-03-26 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2012-03-25 2012-03-26 0000740726 us-gaap:CapitalLeaseObligationsMember bcst:TelecommunicationsEquipmentMember 2012-01-01 2012-12-31 0000740726 bcst:AcquisitionOfIdiCommonShareEquivalentsMember 2012-01-01 2012-12-31 0000740726 bcst:TelecommunicationsEquipmentMember 2012-01-01 2012-12-31 0000740726 bcst:TwoThousandTenPlanMember bcst:PlacementAgencyAgreementWarrantsMember 2012-01-01 2012-12-31 0000740726 bcst:PlacementAgencyMember 2012-01-01 2012-12-31 0000740726 bcst:WarrantResetProvisionMember 2012-01-01 2012-12-31 0000740726 bcst:ConversionFeatureOfDebtMember 2012-01-01 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:AgencyMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:InvestorsMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:EquipmentFinanceConversionMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:EquipmentPurchaseAgreementConversionMember 2012-01-01 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:BridgeLoanConversionMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2012-01-01 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember 2012-01-01 2012-12-31 0000740726 bcst:ConversionOfAccountsReceivablePurchaseAgreementsMember us-gaap:WarrantMember 2012-01-01 2012-12-31 0000740726 bcst:ClassaWarrantMember 2012-01-01 2012-12-31 0000740726 bcst:EquipmentPurchaseAndSaleAgreementMember 2012-01-01 2012-12-31 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2012-01-01 2012-12-31 0000740726 bcst:ScenarioTwoMember 2012-01-01 2012-12-31 0000740726 bcst:ScenarioOneMember 2012-01-01 2012-12-31 0000740726 bcst:ProductionStudioMember 2012-01-01 2012-12-31 0000740726 bcst:ExecutiveOfficesMember 2012-01-01 2012-12-31 0000740726 bcst:SharesIssuedToConsultantForCancellationOfWarrantMember 2012-01-01 2012-12-31 0000740726 bcst:SharesIssuedToConsultantForServicesMember 2012-01-01 2012-12-31 0000740726 bcst:TwentyTwelveConvertibleNotesMember 2012-01-01 2012-12-31 0000740726 bcst:BridgeLoanNotePayableMember bcst:WarrantsIssuedToResetProvisionAndExtendMaturityDateOfBridgeLoanWarrantsMember 2012-01-01 2012-12-31 0000740726 bcst:BridgeLoanNotePayableMember bcst:OriginalWarrantsIssuedForBridgeLoanMember 2012-01-01 2012-12-31 0000740726 bcst:BridgeLoanNotePayableMember 2012-01-01 2012-12-31 0000740726 bcst:UnsecuredConvertibleNoteMember 2012-01-01 2012-12-31 0000740726 bcst:RangeThreeMember 2012-01-01 2012-12-31 0000740726 bcst:RangeTwoMember 2012-01-01 2012-12-31 0000740726 bcst:RangeOneMember 2012-01-01 2012-12-31 0000740726 bcst:StockOptionsAndWarrantsMember 2012-01-01 2012-12-31 0000740726 bcst:InteractDevicesIncMember 2012-01-01 2012-12-31 0000740726 bcst:CustomerOneMember 2012-01-01 2012-12-31 0000740726 us-gaap:WarrantMember 2012-01-01 2012-12-31 0000740726 us-gaap:StockOptionsMember bcst:EmployeesMember 2012-01-01 2012-12-31 0000740726 us-gaap:StockOptionsMember 2012-01-01 2012-12-31 0000740726 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0000740726 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0000740726 us-gaap:RestrictedStockUnitsRSUMember us-gaap:DirectorMember 2012-01-01 2012-12-31 0000740726 us-gaap:RestrictedStockUnitsRSUMember 2012-01-01 2012-12-31 0000740726 us-gaap:ResearchAndDevelopmentExpenseMember 2012-01-01 2012-12-31 0000740726 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember bcst:CustomerOneMember 2012-01-01 2012-12-31 0000740726 us-gaap:OfficeEquipmentMember 2012-01-01 2012-12-31 0000740726 us-gaap:MinimumMember 2012-01-01 2012-12-31 0000740726 us-gaap:MaximumMember 2012-01-01 2012-12-31 0000740726 us-gaap:LetterOfCreditMember 2012-01-01 2012-12-31 0000740726 us-gaap:GeneralAndAdministrativeExpenseMember 2012-01-01 2012-12-31 0000740726 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2012-01-01 2012-12-31 0000740726 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000740726 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000740726 2012-01-01 2012-12-31 0000740726 bcst:WarrantsIssuedToInvestmentBankerForPaymentMember 2011-12-27 2011-12-28 0000740726 bcst:WarrantsIssuedToResetProvisionAndExtendMaturityDateOfBridgeLoanWarrantsMember 2011-12-27 2011-12-28 0000740726 bcst:OriginalWarrantsIssuedForBridgeLoanMember 2011-12-27 2011-12-28 0000740726 bcst:BridgeLoanNotePayableMember bcst:WarrantsIssuedToResetProvisionAndExtendMaturityDateOfBridgeLoanWarrantsMember 2011-12-27 2011-12-28 0000740726 bcst:BridgeLoanNotePayableMember bcst:OriginalWarrantsIssuedForBridgeLoanMember 2011-12-27 2011-12-28 0000740726 bcst:BridgeLoanNotePayableMember 2011-12-27 2011-12-28 0000740726 bcst:EquipmentPurchaseAndSaleAgreementMember 2011-10-01 2011-10-31 0000740726 bcst:ConversionOfShortTermDebtMember 2011-03-20 2011-03-21 0000740726 bcst:ModificationOfSeniorUnsecuredConvertibleNoteMember 2011-03-01 2011-03-31 0000740726 us-gaap:CapitalLeaseObligationsMember bcst:TelecommunicationsEquipmentMember 2011-01-01 2011-12-31 0000740726 bcst:TelecommunicationsEquipmentMember 2011-01-01 2011-12-31 0000740726 bcst:TwoThousandTenPlanMember bcst:PlacementAgencyAgreementWarrantsMember 2011-01-01 2011-12-31 0000740726 bcst:TwoThousandTenPlanMember bcst:WarrantsIssuedPursuantToWaiverAgreementMember 2011-01-01 2011-12-31 0000740726 bcst:TwoThousandTenPlanMember 2011-01-01 2011-12-31 0000740726 bcst:ConversionOfAccountsReceivablePurchaseAgreementsMember us-gaap:WarrantMember 2011-01-01 2011-12-31 0000740726 bcst:ConversionOfAccountsReceivablePurchaseAgreementsMember 2011-01-01 2011-12-31 0000740726 bcst:EquipmentPurchaseAndSaleAgreementMember 2011-01-01 2011-12-31 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2011-01-01 2011-12-31 0000740726 bcst:OptionsGrantedForConsultingServicesMember 2011-01-01 2011-12-31 0000740726 bcst:BridgeLoanNotePayableMember 2011-01-01 2011-12-31 0000740726 bcst:UnsecuredConvertibleNoteMember bcst:WarrantIssuedForInterestOnConvertibleNoteMember 2011-01-01 2011-12-31 0000740726 bcst:UnsecuredConvertibleNoteMember 2011-01-01 2011-12-31 0000740726 bcst:ModificationOfSeniorUnsecuredConvertibleNoteMember 2011-01-01 2011-12-31 0000740726 bcst:ConversionOfShortTermDebtMember 2011-01-01 2011-12-31 0000740726 bcst:StockOptionsAndWarrantsMember 2011-01-01 2011-12-31 0000740726 bcst:InteractDevicesIncMember 2011-01-01 2011-12-31 0000740726 bcst:CustomerOneMember 2011-01-01 2011-12-31 0000740726 us-gaap:WarrantMember bcst:AccountsReceivablePurchaseAgreementsCounterpartyMember 2011-01-01 2011-12-31 0000740726 us-gaap:WarrantMember bcst:BridgeLoanCounterpartyMember 2011-01-01 2011-12-31 0000740726 us-gaap:WarrantMember bcst:UnsecuredConvertibleNoteHolderMember 2011-01-01 2011-12-31 0000740726 us-gaap:WarrantMember 2011-01-01 2011-12-31 0000740726 us-gaap:StockOptionsMember bcst:NonemployeeInstallationTechniciansMember 2011-01-01 2011-12-31 0000740726 us-gaap:StockOptionsMember bcst:ConsultingServicesProvidersMember 2011-01-01 2011-12-31 0000740726 us-gaap:StockOptionsMember bcst:EmployeesMember 2011-01-01 2011-12-31 0000740726 us-gaap:StockOptionsMember bcst:AdvisoryBoardMemberMember 2011-01-01 2011-12-31 0000740726 us-gaap:StockOptionsMember 2011-01-01 2011-12-31 0000740726 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0000740726 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0000740726 us-gaap:RestrictedStockUnitsRSUMember bcst:EmployeeOneMember 2011-01-01 2011-12-31 0000740726 us-gaap:RestrictedStockUnitsRSUMember us-gaap:DirectorMember 2011-01-01 2011-12-31 0000740726 us-gaap:RestrictedStockUnitsRSUMember 2011-01-01 2011-12-31 0000740726 us-gaap:ResearchAndDevelopmentExpenseMember 2011-01-01 2011-12-31 0000740726 us-gaap:AccountsReceivableMember 2011-01-01 2011-12-31 0000740726 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember bcst:CustomerOneMember 2011-01-01 2011-12-31 0000740726 us-gaap:GeneralAndAdministrativeExpenseMember 2011-01-01 2011-12-31 0000740726 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0000740726 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0000740726 2011-01-01 2011-12-31 0000740726 bcst:UnsecuredConvertibleNoteMember bcst:WarrantIssuedForInterestOnConvertibleNoteMember 2011-01-01 2011-03-31 0000740726 bcst:UnsecuredConvertibleNoteMember 2011-01-01 2011-03-31 0000740726 bcst:TwoThousandTenPlanMember bcst:UnsecuredConvertibleNoteMember 2010-12-22 2010-12-23 0000740726 bcst:TwoThousandTenPlanMember us-gaap:SeniorNotesMember 2010-12-22 2010-12-23 0000740726 bcst:TwoThousandTenPlanMember us-gaap:MinimumMember 2010-12-22 2010-12-23 0000740726 bcst:TwoThousandTenPlanMember 2010-12-22 2010-12-23 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2010-12-22 2010-12-23 0000740726 bcst:UnsecuredConvertibleNoteMember bcst:WarrantsIssuedForConvertibleNoteRestructuringMember 2010-12-22 2010-12-23 0000740726 bcst:UnsecuredConvertibleNoteMember us-gaap:CommonStockMember 2010-12-22 2010-12-23 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2010-07-29 2010-07-30 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2010-03-25 2010-03-26 0000740726 bcst:UnsecuredConvertibleNoteMember 2010-01-01 2010-12-31 0000740726 bcst:ConversionOfShortTermDebtMember 2010-01-01 2010-12-31 0000740726 bcst:UnsecuredConvertibleNoteMember 2009-12-22 2009-12-23 0000740726 bcst:TelecommunicationsEquipmentMember 2009-07-27 2009-07-28 0000740726 bcst:ClassaWarrantMember 2008-12-02 2008-12-03 0000740726 bcst:ClassBWarrantMember 2008-01-01 2008-12-31 0000740726 bcst:ClassaWarrantMember 2008-01-01 2008-12-31 0000740726 bcst:WarrantsIssuedToThirdPartyForFinancingFeesMember 2007-12-23 2007-12-24 0000740726 bcst:WarrantsIssuedToSeniorSecuredNoteHolderMember 2007-12-23 2007-12-24 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2007-12-23 2007-12-24 0000740726 bcst:ClassCWarrantMember 2007-01-01 2007-12-31 0000740726 bcst:ClassBWarrantMember 2007-01-01 2007-12-31 0000740726 bcst:ClassaWarrantMember 2007-01-01 2007-12-31 0000740726 bcst:ClassDWarrantMember 2006-11-01 2006-11-02 0000740726 bcst:ClassCWarrantMember 2006-11-01 2006-11-02 0000740726 bcst:ClassBWarrantMember 2006-11-01 2006-11-02 0000740726 bcst:ClassaWarrantMember 2006-11-01 2006-11-02 0000740726 bcst:InteractDevicesIncMember 2004-05-01 2004-05-31 0000740726 us-gaap:DirectorMember us-gaap:SubsequentEventMember 2013-03-29 0000740726 2013-03-15 0000740726 bcst:WarrantsIssuedSubsequentToBalanceSheetDateMember us-gaap:SubsequentEventMember 2013-01-31 0000740726 bcst:TwentyTwelveConvertibleNotesMember us-gaap:SubsequentEventMember 2013-01-31 0000740726 us-gaap:ManagementMember us-gaap:SubsequentEventMember 2013-01-06 0000740726 bcst:TelecommunicationsEquipmentMember 2012-12-31 0000740726 bcst:TwoThousandTenPlanMember bcst:PlacementAgencyAgreementWarrantsMember 2012-12-31 0000740726 bcst:TwoThousandTenPlanMember bcst:WarrantsIssuedPursuantToWaiverAgreementMember 2012-12-31 0000740726 bcst:WarrantResetProvisionMember 2012-12-31 0000740726 bcst:ConversionFeatureOfDebtMember 2012-12-31 0000740726 bcst:TrancheThreeOfWarrantsIssuedWithTwentyTwelveConvertibleNotesMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:PlacementAgencyAgreementWarrantsMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:AgencyMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:InvestorsMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:EquipmentFinanceConversionMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:BridgeLoanConversionMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassBWarrantMember bcst:AgencyMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassBWarrantMember bcst:InvestorsMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassBWarrantMember bcst:EquipmentFinanceConversionMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassBWarrantMember bcst:BridgeLoanConversionMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassBWarrantMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassaWarrantMember bcst:AgencyMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassaWarrantMember bcst:InvestorsMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassaWarrantMember bcst:EquipmentFinanceConversionMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassaWarrantMember bcst:BridgeLoanConversionMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassaWarrantMember 2012-12-31 0000740726 bcst:TwoThousandTwelvePlanMember 2012-12-31 0000740726 bcst:WarrantsIssuedToInvestmentBankerForPaymentMember 2012-12-31 0000740726 bcst:ConversionOfAccountsReceivablePurchaseAgreementsMember us-gaap:WarrantMember 2012-12-31 0000740726 bcst:ConversionOfAccountsReceivablePurchaseAgreementsMember 2012-12-31 0000740726 bcst:ClassBWarrantMember 2012-12-31 0000740726 bcst:ClassaWarrantMember 2012-12-31 0000740726 bcst:EquipmentPurchaseAndSaleAgreementMember 2012-12-31 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2012-12-31 0000740726 bcst:ProductionStudioMember 2012-12-31 0000740726 bcst:ExecutiveOfficesMember 2012-12-31 0000740726 bcst:TwentyTwelveConvertibleNotesMember us-gaap:MaximumMember 2012-12-31 0000740726 bcst:TwentyTwelveConvertibleNotesMember 2012-12-31 0000740726 bcst:BridgeLoanNotePayableMember bcst:WarrantsIssuedToResetProvisionAndExtendMaturityDateOfBridgeLoanWarrantsMember 2012-12-31 0000740726 bcst:BridgeLoanNotePayableMember bcst:OriginalWarrantsIssuedForBridgeLoanMember 2012-12-31 0000740726 bcst:BridgeLoanNotePayableMember 2012-12-31 0000740726 bcst:UnsecuredConvertibleNoteMember 2012-12-31 0000740726 bcst:RangeThreeMember 2012-12-31 0000740726 bcst:RangeTwoMember 2012-12-31 0000740726 bcst:RangeOneMember 2012-12-31 0000740726 bcst:InteractDevicesIncMember 2012-12-31 0000740726 us-gaap:StockOptionsMember 2012-12-31 0000740726 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0000740726 us-gaap:RetainedEarningsMember 2012-12-31 0000740726 us-gaap:RestrictedStockUnitsRSUMember 2012-12-31 0000740726 us-gaap:LetterOfCreditMember 2012-12-31 0000740726 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000740726 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000740726 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000740726 us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000740726 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2012-12-31 0000740726 us-gaap:CommonStockMember 2012-12-31 0000740726 2012-12-31 0000740726 bcst:TrancheTwoOfWarrantsIssuedWithTwentyTwelveConvertibleNotesMember 2012-08-31 0000740726 bcst:TrancheOneOfWarrantsIssuedWithTwentyTwelveConvertibleNotesMember 2012-07-31 0000740726 2012-06-30 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassBWarrantMember 2012-03-26 0000740726 bcst:TwoThousandTwelvePlanMember bcst:ClassaWarrantMember 2012-03-26 0000740726 bcst:TwoThousandTenPlanMember bcst:PlacementAgencyAgreementWarrantsMember 2011-12-31 0000740726 bcst:ConversionOfAccountsReceivablePurchaseAgreementsMember us-gaap:WarrantMember 2011-12-31 0000740726 bcst:EquipmentPurchaseAndSaleAgreementMember 2011-12-31 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2011-12-31 0000740726 bcst:OptionsGrantedForConsultingServicesMember 2011-12-31 0000740726 bcst:TwentyTwelveConvertibleNotesMember 2011-12-31 0000740726 bcst:BridgeLoanNotePayableMember 2011-12-31 0000740726 bcst:UnsecuredConvertibleNoteMember 2011-12-31 0000740726 bcst:ConversionOfShortTermDebtMember 2011-12-31 0000740726 bcst:InteractDevicesIncMember 2011-12-31 0000740726 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0000740726 us-gaap:RetainedEarningsMember 2011-12-31 0000740726 us-gaap:RestrictedStockUnitsRSUMember 2011-12-31 0000740726 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2011-12-31 0000740726 us-gaap:CommonStockMember 2011-12-31 0000740726 2011-12-31 0000740726 bcst:WarrantsIssuedToInvestmentBankerForPaymentMember 2011-12-28 0000740726 bcst:WarrantsIssuedToResetProvisionAndExtendMaturityDateOfBridgeLoanWarrantsMember 2011-12-28 0000740726 bcst:OriginalWarrantsIssuedForBridgeLoanMember 2011-12-28 0000740726 bcst:BridgeLoanNotePayableMember bcst:WarrantsIssuedToResetProvisionAndExtendMaturityDateOfBridgeLoanWarrantsMember 2011-12-28 0000740726 bcst:BridgeLoanNotePayableMember bcst:OriginalWarrantsIssuedForBridgeLoanMember 2011-12-28 0000740726 bcst:BridgeLoanNotePayableMember 2011-12-28 0000740726 bcst:TwoThousandTenPlanMember 2011-03-31 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2011-03-31 0000740726 bcst:UnsecuredConvertibleNoteMember bcst:WarrantIssuedForInterestOnConvertibleNoteMember 2011-03-31 0000740726 bcst:ModificationOfSeniorUnsecuredConvertibleNoteMember 2011-03-31 0000740726 bcst:ConversionOfShortTermDebtMember 2011-03-21 0000740726 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0000740726 us-gaap:RetainedEarningsMember 2010-12-31 0000740726 us-gaap:RestrictedStockUnitsRSUMember 2010-12-31 0000740726 us-gaap:AccountsReceivableMember 2010-12-31 0000740726 us-gaap:CommonStockMember 2010-12-31 0000740726 2010-12-31 0000740726 bcst:TwoThousandTenPlanMember bcst:UnsecuredConvertibleNoteMember 2010-12-23 0000740726 bcst:TwoThousandTenPlanMember 2010-12-23 0000740726 bcst:UnsecuredConvertibleNoteMember bcst:WarrantsIssuedForConvertibleNoteRestructuringMember 2010-12-23 0000740726 bcst:TwoThousandTenPlanMember bcst:TwoThousandTenBridgeLoanMember 2010-11-29 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2010-10-29 0000740726 bcst:WarrantsIssuedToSeniorSecuredNoteHolderMember 2010-07-30 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2010-07-30 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2010-03-26 0000740726 bcst:UnsecuredConvertibleNoteMember 2009-12-23 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2009-12-23 0000740726 bcst:TelecommunicationsEquipmentMember 2009-07-28 0000740726 bcst:WarrantsIssuedToThirdPartyForFinancingFeesMember 2007-12-24 0000740726 bcst:WarrantsIssuedToSeniorSecuredNoteHolderMember 2007-12-24 0000740726 bcst:AmendedAndRestatedSeniorConvertibleNoteMember 2007-12-24 0000740726 bcst:ClassDWarrantMember 2006-11-02 0000740726 bcst:ClassCWarrantMember 2006-11-02 0000740726 bcst:ClassBWarrantMember 2006-11-02 0000740726 bcst:ClassaWarrantMember 2006-11-02 0000740726 bcst:UnsecuredConvertibleNoteMember 2006-11-02 0000740726 bcst:BiNetworksMember 2003-10-01 See Notes 4 & 5 for additional discussion EX-101.SCH 7 bcst-20121231.xsd EXHIBIT 101.SCH 103 - Disclosure - Accounts Receivable link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40301 - Disclosure - Accounts Receivable (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 002 - Statement - CONSOLIDATED BALANCE SHEETS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 001 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 111 - Disclosure - Equipment Financing link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 104 - Disclosure - Equity Financing and the Debt Restructuring link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40401 - Disclosure - Equity Financing and the Debt Restructuring (2012 Equity Financing and the Debt Restructuring) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40403 - Disclosure - Equity Financing and the Debt Restructuring (2010 Equity Financing and the Debt Restructuring) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40402 - Disclosure - Equity Financing and the Debt Restructuring (Schedule of Debt Conversion) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 304 - Disclosure - Equity Financing and the Debt Restructuring (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41101 - Disclosure - Equipment Financing (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 112 - Disclosure - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41201 - Disclosure - Fair Value Measurements (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 312 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 106 - Disclosure - Investment in Interact Devices Inc. (IDI) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40601 - Disclosure - Investment in Interact Devices, Inc (IDI) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 108 - Disclosure - Income Taxes link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40801 - Disclosure - Income Taxes (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 308 - Disclosure - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 115 - Disclosure - Liquidity link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41501 - Disclosure - Liquidity (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 114 - Disclosure - Legal Proceedings link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41401 - Disclosure - Legal Proceedings (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 105 - Disclosure - Notes Payable link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40505 - Disclosure - Notes Payable (Accounts Receivable Purchase Agreements) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40506 - Disclosure - Notes Payable (Bridge Loan) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40507 - Disclosure - Notes Payable (Equipment Purchase and Sale Agreement) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40502 - Disclosure - Notes Payable (2012 Secured Convertible Notes) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40504 - Disclosure - Notes Payable (Senior 6.25% Convertible Note) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40501 - Disclosure - Notes Payable (Schedule of Notes Payable) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 305 - Disclosure - Notes Payable (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40503 - Disclosure - Notes Payable (Unsecured Convertible Note) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 101 - Disclosure - Organization and Basis of Presentation link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40101 - Disclosure - Organization and Basis of Presentation (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 107 - Disclosure - Operating Leases link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40701 - Disclosure - Operating Leases (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 307 - Disclosure - Operating Leases (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 109 - Disclosure - Preferred and Common Stock link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40901 - Disclosure - Preferred and Common Stock (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 113 - Disclosure - Retirement Plan link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41301 - Disclosure - Retirement Plan (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 102 - Disclosure - Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40201 - Disclosure - Significant Accounting Policies (Narrative) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 202 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40202 - Disclosure - Significant Accounting Policies (Patents and Intangibles) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 302 - Disclosure - Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40203 - Disclosure - Significant Accounting Policies (Weighted Average Shares) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 110 - Disclosure - Stock-based Compensation link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 116 - Disclosure - Supplemental Cash Flow Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41601 - Disclosure - Supplemental Cash Flow Information (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41001 - Disclosure - Stock-based Compensation (Narrative) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41007 - Disclosure - Stock-based Compensation (Schedule of Allocated Stock-Based Compensation) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41002 - Disclosure - Stock-based Compensation (Schedule of Assumptions Used to Value Options) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41003 - Disclosure - Stock-based Compensation (Schedule of Assumptions Used to Value Warrants) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41005 - Disclosure - Stock-based Compensation (Schedule of Information About Options and Warrants) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41004 - Disclosure - Stock-based Compensation (Schedule of Option and Warrant Activity) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41006 - Disclosure - Stock-based Compensation (Schedule of Restricted Stock Unit Activity) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41008 - Disclosure - Stock-based Compensation (Schedule of Unrecognized Compensation Expense) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 310 - Disclosure - Stock-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 117 - Disclosure - Subsequent Events link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41701 - Disclosure - Subsequent Events (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.CAL 8 bcst-20121231_cal.xml EXHIBIT 101.CAL EX-101.DEF 9 bcst-20121231_def.xml EXHIBIT 101.DEF EX-101.LAB 10 bcst-20121231_lab.xml EXHIBIT 101.LAB Business Description and Basis of Presentation [Text Block] Organization and Basis of Presentation Organization and Basis of Presentation [Abstract] Accounts Payable, Current Accounts payable Trade accounts receivable, net Additional Paid in Capital Additional paid-in capital Total assets Assets ASSETS: Assets [Abstract] Total current assets Assets, Current Current Assets Assets, Current [Abstract] Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Commitments and Contingencies Commitments and contingencies Common Stock, Value, Issued Common stock, $.05 par value, 180,000,000 shares authorized; 75,975,656 and 107,473,820 shares issued as of December 31, 2011 and December 31, 2012, respectively Debt offering costs Deferred Finance Costs, Noncurrent, Net Deferred Revenue, Current Unearned revenue Derivative valuation Derivative Liabilities, Current Employee-related Liabilities, Current Payroll and related expenses Patents, net Finite-Lived Intangible Assets, Net Inventory Inventory, Net Total liabilities Liabilities LIABILITIES: Liabilities [Abstract] Total liabilities and stockholders' deficit Liabilities and Equity LIABILITIES AND STOCKHOLDERS DEFICIT Liabilities and Equity [Abstract] Liabilities, Current Total current liabilities Liabilities, Current [Abstract] Current Liabilities Total long-term liabilities Liabilities, Noncurrent Long-term Liabilities Liabilities, Noncurrent [Abstract] Long-term portion of notes payable (net of discount of $659,496 and $0, respectively) Notes Payable, Noncurrent Current portion of notes payable (net of discount of $103,859 and $947,994, respectively) Notes Payable, Current Other Accrued Liabilities, Current Other accrued expenses Other Assets, Noncurrent Total other assets, non current Other Assets, non current Other Assets, Noncurrent [Abstract] Other Liabilities, Current Other current obligations Preferred Stock, Value, Issued Preferred stock, no par value, 20,000,000 shares authorized; none issued Prepaid Expense and Other Assets, Noncurrent Deposits and other assets Prepaid expenses Prepaid Expense, Current Property and equipment, net Property, Plant and Equipment, Net Restricted Cash and Cash Equivalents, Current Restricted cash Retained Earnings (Accumulated Deficit) Accumulated deficit CONSOLIDATED BALANCE SHEETS [Abstract] Stockholders' Equity Attributable to Parent Total stockholders' deficit STOCKHOLDERS' DEFICIT: Stockholders' Equity Attributable to Parent [Abstract] Common Stock, Par or Stated Value Per Share Common stock, par value per share Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Debt Instrument Unamortized Discount Current Debt Instrument, Unamortized Discount, Current. Current portion of notes payable, discount Debt Instrument Unamortized Discount Noncurrent Debt Instrument, Unamortized Discount, Noncurrent. Long-term portion of notes payable, discount Preferred Stock, No Par Value Preferred stock, no par value Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Warrants issued for debt extinguishment costs Adjustment of Warrants Granted for Services Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Amortization of Debt Discount (Premium) Accretion of discount on convertible notes payable Loss on impairment of assets Asset Impairment Charges Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Net decrease in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Common stock issued for interest Debt Related Commitment Fees and Debt Issuance Costs Expensed note conversion costs Depreciation, Depletion and Amortization Depreciation and amortization Gain on derivative liability valuation Gain (Loss) on Derivative Instruments, Net, Pretax Loss (gain) on sale of assets Gain (Loss) on Disposition of Assets Loss (gain) on extinguishment of debt Gains (Losses) on Extinguishment of Debt Income taxes paid Income Taxes Paid Increase (Decrease) in Accounts Payable Increase (decrease) in accounts payable Increase (Decrease) in Accounts Receivable Decrease (increase) in accounts receivable Increase (Decrease) in Accrued Liabilities Increase in accrued expenses Increase Decrease In Debt Offering Costs Increase Decrease In Debt Offering Costs. Decrease (increase) in debt offering costs Increase (Decrease) in Deferred Revenue Increase (decrease) in deferred revenues Increase (Decrease) in Inventories Increase in inventories Increase (Decrease) in Operating Assets [Abstract] Changes in assets Increase (Decrease) in Operating Liabilities [Abstract] Changes in liabilities Increase (Decrease) in Prepaid Expense and Other Assets Decrease in prepaid and other assets Interest Paid Interest paid Warrants issued for interest Issuance of Stock and Warrants for Services or Claims Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Net cash used by investing activities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Net Income (Loss) Attributable to Parent Net Income Common stock issued for in process research and development Other Noncash Expense Paid-in-Kind Interest Payments of Debt Extinguishment Costs Payments for debt extinguishment costs Equity issuance costs Payments of Stock Issuance Costs Purchase of equipment Payments to Acquire Machinery and Equipment Proceeds from Issuance of Common Stock Proceeds from equity financing Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Proceeds from the exercise of options and warrants Proceeds from notes payable Proceeds from Notes Payable Proceeds from (Payments for) Other Financing Activities Proceeds from equipment financing Proceeds from (Repayments of) Restricted Cash, Financing Activities Increase in restricted cash Proceeds from the sale of auction rate preferred securities Proceeds from Sale and Maturity of Marketable Securities Proceeds from sale of assets Proceeds from Sale of Productive Assets Allowance for dousbtful accounts Provision for Doubtful Accounts Repayments of Debt Payments on principal on debt Share-based Compensation Stock based compensation Common stock issued for services Share-based Goods and Nonemployee Services Transaction, Expense CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] Warrants issued and expensed for issuance costs Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Warrants Issued And Expensed For Issuance Costs Warrants issued and expensed for issuance costs. Write off of Deferred Debt Issuance Cost Retirement of debt offering costs Equity issuance costs related to warrants Amortization of Financing Costs Impairment of assets Cost of Revenue Cost of sales Note conversion offering expense Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Earnings Per Share, Basic Income per share basic Income per share diluted Earnings Per Share, Diluted Gain on derivative valuation (Loss) gain on sale of assets Loss on sale of securities Gain (Loss) on Sale of Securities, Net (Loss) gain on extinguishment of debt General and Administrative Expense Administrative and general Gross profit Gross Profit Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Income before income taxes CONSOLIDATED STATEMENT OF OPERATIONS [Abstract] Income Tax Expense (Benefit) Provision for income taxes Debt conversion costs Induced Conversion of Convertible Debt Expense Interest Expense Interest expense Interest income Investment Income, Interest Net income Total other income Nonoperating Income (Expense) Nonoperating Income (Expense) [Abstract] Other income (expense): Operating Expenses Total operating expenses Operating Expenses [Abstract] Operating expenses: Total operating loss Operating Income (Loss) Other Nonoperating Income (Expense) Other income, net Research and Development Expense Research and development Net sales Revenues Selling and Marketing Expense Selling and marketing Weighted average shares diluted Weighted Average Number of Shares Outstanding, Diluted Weighted average shares basic Weighted Average Number of Shares Outstanding, Basic Retirement of debt offering costs Additional Paid-in Capital [Member] Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Amended and restated 6.25% note conversion feature Adjustments To Additional Paid In Capital Interest Adjustments To Additional Paid In Capital, Interest. Equity issued for interest Adjustments to Additional Paid in Capital, Other Termination of sr. convertible 6.25% note warrant Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock based compensation Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Issuance costs for unsecured convertible note Adjustments to Additional Paid in Capital, Warrant Issued Equity issuances related to warrants Common Stock [Member] Common Stock Retired During Period Shares Warrant Exchanges Common Stock Retired During Period, Shares, Warrant Exchanges. Common stock retirements for warrant exchanges, shares Common Stock Retired During Period Value Warrant Exchanges Common Stock Retired During Period, Value, Warrant Exchanges. Common stock retirements for warrant exchanges Common Stock, Shares, Outstanding Balance, shares Balance, shares Equity Component [Domain] Retained Earnings (Deficit) [Member] Statement, Equity Components [Axis] Statement [Line Items] CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT [Abstract] Statement [Table] Balance Balance Stock Issued During Period, Shares, Acquisitions Common stock issued in exchange for IDI shares Stock Issued During Period Shares Brokerage Commissions Stock Issued During Period Shares, Brokerage Commissions. Common stock issued for brokerage commissions, shares Stock Issued During Period, Shares, Conversion of Convertible Securities Common stock issued on debt conversion, shares Stock Issued During Period Shares Debt Restructuring Stock Issued During Period, Shares, Debt Restructuring. Common stock issued for debt restructuring, shares Stock Issued During Period Shares Equity Financing And Bridge Loan Stock Issued During Period, Shares, Equity Financing And Bridge Loan. Common stock issued for equity financing and bridge loan, net of costs, shares Stock Issued During Period Shares Interest Stock Issued During Period, Shares, Interest. Common stock issued for interest, shares Stock Issued During Period, Shares, Issued for Services Common stock issued for services rendered, shares Stock Issued During Period, Shares, New Issues Common stock issued for 2012 equity financing and debt restructuring, net of issuance costs, shares Stock Issued During Period Shares New Issues For Cash Stock Issued During Period, Shares, New Issues For Cash. Common stock issued for cash, shares Stock Issued During Period, Shares, Purchase of Assets Common stock issued for purchase of software license, shares Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Common stock issued for settlement of Restricted Stock Units, shares Stock Issued During Period Shares Senior Convertible Note Extension Stock Issued During Period, Shares, Senior Convertible Note Extension. Common Stock Issued for Sr. Convertible note extension, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Common stock issued for option exercises, shares Stock Issued During Period Shares Unsecured Convertible Note Extension Stock Issued During Period, Shares, Unsecured Convertible Note Extension. Common stock issued for unsecured convertible note extension, shares Stock Issued During Period Shares Warrants Exercised Stock Issued During Period, Shares, Warrants Exercised. Common stock issued for warrant exercises, shares Stock Issued During Period, Value, Acquisitions Common stock issued in exchange for IDI shares Stock Issued During Period Value Brokerage Commissions Stock Issued During Period, Value, Brokerage Commissions. Common stock issued for brokerage commissions Stock Issued During Period, Value, Conversion of Convertible Securities Common stock issued on debt conversion Stock Issued During Period Value Debt Restructuring Stock Issued During Period, Value, Debt Restructuring. Common stock issued for debt restructuring Stock Issued During Period Value Equity Financing And Bridge Loan Stock Issued During Period, Value, Equity Financing And Bridge Loan. Common stock issued for equity financing and bridge loan, net of costs Stock Issued During Period Value Interest Stock Issued During Period, Value, Interest. Common stock issued for interest Stock Issued During Period, Value, Issued for Services Common stock issued for services rendered Stock Issued During Period, Value, New Issues Common stock issued for 2012 equity financing and debt restructuring, net of issuance costs Stock Issued During Period Value New Issues For Cash Stock Issued During Period, Value, New Issues For Cash. Common stock issued for cash Stock Issued During Period, Value, Purchase of Assets Common stock issued for purchase of software license Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Common stock issued for settlement of Restricted Stock Units Stock Issued During Period Value Senior Convertible Note Extension Stock Issued During Period, Value, Senior Convertible Note Extension. Common Stock Issued for Sr. Convertible note extension Stock Issued During Period, Value, Stock Options Exercised Common stock issued for option exercises Stock Issued During Period Value Unsecured Convertible Note Extension Stock Issued During Period, Value, Unsecured Convertible Note Extension. Common stock issued for unsecured convertible note extension Stock Issued During Period Value Warrants Exercised Stock Issued During Period, Value, Warrants Exercised. Common stock issued for warrant exercises Amendment Flag Current Fiscal Year End Date Document and Entity Information [Abstract] Document And Entity Information [Abstract]. Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Voluntary Filers Entity Well-known Seasoned Issuer Equity Financing and the Debt Restructuring [Abstract] Equity Financing And The Debt Restructuring [Text Block] Equity Financing and the Debt Restructuring [Abstract]. Equity Financing and the Debt Restructuring [Text Block]. Equity Financing and the Debt Restructuring Equipment Financing Capital Leases in Financial Statements of Lessee Disclosure [Text Block] Equipment Financing [Abstract] Fair Value Measurements [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Investment in Interact Devices, Inc (IDI) [Abstract] Investments in and Advances to Affiliates, Schedule of Investments [Text Block] Investment in Interact Devices, Inc (IDI) Notes Payable [Abstract] Notes Payable Debt Disclosure [Text Block] Significant Accounting Policies [Abstract] Significant Accounting Policies Significant Accounting Policies [Text Block] Stock-based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-based Compensation [Abstract] Cash Flow, Supplemental Disclosures [Text Block] Supplemental Cash Flow Information Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events Income Taxes [Abstract] Income Taxes Income Tax Disclosure [Text Block] Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Accounts Receivable Accounts Receivable [Abstract] Operating Leases [Abstract] Operating Leases Of Lessee Note Text Block Operating Leases Of Lessee Note [Text Block]. Operating Leases Preferred and Common Stock [Abstract] Preferred and Common Stock Stockholders' Equity Note Disclosure [Text Block] Retirement Plan [Abstract] Pension and Other Postretirement Benefits Disclosure [Text Block] Retirement Plan BI Networks [Member] BI Networks [Member] Business Acquisition, Acquiree [Domain] Business Acquisition [Axis] Business Acquisition [Line Items] Business Acquisition, Percentage of Voting Interests Acquired Percentage of equity interests exchanged Noncontrolling Interest [Line Items] Noncontrolling Interest, Ownership Percentage by Parent Percent ownership Noncontrolling Interest [Table] Schedule of Business Acquisitions, by Acquisition [Table] Advertising Costs, Policy [Policy Text Block] Advertising Expenses Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Earnings Per Share, Policy [Policy Text Block] Weighted Average Shares Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Patents and Intangibles Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Long-Lived Assets Income Tax, Policy [Policy Text Block] Income Taxes Inventory, Policy [Policy Text Block] Inventories New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Off-Balance-Sheet Credit Exposure, Policy [Policy Text Block] Off-Balance Sheet Arrangements Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Research and Development Expense, Policy [Policy Text Block] Research and Development Revenue Recognition, Policy [Policy Text Block] Revenue Recognition Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock-based Compensation Trade and Other Accounts Receivable, Policy [Policy Text Block] Accounts Receivable Use of Estimates, Policy [Policy Text Block] Management Estimates Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Computation of Basic and Diluted Earnings per Common Share Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of Future Patent Amortization Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Convertible Debt Securities [Member] Weighted Average Shares [Abstract] Basic Diluted Earnings Per Share Reconciliation [Abstract] Net income (loss) per common share Incremental Common Shares Attributable to Call Options and Warrants Stock options and warrants Incremental Common Shares Attributable to Conversion of Debt Securities Convertible debt Incremental Common Shares Attributable to Nonvested Shares with Forfeitable Dividends Restricted stock units Interest on Convertible Debt, Net of Tax Effect on earnings of dilutive convertible debt Net Income (Loss) Available to Common Stockholders, Basic Net income Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Numerator Net Income (Loss) Available to Common Stockholders, Diluted Net income Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Diluted weighted average shares outstanding Basic weighted average shares outstanding Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Denominator Amortization of Intangible Assets Patent amortization Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2013 Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four 2016 Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three 2015 Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two 2014 Finite-Lived Intangible Assets, Amortization Expense, Year Five 2017 Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract] Estimated future annual amortization expense related to intangible assets: Finite-Lived Intangible Asset, Useful Life Patent useful life Intangible Assets [Abstract] Impairment of Intangible Assets, Finite-lived Valuation impairment Cash in excess of amounts insured Advertising Expense Advertising expense Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents Cash, Uninsured Amount Revenue, Major Customer [Line Items] Marketing and Advertising Expense [Abstract] Advertising Expenses Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Useful Life Estimated useful life Research and Development [Abstract] Research and Development Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Property, Plant and Equipment [Table] Accounts Receivable [Member] Net accounts receivable Accounts Receivable, Net, Current Allowance for Doubtful Accounts Receivable, Current Allowance for uncollectible accounts Billed Contracts Receivable Billed trade receivables Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Axis] Concentration Risk Type [Axis] Customer One [Member] Concentration Risk [Line Items] Concentration Risk, Percentage Percentage of accounts receivable Concentration Risk [Table] Concentration Risk Type [Domain] Credit Concentration Risk [Member] Customer One [Member] Due from Employees, Current Employee travel advances and other receivables Entity-Wide Revenue, Major Customer, Percentage Percentage of revenues from major customer Major Customers [Axis] Name of Major Customer [Domain] Unbilled Contracts Receivable Unbilled trade receivables Due from Affiliates Advances to subsidiary Entity [Domain] Interact Devices Inc [Member] Interact Devices Inc. [Member]. Interact Devices Inc. [Member] Legal Entity [Axis] Payments to Acquire Additional Interest in Subsidiaries Payments to acquire additional interest in subsidiary Schedule of Subsidiary or Equity Method Investee [Table] Number of shares of subsidiary acquired Shares Of Subsidiary Acquired Shares Of Subsidiary Acquired. Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions Number of shares owned Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions Percent ownership Subsidiary or Equity Method Investee [Line Items] Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Future Minimum Payments under Operating Leases Area of Real Estate Property Area of space Executive Offices [Member] Executive Offices [Member] Lease Expiration Date Lease expiration date Leases Operating Term Leases, Operating, Term. Lease term Office Building [Member] Office Equipment [Member] Operating Leased Assets [Line Items] Operating Leases, Future Minimum Payments Due Total Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Future minimum payments under non-cancelable operating leases: Operating Leases, Future Minimum Payments Due, Next Twelve Months 2013 Operating Leases, Future Minimum Payments, Due in Five Years 2017 and thereafter Operating Leases, Future Minimum Payments, Due in Four Years 2016 Operating Leases, Future Minimum Payments, Due in Three Years 2015 Operating Leases, Future Minimum Payments, Due in Two Years 2014 Operating Leases Monthly Payment Operating Leases, Monthly Payment. Monthly payment Operating Leases, Rent Expense, Net Rent expense Production Studio [Member] Production Studio [Member] Schedule of Operating Leased Assets [Table] Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Deferred Tax Assets Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Income Tax Provision Deferred tax assets Deferred Tax Assets, Gross [Abstract] Deferred Tax Assets, Net Net deferred tax asset Deferred Tax Assets, Net [Abstract] Net deferred tax liabilities: Deferred Tax Assets, Operating Loss Carryforwards NOL carry-forward Deferred Tax Assets, Tax Credit Carryforwards, General Business General business credit carry-forwards Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Deferred compensation Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts Allowance for doubtful accounts Deferred Tax Assets, Valuation Allowance Valuation allowance Deferred Tax Liabilities, Gross [Abstract] Deferred tax liabilities Deferred Tax Liabilities, Property, Plant and Equipment Depreciation Income tax provision Income Tax Expense (Benefit), Continuing Operations, Income Tax Reconciliation [Abstract] The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations: Income Tax Reconciliation, Change in Deferred Tax Assets Valuation Allowance Change in valuation allowance Income Tax Reconciliation, Income Tax Expense (Benefit), at Federal Statutory Income Tax Rate Federal income tax (expense) benefit at statutory rates Income Tax Reconciliation, State and Local Income Taxes State income tax (expense) benefit at statutory rates Operating Loss Carryforwards Net operating loss carry-forwards Operating Loss Carryforwards, Expiration Dates Expiration of net operating loss carry-forwards Class of Stock [Domain] Class of Stock [Line Items] Common stock, shares outstanding Schedule of Stock by Class [Table] Class of Stock [Axis] Stock Issued During Period, Shares, Period Increase (Decrease) Stock issued during period STOCK OPTIONS [Abstract] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of Allocated Stock-based Compensation Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Schedule of Restricted Stock Unit Activity Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule of Information About Stock Options and Warrants Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Option and Warrant Activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Assumptions Used to Value Awards Schedule Of Unrecognized Share Based Compensation Expense Table Text Block Schedule Of Unrecognized Share Based Compensation Expense [Table Text Block]. Schedule of Unrecognized Compensation Expense Accounts Receivable Purchase Agreements Counterparty [Member] Accounts Receivable Purchase Agreements Counterparty [Member] Advisory Board Member [Member] Advisory Board Member [Member] Bridge Loan Counterparty [Member] Bridge Loan Counterparty [Member] Common Stock, Capital Shares Reserved for Future Issuance Number of unissued shares of common stock reserved for issuance Consulting Services Providers [Member] Consulting Services Providers [Member]. Title of Individual [Axis] Title of Individual [Axis] Directors [Member] Employee One [Member] Employee One [Member] Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized Unrecognized compensation expense Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition Period over which compensation expense will be recognized Employees [Member] Employees [Member]. Nonemployee Installation Technicians [Member] Nonemployee Installation Technicians [Member]. Restricted Stock Units [Member] Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share Based Compensation Arrangement By Share Based Payment Award Maximum Contractual Term Maximum contractual term Share Based Compensation Arrangement By Share Based Payment Award Number Of Individuals Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Individuals. Number of individuals Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of unissued stock options authorized Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average fair value of options granted Supplier [Axis] Share-based Goods and Nonemployee Services Transaction, Supplier [Domain] Stock Options and Warrants [Member] Stock Options And Warrants [Member]. Stock Options [Member] Title of Individual with Relationship to Entity [Domain] Unsecured Convertible Note Holder [Member] Unsecured Convertible Note Holder [Member] Restricted stock units awarded Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected life (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk free interest rate Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Allocated Share-based Compensation Expense Total Compensation Related Costs [Abstract] Stock-based compensation Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain] General and Administrative Expense [Member] Research and Development Expense [Member] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized In Year Four Cost not yet recognized to be recognized in year four. 2015 Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized In Year One Cost not yet recognized to be recognized in year one. 2012 Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized In Year Three Cost not yet recognized to be recognized in year three. 2014 Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized In Year Two Cost not yet recognized to be recognized in year two. 2013 Total Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted Average Exercise Price Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Forfeited Granted/Issued Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding, beginning balance Outstanding, ending balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Options and Warrants Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding, ending balance Outstanding, beginning balance Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Expired Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted/Issued Exercised Range Four [Member] Range Four [Member]. $ 0.35-9.50 [Member] Range One [Member] Range One [Member]. $ 0.17-0.95 [Member] Range Three [Member] Range Three [Member]. $ 2.25-4.00 [Member] Range Two [Member] Range Two [Member]. $ 1.00-1.59 [Member] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price Weighted Average Exercise Price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Range of Exercise Prices, minimum Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Number Exercisable Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Number Outstanding Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Weighted Average Exercise Price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life (years) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Range of Exercise Prices, maximum Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Canceled/Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Canceled/Forfeited Awarded at fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Outstanding, beginning balance Outstanding, ending balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Restricted Stock Units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Outstanding, beginning balance Outstanding, ending balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Number Vested Share-Based Compensation Arrangement, By Share-Based Payment Award, Equity Instruments Other Than Options, Number Of Vested Units. Vested at December 31, 2012 Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Settled In Period Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement, By Share-Based Payment Award, Equity Instruments Other Than Options, Settled In Period, Weighted Average Grant Date Fair Value. Settled by issuance of stock Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value Of Vested Units Share-Based Compensation Arrangement, By Share-Based Payment Award, Equity Instruments Other Than Options, Weighted Average Grant Date Fair Value Of Vested Units. Vested at December 31, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Settled by issuance of stock Awarded at fair value Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Schedule of Fair Value of Financial Instruments Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Liabilities Measured at Fair Value on a Recurring Basis using Significant Unobservable Inputs Balance at December 31, 2011 Assets, Fair Value Disclosure Total assets measured at fair value Assets, Fair Value Disclosure [Abstract] Assets Derivative Financial Instruments, Liabilities, Fair Value Disclosure Derivative valuation Derivative Valuation Liability [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Hierarchy [Axis] Fair Value by Measurement Frequency [Axis] Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] Significant Other Observable Inputs (Level 2) [Member] Significant Unobservable Inputs (Level 3) [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value, Measurements, Recurring [Member] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Included in net loss Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) Valuation adjustment Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Sales, Issues, Settlements Purchases, issuances, and settlements, net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Transfers to Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Balance at December 31, 2012 Liabilities, Fair Value Disclosure Total liabilities measured at fair value Liabilities, Fair Value Disclosure [Abstract] Liabilities Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items] Defined Contribution Plan, Employer Discretionary Contribution Amount Contributions to defined contribution plans Defined Contribution Plan, Employer Matching Contribution, Percent Maximum percent of compensation matched Defined Contribution Plan Employer Matching Contribution Percent Of Match Percentage employer matches of the employee's percentage contribution matched. Percent of match Defined Contribution Plan Maximum Annual Contributions Per Employee Percent Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan. Maximum percent of compensation which may be contributed to plan Scenario One [Member] Scenario One [Member] Scenario Two [Member] Scenario Two [Member] Scenario, Unspecified [Domain] Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table] Scenario [Axis] Acquisition of IDI Common Share Equivalents [Member] Award Type [Axis] Conversion of Short Term Debt [Member] Conversion Of Short Term Debt [Member]. Cost of Goods and Services Sold, Depreciation and Amortization Depreciation and amortization included in cost of sales Debt Conversion [Table] Deferred Compensation Arrangement with Individual, Requisite Service Period Service period for options granted Total depreciation and amortization expense Depreciation, Nonproduction Depreciation related to equipment other property and equipment, and (iii) $2,538 for patent amortization. Interest Expense, Debt Interest expense Modification of Senior Unsecured Convertible Note [Member] Modification Of Senior Unsecured Convertible Note [Member]. Options Granted for Consulting Services [Member] Options Granted For Consulting Services [Member]. Other Significant Noncash Transaction, Name [Domain] Other Significant Noncash Transactions by Unique Description [Axis] Other Significant Noncash Transactions [Line Items] Other Significant Noncash Transactions [Table] Other Significant Noncash Transaction, Value of Consideration Given Value of shares issued to consultant Placement Agency [Member] Placement Agency [Member] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Goods and Nonemployee Services Transaction [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Contractual Term Contractual life of options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Exercise Price Exercise price of options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Fair value of options granted Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Supplier [Axis] Common stock issued for note extensions Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects Share-based Goods and Nonemployee Services Transaction [Line Items] Share-based Goods and Nonemployee Services Transaction, Supplier [Domain] Shares Issued to Consultant for Cancellation of Warrant [Member] Shares Issued to Consultant for Cancellation of Warrant [Member] Shares Issued to Consultant for Services [Member] Shares Issued to Consultant for Services [Member] Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Shares issued to consultant Total Long-term Notes Payable Total Less Current Portion Compensating Balance, Amount Required cash balance Conversion of Senior Notes to Common Stock [Member] Conversion of Senior Notes To Common Stock [Member]. Convertible Notes Payable [Abstract] Convertible notes Debt Conversion [Line Items] Debt Instrument, Convertible, Number of Equity Instruments Number of shares of common stock notes are convertible into Debt Instrument Covenant Funding Amount Received Debt Instrument, Covenant, Funding Amount Received. Proceeds received from equity financing Debt Instrument Covenant Funding Threshold Debt Instrument Covenant, Funding Threshold. Funding threshold Debt Instrument, Periodic Payment, Interest Interest Payable, Current Accrued interest payable currently Maximum Shares Of Stock Issuable Contingent To Equity Raised Maximum Shares Of Stock Issuable Contingent To Equity Raised. Number of shares issuable, contingent to equity raised Payments of Financing Costs Payments for commissions, finders fees and other transaction expenses Stock Issued During Period Value Agent Fees For Debt Restructuring Stock Issued During Period, Value, Agent Fees For Debt Restructuring. Value of shares issued for agent fees Value of shares of common stock issued Stock Issued During Period, Value, Restricted Stock Award, Forfeitures Value of restricted shares issued Troubled Debt Restructuring, Debtor, Current Period, Gain (Loss) on Restructuring, Net of Tax Gain on troubled debt restructuring Debt Instrument, periodic interest payment Warrants Issued to Senior Secured Note Holder [Member] Warrants Issued to Senior Secured Note Holder [Member]. Warrants Issued to Third Party For Financing Fees [Member] Warrants Issued to Third Party For Financing Fees [Member]. Class C Warrant [Member] Class C Warrant [Member]. Class D Warrant [Member] Class D Warrant [Member]. Debt Instrument, Convertible, Interest Expense Interest expense of convertible debt Letter of Understanding [Member] Line of Credit Facility, Expiration Date Credit facility expiration date Line of Credit Facility, Initiation Date Credit facility initiation date Line of Credit Facility, Maximum Borrowing Capacity Amount of credit facility Line of Credit Facility, Periodic Payment, Interest Debt instrument, interest payment Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Warrants expired Warrants and options exercised Warrant Issued for Interest on Convertible Note [Member] Warrant Issued for Interest on Convertible Note [Member]. Accounts, Notes, Loans and Financing Receivable [Line Items] Agreement One [Member] Agreement One [Member]. Agreement Two [Member] Agreement Two [Member]. Conversion of Accounts Receivable Purchase Agreements [Member] Conversion of Accounts Receivable Purchase Agreements [Member]. Common stock issued in conversion Debt Conversion, Converted Instrument, Warrants or Options Issued Number of warrants issued in conversion Debt Conversion, Converted Instrument, Warrants Or Options Issued, AntidilutionProtection Threshhold. Anti-dilution price protection provisions, stock price threshold Debt Conversion Converted Instrument Warrants Or Options Issued Antidilution Protection Threshold Financial Instrument [Axis] Proceeds from Sale of Other Receivables Proceeds from sale of receivables Repayments of Other Long-term Debt Repayment of advances Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Servicing Assets and Servicing Liabilities at Fair Value, Assumptions Used to Estimate Fair Value, Discount Rate Discount rate Servicing Assets And Servicing Liabilities At Fair Value Assumptions Used To Estimate Fair Value Interest Rate Servicing Assets And Servicing Liabilities At Fair Value, Assumptions Used To Estimate Fair Value Interest Rate. Interest fee for every 30 days the advances remain outstanding Trade Receivables Held-for-sale, Amount Value of accounts receivable purchase agreements Types of Financial Instruments [Domain] Warrant [Member] Debt Instrument [Line Items] Debt Instruments [Abstract] Debt Schedule of Long-term Debt Instruments [Table] Extinguishment of Debt, Amount Principale amount retired Interest Expense, Borrowings Interest expense Payments of Loan Costs Payments of escrow fees Fair value of warrants Warrants Issued to Investment Banker for Payment [Member] Warrants Issued to Investment Banker for Payment [Member]. Conversion of Equipment Purchase and Sale Agreement to Common Stock and Warrants [Member] Conversion of Equipment Purchase and Sale Agreement to Common Stock and Warrants [Member]. Debt Instrument Fee Percent Debt Instrument, Fee Percent. Fee percent Equipment Purchase and Sale Agreement [Member] Equipment Purchase and Sale Agreement [Member]. Long-term Debt Long-term debt Repayment of debt Conversion Feature of Debt [Member] Conversion Feature of Debt [Member] Debt Instrument, Increase, Additional Borrowings Continued sales of convertible debt Derivative, by Nature [Axis] Derivative, Name [Domain] Newly Issued Debt [Member] Newly Issued Debt [Member] Payment of Financing and Stock Issuance Costs Payment of investment banking fees Tranche One of Warrants Issued with Twenty Twelve Convertible Notes [Member] Tranche One of Warrants Issued with 2012 Convertible Notes [Member] Tranche One of Warrants Issued with 2012 Convertible Notes [Member] Tranche Three of Warrants Issued with Twenty Twelve Convertible Notes [Member] Tranche Three of Warrants Issued with 2012 Convertible Notes [Member] Tranche Three of Warrants Issued with 2012 Convertible Notes [Member] Tranche Two of Warrants Issued with Twenty Twelve Convertible Notes [Member] Tranche Two of Warrants Issued with 2012 Convertible Notes [Member] Tranche Two of Warrants Issued with 2012 Convertible Notes [Member] Twenty Twelve Convertible Notes [Member] 2012 Convertible Notes [Member] 2012 Convertible Notes [Member] Twenty Twelve Convertible Notes Subsequently Amended [Member] 2012 Convertible Notes Subsequently Amended [Member] 2012 Convertible Notes Subsequently Amended [Member] Warrant Reset Provision [Member] Warrant Reset Provision [Member] Schedule of Long-term Debt Instruments [Table Text Block] Schedule of Notes Payable Equity Financing And Debt Restructuring Table Text Block Equity Financing And Debt Restructuring [Table Text Block]. Schedule of Debt Conversion Amended and Restated Senior Convertible Note [Member] Amended and Restated Senior 6.25% Convertible Note [Member]. Bridge Loan Conversion [Member] Bridge Loan Conversion [Member]. Bridge Loan Note Payable [Member] Bridge Loan Note Payable [Member]. Classa Warrant [Member] Class A Warrant [Member]. Class A Warrant [Member] Class B Warrant [Member] Class B Warrant [Member]. Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrants Class Of Warrant Or Right Maximum Share Price Triggering Exercise Of Warrants Class Of Warrant Or Right, Maximum Share Price Triggering Exercise Of Warrants. Maximum share price triggering exercisability of warrant Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of shares of common stock warrants can be exercised for Class Of Warrant Or Right Term Of Warrant Class Of Warrant Or Right, Term Of Warrant. Warrant term length Debt Conversion by Unique Description [Axis] Debt Conversion, Name [Domain] Debt Conversion, Original Debt, Amount Amount of debt converted Debt Instrument [Axis] Debt Instrument, Face Amount Principal issued Debt Instrument, Interest Rate, Stated Percentage Debt interest rate Debt Instrument, Maturity Date Debt maturity date Debt Instrument, Name [Domain] Early Repayment of Senior Debt Cash paid to settle debt Equipment Purchase Agreement Conversion [Member] Equipment Purchase Agreement Conversion [Member]. Equity Financing Agreement Commission Fee Percentage Equity Financing Agreement, Commission Fee Percentage. Commission fee percentage Equity Financing Agreement Gross Consideration Equity Financing Agreement, Gross Consideration. Gross consideration in equity financing transaction Equity Financing Agreement Maximum Percent Of Outstanding Common Stock Issuable Equity Financing Agreement, Maximum Percent Of Outstanding Common Stock Issuable. Percent of issued common stock covered by warrants issued in transaction Equity Financing Agreement Number Of Units To Be Issued Equity Financing Agreement, Number Of Units To Be Issued. Number of units to be issued in financing transaction Equity Financing Agreement Stock Purchase Ratio For Warrant Equity Financing Agreement, Stock Purchase Ratio For Warrant. Shares of stock issued per warrant exercised Equity Financing Agreement Unit Price Equity Financing Agreement, Unit Price. Price per unit Equity Financing And Debt Restructuring By Plan [Axis] Equity Financing and Debt Restructuring, by Plan [Axis]. Equity Financing And Debt Restructuring By Plan [Table] Equity Financing and Debt Restructuring, by Plan [Table]. Equity Financing and Debt Restructuring [Line Items] Equity Financing and Debt Restructuring [Line Items]. Equity Financing And Debt Restructuring Plan [Domain] Equity Financing and Debt Restructuring Plan [Domain]. Fair Value Assumptions, Expected Dividend Rate Dividend yield Fair Value Assumptions, Expected Term Expected life Fair Value Assumptions, Expected Volatility Rate Expected volatility Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Fair Value by Liability Class [Axis] Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation, by Liability Class [Domain] Amount of financing proceeds triggering expiration of warrants Maximum [Member] Maximum Percent Of Class B Warrants Allowed Maximum Percent Of Class B Warrants Allowed. Maximum percent of B warrants allowed Minimum [Member] Number of warrants issued Number Of Investors. Number Of Warrants Issued Number Of Warrants Issued To Investors Number Of Warrants Issued To Investors. Number of warrants issued to investors Original Warrants Issued for Bridge Loan [Member] Original Warrants Issued for Bridge Loan [Member]. Payments for debt extinguishment costs Proceeds from Issuance or Sale of Equity Proceeds from issuance of stock and warrants Range [Axis] Range [Domain] Registration Payment Arrangement Term Penalty Registration Payment Arrangement, Term Penalty. Cash penalty percentage for not meeting deadlines Repayments of Convertible Debt Repayments of convertible debt Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued Warrants issued to investment banker Share Price Stock trading price Stock Issued During Period Shares Agent Fees For Debt Restructuring Stock Issued During Period, Shares, Agent Fees For Debt Restructuring. Number of shares issued for agent fees Shares of common stock issued Two Thousand Twelve Plan [Member] 2012 Plan [Member]. 2012 Plan [Member] Warrants Expiration, Amount Of Proceeds From Triggering Event. Warrants Expiration Amount Of Proceeds From Triggering Event Warrants Expiration Maximum Share Price Triggering Event Warrants Expiration, Maximum Share Price Triggering Event. Maximum share price triggering expiration of warrants Warrants Expiration Minimum Trading Volume Warrants Expiration, Minimum Trading Volume. Minimum trading volume Warrants Issued to Reset Provision and Extend Maturity Date of Bridge Loan Warrants [Member] Warrants Issued to Reset Provision and Extend Maturity Date of Bridge Loan Warrants [Member]. Agency [Member] Agency [Member]. Number of A Warrants Counterparty Name [Axis] Debt Conversion, Converted Instrument, Shares Issued Common Shares Issued Equipment Finance Conversion [Member] Equipment Finance Conversion [Member]. Investors [Member] Investors [Member]. Lenders [Member] Lenders [Member]. Repurchase Agreement Counterparty, Name [Domain] Warrants and Rights Outstanding Value of Warrants Amended and Restated Senior 6.25% Convertible Note [Member] Class Of Warrant Or Right Number Cancelled Class Of Warrant Or Right, Number Cancelled. Number of warrants cancelled Class of Warrant or Right, Outstanding Warrants issued Conversion of Stock, Shares Issued Stock issued upon exercise of warrants Debt Instrument, Convertible, Conversion Price Conversion price Debt Instrument, Decrease, Forgiveness Debt forgiveness Debt Instrument Length Until Maturity Debt Instrument, Length Until Maturity. Length of term until maturity Equity Units Subscribed But Unissued Equity units subscribed but unissued Equity Units Subscribed But Unissued. Equity Units Subscribed But Unissued Share Price Per share subscription price of equity units Equity Units Subscribed But Unissued, Share Price. Interest Payable Accrued interest payable Payments of Debt Issuance Costs Payments for placement fees Placement Agency Agreement Warrants [Member] Placement Agency Agreement Warrants [Member]. Senior Notes [Member] Shares Of Stock Foregone In Lieu Of Cash Payment Shares Of Stock Foregone In Lieu Of Cash Payment. Shares of stock issuable, but forgone in lieu of cash payment Two Thousand Ten Bridge Loan [Member] 2010 Bridge Loan [Member] 2010 Bridge Loan [Member] Two Thousand Ten Plan [Member] Two Thousand Ten Plan [Member]. 2010 Plan [Member] Unsecured Convertible Note [Member] Unsecured Convertible Note [Member]. Value Of Shares For Agent Fees Denominator Value of shares issued for agent fees, denominator Value Of Shares Issued For Agent Fees, Denominator. Warrants Issued for Convertible Note Restructuring [Member] Warrants Issued for Convertible Note Restructuring [Member]. Warrants Issued Pursuant to Waiver Agreement [Member] Warrants Issued Pursuant to Waiver Agreement [Member]. Amortization Of Deferred Lease Acquisition Fees Amortization Of Deferred Lease Acquisition Fees. Amortization of the lease acquisition fee Capital Leased Assets [Line Items] Capital Lease Obligations [Member] Capital Leases, Income Statement, Interest Expense Interest portion of lease payments Debt Instrument, Periodic Payment, Principal Lease payments applied to principal Debt Issuance Cost Capitalized lease acquisition fees Equipment [Member] Increase (Decrease) in Restricted Cash Increase in restricted cash Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Number Of Locations To Install Equipment Number Of Locations To Install Equipment. Number of customers locations where equipment is installed Payments for Purchase of Other Assets Payments toward in place fair market value Property, Plant and Equipment by Type [Axis] Property, Plant and Equipment, Type [Domain] Property Subject to or Available for Operating Lease, by Major Property Class [Table] Repayments of Long-term Capital Lease Obligations Lease payments Sale Leaseback Transaction, Gross Proceeds Proceeds from sale of equipment to financing institution Sale Leaseback Transaction, Monthly Rental Payments Monthly rental payment Sale Leaseback Transaction Monthly Rental Payments Number Of Payments After Which Lease Can Be Cancelled Sale Leaseback Transaction, Monthly Rental Payments, Number Of Payments After Which Lease Can Be Cancelled. Number of payments until lease can be cancelled Sale Leaseback Transaction Number Of Payments Sale Leaseback Transaction, Number Of Payments. Number of payments Sale Leaseback Transaction One Time Fee For Cancellation Sale Leaseback Transaction, One Time Fee For Cancellation. One time fee for cancellation Sale Leaseback Transaction One Time Fee For Cancellation Percent Of Lease Sale Leaseback Transaction, One Time Fee For Cancellation, Percent Of Lease. Cancellation fee as a percentage of equipment value Telecommunications Equipment [Member] Telecommunications Equipment [Member]. Shares authorized for issuance Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued Awards issued for fees Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance Deferred Compensation Arrangement with Individual, Shares Issued Number of shares issued Former Director [Member] Former Director [Member] Management [Member] Subsequent Event [Line Items] Subsequent Event [Member] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Warrants Issued Subsequent to Balance Sheet Date [Member] Warrants Issued Subsequent to Balance Sheet Date [Member] Legal Proceedings [Abstract] Legal Matters and Contingencies [Text Block] Legal Proceedings Liquidity [Abstract] Liquidity [Abstract] Going Concern [Text Block] Going Concern [Text Block] Liquidity Escrow Deposit Escrowed amount Loss Contingency Nature [Axis] Loss Contingencies [Line Items] Loss Contingencies [Table] Loss Contingency, Accrual Carrying Value, Current Current accrual for litigation Loss Contingency, Nature [Domain] Loss Contingency, Range of Possible Loss, Maximum Maximum amount of additional payment Payments to Acquire Property, Plant, and Equipment Payments toward purchase price of equipment Amount Of Committed Proceeds From Convertible Debt Amount Of Committed Proceeds From Convertible Debt. Commitments from current debt holders Information by name of counterparty or group of related counterparties. A counterparty is the other party that participates in a financial transaction. Monthly Excess Of Cash Expenses Over Income Cash flow used in operations Notes Reduction Accounts payable satisfied with stock Proceeds from Convertible Debt Proceeds from issuance of convertible note and warrants Proceeds from Short-term Debt Proceeds from Bridge Loan Cash expenses over income Workforce Reduction Rate Reduction in workforce, percentage EX-101.PRE 11 bcst-20121231_pre.xml EXHIBIT 101.PRE XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Financing and the Debt Restructuring (2010 Equity Financing and the Debt Restructuring) (Details) (USD $)
 12 Months Ended 0 Months Ended 12 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 0 Months Ended 0 Months Ended 12 Months Ended 12 Months Ended 0 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Common Stock [Member]
Mar. 26, 2012
Amended and Restated Senior 6.25% Convertible Note [Member]
Dec. 23, 2010
Amended and Restated Senior 6.25% Convertible Note [Member]
Jul. 30, 2010
Amended and Restated Senior 6.25% Convertible Note [Member]
Mar. 26, 2010
Amended and Restated Senior 6.25% Convertible Note [Member]
Dec. 24, 2007
Amended and Restated Senior 6.25% Convertible Note [Member]
Dec. 31, 2012
Amended and Restated Senior 6.25% Convertible Note [Member]
Dec. 31, 2011
Amended and Restated Senior 6.25% Convertible Note [Member]
Mar. 31, 2011
Amended and Restated Senior 6.25% Convertible Note [Member]
Dec. 23, 2009
Amended and Restated Senior 6.25% Convertible Note [Member]
Dec. 31, 2012
Unsecured Convertible Note [Member]
Dec. 31, 2011
Unsecured Convertible Note [Member]
Dec. 23, 2009
Unsecured Convertible Note [Member]
Nov. 02, 2006
Unsecured Convertible Note [Member]
Dec. 23, 2010
Unsecured Convertible Note [Member]
Common Stock [Member]
Dec. 23, 2010
Unsecured Convertible Note [Member]
Warrants Issued for Convertible Note Restructuring [Member]
Dec. 23, 2010
2010 Plan [Member]
Dec. 31, 2011
2010 Plan [Member]
Mar. 31, 2011
2010 Plan [Member]
Dec. 31, 2011
2010 Plan [Member]
Warrants Issued Pursuant to Waiver Agreement [Member]
Dec. 31, 2012
2010 Plan [Member]
Warrants Issued Pursuant to Waiver Agreement [Member]
Dec. 31, 2012
2010 Plan [Member]
Placement Agency Agreement Warrants [Member]
Dec. 31, 2011
2010 Plan [Member]
Placement Agency Agreement Warrants [Member]
Dec. 23, 2010
2010 Plan [Member]
Unsecured Convertible Note [Member]
Nov. 29, 2010
2010 Plan [Member]
2010 Bridge Loan [Member]
Dec. 23, 2010
2010 Plan [Member]
Senior Notes [Member]
Dec. 23, 2010
2010 Plan [Member]
Minimum [Member]
Apr. 05, 2012
2012 Plan [Member]
Mar. 26, 2012
2012 Plan [Member]
Dec. 31, 2012
2012 Plan [Member]
Dec. 31, 2012
2012 Plan [Member]
Placement Agency Agreement Warrants [Member]
Dec. 31, 2012
2012 Plan [Member]
Amended and Restated Senior 6.25% Convertible Note [Member]
Mar. 26, 2012
2012 Plan [Member]
Minimum [Member]
Mar. 26, 2012
2012 Plan [Member]
Maximum [Member]
Equity Financing and Debt Restructuring [Line Items]                                                                        
Gross consideration in equity financing transaction                                     $ 15,000,000                   $ 10,000,000   $ 6,000,000       $ 3,000,000 $ 10,000,000
Shares of stock issued per warrant exercised                                     0.5                       0.5          
Commission fee percentage                                     8.00%                       10.00%          
Shares of common stock issued     25,402,164     2,000,000 1,000,000 1,000,000 2,000,000               150,000   40,000                     616,000            
Value of shares issued for agent fees, denominator                                     1,000,000                                  
Payments for placement fees                                     180,000                                  
Equity units subscribed but unissued                                     12,500,000                                  
Per share subscription price of equity units                                     $ 1.2                                  
Warrant term length                                   5 years 5 years                       6 years          
Exercise price of warrants                                   0.9 1.0       0.7312     0.9             0.78      
Proceeds from equity financing 6,150,000                                    13,500,000                     154,000            
Number of warrants issued                                                           400,400            
Principal issued               15,000,000 5,500,000     15,000,000       1,000,000                     1,000,000                  
Repayments of convertible debt         2,500,000                                                              
Cash paid to settle debt       2,750,000 2,750,000       2,750,000                   2,750,000                                  
Number of warrants cancelled         5,208,333                           5,208,333                                  
Common stock issued for debt restructuring, shares       2,000,000 800,000                           800,000                 800,000                
Common stock issued for debt restructuring       760,000                                           150,000                    
Shares of stock issuable, but forgone in lieu of cash payment         3,500,000                           3,500,000                                  
Debt forgiveness         7,200,000                           7,200,000                                  
Debt interest rate               6.25%       6.25% 8.00%   8.00% 5.00%                                        
Interest paid 347,902 357,246   680,816 350,434     937,000                                                   680,816    
Accrued interest payable                 680,816 680,816                                                    
Conversion price           $ 1.8   $ 5.45       $ 1.35 $ 0.25     $ 1.5                                        
Warrants issued                                         400,000   12,499,980     75,000                    
Stock issued upon exercise of warrants                                       372,272                                
Derivative valuation 1,191,269 3,760,200               285,200 81,500   46,400 300,000                   109,400 2,785,000             757,469        
Gain on derivative valuation $ 8,829,748 $ 11,724,400             $ 203,700 $ 2,322,200     $ 253,600 $ 1,101,900               $ 144,000   $ 2,765,600 $ 7,875,000             $ 4,365,323        
Risk-free interest rate                         0.16%                     0.36%                        
Expected life                         1 year 0 months                     3 years 0 months                        
Expected volatility                         112.04%                     85.10%                        
Dividend yield                         0.00%                     0.00%                        
Stock trading price                         $ 0.08                     $ 0.08                        
XML 13 R54.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-based Compensation (Schedule of Option and Warrant Activity) (Details) (USD $)
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Options and Warrants Outstanding    
Outstanding, beginning balance 20,440,551 20,442,170
Expired (252,669) (302,054)
Forfeited (1,658,919) (2,510,201)
Exercised    (455,098)
Outstanding, ending balance 43,396,863 20,440,551
Weighted Average Exercise Price    
Outstanding, beginning balance $ 1.1 $ 1.13
Expired $ 1.31 $ 18.67
Forfeited $ 1.31 $ 0.08
Exercised      
Outstanding, ending balance $ 0.54 $ 1.1
Stock Options [Member]
    
Options and Warrants Outstanding    
Granted/Issued 50,000 1,567,900
Exercised   (55,098)
Weighted Average Exercise Price    
Granted/Issued $ 0.37 $ 0.91
Warrant [Member]
    
Options and Warrants Outstanding    
Granted/Issued 24,817,900 1,697,834
Exercised   (400,000)
Weighted Average Exercise Price    
Granted/Issued $ 0.33 $ 0.68
XML 14 R48.htm IDEA: XBRL DOCUMENT v2.4.0.6
Operating Leases (Details) (USD $)
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Operating Leased Assets [Line Items]    
Rent expense $ 352,789 $ 463,694
Future minimum payments under non-cancelable operating leases:    
2013 284,447  
2014 278,552  
2015 23,049  
Total 586,048  
Executive Offices [Member]
    
Operating Leased Assets [Line Items]    
Lease term 39 months  
Area of space 13,880  
Monthly payment 23,049  
Lease expiration date Jan. 31, 2015  
Production Studio [Member]
    
Operating Leased Assets [Line Items]    
Area of space 7,500  
Monthly payment 7,000  
Office Equipment [Member]
    
Operating Leased Assets [Line Items]    
Monthly payment $ 655  
Lease expiration date Mar. 31, 2014  
XML 15 R55.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-based Compensation (Schedule of Information About Options and Warrants) (Details) (USD $)
 12 Months Ended
Dec. 31, 2012
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum $ 0.17
Range of Exercise Prices, maximum $ 4.0
Number Outstanding 43,396,863
Weighted Average Remaining Contractual Life (years) 4 years 3 months 4 days
Weighted Average Exercise Price $ 0.54
Number Exercisable 42,961,663
Weighted Average Exercise Price $ 0.54
$ 0.17-0.95 [Member]
  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum $ 0.17
Range of Exercise Prices, maximum $ 0.95
Number Outstanding 39,583,684
Weighted Average Remaining Contractual Life (years) 4 years 4 months 10 days
Weighted Average Exercise Price $ 0.47
Number Exercisable 39,207,017
Weighted Average Exercise Price $ 0.47
$ 1.00-1.59 [Member]
  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum $ 1.0
Range of Exercise Prices, maximum $ 1.59
Number Outstanding 3,306,679
Weighted Average Remaining Contractual Life (years) 3 years 2 months 12 days
Weighted Average Exercise Price $ 1.04
Number Exercisable 3,248,146
Weighted Average Exercise Price $ 1.04
$ 2.25-4.00 [Member]
  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum $ 2.25
Range of Exercise Prices, maximum $ 4.0
Number Outstanding 506,500
Weighted Average Remaining Contractual Life (years) 3 years 4 months 2 days
Weighted Average Exercise Price $ 2.62
Number Exercisable 506,500
Weighted Average Exercise Price $ 2.62
ZIP 16 0001214659-13-001731-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-13-001731-xbrl.zip M4$L#!!0````(`/*$?4)-<.PUQ5,!`-/E$0`1`!P`8F-S="TR,#$R,3(S,2YX M;6Q55`D``P?\55$'_%51=7@+``$$)0X```0Y`0``[%U9<^)(MGZ_$?<_9#/5 M$]41`FL!(5Q=-8.W&D>X;(?MFNZ^;T)*0-U"8C(E8\^OO^=D2D*`V+Q@X5+T M]+1!F4=G^N[8S:GZ?(X M8DM7=P[@:+H0#W@K"'L!JL3)"#\,HY$_LWYBB-5:I],Y$$>SI0L\SRS%H^E2 METYY$.?GU&D,POL#."!445>U^E09,:\/;'N<;>G;O"Y6D MKG&O=&8Q\-)+X;,MK_7$-@U5,,-1ZX6R,'DA`>.>RZ?\8\&M$@ MXG=AUW6]"-S"]J]MSST/CNVQ%]G^>1!11GE$//=S;9L-#0T,W&YHJF$TFIU6 MNZ'*?X!#[AT&'L`G8C$P[(2PXR&Z08;[+!PAPQKJ!_X7A?(3*`P$D!35(IIQ MX$D*WV]/,N1QKPAWH%?MX/=O%[="C?4IM'>MFJ:IS4FQO2H6:VOC911R"+OOS:N MONJ?T#YEC+H7%/)3U_E/['%!YXQ2+I6Q\7(AC=FP@$FPJZ:M<2!]1B-Z3B,F M;"JBLD(QAM'2]%0O&W.\,ZVT-];*:IQLJ966JIO6,[42!]%5_S@8!A]LQ^\43RZ'=J,7D/)0>^8-QA`\1$,3A\HJU+VI#;R7J M?+Y`ZY1\&8]ZE!UC=/=]J.&7JG%NH9#10ME,*'IT:XW[J8@N74_T)#\9"0VU MD$H.0)E$]78^I>I60D,MHE(*"R8"&B\BH#$OH/GF`FJ:UC`-HZEC/&VM M+8H@7ZF9@/A)2VBH153*8$%-TP5KQJ8"YJH^^&1H"0VUB$HI!&PU&Y:NF:U& M![(B5%<=_+_V%[<,`'[5RJ\$(HIV$(U@;E#FKVXI"ZB40$!=A;(,66MF*+/6 M>^CL-"'-*TA*74&L%.("VN8X7.>AJX&[G%@IQ#5:HMANBQ2XLF(WZ]K4JLDG M/2&A%A#YYR7$Z\R+9WTKB7R6^@+RS1'YVN$8M)&.0%])Q#D#34)/$LT`E%RWC@I\W M5*-0W"F#2P7\'MCRYS;JGGC* MC4ZS4,KE7.U$ZLX&4N<38F<+J375L%J=5Y3Z,@R<;02?KG]UBQ=[\$J>=BCY M:UK=;'6:'?.9XO>]@+I0*T7,Z\D*R+>#T]'8#Q\I^V9'SA`"X,QQ&2FN^N)@ MHI1G4LF&'2W#Q&MGM.<-.Q:IK(R+6J;"9XI1:L6V7T2Q\U26*U;#A-/:G6J3 M'^>[01#;?OX@!TK)B>:2]+/IO.H%'X4*-55X]WVB:I>GMQ`P[$&B'9L(Z=S>&$F=Z=5.US%W92U%66,M+K9DO$W4-.N+N4J;HVM5]/35Q9R0&G`/967B\BK1DZEE`S M.[N>=/%R[OU2S0:NM;F"-G>MUXQ`2?>4=9Y7<21NT!2=Z6@4!K=1Z/R%/QK9 M/7]UGMN.5/FKA.WDV4#7\KKHJ_YWX(MCJ29_BUNIU"5[=AO1BJX#U]O6)J!< MPO\&VA+:!<,Y0RB&;Q#/9R'+_^;]E(UOC[K6&H6MXOY-M?96I>HNM(;H%'>W MK%11MJID-^ZLY7>%!@(7I^@W%*?H3A3C?3UW&,[N0(8C'Y1:J)&UNUY^2OCE M[W[TZ:=Z_>3J^.Z/ZU."M\&3Z^]'%^?'I%8_./C-.#XX.+D[(;__Z^[;!=$: M*KD#Z_/DALJ#@]/+&BFX^_3N1MY2K^'FY,]ZE-O9<".W1NKUOP^B3\B#Z]WC MGR3W=\+:;62SZ(S9`U2^W)"N(CQZ].GG&BJ@;OO>(#@DF%4HJV7+(I%ADX5G M5Y=W];/NM_.+/PY)Y(TH)P&=$%";'7PBXNCM^?^='A)-'4>@6^K[?&P[XED+ MJOP\METW_3SQW&CXN=8Q?\Z=CTW_=,F]X.ISK1=&43C*=C15N0-7]<&`*7\G MY[?7%UW@S0M\+Z`)2QLS+,]LC\:?@AX?"^H'2#[CZ"!R-^!.*S5SH#H`/=HE M0)[T][MZ]^+\Z^4A\6D?\+1M[I;R?2+?NC=? MSR_K%Z=G=X%7#BP7^-TLJGTB6SI4V4)=%1GV-S+(V3L)^_OC;%V2WK!4.5SEU0J, MGUJ0J*V6]C[1N*QUG`R]B+[+QO&(>>Z`DHO0#LCT0855%UD.KG=?B2NFJE:% M>`7=_8.N50&W`NX^`M=0%=VT*MR^/:L5;K>:."LMHU/!]NU9K6"[5;C5%4M] MI].4'_&G3[SW?8QW=!-Y_SNM^MC*R75L!:IVH(+N_D%7JZ!;07<_H6NT%1.KUS0/(WM\:4#E)Y21/RK2*;N(URELD MV\I7*E\I@U2[GU^9FJ*W*T^I/*7RE#6>8B@M8XLK:2M'J1RE#%+MWE':3<52 M?R1/V>:'_"4NU7Q/`Y#B!P9L%EM6*6+?8@O(0MPP[OGT7067O%B[OU;`4IK; MWCF]&H:QD`:9RE\I=GIB,P5W:ZG.'(96[_$"X>N8]CN7S`;-C*9:QQ37[ ME0-4#O">'*!E*>;S1A<5_BO\[R_^VZVVTC2WN/ME[QT@/Y$X$*]"FW[,]^0_ MU>NG@3O[EK7%QCWYL.0%>6M?7[?E"_.V?E=>]9J\U:_)6SD:NA.XNP3%IT67841)D]2)M#7)C$WLP"71D!(T.9FQ^0)&]T=$`4A)J)2\GTG^ M$<6N%6JE]@NQ.5#P??RO35A>+_AD\#!F\&_V(F'":>"%#)W^GK+($^]8#EQ0 M*74#RGG^7(N*AK/!"6(_0DI>`%1&8Y\"-KD=>;QO.^*UU\E9DS/EJ3?*9*D" M!$[-]!LEXH&D^+;D(`K1+*?!P!Z(]YR2[(VG"G%MD(U<.5&(KS[0+6%4#8SJ M14/R[>2('-MC+[)]\I6%\5@A%Q?'Y&,-#M1^4<@X9CS&%^7"&29#SY$[;*3N MXG>@4#0KFH0^.'[,O7L*AY$%4#)^?0P6L(-'@1Q2ZX&Q".WW0Q;Q&NG9W..2 M$;#:F#KB/+B+V[YX;'P\%FY8+HGPE[P(P7 MK&3&2(DWR%U.`U.MC>U'_(]0)4)TY'&>;-;4GU..)/FPWZ?"5<8L=&`_!U4Y M%-3LDMYCGG,%20Y88BRD/4F>5RT-!7[):*+0W%FX>/E,ZA*.>'4.`!YS-\:S MC(:7O)D[$+LRUU=DU$MD@B.H91KDC%%?H#*Q=BKC M_GC?=`V]U>=R&$29=-HK`AH[!T$TY]A*$7 M0`R/8EEG"`V'P`4#*P/*72\2)TR>3TO`V02/8^;=`V$RAF)>G@^LH;>5Y#$> MX@7+?!H;4T8EB($Q]"$_=H&VC7%!,C\6[XA&U./KE\D8F$`Z27BA-DB`GZ67 M\"B-^4$"//RP@+EH$B+3(\%,\B3H0_)1^T5P4NO6TB\EW&7XFJ=+!W+` M6HP&\APVZ<>0#JGP63OY,E%O1,3V:`C<34TF>%%(+P;#)1Y.[Q.$\!@4DE)2 M-E!Y&FKFU.'7,9\.:X`8Z1X2!, M^(43^5(E0?JJG_3D<*(>3<-8##E?>L51IG%Q$A*+E9#,1*R>(63'T3!DWG_A M0#$XI*LDQ[Q`4.&92RUN!RN`H3*$5968]^; M)A^L"V5V2JRZF$4RLM`EB,QT(I4^A"*?LNQ4V5&>IET0\@02IQ!=Q%-$*FA,&AF=>''S'#@390H. MTAHC5P0S*G#O2OQ@J(L],,0<.R(NRD2)=:K$P-P:`88@G$A`3&E1=V6&G.]5 M`HJ0/%B4NVD[D'`'5K-#B M6:L&\9AKQ++%BVU0@YQC[Q,$5#8\*`=% MY"DS-?G8]ESR05?:+5D!`$/'-H>0`K%\`/4'1R7*!]V+V'(1N0TH4J9KL$5` MQ211=79_]D2`9:D47+(?^[)^6=JHB1IUL24,<.`@$BT2@+)'%J=8;/$H%7^V M+@_H((P@Y*1X6*([H>JI0%BJ)&%M6CB)#H>3EF4JFME<5T,+-<,91Z#K=DM1 MF]K^%+KGLV%3*RIJ?7R4I8AK[=D*%(3R7,@\B?>`8XG*=YK8LK`K>TL@W0L9 M"R>P^X.F&&H&RQXF9JP\(8"&["\TH9.TK1]KN2=JUGZ1Z2#_D,U>4I1E\"`L M22R:];,H?^P`6)NY8G:Y',)"//?%@K7G!%!FQ-U.UK0I6!15 M;SY'U'P/4:I@LBZ+S^:EK!A:/E`M"!:1[$<5T::E)6LO!%2YE#O,ZV%Y*HWB MHS,RGJ:.Q("8Y!UO#([3L_VT08(#'L3XD.7!DI()1?B8JP(_-*W^:/:XI M!1\OD*6U`UGNA.[G2CA.$RED928*J(A145\!N3X```HNV\/P7S0JS(JO'[@V M?EFO*IY9,CK&F0GN[GL^E1,>P)&I8D.'4//]<)(65_G1@RSAIL-4_!%@X$') M)>,RC\#6`I\.^#!+*8"9DZPV.Z:<02>'4+PPD\RJ^R6;A/#^8WJBM.V:G=:B MC&["2"&S\*$+@<0GG61`)PKA2)0$+G5\&RLDVN^C4>Y%SN[&`[`CT>3ZO0K; M5ZFPK70:F9@4G72F%/F@M9HBD`C_UD1A+Y`$VFG.U(0?HR&`:UK](;I&HM+, MTN%1:#,7/YQ`8^W@J.F7HJ`C^H=`LI#%H.ET:E5CU2#=Y%RMZ^OWA]USTR(N7^._*.5XYEU1>74K47::7#>V/HTS'/96S5,ZR2^3]&V>" M./'M[H^W5+Y2^,K1_K!:.77EU&^!N^+'AY66W<1-]H=A$33?IU/_ MB*_4.T]_^U]GTDT?>_&>QYJ[R@G;/]>NJ5CKGFM7WOEOA:YRHTO#*X*L"EU[ MCZX5S]W9_7L6S([2-%>\BJM"5(6H[5[MUE$,:\7;GBM`58#:[LEWD/2LUHI' MWY4749N_4^V]-#+YFZ%>_JW@[]WMREEW*N:ZUR.7UP,K<)4;7%8%K0I:KU2( MJHINKGAB=(6L"EE/G/,I+6/%DV@K8%7`>F+(TA5+W^4?\T>8TN[%>WDY* MJX[G?;AA]N2B\*68K6KGXFK(#U M\K]`0T+4]C(9;O[K3B+*MC=`[E4WU!W0P'E\S>6Z!:^$>O;%N__/WMMV MMXWDB,+?[SGW/_!ZT\])SJ$5OHOJV>YS'">9S=YTDAN[I[<_TE+)XK1$:OAB MQ_/K'P!5?!5)4;)>*)D[O=V6Q"H"*`"%`E#`X?LU=0WF5N)]>7E0+CC+;/.> M?8_&OH:L65ISZ]6>BWLN[C@7JY8J:\.>AWL>[B3,[7A8E\VF!J@]"__,GW+;5&R#Z>90>B=;WH`S;V@XGH M!G-_'[![;*96T8OCB;I-"7X0S6'3#H.ZFK37*W78#%C((FG*'.IK+!JZY)JM M9+TYTJ\P,=?U/00)>X,-X/$<.,`(,>_H<^^XO&V[(>N6*>N:3BU\4H2H!^R4 MVFY3M\Z9X]UC=QF:(H5E#@6>PD^J8VJZZ4P9?>;QU]AL$S!QH?\.G\H\]^(!F2@3;'!BCG_"A MA]PSU%D(&_H^N6Q.78.4@:+\)%ILPY.\34_2A;C0A]I.^W"_XMML2K=W520Z M8(>79PHZ??''!R[5=_Y\LF.7%TBK4MUB#.FTVEWU9'3:UWSC4X/4DB*G+3@G MH@(]H798) M!&C))AZVZ>8O625NTOUT@_6@KEM9V\1,C72JJ=2ZW:?4D/9;VJB7)R7!?T`= MX1&"\<\A+TL4=:DHV M!<43A1?2G1.ZHHUHJ>%ATA8O7M);I(7SPUW$"]'==:7GZ2O53!LQXRC/C<(2 M`&3G_(<^^EM8Z-,7QG?_%.^%M[A>\UN4Y"V/ M6?/UM%NJPP=6C2NV[^(+D&G_3YO%3@CU'Q9].>=/!M#,E;/T,UBKM M<2_FEJE)&^[6-*]1[FW-\6;*($\!(!L$EX%16*.F=*VW.I"6BI;[EJBY5^I47JMF0N"4 M.6@QYL=A57?RDU$MWW(BCH@U*99R7^R;^`ZU*EE&V7-A60%I.E=`7-1#1H:F MZX61&\6BI6+6BK[073OI%IA8*DNR&%FN33FVN-;DI+-K*OG%+M&J@=3W0 M7&379\*864[J0%.H$3'.+50H<3Q^3H0_X9B"]+>7_&*CZT0+K&J`U$R;.:AG M><=E>#)M-QUF';XKNRJK8"UF795S#;ZYZ0Q`@:4XM`MZO[ZOY,GP^!?`;:4I M[PH^H+&F0%$P%28@QHD=G&E63ERT4585#38-?B+=!A0C923T!#Q(R@:.`7#J MF@.KS]:#$S[BG,60HF@+=94+K@:1?+5`1 M36A5<1*2\AOFN;"37.=\`5]`+2;DK=2%9K;C"5]!Y=0XS\4;E(!K)XSFP)'W M]])O\"=@^BEK,OTYF@S@U)L]@X=?\N(M'9"15UKN;0#5V`EGQ3EEXK-D&B;@Z3495T;#%>I#O^=NRQ.5$E>-;W2BZN4&=Z9#SWD#;8G MF?`2/D5[SDG!YJAS@,F97,=C.6MNXH]C?K#(=_OF/$HU`XO.J91&R'+N6 M*`ICDN+ITG<,184YRM+ND2-BS=FKH@D\,1F[]\E(R,T`W][3^:)H9`X'6DI= M&)^32@`Z,1;N8B0:+6QB-YR.&KQM6N$5MUI"69GV$P=V1=1B#)2F&`/0WAIHYD]R>N0(V<*]Y(_, MG\C^IP7@^V@`D^#;<@ZP='(2&E.1#=W`%^4@&303@X=F"K[;J/[H&Y&#*BD; M4SB.ZF9V'"UZXR;_C+ERWAP4$%@?K8T`_P:S1U#QB4>FR-4#2X-`W#T5-+$/ MQYIUK^-;8FH"/#@!*G>N05S2H&@5C6$72%R'I'&R`R37$N0!=P+^AC&@"AP> M/`D;C[[S/:X*`2(4FBF\LB:23-Q[^^AGKD./TK\):*!IZ$Y<`!.6YCYV4!&B M48@/9DH^S-F9M;AS249`DCCN28AU*^H!WK4ZMH!VLH&$>7)L^T-,/X7H$]B3%#5CF]<&&5-NZ2"SYU[>8VV71G+-D$TVIL)LR9 M(,U"%*Z,0RG"`B(E#`DWB_4FNU1>:O!,-Y]?PI3C&4/!C-S+B3N/HTPY`(TC M84WFI$?LV.P!9\QC1FB%0MUPR%)U0#X,$:8LN_>"5;4TQ^`3Z&QQMB[_G`LC M4<3]9(3@?9P>QO@.!/HYFH42%_7?'"!,DIJ@RCE/18XI#&%59I9MSJASX&LX M1`6Y->?ZAT^-VR0=JYRZ@Z78/`KF6N+VS2U#$M7_SK7Q-[$%X@+[8'OP;2/S MW:UN.K4:3IQ":&]=.8LDPI>")GCY?%B94YZ)!,X/-M"JLRV&*PR)DXR" M9_"D6_"JYFSWO-QY9/ZO'F%Q*K+LT6N7+$+V-I2<'Y&`P5_)`-/)4J>-4>A: MU2PFU7@\N1]&HPRL=W!']DZ$8S-^30.>4`-SS+H4U] MC7ELNFOZD;Z?/C7YMO@6I%E)XEW+#)?*H%>K-)=\A@L_%JY+=*%W566[%)44 M*J@YBUC)8T/!3GI-?NI.*8%URW35&*Q*]5_EFF0!J4AX*Y,MJ8:LF8NRF%@@ MG'WR4`@B2J"0S;1>9MTI5^R%*(1#BS^YUL^&(+XRT^AU!:MXB6_IE64KV'F- ME%8I,M.IA5ZC[<41*Z?0(A@(2X*MOT8C>60K69`L.9'61>X3(VS%TLJ\!R53 M*S%L*=&ZL'Y^29NB4H`U3:9(CD,Y(R?DGHVRL54.LA_)KKJ=L7(&`-B+TAUC M7C':KX.(9-!.N%F!7@.@`)(L58O-"J7/_ MXP=/[3+$2TG6.:G),GF<4B;/^D1Q@-DRL2D*1V$HV]P2*4-(C+W; M/')@[C%;(9)*@)2_+<'3.L,\69^*`V:)O*DIETM$/T0>N6ZUR2/7!\KZ/')5 MV6T>^:H:^#^7EQ^\R[3A6WZ M%@3T',95W[H#\"+V4>(D/E+P-5'8VL!+QZ3+5+1<5_.*8: M8JJKJX-A^*]"&MY_O;[]\]L':18MYM*WW]]]_G0M75R^??N'?OWV[?O;]]+_ M_-?M;Y\E/'K>XNXNW+%OWW[X`']V]OO[_]@7.I M.%C\>1GE1@XFT>1"RB2OY;:Z(S->R;O:`?V;R`FBHCHXL3L?Y%Q43>E2^NP" M)TZ`%T_O!DMFP;P+?&_(ZF9/*1ZR:AFRH0\'TE?T M=<1!@,8,^07G3WCA@(7\'(:ORS+)T0L--H2_0%N_',76Q5D++5Z:*?5`DB5& M[C0VQEQU#G@%3MRI!V3_-SP"6^/""=PYYK@'?GQ/MZ%X`BG/0B`C(B;L`%0& MYW?_"?-%[YY*H!G*3R*]>.&3424F":5P/(,/<\JIS_D>LBB.P#WWXN2$P@-# MB![]1@X)9RZ.&6`5LB`)X$_P]@,/]#RPE)J4VY.\B3PGE'J,)R7.0PXB";_R M81,6`C-R;A`)5,FQ)Y'M7\V6B4#X4+9>6=D=E(1;!=*1Y3PLU3ZC)*^PG-Q(3^?#/^0^$H+,\[%R:6BZK'!? M4<*PZ66"5Z.,&?(=0PO./Y[[Y13R+G>`IYV5. MA3;A>2)7PJ,45^).8I(&3+E-KEX54[+4@6DJ^2P@E,054&F^"-,1IG1@C>E` MM;J:!!H_DY#GSL?$>.Y_R+:I;)S80RC7/.$'(-W763&?S?4YM^YB*[-WCO-=P^XM%&4]$R<(6#P"R"#-"0G\:/=*- M$-K5N`+D0UQ/:,((D_#I4$='6-Q:)J3TR0(XH?ESF(0TZX(&Y MXY'J2Y_F@--%&R`Q'DPYS$!HO,1)IU]_>D5D"?`>(-#9!1+OYG18::_G+/U/ M@A+OQ9;PR4/Y^"JNBUW3A0JT^UL\M_M30/[P][Y\\%-,6S$%EBV@VR/.P_4X MJP6/*L/..C&T0R!.. MV_8?R+3_.KT&/?]!6*)?87OY)*QZI%2;)P\KVGJ!$&W@RV'^A8X(7Z>?_3$_ M)]WZG[P0K(UYUH(/\6[Q'`%.CIQADQPXX:4_+>,K7#F[CHM0'$D7<$ MVBW`VQ?2FJ*,6B.MC$@,;#%L"Z35D:T^"^D_A./^4^:WK/Z)?&I#%,V1-E#M MT1H!)RVM#?,ZF^-)J%7-LD;`=7-HKBQP$<0=H:?O!+WR+&O0TXQ#H6?L!+WR M+&O0LTQEO]BIJ@:[I6Z@[]MZ>@$^H>&@.I7*6-=@9>9V[I\4SB>Q6 M&Y\X;"0&_I-L)/C)%),HU=.L1]!X+H*HCI);J?6XYIXZ/MJZ8J];UQR\.0JD M)AFWT,0V_(T[=`C[QB?V;4,VV0^:KA@C@7(CD'M!5]T)NN59&M`=9@M\6&QU M4WD^LA63-.!JF>;S4`7C`NQ(QC`N48QLM7GPY02ZDJ_/)P@UE"ZE=(TEOL@G MDSF#<1OV@XUC[L";3MTQX[=%YF@K\WRYH6(JTN\>>JZ^.<%?TA7YF63I!HZ( M3$*?NG3CS"/IL_,7DZ[AV"A+OT?.3+(-Q1B24\L?C^,EKS(4+M%A)2ZSK;XZ MN>R876*'4B*FO!0JR),XI3U?7(A#GR`'Q;.>,;O8'D2%J%R+RF42D^(D`+W MQ2(11.ZSHAJTSWS7!,;?I^8/[A1>6(P*-A\CAH. M\$:;ASXO>1R"/HLZQ+KR4^Y][3KJM"YR;.4G/W`'G3*0#>5$]=7P1]_-><," MX(>K[ZWK28L;0S:,83>HL^1?>O(E](Z,I5R.@0?E!4ZM>D>LDE,HB7ZYC4ONWE-(GNF;8'P MG4_;L+;=:YZ=J=;&_Y[SZ]\X.]P[_)2H.8C1@?].+,,"Z!(MVH82-LRUT79![?PBV6*3R?(TD M+S]\9`)::PA8!K<%.;YZ#/UP'QG[Z`>"COP>:1-=:D<=D$`K`3I#S>41;`SY MK2A7G..(C*9>_*H,U&W)6$0C3U1Q`>;K]'Y8^C%H=1CTECW*=.3P\L3[LN_0B)ZO=4%!I M%_ZMM()B-]PXW?$O"_Y555M6M0;_\K.MY2.NO>UXL#M0 M'UZ8+4U6FKIPGZ,L-[BT-W)@GZ"DM_5F/]\;W0EY6N<[/DTMT2&/N-`BIK6! M.;!YK.-$]$JMPWPCA_>I:95;O&N^I5K9W,/>70'L??BM#Q"V(@_UABCY>HVQ MCG$ZK#&:O/S;./:?[2[*.[`J1UWA=99[JLCW[BE[1'A@KQZ=8,+OR>)MPH`W ME?F*R;*W,\?[RNO(<;?M/Q@UH"4OUT%>)2Z+&H9B#W3#V/"&Z>JP=7?T1H:B M9C&`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`>Z-Y6.OL#;J1\9" M$(659CB<%%L/)ZEM7R56P])\FIE5=(-/EIAC*X5HVI9JI6>+K=%H2\HMR-%0!_O,'#YW(\ZF/&_2'=AN.0"A M/B4=X-;2)WE2V".JHG/>>8Y)4S')NA9FN@F;91N2)/`>BA*6M@-*Y"B42QX*W-[/6C#VDRKI0/!KH9:PBW'H.6--R<;IVBU=!:OYU70WU@ M^A2-GJ(^?J[M4YZMJ6N-N6=ZM=GH"@\>3I.OU'(>6G8+2K3?WIY%`,-2GXW_ MZAQ-HF,8IMXA_`W3+@&_@P2UE3F+!-E!;MH>2*%D_]MG-R=;U31U]PRPD>52 M/>)X.D&U+76->OW`])\)FBD"3-@\>UOFTVB\P[WEJ`V^.#MFR+EW>?OF*6I=^G7X+ M_#%CD_`C`'T;N/?WU'SOPT,24=QJI&A3A':EV5;P7]D MRM5TRMGJ,-38<*=,.W//I,LW!?P6N&/6CF[KAAV4:%79[53MR*PEVSKXFVG& M*\W?!@Z6N_F'/X]%X\-VCW:!H>H)4P%P!3'X7G7E3<3MN@DHO$^B6W/6[;3U MTX?N\SHR=654HL%:(`]$AI(=^.P]O8$JS]_-__"#OZ9^,&;?D_;VW[%Y!6%= M^=->5[JRY%EB^U?#PW&9,/?GJP7S)IC1\G'N<)=0X9L]%!B;`I#L/]^NO#R# MZ9KWR?[HAF-G_B=S@@_>Y'U"X+H?]P#I)?^1PUKWW@SL]_Z8[@+Q1[@M^Q&^ MX^)0^^L>`/_X)X>Y]IUU0"->=2"GO^T!8/R]"N3TG:L`YT=,UP[M1\T_>A/WXO^R)`*O\ M90\0XE8\-)2A9G$X*]^[`K"_6/@>'1E%7E,)*[L]8\1-&8]*NDE0QVM M#=56P?_HSEEP#1)P[P=YMBI\OP=@;V`%X`U2"IZ$.<&.]Y1'H0!$&?)O\=W< M'7^<^TZ4@SOW+;W8J(?GYM3XJ6[%&V)FQ$JHRP-_9O1MB#O7ZX^PZ?K/.Q%.,K@HYGM M14[`5R7/X:5?]H#`%S\/9^E]94#_8//Y__7\1^^&.:'OL0F9M$$.X)HG]@YX MS7LY`G%X>>\XRY^OQF,\+8??G"=J>L_%F-MZE3^EEZO7\WGQ,G9K/M=&NC&$ MXU@SB+M`8]0"C?S98;0!&JIF:J9N;X?&=S9F[@,^]H5%5I]-%(T;=";#(1)8J_.>[DDW?M+-W(F7. M@JHAV0TJ^UR9D66;(\6T-T8%>S>B=9MUX:8B"^1?N&'!`W57Y9BU>;1*5S^[ M9DP#$9[EA=@O%0X6DS.PDWR!B=O`6$>"\-:O81U>K0/M0=@C.?>=E"_&!K,38 MOE_R(K3R::Q"92[4LX,]_2IL*@L'WU,U6[=&^F:JZCEXGNO2'2,[3+,TT]AP MF^G7KE+LSMK(.HU5.,4[I^RD;_[< M'3\5^_:M>68/89^SZ,K7V,OBELKP?V&/TO>:]@/\B]L_/\,WN.;N6'SWQP?> MS.+.GT]VW/(BM]*2R%\+5\KT[P[%7<"N6PGP?S!IZL_G_J,4S9BT)":5_*DT M!F&Y1XSPZS$E[,&W3@[5R)<8QU9R0LGUQA@8F0P*Y$@>F/H!3?3$G""4F#=A M$^D]&S.LL"7IJHS-B#3)\2;XARH]LH!)KW135BV;OGUEV?)0T64I8.&2C2/W M@Q*E`0XS\'B8'K=LH>%`-PZ+(!Q MQTZTIK\%QZS5HX+LFFX:>/YYUM&W8I+&NUBF, M6;0NDN"(AX`M:?"(YV@L*^''=]$TGJ_F?11R5#89L?]D'%4MDZ`U<(>GQ#Z3 M1$R]F.SR#$HL,#OTW\0T7Z<8\'KOAC3R6\`6;KP0=R#6/'58A3`R5$TS<_BO M`V]_.!],`^B&H@^'G<#9:GV!M'FY-[U`JEA#3>\$!3:Y0MMNX;>J!(Y%@4]>Y'CWF.MR%89,W%1M?N30MW15LU;G ME4';!Z8'V^"?@ZD7N1-W'J.O\(:-X\"-7!9^^#&>QQ,VP6(`>#:((S'9!R?P M7.\^3&[,\^H!G""[F&F_'%)YRC.$I:NJDK`T.M\\_4GD"K!J;$N/D7 MMJ$NU5"U[;PA4@/6;C%3M\6L/+`)LV$Q@;(=8JB2/BV6CAM@+.(:PRE)EGWE M3Z=YMV`K+`]8STLML&0E2!48Y3`(4ZZI@?CY%]TLVS!5JP1F*[#VZ4XQ3$,W M[&$;L`H^H?PW>Z>=.@0=I>IE(*N].BU@W2=!-<,R1P67[3I8TSZP:+S._3`. M6`[NBE\%_:@.MFJ/X%\C!4Y2=E(KM4&?U"Y%[63[4B?/0=O:)=K5DW41;6V7 M:%=/UCFT"_!MCW#%-'M`]9T[GV,P@O<:SMS/7*/7_KK_Z(%I&59.)=5"LCMT M]GN#UQJ9P]'F^,2AZ[$PI-9'/*T)S/$QJ&7G'IMP^U@K(JD,&Q;:/&TWE%I5 MZ6B(`O<-U37TP$(C"EA#8I12-:Z^U).&I9Y&N=2"[4"NIMA[%HX#E]J97WF3 M=T[HAEAQCX4X&WY;3(K;?%B?)[>_/+D]YL1]\2,FJ=*E]#6X=SSALJ%4+EIL MS"7++_?)I,N]"WQG,G;"2"(!\1R^M#)\'`^DUYCC)DK*O)$`39X\YX7^W)U@ M8%I:.F1]CODS2(9WGZ2<((;)3.\^O9$E1WJ<^?/YTZ7_Z,'@,.W1)A,I"030 M:])[1I>>D[&?WO/!(^,GJ3QR-6FNLZ3^)#WRQ$(_6/H!D<_UI-\C9X;_3=,' M<8\@NL#J1/$2Z*@^1?@,(21]=OZ"Q78C6`R$:2#=9HLOH(`IHT=? MPOZA(;WI$K'ZPN#+X"_^NFL?-/7-4W@ZZ_+5D[Z.(Y](CXF;F):9XWOI]=2' MXW4P?Y+^PJHSF!SZV0$2PP-\'8$2;R0GV42!('=/L"QAC`FC(?G84"Y<..Z. MJ2064`'WCX`MN<;`YT;V3_@0OC?RL3P%HRNKQ.Y!.'.7N$SLQWB&75XI_=29 MSY,1+E6;)/+[N0)A`$G^A7Q!28$[5!21V-'A*00PG"9%;@K8`[R3<92X&,L2 M_!BP,4\\3]0?2;LL/;K1C-!FE$8;,&)MAVL+,3_^(D@4#*0/TRE/>DWY6=6) M](8L5`PG/4=W0K3SL-P3[HZKU,?4W49%=DJ\^)L#U+#SU,!PCQ^`,7[YS8=# M1(BB]_\YB^7?_D,?_2V4OLT=6HKOS,_O3;B/]%<3+:/P$5(V#:"!=<3X(8]`+Q&1N.DFV\Z$2!C9%_4]LGF<8 MT-V;Y4@798ZT/#`=O$B:QK!C2.2!1@1PNX7-8+D,_!]@$48,?C1-V1X-9=4: MI1Q/`*$0/3ASO$6!:``YY*+8%:>A_86+5")^-.AT^`G"0 M9&?_&L(:[O?&:@QT)03_Z"W210)L>4?*[B!L^+`X*MFL.F&$GK M5KPKLS3E+0Q'>NZHN@'4AR7/L#5YFIWV&Y)'LPP[G^.[*_I\3"0['0U<^!G8 MD^5\3,53Z[-FZ`^P)WR`Q1,L%D-94M-ZL?#>_G#.R.CW:NCE^\6^T?=CIN'P7"4_?!=+;E2VNTTO_1XGN#EC* M(7R62(U)5PD1I4ER_`"3XK]C,.LT;DV/UBR'M,PM^N/,'<]PK<&2F*QP06'8 MF`61@\8(F[/203QC19CACM$PK-@+X$5@5HUL57J=LZ*=])ZO1(G_F>4#1D^` M:$[X\0@$`+:+(&?S>/P,CN\!$7#N@1KW6",<[S@6;%Q-!G,KF_X-/@$V?]6< M`0.\\J"L'$'!0&>7$3""M'2>"$^8[96!KY"MH9*<-FJX_P\9TR!].Y'D'KD,5Q)>[/F1.R:,F&A$E9X!_66Z=*BJ MQCS6"V,<]`3"@8D$<^X\AG!\P@\3Q@D%+,Q?VP@_IO_*-T%_E^P-@*\D,,':^,_,I+83/039+X"`#GO M20#*)9B@5$Y!ST09@L(I(X@#4/)S$D@O^:/(!U@`)7U$G*SQ0`QR!UKS!>\M M8*;[Y0TFY-EN3]D.O=469*U$8#IL@2#@:9-YW?37I-><:W`W)@Q/"H# M@SX*WS=P&IZ=N:PG;D?N0(?A>5V>.()S\)-%(;Y-98+.XK$W@1&YDSH*[HJR MX%SV4OF$=^SCCJM'OH^0/BGM3.3!774OO5)E53-ET[:1K)P]X#O%&LJ6,>+> M6-RT<)?W'YV`RVW>HRMV)BP@8`YE.&XG$874(Y)RDJA4,$#_9\%?DH/"#S?BCR$MW/Q`V,C M'`?`]D()`M?/4P?F&/V4$J`XX;H1S+0X\4FC"$S<<`E*>B!]S'DA)?'X"CC< MJA>MFE+QGDNO=%TV`5HQJ2!_YN5,=OY7J@F0C[1$YDG!)DK[WB/CW7]@')*Y M.TW-!3YCXP*>H'"HVPF'9=NR;FL%X3`T6`'-WE`X-,N0;=-H(1UYYBURP2M8 M4LVR-UU[=W=+7_"@UTB2NC.OYK.<0F4/53B[\B;XGP^9!_XJNG:"X`E[S:55 MG%H]N?>L(7UDZ(:6)T4+J/:/\GXKT*N:978+98IIKT=925`N/[^N%HNJC2Q] M'\O,2VQ]$F=T$-&`RW8MZM4##GOIZM*TK%'^JNTFH!Z:*@?+L+_$LD.Z-=PC M62IJJ[5ZLG>\GTV%-5QHGBV#?^26_&2,/>YI"5T\,Z)3:8R(@%$T0ZS$4?3. M\?X*^<$4W6+HP7,!5?SM@8GBAOQ`#3:@N%;&K2/TV)#7+\33[ARL#EEX4.D] MN;`^6'!18U:!L$01%OC7'+.9^6%#MV7;&')[<:2,9-76BN78A+L37D[N//+* MH#F)AD]Z#OG(@`)P4GC/ECYP-YRVX&=\23X_!0]AJ8>'0_1`H>XH<,<4JB?J M92<@61B3::X"IF-,Q"N$QXKRQMZ[?`Z>MR%G-BB=E9+CD;"4,<28FK,`R[V3 M14+PN_PA/PS]0/A*'\@[1D9IX#)O3#ZEIR34#T0*8WBG.*2)];YC8*G#P$?N M)Q3C?3I=^30\!!YSI^X8G26@/($V4N"&?R$/C1/I6%GLDQ&/Y%9.YB429V80 M&LX&PK&?N*(9943AZB1L04<:DA>1B$+4`."=>^[*R4L1R=AJH(!3="K!4O## M_\*'XT6%%"9.P@?7N7/GXH4A\DNEGXN[T2<^+:Q8:UF:^8^8.2:GKDGN+TWP M?73G\S1*ABYC@3)PWIW(J$!IQ\\)$,`K"\;X,_[=7'`L/4:>-E877'_SCW'V]B.*K2*CGS[+04KF[Z;1Y^.?M^G2AO+)M8.]>=/M5MOV<6 MU+>D2RG/1-RJ0-:"?0>35[=+27\FW"W6X!`.X'TO`8K:J9$V_3OBX5$.:8&P M$1'6`\(&E82]`-@#,'WPT"2-V7P>+AV,C*>?EVCOB,^/[B2:_7*!>7X7$N'P MR\688BT9P%&`_F3Z*?*7N>\G"7Q_?'I_^U\_2Z8^&(U&>5RKJ.UZ<]@3-N26 M-N1[&TWJ8=.&;>&:@@*_G#H+=_[TLW3SM`!.D#$PXT[W8[G4<`H&^Q?N9.)7 M[8@%3'=/[549*_B1VX001.*[:5NR:AEILCV&P'*)[S*/5%#2Q2M-T^2AH?%` M-<4T>%SL'BS;)_*XIKGMO*54ED)%)A1UU?J.!EP\ MCC@::>BMD;YOHR#W-TKE=GJQ5RR]8ND5R_,4BYS3+,;(HHRB[!I/6;GD=8LZ M',JZJM,)_=$G!TD\CYSD@.5[>![*;JVD<:[7[AM),Y7\FWCD*O6Q9%JKJU5>OOGKUU5'U ME0L^8X:)9LA#TT"%DB9[)9>XG%P)NBSPC+=O*`V"6FG`:W\F)?7*L"S94JR\ M182]-,A;1$F6J$)8\#"-V$89*1H$C;AQC[FN6"S;.FOVBPYK;<9GE M]&:HAJT.-J@'5EF`JWQ_7AK(%\[0,KBCRT%)R6B2[K^5CTAQ`.N9I M@Q/VP.8^OX7;:Y->F_3:Y`2T2478PK!UV;;L'80MAB-;MH;#G8W<+NO#%KJAR#JHH=V$+9X5;4"E"*I+?=&AAE[K]%JGNUJ' M:@'CF48K>'9%O5,Y$6VTE8:V(6LC+2DS'<[`?+BD^BWDEZ%Z&J*B;30+_/A^ MEM:-IKMJY-/.';M028BTLC!QBL_)M1U*HNI0B.68\2(MEK/A";"\;E,Y,98N MOU6YT$DO"'*$H#)CHP%N*GP%Z;9)3EQ M6!O*R\I8(:BB:,,`;]GE2PXG#C%95X9@C^EU[RC3IA1W,'79'%HU@^7T^"K& MTYTMK`OT('87H@`9N$%:C8J4$QV!!UB:!>OZX.R\PE2Z]LZ=C_>_J!0@=3PDHMHPX;,<_UF"SC='7+:VU@?+Z[=2P:* MF6GERH`QOM)]X$!F(!=*;88,=U*?-];@-V@==&(`!G&BMA"/M-PH*3K:+T*Q M96:*#J]T^S$\Z\0AOYLB.1-4$^+B`VPH/"`M<)+>S1U8EILQ4!.6+#%#%OZ$S1/SH0#6H+TO*LK03O@K M6?B)N-F<4B4!![>3.5U#3I>15[/G!6,+C2V2]B#Z4).UH=;`=B]A`SI0RI=I M/#/G*RE8Z_F9[>!2Y79>7+9<_:ZBZT6Q/,5.[ZJWN4N^>EW]=T]4M,BUKJ[X M?O\UN&S;*%7=*8'P/-CW6DQ+&:FVM@GP:$?S;L$?TMXYM,8<;K&33!+EN?2S`YC)Y"AG8L&^H MJWD*;8%'%TAHV/9`U6QS0R&H&MA(,IU(IIEG0+&1D?+)9A1;&=A(,>H*:>HG M3#"@@M&>8*2K-%L,VY9@UBESF*90JQMC:+8@F#(D@AEBF%(YL)%@V.)FH)PR MO51%;4TO;-`ZO-05,6P+>JD7O\+K3IE>"7]9V_)7>>`Z@=0'P],62*'!M&TU M6'G@V6LP03!]6X*5!ZXGF'[2!%-5[!:M&UH;,TR]5/1+317#J@>N4_GJ::M\ M1=,);;TUO7AE74T7]"H/7,]@RDDS&)[*4;"L]*1C#(>#D=5\4D(^L\1HI6G\ MN%AO'GOIVJICZP-=4RB6-,11GA MOYJ(IV/%1%)Y.%:I'[V>="=]6J_BO+4>HC6:*F6V:QA_[N*JJ<6C08-GR;I$OM/$ M**5JW'I'W&GSFJ"6O26U[`VHI2&U3MP-)\@UVI)M MVS7U`^R:7V),-_@ZO>$-)ET67E/;X7=/[0G7?H[]1F)N*#6F;'K80SB:K2-D M>Q2Z2-,]1FLJ:6IJBJWKZR*HITW3/49TJOE4U>0K26J9NCE<9\V< M-DD/YHNI)+!F#,^=9P_F9JTD,/#OF1.8_%E(("MUP&S@!JL:N(YG%>7,S8$D MAP]V][5F:E7J7GG<.F/@[`FJ*3H/5;4X)6&(:BC\/GH2HJH])54+O?T2**H1 MJ[4X22%%[82BFF#1VI-4S1G@!5#T4#[*:JVJJ4-S753AQ`E\*"]F)8'/_Q"[ M-S]G/3U?!D%W[@I]Z03=N;.TP5!]$13=O4/U15.T&,_>@*15`]=9_R_`_#]( MKE`E=>V#*]6O<11&#F\&74N]W$.5"2UM\B";\EEJ\B!K;'MCJ!AKB90#^=!4 MP&\5\EP^BQCY:=:Q31N9/"I%3&VX"XIDTZSCDE:J?]\DH6-6^]2;\O%L3>I- M)>)&%_`^Y*W2ZN77C!%,M3Y)'U@CT8#D?/5@MBEO5LH=A=IXBN M[((BR2SKU(5F:<_93/W%PJ72(>&5-[D&B.$1YHW!)N&TJ/^]JFS`C]#]V7/G MOUQ$07T7@QV+NA3_#I+]4=*0'S=84^3:6;J1,^>\\IU1-:S)1S_X&$=QP#XE5>$2Q#<:)9;, M&`VU`6JQS0(5J\/6Z;ZA85OYNA&;PEM+I&].\#6XB;"LYC^P!LTW%MSP`C]% MLM0]M^N*&UL.U7X1W6&9C[PASSKB*HYD?4,WI$J+EWW=>`Z4AJE'0 MUO4@[1:W7=9(V3MNGWB]QDJ\^&^'62]E:`QU6VO"B8.S&WSVO49#FZ)EM MC:F28$JCML+44(9H$Q]G3;N@9]J@1UMC&27Z_3MGCA9FOCA9W:]9NJ\U;),R59'NNS*PJ6!9V0-= M!]?.D#,W0T[=A%5I>M?.[&_YU';`)O`7^$OC5_DY<9=5S M(9;)%$DO*OX3^64YLDHL^:LH!OC^Z_7MG]\^2+-H,9>^_?[N\Z=KZ>+R[=L_ M].NW;]_?OI?^Y[]N?_LL`9FD6SC+ARX"Y\S?OOWPY4*J."W>?G_[`^=2<;#X M\S+*C1Q,HLF%E!4>K*@5+$`#4SN(BI4*]U'0\>;VS\_P#1[EW/'^^_H65AD+ M`.XRKVH;4KWWA1.X,!JKV0;.A'I7H#Q15POF/F`A4BK[CH4P/3\` MT831<<#;8-QAP506AE3+EVJEP@SB3;RABD;;;&4A78^R6`?([?^+#6#"% M>27?N_=QBQ;#&5:+=7C#TZ26:C()%=U<."X5IN6U=5$3\.X72S\,J4+P'/Z` M[XA22#"&15R!Y'`>D7FU]CL&WV&!75'2-:!V9O`V6%CGGFIOY@K[8KWS<<1! M6JWVV5G^R55GKRAB*A>KF-**8&W@M"]`0G1>QSCK'@D\@UP4N5&,!9QM\R>: MQ![])"?K%?D@Z$#S!^;%#'@$S)HEK_8^?P(^F&-AXZ1]`>P!+K&6Z%[+B\J[ M8?;^&>\3ARWJD@93P)]83S@;!42!W8%77>:]$7YSGA(L=2$7L'>`!0)_)PR; M-/X=2+][5/7W$0O*([$BIT%^[<"8`8\._['+6*+:82 M&L#@^1RW."RJC1*+-AZ7W[2?`#X!)N""MW$1`K:[ZK+U.]^:+?0;"_`+D`NU M>@_-/2#V04,UP?C'"PN:JN-?F*JOF<9`5VUMFVUUS80YAU-@W7TZN9J=K2"TZ2UG"X!WI]YSM%C@[BFP/S@ZV.+,TH(RA@ MV1SP@RV,:5NVI:BM`'_/[J),`UPG/9@^I7;VJH+;;(@@>S[F6_"%;;."#9.M MRZZT#=4JG*8WP^;XQ,LRK#+4GTO#ZCG7>?"L4NSC]"B99&;MDI)5&!;=XQZFEJ:JZ]D9YCEHZ_#>E5G:]/$E]WO!Z M^:E1JU)**5%JMT*Z,N7:6^3VR6\<(K\JCW5#9L]6=%U]PRI==Y+^LY8<65KY MUR6YJS8B9MWH8RN_.W_+(0A75*IZB[$_.$VVHPPOE MFBEG965SE4'U+$U&;^,>6@'LGBAP./XH4\`J)BP*'V_!63J2VH8VT#E`@ MD8(*`SNKL[&M4*R9M.E$VQT96=F;U&R==[`/%68[`:VA*9JYML)(CA+#/"72 M6@Z:.5A;;F2UV=>S*9!U9DL;LZ5X5_S61Y?W%UW>8R3Y"S8;-:5+^B.4OCE/ MU*#Q5&*`V/DS8!AV91/>A3,)T7F$SY+C([T6_::IV_($N!>9_DVAP3.%$#%, M6Q]#Y#VG,1B+@=GPYR8RE)Z3#>61=X`NTZ7Y`5G:PUR<*A1L%MVS-X#9PFHKCY_^OL7(=HK3%'! M"+T<=)BC3E8.M#.2@WS7Z2B0[NZ!I?S@EXO_&(\9FTXO\FB57R3VO:'UTX4D M?BINND=.LWSX29]]Q^.QM[J(6R]SIV-EJ;(Z`J5NJ-V@4Z_0SXFYSDNS5UGO`IDV M\::3U?L?_A6[2\P2D;[%P7CFA(R,_!L'[/BK^X#Q*]E'"[\T+GQ!!^PFXI?+ MANB0;!\2YE:R/U0465'V>'S?,A+WC+VFY^$7QL/[W+\.S+XO[[ARBX4N^K/) M"9N/MFRH0]FP^K-)SUR[CUS)JJ*!A7*2GLS^B%+4]9^Q0-!U'`1T2L%B#K[7 MGTAZ:ZX@\:]!W"U;5O89O-B+5?>FY]Z>>U\?8,,Z#/>V/XK4;%W&.6U==$R1 M/OO>_2469SS2KM5$TMW*/;Q)FOCQW9P=7O`;HIX'A;5EJ%TW1K)AF`?E@M-T MH?7LVSGV/:3O;,]\F]^PWM*EQ>SC?FZ:TA=[O#J[X6V+KEZA_8-)S+MW[@&) M;S-W[DS8?#ES'>E=X/_%`O@><`N6OJBW'/E2X+@ADZ:Q-PG38K14Z39IR80U MF7/D6`('PF]^\,0OY0[PE5@<=NPN*<$-!^+%V_*#24%:R;F_#]@]/(MEG3T< M-I<<7M,=WA4O$:I7)D9*\/^EUQ>T-/DEP4OKTM?IE,'X^XLW`^F*:B^O7O6E M(L$/'!D`C<,!WR!\-9"DUXY?Z;)B[8W'\C703!H74O.D<5H:`/$:,[Y$\]"7[K'. M#.`P`_G!^M1833N%YE&4H1$+)4W=!WZ76IJ[4WJS,_Y7[,(+^!II8H'HI5GQ MZSQT>".;.>.9]$H5#\-35:N.4.31%*Q5)'*2+G_WA+6TDQO)2"#*,8NBQZ-$/_CJ=`MV?/,[(*%A4V)KN'Q))D#5HG8C" M@H^D93XT'O*>PK!R27B?1I,(U/#V/,7\W8\Y0L-6K49Z=V8/K MQR&01JB9<.8'O*X\KU#P^H:Q0JK8!-%R[S`U^,Y_8&]0FE(LQO58<+A@P>!3 M[(8S`5MNZ@$\3=\!.HD"]7SO MS_V0*\])@FVJ-G(*0I?MM&E0TNV08/!NS@/$'O<.=Y?^*HI8YPC MQGX8I2K+%T0Y*?FYBN]!,602E!1Y!Y9QYIQ*^=4GYFG+XZC$DJVWS(!"H5<) MP*N4Z1N64VVQG+*$-6$2@J07[)PB= M.WUJ+#LCK`PO1QAD2-#WB9:&A0Q22Y(H3<85F@,1=HOPA6404BL0F@D'B#XE M,`:-!-AH8)G!_L#N$F!7.7?N'#2K>#79GI-DMYLX"))X8<,93A_Y-Z7M8*1[;/I".@SV5'P?FADII'CT8M,Y=L*A M=\RHIPN,2`\@^/4:9$CEXG/H(,B;\AFKNV^H>8^`#MCV>$G0-B4@:K^),,C\`SO8@,0T.'C M-1"&RCJ]05B5@:G\#1_+/_?@`\0I.JHV&B@V3?:0>XB,30:B]N2R^83/I2@_ M_8W$[S4\*;1M$A1",[WVXA'0E%CBL>EMY&/(SUXF&;@Z%Y0.GHU/;# MOSALC[<-+OMWE6R[55%?/>F&+2-A*8]0L2A6E5]ASJ*(FYID(JX!A#C M$'43^R'T%)IY<^@I5,&E5)$'=6_%^)SX2LP\1K M,I`^1:2$4#5X*72D4>(2W'!2$%#?L:1)&/>>K;X+)1Q-U<72\9Z(O$);RMQF M31P6POOY`4XCU"$-6/A!$+5N"7-H9"ZA!!]$W/QI!1[\&E2R&R:=`2G`$A;& M>6A2X_ED[E`#/73GY`XUZ;M63ZK">YB<56$W2'S3.7<4D84[2N7$#(P"T-I( M'?_1XRR3L-CCS(=]@5R$Y)0L>KG$,@!4L!(`+8@'W^=F[B)QZV"ST'#J-DUP M.@;(MSC`\$&4&`AK>`!W/6";$*A=-+IS',J7`O@BFL&X2W),KSPDW%65)^!, M:`/L=13B\4[LV(GHI+WZ0$A`AOTJ'?4WO@%7PGA'E4?1QO(\[M+,[]\`!.ZY M28P@9`OWDC^(OD-/>$J"AN-WLJM7OAR;$.:^X[)7?Y*GR$$Y5,`)!?9#+IR0 M-.R$Z:;Q?'X)N(QG+**@S^7$G<=1-KSZ,"P,"+0U'M,C])IUKA7MUU?2'ZEN M>I?[^SK]FU[W/OWX)A&Q>U1832^EYIJH:0H*Q!$=(G']Y!8^DBJ%B1O-%<&5 M@0QKS2LWP_*+CI'D7"'6YEXR"DNDNG8BN*BD&ZFR!.F*J3M'7T'J2KK)Q.YJ M3%*@CG2=5+HCBE.\QN`,7(",>7B*FP"23[5XQO02<6SB5(D`H-F=SL M!PO&;IB:Z66D.2EJUZJ*)@Q7!%N@`HFC&1\1/0(D3YQ+^-?%OIWR=@3D&KJ9 MC,EBIB!35&T+ON)AM*%99J@5,?4RJN:EU,I)*=^BWAT?J*%9!NIZ5T!IJ0+? M%"QMH!9H11P$;WI_?-!T.&%EH)W.(6JW]L+[.$CV8M)^E?U_E:'2 M81JT&%^A32]/U6$UHKTK.P1Y1/#&',M MYG,G'[B^KN!3KGQ(,_)G$Y46%752,C*G$1XIC4&<&DA7_[<#QD?P)*D<31LY M.:,Y_V[0M3VN%&0G3IP"<3Z"1Z.4S?&9J;W0)$6+AR=_$2. M7I-O*CW"BCD6Z%U'%Q5Q=9X;-3I>@A;GEB2,AM<$S`G%<&%P)W9V:G@3G\,! M$^:R?R(19!ZYXQ(15RU.#FST#28>=%YS-GCGM1"KHS@2Z`&E^">KW"% M#+%"&/"<^R$/9#D\>HGESX)X''%5XJP$UV0,G`*Q/7%X$.P'NV;%<-*-W%-! MU)GZ:)16YE$2F(FIFRY?!7,[12:MYW,9M_[T;)MM"D76S3-+0>\6-*R:I(3] MD9Z*U.+6(0Y)&9S4:YY[;.BX%[KP0YK,QU_#W=X8%,,TZVX5>V*FN:2APR'@F+3EI$&B= M&Z#2,%4&(RMGF)+=D;S3#9,1Y,F@.9YXI(6BW)0[R%TT,(/K3P;2QUQSEFH3 M`M>6IRZ90S(1"N&>Y-7<]RDRLRAC2)`*HQBP%*?C(]L\;FU81!?>`%:E[3/+>L7R*5K- M!2%(_+IWC#@#=@=&"Q.S1'XG+N:%,10&88`7)JC@69&43@&?U$66@L>%HRH= M/G.?B[D;=E+JK)5`"TCF7H(*(&>:^'=`4](I,@D:-ZA>Z;HNZ[JU5MMG&>:% MQE\5FTNF$;.T\LQ?#V>#2I=]I:\^B3VU?+.:O!GTT"L[23$^XC9VC/BW*'N< MA<%;%D!^&4IC]1R%OJ[56'AC&"US4F'"CT.^#["ELHLT>*M!>C72A[G4=4K` M3ICO#9U$XN1,O0S\,6.3,,FE`44T=3V'GY\QN!0OEYB`BC;E-6QGXYNGD!^Q MP3+$[%]N*R#W3QCLO'YV"P.%YYYY<'2!/=`/*.=W+(+X@-D2CH_A8"6*F+X] M?PA`JA!O;>>9R-&'$V_E,:`R*`KFY3P.&.%QPW$V2LTMJ`](=;@;Y.TA<,+-;2((L MI`[3]PF_1Q4A)'"1O"R\7]@FS,I>\! M1B)9'&^HP;=\VQ*KFD]QU@U9'YKIA:Q_Q4X`3\)X[LHAWP]7MU>PRG/A]TG! M2]^"EZ[N\$@_8>F=N.)]N*(G=PP418-X[`;C>,&[H>-")Q,)SJ9T>-IW)Y/, M`D_YC:]7PAXY/ERQ,LM17@W.>YJLC8SMXKWFP"@$;?+SI^>Z2>9[67$MH-9( MCJF.6%U*=2%+/;GYDS(94"IW?PNT#+P[XHLD+G/AG^)GY&QWXCJ!R]TAG)'I MI\QV"'/!NC2=)3WI8#-8<HZ"2L2:AA'Q:E`"O%R>MNY8#M3!":G^Z,6:JT2%,SO!D)C0V MJHQ,TK6XWLFI,'5$KQ&[@?0!3T2<;"'+3^"N)L6<#$7!/"_2LX)L^>`9CSB" M\186]IRJN$,KHG)_53)+&I,B&S(?W*B/0518D'`._C1%/!R*EX;Q&(R6'*5IV2WC="1L,(X' M#X#U(L;9@V45!S82PR2),0\ZWQGO^/7'.RP'4,A67D5](/T=S!$O48^E]98! M'SJD;V#AB!4)$]SD++.9#DN868(+[_GD60YP30H<`:H;'8Z`$`Z$`6/#TY7NKT?N34OE4[2#38JL;Y30.R(;**?YGJGI,2P1>2LB_ M4E*A=+]*9`,5`,U!L^5&\=^QQQ*MJK79)(A3UNT/`1-^ZH+?^Q#;PNW**G"Z MIMJX^EB)6)E MBQ3'U4D\%NN3:NF")LV14.P$)2LOQXAT8YD$.J?!L;#.R*S:G0C9.+G3_5B1 MC%L=AEZ6/'3%HUK.8T:@9`-R4-<66=5W/[DJ7SUKU5%\YAN6BTV'NOCW/ MYRW,FP]4U,.KDL<'<6)\_BC3RXSG:SJGGLW`*7%^B M0=#EGHK9+'W$9;&2%:RF"043-J<8KP@7]C?M]/R<"Y_\BXISQO/21$*`890GXY3GCAP1Z" M%74"'D/!!2ED]_V-LC/R9,BRH0M4*'A%\\"V2JO<*T*(`S!8>KPA9G%36[1H MB2:+(D2[;D6JC9SD(%0([XUYY7R,/277:87-Q>-C#;Q=*GR8I,NL2&)-$G]^ M359314\SB_/3M,8W0=L:.@`2#43:K:QMY#3"EKM4F-G>?I!W-,(9%#Y)#[XK MEDQHR.)1@Q8]8+AH//A2X2%3Y&H5(MY0S_%"@^:B]:D^1Z:7"R+YG$D?6'G6 M"OZ.\'">]Z"D=N2$H=N!5[5\*AJ^J4M_XH]C(FQV:RH1:#X/KAY!`@HDB\B5 M_$LYUQ(=:7AIR^`O%HGTFA2I5%.F)Y63X?*J;'BYF`Z/Y%O-:!^4(E_DN$$C MAT:3V9%:_$U-Q MB)R[N9L<-ZM/6*(6BGC!ZF&J',3*O;\B;[PH"SSDZPA=124D<@E")M)EEQZ^!1E$_,05**"VH802M3'?X[=UFNDJ M7-D0"9^@>,$C!9NCGEV3J.6Q7$PR53GY$S)G42J?6;P-DI((.4YLM6]6@C.? MA,$L?>>NV:OB82)'0WX#L'1="OU(5R'=&P[C>6KQ8\CCWBVX&^/:>%&+1 MT!\.M+RAGQ-*7GN#,O\Q]R?V"EE9_#12<0_F,7<%A)(6HH!*FT\N*>!96A)\ MB5+N:XD@64E+)(;=63VUA2OR$JY1H7LKES:079K9EJ6"]W@EW6%G9:F M@#529DVUB]:5+O1"BD&NU`7GTBPE>@-(L!@,5DB@'#5,QLEFZ`C#R0Y!&D(<&=,PY(\Z0.4"9S+Q=FB5)22JUBR!3%J11%& MJE:-%X&KHHZ#5L?BVT<_F'%YV0T?[3`"Q\%[B2^#%GE]"+7 MIF3U)+?8$Z>.R)'*6RCYLV[>H)I68S-AS@1I%G)_6!H7)]L/SR%I#:5RSD11 M:K8L8R/L'3@T"F=^@AKA%0IMXQ?+$A4*\R:'*J&!@E6M),*_CE=]]"Q5#N_4 M-K>NS&XYBT8KG8V MFR[<&1#EK,N+1S8BOVC@X M]6>5K#9%:MMDEZ4L6Y%MU:J.&'IP9HA<)W57UJ#,37:$@?AYM2@<94]C43\1 M'F&BFK^@#H9:#35/&].V9-5JS!+/)UEJ0&!#HY+?56\2W33\>X\GMN."J$,X M0L`9.SEG9+T*DF+OI`^=\E'*#<6M!3*XNB0%S5=XDT!4!OQZYLF7X\6LG.:+ MJ%0"8:7^[LQ_1-]E8C,G_N,<&(6BO^LN\2JZ/.2W=EM>#J['[AFW>TEEK-Z> M2VXZKN#(=4()-99S(T45>?+G6V3'S"C)+J]0\."$N''C"^6:C6XQI8K) MU!;<$+;3E#6L5/`KE=[U-7$"?&EW"UW605EIY4+2[?P6ZC-X]J7>U+BEE"]9 MY=M<2Z=,)9OQ[5%T=GF5U5=,,B(R-]FD="]Z.8>#;[+3W!-_!BQV>DDX?^$OO4,@`H+B+D'NY%J)%.?M9%.;5.1)56_Y MB%@;V[Y3K+7ON\-7O(5&"+1*>G=A9@T_2J7'Y,8>?9VBUQ%*Y_&R3,4HPZ/? MEK+"W/18OCXR"5Q^E\G%EH8\S:]E[3B0%[)61'I+OE=<40,D4422_-5Z/+CO MR[JE)`XLT?&*VV>)L?[*$BF(!1=\868`8"1K(XU\E>(M.&7)+\_)J,JZ,I15 M4V^\>^D5;Z#E6J/E+0_+U&5S:#4VS5I)=*0`:T=]&)@_OI*FF6C24@`\U;H\ MR1DCP,I@6&AL*.I>Y$K1IIZ"YHY#9RS^FQM])E;H$05[3`O8MUM%A+01[QYW M%B6$.*V[6T%(;U5!2!]H:QN*Z%B-Z(56$-JW`91K\'@R-#E\$*60?F-GAD4I MKS@]EHJ*L9G!PR]GB+O\I02!$'?,G/D3KMH_X@XR-UZ*09O7%[DEY-DT=Z+0 M"KJPBP50VN!:5<.HKN>`:N?BMLG%O;0X1[E55!'PREL?Z;$_W].TOGLPW:0N M&SUYJNGF<-VM\88JA9;9,D*95[/B@MI'=A=0!63!+QHOOD)YT@!UD18XKE!G M)9^.3T:5$\S=+!V=O$Y@<[*D;OWJ]9+2]:<@&U>.C.2+.8KR^SS.D(;L*.C/ M?:K\Q'H?^&&8.>1YIQIBTC0/I=H_S;,3D^O+XHO*FUHY!I`+M2HWXY70_5'# M*IKQ'-;(!_?;,DE27I6B^EB0&VL4D8.;&N>LJV;B)">JK,_T^8:M:^IUE+F" M%_>!TX#-6PQFD80I8_GX1.41R5I;HJ-1.>2.#_"FHD27JB9EQPZP1UL10(1& M2@UL&>\AXKFAY/JX(S_')X%8GN^2'!?"T!^[ M/&NEN5U1Q)-=LI7,5;;@O(^W&5#Y%;T0J_X&/@NL3BF4FDSC4T\J<:LG=:\8 M6?.Q>C<#9FIB[A%EHZ94"2G)G*?YA/5TDOEUU(2A\E'T520H65L1UTH+_@DA MUYC]GJ3B9C$:C"\:FB6^'.3&1$PKF#4KE:>8F'!5D36P11]@7H=]924*12A239F>:LB626V\DF)=[PU4=>Z4 MW%-/X!6'7_L.V85RX&4RE*_O'<&;9QKMV@.O=>9I`],\H#/O/$5':R\Z5<8' M'6F:#N'K)R;IF=K^Y-J=5+UCG+5BW!:-YM<[]H[-2Z'Z;TO&J8LE#C5>5 M&5(&)&?)=57DDQCU^@+R5;&@K)8RR*U:4TX^*QR_R^3, MP*8.P$CG&],CWFN^0W[%V$?.5>5,'ARJ:Y5W_"570!AN5H'ON6/A5$W\.!.P M-]&E@.VTL;UV5FW9F?M)AW@L&N4DC17)P,=]4_^)'&LNCP10&P=RTN<]+?S$ M$>:='X,JZX""3.3B*%ZS3QPVCXR7K!HJ6;(Z/2Y22]";)"($\!C5YR57"66K M&!JO:)M>K,R?R1KU6%VN3:>0!_7BD+ M2JMU!"0I4&F65"&)DNKU%ZK[;^#P&]JRHFM;._SX\-[A=QI;S3K1QE44:EAX M_!)_7RDU?T7+$?LWVE`K)I2EIZHW5:EYHZEDTJW0\?]<7G[P)A\#YQYAO;RL M#)@D'_[S;1Q>WCO.\F?,\'WOAJBOXH#=`G7>(?%__=__2Y+^,__0)P^S@''N MG%OM.DT7^H8FORJY$UC&MD\/5$W1M(&M&M80_K:'`X7_[X+2!@&6[VSZRX43 M7OK32^R`<*EJEYHNABF5`V//Y:-^_\:"&PRJ78#\C=V%,P]_N=`N?L4+U47T M6\%Z,(*,K/8$&1)!##%L2X)@;XT.$T15U-8$495+H(FNB&';$$1%#K&[2P]U M-+('EJX;1AMZ:,@@>C),J1RXED&4@=9E!E$TM35!%.M252\530S;AB#$(%VF MAZIRM!!)VUS#($`,_5)+AE4/;$$/KC0/Y'//V6T M&:Y5+#?O\U11+GZUP=Y36I"E!/)!J*(I^J@U590"592$*C1'QZCRA0H1?IWR MTT_V2-A,G]IA9(8-UQHK@E+">-,YI0JFW'"]Y1(7Y0IHI0U-31L9+:A5BT`3 MW>#H0J5'/_K!/?:'P`LTJV2J>`HQ4NVV5.$6H'0ZW_1U`CX^;:M`69+9A2=K1-5L,4RH'-N&F'Y@E]W8* M6D7MP*NF%94>_JVET-9Z`@!%;22&-T_0&53W:8ZOH*8KYA%1TS5#'1AJXQHV M(%@:WK0U[&(%/XG"Z]E5I'=^$%"21I4-T/0X'2J-EB?2Q"+0"U9U_GAJ#-H= M3U?H8FAF`UF:,#@^KP(^YW)V(W5+#F&PO&\`.F%511 MI_[Q/8==2D=3`UT^BE7O]&D"]8`4V6/1R_X>:HQ4H]!E9@I&V"U?!2 M&V58I1D&2CU68$1:AU\K=;AVQ\ZB5TCV83YZ);;O)'IE5F*%CQT4*U`(&QUS MU+PEGRF5FF/.K_PX#1*H'P>K-C&U]5@955C18P?F0%UOBY78`D64H[`AZO58 MB=#(@;7%H?PU.^1&V.%9>#<`; M4.-;FB>[EASIHT+>;-"/FFTC8-=C(P,^6]3;LA#MSTCK,[2'#4;CLHJ M,`_<]AB5Z;W]\NT;H^_\VNHUM1PF1SYCX94WJ<>V]8AT793G+&IA>),??J@; M)9YM#>GAR3(LXO4C='_VW/DO%R!C;!M&::#2C\7<"W^&-_QR,8NBY<]OWSX^ M/@X>]8$?W+^%/49]^S^_?;X9S]C"N70]O-,T!A#>EFDR94%`Z&%J$-UHN,); M%?=T?P:[(WQ**^9]=-S@'W@7Y.N4,M?"3_S>!2?5\RSYJW:HDOZITIV9+6E9#_`Q2\A6YBJ.9'V"M MEH]^D*C-S>G9,!EQG]6.C?.)S"GG6BTYET`H<:]E6Y8UW)+D#4B="MV'`UT= MV1O1'7C:$F.5^M%KZ&YJ(W5KM;%/NF^KH[NP'581>C5',-L!2U71M M:#\;S>]8:#EFUZ))0!ZWXD][7S93U8N7&:N@V`42>UT5Q2@Z--HC<>O\N`I# M%H6?LW)Y97:K>:9J;1I.,]LLU4X/,,]%=;0YJALLZ'Y0_;JDDL_>_6<_#*^Q MO?;4#QZ=8!)6HUW__-XE43-M&Y/&5OFX!72')<,^95G3;4NK/.@\GPSPQS5\ M=J/"H+\S#\M?O\,:6]F%C&V&[IU'5-6TFUFD%9Q=(-->]P/5&%;:8KLF4_*= MN#56,/6\R3N8;NI&]:1J-WSO7#6TF^6M-:1=(M@^^^!3[8 M;]'3M[GC1<`U6;6]$NIMQNQ]U2UU6$.#-N`=AQY[-:V&>AU3;$40,+0FUP!@ MX-Y17T<<\6&QG/M/+,"B4EB7W/>`WD5* M#M=3[!PZZJJFC&T#2JD:X#<=_8 M'VS%@:%UVZIAZLVQ_^)[R\"?Q.-*E`N_'EAVC2$0IAK-`EB[P^UP4CLT%4/9 M`K>D]JZH;NO,K+S)9Y6B6];:E6/;O3>CU3-*L1SM\>B>P0M$&(#4E:, M.S81[2)PJL?WF1TC8ZUKJ--\2US[U;XJJ:E M'Y63A_9@9&U14+`\KFE-;:MX=?+0*`ZW1''8&D5K9,.AZ%@XYBX8HX;96%(; MQCV*]E:8$QO=\K;-XV@G.-?J MFV"IZ$D].'US+.WRQ:\#JV`%^,X8U810FE3ORL#&C?7(2)K;(ED>V+2OV.7H M>6LLT\/XUVD^F2R]>QM&(5TB>>>$;"(NJ(=I,R9.B.?-L7M']*^BZ]3[K]>W M?W[[(,VBQ5SZ]ON[SY^NI8O+MV__T*_?OGU_^U[ZG_^Z_>VS!#26;@/'"T79 MP[=O/WRYD"K\:[??W_[`N50<+/Z\C'(C!Y-HY1TNKI1?_RXU5&MLKOO)PWZ2?C"A3"GJ?'EU(_]\:C5M"SQ<:+I8/;D MU'N=H2A?FG6ZQB]N]A[?CL(];TKXM<"+G;OZ4-?<-DENC4LBOC4I+?F,V M/R7OBT_+.1^;`/I$NL%OD!Z&T<)YX4T=L[R>FX`TU M?=[N&_F&\1P#(!9O)9L,QD^>[UW^*P;TIR[V""T/!:1@410HQQ.- M`Y$>O'NI&'//D^>!YQ$TSX^D.Q"B'RP8NRA5,8`XEZ)'-@=`12=89QH)FJ'\ M<5&DWO,3Y'Z`%I9(]!X7S_+6V>+!0?9N,?*!ZA.M:@E\!?Z&@\/QC$WB.?;4 MQ!7`U`SI[JF&S+(4AS$A51!H!QX/&+ND%K0K$\=+;//H>2ZV'W("WL@^(2*! M.I!N9GX\IVZZR1I)'!I\](Y-L*C3RIU2]7 M;"[U`ITRE^CU!_;P?:#&Q).*;O)9,U'>3QXY2&C!DA+TXZ"@:Q.%F'0]!5T7 MT(0`=1Q*_XPGM($Z\WQ#>M&8$M'+E"UG1-[^/>LK+R=88"`&NXP+Y5OH5`_\ M$`=$GSAR4EI4-*D'HJ2JWL$!=ZZ7#IBY``*\'F&%-RR.`D#-#`ID@E;8OZ-97MHNIMT*V$,$$1$N.(GU,`*#(1^S' MF"W1KA'&36X8IFAG?8&YR#FJ\%6AI77`[T1P<\Y-2DH4!%\L"\KX<&C(MC6L5`)G8/2)/?ID-$X; M8^^/['A`"UK<'/,\F_!C8J'H>6FG%DO#2X7W%ILSGN<0= M$1^@G9D$`1[UL,$ZIIM5@5%SCN";'LBEX][/HDO$"7=#V!/7GE7"\OF'2Y2; M-_ZHB3@W5M`A4#IC)2J+>>G!IVCA<%%K-$N*YN?FMD;Q<)>W,0(W_.MR"H9= MUHX;;8VBI2'6%17#<0R.-@R*1*S#!G5.X:3[Y#(P1<O.PH;C;./&6$E#OQ-"18 M8G5"SA95:X"TG:`;C0F&P\T.K(,GXN@"=7%XX#+4Q2BE8A,58L(7)0$W?=,T M)I,S.<=(2R="$R1'P9`](.N#\/$-OLAHN/_]Q80]"]M-@+XVL>_1OB\+-`^(MI[0/N@DO87,-=\'BX=A!J=S/1YB?:5 M^/SH3J+9+Q=#Y:?<^X+LSPF2&:`""/UE^KAF_W11HV%*W+$60OXJ9['\FW<7 M+CD;1I-U`.C:3^A?1M0\O%6Q,=>N@VL+KN7+5F?O_(G>@`]@Y4T*AMP*3^21 M?YM?B6XMBGC/NZ_?WW_X?OGNZ^WMU]^0TB@TVO*'%/IS=W)1":=J_70"ZX6Z MHW%Q7@@1U`TX5+J[!YGT@U\N_F,\9G!XNFC%L^)[U/J=H$G3L>4[V$W2JMVT MCE-.EP74@67^=,[HC=1F].I8'(XW$3L_!O^0=YI*KUWA8G]SQBR@#)3SQM#.Q1K[^KV)NJQZ(KC3PXY\L"H+V5,^;P M]>CE&?PM^0K61O'./":XXH4IQ:=+GJ))'"1>'YY.P%:.Z457DDPNS%?*0!O2 M=_"7!5_":0!ESWU@\Z?.QV;^&8>1.WVJ8[L_'*Q&'9U.9.8/ULKWW1"9$6&[ M1X%YP9,M?J90G1/FLT.XQ]`I1256`S(-L9CRBY,I5W)'"HYY"CXF$6,>+PW3 M_`XG#'V\O)ZD%,SS+F"9,I M8I(SBP:DPM2'`UY".$#IPP%].."4PP'&B1"A#P?L(AR0/X9=??[T]R_UE&\% MX.P(P8XHA>T)I@V4-2Z]]BZO"KI6L_LSJ(I"W06J[B/JT0MR M1D-S,.P(N4Y"C,TU4:=-]M)>C+>.[?02G(NF:(/AFFA*+\1%BID#O=^,]R7% MFX6P>DG>,"C6"W(?9MMCF&W%!?N,.)N>QMF&&\39SIC^WQE>$@QY.),ZWF'4 M)?%^MR.O"-(`W*\T6Y>M$?_IE29KEB:;AE(DM8POP^MX8R>(.S7,[=,?G.RX&U<"")AD48,,K5;%@&OK@Y3=>7*&R&T36ZQ@*T MYE$"G"Y\J8SX,<=RM1SWR/)43;DMO0Y7P49.*.(HX<]P'G\CO;),V5048G%] MI,BJKM?>($VYRI06!$EZ-ZWJ$O]K%Z>W83ZO3S=W"_;_]WO0\.#NH*^R0 MZ)M&ADB*IZPPA@I##5HT7#]5-A2^A&NY`V1Z$PY1M>PM6MMW^%YV]5M.6$:W MLIDLI4!@./&2H@_.Y,$-?8I6`Q%Q+L36@.7ELF7+P^JI M5#.9HG`QGFJ?SY,[<6P\\]RQZPC9X9.KJB$/;7N?TJ?"#B0NI.,N("/[BA'( M?YJFRD/3SF83-_]C8-9Q'!`;>V`@150&P,."2S-_/F&!X"O+U&5S:&7C`UYQ M*YG'2;H&`CLR]X$VL&40 M;H#(5`+*I$20@/&H>")!Z1Q9I1;7*X@WTG=%OE_J5GA;B/V+,'V\6#A8VR-, MKZSFLEL<-*TP36-CT_B`-"X0R3"K2'+0Y(11?7+"3L+=?Y.^7;U__^G+W],0 MKK;\D9UM[_PH\APRLVO@N34JNH`#J(V3AO_9Z:A=0.)K'&$O%]1G+5USAU$8JY[9 M)A52)=.]\CM7Y?>'\/&=M.!=/P09C@)XW$-ZQ:\F)TW_I\S0I;\N!Y MM!58'AN$-8KTT%FMS^7$O>ZN_3*>_C)NDS9;I3I.*7,V9PQ7%3=L?2._@O;B MEP`ME[/FLD.9WGF8!%7K@-(X5)HB&X8FJT.E&Y0Z1;7:,U2.H=2!JG>#1KM1 M[?75!TY4L8]*[K(DO-/K\9,6.]FTAO)(Z=5XST^[X"=E,%*[0:/>0E^GR/\H MAL=[17[*@J?*UF@HV[K1#4+UBOS$^4D96'8W:-3;X\UJ_`//?.K5]RF+VVM= MT63%[+#V?M,K[D,UNON4]9YEYKLJDJLJ9T^-S; MZ^[N\Y$R4,[U)*/U1R/>2_E2U=QR'>;NX].?+KI8SG*'::(=MJGY'>,]0.]?A9 M72PZ9VN\3V4\`X%[K9F:;%FC;M"I3XGOG=YS&>A<"]5F7+ MM.61VBONGH]ZQ=VF'5.?R=AG,O:I8?OF@M.H7MGG,O8,>\1]:ND&')M>; M^L%"]!^\\^-(XDW=*IN&^6MVP\8.34=MH*0JQ0Y*.2S.]"NP+8;OTS#8MF':'5R]%X\QW>U;`!^HB=7-.P'0/\G2T< MUSM<<\'SE:[#-O'K):U&TGJV[7?KLUB87I_T^F0?9ZKGGJ1/D1V_.]X]D_SI MZ;!CDBG)NY^NMK#NW4U==#>=G&!\B3'\<#IBT7M@>Y'8,XM=^UX4..,H=N:G M(Q>?W2F37C\Q)PC?G)&O^,QB7J=H.AV@A?P1^\7WNT._.YRUP72>,<1^7^@* M8YWIOG`*0K!%IGF'C99=_C1#U@BYER+G':?&\YY1[2T M;L#;:[FN\LC:S;!7=+VBZSH3-RNZ$^/@C>-'?2G`Y^>9;7%N/!:%=[I7[@Z) M$R_/VC+]J46ETYY9>F81N7+:'EWC+Z4@[@FPPSGNB4WE<3M%W%[#'5'#:?+( M4F6K+_S=Z[DSU',GQKI;E`%OO/%U2PA^80Z8URI&.O2 M5!<+=QX<=TZ5O?%KEMWDE*9^D+XTK(4='J*W-RU8I^JV\R]N__P,W[@1+/%X MQ\U(OK,02#^.@%PW5*3]=\^-5HOK=)6A/[9:=F067'=9TD>*K.HZ?0.[JJ+( MBJ)(048$7JD^1B)PMG:`^6!6&1]:LG'D/K#Y$[&O-/;#"%FU9K@;2A,&&G(! MBFTBQ2'5RL?*^8X;Y/@\#F"BQ<+WQ&"?2\_$B>AW_/L>N9]@AB>7S`MY;7WV M`_]F^**`C?U[S_TWESYG//:#B>.-0<#<:$9S/`"0"$$XGK%)/&<#Z6H^3UY0 M@P&.@:\F<9#`3C(-?SP5B',Z\K3//@BP#(YH@_!4RQ:P-L!";O344F,EK(MD MF/I>U&[C+!&"H/V9R(IS)`1OTU5!;/+9UKW_O@HCJ]!6X>MI@+D*\#L^#I\!;TV%G`";OWNN+5.Z@`631O[<>)/ M%2B??BR[`JU>5`_&Y`>HK[IW'/9?*WWO*/P=3=531N`]VMT?P40_923^@:>+ MEKK^,$;+X<+Y>10;;+J#73EHP/+8(*S;%,[X5L8I]D3NE_&`%T>:5(?XZ1RZ M#2OK=HG^"E<7.X.+X,K()`=F-ZC4WPX\)]92!Y;:#1+M*[?SQ#7\*#TU]$[ M'=&[O.P&@7J%WG/5L;EJXSM8FP;M3TK1W[`H`CTOW3U);AC&E+KC3WG>R('\ M^!W(-.@O8SY;X+M$X&Z&Z7NF/CFF/I/KQ6=X4FD;9E#[<\L)6YB:;/:!AIZY M]N6/TDZR_TP?:.@##:^(Z3#>HU*OU:#N&> MJWJNZL,,?9BA]\B>@$>V2P3NPPP]4W=B%^MPF*%FUO+6N*GG%)O4_>>!Y/>!E#7C7OSL&:HH7"A_G2>765 M\V2J+?K*,K'W#HU(:C_6EFL,8_@J\D&BYY(I+6B^,"F1>.<[P00_3-R`C2,_ M"&5Z$+X!2V0\XP41L0YC(,"_9QX+G#F5\',F"]=SX;T.%I!,*C>^U+J)NUID M52PRUL>VJ9(G?.(%&<._2:_=-_B3:1CT$\ZGRD9SR<\MF."U2^_1LK=H;=_A M>\`*B^7*K3NY5I1J/M")M0*WOAA9+P;'$8/\5O*R^/\( M"02G5;QY-T'5K6O`GJ0X'=#QV6Z!3Z-S3L^L1V+6M1?ASH997U`B=;K`?Z\] MI*];]O4.9KXZ9Y[YVN"&/KR7V39E8VAW@SA[R*7N&>K@T3@%N]O:>VQ9VN$P M_#DD4J>L_IV%S`G&,]+T$_;`YOYRP2HJWWLH7GB1Q+SL5CVUW3K9.WX+I&J%/L8]'ST[GP4Y^; MFS\4W/J1,S_2":!E%N[S[:<^2;&MX63KLC72#LH"IVG[][S;.=Z5-4N336./ M!=^ZGV7;K20WW%NDV,LU^J[-8.,YD;8B#W6M\J:(G"894N[@.,)DQ'1FR7]@ M/%7'`^C@CX`E63L5O<63ON++P']P0TJT:YD/=^0VT[I22%C;ZB1H#4_,1('5 MUY\?BGH955@Z$3I(N%15;5G5SJJB5NM"B:)/41;-;D?E^BHPAY=OT]KC5MJ1B,9.G'`G)^\GX(3KKPH?TG#FY^`7 MY\CX/Y>7'[S)Q\"YQ[R4RTN:=44LQ(?_?!N'E_>.L_SYO1N.YWX8!^SK]#KG M5/C.YD[$)M=^&(4W,R=@[]#O\,UYPMG#6Q#.=RC[O_[O_R5)_YE.%K./0+:K MZ=2=NS`\E-P)$+S\[4!51R-[8.F::0Y4W1HH_'^8`.RAW']GTU\NG/#2GUZB M^^(2_M%5,4JI&H<7+6G0[S?O+Z0)&[L+9Q[BZ?]773>&\'P.XS(XV^,P:HV# MFL-AM#D.JF8-A]JF.'P05TW#ZS@(8-GRF)1_2ZFK;+@:A1$-.(!L,\UP_>LSN.1OW/!)DUL%7#&@Y4 MS1Y6(S0%"/BR*"K^$_GE14(6JYJE`4EM:"KP?QFJ]6#N#%OL3;\)MOJE9J;8 MXB=+S'$JV-JML55P-35-8,L_Z6*.4\+6U$<(K3UZ'KH5T^P)7\_U[L-O+$@V M0'>MP\/C M]-Z=QUB"H0HK\5OWUDH`MAO,.K5BK3#[YL_=\5-J559B6'IF]VOXJS"CWW^] MOOWSVP=I%BWFTK??WWW^="U=7+Y]^X=^_?;M^]OWTO_\U^UOGR5UH$BW@>.% M+MK+SOSMVP]?+J2+610M?W[[]O'QBI\E7P-H-Y$31$4;?\=1S%UE)8LP%CLPO>D$!'!\B`8FR4YO7N2``V7RH]X#+9)#WYBDA](<.(* M)6>Y!(ZFP&?D%V:9`=VQ"@U,@&'9QX1FCJ"9%U-X%RNY$_4D/U<*=Q('^!_F MC&<(GNM/!E0RA8/%(\94T88KDT94>+`9OMD:C*0"A"PMYW%('^G-6,1O5 MRF'_BETX,^/I$IYR(NG1C^<3./2'3$)9IJ'L!PO&^$U2Q%[REU3L!0L#!2!2 M,!AO:-14XJF!CU-)EN(P^28*F`-GXBL&BF3^AF?'7!/^%$_P%R[J$-]$D M@FX5,Z>XL^D4P^\`OA.&\0*?`Z4%\X5B62):*?PFD3:`2L0'3E_8U3,WSAR/,<_92O''=-MSQ3RHR_@5L_\")_%7.[=X5 ML2V5RCDGRYWB3;]^&3N>S7=R.BQUF_4Y?=W)\#EF?0)5UA5#-HP]%M5Y:44V M>N8]'/-:BB;;VOF7UVA_V>/4MJ3WS/,7KGJW^O MZ5*6>)/Z+I]-+.UH7-Q%'CA;OM5E33.Q,?W9\.T.DI8:2Q*=V@:6W-/=09RA M+UQT#/5PU%K,0UM61K:L6@?,<#K74N*=Y(+S95U5L613UV7;.&""TP'K;VT? M/3EV`G;OE>A]S;V7J^>G3KJYSCEVD5U@6+GIW\>A>]GK=7G/3QTA5)]4U")W MM`\XGU`O%2%H6)^N&Y39I)[[5V+V:]UN[9J1.4V7L?RS.N MO/C-CY@7N6G@9>I\6:HX\LP)JBXWF, MU9'2*J,;5TK-EVRLJ=BHR=(=&SMQR/!)-TC*:>8J;MXQ5JJY^5(+;&ZTS)HA MFZ.AK.I&!Y99WPZ=^ZV!>S'YS_ND'US'L)@L6P`18 M:Q'SN8CL+1\6.&/C)V.@J[;V'+I5S9+KTQ!7]&BPPG4'V@QQ6XXXZUOL.G- MU<*/DTVP]N>L/=-(P59#YEKF;6[/M#)+$WY*J7]/+90[1%8S@9ETPVS7BVJ8 MEU3XA*M(WF#XC9H9L,E7[SO:T-B= M`!X`Y1DD'S&V$=[BZ;+8@V7WT_9M6ZK;MI3/1I6NU?J'#E!_'Y1,;0'^DK2=#HV.K>Z#W2]\OO8!P]1Y#M^!KJHF\ M`ONQ`VT$2>T=?7C$G;IC!Y!?$VT['_[J'D2]:MD+Z*V;!1P;T%.`J.?1?OL[ MM^WO_\4^QHZ^82O`$*CYLWKKO3?A>A/N]'BT MUX%'U(%78THS^HV:.E,OWW-5A3V;'=.(NPM9\$")G#U[=06^\V&OWSW_[!FL M-^5Z4Z[K/-HKP2,JP4\3S`T?.W.)YZVR83.8MXYZU.@1?SUJGP5KU MYEM-<="JZK7'1F+#6MQ=DYU6Q7%7T3@?$:.[`EM*6,OZRAT3NYYC3YMC7W]F M#VPNJ6]ZKNVY]M2X5NNYMN?:D^-:_65Q;6N_ZDG5`&KG`NK>\:+WT_8N^G[I M^Z7OE[Y?^@[2[U27?@?-BJB=4O(E-U+TGVI+?IG:B15-_.)[;5,'GM\MKQ-, MO*Y'V,;UID\"JX/7X+N\W/D):DU9O4ZL0R\DO9#T0M(+22\DO9#T0M(+22\D M!SS6M6ZAWM1)\N2.<)3=(#GD^986HDZ7Y$32U'$#Q#+>]H2W>>?8[@KG,1M\ M-M1&[UY?S^=IDG4LTS%-TO-^S_L][_>\W_-^S_L][_>\_Q)X?P>]P?",=&PT M&GLO=0"XUC'3KD/=KL%IY\#>JC53S\\]/W<4[)Z?CT[B;D+=\W//SST_'QWL M4^/G9S=U/[E`2:Z=R;J`R*G)3"_I'2)VUR2]Y^>>GWM^[C2)NPEUS\\]/_?\ M?'2P3XV?^ULWZTXB[UG@/CA4@ACSLWA;\M>MJWV\D-30KHA9Q\VF\[O.;_G_!?.^2_1Z.GONJS>=9EG@9S^PDN? M_-D%K7)B.:"]"/0B\%+SGWO>[WF_Y_V>]WO>?Y&F3_Y`]3:BUFGIQ_R)H?1W MW6EHI\>;$@Y'`0%7'ZF2O&VSI9#N_&#"X'RJ7$AC-L>BAF/7NT\_+YW))/F< M\(BB_)1[=Y#R4N0OJPZX?WQZ?_M?/TLC`7&)9I5,+(:H-D*XHLFZ?.!M$10\ MI?/[#6/2%S^"5QJ>\XRY\_.F[P#W0T\(+35]XDEUSZFW!) M?/6^LW$Y$3'(G(*$M'QZHZFAD#6S5L.V!JMGFP-0-;:#:H^%` M&:"`@LX$>+ZSZ2\74^"'2TU1M4M%Q7\BGW^"?W15S*0TS!5[+I_H]V]`BPMI MPL;NPIF'6.'T5Z6:DDW`'Y0^P^%@9!$BSR!,>9+3I8BEZX:)JSQ$O$;/8YF& MR M,=Z'7?+K-[,[.![(TOCUF_&G\EL'$=Z7X=`=A`]F!Z#L=@/EO6WKOWY3.X+B MWG;I7[]9G4%P+ULN2N9^4/R'/W@(@X' M)]6!W0:<.*8QZCYQCN]!X,323//DB'4$9\()$:L+?@6="Z+:?6H=P\,`S`1# M-<7H/GF.X6P@\F@CQ3X-\AS:[R`VN>&>5-%W-_SK8\#8)\`B8&'42)RJA[MD M*"F*OL90JL+@H$0ZAHFD*$.MRV3IB'&D*.8:%=TI,AW++.HZF;I@$)V$-CJ2 M+82$67>>/3H''<,*(L*LL:&/3YBCV#^*8ND[(\Q[-QS/?>@WM^^*\B_^;]U^O;/[]]D&;18BY]^_W=YT_7TL7EV[=_Z-=OW[Z_?2_] MSW_=_O99`FI)MX'CA2))Z.W;#U\NI(M9%"U_?OOV\?%Q\*@/_.#^[>WWMS]P M+A4'BS\OH]S(P22:7$A9KD]%UI\`[29R@JB8'+11=M4M95=]88_2]YKL*OKB MCP\\E>K.GT]VWM\56%W5I$L)5U>BY95$@A(BM5H);W>X[0(1W4HP^8-)SL1? M@HTO7=U<2[?^TAU+MJ9(3BCY4^F_'2]V@B=)E25-46S**)NZGN.-76W6A&GV,OP@>7\/C87KTB#.FXBQW+'IDS),63O`73+0$ MO>#",CG(4/!N!"5'76F"FT:)>8J,$LU`6U]&+D"06Z$9?':"\>Q)>IRYXQFB MYP>@MO[-.+JNMXSAC7'(>:&*OP;2[2P_T3V0@@^>N??P[BB9]`G)$'O.Y)]Q MB-STK]C'_Q!%0\ZE5*&&HQP20V-@'Q#/^HW!=_G;F*_G[('-);7`:F^(0Q&" MN?^X"H!_%[+@@5*.!7IB%KTX"R$6PF(#:@C?>!Y/V,^->=M'2&1.TG''#'?B M+?*:,\:O$\K*)/EU4IE->1=(;VLR8]""U/O+Z?.PIT__2S=/"U@6Y-! M$`-WNA]-TI!+OW`G$[\JH[>`Z>ZIO:K>1`E:+AYR7HVM\G\8@^C#+T6)+,I? M?D=;D=5FA+>Y`=%+4B])'90DK2!)0GQ\V&H"M`F\M7L:&0Y.P"3FTJ")"\9# M!'L_RIJ7?Y'O1?XEB+Q> M$/DJ\Q&$A5O/8)1&\#7(E.< M[Q%D"WQ[")BZ4U``<'1(E%A0^)8?#R8X.QB_*/YYS'=S2ZJK!\`_TK,5*(\@ M%M[E$\K'>._:1@AYFQ)>O-A\,IIV\I\W= M]JJ[V_TBG=DB%2Y$=W+).G=EFR"IO>2<[=LMK<3N\T@7N>)E"W*Q,&`7UZ[G MF:[Q3*_\]Z[\_Q]W[GQ+/$YGLP/TC+);1OF*SH>>.WKN.$\;LC=/>O.DURN= MTRM7/!KU6Y;3<9KJI6>5_1LH:7BA9Y&>12I9Y/=<#.HTF:0W4WHSI57@`\)2T8.@!63- M7O+WMNZRRWO19W&]HVL>XYKN>XG7"C.G#]Z_L&LS/[N%Z)!M\30/,KAP`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`@Q M+BF"H,=SX9W_78>NP7S\K;?#GMPM+CR_1ENU$ M,$!,)(4SQJ+&=*].K03_XO;/S_"-&P&UQ_MGZ(^8??&#D>\\\![+\NI0K*V9=+YXDR_)#/X,L@ M!E;*7T]TELO`_^$N@,?G!FWP,G'OD*#!TA6Q59M_^Y]LX MO+QWG.7/R*+$H>_=<#SW,:4UO`5N>(?,]NO__E^2])\KC^;*(?XFLF"_>M^3 MG-=WF/+Z>RY?]!.FB\+//K`]K#@BE+Y!_7.QCXH&JCD;60,G^AUDJ'C+Z M=S;]Y6(*F_W?W[[(,VBQ5SZ]ON[ MSY^NI8O+MV__T*_?OGU_^U[ZG_^Z_>VSI`X4?B@5F=1OWW[X`']V]OO[_]@7.I.%C\>1GE1@XFT>1"RE:TI">2KP&TF\@)HB(+ MG$4*;H+B%!9PCQXRG/ZY#KP.@WI>B5H;I^T^^RA^Q%7=*K'WV$#W4M,]J=DT M&?@\A69+A_BQ$=H.\BX*6Y]R_(R4X[),;AZ!Z+2@OHS0\B&2DH^]KGVZ;!TY>Z(Y<9!W\Y!W3)5N7-PG[8MW:=+[S%=^MA+?>KJH9.IUN)]VGB[=/$7X3/?8M$\)/` MJMO&P8ORX/?)Z%NIF\V3R;LKF'VZ>I^N7I>N_MP\QAWF$-:D/XII$;P_W&BV M,EM8G*[X[C38^W?']3[[89@X$S]Y'YS`@\?"8D[DOM\F\TM%0JRF*.K; M__GM\\UXQA;.)1:XQJU_Z_$$]-*" MXRZ<=ON1W^N*IX?!+QC$V?W:YN=_L=(6UA"'7XMY#M4;9R;JV.NDQ@DO M_6F9IO;&@@*C5##1GB\GC2B=_GJ,6J^'FEN/T<;KH0\M!?CZL.OA`CQ@?3[@ MG@LB=._"G%=4*_YJX0>1^V^:\<./)6S"[`M@?/O(Y@_L-T!_)K:69TV1\F[- MC9=:7B^,:.1RW=!S-'T6M,\AWG=_#@>=^S^9$WS$>U*;TZXTP_Y)!T/5;4E7 M`G9'E+N=!8P]CW0TQ_6>2[M$_'<(]^L\A&_$M-JS?G&#)T&Z3 M*H&R-9%2<[/QD?TCK2DCS6Z%-8"S#^Q&+;`K6P*ML=-593C:-7:_AVP:SS^[ MTW7LG#VXAYNHWS3ESS:894`4\4NBQ'`])=0")?*,/MR`$JHZU`PC;^UVC136P%8-&^QWS38'IFYHJ26_ M#8?4S]5`),W4K2Z3:+@AB9I99SL2C72[RR0B+A*\-'J.BJFAY`M8P6>-^:^G=9I\27OHNB:2W(Y(]TC6SRS2R55,?"=G` MOXUGJNKZV9HTT=`R.Z^M-Z/3.GV]%9V&]M!43HM.ZX1N,SJUE#H5S:,.DXFK M)H-KDV=L;%6SG+1-U)8LS5RS(5E455%'7:8+V2[6\-GL4C5+$[LH^K#+9!FV M)LM:XWDCLNB:IG69+K2I*R``QDA]'KNLSM)D-6NZV7VRF#LA2WF6)K(8VF[W M(C=<^KQ2V-5:;'ZQ&%=-::J5>*["M?ND3R8%^92M[;',OQ,E\V_>A]^ M1*YW'[OA#%?_Z_0]NXM23!N?.NR2JN;0'JE&$>%&^/:'].&6>&0:2CX;YEA( M`P[5VU3-@NN7FIDN.'ZRQ!R;;W;J4%=TO3LD&"GT\XN((B=`\S.'5?B&:<"2YQ%NAFX_Z!Y,U5OJ4!N. MC&W1]?W)HSO'I\NAQO+G;_[<'3]Q`FPZJB]Q6UWB]@0+A7]S(DHPQOO&V6*? M3EGP!/Z`+;'TO(.LOE_$F:^H'T.T:O M)Q(L;%(MFPIH>PYG#6DIYO8]*L-][8.DWCR%`-QXYOES__Z)W]/&NO8.S\Z` MZ7PJK0T\AM=L+O%>C'2'*7R2_\`"44<\IO"X-,=HOC_-U_\&T#1%>F).$`ZD M/[!R]P.3L.XV7@=_0$V0@N5RL%:Q`-P84$ZB^N$J/C`@:>Y@N*3W.&!6O?\12ZA[HR@A)@4"""!5"4%U[$5@1_#YSN&%SB)8<;^8NEX M"/RC&\TD6&B&;0X`>VQJ(!Z8,UX]/H$0E<1`^NI=WOM8_9TS(^,Z.\>/R(:" M"E-_/OZ]5)CGFNAQ>AD&!`"EU>(:$'T(#">TB("8K3"85PA#\WT:J`K*57 MH7;0BO-&?<7YYU6A'9H_=>(>,J_B7V=9_"E4$E!E:PX_.-`YH5WEM>,W\1L> MKI?EAG4!.@F6U5RMN>IB^4MKT'?2*@9WD"V+(H$D':SC[?K:"7S]S[P#;S=* M(PO&!BM,-_1N$&=?'>I/7;:-7K9/1;8[UET[$7(XI6EJ-ZC4;^%U8F[V8MZ+ M>2_FY[V76[V0]T+>"_FY[^7#7LQ[,>_%?`]E!C=.TBAEA@1^&'[#%LXBR2G[ M?-A\'FVHE.[$9)!L!O+!+W;BW&=BG(IU-*A(N]"6MM,27 M^F0"XW]@SL"#"^_#E)@YXL'EW"$\9,SWF,<8"4V"XS(FMGB8T"-AHDQ$C=_& M,Q`PR@Z1QFXPCA>\(!Y^,<'T"\RT$('TL1,$3SB?L\#4&DHB\OCKI(7S!#M7 MA"DLF,F`24,@M`/I>_*!"HG1$'ZA8<;FHLD\IRC/@K M\14TV4#Z-)7">#Q+(,7$()!NS#H)TK$\?85-*,&')_[D,EKX,[F4CA)^]#*. M!GR"@S>\K0;'%"X$'VSW":4122Q-BYC"2T4F4>'Q@?0Q^P7>/V%@12_`?"$( MXA!?D](&2.G,GT*1R^53]A/F8`']TI0=S+>:PAS$;X+UJBI^@^Q*CT[AA<1" MGI]K(T1/!.Q?,1)Q-1ME2WME&V5>VD>H6"RF-G\$)7X-2MWU8B#5UR6R"E+A M'<,$,_[%&I3WA\@?7BV\W^YC_P MG1A+T6PMES.\1\S.:XD.5RI'5PS#L(ZV1#`!".%X[J/>*UE=#0_TUM7^K*L] M6E)??+`5;.E2$M6^B7U.QIIZSZ:,)VLCV+3G8[ZP.TF2J^=),538R*.9/T%; M*F"PDTYR(_,F0V[WQW1#F"@>1WB2`:`62S\`>9(F[A0&,[*W:./E@HBYNR"D M]!7..H;IW8A;!YQ@1B;U&D%3 M5D[2T?TEG`NYJ0C,XMQ3Q5L9#1$TO#!W>N[^A6GN8(AX9*>211(BGR+\-#:@ M1%)A0U6M*GI",B.7-T:NP:",.B;KD^V3K`6:<$#1,:=8S@BGA70>^1P!)<>+ MJP`3-,;A8>8Y8[*A3B>)%XLDUK(JV=9A:NSRK%NR3N$,X'O\IDCE50(UR6[6 M&G-TCYJ0JRIK,W(/D9YX*.=KQ2ZS2_`V35Y>FXBYT]#&+K;8M=$.]4`IPNU6 MLHUS>R./=L^*I\.*;9M[G2@K%F.H3=&\4VK65F&O;!H_/5;0M$&$SB]PNJG6 M[!>IZXNTBYP,Z\1:0W[Y^KEX;MTR5^.E)4ITXM["B,.BZ;)M:;*I*-V@S[-5 M8\]3Q^].]9ZP],):NRM9I,M:+MMM+ M23;/4.V]T!U>Z+I&J%UJ])Z?>G[J#?5U:GP9L+';>UU.7.Y>JT.]VW;YFYZC M3HJC+%4>=IF?]F^.=Z!B1\_XO0G3F\0]/W5/F:Z:Q`*5C0I^GYJY_(_5^V'K MK.;C%"Q?H>KS+QK`8:&#XGQ(F-M9XIHACXP].\GW4G*]RD+ON?>E<>]0UE1M MOY[XPW#O)L>`FKW+.*>]:^5J+%W).=+VU439G2H`>!'%G^?L\!J@(0WZH+"V MDOS+@R[^GH]`/=?V7'MB7-NVP&97*R_<8F$R7I`%-Q>J:1+B28D7]`AYD[]< M/3)_FG^^6#2,NEAB909JOC>X&4A3-J%K`;DA`=6,\^%5##^*7^@UX[3B4%+I M).GMMZZ/G9+VL9,F,4U?*!71EW_HRS^\D#OW??F'GA4[PHI]^806CU*U]B8TGN29@YO+UEJV53JT83=D);+P/]!S1KG M3](KRY)URT!?#>]!A(TS[["OSQ0;63KWCNN%4=+-,FG9E$^B2E*E$"8=/@5^ M?#^##[HVD+[XO+>2\/'-'&S6Q+RL2Y/HEU3?2(>Z\:#%QGM+NAZ<#%UG3KY" MZJH42J&+%:1PFJ6/?47QY_Q;W3#!IK9YDVCU$SJ+)._L='H9O>?Y9^/T*.T_ M>BP(9^XRRZX+$PQO@2[?L:?>0KH:4W*=.K(MN07G8%9<1=".KR0U=8V#I4\= M.X%1POCNGVQ,C4<=SXMAS-Q=N%'2M_-FYL?8;K42:G\\CH,V(`E6I9FISRR^ M+@YI.L&PE,.WNW:>#5T":QH.LO";XTZ*/0;Y=U5M!7^$[L^>.__E(@IBMN-N MF3\6O^)OI[U^&^)YLNM9V6*]YL>^T>?9M%$_R9Z??["D]"7MMMDN MRZ@3(_X63'BS23>:9:VU"^T=TWZ@:.KQV7#_7)EP&;!P'+AW/)/^ZN9:NO67 M[E@:&LI`^MV#C7[-"^3J3J,5G2;+?3\Q4SZU)\G`8_^*17O/*`*88IX(#[MY M79O/"D.PW*R<;![VPPT)_[4]0($V;F M6[W3M87DSD#)I!8&,;][`!^27NQ@6=7U:877EQK)BX[WV"HVD`#F:+[+GN8U MVK-&`7\'6&"EYKQX%`_X?/(2NL(#O`EZ>F4^JPE;4-5;3W/8+N27FJHH(T6I M(-?6&'29L`?K'0Z$M37S"(2ML8JN(G$8NDF25K+QE.M23^/M9CPL'ZNVKEHM MJ+T=+J='^(/QN3I26K'Y'@E/R5I7WN2S/W;FN<-=$VGKQAR6:S5KI+>@71VP MQZ'.P5A+LQ5EE]0)P.9A[QG_[R?O2E1M_^8\<8.&TZ/YJ0-K-<501KI6($$S M?/M#^H`[IS4TS'T@#7S#W(<6>&V?8.D?[DP6-@-]8S=^Z)`UMWAFD89A.N M.=!VC^?!%M6VAHULO`&6WP*V=-Q)P@/BK`#&W==HQ@)^+JY!O\W00^_FFFZI MC!N@NT.R`QI]B&J.]T^P["Z/`10_DM1/.:JA3?$@LOZV:0V5@J.KP.2Q4 M-4NCVC248>DHU`AL!?[H,W7FU_YB`4>FF1.P\"KGN[[UKYWY_.N2XMU`RS^< M('"\/.-L-WZ_$D=@E+6N":>FE2UF.^B[1<:]"6$5&55=U'AV577@&'ULO&[(W1.C?('Y7#- M-%?\2WNC_"0>@V;&L0'F-WV=\K\C%P>QNTCL8H*L+9\^M#-J9.K**$^OEG`> MCA@'LU.,H:7IQ@YH$3'@HA+&A>\.O,BFH<'_\H@5H-D._,,Y$E"BA]IVX+_S M@X"JX855B&2_"J):NFZ8`SC0/LL2K)JE&4%[-*K%+P-R=Y@.6V/:O(8;8JJ9 M5CT;[@-/M.T-RW[VBE;-TH"GI9(HB:M0A&_!U`4 M?41\IB%89C-R2@$Y)4&.YE`J9VGR@8PLTZY%#J&K1BN7E)I]<5B5KQO#D5*A M,A&238$^F*+7S:%F6#L`&I>>.'G83O#U2\U,"8Z?+#%']2Q-@F\KMKHC%.S6 M*!"?:UJ>ZS5=S+$Q"KJI&'J%EMX"!:&56J"@##G0'`7QR1!S;(S"2!]6JJ7M MN-]0S8$&Q[GGB,#J'$UZ1[=V`7PB!2.[A>)<*P4KLS0:-.;.Z$\[./^W/2HQ MPI8[>>UL.Q9LBF-?QT&`B:%%Y/(_$6AE8%;1<\)+?UKFK='FPJ$.57MH5F&2 M!ZH-3E?>!$[.X[4(%IXCL->KMA3;_/IMHK3'G<;TG;,'"4EV*:Z$9C55X"J?^RO`)W1%:`T3'XR-X#R60EX+T9< M7L&++',VQH"D,Z?[)V-_L8Q!OTA+6#IQY3:B*]).1!=(YOXC_`H#QWX8X360 MA1/\1:V=T@8:_*H*OTT3A-&EZ\GB+S^.Q"6?'=X:J1:X59D-(YR8)YXF.C25 MV:H?3_0BYK:8'BY?6->&Q06L@JD.K?"3!WO=U>0!T0]O_:OIE#*,68BDF<1S M]G6:>WI5/3]OFEZ1[T^1[U%I?_$C)EG2I92M*=Z"(V9SQE@$X\$%/I#Q@J?T M^M/[3V].1K?_P:0[=N]X@`^BAKH7+W6",G>(N_&+A>^AZH]\"5##GU&=#.C# MHQ.">#ZPN;\DMJ7!&"#^$TRN0<"K@ M#Z;$@E\NINY<'M7HH,LE87YMKOTXB`;2%4",=W#CN>!9-YTD(0*3W#",^277 M(JXP`%\<4@H!?H(YT40"<0*&QDV%;"9*3?,D]D-4'4&`B]5P3$56J;6IG9N, MWI6?C+]N(-U0X9DB^0#*F?.`%[G_%1.380LNKL?3269T91=^?W#F5,&&9GL? M!XD]1N5TJAN/:?B&B3N1/#]*7B)A_9^4`/F9V\ZJXJPIR(9JR.I0HREK82X3 M$LAFP3P-:X"%=[B!^DI5Y*&ET*K#DQ65C0`<+`@S*:^/*=NCH:Q:HT;@9"Q+ M`V`P?O>].,?(^"E9URB+S291;V%!%Z*0\6.&.+34[3QUZYXVU:L"&_;*^_L`=M`H MWQOPE2[K!DBL:=)@^*AJECP$[LTN],^?9*Q.%,:.QRL2H5I?@#+!4O,>6ARD MVD'CA&Q,M_BQ4%1VV3^GUX7H[_)4]#P[MV1^AXCD&)Z]09'+)0U^](,;%I#Q M]#6XGCON0H2V-QEQFB>M`]#D<`DYYM`HN%#> MF?_F1&"\8H[O-2G6>P;'`58Z$[=Z\N4<>W=6+/*?,1S&ID]-]2+/YVBM&G"V M)DZ2OO&C#:8([='`V1-6A6,U&0I@H)`%-R?D%EQ.!NG/#JSSA!8/#`,\[J%) M(8I;QKR\DC1W'L/8C>2<;2@,#1?[$X?H<K4\V2?!^N]DQ/. M@_\=`S)@S@M3_/KV6OK.0C#GL=K0)V\\D"9W#F^W_!OPCR-=.TMTZDNO+^#9 MBS?B6)[2,ZEI=#MS@PG,/G&I<--[E]^PX2?`Q!>"9NB-`X?`S\Y?8#RZ$=AN MO'L0F%Z_1\XL7;6KZ^OTS==^@)61Z!CZ^@)^N7@C2Y]]SY4^#^"_CUC-2I1Z M2@NFOL8/"/%[>!1_.I>1"ZI'#QR M[O>I.XD!3RS6%$=/'+?`B2<%^/';WX("B&/WP9V3\Q]W#3@@%^8O/9S#1Z8O M0L;^XIZE?\8>KV8EH.=1`Y@HB$65JP`4GRB:Z,C-X,!!G8IW(D$+V"?`@H4S=V#U MJ/.3@#9,3OE+X!$FZEKA/36TS>.L2?<<=]@)G=:R0P@:_N[4'8-2"+#6*54] MRKV9\/AOQXMQ>3BCZUP%S.",3.X1-G2N@*?`8'S`?7CT,0EGNT MN#)?!S&TG/T)D_A_P22PSP`Y.2_@BX`7@ON8%[%-2^F2APA/T%QHN"+++3;. MEWQ*GG7@7)3XLP#:`,6+.XKNT+GE,?1E`?@#Z9T?S=)A87RW<","/`"BAQ*> MKH))XB\`\>74C!=PJG/_G7R?(0)K-79S02=!/7)Z<5!S7J-5_0LH?F1W`:V" M9HIE>'#&Y!S+X9=.(OW3=W&)0>TZ;BA"80$3;HO4/Y?@1T_#\O!3'3SLXXW& MW/"$B5+NX8O&W5!T1.6J_M$%5@92WKE\CQ%K(]Z3;3+$GZ\,S<`>);#J6*:6 M/PG**#_6#Z7XX'<@*54`?VT1F'&LV(G3M(X,FRH@+'P*0#+_R5\X=$, M5H^_*2%!F.PF.1>`:JCR$-Z8F``.G9G0:9D\S*5H9\?V5J9XR5R]\IKZW[L`[*?29VJ*8RU$U5W0Q,(#^=?&=@"\%J?`"1@MVV!'OE M0WLGNV;9AJE6D[T2HGTAN<]5,TQ#-^SA#I#,9VNN?GU4(:E,S-P,]'VN@3W4 M#,7:#O2/CAM@9426E30OHU'QB*"NIF"BN#V"?XT4"_Y*LGD;G(*U"U4[V1Y\ M@CLD@+5+`E1/UFT":)4PM\6X>G33-J&.5,T:53)[!9S[0;L`[@8(5XP[`*JE MS-G*7ZKTZS9,O&]O_C9H[34=53=&A:I$E6"4\$!WSX6W@3-*B2UD]QK"BTPRGSC8C7TYTZ/R2(G7I M4DKJ=4K9,I],;LHG;SR/)SSK#=U,KVQ-E2W%YFD;JJSI(WFDZ-3VR4GP#+(: MJXFOCG=&$)Z>-(.DE#U2S/UX9&#;O7;?P#M-2S8L+7VG-9+-X8A[]MTY^K`C ME*;<>\/B9'^#>7`BPY"-H8!=TV5;-=`3%7L;S(+3J+*=4$`A*-AB.?>?&'KG M'7@R27\1Z7SDOFR8%;UZ,/4#8JK*JJ'PJ4U=-D9\_JSE&7Z*O;$_QXL%6%0E MI7IQUM-)$\US&'**%R-K`.GN_`=&7>"`[3#Y<8Z^[>`>L^U39R<1'T,WC;EW M0$XY25`BCRUU6,-G;?,G(K8]XMEE%#T,1.50[J86&6GP\%#E#P_YPPC7"L>@ MD[DI0>HTU^@KH+I">Y&PC)YZF(%"A]$L8.R2UH*"&^3]YB3')H*>_X@Y:>CV MEX&GHQGU'!29D9R(Y&A.8G0`'N:]DM^>]R?$)#E!5;W@?29'.2VJ%(K\&>R' M0Z(%+Q@[U+UP[HQ%UEB*!?F[DQA#Z"YW=^JH0Z+G-<6M$8*?,?\\*_3;_`MVACXJS@951&@ M_NG]XZ^7):\E9$7T?W,]/R`/`;\=]S7I:OJ-!6,LA7C/WCU]9`U:T-"5$Q+B/'-]#J>8)H%[\J@U'N,OL&?=7:--E$=CVCQ^X&/O(,D9:;H-M#^@AZ7&X`I;6 M4!]I>R/'I^3.8#MR5#Q^X%KMJC52\@4'VP-Z2'HDB"'(Y!3-4R#'VX$X+P&_IHI"0X9]\T69CO\ MFE>K._A9`\-2=[U\JU,>;?6VPFY-X<6N8`=K9YAV"98M5FMUDH-JOI9(K%F4 MS9#85@M>/3CN7#2QX+7_#/\<4`@AY]:BJBFZ;#NICX6=3Z0V#%%XD9W;Q+"I]^T'`"^70_:N;#]?2C?C,(TWX-@+U%@NT_+ZYC=T)QY[F+I9PB3+<,DU=AZ$P$;:_]"=[<TDW5^\D537PR0![FC%OS$0-EVSJ[-T` M"P;L(H">GO*QO`Z6`W&""=;_<3'OP%^9@,.6X$P9!@CH_"E[*2 MHCG)K0#@6P)!8,I^B%*&*)"KM+I#>K@0UNR[B_'YMK8!S MZ=:VE^Y/'K#OO4M)!)?2WWU_0K%C7!R*Z4JO;_VE.Y9T4WD##]R*8F2?@#FG M&(IGEY^!S292-H\DNAY2A2?@&*SLY$4K&@%XX^Z?@DF3&DZ"@[GDAL!][V=N=[.UN^G9^"=+G/)Y>2P0\[O".]B4%TM,K M:)QUD'%0T'R43A/F4/%Y!4T"&4SY?\6P M3!&_23H%N<-B5?!,6H03*WO1DKA4?F;A!Z@@_\+;Y*204&_P6YW>>@KA#!QZ M3*'`B[=W3NARNB5O1'2*[TPOAU+F`[\O2S3[%UXL3(!WP,QX@LF$2JZ&,V`A MFG4X*X'*P8`%XI?R:(`[`T(B=]`<--A4?N+3^LOD+N!:(F(:!E[(?%KB0[P^ M&WQ%"_%$OR:5VR8N[FCS/'K)1=8"AJ5UYS=?(W'QDP+1M*&$\8)5S),"R&%. MZA9B)@?[5XR?*&]M(-V`50S:$!3DG)?)&KO!.%[PTVTH,E%"ERYX`X'4-[R` M:\H\R`Q"K7MXYS(!G>MT>`N08?Q>(;+DHXF[L#$$[KUCA6A MILC4LJ2_X<44,$WE/I[3_6PYS:F)\8>ECYGN:$CX64X*/L)+3,$DQILT;6W. M'G`'$FN4WM&F2ZFA9+Y!#@?;)WC*%9(JS(5?6V_@EW'@,_C!7\#P[`'.1)G" MR79,RGSSO%C<&,:=.'`7Y24/$SJ)FH)3-T3,>,+A';MW/2*1,\4+V3=L&?'< M+)7?7-8&T@=*^'$F@H]=FI#?L);AI9B=EJB3"F@2#=,$%K^2ZTB$XAV5%2R6 M:Y#4(')76U>$V'BLS"_>V/=KW%4T.1"18ZC M#0P(<0L"X.3)6TVZ+!3\0JHAH0F_[9ROWD"4XH4(P3(!.((U^5$"F$ M$Z!T)17O7K0Q`KL0SRBL,4;@]&MN;XS@>@5LAMEWL!S<*Y`8()I&!L@WGA?) M[7*JI[DZI.'T`7L*:&(J*QD5-A&1;TFULGV/)`"3+8F[QH5WN!PL/$#D:J:F MDD-J6ECZKJAF*/P766D")B[E>N+J/'"$J<%7F2/IS&BO2I0L6GL=$CG@B76.&#D1SC#L?&,0EH3CV]=HI3)JM" M&W'N^WK:O1E(5VEU0TR=="98W4E4V$!HB+8!UAL)0]A]4--C"82&Y8!%P)1T M\6F!A_,"C<1):NID=1VJE&_1;@0[253G<)9@$3-,6HT"/Y?1*WT$<)?QW1QW M2&%>Z8[8:Z\KZ4IQV);4SDDP$A;`Y,DZU>_ M0"O"R@TYVAP3L'%M&`U>L\5B">0XI&*M0%0G%92H=+@&Z9K#C).G;/#*"7SB MTTXI1(IVC,SEAL6@1"YLLK!\3PSI9,.Y#,G`SUN5.A#WGXR+RL6):'N;^GB\ MH._3@TN('CQ1._K_J=SP>%&[5ZZ_0^'Z1],&AC]NNX&]<^9$^)L9`S60[%PJ M[5Q92C3=,@#5]G4ZA9,8+=!55D`T7T:C?B/C!<4`D.2T@1H\.UJFEG^F7EPJ MYY2Y[T"CNP_B3)#[B6\'Z$/B^AP.%3[!29I]/(8-*Q.6Y$IMRG%8V_<-GF3^ M2::@S\]9P-UC1H`NG!#EVA-H4_G)>U)ZU9M3=DQ+A!-WR*DYO+X(2YNH+ M40VJ!*+)H+QX#1HPT[)HX@1"%285J,0UA(.8XC@M:;:\3?[`%5PU8]'YL)FO M^%*+2Y_;H;KO/OR,[#IZ4@SJ^4XOL%4O09TMTP8``,=K M`BTH.%%XUUGYZ?A;:%F2PNW),M4Y3;9QM-7YE`Z?A!-3D=\CIU&SO4VKBPUGK6*DX@QW&LK;CXU"V\ M:Y^FF;*15TU\AM**[TST$YVU(HJZX>__DI;76&['BH__4WZQX?OMY^NKSY?7GW^]/]75]_H,716K1Y^6/Z] MI:!WPJZ!_Y#$[W$/YK8Y=6+(;8>+/%C%8W5JL.,+*B47GH>)^0/EX]`J#@3V M.Y_2`P"(.SQAY/O@A-*C#]L#GA?NN4P#0>'LCQ3*08R>]43DFLA4K,&`^D*UBN&O3?9LLF.R&S\&^2M,S:/LLQN=6 M#H"QY]_A%6U^2]1;QF1Q1>S>#T!EDD[_C-U))#WG;TNY@7;U&[XS)L=K8(2% M&POO*S[)JU"L>NN2&J3P?N'0Y6]2.1RX3P@;(6WXA!/QI0."AGX2TS).1ZQZ@@.TM%(06)+_W= M$ZA3A"ISYR(E!!94B3AO)7NKGOR5S=QY?"YR07[7/39`C8LX5T"9?AWL+ M$H99%IV[=7:5V'4;G*$MK*6V7H34PY-D4=1E"N%19L674#RT\)7(5&UI&4)4 M3)@PRDG-31\O/?SDTC*$TU,8BHW3[JSVP::IHZ5L57@^N9/#?;L?>+^LH6X;RBX7HA74 M593?`&K=4$S%V`W4=F6UE6T*AJROVG(@]CEBY9GGK02R@;F#E:B:YT@K405* M:Y%HQJ%NB_LTG,.P:E M@*=?'?808%6)80I+$?2OTZG(?*#$!U[<%JQH.@O7W\+;?%A_#^]L[N'!XE\6 MTV6N3XF-ES>"8Q"PJB07K(K!\3F4E,2UN2P*XZY_`[YRK>' MU3;VT!I:=DY=KL"S/1*'N]JLF$--,?3-L2A=Z*_X_L`5=RS%TJO7H^Y&_Z:X M'*Y8SG`T,DQ+VP87:LD;?HSQ!NIOZ)2,%]]$:['W,2OBU_SLWLTET[84PZY` MLAFNK1#/&U>;#=E_'RW;,(SAQF2HM,A:COWDW6(!XC\I06$#DN3'[9\NNF*, M-B9+'L1M:?/H;T,9,6K_=!G:IEFE&]I"V$B6[_"X4/U?6*6\%)\XK);73<"^ MGBF*H.T>SP.66]2M?#G.K?#$$J^8-3?U@T<*YQ>1+/^\=\:U`"FC<$*K!Z8M M3L7./.M0+#V]A[,9K[#X*>ZU:;BEZ MWC/8%H4FYFHG,UVL*+\M:GL5&`4.Q@7+K1J0"DQP!9UPEH_!5WQ?I;:?7:OP M("NU`7X'=`$,+:6T6$5XJA%IR)MH?N3`?@'#T/55]-KD3^P&TX,MI#:RRJI] M$T1OLMPHL?SD-7;(>4[)L5^GUR(;CVR5O[L/S%,S,FPYP8$+'@Z'NEKFARTA M+Q+QF^-./GG_U_4F2IOC;#[G#*:V3IN6/2*CC/P\)6#9OBP.9S MD*F:I5$AC[1\J?U=(Y7+O$'(=.Q07-'5N!UN#9,UH6@.C?PY<(QI.9@XZS%H67G>^6VA/@P)+$V(8E=((F= MD,3:G"0@XT-K-R0)/_K!MS@8SYP0-MC<02Y/B]J'Q-9G@RY1!H:J/JOV==4L M340`22_JKV98J]'_.L6^9Q]^H'46N^$,OUSAA?JG#MP09V@JAKJ*FBWFV#B_T#;,*AZO@'*W MZ&(JHJE3]IX]:L97(0PU@2__I(M)E.IIFC8[NY@_M`7&J1:L0K?X(X%9G7Y; M(\7ZI69F2AP^66*.C9-XZX6Y"...T.26=!LT8;>F->1HBD^&F&-C-%5].*Q9 MT79X8M?0*A33[X\IGWH-:BEP=5@U&Q^5#QSX-L_0`C.C"K>VEL7V2![.76,H M0_LY.-[Z5[R^XV_.>.9Z+'@"T^L#?+-<)"[@=H\>V@.C51G5:V`\!`D.%]T= M:J:R:Q)\"]#5%SU]FSM>M)X,M8\?EAL,K=K*6`]GB1R\_W72U_D;B$W`(G$I M^!WSV-2-JEH\<^)L.?CEY/;6);)NG)F*]2K=Z5-=BNUA\X?WF"N,N>>2JDN7 MTO>4DR3DX8W3A)\)9`N"'Z*HR)[HO9K5C#7!B-IXG5HR%/7U7V\D!E_Z3PPK M!:2+@<65!]+O'A6SI?KZP2),JCG@CW*QN,'">9+87-0(I"KA[EV,E^$E*HW% M:_O"6)<76@65XO#+]_>@0`*J/!,O<:RE_"0G+3?X>W+%!S]]O\$>(2SI2R(9 MJBEA!6!>/S@<(*(+)QK/,ABH*`>?6U64G[(RK5@91_^)ES'(X9(K39"'-(?4 M)`\?7=,WLWD]6!))^VD@?1!4Y34N&"R2*RH[IB^+TAH%?":ZTX\5NK!@AA?- MB.!8Y,+E#4Z2>EUW3^D@7J`5/Z755N&!M"Z`KHK*X`@EKS+SB!2:"#)1$:D" MI2(?[PO`UZ]&(WEHJ33RU4B1#5/'6O"Y0@:[2H#?=H,I[7'4DR1@W+_VQ?_F M!+QH#>UA-3_N.9/A&PMN9@XVD]Z-JV1K%$>;H]@RP6&O*-+,X549I'(8'#^)MBLU^/&?#[)^:Y#BD.P2H7TO MUK,1JM,CA]"2NW,E;XC2_K3B+E%:.NY$)*8D6V1EQF&[1_>>1:F.K&)0M!58 MA\!ZGVE]AF(I^0H:U8.Y6WR/%&BW3=72C"/@.]P` M7^[:*OFU:([-*T2995OL$/@>]/*2+44W-$;3C.=^PQH?K@DDR*/QZV'4=-2C1`E@KN%5GA26U7)H>V']AJZ&F*@6_3?W?VM363):=DG'2]3Z:F9@%\EF;>8EX4 M-6>AUA[80&\@O6?+`(3*25N]!?Z#BRE-<9AT)`.[PW'O9]$E]KB2%BR:8:_" M!Y&HAFTT%S1G'+)I/)?FL`%DF6L"DGS>F>A,@UE7U-3P0>12#22T=]P@%%W_ ML"^+1\5`QY0P3VE=/))$_7)<'M4##'^,V3+"IFX>[]\7B'ER#5:HHUV:2):" M.J4&?\MTYY+&SM(9BXY7:?<:<=)A/GD'0@6#B#,Q561G25HMM4Y+ MQ?8[8?P9$6[4:=ES0B/IFF$/#+5%L*E!J:U.\NLW_<\6R&;@'`!/=1=XJF4\ MS6?B^>!BLAXL3J,:HVUP MS)_DJD)F#;^G_O1V-_/6N=,WNYE7=J8WP%F/<"66AS?N#44M5H(J@[,M!H=C M/U.S[+S%NQ,,DHN?HS:U1=9>_%R9I=%;6\]=S>A\]KU[/(M=\YV7ZE!^O0/3 MR,E\_AL\?\S;^ZJJF:9M5U-A#=R')="P-8'65:#9C$"6;>OYK64G!.)EX,3H M2NE8>4(@8*CF0%-U_3DD6)VC<=>I%Y,5(,L8AV!:CV=@:[S'1HX^61OYFF&- M3QSZ+J9IJ):>1[0!MMTC>L#+MJJB%7>BW2#*SP;KT>7/]0Z+LW%8)*O-FT1G MZWTR+HL"`I,,@:JS/QWTD],_74%+?WJERJ!$9-`B_!Z5)H.HR2!K>)X/FM\Q MW?!BUU[N9K40VQ5]D(L+P3#\#YXK'YPY;A%7$15W=KW[+#]_PS'[3V$O!>(V MA.\X!#F!RPS?6>3@!<8/3H!-C$,XF\:+F#I=OV=3=^PF1L^ZQ_;.`9>J,C+M M8AF8]6#M$]M]1BXN5?@_>VA;YG.P?6!>S+ZSL7_OT2Y8%;M8^U1O`YR1#4!K M+>46^V2V_S_0H4Y@_QO_XHC0/L\P'(%!`/;#Q5V:FMSCH8?ZE^,M[JQ'F'3' MHD<&@V(>0_#C0!K'8>0O6!#*((,8FPC(MY]%14)8"0P")/>^9TXH^6-N7,@\ M`,+F=$-[&;B\?WMA7FJC[O[`F`29%7ASW_4H>^S1C69I&WMIXH-$PQO%17Q\ M>NS/\0X_KT7^Q)O>.Z&/HY\P]!`G!DY&''XMG6[7)83"T@#\/,AOFKM`E,D# M14[NGG*`3C,L0\GS([!THC3@LVK!Y'BES'!_DXK<=1!OP?"X6U@,F](._8"T\ MA_,E7^P0=#DP4@0LA%IKZ5.Q!_QEQN9+6-7P+QD9<>PO[H"!",^'7C.EA%/+]0+JEV9W[@/$N>U+TM'3' M%*=+L$.V<283H66E*4,H8#:/L0F)B`]R)XUG3G"/EW.GDN]=AH@F^L:%[9X* M@2BED%(1>-4/)IR<8.("PW,)9PX&VY*G@$_2"*4CJCH`$1A&[!)R`]D6L.?R M!P?252@H5P%-1A@1XO,Q`IH)E)#-,!*P"VI/TNH1+'!]/IA>[?+2%7.0?2#I MIRFND>`)F9//*U$0N>01%SM@R[DSYMHK6QYD0D!V@8'5P(4A7DRG$&`''+=" MEY!S&,5CLS5>`(:(%ZSE'<-RZV$A)IN$.)/9Y-;4""8KM$@#I-5$>:'*Y9,G M)<9YB-L9T.]15(8A?4-DA,4&^X#\5#DY%.H&!#R8\`HFN'P^AJYI_XG8>.;Y M<__^B1[EJ^&FL6QLI@DKX]V7%(;C`3-@#)O"WG0[,UGG,`OJXQZ61L`3F+@6 M@?%+Y$2^0^(>@S,1$[AC@`Y47C;ABKP\\9,\V+@[#)6O-7(K+>F%ZY0)&&TA/9BKTC8,2RDZWZL@Q0Q`\KW?.>._;J]PAEW_6'^(K3[$EO>I MK,A:1%:4>*RP14:T1:*5$51ND4!9L&)#S)+R[I$CZ/,2S1OQ^=&=1+-?+K#X M5^Z%0?;G)'GQMZOW[S]]^?OENZ^WMU]_^UG2EC\NI`<"^)>+.S\"LR3=_*<^ MGM5*>[SK84Y::9-?BP&'!,N.>7?ADN\P.'VVQ423DX?VW=?O[S]\3X&]`ROS M+P09[7YWL@(X'D5A4>$+[0+.AH^!L_SE@O_W8F,S:QU.6YA98[*7ZEP?>3?] MUL;AP:'&;7G5O*E<39K@ZO.GOW])+,XVW%BUD-W@SEZ6.LN5)RM+VHN2I;?Y M'360[NZ!Z?S@EXO_&(,].IU>Y!$OHR)VZ*'UTX4D?BJ:!T=6\5:R^PYBM2A_:( MHPW&[TY(V#41[WGV?'E6DPW-EE7+.D_6K=N='F=NQ,YR;_K="VLVIGY?Z@;4 M!Y=QW5!D4S'.4\)[QCU?QK6&NFP;RGDR[DL\.%TM>#HK1O`PUY'"NS?,<_U` ML@::^=,+V+1V*45M=,>K+@FTK-J*;*MG:FWV_'AB_'BN)_:7=^QY%[B3>R9A MET?>94I4H3N__:.W'5N)MBJK(]AN#/4\);QGW?-EW9>V*U6=>#:(SY[LGI7U M(OT6!^,99D/BP0@SF:2K)-MQW0:V!:$ZK"&:(]R;&YNG@=7!-WK'Q%KN>]F?$;D!]<.&V94,=RH;5GQ$[`&K/ MNAO%=&55T<"&.U-/>G]4+.Y3GUD82DE?Q6^\LWI_,NSMW9WKE=>@5"Q;5II" M=,\%JH(C-UN_*FWUII>`7@)V(@$MMM;3D(#VQ[D:03'.:0NEHYZ$)2HO\5KY MEKMG$TE.37<`+M+$C^_F;+=B]LPL@(/"VC)M13=&LF&8S_$%K>.<>O6^<%[6UUYD\\N+]OELO`6 M0:TO6K#!V+Z205_)H!NAN-U#*[[(5T#R5]#L*P?LE1MZ=CY]=C[U MR_O/YH:BTZ`AEM2!;:3S$*V3D&YLP^L/+MT#O5_ZE[GTK=732?DFD[.9%#D_ M>*O'3:N(''M=>@'H=5^_]-U)BCB7J,V7KY^E,?8\N9SZP:,33'+$ZO_J_]K' M7YOMO!6ACU2RNJ'H.A38.'Q](UVV+4TV-[GL<$JABIX?3XP?3=FV57ETKOSX M\JX0_)UY+'#FTET<`G'#4!K#02/W&.K`W]G^=]U^][=,%J`]_-5CO M?48]VYXMW57;?ELZ]BJ>NDAO+)+=`_O4 M!+_GYYZ?SXF?7]XQ_CU;!FSL]A&+_J_^S/Y2=I;#UZU2AWKSJ?V0>9=M2[3U MW'B>W&BI\K`_BC?:,,=&HS]8]`>+TPD: MH!91\0Z??B-!3I6G&V#''T+#K2%;J5C3LE_%TEG'/O>1/3X>Q M"!9I["]8RWWKP#9710/1'5A@7??0'3.HJLJZ8LB&<6H=KP^AEWKF[3SS6HHF MVYIQ-LS[[!N2)[>OW"]$S&LCV#Q'$K;;9[FW3%"G:*%W_/3N?#3#FZ& MG9SNIKB?],AP==E$!IV=H]H)1U,9H=?S+X>?5$61AR-;UC2]&Y3J3?1F-?]A.F7C2/*GT@03/-P'4/%L M'`>4;?)S;[6?E/1UC5"]-N_YJ7O*_)RM]IL(,_K\)>:TA1(8Z-*C$P2.MW'C MZ=Y,[Y(@JKHJ:V:':P#U6OUTF$F33561#=ON!IWV9:&_A)CO=Q9&@3M&!TU( MFC_VW/6JO@^A[5>B.Q=+`XDWE1.\7=[!0'`7>>!L^5:7-MU><]/'2%4GU34(G>T#S@_^U+.P05-&2A:-RBS M2Y7=LU//3KWUW_>!?2*7 MQZWSX[L3L>]L['MC=\Z[BC87:MQX@KY:X_IJC<6]^@"U&E5E;;'&-BDJ"<;' M+ZI['&C%%_DZ6=LBT)P&LZJOSJV2VP8%#-?7^:U,I]I[<=\=NX->!;:3S$*V3D&YLP^OM[.Z!WB_]RUSZ'75>/BE_VT MV!CI-?NQ9%[(WDAWS&-3-Y(<7`XGBB,_>)(".-[M[!K?L9>\=[7@^U5YI&BR M>:X=U7M^/#E^M'6UN0G?*?/CLR/Q)[?+W,#NP?H]YC2[=![^GJ"]YI;@*0M_ MS[AGS+C62-;/E7'W7.C\Y/:TZYGCW>.FAAC%%.<"^.?^H^.-60=ZA_9_]7]M M]U<[+_7SZRYT8I/H.ZL?9&M\K'Q-7V1ZOKWVA\BP)OCO\NC,+4TEZZHT/=;W+=[U962C.38*1GWA\G8!V MN.T6I179U^_:AJA;&1=[M"OZK*&`#X2Q-<*HBK*NB9J=T9R;9W&L]28:[AS, M'0J1&XP>8P\S1L]H.G\BF=>"<4?%BHZ6:3L4=#`Q+.1^626C;3H'02RC)1KH M28NX8N^`%4=4C#XI"J6E7=-L,,[Z]^MP2OGNPZTCF[=0&>09Y+E+\EQ['2Y7 M2[_A/'*G%==Y!6L;>8A?H;2Q\"EC332=C!:CG2MP!/D'^=_,BZJF*AIZB>/* MW&L`NQ)?NJ6SR?6_\\F%YV-7?^4]H_&E'[G^@X=9.@E#%(47BV@1H)/9/(B\ MO^.7G"];;F1T\Z4Q(%3Y%JCR-;7&JWSUW'Z_%6L7+..G5L2*V<4(7Y$;D#+4 MI!M]6TOT1IW?NQIV-*PV+5IW[@LA,[R8!Y^>$#D&Z3]<(3=$8>:%JP>,U)^]V33O4=H=_/\B MC+S)2YH_6+%?\G;7I8\ILMT[C/7H!NO1W6';O=KV=F^A]NV%388I-^>[]S>F MJ&^#M+B[82^W&C1M7<&GB[IN==_G%2KNK:"MVZ0V>MR%36<:'ON1L]A!XK; M9@G@1#$C2Z*)LNX4-R2]JE:K<,9C;4W:(6_0>;[/QU/6.F[8)E;R$DVDX'1* MT=,I!Z00T_*;R2=<[E`8!=XH0N/["#_\V?>B\.2[&XQ/2/][+WK)S'12&;,_ M.<_UUW7F(^DUF3?SCI_TIF-OW?YK]46+VYGNSP#E9!%38"8B)R^@[MC)* M>X:8(RYB@RK$%K7@NHWF@H>#GJV':P*H>Q?4_0LBO^5;V4^><9CWL-]XER,6 M/N+@:+^U(T<,G+D1$BY<+^"9B3_@T^+*(S*?4]H0Q;E MK!N^>=9T$-SN"JXBF3TH'J]V\(T3[^2\KNS);@@:$\\TP6M+PE?^`@TTNZN: M+9HR."4071Y%5Y)+7!O`D]3V:-'TZI9.77^$IFA\?#$/)LA+2I^#8O=#L0># M;JHUR"S(+&\R"Q?(;3JI>Q1%V$<)WUX$+PP7Q&4)\PFF%%.6YZ[:6?X#M>SM MK&4O8%;XJJ[I7BD-J`ZWJL-!H0&L&`_<9LN]39X_R\&G96C@[A(#-MI`='D4 M7452C6Y*+6RTP49;BZAFKMF:(XN*UM'6]R"XW15<65)ZUD2I@XLFV&8#Q>[+ ME@7(+,@L;S(+VVRPS09[!:W<*X!M-MAFXX>K5JE.K[?94AQ15MRD%D%CQ,P-1*7$2;U.-46L MM&[NE#O^`X71+ MZ'$>>'^C\6=_C(+X/9^>R.]OIZX??G@Y_X&"D1>B6TP(NG/]AY*]BP]_#;0S MSF]GO!W),6AFK,BIMZM-XG\J[^]PV;VJ8!*PM?P4H;X]U);-Z[^*E)T(0=.K MG^S[=S?2D077.X=O$K163DLBSRWA;R)K<"BR*V<>QTO%1+8;]C1U)R7!)7;" M[;4>D?V);A]%+9PS@)LMW.TVYPQ:OU.FN/Y&[Y0)OD,SU_.+AWB@F75H9HX/ M;K<(=4=+0>0A]@"XP<*!A6NYR)=9[QZ:!^%18.-]#&$^X4=@U]LP0KP/P^Y* MM)8)=@\3CMPIU\V"U`+QHUJ0QP>UXD"M3O$<7Y`;A M+[W:<>C=#BZ/8>`ZJ.)'G^+H#[P4>*FV"BAOP5]?=\3!/W&@3-WV3]U0I`J' M=%M4R$Z3E*5D%&GP-9`EIZ.-)[EL!\1>"C1'-&Q--.V.WJD$8E!(#'1),T$` MFB<5'!-Q3'I'.T_V7A8+^R15MD2YJPU(>R\&8)):(XNE.RGP>82>O<@HDBP/ M%,EPNBDWO;=AQ:3@C49!$S79%$T+!*(%I#87VT@JW$_3`E+!FY7U9I`@:@&I M[7!DJFZ+B@X)HQ:0"G8,[%C5[2]HE!%J@"B"*+)8ZVHEG"WW7>+A%A*(#RK&!Z8*]ACL,;O0(/M3?HP`MIMW MZ0/;S<)V=TY/2F\70S/IPXMT*Z0.H-$ZKS:Z67G3-5%S3-$VH;,_"!R;PF.U MQ#X2]^WR^W?E"OCW;/]N9*3(P-*"I:5G:571,171S'+M8&]!L'IL;SLG_@W? MSG/XS38E+^QY&SI,O@"HV(4\N21/7?P>-L7\%S M8+K7DMN4"RV92:1/^.J++^?+!@7?YM,QZ]T?[2?6C27V6*;?!6]I>/;,+T\\ MN'Z=+6CKI_^+&V`3&?$-0OEVBAQL5U`T.F!`NVE`&33!KI^)^N_GJ)\'!EV3 MZF>"02,EKNSG]@[PYB2T.VIN=7G#`>:Y'8L1SA/1(!P@'(D+^L.I_5<#33Y]EWVROJJMI- M%G5=%16KCV?86T`SP M"3Z]JA/$+(U3W8`3$`W3$ITRQUEX\@00LG1*6F7)4;HIJ#U:23N[^XB"%X8+ M"%K@$P0MX`:*!2VF8XEVF?X)//D""%HZ):VR9-K=%-3^Y5G.?SQY`80J\`E" M%3#^18S_SYJLBG+6L0J61U*2',@O$'YT6@(56S)[=CU#EY,F%_-@@CS8XX%/ M$(.`!R@6@ZBBH%+M M6%I;0Q=H0,DH]-$-0Y2=#-=S*$T)`EE/--26`2=P0)9%%VT%.C,T#3R(:^&8I6?-I+J<98%CCO`)HA4P_R6.&!BJ M:)H.&YK@@$';J6YBFT?KZ'YD_Y(F<,81/D$``N:_3`"BB*9ABXX"(0C(((0@ M#>9`X)0C?()/%0,4..78?L<"1[[:@0.)FF8"UD-P;*Q3ZR80 M:!#H3@DTA42`WH%$0-%3DFK%]5[6'/&VWL.\"./YXML4=2JRW62+?6BK:Z+F MF*)MEBBZVH]Q\\2L9<:GLKZTAW"FHE1$P_ZG);06K3+,ZJ3=.8'?]+;'D8LG M_>W'3:?RC\'@W!]?!.[##/G18+"F>]OSK'[XU_$B'#RX[M.[^]$C&B^FZ-/D M_M$-T`P)^:%+3EG>1]B_K@Y'^XTT7\DI,P7,R6WVV/+7CCWX[H#BDIBN.8DNY8 MJJ3INB0O_R47A?O$X]^AR6]'$XS<@/CN@:R0_Z+Y\B?\GZ:L1I#WQWB_`N+L MT^GPZ^VY\!C-IL+MYP]7EZ?"T>#X^(MV>GQ\-CP3_OQ]>'TE*)(L#`/7#SU" MISL]/CZ_.1*.'J/HZ=WQ\??OWZ7OFC0/'HZ'=\<_R%@*>7CU<1!M/"F-H_&1 M\`;Z)N:KSRO2[B,WB+:E9#>VVHQ[1OBO4+`1TI&Y7/]A.:G'8TW)5>PC'"?] M=B0O?WYRQ^/USSM)B%5\F;2.BN9/KW^NVJVP[4FD:>KV_?-M"&27@*:%LE^1 M&PC8C*#Q5AB;&<%N+P]*,U=K MU3LO_$N8!`AA/<,3A\)("-P(Y4D*OR*@2*;Q4Y?9Y,*=N-]`PFNZMDC/I-= MAJ8?G.S:&P.279#LVDQVR9#L:BEPDILU\(8+; MIUE%6%OGES"=+9FP!K6P^(2IDIRS8"U]5]S^EC;%65V[J*9GM8Z<'BCRVQP: MDM62Z>)"C8V\61;4O\%5O<5%LSG4W8$FFBP1(SJ%355`U=9L.3J6F&DK]YDLU9PB`9 M_&FF+LN,V'NM8<:R[QB2HBE:5293A\K2.H,1IZ:DZ[)]<,7WWA@9O)F&P0S% M0KSEP%>&-\4T;?;(*8;FY(AH0?QV1FH9B@7X+(AE<3X50V=E=39.7V##*%N' M09HV5`:OML;((9;BLZAU+J'8Q M5IN)#C!]!YJDM*$R6-55DXFBFC%1YJ'10<(@65&L8FD&(^TLR%YN$%N"/471 M+=NFP=X)N3WI`9'%]H>7Y/5W_+\_4$@6:;^%%+Y=^&`4+\F7X*7I$P?#1]5=9C]=VS9?^\LV'S7_Y]Z5&^3]" M[YWO37\[PD,AZD$_H3[$+YE-_?`=?M5O"15MJBPKQW]>7Y$LTLP=>#YI%S'" MM!SW"YVD=4H!=`Y8MG"%S@+3^@61,_!H?/*,`O0-4:T25N:9R@VH\82$C,[K],E9YK)71W%YT.+*2OVBFSW-? M8&60PDN"53%EN@NHVJ+HN\;:(:ZZ#&K#!FD]],0EGM%,W$D!R2DJ.?7'?RF2HTBRWF/)N9G[SRC$ ME-PLXO-_]4K&SMMBW.P@-FT]ZY."'UF>=47ZPH3$6@?6Z8,^FH MQ=RG2H=J@'1P(QUUN8]4Z3"[:3M>Q]LX3K$^@W2V.H)TA]][&/1%WU)G$<@F MR(O])3X%=(MRV5WHK(+0%:QE*P"=#M#1TKI:VEB!UK'0NF+096M=&>B:U[IO M^:_[5N9U0Q3,-HH::QF^WA)'1=ZM<:R%B2YA49.[>G]K?E6O%?4,\"BK&_6T M4KPUOMJ`1Q7]J,6Q$#SDZX;`H.VG_GCMME*OU]]^3T,+)>+W)V MVR@VLV:2;#G_[!J@6$(762^?EBBJ%J!(4Q>;6$E)MJ%UQJ*2KJ`7`4*7JYZ@ M]6"8])8F?:*LF#1V#XJRVEW\&O*&LN+0R.\#?@WY02P")N!'1?\:\8"R*M?E M`6O$;UGCL>I:%IXLHL=YX/V-#JR@3AMU73"1:1_3"R8R3&)BS8QF68XAYQXQ M/X`A2BA\>HUTO"!^AE(E>_JX];882P)#-533I!'IIS/%-QJU=4=+5`ULK@P: M=;V=1$.5-5.R27\*R3&M3$QD:Q,3_--KH89&-"1AD!QD3%J%?EU%QBJ*C+V% MC+V!C%4)&0N0*:(S#@V=<;JM,QOG[:DBDS`N>T^OF(;M*!1=?0)7?,/!U-6K MAH*=/8W<`"LX:![FS#RRR;:U:1(XE`U7+>M4^==A:7^MIA)L-@6@+(-RFM*U]2PJY!TV[(/S@[O#I47 MBZF*9=!(2'81%ELQ=)D.++M#Y:X?-<.BL?O235AT6Z$%R_90.;#HJEJ@M7H; M8?D8S,.P!FSB<1E5";"/C&/N^(:E_LW_Y)2+85H.`).I+W7OZB<[?&SP`)D< ME:E[OSXE2^E8MD9Q"ZR#P#"XVHC]BK)V9&H^A'Y8^[&Z2PO3VH^I-(IC&FT5 MQ1G6#,H0T["FTF@`L"ZCU[67+*;J-8UV88!U&;VNO;PQ5:^[8L,_+2+2%W[L M^0^7?A1X?NB-Z*&:.OJJN4].5)7:$JCD'9&V0S6(2N6J-FAH='5+&_6UJ#1E M&SZU"+7,SKNN:8YIY]]0=0`?_$Z^4V#R=S6@5-F#K.NR85`,1;HR^:L>4GF3 MO]MSJNSDJXI5C_FI>?)W?-'Y#Q2,O!#=!MZ(NG_(>A=M$Y7JUFG6`1?DK1_@ M431Q2>`I<4-(P(X^=G0M9'HSSWHB`P;@+8W^91@N:-T8ES1BGV_L8SC#/;UU MC]4,JXIA2+:JF/JR>,>098?\STI?NVL#67N;VO@GU5F-)&>,E5L);!L N3 MQ&A)5,+<$OREU4I+$53P#E1?F516?[!9RG4@;#2F$]A8I;&I5'+?/FSVCJZP M0*?42VL]DI(:;6EE0F7*'/<5Y+H.NJ2!;)?+4;<;Y81S-O6C7/*E'5#EDASW M%63&JHS_JDR==+M!SMSLJ@'?XN]KNBRD5-

FSW"]\&2T%*]:0"?*OJ;V/E M'Z5NBP-\J^IO7I\+1X/CXBW9Z?'PV/!/^_'UX M?24HDBP,\3R%'J'2G1X?G]\<"0D9A>'=\0\RED(>7GT<1!M/2N-H?"0,!O]\ MB'XE-(R]9_)1V/B\(NT^INBWH[/+^]NKDZ_OA&_3 M^>BO7X6+3S?#P<7)]>45_F[HS5`HW*#OPMU\YOJKW]Y?_M_Y.T&1GZ+U%\.O M5_@;+W+Q3*^^^W)^^?'W(1YV/AW_*ER?W'V\O!EC$FF2/CN18_"R?VI,)P_>2/!4FP14_W&XFB#1?Q#&`E> M**`PPMJ,E4QP(R%Z1,(#44%AC+\2A>5S^*_)+][^"32Y56(Y@*Y/TK:@PD+ZKD_WA;3O3]:_Y!GM3*-0)$& M^,L4^%LGN,_^&-M0@L=RZ'BX+9MV1\SDZAL\66AE%+/,8%:+?#8$K(H*3`W_ M0P[NY6V)[M8B)#U8P.WHN\N"AM@'24B2!+VJ).P^6.7R:9"$%DF"4542=A_, ME015,E60A'9*0FJT7%^)6GNPWPLM*E)R-?^.@N4G;^9%&0L8.B]8+5;R/'NQ M!4]%-Z_D9O_H\-I-V++<<''8ROED.?;)@%IUU+)<9G'4*OC/_,NA`;9DV)CN M;G;"*J[[I>^[5_J8I;^KWL7KDMS=4U>.*EMR;0BF\]HG,&M8?R:#2;IWZ+E] MH0#+`["L8069B*4AFP5Z20&4%:&DM@1,!$]7'5,Q\P]2\@C?QL&-VN';?U9?X`A8'H!EIUQD?Z&LV446[#7``CY:R=G] MEV4E9S^@!\_W\=]^<*=DQ[R&]/B!!'5M,_7`Z0#)J2(YG=A\!PW=SF6E3LT\<`=10MW.D3!3&U`3%)IJ7L+^?VM_E6_ M5N2SIN0CE7,0C>*B43"1I%NQLSE<9839BM&++Y>MM8U4E/&B6C[;:JJI:^F_RJSLIA M)N_N9U5/+DVH`8&=1@]O?1CLF&@;,V(;RW8*BNTDM/%, MS8RG/UZE'U):IX1L^BU+?8T0Q#E%U(CJV%+X9#K0# M.=":D!I#4^?0"&*.C+62PG^DD/LIMW&;]:=Y32ZKK_($.:C:HT M[SY(BV;OP?(-96.-<8X>8)AKA7+N^NVS0))RONKS4R2+=)CC#1R0\ M!>C)7?9A)?UC)IZ/UR^>.\4$8U[BSE."1YK>^)-Y,,-AWK)9CON&[%/@X2>> MIICT!^2CP)U.7\COT1-I.>,M6^!\QM8&_W1/!@W)BTYF"!L3=]G,!L>DPNP_ M[7U;<^-(KN;SGHCS'[0^/1O3$;**%U&B>J8[PG95]?AL5=MKN[9WGS9H,B7Q M%$5J>+%+\^L70"9ODJR;)9&4-R>B[#@6 MZ)03$6$:CZVX99$9+U+B3(.04O%,<%C4`SS/8OZJYUK/KD>:*7UVW,CV@@@S M5N*3*%Y@)MCU6R_Q;C"W3YIE9RFE\+VWQA.R%^8GC)X1N7VBE@,*,]`P?XM`$4]W#L,.VPA6(07@NB`ID6\_HTF[G07T/DHC\^`5!> M+`_IW!@.^Y,AN"+7@14#OFC9.!'@M#$!VB?V>+;\[R(!U-@=C8%Y/!>FBK]A MLB8.+&(Z6&1A7W$0AHRU)H#=,7P.82`1-`.\\\QX/RPG&&`I;GUD-J/:5[K: M;N&>27VB,Z3=>F4P)H?&`O^B&!WJY"?=;)O=/CWYTT`9M%53:R,B,:.4^\)@ MM#`%]@,>YTPG\.[ZR%W0X(RP_9DY*!A@"-,`=L?6+?Y,J;=N@A!@3_*G0UFY M'(=V3SZB%V2+*`9)@#4KM*NZ\H,.RQ:X^1<^`ISH"@P_`N@!`D>&)K MW/KH\C:@MR2,T]?;2'[C[API!7`[Y"L4Y)3 M2/$@[.`JTU#](";.#ET&4\,%AK4,(N1S(%*4V)G<%.O]S#P7I`+.%;2K]/T@ MXJFZ\/6HL)O:0%"86.A&WQ%#=LH="XO=&/:X2<(0"9G+THD5?FX?_#-M_$ MH+F(%>?[ZGI(AAA0Q'=2,65`WG,2N3XQ6DB?TT'@?LD8?R9X]@1BZ;%I$D:8 M;*[X]A1/'DYMKQ"J9NL!A!PPPK/7)#TLM!R6B@;,`IC.@*2";84@4"C+8!"Z M(P`:@NPE0#.1BUL21`#.3!,`_$"#F`'0"9+G>)AXI5:SY(2H?KVX,$^4W`"[ M((^YR#47?(QV&0`CO.D"J@M:K\,`J1,$%L\]Z'G!*PGV4N^IV,/]`#9#4+>& M,Q*Y(3SAX>32!T@LSEJ(U1'LAU$1JRYI./3<5D2UKA$_B!$03'4'/ M>3J^PM89,]1RA[`!P!\.@RDX8`C;@>?A=@:/=A!`F&DQW607FIHBR8(D`FH4 M6\0>,']CZ$"3U#Q_B3G-$<=7"]/%/3)58#C%0;F86B`='2SH.Z0]BM16;CYP M/39[6V@2V$H16@B-20`$`PGHMP8*Z-4S5%&&<9;A,F^"X7X<99VV6RYEWX3^ M_,"_A$4/$Z&#)\).$%_!<%P?6F0\76>41+C1'W8]JI!\M[!!^<@F#9)XA3%S M?$6QX&*&G,A9GG2;8#)-$!9@I,:IAWA1MQ$0K(5(/(Y)(C9`FW MV<(HOG3]MO@+0`D[)UA1)P>*^S``>0FZ`1+Q4ZJQ-@8?I>'G"G=Y^7'%.VA2 M@+APN9+NHGP.7ERGM.R@*5H8.GCI`1[$@N?I=//LO$G$<+/R0&I'J32;BI&T M"\X-87NC^042<0B/MV;,"B/ M^X$7C&;<3D6(@#X(V_R_4L6QS%.D%V8LY89E?`YQ2&'P@]@,AJ8I*;^DEO/0 M124P0KNH,*REOD,<#\R-`>5:I/#A)@+*`W'L@HNCO:0%3E%JB#1%W#%:=\,A M*M1H:-)@7S!;-YI-8C#0@_!,H`AHXSZ%UN+"2,HM\)?!P`1*X73',,_4VD_( M18),#T,,\5M@<]BW7I@73&G8^3(@*5"U#'%]@^?8$J0!&GN@(OELZ*)/@026 M(![\/8F8AZ)L#%PELH[S/17]B*#(1?@]-(B;K.7CX+F;*2!=-H+9HQ=(/.#! MALJ=H'R$*)`[K3O_ M:-M04)!01Y_3BXY(,*POVUX@H0^C*2@-J+-8D6".Z)=5M"I-MJ)Q[]>=)6_%/H+ M\S^=M-_KNX>/GQXNK^^>GNZ^XAI;]O>6-OV!HL=U+I!%8>B_7CP'<1Q,LH;[ M1J'A3<&R;EH[@`7+%[#P+%''W2!:1>Q]B%VEBQB-@'7Q\U^ MZQG<7WW\>/O'[QD*8/W?7GF^\/_#FDS_YC]'T[_58UAJ38?5^PL&1R"O^ABS MT?*#U]":_GK!_U_P4#6#%@"\^G+[^Q]"-JV@[K*1OSWP#T5A$[:>1T"#(/SU MXC]LF['A\*(XPT:+&-Q!UG'IVYRTG]7=`$4KUE7\PM?_6./9$ZJW`3!V_]-Q MAD+6Q-MC$<`&+4SOZO4@SGZX^W4,&OA)\797\G93>/O88]J0R<%*T]1Z4$EN MX6^QN2'97+*Y9//3WLM[DLDEDTLF/_6]O"_97+*Y9/,/=+R0?SR=>($O@3^Z M_(*!>ZTKN@S2F-.K/UD6SHFAZS@/C^;!+[5@#(CM)12!)TZPVA1R@J?N%/L< M4\BP/<;L(_S6CQO:R82G-,`O'#PC95G@,H6FSO)@43KI]WEWK8DU$W'/=-R( M)_O%^,I"`+6XE_<#@K98E0D/V-F M#IW"\]/YPK$S?Z9P[CHW/^J,3P,^\4B=-^:8C2NBN"'F1.N+C-/CG=;G_!?H MOQ`BET7<9K0!4EK>+!(!%P&%*(C0NNQO5*G5($/*# MEN7\5\*CZ^D)<1OLY(*0'@O%Y(M)@AHC6_!FCHT1%A3.1F$B5X\WK:=@ZMJM MOFJV8=3Y%.W"%'E@)L`M!ZB0'J,0;[7@G;IV'I*^%LI4TIZ')178R8KRX`8+ M]Z99'N!'H(K`WFQ%/'N%N&!7:I)'?5#C):F`ES].#8VW/MUQ>K)^-"@.[L_\ MA@0NEP>(5UH4$,M;-#]YF+Q@+2NTJG19F\ MUG30!F$W9#PBS_KQYK72L+0G#$6LD]BY\$7<9@"^C#9@*XYA3`F/[`!L\JN@ M_+=G%K\RL>\LN9HZOY%0M!S[(>*N5UR5Y>%\>3@/C0JY-<+0V\VFF&UT?(]A MOL6Y"]X**2*OR'`\>E&$N<(C_!H"7QP1]2;B9OQLG\1;L#!/O$@8SDID24-N M"YN\T$90W(0@$>+8.[W]YD'<-7[@X&K45O-G@2>R2],4<PL!LYG(`;97HH M16&1[A>&J+L2X%.&$+="4$6Q0=4`&(41JQB'IGWE\.05$$BKX/C'&&$"; M1S+RZ,J(>9ZX]&X3#Y;:Q6$,W1^,Z[&IND,()J&4JC2"R"(,L' M.LQG&9&:/@-!EH;.K^2&><#]K55&#S*$/"$.E M`[SZEGBQ>TGAI[9(-"Q2(&3D1!P(VM'U3\OSQ,*"N?$:A-\+]U'Y8D<8".VA M2D+Y0J8!;2ET/95Y4UC5Z'N;;+%@\NSZ5N%Z591I,5$[C7OE:(C'A!F19"#* MEQ=E(&@\F+]!(!.UI0ST>#<*<-_!=!#0NC4*F!$'\)?.CI2D+`ZZ M-60X"@L=$LPA%N&WS\=6.$(;9P@:W25I7B^H@*4;GF`"8?9D5"S&.#,>'$T< M3L&3V5.`D^RN1[H1BJMV&;F!;)/$%P&]%!O.*;=D-#EAQ(8>X%V2G*$$;T;Q M_&8M]B*A2N*?U#5=F./1T@X9CJ\9)G@HJ.7/4;!-[IP`-]FI9]E<>N7+PV\Y MNI/T2G#+IW)A"`=\;X$N0CSD&4I#DC>$!EAL4$_(#.FP(="W`"#APY=A'-Y M6'X2\9O=A7L"^"A?#3>[%83W4QFF&9D3&'AW$S4Y?H$(;P-EZYS?Y6CA'I99 M2NF8N!3!NY^(1+Y#XAZ#+1$(0%=.(A!Y>8,+_#+CRID5^DT"137:7`1DLGFV MAX_Y]8O&8+\T@<+]D67WXDC32Z^/D,*3_?23VNX;W;;:TWD^$JW=596VUAV( MA!"K^A@6[I'4Z0)#%7BZ"7P\Y\JS/MWPS"(/;O2],9CZ7,JX$9(Z':6I7:8! M^K=Y`HTH>?XOS*"1B*M,14;V?6*'KS?(<`%F&@OQR.B6LH2L= MH$'05;PDC,A3E>;:((F;*D^B)Q2HT8+IT*$,%B%ZY_%ZV6NFF8#2PF]8B==9 M[GY-L]3D:GUV[Q0OB&6Y&#CZIT$4X=7'-"4-4:J=YBK@ES_;A:M9^5;2(JL* M>\OU6#HF^@]]\+?4>A<>X>;@9TN!\)IGH8FL24%M)1T5ST9@D1-"'**(]WA-DR?03;CL+2`*B%"7_*LA-?[5FJ6SU`5?Q"YJ>`5;)K4@T.5%*4;$'46A MJ/*99^/@6HK/CPHB=^)Z5HC)K-`6R)\*2F9XIAU0UAN'V72;%#@6%27.ORE+ MTQ-@6$Q*R6P:IC@<4*BGU7%:HCQ.B^=Z;@P_7EL1*(VH#H*PBTBQ1#,.(!OA M1%(;(A&G<\1N*!;Q1$^X!S$)6H"9KR"$*ZI->"Z;"FGPEKYIP[1:RL?'',(WL MF^/C5&H74C'$(?F"9^)MX8U/#=9T_N*@D3O9D'R<;DM:SN:>9P:C/)&T808^ MM!<54M/P;RC1#PB;YWCS]1,#"(2WC/I@I1[",@VS5.A%FM/FB@X`D&V7V6JE M0_>S+ILCU?:?D)1?A*5UYC=8&=?>Q9G.W&(]D]3@.3W7L=TF)H":[OC:RINX M^UV#Q0"THU[C':R]QGO,.XV][N;16^)Z\=/=?7JW6.D8TYC?+BZLR8[#7K)E M'^C2Z.I[TK`YKIKHVP-0-KD>NM>`RWUH.:MC,%.]'6]?[RS8ZC"13R2`4.:L M"RFM$]H/&6!XM*E*+JX:_$7K^S2X6)-2!^U7Q^%(5I3WHFVU-.\]$E8T3 M\Y^R*)LL>B6/=%F;3UIR7ZVXKVZ$DM)EP?OR_+=:CJ[=61IP MO*&T%>6`&\BY'`37$0,GBUN]K6E&6]4/Z$NJR1GP%D%+W5/:P#Z*.SY[.&.#>HQK1@-*6C:/6@S#Y%MH23A)/4OC?SQ$NI M+=E,2FT)IUI0YN#5+$\X\^)](6'VDM!^3/F+"=9YN2S5;!L]LSWHZ=G!Z["< M<_2544IW+#>)=:W2+*-;9THMIFQ\*T=S&RM:6%@+@5<]$.DT"QDW*9UU*>?F MN2;8W&J9M6[;&/3;JMZMP3*KI[W,_(OCE@&X:E'S`G<&&J6%U(E(JTHD*EB2(YT@>VJQK!^>$GW6BK M/9.7J``QV5?TTRXG<3<<7EY;'A49>QPS%K>N\CILC4(4B1$_P((YE\]B1A'- MJ%!9[J`U#JI8OP>&*0ZI_H2HAWD?!C[\;3=L!6_]UE4R2J)8Z`7(N9^O'J]; M;A0EF!G_\5OKCX!^O$2FQ+D,`ZS[QR>SC/AS"BQU](3UEK`R6NL*".3P(DW( M[C]%6)$; M6A=9R[&94>+RXJ98-"ZTJ#YHE'95J-1Q$SCN,"M\AOFTL1P(R#$[H>J$6#6* M][K0LL4WYL>KZY:J=GE9-5%'4PC3O.F\;QC+F!?!X`/`"HH4@T>5=*>A&X1I M,4][86SIG$ENXD!!+2\"<_P+.^F,M?3.E/[V5#YXU9^5H0,7("4WTA M4A=0W2G40NOP= MC>`U;%*4O@;J"+K#HB+9LVDZA16@-.:E(8B99I5:LRDW1K/9.XO_9P(H>9O! M.7=KNW/WK0_P'6&-@*AUV?H]"!PJ/8*+7X!%5'\F[=VCWMV\=ROOO5"1GFHN!!SCO,X;GP>6LO` M5$%OX#/2>T+F6:+`;K'FO6@1.QX),G9*DH\J%$6%J03`0&%$]16PWLP_$U@F M-"1@C$/@NR"D9[(Z\EB\B);$I3*6DR!$`?D=JQR20$*Y0>47L(+B.@IA"WST MO)ZX1<4%.-W2'G$ZY3Y]V#RC",L.8^$<4;():09CQVGQP5N^Y973&!D'^LGK=%+9C,5VL@'R M,?.:E3X5`J+JUS'7P#NM1XSW8#\L+";)[5$WM)-)6E>1%S**7*JF"@12?^;5 M*C/P(!B$6/?9*!]ZN?X&Z/4_%ZIHB_%R=3#!$G-1_C:A`^L64'U0:*3[A.YI<\*M12Q3>&;H0SXZ;3,P.CC$AD#;&X M[B.;QMR*4@UN175:GZA>E.4('+O4X,2-8RQL!9NIESBI.%DRFE3"K!J6Q8W! M%DWQF0V1A_AVTA>FG#M\JX)ZE%H',766TDB07(I*^ MW52!X.4UD0FQUA?8)RMD623P0J(AI4D;P%7JD%?3FH*%@[!/@$_=?ZUAQ_26 M.%`(&T#NLFQ>R?>LE1'8A;A[Z@UE1+U4C-V5$5ROD(VQ>!LLQRV/=Q,*B*:1 M`G+//79Y,<&Q)/-$86JQ2X!N`JSF7P:O/G:UX?B?64HW M='BZ7%'PR8CP1QY+R^P%8(V5Z;-L*@&]&[^B10B4):&5D$Q'ERWWW>;BZ:]6 MN"`7:?U.F[8CE@ M$0H5VB9HG)=H)"RIH66S%#C+A&]9;P0]";V^J%E@J3>J3QV'0;&*(A:8F";/ M'NZ00KWD+/K6!E?&)%EPU&&9.#VUE(92+7;,Q2E!>1*VUO! M/YP9+H"HD(P26,C_I7+%XZQV+Z6P>6586K.!X8^[;F!EQW"ZW-F$;I:CCB`,1@3:1%B'!;:68!NF]%` M)U:$?.V+:1<[CI`YR4O/"CMR$ M+SFZ6]<@V4E^XR.C$(MK%EL2QR-1YF/`Q[Q\M7!-Q,!I.WYFV8B.YN'B2I0;8GQ,PKB9&[)IP'<[ M3/2"[U,59WH1J[;:P.PS$@`3//G9@],+=-5+$&=3[CZ*2"3]E9PP0*.L>&MY MG%1@O#Q2Y,SB^/BSN.Y_!5E**P"/3*B4+!/Z"8L&X@0$CZ)F4W3D8EQ5 MX)=*57?GM[_E,9%\N^XK?_E;ZW]_>GBZO;GZD@8^TL8YC<"5<(!``,7=EC%X0% M8A6#W):WP`5);@.U'KBFG!UA?WML_7YU=4^/H;-JT?AAQ7[G#KU3N(;!2WI^ MCWLPU\TI5*JP'4Z*PRJ;U9G"CATLY5QX'AKF#\R;0XMSH&%?!Q0>@`6\T<(( MPI'EN_^R1#A#`-L#V@LCSM,8L.43A0HC1D\X>1FM"0W?3PT9_+(PG>(%M21PB"I[T5/B)4Y MV=Y:@T[K"M8K@;TWW;))CRA&(J0>2;'[WGB@7V7A&;1]EL_G%@S`Q`^>(Q:^ MD!7J^M.$-*Z8C8(01";)]"\`8J^E%_QM&1IH5W_D.V-J7@,0)FXBO*_X).ID MT1)OG0A6L:!_X=#E/:E\'+A/"!T!':>723@M' MTA%,YX,@QBP=#=]I,B4&)P0Z2.[^+&`F7;O<#_H6YRPG7SM7V0K692*V3#_P M@A0P MT[)S]RV]2NRZ*YRA&VA+FWH1,@]/&D7Q5J00FC(+OH2RT<)7(A>U<\L0H6!R M)Y8XR..JCY\9/X6P#.'T%(KBRF87-8;_?GGYR7<^A]8(E^7R,M4*RC>\Q(>_ M?TBBRY%E37]YS&>=QQ#>8T0N2(8GV,BO44_X[=__K=7Z>_9.X1#EDSCZ<7Z] M6/RZHZJ#@=E1\G\NZ!`%FGU@PU\OK.@R&%Y2T`_\5U<7G\&ZB'`]"F MTYB'T7;3T/L#LV_JAX/2IM.8!]2VTU#T@6(>#E0@+W;!U.)K*R8Q&!B#;G=P M0*&TX2SF(;7=+'JF,5",PZP%@6/#6Z_W;]Y?:F=7'YX<.?^LV'#Q^?/K;^SS^>OGYIJ1VE]93%"%C>AP^?_KAH M78SC>/K+AP^OKZ^=5[T3A*,/3P\??F!;*KXL_KR,"V]VG-BY:.7ZZYP?*_T: MAO:(X0!EA?<0%WH.>'D'5[,UX&%@8":&PFLC/$^T^HWQY:4WL*PD'@LK&H.? M*-J('T*0=QT--4Q/C_\KW$R=9@00EU/1_^0'Z$(HN&-4<]F[Y5NM^*+5^@DP M;.1O=_#JT'P?Z(4J^*O;:`%[#(C3;W?[>MO4WNZ$A5D8/8ZKD+H:S;2%2X:= MUC\X$Q,9EK=),0KH9_"XXR.$1L@L=E]@?$YL>(8QQ(ES_P<@0(;^!MI^!\^+P1/V>@#0_MWV.1;ACE!5V@N?@0;6MF!H-%1]$ M[Y]KT[5OGWQ@Z!Y"CUCBQ=:!+SI6L6QJ<=G4MCGHMPU%WV;5U+8.K*T:>DYH M]$[SQ2J07*R+WM?:6E_COC%>6:O%?K#0=B/&G\$V=:,-]B-WV*#GBI\K13&S MZ`09CRCQV1=89P,SF'.>G$R]8,:RT^2L6;[:\+#6;_=4-9T=OI,/$-N]_7@K MF!K'#S)N^=W679U"F^H=2Y2;6UHAOJ;WY+A[I$E<8;PYW^2C7+G9Y&G23_KK M+-!4Q5%+*DY15^VO-4>IZSDM3^OW%A2\349]/-+T.J9JF%H'<+B&-JO5OV6M M-)XX_4Y/UPRCH^J]]^!F22,G0!K!#3UM#RQ5;*1ZTMQDTO)NR/^.,13M,<^6 MLI9>:YL0C+.A7%K->]O+)0.T!OC/AF1<.YDZTK8RF:^"H@!ZPBG3MKVS!6AUN^?>?@_`Q-4O6TG+AE6KE*1!Z[<+?YIP:MIPV=)2B:8(V_),N M6E)6M+5.U!A;*`M'9B98ZEZ?3^I=5O=B*^O82=E&A3HF;$!OV9`J2I]#A%-% M?.J*-G:BBEI?J@PVQHIRJ>B7FI&Q$7[JB39.BRHPL&VHTK_4!CE5^I>Z(MHX M,0X"<6F""C_89#]:+7.7-K-."3XP5?C?MR(WQ,?LZLTZ$BU_KUJE1H?]WMQ< MTUL^A6II5YVA:@[ZAK*IH?INTM&_K^$=!V.#F1_Q>.JUI%O^GL`,ZC3]=SO= ME[6R5IO>0FEI).R7_Y[U!/GOUB;R?6OCC'<]4 M]4FP'Y'[B^]ZOU[$8<(.`+@?$\^/ M?H%>?ET2+09ZFOKA_WS]\FB/V<2ZQ(-UO"MQT?I0+:[6\N!J1&W%@XT&4V4: M1L.I9NA=K8,^DW<0;;&-3;3_C<5]_8C6'?3?3;3%-DX;:*A#H<*X+Y]]\(VNW@VY3>13F MW-^4;&:);&:!;/V=R-;K=IM+-7-SJE'Z]"+5%%TTL0O5-!W/)PY.-LJNL&DP MT\+#QU/UYR^`J+JY/HQI8;S'(\GJ"U8;[H=;W;;2^X-:$V3Q?L\&YLT:`JV[ M,W1(`V>IIYD86RV;3 MJ!]-*]G5>H9N]$^6I+T-=\75*-UJ5P0UX<11>G1%0]5TI;]PP_YT2-K;4559 M@]K*594C0O(D5;WCX6^M4KB;TW^!D7N]$Y>-Q]*NM4$/[/NC$Y)_O6$T\_(W M*E0?N^:FV%L8=14D.K[J8FB&NCY,HT84.LEM,]!C&.+E9,O=_7>G6DQ$F*C]WI<21QH:E*W]371U(>%1#' MBV9?S(*W693:L4]6/6"?IUM@_G8YE=9NZLN&VM0F4LHK)GZA8R5PRP+=^/9_D?V^EK]HZ M'Q56QG2'L[?R\IU6@D&UW[ILY>AI0 M"N,\=6* M1LB`L##+UY'*Y"%?"_9.R1_MN$2&V@;+F#/_&SU.+*KCS9%&THIJ"@)\+%&M MIF?VVKU>?V7F2%Z2,78GO$9'/NZ0Q2C#LG(NSU@+26)F97[/.S_;#OOM##F, MLF52I3J4%E^QO'O8NAJ%C`L(2N1[Y7D?W1$6^&IC[>A.&Y[\@[U8C@4+%DZ# MD%^,XP4?>0MNE-7KA5T3J\Z*"E&P'1(@?2REY-'.Z+@P?*QBU,9B-6'P8GG+ M,N!FI:ZH"I=/!<#3$CU#:$)D>,U*V?BB>"86\1RY`%-^[2^KQ,/'N_RWO%8P M;F27#-I=6K?KF8GB?[C+IH6^80H_9L6GADGHN]&82\Z%:5$V82Q'(^HIY;5X ML`R,AVS@,2OBS!!A=4@GK5B'T^.Z!*SN9_8Y6+QJI&%%BBQ=,SLL1]XP6B6E43T/)@@E10*`U`!XEE; ME#T:H08!`]25EF/->(G,)"U/"F^-J%(DDB=*2R3&.>:L#+5V5J",JJ]:5%[] M+I6:@CZKR1,EPR%6W_&Q.E8`+4>HX#@\5?7$,Y:&."4;$Y0A+&H6\^2Y M6,8.M$P:B3H!`#E_`99/CI9NXJD>);P$.CK05#B,9[Y,0]Z4XY<4W*V!"["PMC_C MNR]/X%RTJ'JI$8-,)&2[:(%JI('T';JB/F/$L+HL[OO9U\@(*\@T/R)>&W6A M;TIV3]5\@V=89U&9CY[EG)ZN8$8SS#0MR`9CGJRAT/XR.;_E-%KT/+F."W.\ M"WG"YZ\L'F/.A1=0LQB[22:)1[4(_R`Y?#>(*[.19G#:I^-9KD# M-LKGNRYUP+;Y?`W#'/35WJ!,VWW.KZE+4EF*Y?HNR3T+;6`W:\3N4G7E"DL6 MOF]--FSU:'P"VQ#_C%85>^[@*A>&#U0W0QT M]E`50UXI:*,GS\>/?OPB.G.EF@_MIQ!+W,J7>'M_=U7E,`BK5(LY(7,PFP%W MUEIAZ/)JH$$()@3ZDEW_)7#MK"2IAQ8#5JT%)7J"95;):*":%T'R'`\3K]3J M,Z9LH=HP\/6+"_-$TQ65JV)5FPFOS$N/@9H2C[T9ONE&'=!X?.!;TB0=QG4G M%J7&1?!*^E>I=S&W"/4]K&V#NCYV$H?P!'IML@>H*BXJA?CS&,QEF+,-,\92 MKD`&;#FM,HM>!!C<")_$"8@F.H*>\W1\#;'T#3J>AFE%'9@"6&&^'9"5B.[P M#@((#-+0Y2I:O-#4%$D6)!%0H]BB186'L9HV$P5[1#F?'7Q%5>'P:F&ZZ%NQ MLYK+PE2O2XP9F]_6QY::';(K00&A-N4,,"#K@!#NH] ME?B=;P)HBE1(.VV#1*'V?"S%?`F+'B;"3Y)P]*1?89W>K#X+NHC`$$)3>6^: M]D9;S)+]JR"B_L$\BH.T/';%63G;NU8]E1:]4XV.INKZ\LWK[9IW"Z^M.._N M4V32W*17C6U^PIS!L1;20[$4$GX1A#=)&`+)^:'Y[Y;K?PFBZ,XO/?D'B^^& M3]8/09J]M9?E7MPTP&EUZL7MXKV4GM8MWKG;X[S*"_#-?W9!NCDW,*40=*H" M0(F@*WX_>"WG;K?;+T3'KAC*?N=TR!K/F@Y0V&5.$;L;?A+[-S<3RE])7?5D M=-6"^I0M;V.4A"I#$K-Y\&.J!"-6)@ M_H'>.,/?V32F$R)2`_!\CP[[B"6@HZL)0VTP/S&9Y)0$W61B?6>9#BR4`3#S M)SP$BSO1+3KQ$%H&:BZH?*:J[E!$-]"KGFL![_*K8?C9R8JA"><=S82\J6^\ MQ+MQK+S*XE)*I0=+R\8#RB;S12U,5(%]+!GG\(B3_!VB*.T-H$7QXPX89>+% MD3B><%P,#TD/,8.H0*:]J4-E<566;G^*N`W0EA[O@YF^^8OEFMWJ5=J8-6<-5/IUV/2Z1KM/.ER`ZML,!6,V3I,>CL3 MWN49V_&GV=IWF_(LK MA;-6U2PU?6W^U((+0=&%WTW3.VM3IBYPIM*M9I9KM!"ST^\/WJV$B%96S;\W MZ/;JL@D5=L_WS'^AE57,/-#-FFQ'A873E7TL?]K*RCPQ>'V^+O,W]S+_A596 MYA`SZF*$";2^0QDIO+_*[E1,TZC+G/D2[3[GXOLK\V9T366W.3/\G3E7&/$V MRL);/KI>`M_R*)<%,FSWSO'KCZA*S]!ULUN4^]N-N1HB';5`1-]4L`Y5[[`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`T M1>N7A4YU-#\A<7,0#A9+N`VHQ#H?#E2\`F@**O@D0-63H&H*J&@)MP,5K?,! M0=4O@:J?@HI<5JI!M5(EJ!!4?[!7;R8RV4)SU>*HOSV.^I7A2`JG9@BGQH'* MD*`2H+H.76?$O@26CSBZMV9X@5*BJ8RF+OXW0Q-\,NAZLM%9'B[=,#@1#GA* MF<_\%IT_NO(7+TQ?S^X]R]]5=@5/XR")+-_A`@R;JA9FN*A;P@Q7_H`P*Y3Y MT/(R'ZHB8&:6(YP;AK*BT,IKYEW/OOGN/Q/VD45VZ-)UTMT`5BS#AUB>X@#O MD]`>6Q&FDJ`T"FENOJ?@AA+$4;);^#%UZ%8+2%S^+0&)&*D.D$MN`N6;:]/P M67,I6`,6RU6%O/'##/X$E9K&,K>N=;YQ0DS]@&?\.Q]Q?'5]=Y), M)`_LR@.JY('&\X#U0_+`SCS04+.CYNB7,!,P4Z1Q>PC-6^*KLS2%8(/Q]5[C MB`HA,`>O03+*E>4\,M\-PKDC!8DO9].K4:;:[VBF2?>/^Y@%5&VDHIB"[$O@ MCS#U,(+M77%5-]84$_]]85;$[K+:#@<(!KL7%6APWXT!V)D#\'JVTP3XKLX\ MS)`[27S7Y@//FJV6-[8-6CI\?,E*WC!,K:/W!HV7O92,^-$=^="R#3C[(_!M M*QH74^KO;<._POJ./*GGW?#6<86[&N/Y$80OEL0 MZ8-"GHINEGBI:6`[MM7,_,,XC#Y;;D@5PZ]G7T3^V!E=!-EMR#!(FPX0K[#2 MX2P[3ZS'^6'3>$7I=;IFWVRZ0,YOV?T>!`ZFEP'-@%>$8^R1A2^NS:*"EG`] M>TRHSD:X%Q!*S&V%.:.C=@=JTS'W$2CT0L6>KF=_6""+=]SWA>`"F MW.H]2XU#5%`$QLS!(`>@@GO=O;?Y4%RDG]WY5^1H5'R[ZGP M+R^X&82'N-0L6;B6+"PRODL>KIZ'#W3"GKD[.7W8(2-<)9?7DLM5+:_K(/G[ M5/D[NQ*2^F[K$E'38-;)HK?D!GFR#'2BYR1G5\K99Q'\UUA6 MR?8_R2F5UQD9='3%%PA4O&!X],)NY M+W@]>L$P/H!_>W_A6'-%G22S;,,L>8'N)G/)'A,Z4U.6Q-(.6.J9\F+5FS[& MN;0S$EE;(4M>V9-6^Z'PU=,-O8^F>N,#]S);]]%FO@74V@UBZ=M@BT@8;06C MGH31(HSN?"F-MH.1*F^GO7GC(0R`Q"ZD?)5X,?7X&91[CSCS/XI>^I3-B M%T#V)2#W!\CT[J+$X%88E`4+ZE^PH'&@$@4+\$!5/XGSK0I3_&XSU#TG$"A7 MCGP*RA=O4:O]$0.XON+-2>@)078WS*'FYW7R7Q.`C=?S'GF^^`S8_QI7=DS:.;$ZS\3S]8:+L1NP_! M$M\M_3DADEY]&H=,8G`[#'8E!O>+07F^O"4"=8G`O2)0'DUOB4"EUT'EKN$` MO'JU0F?WD\("**/:5(QK&)(T`PQ.O==4)#G,_>4+&UG>)QKIKMEC8A9:=OR1 MT=G*K6]+"&T%H6Y'5TVMJ1C*:Q']5Q#>)%$<3%BXHS\L?5UN:-M@B&X(G?5^ M)N_.[(J=[J#/L8-:41_V,E4_;P@5M:)#7'@?LC`L6PQ7B-D1S[KMQN-;WW%? M7">QO-S`N+=F='_M>O;DQAZ[&^8/[1@E)I(Y2VUO!U8Y>S&[/8](`"&`>FJ6 M2J')`-I_+H(KQZ'*,)9W;[G.K2_*+$EL;8ZMKF%*<"T%UP.++==GSB!C._?F<]"RP,E[=)*L_EY(O:?3C>O`BN275M> M+E&CM!-71D)L`S=>%*#7^)C%[+!19-XE)[7,J%\%F.3)M034?@!5^*<"*)T< ML55L7NL+8O-/F"%;(:T8,U!TI>JQ/B\*K[%+CDC+_\["ST$H3NLK9&VQMMN@ M30"@.K3I$FVGF(6GB5#4)!2;EM.F:3"3F=).)MF3E-$5,X_,E-9'_,V3A M)T*6J@HYI?$RF">`K`,7P'P!MG7P*&T_3P>@-=IJV$^2+'*6^/NH,)-+6V;V3D%]R#U.YI)MHG1 MSRO:-!5\7P)_%`OI\[YH!H'263YSA.C-):U=QK!(&TRN:Y&S+=GF056 M"U=JLWFEN0<1DE85B3'N>C5- M[KN@+)!-%_*,K%%G M9,U#EKSMFB+K"EYUF`-X0@75PL13=%Y1JV.*1N&KI^N&>M[9S'@$$L]W^SLJ M711Y)"I+@_E3@[+2#425C$"J<012\]#4S0(]S>8Z)^M3LK%Z5V06XDD%9F`W MO_/E+KX'#I'RMH[53)L(*!DUM0)CS8F::ASN9$CH"MS5-"2T:2"3)2)K62*R M>4B2)2)K5B*RB1"2)2+KE=ZY:1C*2D2:JM%5L/RVV60@';E2Y#9#RQ,J_AX$ M#NZ:?P0^*R==C)Z@[PCD(>E]C\D4&F7AC@<>&YS3WN`3+)P"2&>2:79AFBX6 MX9!,^`MED'!MO**'>^`WWXVCA\=OIZLRIM:5 M#%W9B6\HG8IDFW-BFVPH;LCL.)`6U@YLTW`=IF*&D5A"+.D8_B3+(!^F##+6 M@;%">TR)M5Z8%U!FC.J+(#<.I:K1T51=;SI(E]0IWMT9L!`=*@&U%:!4!6MN M`:SPKVXA%K^IZ+H)?!O>#4FL/;C1]^O9-?/M\<0*=Z]\O"O,WCGP]Z49!]76 MC1=:W?_`Y:V'JAA8TX%9I=YR(+WE=^:S$(PZW[ER)J[O1L1%+TQJ+MOB5)1` M[S7^@E?F<*;L'W=#,K@:7OZ\H6"2IQ<24/L!5.&?"J!T\L1.BU$I6E=FLI*9 MK)HACHY:-NM-#FGX!E<]:YP)H!2JCJH)0/%/.A7#->?J-)3!U31@U;E<@V2, M%(;;,(;`:O6,T3451?)%L_DB,ZPH%QTR0Y7Q6TWF!EWKFIVN*KFA2FYXP$B4 MG9G@J^N[DV0B&6`G!FBHYEUGZ$N,R6(6C2MFT31\S;G73J-@VKF[UZ+,OS8W M@9),EURR"Y>43I,DDQR#24[UW*N.7*#T+[5!Q@7P24/#`0H5OWX&*/R$M9851;BM^WB7H_E1X/=A`$2*R3<=@Z*455'>\28$=U;=Q-^LC-Q#I4ZF@BU*0COCF. M^%KBJZB$]0M*6$^(LH%4PA:5L)OJE;#^]DI8_]!*V#HL2>.PGL9A$[$DC<-Z M&H?UPU+O4BU@B7_2"$L&QY*I2"PM8NEC]5@2*[<-EL3R5H8EJ2_55%]J(I:D MOE1/?:F)6)+Z4CWUI?IAJ7NI&#F6Z!/7O16#PEPT`XM%]9J*)8>YOWQA(\O[ M1"/=#3V4#\6RXX^,*O7=^G:%$!(+M@V$Q*KN&T)6=!D,,0)/I_C1`8:D&XB4 M/`6^H2@#_%?#[V4T-,/\-I-\3)XC]L\$!OSI!?[UOF)1Y;:.RRPNEJ2%]W-< M9N@0O^P7]YA]5\62>LU+039/*M4X)*E4OK&`<$`E15-[!BDI)R$B]JBJE`_. M/Z4X"VOLXK'MZA5=G\&_O MA\<-7R`$R[_%H%&\N-C-6>&A*_&P]/;X9T;-W`V/?W>\8D2H M\GBUO/%!"S"KIS%L%UF+8D]!V_K]_I^3`$YWT)-6PPZZ%.&F$>J4-!S>`+O2 MZ?<'$NN58OT&BU^R<(I7_OZP)CON_QS9YPIDS91`/A$@WX(>$L5!>+9"6>MG M6;(DF"L#\X&2?&5>>4X?EG=QIG#O#A0)]Y.%^W7H.B/V);!\"71QDR!3NR7: MJ]-4*KT.(8V#JAB/FPF2\23C26/FZ+S'S1K)?)+YI/%5._9,S3#)GI(]I;%8 M&\:43I'SY<@3!'5?>D!.%-K;7>*7'I"J&$]Z0"3C20](1;PG/2"2^:0'I*;L M*3T@DCVK9D_I`5E@3.D!.5^./#%0-_1B2LWA?"(@ZNKE7!CDG(E6/YW M%GX.0I$+Y)RP8IH\8M*@@KH-O:QTQ&*Z5[:-KHSH@=G,?;&>/7:?A/;8BEAV M$>@`Z8[VQPIIBV>X=Z90;[A8;!3(3P,Y,F^W/(&46;>E)59$0L^4==KF'<'9 M+N$[CY;'SC&UC*S?5S@GG]2P?E^%Z.CI!GR2:0??2JP0!DYBHP;[&">.&YP5 M+F0ZRK>WEQ_,3C"IT=UPB+49S@@769II7>NBY#`;[YYI5IKI!\P>_(XTP#_< M23(Y1[PV7([5`ZDG`@F#0P(/)IJ;6W2?R,A/YA$,]]8,/6QU=AHO/3\I9XO$ MS?Y'#/K^5TP8"#UA]8J[83[5LTN/-0?]TSA=.4_HWX7NR/4MK\P"GX,PG\XY MPEIN\N_!\XE@H2NQ(+#PS8>A)U2!Y%S]6[IN=+IFO\H2:7N!0UX>IEA-AKZ- MKI)X'(3NOYCSS7=8^!@']O<[.GA%KT=T/?OT@X6V&['[T+79;A8DX8E>I7R[ M9X6@KD30?A'T>DZ>5/B/Q,]>\7/GGY/\D;60JZ^%7"$`NH.^UD&EMJ'KGXJ/ MJUSG"X]\D-$U3`F-I=!X8+'E^LSY9(6^ZX_.2%IT%5-N%AP"40RZ M)D;XX+;QS7?CZ.'QV]D@01NH,NRK@(X<8*!H/3SFZ7;4 M`19:-IL=KU$X1/:%O;#=*R1G[=WZTR2.J#'MH.=`7YD5)2'M M?)]#*GIL;V\>+;1;:!5O2R0A7EX\)[QW)=YWQ;LJ\=X\O&L2[[OB79=X;QC> M2R@_$:1+G!P`)W0;2J8<6(*0O"2OR'=A>;E]%:6=N&<4$JHJ>$0G/6E+P`)- M3/#V2V!_/QLX%/ZI``@U)Y5B$JDT1=:/TV$B0(=4-#JD^ M.EAD2'6=0ZJ/#8<&1^X=A52:24%.W8ZLEMGD:IEB+8^*%5UBY?0R@U`G` M^9U_SOC696C5VY#Y&C@P5)NJ0MP-N3"L84#>$5"C(6I459$!>.QZAF/=70DJ$9'4W6]Z4A8 M$C*U^XZQ<%_^;.`@(ZYJ'7%U;#@T..+J**32=#H%F<_`4[Y/US06JK,#O%FN MMT-)`$VO!-8-W1+JC.<30,B]TEE, MKZ?)S?T$-O?R.&L0N2-@=TA8*QS6JJ')L_B&G<6+U3L@.C`1MX+H4$2BW+XA MP[G7Q[URF#SR#1\A\H_`ER'0,.FM1(&R8LCH`.V*KX30-%."/[>&2I-AX=]V$` M=(G)R([QIE2:W/AZMGO&TR?F,3N83!)?!-!%6;,50H26\&`0Z1,$<0=1!CUA MM/2DT;+>:'D:NZ%S;P$&/P=AY@KZS*I++Y*NY5&Q(@W>FD5C7168>":LGQE&2/4U,>*"W:D*W5,)/1E1H:?4='@G1U%C%0.U?GH>&@X_&MPF-K^5500^EU^FJ5$;9[ M0<-U$KD^`UO3_F?B1N[NM_BNW3]8_!J$WZMS08A%>A<(6G_W7/_[+\,@B'T` M]!?XT/I!7\&`/%@PY2+]/)O"1T99DIB3?AL&7GE5BR33/^#/'_#!BV6]E5H. M610DHWQXK='QEI4/*?5;?T/ M:S+]6\MH#8.P964W[P`VD9U$B)N_?RB-5Y#VW__MO_%Y>(%=F@)\MN(@3$)=(@N_A_,YN+#;]ED M4R)5)6Z&=C@;^7+,ZXHD/0\N.+PNKQ'L(@\D!YY*..BB!*@@=%OYZH1:G M>K1UI8,DU<3LI\4A[W]UW^BHP6N\:D;U7.GNL59Z64?-7NDW9U3/E>X=:Z67 M==3LE7YS1ANM='F[1F4&OO[W?^.*#_SY_P%02P,$%`````@`\H1]0K4,Z[-$ M&```G$4!`!4`'`!B8W-T+3(P,3(Q,C,Q7V-A;"YX;6Q55`D``P?\55$'_%51 M=7@+``$$)0X```0Y`0``[5U+<^,XDKYOQ/X'KN?2<[`LZJV*KIV59;M&L2[+ M8=E3,WO9H$E(QC8%J$'2C_[U"X`/41))`11!$]W=A[9+IIB97R:`S$0B\?/? MWM>N\0J(!S'Z>F:VVF<&0#9V(%I]/7M:G$\6T]GLS/!\"SF6BQ'X>H;PV=_^ M\]__[>?_.#^?$F#YP#&>/XS%]?3IX?J?Q@UTZ7<]X_9V>GX>/;8AV`EL^AQ& M1J=M=L_;W?/.R/@O8_RE:QKWW\,'Z?=^^<+^]VQYP*!\(>_+L^WY7\]>?'_S MY>+B[>VM]4P@:MEX?4'?TS$[7?,L>O+]F;C.]EGVSQ8F*_I>M;ES]KCL?C"_[7Y%$/9CU(7VI>_//[[<)^`6OK'"*&CPWHMSSXQ>,?WF+; M\CFHJ:^GN>I>)++F/L'^=1X_=LX^.C<[YUVS]>XY,8L'PF03.:,0&T8(,L$N M>`!+@_U\>IAE`\S^>#$G*PO!W[@D$^1<6A[TYLM[`CR`?/XI98._\X6`Y==J'#K._2XM0F%Z`#VW+%>5,&4X+JC"PI@Q1#4XM[^7&Q6^">'G87M;! MUGP#"+B+\L?':64,7F$[8#S1H7B-?.A_ MS-`2D[7X0'0L`,TJ.;K^-:!LW$!$K9[.^Y2Q*_#L/P#/)X'M!_39E1!C8&DY MI&K&-@RKA#=!/BJ%Y\:"Y!^6&X#OP/("$AJ4$"/+UW65C,S0*]4)(S]#,^33 M86;[5^`5VL";(7OF0"&F((0.A%7R=8=]0.?)#^N9O4.`!;2I5$$+N$*0CFB+ M#BK;Q@$=56AU3R>*CV[,K9238T&\SD['< M>+V0G6\\>UGM?+,(GCWP:T"9NGX5'DL>J)0'.F#P&CQ:[X(6LETMJJ`>F:GW M`&P`7X7'C57I[!HMU&AU2^34P!M+P3J!"^;+B><%ZPW/'CW1AQXQ#[SGX2=RG'O8"OQ7 MW`3^?S#LZ0I01H"WF@5P79;T9KFSK`>E)?#L>OE_0@38F/H$O^T^:3(9D<*(<50O1;A0OPPJI M.%HN3KS)&=,25HM2.F&[M?WTIS+\H8V'T48AAP!!3!;P_?$-WU`'9HII#$-\ M%GVRQR19K=JC27/Z1%<8FXX#YR06`Y4L'@:C]P&Q7^B,.%D1(#^"T<8BFXKG MN32_EP0Z*W"+Y08SVCR[ZGA*MJ42Z)"SL-PM@G*L@HWE*420CIK_`03/$?MM MD6F?DAIG8T@9M^++&:HX62>P#2K!'=\,K9_!M+(%GI=1/)>(_Z]2[0MPN5VC MV)]"X_4D5U'.N(>=BN,1*9VP'^J44KESJ\GC]95Q.;F=W$VOC<7?KZ\?%S$M MQN\IE7`AK^#=!\@!3E@&&'/K8CMZRK6>@?OUC'[POQ//HU^?!H05K[7ZHV&O M9?9:@UV(TF662\M[Y@6'@7>^LJP-K\V\`*[OQ9]P,,_;9E2Z^)?HXUU2NPSS M5!(F,;J%'+,@B65UZ0\V][Q2?XKM-?E3BY`/:FD\SFP-^OV!,DF$6!"2,&5! M$Q(+NR1X+:0='Y>$!!,'$%X!S/X[,][X#F/XP9FQ(32,HL.%VO"9$7B4>\Q3 M--NR1HO8!Y:Z6XD:/7'A!>LPD#V'=!SL8D*?$=+X82AR!_P$E%[?5&>R!91K MU*\H`)%:NWJHE>TP(HK9!Q6F99H]HM5\)(43T]%'5/`-N-CS+C ML=1FK]-3-\5FTJQ1=<=ECG38UT.'VWRUV&)A]KN]MC+M2G)3H]Y/P2FRB(X> M%A$"0I$8J=-S2*,Z]1URFRR1>>K5R]6A`=,&$/^#;4KPPO\XNN8K2&\P5K=& M%I&N0X/"HNLUS.;^"R"A['<8V?%"TNUTU*DRDV8=.CPNK%XNZBVTGJ$+?0B2 MJ<4T!X.1,LT=$BP?*,=10Y0PW\8+"OG/IEF%Z0FI8C]@RA==KV7A>KUQ\0<` M#\!EJ9\,+$8CLZ-,JT?)UZY@*4!T7#!LFP29.UJEL!"KX7E M*BI/?0"O``7)!#4<#-7I-IMF[3H]+KI>V9'TIG0B?6?<[2I39`;%VK5X3&J] MLB-\GLF<8'I==1LB.50_9Y8](GVDSX$>^KP"!+[R(O8LSZ"M<&NHB/(G3+5B M,$3*'>JAW)0LZ2#3'(S'=<1EDA%UM@@8K1X!6:=G43I]=D;J5O\LDA4;9*$V M8IL\*KI>D5E*?"KTL*TN"$M1JEAO&8PGVBJ>;AJKJZJ%SS%MO2++E#RL$#75 MYR:L-6-0=!7.0$?(EY].LT09#`;J$JPEF1>W2E']Q*9Z!('&CM/L"A^\7D-^ M]-CCQS?Y46V`V$'MUF#44S?%%A#^9/T*0M+8^4@=,GE3N5[YH!N(Z)=OJ:>> M:ID0;:0`OS4>*]R,+Z9=A>&+[H'%.A5'H[$&+U!(0RT]!YA>IZH MO00\>HWR./49ELJ#*?;2@C'3'@Y,=9MS1\E_AM*E,-'+CTF:4/`%+:H7ZID= M=9GA#(I5Z%3(OTZ-XD*I]=)AJGE(5$6MLD1^GUKMRBL25Z^U=N(X,*1_3]>4 M&9I:&^A;;JL_Z"BL=\LF6KL:!837:^5\8"=W$'"N+8+8::*);0?K@._]1SUZ M6V:_UU<7\1]GH'8E2V+2N%W5GR_V(;FE_Q8_7C4H.EZU>*0_OE_?/2Z,^8TQ MG2S^;MS]''AZ MN5@Y0H8-"`^$5)B@%F>D\19R##R]?+D<(;=GXW>$5)@J$V>D\19R##R]_,-[ MZR-LKX, MVZ\_T7"/T$68SI!,5.3PCR_W&T:RPVRL7[8;L"8H/+R/VETR7!3F^I7RKM#\ MQ'RZ+/-3JR&]IK`'L(D6][`35LND8U!=T>L^N<;81R$.>27J375F$DFXD<;F MSC?,J),V'*H+>XI(-T;7POCDE;(W5>^I.6ZW:+;7ZRK4>0[9YNA;!!>]*MNS ME[/4GAR3K:T&$UY8D8E2KSNH)Q@1X*:1%B*+ M8F0O(TWL9AUT#\O!_AOR MFQD!H1,8:Z(Q5C>V#PDV1M-'L-`K=,Q.;K;,@$^`;[TS8U?8 MZ$24C499A31NL7$<1&T--8Z)\W]!>&OS?!G?IOB-_1\X-Y@L`.$7.+?Z`X5M MC<1X:(Q=R$,6&X4FF\$<'G8+$A7G"@?/_C)PXP:95**AVDVD7-*-,0!A?&*] M:Q(2[)>(SM#A/1)TLAOUU6T>B+#0&#N0QBNVAX-]@H8N#H<"QA=4<&#:8X4E M(H6T&VP">0C%NA]KJWOF",^72\`ND@LW/P:=\3BKN4KV#5DBKVRP8HO%C\N] M-,D+'(H7]5*(3]=G]E3@!JVNFTXYIAIL,M*8QE:D2[U\UBC9:=;+ES]U[N)1 M^@TVCB*D8CO09.]OFS?]AK'#.C+=802BCNMQ0/1(0R3/LAFI:""TS$$W<_VH M.MDLQ55C3*8*5/7JPIO>,@L3;U?0XQXUG4G7,%BW^D.%6T]'R3?&-*2`BFS@ MP/%LI@WPI9'U\V&'&&.+[O;ZZHH8,R@V1M''T-"K\"P_8$Y*<=NCMKH=B:/T M&Z-W.:1B=T&3_&*F<'LW=C#Y%/;=$6&AV<90A%=L#YHPBX+QQEHC$E(8M6XDP:G=OKKB7?ZF]]?/TP>9_2!F)N2 MG?XB#1UT.Y!H]?>-8,^CFE^R3HSM;E_=&9L4)2&CS60WREQ30^SWA^IFY9A, M%:.K&.%M%X`,P?0ZQ,'&.#MP%.XM#,VANI!IAU1]2LJ5,,_]:>X>6G1FB!T7 M"V_J".A$OYU/+L$2$Q`^]VB]`^_ZW2<6%1,BBWS,*&7>`)U^DS)%7[_:'D]H M#SI*2S14<5Y^4DH6RO19K&Y[I"Z7E$&QBE%0KUTD">0,7$ M/TO7$I!H5FFSM>*P3?NV4S^[8I-.5UUU%;F%M#]_6!\#I'';J4=B+">P6>D` M#1^)QZ>J\'>?7:(<]CV,`Y'V0-V%><)\?%Y<5@:HO`KMAKIP?^AJG!)&<6KQ MC2XYMC]*]4T)$RA7;*-+]Z!D0S`"@F\'#FK838WIE=\*_@80?9?+>C$Z:XB@ MYQ.>6DE4VNZ,U'6U.4*]"FL5T4WBODB`H5>2>`'XIA2_88K=*[7%HV4.3(4; M`/F$ZU:N(`1Z[38-_7Z=T9-0I?!BG>^]]"Y8/P-"HS_H!NQ,`*I`M*P]C8R3.OPH[PLS&6&UVSQ26<^#Z!SP&__?<1 M3RW7C6[/3!U:9@G4KM(JO+*<-V4YO1S7\K8`+.4.&!6BE6/L\.2B.6M^PV M=.O[*@#LR-QUU'+5BR4:#0;JEJD MM"^5O"#\_JF.U-[K;@*?\OD=(K@.DNNKKUA;Z2YU?-57:Q1S4=Z_$B00&R7+ MR2OL%"O%3*5[3]):/MB+D`=0+V=-4-`9>GS#_P(6"3=PU*6HI?G1REYR8&S< M2E"1R5##`%MIU:W^)3C2S6RRH=0K9A"6]@8')!%683Y`GB'-S"8;R,;E\2JR M&OB:#!&SW8`E*F%(-ZO)!+)QQ52GABNCPW`EK%,Q>#L7Z5`EU0KFU#`E+HFG M+PL/0*9ZEK-S4\.!PIJP(\3+1R4'+]Y:)/:\J47(QQ*3-XLX'I508$A0Z11>-"O`0%-,002@O$Y@#56_ M?JTWB\5X`#9&-M4K!R:'SL2_`0[S5]F5`0&E\;']ON6SX[?#MM(ZU.IXK6)H MB-O`0=_2RN'6*\C,P8'?1$'7AUNJ#C>5OV&2*NS*),E-HTQ'"#*]0LD<2:H\*;2*]Y/9+!1)E06V,9%EZ=FH,>'&>A[$H%B6,@QPI)M@U]/ M*)V/3EY%1VM4^\W>'O^U=OMLQ!7^%5$B4X M*N_`%!++Z7*5KJ/3:-?O@-C0`TYK MT&UG^L$Y5SK*O5TSLRA&1Z^T4*&@2:?Z06<\SDIHE]%^E>WX:U1Z)A:-V[$N MKVO^Q^@\ZM:PV?RF+@THSY!F1G,<5+VZQ1<*.[%_#6#859DMC'V%;:"$^=#, M7G(AS&LXKZ&9W($W_B?N/'74)1;%F-#,0++!TRL94KS,\L]O,%D`\@IM+FA? M836X'#.:64LQF+^W9(?9;H\.VATQ>,Z?*88\U9%4%Q@_+>P7X`0N,/#2>$($ MV'B%X&_[CT6)J!+=CQAA3C?]OICH?)DFF7XB(GAJ"B4^%18IGIO#Y3XW21N( M"2_<><3A$?[D[ZQ%[AWV_P78J>&(U]9HU%&79U'&=OEL3!F6]KEA2K7I7Q_Q M)=CR-$.L!':.``T?NQV)\*H&EJJ8Z&JTP7@VK%M9>J5\5*/S^(89.IF-4S[) ME"E+?YJRD++T\B&5H\-.0W%\LLZ4?98Q,Z;^-&=!A37.O?U4@V;GM#@\67O( MGV3/C*<_S5E,78W;53@U6.L<[DS?6)`8;(<>&-]IV!N$;<7DCTFQ]_#7I-]R M:D25JA%,WK_EOF6:@Z&Z7==BXJ>V1K0:2!L76IPZX`>'`WX1;#9NU#O0F%K>BW'CXC=CAI:8K*,\C6S> M)?5*]D;VPM3[3C\VN;T6@/[N`FX_A_<#J#RB<9R#\A,"6Y?FRV\8.^Q$1)PV M7*;H086@.U,T$I5BJIDR\C*[C>>!D)!LW`0@/#.KW;`AV`CM&2.4RD4/V M\PU`"!&]HN[=Z[%G=(Y%*U80%5VAVQ\.U&WG%=/^?'6+8].XP/34(M/^X-KW9LO,G^8T5_O7HV]OME/2GIZ[QZ7>US,ZXHZZM4)I4^44[ M_9:D7UAGW%57?Y%!L8H1>`3Y>*@=DU>OE?,6H]4C(.L]X3L*NUEED:Q1?T3^[.KJU]ZKJ=;AKZQ+?+/7RS[E__^ M__SO_]L__H]OW\X7?S/WJ6YH7_K]JZOS[Y]"[[VXMC& M;D6_9UN]X4`;?1N,O@WGO?^WM_C[2.O=_O"_2/_NS[^S_SSJ+NE1NBSW[X\K MU_OG+\^>]_+W[]_?WM[ZCXYI]5?V]CL=9Z@-1]HOP3??'YV-$7^7_;-O.T_T M>X/)=__#Z*MLDKU1WT;\N]IBL?C./XV^ZIJB+])!M>__\\?U_>J9;/5OIL7D MLR+TKUSS[R[_Y;6]TCTNU,2?)ZD:?8]X3?T&^]>W\&O?V*^^:<-O(ZW_[AHA MB4?,B"?YA8JXU_.%[-@;Z:[K+ M]:U#7&)Y_+>4##[FLT/6__R%X?4MA(91^=_X;VS]T7X)O^E]O%`MVZL=HXDNQ0O+,[V/*VMM.UOYA6CHQ-144G3QUXZ2<6E: M5.OIOD\).R>/WAUQ/6>W\G;TNT]2A)&U;CBJ"7MALHIHDZ1#J7@N==/Y7=_L MR`^BNSO'5R@I0M:O6Y6$7%FO%!,V_95U97ETF:V\<_)JKHA[9:VN#%.**-,T M#=-42=>-[1&Z3W[HCVP,"1*L%Z4`W9M/EDE7M$X7U6IE[^BJLIYNZ2:P,HD< M4*ZNF"*VV;`3VSBSMR_$.$G7Q*KV67**4!KI@["UYT-\E-20^+53,'JBI>T=6Q'R57C>ZTMTU.*BM MIVNZKTF*P=ZHI(#:H&OB.,2@1PY=*%O;X@M'BI(7?:74`+RC%IZ_M]]2ZT^* M!$>IF9=OII\33SG77G^AU@]XTW"(84W+?=+7&:3;(U)JFFQ953FI]Z-:3R01;D.`7W:R/X!O= M83O<*RE(I*64Q./-O@@YNJ.4F%P;L@AMOBFIE+Z#0ZG`XK4W2H_H`T(*[;T; MQ9!%IDH!<9B>4G$DB"BD(9Y24:08#$4H8G:#VAU(:.L7.756B@\=(4'E]L*5 M9=1`&W/!&KL-6:Y/7'>W?>'>HY_T2P\VOW@O_=\4H]RU]9WW:F.@_P\F>WH" ME&'@K68&-AOF]&:^,]$7"W/@KNJE_Z?ED)5-;8)_[W_CXIW]6%#Y79N]>-1* MOZ_J='L+=.9D1=>LZ7T4)=S6W_1Z*4^X%4X>[9T7+-J8E<+J;^J4BWJ9X$Y/ M'-OJ0&S)E-[S".QVZ? M[&L%255MT20I_4E/F!5=!T8E$G>0)!Y?1F]WSNJ9[H@G3PXIOH*M%]UY4;S/ M)>D]=4SCB5S;Q1:S]?*X@:,I>I:*1&<9]_HFEF`Q4LF+[@)*D*Z:_R2.O;38 M3_="_2R(.%M#8-3*'V>68F>=Q#-H`>KX8VC]!";!EOA^$>`Y1_P_2M&7H#(^ MH]A'OO*Z!4]13KAK&XKO(X4P8?\'!XIROO:?WHM1I=AL/W@Q+&0^*;[!79,G M?7/KV"M"6(2='!$;I4]%UR9%QZ!J)#^ZYN#^+"4>+XPE)'%`DXX98F_5$Z597LGI0G;_V/E MM#W3`9W5[I%\H[^EE_&CB`1I0C-&4DYU-,,WP][J9EF2TX913R\?_MN6;!^) M4Y98T1B0DJ5'VF[C51?M_CCI%-,OFI;)KN;7])_AUTUO0[]/A^U]ZT7!A/3G ML^7-_?+ZZOSDX>*\=_]`_^_'QRBSQ%Y]XAE$,,/$`YYVMBKX%L;_9%L_OD+_<7_Y]L?S/ME6^RJ MPH'M:[/9J#_K3X4"Y\)>Z^XCE_C._?:DZR\\>/L[V7AN^!N^VWX;:$%L\W\+ M?BV><9]^[G.VG1"23`82[SX_N#KVM<$(C/BCV:0(C[7IQ`E96#OVM@@$GIW/ MK^U0E>`A_^Q_O_1>'--VZ-A49W_I[5Q*H,V]L''DO@FX&$\U*-`R)ZX=0$DQ!%@.<6)YQVPLBQ@7NF,QNR^D M?CR90Z$HGK)V^'(Y#X`;X00N.D>X[Z(_7DP&_0D,8/M3E=_AHW$.@')/WDV7 M<3`#YT`TLP+-RP$C5#E9`0!N_[D&=6']HW85N:(_<@:&4)O&\715]#`VNWPD M^MIT.IW!T7XXGTJ52Y=_K'99_.*V-1)6DA](N=QY/.&1;MG]Z7PZKL%`/)JX M7O@D18#;SN#D7[GNCACGW!EZ2RA]!G]EOB%O_!/WTG;8FVI_.AH,!.:'V/53 M:.@&%EX)IK%;'D*N?-T4LC6HBJ5X;!1@YK,=H#EN%9I<1_T7^H-'Q0OFDV!V M`^=QH6299D^$`N>"`@E`G[0*=%^7)9@4W/#++.@6P%Y4)`'NTU;ASG7[Z+F2 MLS51LKY3\XZ;7]*9;`=HSEJ%9IAP=,37<+$0W''*+%R<>$HP'@`Z;Q6@7$^/ MXPOB$"JNLE,E*S5K&A0@%Q)&`/>B57#[:IS-(M7HRA>D_'E0`%Y,'*$W8]`J MR+E2Q_%/RW7"U."A?52^Q&5>&TUPEU+HI2I+&@I-*2[%4%O:>-.68G0DL-]` MU462-A3Z4D*.H<*T\#+/LX*I7<3/Q\IVX-Z0*-!,93+$K(UW\9@?>L15]K7L MCXD"M70V0]A:>)4.\P=XWBCQ^`XR%J`'?W`?4H("\UP9A="W\=XMY*MNHTU, M"@KP\Z44HM_"2_I!FNG)F^X8-\1;KB]M9TU,;^?XYL18<%F'WPQDJ$.A(Z5D M&:I-&R_[TKS"QBA4(0^%XI239OARWD*?P:EC_\FK3+$@`=-EMQB7V[Z"N(@2 M!KYH>!1`2S$?XHHTM"53A\6\4>NXLILW?7P4R,JQ'T+;PFB7M&3RO>=$D9NO MQ/K-G0L%Y,7%$L+?1K^=%*,#02!EF67>#@4H(9A0`Y`ZXDZ,_]KYY?C/IE]*6')L/^ROC)GMNNY=*N"2X*I0AB^K5U" MA+&B3#`J2M9]YF3UU\YT.=_IZE=K&&(-'I4?OB,\PN2<.J\+N"^/.KV'+OL`7`KO(@+GT MH8E'>**H@2)42J1^XQOB^57;KVV7+J;A;`96<&%OJGKQ3N4R1`>MZU?,XJ(- M>=''6>S09,N7%"BG60O1097"9JA9D5?9KS_T]]7&IEO*/W_Q'+[I!;^T+8^\ M>Q=^,>!__N*2)_:#4G4\JA^F)*F/?184\;YX)\[*I,SQ,[F1""4A.2@L%SEI MQ8[H-EU1@K2V%.:F(["T^N+TH-`%27G%RC";M$<9]GI9Q'RQ][;*B9[BL5%@ MFL]V_+C0)CCW_&_[C`T$E](RSXHX`95@/$9T@7&WEKGD)&.EY_)A/D6&QG>S M$S$=^P[:=/+N%__@WJ^Z/47[)*!8NNE2B:IGM`GD@Z(@C)\A6#T].1I0P)PA MEPCG-AVU?LX1__6E[03^)5]]ZX[4%9."`O5\*<5I=>U;Y2+&)O-F`K5QXB\A MIU@!4"Y_&1/EH*;C7C(IJTG!GC4!*^-6)Q"?U5=`I+$QB%*!)"I_3H$]K:5+ MGPH9RJBU"\1(^7+CDCHK!4VHOGG\0U;5S&PPH%`CYY]%(X$8:5`CYX4T+\&RV,M;GR4\IY>7++J/]FOWPUB^NI)?SC42OJKO4'+KZ3C_O%!;?3I:#B1 MCV-,&T;!"LD07K@<9)C`7?J8MV3R.>4+7QM-L\]662TY&+C"EGL`@Q+J"NMP MMJKD2#':/46LH#_$1Y MG&D#*%,]9EGC=S4J9^"K;*`/-JY@1XS`^384P.NF"_SAGAOMO.G&UG&DP)59`__'$C+ M,B4=Z5L&*[B-?`'+L>]T-@9[-,R:5^D^>$N<%;LS/Y'E^G?;,ZVG\"W?#;`U M^E,-+F>J'$DPRIR*;,:^64Q^+5=VH&AC&&6/NY<+QG=//Q+_"B*-V7LG5$!U M06+J4'!1['5YF1T:"JT-SOYA6IR&FIB0M5!+P])FF8> M\OYISO+[W:-K&J;N?"P=_P'V!_&>;>/*>J5L$W*VV^XVNF>^DIL=6Q/+]4$P MU,EF\^#HEJNOPMSHV1`N'E@QM8WL>I`B1]YXL93Q#-52&>+"4=A!#,1<%0=Q M3FQ'50RS7*Q[4D%BLU:+^!@.1H<1'_?FDV6NS95N>;V3U68]6"0D[H%(:Y MV;'=*VY`;YV0"9A6KHK'\AE"1 M@I,M@[(_F6M@5=B54*A@MX'2IRB(5S$2N*\F2J4)=`=H?G7&)UQ%6H+S;[(` MNS"I)17;>LUTORK&YM-9`W$0\>/)=J&ESQ MX9RYP59-.F9Q&4M9J7SJ.H0#\.O$9`H6)09(MFK;\D"7:A5(P?4/>L`4 M495L&U$D4?2A:M#2`PH0:^]"JU4@K5IH@J`[>8GBC[F#,%3!':&U72(:V9R` MQ-?TYB3KK@710T5^%#GL/HE#^"@%,-!N>&3WPBN M\&YU^NI>&YE^3!52_C3.RWW.^>D_TN9#*'_%\73EUPV[IBS7>R,&MY;1:)R3 M]URAOGG:K"HB6_+!B&J=2S"/WCF2QB_0';Y&Y0/BH`GE$[@-9)C'[S#(X0*J M/T(E",5/-<$X2XLD"E;(UWD]^GL%VB0OW.AI)8L+W&;JK6/3RZSW<;MAES[+ M8#&&+PM*OFJ;-P4HL M1K.4UV<^1'!24E+GH*0JLPO2Q1LJGY@O]'>9`\:`+@`0>@-)*I3>""XE8K[P M7T..Z`8RI(KB(;ZQ4XBVNVU`[F@(5VUB;R95"I0BYD0.FI`[W#;;#_U]GVJP MDM%[,]6%20IWD`M;9=Y516\S>`0"K$^_D-L/JI1!.;>?["N_.H!CE<^0#Y(G M>857+7`55W#5DC'Y@/@H9O+):FU!8/:,K`.6D6ADM2"1T7&02!"]X?;NR(J8 MKTPNA8-!PC'B(:H&?IS9%GO%=_P^Q:;[YP,=(:S"Y=HAA>D=# MA\'T0PTLKSUS9@4KK0A,D0=<4AJXS=$C^F-_$V4<+!,F?=H*ZGDX9AQ"H_6G MBW%]S"0FAE#.=(@2B2\RHL"MFE\MGJP$SN5#R)#>Q/)D`.3HKV4[\FTU;;#0 M:F-#U>M$`5A2MZ!#]@]+L;3V#>*(TU-BK9ZWNO-G9$$L!K6=/0>3E]??8V,X M\OV`[;9IA^KAQP'Z-9"Q'H$EQA'Y)<81\1>GX=QP&<9R)O`C0 M^19R"0IV%*"0!24;;`7+K#:V2EAF16V:'-C2=YM4P:`/Y9`3`E#81-.Z6QM; M#>FN('*D@&#PAY/D'OOU[;F%;)]RCQUU,5/PL:.PHJ9"E.[\$$FBC5OK/NOU M[:HU:&==S-2KG3([J%`2^#?/+ANR!0EI739DVY2ORX;$O_5UV9!=-J3T\T"U M6*OI<:R5WXF!O<#U3*L7-F+O!9W8_V_ZFU7OUZOSJ^+E>.*1KZSC!N]7AJFF M$H^PL7R-[:J%I,DTM)=8$6G#*%@8&<(+5X(,$XTOB,+-SY3TO0=KN:Z$NL(Z M7+SENL`4%+*"WO;+Z2>/4$644%>#B@@,-B$K^"VT.'@[KY]1&,,]`WOI+$A+ M>;5K4>/(JOA\BI:2>:Q?Q_T&!AI8L+HT%>45\]ZS5W_Z#<+.=PXK\4@H'(;? MU"?9H*FO32<+N/YLLF2H4/#2V$:%![!SKM;RM["T@="`:$.V*U^FUN3-VC9^Q\.@7+,CB:#07\63((T)OB1*\@[U#ES6JX=Y6Y98-7 MZR/B$%'R.C`?R_K_KTN*3GU(J<[LR-0<<, M2R1-X'16-&&%)X5WLN+M9_QAW>A=;S(2<)!R+18/HF#12`DW>E+(906Y%\NQ MC1VW6.^]G6':"?H%U<12H!`/4C<4^:S@=A@=[!&7.X]N/D%ENM!/1NW4DT?7 M8\_B??%J4;3>B]%2?BN0G.ALYSCTQ[XV`JPD4HP6%>I=$?%0\\L+$??F),G7 ME?7P9O\OHCLN9VW6L'[$Y+1/1<2B_!3[)F6-*@.)F0.KEEF"H%9JBE"7G>J.T?\J8-FC][(GI:J2@B8>+VGDOR MQAC2FC;7VZ<22;'A]L/O,V2T3K:]I4`[,H13,VAVL>_ZTZV>^H%E)>B.62&\+OQK.:%NK! MU&C6:;I$6G42_[`M[WGS$6PTS`TX%'B.4CR:F6.A02J=1=RWL!.'Z,OU'=$W M%ZY'=X^P)GE_,IJ!6=!IDS:'IH08<'M>?"V,N'\@SI8KH0##E'4F&*'A-",*"-.E@-LP2.4\45)H MK&E@738EYB]_+$G#6C=S]>P_&1#F=D862@A]CK:T*(#*W>#0YKJ9:T:;!5GC MQ234IG3R/+L1/(>\HEE=;;4"<:=JMCA2)"DGU>+:AW<1S4>TM! M)XY#C)YN&;TS>[NUK1Z/=RX[3.;. M;.N5.&P/6*[]GSV3[F+W9$6_ZO'<[^ET!-8PIAIMJ-2DD"1QWR0S^?Q#=QQZ M@KD7[_04,5V><3X8"/*NTS+K"PV."N),UG&__F3R%59]Z$^'"Y$+KPR2X9BH M`!0QBOOA/),=_N&24Y?02;;-P"6B%Z8'E0+D2@SW:_L7+(.D#ON38`>Q_-F!=4*[.3P#-$\&F>"C,7X0UYXQ]Q M:W@(5Y).B@94VY-0,HUG=5;3`"LYB.9E.L@&+9QPUCTGE%[KO*.SKA*^Z6 MLAY2MDO=XP=V$CG?[[^8PK&2-JO2!Y%\>.*M,%\*2%X_JJ`)%(=0#SA4 ML[=R>WB.'DIC$6V)&4RCCXW(81`I3[U=^4$B_]_)Q^##)4?PQ2K_VGKSICA&]OX_& M8/O>WD05;`AV8S@]%,()>Y=XXFKHGG[$WPF25/C<,0&6P6(06)>D,)!F#K?? M0Q"L8-EFXKY791E.V.C/F6,A`>W,Z!<'U)':EL4A.,:`A8WB))2]FY8611@R M-A_4<).M1F7Y97FL3D"\%M]&I*^WBA&.LA'%HFG%_3=/)&D2B9VEX_D$+&&H M.GE*WKR$4R1?H5E15Y\TU]UM_=]QG7F@5NPI'>W/OC:93>!>2I32JF+1J=&%%EO.'`\DNV.K.PGR_PW%11_L3BS7<]-BF`^ MA5O"4&2W14L!T4(>YQ*)X*?E1#R)^0^J9ARLS>EH5"0FL>I\;=$H!>+$'2Z3 M9[(EM_B3E6>^4LJ/MW51,85ZS/%\^MJB:BKDCSQ,.H]7/^QLYSU3HNF"^VE1 M;A("8'=?>F\(XQ!O';K'WS$(DK)8C&HX7Z'H;[FN*L4/>7QXCBSNB.M1_CSB M&\D_*6"N[\Q)7<1CN(PBM<2V6TLK((,\]%V13*$"3)$Y&"HXIN!#<&MP/=:S M0+/#>Y6!$:S,>?N#@<%>"9KR&T(]R:1'V`;F.'/#9,`:8/VM M<-4$<11--Z@E=/$T73]/%TW3Q-%T\31=/4[0E=E#.)X7]/TSO^L[% M*LD^79BIW(*#5#D@J36X9S4=^0J.%N#"5A9#VT5&?^[(Z-]LVW#IK>S&MLA^ M+)_[0`7DZKQS.A70[N5E8Q+'SQNFHQ%<8*!JZ2#1P?W.EZC&VQ3N^4DLY M:+(V&@BB*-(BY-7.CEN)`$6-/`JT+.-!Q,5OO#SRE>5GG_Q!S*=GCQ@GK\31 MGPC_D/6MO=1-AZ57L1KJ(U%_T(9/U'+,?%*5KHXL\E0CH6`H_<-QS3%F;52@ MI)R0)P8I70#_B!X%3WK@$> M\":JHEV>UM;WK"[[O,L^[[+/&>FB,C)W]S]#+L8#L`JDF3.W30-DQ8@\#B!9 MI*''U5!Q4"!*^'T+[UAD0D*-=;9OF(BB+' M7RA"!:O@]W^H;7M'5L1\98]LMSMG]4RE=O+D$-_N/6/?(,Z+ M[G@?`7]S;2(JPIL">+E)\*I`=:'A3@@Y=4SCB5S;NB7D8BS*&4J!/FLHO`#+ M"@"WKZ54Z0J@XPNB3DCF(V;2'P%4_`%^X3YMQTR(J* M+>P//X&+;M^?"A%XJ3+`?0Y0"\>EMK1I/85;Z:UC4T$0)ZF%`O=]RNK*'0\1 M9(5XQWT.)(Y$%@:I;WQA/)#5LV6N3-U*=/\Z.\1H97)&^[%B(9]0DSH.(IBD>&T\ MA:]J#>VA?`WM,-ZU9Z][B1Z/O9_LJY[=XWFLO>"M3U6=[3C(-C$EF_'!YO,% MTW55N%6]ZG55N+LJW+F+HZO"_3471U>%6Z!M7;G1KJM]5[NQ*ZBG3C1159B$ MS7MGNG]>.NR"[Q&'N-Z=[O&B,7"^;7#RD;E^W4E&P?MDLW/=WFUW) M-Y3)2!A@$=,U,/"%E#D?0=R.8Q!AG#-O$[&,4!3#YE)>JI+_!54Y#3W<7O*N M4D)=M[*N4@+22@F3SU$HXIIPU3?8D>HWV##+LJY'V'"^[A6V>X7M7F&[5]CN%;9[ MA>U>81N_[W>OL-TK;/<*V[W"=J^PW2ML]PK[V92Y>X7M7F$_F2IWK["8%+5[ MA>U>8;M7V.X5MGEE;OH5%FD>>_<*6^D5MJOIJ::F9UN?76<4?['JNVMR+)XIS89W/??DT>5MF?O:8`+FX,J;O(*K.Y*:<+VP M7=]R27\R@[LERI&@8$LH#&'D]"XJI,;7??5F+P'/]*?E^K#O!Y=:;']H,U'5 MB1J[N._)B.QZ#);#-*2Z"XCJ8MH5#DLOO#K\1BSCZAEY03HPM MU7UV(GCF*PDLD>`>,AQ-P(PV*0K0K-Y<90D7<5'!XCYY[XA+Z'>?*3OGY)5L M[!>V"^SS,AZ)2KHJ:\*3-W_[5*284)%[QQ2?6:I7%V:9RYBZ-+X_R:BZ-+XP0/ M&.[2.+LTSBZ-\W.D$I2=.R@;L]QYKD?M:M-ZNK,WFTO;81]2<4VGZ,2527(+ MXK(A8<+]*EF5_1/#,'WJX\MC'!5%I0`6!@!*^>?665G0D+^7=FEL-5FE71H; MTC2V4>OCSQ0>OW\0\^G9(\;)*W'T)W+Q3DU:E MCGL`&TL6Y)9;7:D;02"1WWCYPBO+?Z+($\NDR>9"YM9TU,C\$@*YDQWG.A(#=?=T%4 M@+WE56KRMPJ?;UFYC`;-^:J4\O)U%T-IR'%W,5=X?[K9\9P(ROH4WZM+&KD( M%%KR-0;@QGN,6*"L`Z2M-E@0UY7K[HAQOG,H`_Y*Y.RZR;X(X6(T*&_3$5P- ME\+TM%#=*LF\Y79`H=OS;X[MNLP(FJ%]F!(0W$*-A$6MY>Z]XC8]V__AZCT! M$/SU5#8'M9:['XK[97A!5+1O+@*"OY[*YJ#V65W(737!KJ=;\;J"N'NZ=94C MJR.<4SFRN7VP:G+7I%QRUY6UMIVM_\')H[WS@G0O-YGO!="T+S$OGS9T*D:) M7Y4;]^7%Y/@WYY.=]TR!_C/_&.J608J#.;-A7+7XUT MU?'.I:GQLRSG,[B<"/7TUI!MH%@QLPU)5>"U-Y-!@01J3:F$5U_5PCLF)3ZD MAPB%ET8OF*VC5@45+'@)Q-`GM8*)NM8]Q:BAO=A\HHIL@6T$&CK@=8DJE M\//EY5`*LYHC*]50_L6U.0/'QCV`]6FS'V^T7">>H@+_&U_>-;^.*&?BB^NX M'+HM>*L^=A^7$\BQ(+)B1D_)DVE9]+NG.AUN15CSM0EP7@D23ENZ<)!(+ZDG M;0PVKKC=!)\P'W1BNZD[_T0Y$RU=$_6B&ZC[]`NH^X'\:ZTLT:!KH(8WJX9* M4-3PF-K<]E"B5H4R*(--8?XY"EC49F3<$;;AT8_/J$Q8+M5.W[`FP$/6!%B# MC0]NGDGDZZEQ$U1*.UJ0[:%*8,=V29;-[C?2AG7H-\39%U\X%?0@6"TSQ*L% MXEVO#=>RJ@'0_IYJA6W"IB/ZOV/&'U>NQ]G1A@$S[#<'?XQM?:5`&75-2^4< M]ZN-;TF^V0FZ!>[H+,2B/VXC8D+.<;],^'137)*Z)GCIS<0L_O-6HB;F'K>+ MG5-^:>^+\<2 MN?AK1UFYLJA-M^.B6WK/Q'EXUBW):G&3`;HJ$M5X`CSQ2A-\8UNOU.PFAS7S M>"6><]TCE[KI_*YO=KR&Y`1?^22%'-:1N%[3:JE<*@1(<7![&N&DE5G,.T5D M+=S^"K+9+;AZ5`BWMQA.9/?$\S;$D)<9<_K-I!V>>`CO%E)-6M&X*[BAE90K MI.7Z=VX-,*>MRR4FB/*M?1T5([M;1;5H1!LC@U5(+%$I4NKT7K30`"S"8[?< M:E`>W`_.-5Q/]PMJ3O`5TRW%"FI74E2[?CBON5`"`!NH=RDI+:_1%W2,?.?P M"*J+_28U3/T#1;\R2 MW`D0OIZ)2.W4.A?!K^H&].T[WZ_#73J"&ABU._F21'6Z6Q[$3^J7NTYDG4WP M=;^[+I2)#Z2ZZ3*J\?(H7A5H+I"?4/2R3LY/>G4Y$'VM=3N4[PQUQ*XV5(Y# M;>QJ/>NX1)6-,F`,!6,VMS)GK6)`J M6P')BK%QHZ1:1B"%\C`CD#T>]OCK8>\'T=DON6P+Y_A%CY#)42IG[[DN\=QH MZ)CPR%:9#@1)_(JR#?(FKY`QD39T?S*?".+0@!E2D5)4%*DH0T)"%(VONDPP M(]I//Q*Z?^F0OW;$6GWPS`]M/I]!96!*S%]>4T7+.AHZV%2UA0;/7/K\"K2W M#(2A`A>3$/J<4&E1`*5,XM!F:.9P:+,@Z[.8A/`G<29D$?WX+Y,X].^?/Z[) M*]D$XEB`9[I6)1>F9OPRGK9>?1CVUK1O^)NDT/"(GB'"W"A0%&O=BU) MJ,S1$JH!ES:=-6DBA#]B6KCJH(72[E67=7#5@$N+#KN\>QJ0+U'535;>N(L0 M#ISRVF(@*%$(:-,=$*!R(10`,=..2Y=12URHOC?XQ#*R%SG]PHUM.7MKWG\A MI6L8K/R0,BH5K(P\UPZT""IZYR37A7)U.%H]4G)L0[FF(M=">.6H>N='I!]R MT@2T&-2K"*P%!7TF-VK9"@5[3ASSE8[\2BY-2Z?SZ)M$\-T>O?ZQ/)Z"A644 MI$7E:JQ-K<)56E[N+3&'Y'UT=1K"E9R;V0QSG7#Y!JL%H`T'0[!8KHQY@1B/CJ),V>".U!7Q,(QY@+_''<^+&M]CV>#.F!/Q,(IY`,OYS)@7-;['LL&= M6*;"X+Z.XJ2UQ1C>2E1!*9*K2KKD%D<3-SN3^W>'2AQX(OQB\LMM$FM#VZ5*<;EVTI7Q*PG/96P MX3;]RG*?POQOE)YKVW6OK-5F9[!J'A>ZPYHEN_W%>`[O48+FXJLH=Q5X6V+* M0DF$9_VSY$F'/+-WHUTBUAO`"[/C7&5;<@BL/?$J^B&@G=[IS5L^X2 M]U[?^#6>=&M%@JKPW+?77TP&8*6Z:N?FBR^(0G"WQ/VJ1C(/CFZY:^*X-\1C MIV6MKX>*Z/[BRIT"8:#&$^1JK%S@T%XI7+?ZZM3XCJ/A8`SOT%-$+.KUGN7> M4P_68;F^SLNW)R/HX,8Z%;ILQ@U\@&?)C)O:5JA8(03AG9DB;$/@KW00G.#Y MKS_7!F#!&54(4Z!,)9^2"\<69HL5M\\UAPU-F\[`[L/8%4!>-HV[&:L5!1L= M%P6[(Y[IWU%ZK(!:X6)@\=^S/Z]:!>R\GWV!%<4IQ*0JM$HU.T&1&6YYB/.T8$0^&'_FYN=]L3RZ*3)S]T M;XESL7W9V!^$T!]7E)K^=#09"59^2HEO!3,J6.^@:A(?"TJ%B_MX2&$VX,?Y MH7NK9VJ/[7WN\[A<\P\YJ_+]("O/UW(M*B?8QH\?(!WJS^8SR*VZ)%F?7\<2 M@L?]0)3#(C-IF.0H>N=*Z`G+'P^FL)7H5=%+LKEFUF8'@"HP[>HUKJI[^F9J%,Z?EKN"UF9:Y,8 M837QR02L^G3JK%76I3_DTB)!_A&S(@4QG6F=G`[_7H&>RPLW5MH,+G#?IT+2 M'][L!.D"&S<'@.CO&P5`R`7NRPC4A@?TWM+0R206G:=[?+P0?OY4,EY,-##N M13,JT7AP)8B62H[0VO"^E,$#4.7(\L"7.;^AF*AT?N=HL!0DA_MU%O_HRTQF ML`Q42;%>+81BHADM%)1OE.$?1=G%:H]IT^/'M/O=RXM_L=$WO3/=?>Y=;NRW MWI6UMITM/W,*OZ\EAV0CL@$3XU5NNQ,U4&*(CL9@I?'W)JJPML!:14$=#DWU M$,MIXI.%NW17RFK"1G\2'0L):.]&OSB@SJRV+`[1*0*PM.&<["P3,%\52(GDH.=?ORTS+]VY)RX*\?DT!(.)S83R-*^')Z6[;SG`Q"HLE`9ZNZ.`!(`. MYD95MA:>FE)9@24A(8VV60/7\8/D<`Y62B1E3E5ZN73,)Y.*E/W6#V/0^K/1 MK"9V!+,KU]1TF,2ZF2T1W"]R-SOVM\OU'SHST3V>)DR,_G0T&@^DG^7$@S2` M2SXWN)_G&+]QDH7/N6=2VS06PJUCK@C3KP5@WHHD%0VMO*(2PAW#Q].N(I5= M.G?FT[-W\4[-?-,EG)=8GX-/W?YT-@6KX%.&H`8TH:+A!/L;T_4Y6)I2,5(:/XP+R`IWL0"A?H<'W#U+!>6I66?Z9D.,TP^1JH/I M1$7:L.P6I:1YF'W>`JUY(,XV^AVWA@1AWRFV7?Z`6-!,Y3)`;(83L5#53BS# MU[7ESG,]W3),ZZFOS49P$999,S<`JJP@`C@7..',Y!HLZAWTQI_PCM?"@+H0 MK?[!>#S;.0Y[A./UE5?^/_J:IDW`S`<) M`AK8?PJ*)=2'`7^Z:E9?/-;> MB]MB4`\#RM\?RC-W#NMM>^8^?*NO MQ3%=$#^Q\RQ^TEW?/]L.=RFQ::(TO]%8\.J6YCG+'DWYP9LA]LAO)L\@[F?K M'[9AKLT5#RYE_EN+$O>3FH^K'<]FBUX%;VR/)'@3N-)2P"L^01-X5A-#F][" M#S?&6IZ^5>PI$G`(;@,I6EF+!DH)/=1`>?9P;RBGCFD\D6M;MQCU@0LHP81\ M+;B,D9H`2)(QW'O!PQME]H/^=_-*#A3-3?`B7\DA?\`FL"K&9@#9H*]AA.SB MKQVK*6QO7VR+V^ALE[9S3YQ7<[6W610HKB([K@+5K`397JY944'@5N4,ELY8]Y[-)K#U M@\?R!'_R54;+3=("U"5%A-O6.5G1;=LU?1ZN##/8EQG7;$-_U36/K/Q9>'7YY9HM9Y,"QY?P M;^8KL;2^-AHNP$(1JE!6RQ+)T(-PB:B2+O)]<6O3Z]"_@\V=W:U8D1&6;7/K MD*VYV_8G,[CPAMS9L2A#$3'AWB//R8M#5F90T.5EP^OHGEA&DL/^?""Z]:MR M!N83@`7V@L+"G?UP9KO>_MC9%D\Y"[F38%N]F5H@B+;E05 M)^X\B20/5#POCFWL5J&Z`^;(I!.9=@_R:XL>LE[8N[0$]8]N,SN32 MU@KU*23AR-%*L M1G!-AQCARMJ)HN2XZ7"Q6,@C)S,F&A"+"B#"<]BV;3CF9C08%(CWD!@2.9JI M[$=@CC#NI1(B2:N6.)HNP'+)RI,%Z0TYC!%HC'FE&4(*54#>1R(4)?J\MJJB M`DH?:\=J:8QY5*M%D'=74I3X<_&*N4J!RK@K]2^#[`K-,0Y7U+XT]`7<[/E" M;4OY>U&"+F!7@Q*YTL!H9PHA0E&]@U)]9[Z#3`1N.2)$0B_9T"L4Y']2Y_DI167XE'O?% M`N*U>#^TXLM$#<)1A))8-*U0_SR1I$DD=F:.YQ.!<[VF'G&YY*DX>@K.'93U M^LWOS6#Y/MS?'-ME[V##&5SP@7J"52P_]1HFW86O&D*XPV`*-36_(_YC;'A\ M^QRSIWBP5!(%].'6/K4`X$Y24;O2]MI7\)35`J^S<)3@5K>:(,"=,J-6"&>V MY3GT#D/7)ZL0QL0PD6\'!4K+5]+%#!APY^2D1M(.1<6N((V\-JI+4DZX4W14 MB08HRZ'12Y+:RS64A&IUG]2SS@3I(Q!@'+X$MS>_I.*9E6C35@,*8;!H8=!FF^R=<86)U="I=?56UI^S+JAP,GVL-GNGN M\^7&?KM8K\G*8P[Y$5PIRXK$?0HERQ`X[E)9%44'?ANO;W=7$0A2X]5;=>00 MZ`J3O&>7D_?AJ\\GN%V7CQD"2GFI(4Y+B4C"66,S?8%%)/ND-;`F<]2E[-&7 M*G+TV4(J!`B4--/F]89$)"C7FR"[2)G(\><;J6`5R26FA'8)17*[T5?<%CEY M(M;J(RY./9`ODR`WOK/SI48"M[^YTSQ?\\^.O8[Y#\;3#@/K/DW2.608Q?BB:) MQMX/;0AGLJ3,67[9)07"&H\-P>*:DS,I6&6RT@_75QJCN`V/)-5G.\>AK#+B MX1J-"29L&"P!V[C=Z]>V]<3B,0\T;C@'6UJB&1M`+8]QW*'ZF=P".?F5;^?[ M`SX$",`%"`KF@U8\P;M"-M>'D?FM?2M(9;.6LA05TV`_0TD-&0"*5<]`G.&: MQ@"0?Z`D8!*D'W;6K84!I?6M)*`0JYV0=?2^C31V@?P`]6E>+0S4HGD"!X8$ MZRA\&!7PJ^52KR*&]V3+G1@GEG%'7.:.,NZ)9?+(U&37\,@-/Y[*UX4M-+9R M%91HDUZ:>=SWDY^6RV(964BSB`^6BBJ(4$\!,7NP)E"39P_W[?_4,8TG'-OC2/I%WUE2@Q M'/./>@?^T<"[[<=9K()_/+H\K[^O:5.PI+,*=*FZ'EWJ*W*R9;V'^[/Q$"QM M*&U2!Y101KC?K/89^*%[+`'GXYP:XI0%R';,:=.V`N@4.>$V=O=9 M"#MMW%$6>!"$<4N<%?U`?V(LP75?ER>C%:H@*4?Z&ZQPF^9_IF0XS3C^![;O!%MS^=3<'VE8JT(=4A M=1+'7:!*R.=>B;_HPSWFX&YE)0AJDP[)RQ9W4_K,]H$WY(U_Q-MW#@5NQ!K: MWT8T(-6.X@*,&K;C+#J4T8%PCYU!W>V0]TEHESJDBR_0A@7.[2&H*$2WOTO3 MTJT59>C,=EF-B-$I6(/50RILSS+QA&Q>L#E M"*Z85WG"VJ56144=*A12%_L/_=W<[K;^8EFN(Z9UW]G'"E"R,'7;]PC?Z?3> M;?!`#_FN$66F0*H35:45*@-2YWF&R^Z,&M>$>>H8.S/Y1@TR0R(%NZ@T0G"1 M^BFS]C/F[^=[VF[E\<^HI3T8R(<9%AH;*=REY1/BWD8WHX"QX6(A'\A=;/!V M(2\AH1#Z.5+HD^<4M4_(DVV1*^O:)+OEFI4>#=PG?!>3]S#(#HL5[A)2"8%& MZBN\T)W-QQUY\0EGSVLL'I&I;G\^G8,]7*9/BQ1Z*3F%X5)(/4O[;_/G9.40 MW254CY_,5V(1UV5O\C5%R`EF1XI\$:F%"H#4S?3@V#LJ!N/H9&*_L)U`/$%? M33K9M4W-6&OOF]P#\J"_][798`ZF*PH)1:I50%"$"HC4"17&%M[JID%%,QJ# M>962,R%5@31AA!@B]?O$VGA.M?-5]^@VF(CWHUIYZQ"/J>5`FX#M$+)4(,6^ MC!##B%NDUD7F78@5WO0N"7$O?:-I_U[$S&7!3E#FYI@Y$5)E4".Y<-M`>M%@ M&N\RE:<7*.OBG3D\=Z;[[%O3W([6!L,)V(4C=WJDNE%(;*$*('4J1-H5. MR,KG8C*$Z\:7,3%2V"5%%0*.]%6`D1O'?0=\$",^Z/PMSM_Z6$0XG,.A&"E( MM:*T/&,]01G)M,_7TC&?3$H)^ZV??,A8F8$Z)C)G;X4V9$LM5(!)?SA!J0"A M$7QMZH_FQH_O#TIOS@=PUXBLB='"+B6K\+:`U!/`+KU7UG^8EA%>@_O::`*7 MI'D\'U)XLP43;^3S.4)4LUY"\R\R@L#&$J_&G^@&6$QN\0409?&;..":<;%_ ME0DCKZ=P+N7?_GV M31)S%1Q(D74Z&T_`MG$I"I#"7U1Z4;+9#.<-?;^NPRNQ=&J6[GBFS0/%W'VV M-T9_/M2F\L7OY`9M!;XR$HE#P=!ZX5(9\EU*=V1%S%?B*%#:C25^:CK]^&F9?['<%G?EF)RX M4$LGD*LREX(&%FH1J41(JS<&E"%]J9L.=SN??H3/2Q\\G, MK*P4(D078[2(%M!2P-Y$:M:N!(-[U33G2:$?OIIB)ZT372+@WS90YE0.:SDU\1U9Q[\9?63Y5 M)H`=3LLB7,P3T+H6K3)0%&K1&FTNGZ1%:]VQ2,$XVYI,_EFB_(#*S^8,\#8-QR+LHW? M4.S:N'[M-JY(P^X/WB)"(**KV(9JRR31YN"]I@!$8\Q!8I!T'B\3F5 M7]R[H(0/'9@?@T>(N":[D_+?G2)\\INFE?6 MRXY%A]C6BOZ5[G$/V3YAH1(LA@MPH4!1KV!I%%.9H\>:&G!!?Q&3$"'0E:;= MJPY:*.U>=8*[8YVXX+^$UB0-(#,'AY8*!1L6^/>3XQ[LH%\R(XD8S`+_E[VA MRI&X(LK7GBTTMLJ%5IN2'+9)*"Q%W";F(5L/SZ9CW.J.]W%I.U%;%Y8[F>!, M/CR]Z/"?2D6*R!+WG5CECT$@_$2/E+?+:Z%X,FJL6:PS]Z(UV" M;2![M'Z-!&*D08T4&,-Y_*,P8/_Q_8#_:_I/_Q/!!^$HIL>H&`\F@U'O6^_< M=-FS.#V.Z#^XI[X7A'CT?OUIN;Y!T4LX2?F7_M;[]9QXNKEQ_Q92M\?:_V5O?W.N4H&CT3C'OA>@R'W^27O'G?<_E*R9T4`W:+F)JN5W:)L4#T8 M,W%`RWOD!2,H6$X%9+S7/".=%=P6*2?^])AXP4-D%@ZG6'!(9P6WS<>)/SLF M7K[WD&"$!G%(9R7,(4>,P_D1\?.";8#.L>"0SDJ``])B#4)^N4FSF()=?U(G MK7C.9>!6)R?*;$YI<#+[2QU*`?TM*)MMH'M#`SI9)RI?ZBOL2@T:&I[;CV&^L:;;^0C_Q/BCW M"[BB3T4H4:']$/6^2@H3]X5G/["*\A761IB-AV!EH-(F18J\A(QP6X_[#(2U MB^YTCW!WF7%+G!7]0'\BE"6X&J[R9+1"$23E&*@&TAIA&:U.64`OE8Q?GUAG M/4]//\)7IN"+;G\ZFX(=&A5I0ZI$ZB0>51QKCV:Q@IG1[_K3T6@LWWPR?\`V M(9XJB=!>0-HF2,C,Q3O=^4R7W#KFBD0?[NELO?[X'(+:I"CRL@TU!ZFIF=DF MB7^XY-2Y(<=&7YM.1V"*4YP>I&I33;"AUB!]">!SX,Z[@QT=)%\,0? M>D\_XJ\$U3E/WG3'B'A^,1W^-^Z5Y0N&]@H0D5$^G32.:J MNR%O_".7K;0A6!JC'`U8U:>P`$.-0'K-SF0HJAC,FLC+/V-*C=E&@$7R"/%% MVO^NZWE3I>>-AO2>&AK4+%646]3+G>=Z.J\,W-=FHPE8=F+6S$B1EA56^%"$ M]!+;]2N#ZE-]OU&FM'^WV7_@^=M>7R/LYUC[GPQZ"5W\33(H5> M2DX!UC.<4)]L;2J4?_,+I]^-BT5#LX<\JK5;<[?M3V9PQESN[$B!+R(UY/VK M#YM`1,(*K=:+=^;%8!HM:H("L?+3B4"J#B5DB+RQ?2I'<6DC[GIG[7@7P]K5 MXI"*MNE%AA0#Q4"Z6T2IG">NN]OZ'LL[T_WSTB$D^?3?7PP'8%=$62*0:D4) M&8:[!5*OKX@CMN6M/&*P)UW*B0:?YY\R>8NT($5F<7_DUJ'_N[VA1A*+"O0U M>@!G2\J3T4*-2)5CJ!M((ZFR>#HW7TV#6$:PUTW!J@C*$M%"O4B18:@54YQ: MP1\[N.73UZ;#!5PP0S0/4FC%@@C10^HRN!;$?%\QN?'K,/-^:"S46U2S!BYN M_H``I'@7%!WN=%01,W'T0LP,V/50@H`6Z4&&Z'"GPXJ82>L,K`T'`[`,B@*$ MM$@O)$09Z`?2T[[KLISG%Y+OLHS4S.]Z[DI%,A?HN8O4]NO::8.UTT:Z>S/Q M,'\4XXZ>.<,!V&TM.1-2B-.$$1IH2"-[0ILA@W7*L@:7Z2Q!`%+$"XHN5`2D M`3]B;A@#HIT:$OM6P9T44(@PTDOY_B%TG6@B)RH3!?%,>ZVX8Z,,-U^M8V.J M3&II>%@,80DFVMRQ40:*+]VQ4=R4'`.X$L3'G>9JH;V!KO"9_`+NA,I:P6<7 M=0*"K5K%+77H23`?83C!BZ%$@6(@(*O7CE8'IJP4(D3G<[2(2O1?`4*T>LL> M=8C*2B%&5)M@1;3KPUR%@:X/<]>'N>O#W,H^S)^@Z^TU\3Q62HGT?$VAW'4\LX]K6K<2$UU$H MW5@#>V:1I:'\FGUP=(/$([K_(AMV[-_KFS#Q1YLN9F`,YDZO8#&7!3)TF%P^A?KI?>,W$2S/6U\60,]N:6/S\"O(L)";G52R\&YHHE M=[DNX>5_H]\DKA8GGJB`QT^7&`_VA>N96WH:1M\(RPCR>A[:5(,KEP-,/`)5 MJQ$>W`GZ`(+8JU/&KJGR#]'`U'Q.Q4N3-^X6BW?DQ2]:X`;;_'[^Y&0(=QAF M3HU`1Z1%@[M38IPO9QI]31N-P8J])&="@%\:X_A+<<2U1Y>.^6122MAO?6.; M%2*=@5;YS9P=`:Y%)(2[LO>G:,Q2^;HATX0%::W=?54,7@B($:9A;G;L5[<.E>^*_90H3T6O(8(=)Z.^#P`5+5:A`O)%WL3VLW:.JJX91;I$ M86TV^^6Z1%6%O4)'**Q]70N)!*B&!_Q[W?WJF1@[]BBQ-Q>?B$YX2:^"%O/B MQ9/ZZ;_CZ6(.Q75)FNI>!H)J)]6E>=3ZM+4E4;Y:WY2J6VCY'BE8^R!_]AXI M$(AG]T/!6@SW*_9#@40_K_<)ULJI7ZWW":0.9/3RF755(&<(YDAMQ?]2!9]ZB- MP,K%I,Q97ET?J.#=-37KD^F*R[5@'O>!#NZ*/PKPG6CC,13G*@E5L5@DP4\4 M/("0,W[S+DM.4#8,_D4"Q'F;%HG`1`.2,WYKK%+,)%2+),`(U*J>;L"N;&H\ MW3FEL!3!+78:YTLN.C6&DZZ35.V=I%2C7[C;U`PQZEDG!A3>%J/^7A"JEALJ9`Y19%=^1&@S1^*:]:;7&:4VWQU#&-)])CJ[1:145_(#9. MU;J);6OO+<&$&W?@'BYJ8B*:4]'S:9$>Y?G<-[ZPRJM@UW]AL6O&LC3?7:/R)MU+H(W*IT/4C1>C2O%@9JT;R432^']79L>I\@ MH2E^D(C'C;-T%H)J)"G7UO2!E!^R$HE)1U1JV'L(2QX!PNP MF(Y&8_G"L1DC*=_`,L1]K&.9C+5)R2[U5=AL:S8>@K7D2)M4.8KI+XKBLTC( M?YL`3%;$X]T5C5OBK.@'^A.A+,'5&),GHW&0)66$NVR%L+P.JXX7_8[O00*\ MTY*.7><;+^6]^OBS73!YA`V#* MR=;<;?N3&=SE.G?V!C`N(A'9.WY"-*RV2"-W%#"&ZH0OEQ#)\1]ARY[F>;AF4 MI[XV&TW`^E!ES=R@+RE/$#&<8X1PAE[PD!N_QRA_*)$/YQ`/T@`F^=Q$[[,H M39D_*"EDN5ZS36%-'(<8AW89U:SQ$&Z)Y<[?Q$(K))1XN2T0`BS:^X,8@L5@ M`N832)^V`3RE9!##.$4(XU?KRU@4XO)]&.J4OZ[)8J.09S=5G/<7(XHX-L!;V5.Q*&J9/10I,%.Z%K$! MTW7-Z+IF=%TSNJX9[5AU7=>,KFM&US4#7]>,\+ULW_%[:3MQWE4BHT_04B/% MLRT]KLH%5GO_C%+2PYWIM,_*@WU'7!9(9K^:;!6?6,8%KYZ9C`]=KF-VPS]/ ML"WPX^5$0RN9N]6*!88"[GRK0[:OK%?B>NP.=ZI;?Q*'KJP@>B/!F>!**JE? M><-_*A4J(DOA7AL!2I>$8X"5>_$ M(JGGSEC%>BTCH2,W1?L45B$+C2NLP"]26B3U7+%4GO7JV]<1"\/T3<#@<@,6Z)F=J`+4T M1B-X4"[!U/.BZS+7=9D+]:SK,H>QRQR$SZSK,M=PESF(4[SK2=;U).MZDG4] MR3Z;RG8]R5K6&:KK2=:"W;+K289:\[J>9%C.,2$;B;B'=6Y,TX-]9F^WMG7O MV:L_Z8>"!`,!ZVE-4-3-K/P8E^AZ!B0X_+%#GZ!-6BY>,2Y3>866'%7Y7BO1 M/JT$P[@5L8NE[V+ICV/I\1JJ7;)2Z_45(%D)L7G;)7]TR1\PYWK5Y(]A3O(' M@Z_'N](1H^=;Z9[)/N'?JY;U067\G\2QEQ;[*9@C,07_:M7$#V$WM0#\11T6%?[#])ZIFEK>AZ^LAU),**X@W25MG5:<3L%B+H!>M'`5 M"JGQU2VC#G3ME.9T,I"OJUUUND;508F0<&>KA)Q2$,NK_F0@WV>Q^H3-JH0: M0>'.BQ&*AYOABRG8DU+JI!4FDX-8N)07\-_3/F""NKTC0RF`V'@KRPR&XB"=M(`A;@G_<)OT^`Y^Q M9W)1$+-[)B,UQ?=92/:8N/?H?XR@RH'^Q%B"J^,O3T;C,$O*"+>QO<]2XNH0 MOV[S>NBL`H*H["<$ZAE4-`ZZG(2B)#:4F`O-'Y8(%/V.-_R2OU7G#]@`;L6X MQ)V\+N0E[-7&O=!^:W=]LR'&Z4?H'PB^Z/:GLRE81F)%VK!H1BEIXD^*[^K\ M'.[E!>O\S/!BFS1%5@YA03V&8?HT)9*K9V.X#CSR9#1^ M$6*XEU0H"5/$S^`=CX9@<:<9$S>`K*08`BP72+'TZU8MU\F'?QX?>M1'?@IV MWY(DH@F,BXLG=)0,<`)^3ASS5??,UV01\*!60G\^F``>Q>D3-[(O2\DA1!.I MWXM53V+%DY96S$^BU]@-J]-///V]KPTT.&AEJ6@`YC(""C%OA9/LNBLS]9T/:OF>UQI2Y_K7:GI=#N'LIM<:4A=Z MU_6Z&MIY7:\UI([XK]WVNAKFV6VO-<1.]*[<7%=NKIYZ5=FA;$"P58LS5(>> M!/,1AJAKCH7>CM./&Q8*1'Q%9!$A8`M/-&7MBR^'[PB\F?*ZHLK`N].M)Y_N ML0:W44:SU`R1B+L(E?D<+2I=?2GT57ZZ^E+MTKRNOE2[POM;6VI'(C6-Q>$5 MR<6O(4>O<(&=8FSB#NG/XN5^]^B2OW;T"YN/DRU/:4\D&`HBA$N@F#H'-F"E MA($[[O^&O&T^_$12)IH$^8(WB!0LA6,T@54N,]B#\=-O4&"68NF;8PX+2;A8 M[1%P!A0;&U)0'-]]A6RWP,Q-9Q?,4JQ+\\`9J$WSA*9N)MMM,'/3&`"/AE-; M/O62<+3\UGF)HT<0@I%;$%4PEE+5RA#U<7G3',9PV[*!-_F.N"S>S'XU&4<) M)N2+EF6,5#3NS:1*@5+$'*I0&G>-VQ+5:E..!]IA;4J_MF[6GXMJ^77-2J% MY:EK5-HU*E6GLEVCTJY1*9YPOBZ0M`6[91=(BEKS/G,@Z2=H5'KJF,83N;9U M*QXWT?]$OBM(^D#*#UF)-J)R;.%VMQUWEPS;2@IXFFCR4:+R`S1"->V(9[*V"%6>^)Q:5\T$$;Z+KJ;R+OM#8383!EF8>]RX3[Y2,^J`A M6R*V7CZ4)V.D)O"29`SWQA&E_I]^A&7=/KASSC>PY@NP6U;FS.6WD&C81)6Z M'T1G[[K&TKIC=8)YFU#=-=V?EOWH$N>5`7=EO>P\^K%MK>A?Z1Z_:^\3%NK# M8BAH2JQ8*%#4*U@HQ53FJ,9$#;B@OU9*B!#H@M;N50NSR2UUB&C9)8"$R^TX0IUB>A7AL!8I6$8[DXU\ID:"W7LH(Z,AN M:)^^*F2A<7T5F$2E18+?:BK#6I$(!+5H"UEX>+,?GNV=JUN&7VJ*#9JX+AD7964A(*/CBK)5-\J*)<++["[*>5!4"KHN`?>'7K-G5I4`6I3`<' MB)Y`2L&43+(!Q%=-5E1]D!>16*`%$!V"E&F!1(P%$/K5PW+J05U60A':B#M^ M2,CD.FJ=Q"0B7Q*PR-#J+@%Q&/MV:[I^#4!R2X5%?Z<_^:B6OT+GC%Z/DF8` MDG8-*""5=CFD0\:")X^`I>5ZN?-F3N/W9L?&7*[IJ>VY#_8I\<,^.&/R*14%1T>O!1)2`31F`>%F#/F-=QDK M\N64*Y M>*>VA^F2Z$^XG(;R^='5)\2M!Z5E%^C)`J>>A!1?O+^8#@_@/=G:.V:#WCKV MBA##O:323?#Z2OAV-A;UI\X)D2\T!QIMJ"RA\'UGT!8-R%+U@+G)L`K\>1,@ MQKZ(;$+@D;Y$"YCS(^4>')W=/'^W-[LM-UR'\ED+LT0.GMQQIF\VQ#C]"/D/ONCVI[.IP$<'^#HH3QL:I5$GXU"9D+IOD@<< M=SY9*VKD)#Q2?6T\'H-E'.9.CT8C"@DJ!!WK_5]W-A]WY$7_V')?I%\%A$FE M/Y_.P3:']&G1H"PEF1!=I/;^_KMIF'W'?NM;M=1T&JRI>$N)>^)N_)B9>,E[?]RD^$!G8UL@H5 M`JGA?^MO8*[?F^WBW:/D[TSWV7^F=*F%HHVF<[!-('=Z--I02%`AZ$@O!OLQ M4I?ZBO@;67\V'@J>W""BQN))T2`L(9405Z3FVCX'5Y9'Z$[EW>D>N>=%W!*A M!C.ATPX"Z2PRD&(O*;E0&Y"Z_?=Y2I;:H#R,0>TZ\;1(T4Z13(CN'">Z=^3) MI!QP/U5P-ITPW\(3?X!D+U6WA)+F?7"'E7P-&^EQT:!92A(ANFBO9F$SUT05 MEK.=XW"W\F!20V_CXXG1("XIG3`>"NE=[#E=P;5C")>/I[ M7QMH<(#+4H$&_#)B"S4!Z25,Z$0.7Y+YRU+\G)ST'-?;VC"'(#0*4E&:@:X@ M/?9+B&B!.E)<*OQ?(0M%J]Y]RXVW##ZYR\N>=KR8UVABNN;C1K%#D/I?G/H7G]F6ZY).>4V'C?C MRB=`I`^,9@Z'8>U[74G=D\W&?O/#FX?R>2%28Z)!M;`$PL6-U+\0 MO7ZY['DS:@S`W\`8$V">Q(R)T8`M*9QPS2*-`$YY`N%I=\>O'M/18""_>`N- MC0;7TA()D49J5X8A*_NU5WF,LWSF MTR%8U3XY&M!@7EQDX4)%>NH*PXN<>WU#;[6^R%A\T1RLTU+^_&BP+R:J$'>D M^73BS>O!OJ*VA4L%[.<9R&?3YHZ'!L9"G(<[.%(4^;YSJM.[^6^V;;A4(C>V M1;8O&_N#D'OBO)HKXCY0-EU]Q:C\'U1I/4I],I8T.+:TZ0BNGYHZ.M&H$8SH M0WU#:L!'13).*.5;3HA[9[I_7CJ$)%^Y^XOA0/!&J+BB2`X1:%2EA-3"NSI2 MRU'$T<7["UEY="Z-[O%R.K\,# MN$@@>3):H0.ID@NU`6E<6!9/Y^:K:1#+"/:S*9A)(4M$*S0A16JA'B"U!N), M16K"#!=@S\?Q/&C`%+,>XM6<4^X?WP]$0'GYT_]$\$$XBNDQ"L:#\6#8^]8[ M-UWVWK=S"/V'+ZY>)*^>;AD][YGTF-1Z>V+K_7J_>B;&;D-Z]MK_/$YS^%OO MUW/BZ>;&_5M(_![?;V]O_4(LP>H.0 M"*!@<;K$>=$=[X.UR^4EX&8SL-ZHHOG*/XG?D9?C]M_[$P3EL,>C*5QG)EDJ M%*QI&;P2+RF%I8.^0T*J`(#:)S6JL%`MH3`HK*AU5`GIX&^1((RJ"OA8U!R) M5K57`A]4#\:,FP;,Y,O-"490H67R,MX+=DMG!7=,R%X$1()X^:IP@A$:Q"&= M%=SE/+/+H$/94)7JPY?:H^KD1-W1(PM.9OSKH13P6TB9;$.92?7K9)V:!]AIUM?DE&$R8JI0GL)MGVJ0*%+4<8.+"#T)IH-]'"T@` M:"MJ5&5KX:DIE15LM!+2:-LV>\A$+?5H"D(J9"-N6Q^/FVA1)Q]7F3Z0L<`>(B[\%LM<&(S#BCV93]@B7!T%D[6?PBWM?*.B[A4MP M4>C9%C(:!4\F-@-YM]O!7RM0L/*"#Y4N@R/<.G?-7CGWR);OGK#WMRA@2.4& M]QG#ZKFM/F*J1_+66?)/44"0Q@ON_D"\T!+C]N"L\?NYC1<3,$]TYLSEM]B, M,Q.(D?)F2[9*%H-F/XLYG7_TKA,)MH'<"_5K)!`C#6JDP#F2QS]^STB9QN)' MFTUMS=;+LL`F"R.:5L$$3#EKY'-&, MD>I1QBQ1A\HHR2YN'T#5IMAU5\52MMDKYP%9E_+2,@'45V5MRR6L<*`F]=4O M2/7`+RNAR#6#N$E]=M`/$-#5(K+J`5E",!&^LPE:?`L$'@"!K2Y2I![@BTHL M,G\QK_*T3`>H!5XV,Z6FM9TICNB01@QHM?Q)!!5C]U=94$R/&''-9[^8DU^; M@_5B@FM,5HR4>M0X`SSQ/E5`@K@O3<)S=[GS7(_>!7GYO1E<$`L*Q[@2 MYY6YBJZLEYU'/[:M%?TKWA'MD+!0"19#L&J0X-0K6!K%5.:H!&X-N*"_\4N( M$.CNW.Y5!RV4=J\Z@9.B3ESP>SMJD@9TU?-&M33S/=5_]K_=.:Q#DO=@_Z&; M]&X;)9\F+DT"8S#E3EAH;)4+K38E.7QV+2Q%W";F[49?<<+]9.*(CY#=!#_R M#AVY05NM#L7EAML%L:_>ET<.RKW7O-A;.9=W'Y68H=4:4E&BN)T@=[KUY,=( MCC6X9]AHEO*''Q\B]#!I<+4-$_,HT-IT\4;%QX5\H;];'3`&53$>0&\@2872 M&U'1>B%?^&\'1W1#E60JB(>0V!\4HNUN&Y`[&H[!R-V;294"I8@YZF^?PAUN M0_>'_KY/-5@SM+V9ZL(DA3OG`&0Q4UZ.8K[T>6$6CFADPI!F!Y>$W-*MD/Y.?_+W[/(^K9S1 MT6,N(17YDQ,1JH)843(#S%B;`OBI]45N[][I'5 M$7XDQNG.H[_AFQ+7U6)]:;.&0P->$;X#!&?M1)!O1;>.N>*&Q$C^64=^X-:@ M*I9%@.\<)[["FJ'39(!35VX=>T6(X5Y2J86&Q7*=J!_2 MU\;C,5@.<>[T:-2@D*!"T)&ZRFYV[&]CM?5OA7R#D^\-+!X$#5[Y/(8@(?5H M[;\&7NHKYL/N[(BW^GHQ=X7A:, M\=6?`]YSTZ=%@ZV49$)TD?HQA-:"OQ>=L2-CL^$WOO%,?J.5&1(-AD7Y#^%$ MZK3(=)H>R:<_'2X6\BZ,8H.C@;B\3$*PD?HW?`[HOL,8O+0=\F1385C7)ME1 M2T]WGP,_'-=?^5NP[+!X`"XAAQ!:I%?B?;/AG*PO*>?UJ>N?FA,W%X']PQ)W@=3%G&N>,A M!3&'\Q!%I%?5?5ZN6,,Z*HT[W2,\E,Y(/%[/Q@NP!'=Y,I!J@:3D0FU`>B<. MN;C53:.O::.QH!:3&L"3,Z&!-(W]$#6D-]Y]34S4A(H;]W$_*FO/MP!#5)H* M-'"7D5NH"FVZ'G=]#64NT=E]#9'>GW^C`US;E!GKG%X27W6/FI&Q2KLWQ+MU MB*>_][6!-@&SOV6I0*,`9<06:@+2&UC7_;#K?GC<_7`471XQMS\LXR+DX7D" M;]AH,)`/2"PT-IK=J[1$0B<2TOB8Z&G"90^_D37&'RBTR1#.<,F8&`WHDL() M(48:5!S?L#[8CG6VG#Q_D)6'C%8.#;E1)2P"X=_M=VZZ MS%^X,MSG^1N''H+Z:G;ZY9&(U!\2&>FT04["C+FK>\#SP,JK]F?\/4 M[,%FSQ+Z9A-)CJGI5-[#*3&B@G56!(7#!`))7G$71[G7-X1S_ZBO_GQP=,O5 M5XP:7O`E3&WI4VZF8._O4B0TA'5A\>`NAI+&3JC283XYUU_Y-%W989&!F,4U M\BHG*1S]L"WOF:5*6%1&$5N4JS'8$T0A4I`I0*ZXZ=4J2B1B3:8%\!3!"VJ`PI26+N_!*F@R6%GDPM^22L.CO@*^H(MQ4 M/FRZ\/C(=$%*#K@KK^S'$?J/\>8JT.-;>@%:F2_ZIC\;S\!J96# MNXS'R=9V///?7$E9Q:`U<1QB<(F7"8Y6BN`K+ES^4'[@A(,MQCKQ" M0ZX@CF+,,'L0Z&7JA3C>Q_WN\;_(RGNPE\[)JVYN6``!W6"7+[SNJ/7$ISW] M^*'_E^V$?\/#8OU(LO%@,85B7`V)=2P!042>E;)H;:!>,D+IVK:>V$-) M4L3+QXWYY+MZ6,027`?3`H0TM)&6%!7N\F5)!MPK:V5O252./7PL96YSRR7] M*6`V:`$Z&H*_G*1P%\4*KVUT$PR+'2_72^^9.+Y0^MIH)JI9KK;*9-KL#0%= M1"@1O"A?#JF6\E3E,&7YRN*O:"9[`V,IZWU-&PS`O&-YLS<$;Q&A1/"B#!,X MKGLZ&XN*A2J\K2JN!%OZ8IK"=837?*:Z9X2B;!_^1!;T/=-F<"'3!W.5OYL\ MD`VA9]UV9YG!D]\A&_366*!P3^YXBB((L@0=-:4KPAONMTQFD%(;9,M6QP/] MRZ`?WW`.5SQ+/&5Y34NQI2,DX%)@LR96H(Z2V(@,S0PYM$L?>7,?RO'LN*$S MC#96Z_R;!5E-#"CK_"L%1:A\N8RC[SN=SBY0H_OZ-*\F!FK0/$%GZ5S&\7>0 M5NEG!.H25Z,?-U-$+/^99<5%!M?I1Z0A8TT#ZY(G,;\"Q0=2A$-_MIP0V]"C M-GVG`-*#TIMVH\#GB*D-O6U3=3>QYU/V(8NKY\VO4`^*<)FL'R&^O>(V^:5W M)2`#6M767DUMZV:N'K7-@##W4!)*"/TU0EH40$8Y#FVNF[EFM%EP&RDF(?Q7 MD\*1?$$ES.6:_Q5WA!:H[EQM-@78*XC@+!T$F2ZZQ@_P:@EFL^,$,];GB_RU M8QEF%Z_LU;1P>ED\@C]`Y>0R49W`8,4N:F[G5-4EOM^G)9;4@WVJ;YC&W3\3 MXIWK'@F]PT.M0)Y9T>%5O/C)HQ.NORI":'S!%5=5?BPMIF!F'K3A8E`/`_&D"E10`@IQ"HF0=?3;81J[0-M'?9I7"P.U M:)Y@VY-@O6V;WB$3M>2D%<1/'$#V1@?ZH/_=O))$#=0;VR-A3`OK/RF?<9\_ MH')ERQ!^%$M6B$W<]Y(P2>S,WK)X=MT7$K4@GGBT^Q^F]WQE&:R(SD[?\,IZ MIRR`,PR.'57%:FU:>+9AZ-AD% M>GK8+M+/&#PQ#-,7Z*GM./:;:3VQ)#2XXJOR9(#KM$1/32DAX=YF]UD*.\2R M)T;*@LA5`8%SIQ]' M?JZ3-]TQDEV=KBR_Y&%?FX[@JC0H);4)O0&3->YJDL6=J@&KK)`,X/6A)%7- MV)W518B[N%8A#J-V)=2FVF<6TJU0G4#TJI,O6.2E3DLLE).=]TPY^#C524[`1_5!<:F4X-6$/^I-6.$SH""$E#G5O2$$T020!_@D,DTT"M\W;I8'QOUZ*+@W5]&`NU[X8^?YX#*4)1^ERR^ MEFKB0%TM#2DP,O3O@/4VE$%)"W$&PJYDM+E"V#(9CO8+Q.5,LC-R@'"KEBZE M$#X)[J.WHJ'R$KH*EQU$Y+>4D1#:%`@:O"$34@SN$0>03,/MW:9`06 M&XH6P509X`YZ^:%;NK]_!H2/M`58VY;#R1#!ER&'Q@-8JM5A&1_78;DF3_JF M%W3E9;%VA>NP\!$2`U2MPW)MN^Z9;;%JA\1:F20H;4B/9@VNJ*-HRO*'U-%X MIQ\W+`R.:F?\ZP]NR`1:+F3ZM,EV]8UZ/Y?J6_I:%7[-/?^COYG:W[=-[[QPL:DB: M#`A%3D;%=T^O/%_,16`>PY$S-`)C&;./7[R+[\LEJY>STS9GN.!_T5SR6[&SG M.%SMAB,X7ZP\'2AV9DDYX4X"R1,#4'HRO'FQ?Y&OBPU5>=8%8$EU3!RRWZ9< MZS1W8?![]I]'W27T-_\_4$L#!!0````(`/*$?4+"HY?R@!,!``TF$0`5`!P` M8F-S="TR,#$R,3(S,5]L86(N>&UL550)``,'_%51!_Q5475X"P`!!"4.```$ M.0$``.S]>7/<2)8O"OX_9O,=?&KNL\XRHUB!);:>=_$>)4K5M%:*&I%9]=K2 MGHV!$4X2-X,(%H"@Q/[TXPNV"&R^PT&EV;U=2H8OO^,XF[L?/^=__S]^/.W` M"TS2:!__S[\XY[._`!AO]MLH?OB??_GMYMW%S8>KJ[^`-`OC;;C;Q_!__B7> M_^7_"/Z?_X___?_U[MV'!(89W(*[5W#S\<-OWS[^7^!3M$-]4_#Y\X=W[_)F MS\E^>]B@=OL8N#/'>S?SWKDK\'^"];][#OCZ*VV(^OWQ[_C_W(4I!`A7G/[[ MC[MDM\W^YU\>L^SYW__V-_R?Y_ODX6_N;#;_&_WQ+T53W+5L^?W[]_/O'FGK MK-?KOY%?RZ9IU-80#>K\[?_Z]?/-YA$^A>^B&%.]@:A7&OU[2O[X>;\),[)4 MM>YU5-[?2@HZ6^#_>EX?_],YQWWG.^8]T6T!L$-,^R5_0P@%`ER[9[^`W M>`_P__[V[:KL?1^F=Z3G(7WW$(;/?\,-_K8+[^#N;^&/*+V$]^%AA]>1#/.8 MP/OC!6\,@+ZA^S>XRU+\%SQ:^@[_Z=W,R:GX?[>,F[T^(^9)HZ?G'5K2OTD" MWSR&\0/\C/^-IU8*OF-LM03<)^'#$XRSR_WF@/^7L)52,GIGT$,,63,M1!R- MS`_^5(+6%/T6/B=P@U58-_*CKKLD.>V)!7B-!=A9$,0=8VK`?(G^CP[-IAKJ5YA$^^W'6#'F]F'U@+_)PJ1',L7A-P=63<#M/@MW M:J$WAU0-^@M4O-JG`RI?9>3^<2N2@55N#*D0M,#R9DV'](HABGRG])-$CUC MJWT1;]^':91>WW]-8%K8\ELTZ'O4XX_SA>OYYXYSOA"UO?@OIZ8W_[,`GF/2 M=]AGWB?%JAZMZT52+,!]LG]21W^V1V.%=R)C.9[GNN?>;#WWYW\!^V0+$[0Q M^@MX1BHOB;+7__D7M$WW^*XC#>1.$. M>9D9Q%O`].(NS9)PDYU[\X4^+>#'PY)@L8\1PIEI4UBV^>4$T%6.@J9 MZFCON/Z*:%1WN;9:1)CPZ^9X%A!!T0CDK;9M9#>>R MT73*OVV]\E5WYW35W4EP,1LA1GF9"5)PFX1;",*"KY.RTQF((:\VWFXC^C6^ MAM'V*OX0/D=9N#N?+]R9/K^A?5))KF:EI&3HC@[^;$:7VK.;C1G@:_<;AC$$ M51N`&X$H!GDSM9RJ1PF/P:E-U=O>H=`,'EUK?XKLVJ3!C,)E1%/GWF?4\AWB MWHT0]Z8IS-+S^6I%/O%:"[.2.21YLP-GR8KT=[),'MT;K.P^..Q`S,%F'1>7 M+&S6.G=`KD)!2'Z48B,]UED]&S5M+_U]M9ROZ*K8?>/3!E>[;6W.&5P(LTQY M+#5?S_59RZ.I5'!0)^QC1CHZ=/.<7-)6$^"I3N1FS&`OAN#BYN;C[72Q6OJ:G2LUYR_] MJ(]9K3R+)8XI-05KRX\)>X$;=+PZ(.3^UX;^*N&'G7Y"C4I.(^-UZ+BBV6KF MY0Z(Y1.W%,Z`GHVO+3 M928"#'IW`U""_'<@OK?H^+;ZM:$!!NU7CF5K)//4J5D[$^3.(_1&E64KA%.E M*>P>?@C3QXMXB__GX[\.T4NX(Q$:V8X`SQ?S^4(;OS)!D.-? M02H+AF;K[CCY,<3:[EL1`6IT,SP_I`"W)3%"Y!^U7F<@S$#1$9">.D5"BX]A MG4@TG!#&+T8,Z8)^-+LO7\0(,N*D"$&K!&2#_P&KCIS2L']ZBC(:MXAVVMON,GIT([0J?%4E0:TG5 M?;VM>E;6H\['9.6FZK[^]=>KVU\_?KF]N?AR^>'ZR^W5E[]__/+AZN/-EWT& MSU=4E?BY*K'[ZI*?&#,JFQ=6@\\W:/W(KK/'P[G4V>H_NQUS7R M44O'7^?NH=T7#?W`36C>SMD#^BL@/Y]1Y_D,7*7I`6X5\:`V!6N`!YNJ]*1E M'ASCT]#:M=VWJ\/@S:C*(1@%4Z:4*?_'^6P.GL,$O%#N=%:SL]F,_'^0/H9H M1A`>LD>TUO\-M_\?L)R?K='_7\P71*TZL^69O_3.5F[9.B+L#4+RT.02;N#3 M'4R`YYSA?$`.Z77Z5_<,H)[/<)-%+W#WRB<:E_`>)@G.&%5S"NPQ) M!NJ&SU,VN(,N?M?BGUC#[PT/9KCK:IV'Q*WMOECDI$2WC\,')RB:@[P](!W. M0-4%_9OWU4`QZ#?X`N-#^?9IN5@ZVEG]>$XU_#U$QRE3G[1WG;5'58K=MS\L M\$VQ;P^&BF?S1H+7YP-?5ZL#8I!+.UV-X_:YZ^FMZ3+;?8O.2H)1MV(`3/!; M#,,D1FR;T(:\W)I$+R'VN3]'X5VTB[((UF)*-%[(],TLR[D\-%7\V].+QG+E M'IS=MRY<=!CB9'9$0=68[$8%DHXP?7Y-SL*H+-WB./3T"$4F=B6M-!1V*CT_/N_TKA-_@CN2_;&&`E:/OTG!P>CG.%J"N8._AKH[K MKUWZ5>R^1N0E13>K<^()BO;O$MK!*-MK<4^L8?N&HS+8M?`1E_3SV'W;*$"- M$:>%'U?P-7Q%L^[(\78A!_#',XQ3WNO&3U$<9-'=#M+X1'S4 MLE[[^AZ?]\\MQ_6\=!4L/]"/?HC<_-I]0\1)B1%6Y\.$V#RC08'<:3\8/[\6 M-\8"MFXX,`/]O.5R15?=[MMW'C)T.RX<6`+:]AUI#*K6H`@$YSZ@OHI?D&3L MDU-F9--.(FT\Q^Y+PU[<1M1K'X*@_%$%IVE1 MG+HYK:$5CYKY,S<76+NOZ[I!Z]9XG3-7O"6@RFK^+OI(RYFK[8ES;28Y]NJ' M7'#742L2%3.GPFCWU40?;`XM)OZVN0=`_K)Y5[50P&M:=)E>7FMHLGHKWUW2 MJT;'[MO:3LRZ]5C7Q,%G!7Q5OOASD6K4YI2U3*B,S;HI:.&VXV>W7NYNV'UO MQ0+?B+_&`"3X?'7Q_NKSU>W51]Y$-7V?5+?.T\^4?2JP;.R[--N/Y]A]\S2( MW:!*;`505XW"SY7KD\1;$C3\N-^ACY+BEW'9*[9OGF/"_6N=7AVO,A+7QKGM M7;%.F--S,AL=*3ZJ`;)@): M.+N*577SO9?=EQ%#T`UR:]O\=;X4#`[K^Y*ZMZG:6;%O*WH4-IT[B:[=-[`, MZ$UO-SMPG*1H57&A<9IQSEU[^C)3=\^KFEF[Z>GFV9H/1TM=>.YDKD)Z23"O M3EMQM*I5A<:^\_0]JEU^PV&.+;/7:BUGSL.?1GH3N:FL`N]02>A`\*Q?U`U4L"?=5.J+^:U M=VH-[-I-52_7'ELSEQ['N).Y(&0@Q+2;,`PI^%QJ7K6^0H,'S"E@DYS-IH^K M-/7.C"8@<"=S[3=$Q2CZN15*EYX6W\HAV;A%HH'39!:%J\\=UUWI2TC2-J4D M'[,14?)O:W/BM.4;9LNOZUCPF]'##$AJZO=YG^"%PXG_8MRC*(`.?HDA3GH& MME%*2DCC?_^/Q7Q]YJ]I'L'_,3M.`?A7E5RN1VT;YO*FEFYK/G?R-TZNY3=M M@^"UZ^0A!`'Y!>0_B3O-]0FJ!_1KS].F@%MFE.-,-A(*QFQM370&W8YX=E]9 ML,`WHGP9@)2'9'R:UYEY9ZOYFFK>M;\\6Z]]*?W;RR!:U*]9'F\HW[;62'G0 MV!37[AOB0>RZ5>\0@%/-*W1+?)T]PN1BLTD.[2E,O+FOSSGHGUR.4;D)*WAV MJ.-\O:)GFI[=5W-<=.CF91XP`6D,\M8*TN2PLH(6+\,&'F_X'D,=200A=?$\ MNV_N."DQXI'P84_5:LZT,=KUJ>/:\E#:6WCZZLOT3JV!B;NIZN7ED]`4FNS- ML_LRCX\0@UX#(Z03E:R9N\VY#R:YF\V;J`HAKUT:!>O9?:''0<4HOD4KE$X7 M0_A&CPS8NBGR=3.UEFT>$RE'G-S28[7.DX9X=M][,.$WPKT#('*^571&T?>- M]7D8QMFUW:UH]BAJLM$0%L_NVVAF&LPY$PQHST3*C'-NRD5"P;&MK9^;2$!7?[J/A8?"Z=>L@@J!LH:`L:.^G MU:)8S7)G0Z&VM"Y$GYX[^G:?ZC+A-Z)(69#4>#6O%AKOZ[5"W=Y2H6CO!O-J MH-Q<_1Q&VX_TP/@BWG:?&0O08 M4.G`)V."30?\E*+]8K:@YTV^W0?/#.C-^B!M$$X]#L'CNJ_) M_ADFV>M7!"-#2ARG#7I^@GDM*' M_&QM[FE,7LJZ/`( M,Y$6'V@:\M/PE'A'\GUGX=O]#$R4)"/^DR"XNAQM4`]>2)UQ"'^7)\3-0Q`5AX$"*Q$8+#S#" M$Q3M0=$!_%+K`O(^G$\<>9A#DVFPA_M;#,!0Y_QR,<\$.[==^?.38TCQ?1&9&YWN,T@=OT\VP\@J#?XMR)) M_T6&O/2[0T8R.&1[\#7DW]?V?6,M+]),,FGC+5IG`2F:*F-N=]@+`WH.[T+\ M%=HPCOP)FH*R6WUU+-8K?9?VNLJI\-#3S;7'=LS/]83=UZ,<5!CQD=GQ!/6* M0?]6E`SB+.K)\.$-.07&&)G!1RC[+%QT'8T?VP M?WK:QV0F--)U0CSP+3E2_`J3&QSR>[Y8+?7M^Q@`R#&[$(4%U[-T=F:+)=4W M2[M=97YB=$L"-Z*`]BC>5:!.:,$![49?60#4$9">^@1!B]=BE2`T_!BF+X5- M[X*^SUK:[8Z+D&/$LQ$`5LA$_GZC?+P!GI$DI%*20.9++\H7'Y@_]-4IZ)E8 M&>9!H.*OA?(B7ZG;4'56#TGZ];EYCFY3WA:%7&8J^8A[ZS&2UL@F.'M6^QU$1#T&NLI=V1AJPDC*-U MV\&T:UR1M\J7\"Z[BM,L.>";R=_B\`EGXD9*^S)/N%V^U7#7J[8;PKM-FA$> M==R<0_%?F,>5XU<)]`4',P]!;Q)RHV?W@PEAFG1K9E%@`>X(JIZ@UA44?<7B M9_E9R'$G+0$5?%X1<%;Y=Z&Q.4N[HP`EJ&(7@^U^0X8GJ7FTB4,3XJE`G+5* M1!E2?JY;)I:3%HF&6\,Z1!ZL-E^0[[*R.RA0G"@CKH\PO,$B(F=E]1#%8E!+ M"X!YJ>T>25025"6AD*.!61Y.$R3,J:NZLCM,4(:LT5VE;FQLWI)H_A8ACE+E M,XTJ%@*>4S5,:<-I]O:5W;>I_B+&;TU&-E]^4K(P6ZO20V&,VMS#08T=&L:/JSFVLOOBBH.*T71W.YY.O2V8 M17V0`XSI:U,LS:2GBZ`8DV,#V?ZZQ6R(9!CK=%Z2S8G+$_UC<^S8[@6Y[J M7)`B(QI=#%M0-,W5.;C?)V"+#]'ACRR*'PY1^DBNFS;[E#?].2?_:-'[%LI) MPQPP]O<7^5>S^_Q<@!K=1H(?4E!UP>?CI9#DO8B4%/U$A2*]W7^#>,FC'?P" MLZMXLW^"G_;+'HA=<:J-]`K M?=E3=0!6)6\:E[`IG`HG0XZAE_.:W8>J!J@W)_RZ2*@IBQ0_<"\GP8F3`9T& M_((G^BO^F>2(+28#=Z_@%SP?B.*_@G)*4,TI_%!>IYAH]FE_!DW3XRZK9%3L M[M$,#;[E55>,T&_8%=='R:G224JE$R.ELT-3X+_B?^.DNO@#8Q4#]J6&"

  • >/#$TO*?+\U)4"/-C56?BN M0[^@W==-O*1H-^)\>()Z>^S`D["P,DKRE[P39[9==M;08QYM8?RFY1K^.N34 M84&_C]TGF_S$F+$IO+!PBMT$%@)0A'0!])]HF5X@&@SG8SJ*_.(4!UP1[^KI M.8P2;(4^/(;)`S[F6'DDR&2E109:YY1D?$8Z2FYO;T^6G[Z?]RU/*\9(`3M? M(W:ZVPMS-A.:`'M-F'NCLB7F:Y&RC`,?7(_78IYQF_Y)>_L%S5+O6YZ/E`&] M=B]D$$)`FH"J#<@;<28?8"J@L9C/2>9#9Z:#8PW4>A$ELTQ4P%8A!BL2^D3` MMSQKJ1A![&R/-G_1?GN3A4DFIJN%``9E>22R%87U\DAW\"&*<=4`K,PI/*VB MXOPW>XTK1Q;'=%<_Z+H,PP-Y\BC*PR0,U"EK0[ M*/J#7XH1.$]1OX81`O&?48S^;P81-=FYX\TUGILV)Y0,^60AX#B7&@F1`E`?146JU>J1;T8'_$?@W2(J7X8$C<@OW"<(4 M"1UYG(LF"-&B?\`Q<^=+?Z7O7(D+BAS?2U)=?S?./HRWL+RFL0@YNO6_`":: M."'O!*I>`'T>N\=#L]4O`\]7,UU?( MAP6!K&"(T%C)`T-OQ_4\ZMLN;,_BQDV-?AO""RFH=SD#92=B/>K=-,J")FMA ME2RTV(;AWLL\?FQ-OY;M*=Q$"#)D&P2@'4D&$8=06!S^'D8QO@J_1M,G:'>> M12^P2@:4?H$X'B0+?YP[,X=>!OBN#J%@Q2$G&#+4%N+!/@;^:BX-H%G8?1DN M3!.#D*RID,3P`7M`8F(BBB_`'7&4Q[;L!G91>!?M<"4YG!/%B,AH<:ELE9B& M;\4\A.=Y^9>S._&A&$&Z/2PA5%1`\L\ MDOGU/8EK23'3K&=&C$IS0CQ6RE\G!ONH&@0(",_Z+8$([%YG\YOZ>?E-7;\A=V!K1Q4&-3N`U`:*KUJ MCYG[0I"Y4SP@1/-_/'K(3V/'$2>X\[E>1=X+0)[+N>FKL_I`9Z)V:/R:Y<>H M_,085.QMZ2AM0L[`YFXJ3$A.)G MAT.4?TJU/Z3Z_V.#\2^Y&9\^-+T-?\`4ARL@/EC.]16"/IE-CJF'H1BF89>Z-8`,J"+K$ MH9?(88FH=U_X7JZT['X*)D#->!:A"]*@5:@ZZI0'/<>!M@E$\U"0K3_17S3@ MR?("Z$+T&#H:%,$6%(W!+U'<9BL2E>*1'!!M>=A!A'-1S%:NONL@%@@:I&.8 MR%[A:'3WUO2]A>5UU/F)&<58]"'JL16X&ZCUTRD,YO81(PH#VV[BI'OAZN;6 MW>XK)#&"QMM3#$&KI(/:!R(2D$;G2\L#/HJ_OK^'210_T/C_A;M>N^Q%HAF& M5,W>+)B[N;O9VUG,G<(T6UX>780<\^I^$%/%TJ4;=!73%UE%/Y$765RLPECM MV2[^;E9W9E]]>B1M>;5S$7+8&5RNDK,`-F9&YRS;S,4T;.6:[6)T!C>ET;NP MG/0RVO+BY4+TC.2D#"/KVLZ2RBO[@M,%7@ZV@:&%C[[!%Q@?Z"&(R;WLR?SJ M96*(O#Z)..F[G*UI/)+E-G!T[5_+3J!O)T/D-'NJ7I`'9TZ1NHXO"H)0]Z!E.5@W(77=NJHB]<[8*CF>V9JNR6@ M:PAGX2_I&?%J:E>W;"295_Q,N+JL0*W6&>DM7.>,GXL,N?^6R`S#;J#S0Q(= M1^\=+2](+4[42+L#1GC!ATIBV/+6+%8X-:OS!1BG1G MN9[:E3,796-;(P:,=9.T4Q=J]#6!^)%9<6J6YU.\B+?7V2-,R@P&:Z/['A90 MJB5*<"&Z18MM0"_WV==3N_'F)\^\_>+&V&7&\H%`/@+))D?&$$H4(VJ6\&(FC'>@)P:TN[Y$\/N?RB.5P3^10;)=&\]#3 MU\:.Y^NT<=54LB+3"[J2@Z-F*QH$L;;]PJ4+M'[;T3%S4/PB]"JZ[5-IVHWH MY:^6K42]&,L M_;1/;F#R$FU@>IU\V(71$S*A3EZU3@\[\F"1Y%=)LDN&YAN'I%&BQQ]KR\]H MI0@S(Q(R$(.BK7R)&4%>TN,Q6"]"39^#:QS?IV_2UY9?#`H3I=UG$446E`5E M]O>`]"6.="E'6("*_NC3`#H"GRA]@1FN9O8UV;]$6[A]__I;"K=7\:S$E1QF!_QLI?B M^$C12U+?\CGO#.Y>P7W1$81E3_W2H\4*V2P]#?O#,8B_6M/LWFN[+PQ%2=)M M>P1Q$7DA52Z_UN3E%]P9X`RD97]PH5URRHL6SUOHRTS&C\>4('73SR]/M4OA M%4V;/Y_9?:$A39L]$M8.4$34A"_F);A.R_G#A*2N<1`A\N')&X13#J$5D@.JP?8-@AR M\U?T`]K]BE>4I)'\O2%<0VY>V5_UCJH%6,VWT5A\G1^/*4'JII]?GHZ<^MRG ML/OR7IHV>R2L':"(J*G>4;%PGW.Z)!`75C[J@X M<#9V5&UNH9H=5?5.Z,A-6JY,[ZA:@&@1+#:"!R2J=1#R#1WZ#>V.E)"@:LP= M%0.^DQT5KO9;/LQ1O*/J9223#J$5DL/J`;8-XJ]G,_H![8Z0$"5I)']O"->0 MFU=[0JU=3IRZO/]\R0O?]EILT?"V@&*B)KJ'14+ MUYG<4=DH=:P[JMX/CSV2&=U,.Y.,5^*A;LP=%0?.QHZJS2WDWU%=D6IRN+HF M\82T'J97GV/JPU\_(%W2H`N-)W6#\\LR*S]Y%>\. M]_4L3W+.3(-^7F8#$A0-\4L^4K#EN*U(?2(.)M"3B,8>)F^FEV'HO%JLO24Y M85F[MJML7F(8^%Y%RAAN8)4<8+^8U'.!QX(@4-6E0D'>R!:/9@L>62YG)F2@ M.;CJLGY;?W(LTAZW>S8?5O)18=Q?A_&%'S\UP&M)]D'DC?:A*!,2R#AM=SN+S9(0!+X:[AY MC&*8O%[$6RPRY#@$\<'*UUARG0V%&C[GI_24Y8=&(#%$^=FHW3?E@A095N]\ MZ(*O:-A'G/`."0@L6NF5"JTJWR:AZ#0#`P.L5^O<$ML=RBA"CBG3P(&I,A+9 M'N2]0-F-''9_%)0,?'`.M^DGQ$)5(AUZTDZLT;GC^[Z^@^_!^27E08"\4A0& M^R[0]HM\(M?N0`Y.2K0+`!>:@WWS ME+1S>J+LVAWP(4"-D?M.?EPG<@#I]K=\3*^"_V\>0P3]MQA]S2OTASB+7G`Z M8O+G]\@#VR)\^/**5.3^BNA*4;/=88NF)YBOR;=&NTRT3]<7YZX5NPZYT[>L M_3*K;%YWOJ#[5=?NP!J3RS".D=1"2X^%I?.!`YX0E#,2AY/\].X.3PKJLP(R M[1DH)\Y/-?*IK=13!FW\SZ2G&'T+1?/F%I/F]YR[=D>M&%Z)$7T:732=:*WL M$0+X`R:;B)X4T>^;$E7U/<_H*JY[ONPSF*)-.(['Q;ZSIZ^2>]>TZB1^@)@V M83WN0AQ3&M]D^]4N*PW&!:0/S0EKQ[@I>*9M5?.P=A?=)`_W.L9'71:N2P-+ M7Y$A'ZIA_/\-:^T)I\;6)C'M/L[]HI7KW?$ M-!(V\?F;+]?RT"!)THS[4@(@6TY3R>V9B@/5;_"YC/[X!M,LB389VN:$Z6,' MBZW,')9RX5(G9[++T29QO&,BYWHR(B=$FTFS)@+PU+)58Z#-^E]!-0S)@W"F MV,H)LJ!V>SRU@7QC^C[R>Z9S92B-''&)4L(9LL)=8K&P:?3X6%#[LJ2,(.XBB^M``S2IC\\$YD#0]`KGZ*(;#058.`&T6"=GV/_K+% MPOP"BZ+LR-TU9].:`-2*$A.!7;+3UIFH2'IF[$W'`62D9A2[-(SK1#A*(R10 M*YZ'/XR8EC$%8-!XM'1>N,5WF4[,,`LIILW#`)XV>X!8ONH#+L2X_R5*T6?Y MM$\N]X>[[/ZPN]AL]H>8L,52;UA`Y]32',]#5(W7>[J1U#WT0MNS/A*'G0Y3 M"IX947"QV^V_DW`]\N1[?TA)>Q#F'70PN"[%/BJ#MRGS[FZ+_-7]W+/^8)F1 M"`,*G`U)4+8D+%VT!1="'%T_$\-9%,X=9+SU9:8YG4Z.6OK3R[`Z!8X.O6F@P8@JX7(FK95,MN:PPV;>RPVCOD@?!.;J+L#B5B)<'( MOHH13$#?*U&^W2C@V[_O]]OT(MY^V`$[S(0R+H&87 M:$HBV.-$\8VX7"SI#;EO]P&X$OK,N6'B((_\-#(,N3FM#02*D4!MJ#.Q3-8W M&=H=X2W,]3T)3,(U5\JR+/YZKJ]@7%[<=+<'.+_N?7CU]N;\#U)_#AXN8_P*?/U_^\$2ZT M]<_\U>D5,6,XMQ.5E^VG?7*<#W#AS;VVD(&[39H1;G;[%18IH^#>,`R]6*WO?Y=@<' M"-&CW<<1`'4L(Z3<(>X&:OU,.CJ+B3LZ#<9G'\-SD`MJ=X`^/S&Z69X;4>5# MT2[@`N=(+7PHU$LJR[8`QSCNQ%G>:5SX,@_BN-2UM?NN0H0<=K[?[C<'HGV; M%TDJ^;_"QKN+..<4`?3MX/7]/;ZGIJ]7\'UU'0LN*JDQ$'@8@*2(B!!8B@9# MY[6[M/O!"#L1VM4_*Y*`M$2._SV-ULG?59&24$<*7Q^S:]DOV\3LC6TRV]=Q MO9F#==-\:?U'.=S$E7P?&\W?#[AK4A6'V]M]RT7%QT,?*XB M"(X'4WL9*)#`'9X?ETL02_[(Q!9:_)J16;WARO3W6I`7-[YO]X:6F0;=C@PK MD*#>$"OO*A^*P':5/'6Z>GH.HX24#GP,DP>(YEMY2_N$#4M0M1!]8XHY'"

    8'Q`9XOG:6^YQI'4\DQYP#J M@B>/FSG+>6[*[+[C[T&M6V5V3QW@GS"3Y3^JX#(MNE`[ES4TW\FB81%=+.BZ MV7WAT@_)IO''P*:GG@E!A!AC9A0N`"G/09;<'B%R1^U'/-CQN@2*S@ M)7Q.X":BMYKQMNX3GZ]F&I]_]$PL*PL<%%6,W]V)J*=EKI[L?F/'0X811<\! M**BW)3J[6XNR.RM4-1[BOD^LN/;KT=D=3,=.@VTEF!7+$QV<`_=<. MEBQ=[W6&X[^?\VPIO!S^,4QBI/33KS`I`M2CS?EJL5YJX^W6*>6XFI&*@I_; MFSLS9[&DJV_WM0<+?-U!5G&8)"=M+O\#L M:P*S\`?V1^;ZSHI98<@QM`2Q!8NS#T&VTN2-MS^S.QI"F"8CVEL478`[TAQ! M13?P$NX.`F<7-0A1^KQ/(WJ1721&G3EK?1DP>^=6)@Y,9+7(0%L_8E4]^AGL MOF?F(\0TMP]#"G[!3?\*'G).ETEQ7$U,\\Q6N<*1A"%F<#U];G?OW*IXG(VL M)H^W]B/?(58SFIG4 MM_SQ.@<5NOUV=BC4,\EU-^+L(DUWU>,,H#[\[)WB(2%"\/%'AG8'ARA]I$DA M:%+%F3O7%_DV.+\\F_.25V?U@;Y$Y[A4Y]@=*L)/C#&=S@7KU'>!1WV*R'U. M&8`Q3,(=O@K:/D5QA-_U8K^_3.LT`TR0-Z:WC4?-Q9)),?."'D5O!9LWE7Q_SV5^/)!_%X(LQ==D?Q]A*^_-25G.M1;>KF:2Y.->R"7/UEN1Q3T$KFS4]@%HKS_?RK;7==]Z= MF+5;]HZ)<\;Z*L!8]%X1N[NXC-.'?8P\W0-.?O8,$W(:G;Z']_L$TG:WX0^8 M(@\Z"='GB>(P>;W*X%/Z!:TJZHDH0\,_7,5(D4/\^'6VVL^MF1J>I-99R<$-"0KW';MOLDTN@Q%/UR!!A9+* M55!$_RO#0XHHE3(E<9F8SYT[^FY8.B95(R8504OLY!R MS,QM/?(,F[YC]]4W&P%F&'D`15!Y?,69,/@E;_E7Q3RKY51X')YMG`)W]"C. M)AVZWG;?\#'38.34EQ7-2?U2&?=A>]C@Y[?%<]KK>_KO++K;07R56%X&(#Y8 MZGLLS@Q$ELDEZ*WXGGD0]-F6^;&68_>-GSA1#)*AXK6X,,"`I&:LO1@7R$LG MP#>:O!5;Q:3%HV$=8U5^++N?X@I2I-_G$8$5Y-W`AWHJ!5#K25.:"EV:%]O> MBDNMGUN[)@^)'Q4RGRV,QP75M MWL=1T]PW7*SI*MI]T3B(W9@OT8^CXD2AI#)72(>F))L-=>BK4T#']_2]Z^J: M5I8UF8FI6+2K"UGF%5UFVV_>&&DPM#%D0U,Q+MT3JN9;3?9['+YML>@=75:K M5;[$=@<+L1&@W\8SH`BJ5OD-[)G@O>H7F%4W-^>.FV<9UG(3>C27''\.P2Z8 M\J0=N4>B+I-K]_U@/W`C-WJ]$`+TJY":_+*/]_1*$%_PX?ZEV^:NUOH")COG ME61$#G)*INSN0Q:99IEV[;ZR8"?"#+.RP@EN\21@GSW"1!<#:S'TXS%PP]1W M]YG/:*9IW[7[[IB1`MW&G@U&4&]61%S]DK?DO'/KG+&\MO;\N6N>B=6$00A0 M-\C3U7W^8I4_:'?MOI;C)64T+F_'T\_NPA$2[+RAY7S!&LYO'#@P?!YR@4H/ M>%R[KQGXB3%R!,$-*[BN.2C@E_PD[:^`BZ;OT\,']0_EY<+7#>__9\1BU;/7->OOIAG=,JYM)N:CJ9M3)&9;R4:_>= M&"L)QE5H.XX652KLSPY_<"U^[&CLV_!;>]:]U/+MO)%C@F_4/NH$T/(0=:J20 M/?4Z!D;8L]L;J+6>>RZ->7/MCC<8Q&[,_G<`J*G+HQ>VG#R)SP1Z#NP]W]<7 M:-`_N22G\A)6,NU`Q]G2S96"W?<17'1H9V8.,/DYE<(;"E9>T./=6L#D34=W MH".YX*3O##V[+XTY*3'C\G)A.CJ7/0,Q;_++;S"%:+T>296^%[C;/^,@GG*R MN;OVM&GPWKGE>)N7K(*U^_NM_&6^\'9?N'%0H5MWLT,)BJ8DW5FML5@`.2,' M:-':XS-V0V?W]BN>)-*@%,_N&S5.2HSH;#Y,QYR^K3KPCFJQYGD3 MM/6EUX>>W3>O[8#UV^B668/BKWPL=`-)JARD"'\-DS]@[>CVW%DX&M\==$\L MQV9;ICC M[DZ%0Y.[[G9?:/&08<1HO,`D?(!?#D]W,+F^ MSTO>D0)XZ?4A2S,T!QK\W%GB,DFZ.)P3C1S;RY->R`+W2/@[KNDUNV_W-9HL M:49D1A)D4/0'(1V`5BE-Q0(&]-$L4'L-%`"Y=\%F\%A`E]17A]?X\KL=W#)(%;G$?K*DT/(?HJ'_8X`\72=SU]F8F& M$4C*C1"%I;0,]L8Q!&O777K^.?IF"]_NFU,A>A@D1$6>(Q%LP3>810FL%P9$ M_XMZXU,%@=2)%]MM1#_0US#:7L4?PN_0BQWY_Y"WS.%WIGE1("/J(+U M^WLYCN^0P\GYTNX;+!XR=)L"#BQ!U1;@QN^B&.3-P>^T`^?[A8OM_SK0%#;I M[;X#R<=_'="W^[!_>M['I#[G26[&\_EBKE,$Y!'*2HJ.-:HD2L'H2\O#%]01 MJ5\:%2$-:B.!;`].1!=4HGL&Z("@'+$MC>F(Z^43B.'%BH1!Q=HG"T^PHBW`"=^PYXN6)R[\_\-Q/L,UI-VW\,P.R270OP7KK'UBUH/%3PR=9Q78C/*/<'>`B`TUUN[2C5Z_K*I=6QX1EYH9 MY]:?4QZU.V;)\$K88(+5D<-CN*8KLONO MQP*E^#Y.7^)\&60&U`3SFG"I@*Y1'6?E+NBGGW[P`2.55O@;3%"Y?`DBMG3( M,U`,"CZ(1,HI8-/QO`![15?,>G=R"M';^8G1],,+F.FTQ^HR(@Y*821AJ^2@ M^Q"G<'-(B(FM#B;PD81Z6?TG/>.@2+$K.:YM/8*C7RH'J.<1Q>.AG)GKY9K: M]CA9.=)LL)<]^'B,9#Y,;B9-B=IHMM`*41.R>B??FYSOYE]\^E%`_<198]]Z M8=8O;[%M2T$"=R1N#HE@?JK.Z7>BO>O3/B96M8B;GWGZKFL;T\D)"`/Z0@": M35>^Y]&5M3N`9P"Y;DO1/WU`?\YW0F)/*6HST/='V\L#?G%$ST[HT[Q<+C[^ MV#PBD#`EL2EM.<R._!&"7T&94$8Y+'$ MY,,`.DYQX9`_1RT\IW(LDW+%&.HY-<%JAGZ*C(-)MB#1J4E:8P\B,MPR]X'SSVIW;(\:`HWL191` M+40L)2*6E&_'Z7%;OB$!L.A_EJQFIGE/K+=-_Y<=+!S]C/=D&=ADDFK]T%< MP?MPAR\6I7?J/0S@O$6N=@2XFMX(K.V^6N>B@Y>K/\:"N0UY4,GQ]$DZF\O] M4QC%:(JEOCORUBGEF)B1BH)Y.YK[/JT(C/945O,L"WS=K@4#AJ"1O.QWVHSS M^APY[:@3W'X,DQCQ?UHDHO3G*XTUN=KFE&-25CJJ1YLH^ZM@X,<-3OI%2A\>2TMZ\2-*S_WU7-^#W-ZI MY?B8DZJR@%)O-YS-E.RV%S.[[YIYR-#-V!Q8@K)M,ZED"G[''429^S,2FBOT M3_+M]86!-^=3Q,8]^!N\6[5=^\M\<>V^LQV";HQ'V^>O^!+\CEL`TD24%:_O MB<_\N-^A[Y%2/K^X2[,DW&3XZ^H[26."H(AA^:AL\'!O=YI.:4X_C]WWIF($ M&>-W'E3!A^LO-]>?KRXO;C]>@IM;]#^_?OQR>P.N/Z'_NO[PG_]Q_?GRX[>; M?P.7'S]=?;BZ11H['TI45&[#NQW$W#+3+Q-D+D7,WX&[P>6TW=KUEG21[;ZN M[(-MC&.;<]>U,_F5F]M.)>#<6>1I!_0<_S9GE.4[%@HJ[FNV)J*X[C*8X^5+(DUH.;XWR9..DMG,=';J.=E^F,:`W=BH[C$6"(^F+J&:0 MXL6&)MQ`'P%MZ1;SM;Z#668<"MA7D-PCIF8;PUG2[*"+F=WW:Z(DZ7[:949/C7)K9:99P9Q]#'(RFFLUN^_OQ(EBEQN9ZN:B\(X#CO)L MQE%5.^3_1^D?"!&@"8FZ!;N>LT1<,X]@4;I8*2'24I: MQR)AF,LU_7)VWQS*$S>JM6%!V&-WBF>'Y3"@-HXQ"6*,,)^."#6CR[D'*X.9 M\Q,QNZ\U59#'+D=RD>4*L`Y+U%F[2''&E$NP(%M$^71$BL]W:QNKB&`F84(+ MQ_8[56GJQO?FF'"VNG78E;LK!6A3=1<+Z>I%^:&L.G94N>P&)PY#GBA^MK7` M01&CG#$,@M,HD"(+PR2=#`.C??.":SLPP#8VWO4,_)L?WV7"FEX]M?;LRMMAC]-ZD*7U7GU&"$<9W0 M;S#-DL,F(S\2SZ\M&%#$DVV,KE'66"AADJWF0'1?GWM.MM_>2U$VJB4#F!$6%4(-^NHBW[Y-H^P`_[\.8\%S;PR,1Z>F;2*,@<=+')%.]8U*7(O>\)QR& MP47DJ&X=#U(&#R]_,E*.!]"`@(X(\)#&A4^%ZV>U]'$ZA'V#EE95KB)?)B9/,8A<53I/[*QJP)7TFIQY',P^\;,?1TG_^(3#ACAHW)\MY,+ M;Z<'"JGLW9>R%R+9NZ.RMT,CG8$89O@&@!3FT>"=7N7U[`ESKA5YHL6@&@6M M!S>34)7]J?M"'ZDX$PX5Z21H5,^Q"Q6#EUATUT:= MV#J]H"COH<._(7__M$_R$L/D3<-*9ZH4'C`Z98:!<#;A:0ZT7$_:<'01-*ZG MU(&*S5A4LE1T-R-#YH.!+)$A3@/4&,CWG<5BPO>JW1198("ZL'4:H#1O"!(8 MH^^!ZU,KMT1?X'?R$XD8<_5EFV,#H5%J^@AEDI;:`,OURW&H@FKTTI@+FL_L6T+ M),@/;G'_JK2Z3KN"#-Z','T\7WBS65L>)I'-_>G@)F2EFPX^D2G&(:HBS`[KTH&.X<2WLC4`#0+P*$;D1,4AL!6"PGDH?#I0&7%(@SG<"<=) M,Y!FQ2'Q,$Y.+ZV4')7GQMT#I`;)&==;ZL3&9G&((O,>A@QB1*/,'SE9(%)]]:HY#+N)R7WS"(=.#A(UO MG88@=AJGYYI`I?O[[#L:#>RB#8Q3P7(\O3B_X=.*:)/!+6EV@:;;?H'9]3VR MJO&N/\61UK._F]@C#BEEJ#BRSZ#'W]DR&=`[$*.-QQ%-P']4VF4 M4VX:F21T8%0:KIQ_]PE'A7.2.:KMYU$P>\:!LJKR_8.5;!;<9ULLFGR/;/VIQ M\IY_^@G'T_/2.;[[RHFX\%R/9)/$"R?G1U(88RF$Q3@Z?%;\XS7AA?3C#YAL MHA1N218]G07U>`'IE%3&!6`3T/;!G&5^'>9-^#*2A;9Q/=9A@`%I^>XN1+^0 M(JE(KHB-!A=)@FLOD#WCW2NHM_L:OI(_YZ=$^0QGH)@CQ<4;*!!S@FG^@,@R MP>2TG.V#D5*-=!/C3?ARDXTZ"ZPD"\[.4QWZ!9`US,5.@S7\+4YQ3E&X[?7< MV@HABWBG@[-IE"X12IDD;7A@ND')O_>$KS_Y*1W5/'+#93C3*<*41P`XTT$/B\"J/.OA8&,%QST3$5@^ MUW5PX*(22;[+F?#=I0"IXSNU_*`[/=Q#*9T;DV=`_PSQYC>KN>285=N*T8H( M96-TC4+(0@F3T#4'PKL4+Z^(V!EOF9&,U1YD_X)H^!M/$]N&&0G1[;=]I5TZ'D/\+=`9Z4`%^TOB;7>O[? M@*%%J%B('1"GEB&<15X_V)_D6_,ABD;RU09@]9H9TO<,U'OK%A:3EV6C"PNK M[6D9@M2IG]&O.,GGYL,TC6EM!M&UFID(7WEM'O'M-#$Y5Y=7RFU,>\EBY,VT M!8'P^66=X^N3"T9J6.2CIRS]BGZU249TL-,VIH%A`=AW'$`&::]?;DITY(X$ MK),=YF.!SK'*>PN??L%)1EWP4#?RT0`'5!:OK568U!P/,+"?U`&!=<+$Y:CU ME:"GKQ_]2892?L8)R2X<++PB*/+%7F M%WDLC3_)"`HA,L=T%SFQLIB[:DC\D+0>,E&-.HH(&S_1F(8(A/3PF_PIB!URP^6L==:5SS_9)&,D6"D;W1T;QMAY[-%,QJ]. M2/KK^R(^6ZAQQXR7+Q:ACD6*&$K'4X]Z/MUH"2X:QW3=>(`.>W%#=<--2YT" M]\YFL>-S^ICJQ-,P@/ET`R\XJ;3!%>2#S.(5#LFA0A^1C5/EW46;Y9#+B62I M$I]_[.F&=?`1.;IKR06WT\MLK0-U1Z5NAT8J"T"1ND_J1+"JA8P8LBTWLX"X M:2WA/(2:18Q.RLC33/7SZ49R=-(SIG?8!6K8$RQZZN1R!=[=&&S.Y[4U:L;3 M0]7Y=`,M>BBRP1OKAL?B>96?6R?CRWM38_`]EY=T6C$^5SW3#6+H)FAT[Z<3 M6J>G$ZG7[N3/QW6U%ZW.C/XP@P86C5+"0#:3N#3'6:XG'"W02<^HWE`'*":[ M4`E/T=N(\!B/T;%#>/AL36,<4O9WNF=@W02-;VNZH/744:`-00)C]#44Y5$@ M8(YJ<;?F&M$O+WIKC@^2R2(?1U7BIYEVI)V.,8W)*1@6(U+5=-4J`ZN?0P96 M0C*0UX2?[E5_"R7L=V5G?/HRS>@'?539D-Q[O#,/D\L5)D%)[X=C.;_,FO#2+#M3OOJNU.O]=B MNI'*PX2-OEL?A-CII&V4&I'6*MCK4?;K1FI_LQ+-(C^MA=UI)LL)[V(&J!K3 M(>N'QF)=BA'PQH6.84*4C!\5VR!*7*:HHY`[=;47TXU6'J1K=$,TA+#3#CW7 M1"G=WV??PP2"7;2!<0K5"=4WUL+1;6\!]`L:"SQ]PB>X."P"R3:TLUC2Y+,3 MOM(1H'1,&\@/E\4N5J/F10OS:FA?Z!E?;>RQ1-NX#9V2:'/96K:A2=H;&IF[ MF&ZTM!"MH]MD$=0]M[Q9MJ.5#Y$D-P3]MSA2Z00S5,9MVUT*'+>,4/Q7C$(6 MF60JQYY_Z^E&8G-2.::9Y8,Z?!,P6(+;O`@JN"6P70;Y;A`8:Z_3(,[%=,/$ MN>FTX7:!%S2+USLHE`IO'EA95OX>PG:AY')6V2JOYU]]NC'LO&2.[J)R`BZ\ MTR.A)"&[R?F1_!U70U,H?OBWEG+3\_4XEQVM>#3*)B/Y3"+9/I:S6%%_:#G= MBT,6TD;U2H?Q,=D]TB0?1W$9-19V,WZ68Y>T\1G`]K%(`:/\HT_WKI&-N/&- M'0M,YL+VZL2,J2AM:U)H`;=RG.J[PG2RR!9KS?3\&T_W&I*?T#&M'#?:X>,7 M8Y7L>?E5P2',-`23[RB&O4`ZW6(LIWO_*$*J#0QY.5C^9&8: MDLKEGC*71Z>!CZ""Z8<]34[7Z(>Y2X%?:(29\?F-WD?3<"9GNK1T+:3;X MA0PX6?Q`767JA_A-WLNS0VZXO+C.$NDT0]=RNA=K#)2-[J4-8V0O4,\G(Q=( M!6RQ&OBT"Q_.';^M'G#]=!ZY@._;6%$#^;1/T[/X]&?CL>58_]^B`5S M'[N>Y8G\NB#K]G5O))!&6ZII"CKN8@1>,UMF!1F)ZEN?18X&OFP$9,`1Y&T`;`=P*H&8`M^-C MS<82ELHPIQY>"J`LN9>KN M+/SE$@U`UMSN%!)"].CF8Q%00=&)9%6AW4"M'_B]Z/E_ZV1SQMVA;7S>W`NR M],?[#_P5UKEZL3L1A"!%IG9^8O`JMK\88GO.75XQ,#44U*G^A/Z6(FO2EBQ( MQ/7HG$,-[P]#/^7V9@\DMV2M+4_:P$:`*<7=BZ)BV=P'R4_U2$,9'L6^3/&9 MA[+PBG%H.8-*_NR&WV8FCP)?&-);B2\G6Y[UFT M7;+(\.31^&HXLA_R*3\>M_:H4;(\I\`@=E.(BZDQ]0YR3<7<5;^.,_ MX>NYLU+E_K6.+\=5;)`+]NIH/7/HZMD=4C$,7C?+#2((\@U)W@20-@`U$N)# MX>/=:E88;GDP)A_(0<\*NO5UG<[KX=@)QD:XR8+,^RFKE1=(/5-HX2QV0@X M8>GV3NLE77*[KYM823#$Q$,X2N[-+P+*EH`V%>':3]$.)A^0C_JP3["U574U MU3*Z"A[MAWO,FL=MU_16S_+WL`/(S3!BU_0%_Y'?0=%`A.N^'NYVT>;3;A]F MZ",.I2GCX[G:V"HXK@_J,;_56Z[I[<;"[BND7MQF>*U]\H+3Z*^`_"S"9]_@ M0X3/T./L2_@$T?=3=;C8-KP*;AL`?,QPIXUG^4F$W9QM5TB_A7?:M7F^G'@VQ MYGC2S3&T)/M*T5"R,\=P";*T,[TXMH#V!9^.BD5ECQ#@ M(<#1&,*A30SX;N&/[#UJ^P?A+(YG8CQC:Q>//BHXY*,:AGXM$M(PMSS"3XHN M"R2D$UQ31'`(U&V'B.!A`!E'O9`TM2]C&*#=)J09%-@6!QW*DF:7U'3BY!.; MFJ$Q(CALSRIMEYO&HTK.;[;,/]J<2&\U%<^!QE MX>XS#%.87L7Y!.$.7V"2?/SI]?UGF*807D;I9K=/#PFL\9SOSK7E2I2")B=X MBE>E?)*D@\Z6SUWN M(=UU:UT9-6+9.J6W.J&NE1D^7!/FP$Z&9^)A1M%D;X\/I3&"4D MR4?%^VDU\7H^]-I&G&G[9I;C73Z:"A;N[T4^0>Z4VWT&QT6';H;F`1/@QGE6 MLE^1(*"V5$&KY.W*5*S=Q5+;!J9W:O7O[6NO*2UUIK+8L#4].0C2L M3B%%\D,33;=84]ZP^SY?/;&Z95(YXJ!J@_?&5S&R@*@9N(0O$1KW#/UE`WZY MNKSZJ[`')HRY9CV=N:_O0$L>X$CBW+=`T@)=O\-SG/Q`Q>Y(=N6T6BO.'8!K MTDR.NO`M43$FR/:@&O4,%./BHZ]ZMQ&,=@L?:]F0O25!;^SM5`Q.-BF4FRQ_ M,:"!6B.[1/6XV2TX9]83>)=5SGSE/[B#3V;$!;1]3CFA8Z6CS)/2T9[X34L: M,6GWX0@C!;J-&QN,`)?Z2,'7\#7$M3J$4TL>358)R]*CK^6UV)..257R:P\E M[0Q[HB<6*[K0=L<+L))@1$4S@CEF7+7<:D"Y&N+6`?5:6]WUC(9/S.V^16?" M;U:UMH,(2&B8DMOLB\UF?XAQ8HNO^UVTB6K7-]Y@@@IQANV>5HYG.<@I4_=W M=Z%J@5Y@S>T.EN2@0C<'LT,);J*'.+J/-OC==]4-%/V$78;:N$TT]0VVO_#T M%81F`B''[\*$EE59&`<@'X[><537]Q_V3\\P3LE3FF]P%V:XB&6: MI22!W?LPA5NT/3@YOEGY\X6^':D<.,F]@.J5*?<,D@/3$S/*'+[=5QBJ236S M8U8+FE;>>W>'&X/Z>.,(JI[-^%L0U.;F7G+@M3.GYRN^W8$#2NG4?EB@$&Q0 M.T_8WQ\))\C'`V3`/(EK+L3%H!)FMT)8G[3<-/JKP9H`$HYH[]R2#B@G7:7? MV=^/JE0:H36W^RJ/DQ+MWB87G$Y;)7PL\2%,'S_M]M]O#L_/.Q(5&NY:(_`6 M"T_?83$K"CGF%Z>U>KK%.((SF\WH9MGR/&."%.D6"S%8`>Z&TX5^1P:AUE-1 MF"@W_VAZJ&REK+0\/V;]A$3'T1C!I=WG%<(T&=D8B:(+CF2EE*%Z-3I.[^EP ME\)_'=!X'U^.PD'GLYD^(](UJZ3'Q$Q+Z2MU]:#+3F,1EI:?6+/2H-T_8@02 M5`T!;2E^4W,R9?U<=K'6]\BE[N@/=B+,7!6RPFDR,V]H]V;_!&_# M'RT!?>[OCY6(7,_05=?;L3=W#1840S\R`ZXFL= MS&Q*,QME9A;E7'7S%LZ:KK?=D=#L1(R@F-N1U-A74?*D?1BG)+KZ-@FW\"+> M7F>/,/D&-S!ZP<'6:2MCN,Y*WQ60$"8Y,5"U#&5Z)J'Q5O,5"2E>+.V^DE5` MG6Z)DH<8D"'.`!GD#)!AR"-/,A"HC62%)&IQHJ8GB0VW2VB\9>XVS"@SV!W& MI(A"(ZZ:&JQ!'F68UJ203]AJ$U;7_Z[&+"8M$\K)"1,%A1"T-29KZN6>A=U1 M"RSP=1L4!@QM;"F\=::9":^?81)F]=H([MK1M\_HF%12H[-2K*-N6`^4SYZECL58 M5!!UP;!,W>F2.W3)[;[H%Z)'-RN+@&KR]769>QAW!)6WKI/-&8O$V,;GS:(P M+/V=5?X57/H5[+[J%Z2(G=GE2L"(P1MD>XEJ+WPLQ%;EQ3;&;VPB6;H7NQ1Z M@+"R.SY`C"`C6T0A:`V.YPP9P('%C_L=^EXI+?^"IZOV5>O52E_@2^_CB+^GBVWU4R4F)]G@8+CC!5\1G,$G@EAP\?M@_/>UC0,80C^]J M1=!ZIK98+#4^QF?%H4,"V,CMEX;NRT82";)8VWVF(DZ4F6@;47@],J-=4`S: M!QL$A=%LM*8L6CGYE;S=9^N"%(UC1H9@!?5N_P;R.G=D0Z#D!NOH#5>\_0:S MB*;:;PLWFFE\\,L!1$YHI"@NGXKP#$*4'3UQ7MM]!"I#EF[YD<`65(W!5S2X ML"/V%0&@TY,KL*][-$HY]'L8P_LH:[_K]%8:S8TH+#E!4K@8A5@)#SE?N/1@ M?&WW*:T:`G6+FA*403Y*+?[B>"!0C*3&DLFSHY8]TU1EL[&C$ATR/_>9TTB` MM=U'R^J(-++C4@;WU$+RB=[[Z`O,ON^3/])?X=,=3,X7WGS6YBIVG"6?]I?C M?08T!4\WFGJ.M[3\&+@3LVZKT#5Q\/X*%+^`W^EOG+J[^Y,Q7L.9XJ#F]=II M6\>EZV+W"Y<>U*:NR;HAJ&"H0QK%,$TO-FC#G$9DSX#_F4!XN7\*H_A\Z>@K M-3LXNR1[^M/LI"RL)VK4A&XZ@:`=J#<]`T13\3ALK8.\?48J^ MN[XXLXXYU;-R&R%]#(S;.W//WN^<.:N2:YFP*2XQD\C%ZKN3C_>O7,$'_/'?< M^5K?_H(#B5JNYB.YB]%[1T%&Q.[]B``UIH5A&%*7>)R!LF_=Q[I[!;2[`8G1 MXD;9+3$-CXEG%&RE+0\4%2''B&T-:\0;TEQ6L6[8*Z?O7VG]1$/YBIC&- M*R<:R:!E:=K+T&7>D9S%X(O)T ML7V!28:&B!](=152QNRU'I>VUEB&M7]R.6GAIJRLR#K0<6EY)!83?MULSP(B MJ#4J:OO0=N#W_'^%8QI9O[X6%]X*OFYXZD,=/582C'CDC&".N/SC M#QR)S_M@%Y=IN(BW^'_P,Y:7<(?S+)_.MY@O]64I9((@Q]B"5-9KD`QW=UW' M[CAW'C)T*W$.++0<#WF#B/]1:ZY.I_,QB+:"/%:)06LIGN'NSFJQGJT62$NXH?0A` M3L2EM#M4\#.2$MW'9V8JQ^9CW8YC$R,%/O\*$E/D\-0*KI<9J:`.3 MRS$Q-V4%(P]UG/NNW0'S;`3HUM!,*(*B%;X*I062U2EF5@[0HIRMX.V&DA[J M2!2,W1=&K"084=:,8()_PNCA$9<"OWB!";[N)ZTY/>>_[_?;[]%NAUSWJSA# M<**[';Q(4YBEI_]-<9P[,T_C^Q!N/'),KX+\0@[XQUJN';OCDT5)TFT'!'$% M13^RY:Q:`MKTK.U/J@R'!*=IL273$;2&P1$8BQP[N/38P>X]@SQQ1HR4-,S@ M:YB1OI.8P2_'SX.KF,TN=]&NZN[S_OXX?/T0O':?DPT@UVY*>J>OU9!4:`T&/Z_>*K^&>;6[NF^K3EBNJ4Z8 M*->>TF!&`S.BD:KHB\NS[Y/7QA2.M]!9S;=]6EFF92:F8MJ.+NOYPNZT_@/( M]2O8ONF#\F>5^G7HZVK2K^.P:HM^[>I"?"Z?:@.[PY"9:3"D7]G0E-P<\:K7 M+_![7A$QBA^^)OL8_7-#\D+FGG-C9G>YTA=;SPM'CL<5$%_P/O]0SLKRLENB M).E6[(*X`M0/5!W!<4]U5D"):@R8JS$\=4E#5!)NT@2G&!+P%@A0_<,D^P5)]'/+N(M?ACQC,=I M\(^O\TTR*PPYL9$@MJPJP3X$VN!:+2&\I.@V/9QX@J+]&:D`D9'PCK*/.F/# MSS1ZZK)8*B'-NBO,0Y`S((^>`=D=G2A,DQ%3(HJNE*!CT>$3CV\PA6@A\8N\ M2_@"=WLR1O[BN@C(FGNMY5742`8#`CFA$".QD`>VWJNUW<:"@PK==H(=2E`T M)0Q>:UQD!%!G);AX1(N!L$L,&F:!J3>Y=5U2_61W3@P1W6&MS#3HU_]L0(*\ M(:BU5*GPF=E!D[JWA=M;5/U@7Z*`5E0!V>[X\!)C2,USPFJ3!LXDD/C1W_LP MA=MZ:>/KY[S`\15YU!V]0+P-*9]B+#R=9>OY$GZ[@[W!?7.9X!VSQ\7Y0.0$ZE4F:V18CLMUF=:DM>P4"*CD=-W MNX^I9,@R8K4D``8W&1*<%@GD$Z7;)-S"HOYP?N&?XOO_Z`7G<2TY9[W4ESB$ M"8.#(YWAX$7C#Q:FYWL%0[8-W*NG76`/T5/WDN_ZY.!7=]/RVZU@3C-;3G M24/BUTV*\PK$1O1?^]S!KV$Z0P2TI;%`_ M[ULN]*E"0522FTIE2]$L\<$YXF(QL_OX7Y(R[4<[4O".ZGZT)?4C@]#K,3I, M7O=#XDQ'EO?TG.M,4@R;YSN"(Y('`7;;)%G2S)SSR($\$D=\UG/(RERQ34DL MY?49R2MJ_80:DKG$!')__RF*HPR2G!JG&:8^';)#`B^>]DD6_3?!E-^L-UAS MX6B\]U`(58WH:EJT4WE6,\W"6T[#UJHDUY0!5HCY2`W04?-,-RW9$^G0H#YV M$>6ES%:KY7*M!ORMJH9.4Z]FFM5B[7@SMEC/7H0F\+`^LU4.P$1.N!3K1`>]*)9"6XQH5 MYO>O[0-<_(C2\[G&S&T:<8\J]UP+JD@9],[IS+P\`Y5G=Q"+N46PW%-@IT2= M'X'+?7>,]3N>E[="LMP*?(YB>)7!)R0Q&]Z5]%%L>5JHP.V*AT!?L<3`#*#$FWP)7R"E_NG,(H1ZZX-2WDUN0[I[2&M M7RIK'1W?6]*ZKI[=1W2X'?:A[_8**G*?K>#E_`NJT;] M%3[=P>0<'][IK*#;-[D'&79DFX0=OEJT1CU6.U6'LK^AS1M?M`AID& MW8S,"J2K0"/:H>0])'F8!%V,%+"S+>*FN[VJZJ+M:`+R9SGVS".!T*==K8TQ:#ZI6A;MI*2+2?,. MQ;)2]\VU.W<*,PTC,6H7GB#_08Y9\?O[>!/M(K*EK%G4A;Z`,38,:EF9ET-CCE#_V^"K>).113[BC`_C/$.7^S%/'1S--88U8QK0OE=HU"2H]V47`D>GP,3+M19 M>U$*G0GAY%D:/@'M'GD]>Q.B.42@'39T`"6/'2V'PM??)WW:??ZLFU2+[R@SZZ$9SBYIJ$-$O>(HT@UOZXS^C[/'3/KF' M$?G],GJ)MC#>$J9T]1UJJH1J0'C%%XU+DEFG6<_8/,6A8@6?W+8M>PNTQ_*(DX)H. M:)P-U@547[R*L$; MZKN>6WY1R4J"?JO)A",HV@%D`T_#]LX`OI)!^U/47!N/:S)9MO!XBW$9[$ON MQ?)8'MLO1WB),60$.&$%'^_OX88(`2SNZQ'?EY':&ZGM'YKUBMQK?MZGZ<5+ M&.V*_2NOA<*G&CD)$6>]*KR.^=(SM+RA$2"%.FV M'&*PR.W]57Y[_YG.*62SAR4Y;U;+!E=@BAK&FK/?[!^C5__&/W&;XJ$FTT=%U@@R^')YA@ MUM(E:<4C$>0U^39LOI2\A%%!/K]DE6,Y*^>M.(LG--ECTHZ!"1DSH1]D&_ND4AH M8,X-=I_;R))FQ/)*@BS>CX/O1;J.,$_7D=*(K7W55XET-1#EI^U+;ZDOD0<7 M%BV2Q4SV@%QUC4.^JD._JMWG+W*$LM#Y?+G0F":[=VXYJ>.EJ\R>V]]O[=MM!5G@Z[9M#!B"HS)SR$PU M"M)IX6(]%67&Y^)F#9C^?LYJL43_CY0+]>V.G.2DQ(@.Y\,4Y'730N&Z:3WE MW5H*NWV!/[+;[W#W`G_=Q]DC$KBUN]2FP^6PR4F'ZG4II$=RW*5G>2ER)?3I MMB(J0`9#14_;JIWBIS`_,D!'`W2X4>15B[5Z`_+:L':2XY+D.G9?T"FBT(AU M5(,U0/SKZ12[;_L=&N#AOV"8?$(D8>[R+;&2)]!,"MW@JHC)W.FP2W=M=R84 M%>3992%;,0H:R'PL@`<#>+0Q!-4"\VBAH$H:Q]-AB3:V.^I,#8$6FL8.J-@R M+@P)W"V2+8AX:S:WSS02;".)7,>Z2,L<'7?I+NP.-E%"G[7FL092A7TDPXTB MKW992'OD59V-I.,2Q6SWO8`B"NVVDD=8L9F.G.)^NR*ER`$4VQ.BH$;?:O888?];Z"\MFOZ.,(4U)BVM[_//J'QX-0,C$Q M=G8_O#"U!&/[)"J)"3ZF6?04XM=9]V18$,;Q(=P=Q0,#2,<'"=R1IMD>1)76 M"@FJ?U>E@GY+X?UA]SFZQ_[R2E\&+!8$NI1!'XW#$EWKO73]J5[&-J@8S[:? M0NDWT&>`M@>X@T:N-VP]1^%Z#CM6]<:/%[R5,]7`GS9"1K8I+9"*AR$'RNL[ M;E[_^WZ__1[M=L@@ZC!%<):K[4HM*ZP])Z[LSF:WV9)AA1R`F&.*EEP1+& M$5;>W.Z-"A\ANF6`"TU0M6Y]&'L&)]-$L#'HJ]E@I#,WJ/8PC$&MN=QHC M7E*,^$JX/<7:^6+CZ+LY:)I3C M:B8*,`.W-40+N5S;Z]+W0=;.D#V3!_@W$.$SF@U,2;&HD#1(0=Z>,U?!EM27 M2J/X(3]5.I\OUOIB!YOSR?$@"_XR#T&S[7)M=Q'[+LBZG82.>8/:WXN+"F7\ MIB@-F*)N^<_XCXHPGU8>:*]'_Z?C_\Z1"_A#IGM MZI!\M=*7P;I_:GE#S$%6P9\#W5S7\GT5$W[=FI(%!#7:8;P%Y!^U=L(G"6R? M7)L?.2XG-S3M0#?B.]F]*6*DP(@&9L/2S=3J]D':-+&Q?5"KTCUM['J6UV'K M!FU"O;;.3-CO#)2_`?HC'^]]C#.TS/^,MO`;?('Q`?X:_J]]\N&09OLGF'R. M8IKHD"1QU\:/C"#D>%28TH)O60=`WK"]NWI^0G3S-Q>:(&^#8\-0*U`T`[_C MAH"TY/0C?@V3/V"&'&JD\)N>=Z7S78T*F0V#'/^+TEFP/V-_!^U4[-[>\1&B MF_VYT`1E:^)VM)Q%"+O3G.RAQ:^V4`P:CC9K?_R]['9I."DQXGCS86H[C./T MO;\F^VS M$Z%;TS,C"8J69X"T);J^;"WAZG0BJ,6I.?Y"8XD/!@2:^+V7Q$&./^J]LOQ4 MD(.*T7B^`:6?Z24B4+DX0HM;8Q?3-SP:EMZ^[\[F=N]J><@PXLMP`*H]2A". M/OT&4XA6"Y];7J)-\FY/YBI=)M];Z?-B^N>68VY>N@JV'NCGS%=KN]4X&P&Z M-3@3BJ!H1;1VK9WP=I3QJVO1UQ9PO186?Z_O4;?,;/T.*'&_B`ITKS$LD+;V:@M+0P0#FAT+)"S2+2XH,[ MB^7"[L?H"JG4;5'403TJ!YT/`>Y>3^X&TC/\MW(@4(PD5OBY0M_IWQ4,J3&( MD!6%*KGDI;4I?`,C.(NU:W=>%UY2S(D1$YXC61DX8!*1BXO-A@3A?H,;&+W@ M`7Z%N);>N:_Q]+1K4LD(1U92RC#'K@Z.X_EKM,ESYK[=P3>,%.CF:3880=$, M5.W`[[2E--=^@5F>5>!\[L^=H[KU>EFWFEDU^_;1U,W#M5Z>X\\L+SO`A)]C M<['/PIW8YH(%28#^!,*"C9.RI0;N-:1XC7(O@P:N]7*7[KDW0T;0[@?#S#28 MU\+M0-KT,*[6EIV!O#4G.^]V^^\A6LE/^^1R?[C+[@^[)I:2%Y:NOEAU+BB2 M#"]'=2D!7,.L+#_,%Z!&NU1P0PK*+N`>[4>+3J!5;`Q*C)YG1K9+3/-Q$M

    WO,K1$'3=!F!@_H#^#HH&=?6NFDFU:/#1F+2A MF3N[+*EJL/LLA0&]$9T[C*-@6=1@"VN[4-[W2WC5\"QXV;]%Z1_O8;QY?`J3 M/R[W3V$4GSNSM;[;JZ'9Y;B7G[;RF=-03WB94SPM_9._1X'\XJW-GM5C/ECY)P6CY0R(%U+$SZW:_.>!;:C*9/--R M0PW*)Z?HRPO>.C90?*Y>@,PT)@#OGE>Q^NVAIU,DJC[NRO*#MD'LQG7O"8`V MU2O^;*@QVU>8X#^$#Q!]V+5OD&%K,RMFV5Z:.IFVWLM=+=UIL6T3O7'&;4!H M8=TS4+72P+EZ4@2-R[G-_$`]O?+S(+LK9K,18.1@C0E*4/V1I*B4C?5H3)H' M]\W6^J(\VN=4S+X=='0R+FWOVGZ#W8O;N)JM3=[J&XA$?#8G0?#*4]&5QO15 MW1.KYLT>BKH9M.KDKKR)'2,TP)MGU1,$W<<(8F>Z9,/7F+6(,W4=C0>Z?5-+ M..?A;69+E&6W*P M8OF&OQ.T=O;JFEG%.=3E`7Y"'_'CT_-N_PIA6@:O+1;ZG,J.2>4XD)F2@@V[ M.LP]SVY6[`>NFQU[9P_0KP!_$U#^+AC7./0YM6S91V',QD:]JP/.%&'YL>@0 M=".;\P$00?$##GIY052$VQ<<89B2-W#[[!$I5.%`F(^]J2RK`X'SU4IC[3=6 M%'*,+4XK6S[5V@CSQPW&RB1;5;*A(- MY<\Z`JU9.7L;4E$18\1`<,,Z.CI/1$XV>6_>E*OU7`O[HSGR$S?/ M\_4]JNN<5HX-.:@IN+&[B^,L';MO<0>QZ^;-(0`!;H`UY6F*=J'SVM_BNZ,X M]MISH7,\G3YUV3.S',/RD53P;&^OU=+RQSL,Z'7S[3"$H&BBX!$/TT?6XNR. MR[<-G[:O%[DKMSM6G`6^$;^5`4C%OY(O>O)#E(O[^V@7A1E,\7F5OB<\C>F4 MG+GUH3\Y;:LUG7N>W0S9!=G0T>_IO-6A;_6+*F;3>34*O=JUT/QK2G1+++LAF#DP;\^8GHX(; MEZL8L3FRTY?P)4+L>!5O:G?C;:?_'7?U7>/(<1`'NH*A.KL0"9PMJ`3:_:25 MF0;=+,<*)"@:@KPE0$T%K_N'OSGC4ZJQ6++YL*JK#WVW@^R"1Q?2[LQ?'%2P M\Z7<0REV2*T<>EZRZ+EJ'EU:S:(-IZ^KRS)?1_JP;&[WF2,[$4:<0&8X`[S) MQYJ?X4.XHRX!/9#WAH[*61W#DY'E>'0(9L&8S79SZOC8;<'[8.LVVCUS!^0W M4'B,`I^7@K7V.I+EX\ ME95)BB1O%XG MN+Y`]OHKS![WVZOX!#;:#E:DDW9`N[-Q)2 M=.FV9#+@CLIK5-W1MP!T`$!'`,40@M5G'D-$2!U@K@>V9`O:EMZW8X/$^,V3R$&%=M7+#"6@3<'UD9J]T,:=C$?B8[)G M\UB\NQ[HP1VP[`#PV]AB=%!Y7[G&H#.0P@=H#E"?Q!:MH>6`[&?1<]D'I6 MQ(Z30TV1W3&-VFDWL]O23$7+%NU[S.WS,H.LGKU=HVF2]#%ZOKA'R]/&TAK/ M[U3C-:40Q)>/7R,PS[5R7,L/"'71;(\GP0>.OG20 MS##TBF\/M:Q260VQ7"WI9UK8'94B2-'8QK@=%I.IEFG@NEP"HZI+=+7+ MU+Q;EQI_L?`M=Z55TFGN[ET>[-%=/!T.Y.,!.B`HHV#P^5HY)J"#YE?S`(\+ MR,#C"KH>Y_C-"7K3"58R/C$.EE_D*B74C'.K$G*?P)>2?HBWL"GKG/6V$QA> MWW^#X>YCFH49_)KLT7C9Z_G<6^JSR5VSRDD?.RUEP>RN'J[EM2/Z@>LV;;VS M!_A7S+;X=T`;@**%8N;44_=]'.9L5G/OZH%UQ-+NN+%![$94\A"*DE73YW## MFP;R!]P<\%'%]?T]?H=5/IN;>VUI13J";-I'D>,T9F3EN_KV#C@%B^6;]0'D MNO5@__1!^3/(?Q=\IC?T01D#NL;@M68@5WL/C+IM\VI1R3,A)1/2-M:SZ;S>R...B#K5L1]LP= MD-]`]2/`OZKD0BU.H&DN;'A_KV^ MA>R26)ZOI!V[*I^M%D?/86<5D9X3+../M>[\HVRL[LUS6 M;A:/6],"I9;GF^G%;G&;X<7VR0MF+'\5Y<:C&[[M19K"+/U`MH.XD@KY,+ZZ/;[>(N^O(` MSQVTQ]9H]]E0J.1P'E+;>;UG!-=W[-YMR/GMRK!I-IN?::A'@U#@6Y!\*G7I:?UPB29.0H41!!K/$^?K?! MA4YV)%9]7\KDCLSR[UK$JBBF[7BSU5!5%.UBI:0^NS3AG%)5#N1Z2\L/GH0( MLL1D':/BM5A?\,./V^]P]X):[./LD3-,7)2IQC12HTJ3J(W*!Z))#!=VYS(3 M)GZ)*BR MR1RUX,,6:0G">`NR1YA`DO9&E_P@*@KVF:WU9<#B!V1*?GH6@%]^JL%<;_4F M7+D6HNPQ4"?(1`P4&D*O@6KRU\@&:GP!DS!0Y6!$5;Z)PXI>`6V;JH[G>8DIQ-UQ466.6&M`$[!(90ZMA M:F.R<2V3%7(F;IMJHQ$U^29NFUK)LLLZ-0%B\S37)3;?]Q7'6'"@5^`Q)3+= MY/,+3#F6ZRW?BEDZHHW0,3,0D?=_K-4@-UAK9'(TM61*FJ!B+*,2W)EH% M49:9H1-XV`CY4J)";FUWK_DLY(5<6[Q"QZN]WL&4\O0@S@[^/>E'0D8F=:G3 M08!AG=^.HJ'@0=ZN4.Q:6)/QW?+XO-E\R]S;L7B6.ZDCW4X2V!E4[GTS(YX6 M7^2$5SG?/#/R`-OKY_%Y=<@/..Z7O_"=E-'OHF`,"]^!)2A8\EF!^L090C_^ M>(9Q"K]`$D*T-/4^\&1NI0P\2%8'`Y_V8(SJ5<='02,H8C;H02$?R'].Q_K?DWVVP.I(G*3 M';;1OI:YL.V6J<,?:!]%CON8D15LU]&!Y`*T.RO*`'+=2K-_^J#Z&=#?!?,! M#'U0QGW2&+S6W!FU]RA23]J=E7@0NZF]T!`09:Q7):5OS1Y`DL^?^XN9OJ%B,QF9)A9[>V-C8O8?B(4.W6N7`!%O/T?A7;2+LJBE^,9JIK&"N!@J50(BNQ1-H>$<<;&P/$^;)&7F1$L$ MWI&T%0,`-$(A:3C*N#:(PK)!@IRGN5#0E(2PIQ@0WX@>6"P,VCQ^:*IE3 MLBA-P1,9=K%P[+[75$&>.3LHC/%(_LI1`!V&R"$>"!R/I-`BRK"D9K,X33GM M,9`"PQ(M/15?58(^PZ92'.F1O-:D]&NR?XE2U(U/$!LV^^_)/DVKQ$#>0I\# MVC^WG"SQTH6%9:`//I1:VBL*C.BU,SH;CJ!T]3+$O*&`J\?XA;7XK]/OH?)-D4V>+DRIY&[@2CF,!V&WWRA_*!Y_U@4CP M;S&4<9DT9@`G(I-,AI!Q3**.[4Y6H8"ZT0PB'\Y*/#>UALKE[1M,8?("<23R MQ6:3',)=>K';[;_C^DJ?]LGE_G"7W1]VZ+?](<[(48&^"&#U>+7+I_3Z<<@M M[US>>C6]/:42FBVPO4+`>6QR,0&QQ\449Z":Q3(6(;\K2@0 M$281Q^]J%I-U@EJTK:ZB/VWWWS;.[W\CNP=(;1SLL M)A:YUT,&`\^O*<_'\"',X%:10>B&%%1\'DKS>2U,L!8OM#*RV6N96QES,]'5 MPM9M_?S9=#94W?@-*N].$,=ZN]9,X3N!OB^O>_"E;\FN.!Y]OH5`P< ME/=S?_=`4[H,YB!H'(T_@*K'!!0]T;]P7W+"5?8V(T3:O7I[I:C7VV<9R:?Y MZ9:3V>UR$F5^)\`'$$G6OZO#J44&E*S7@-2(S+&:6UX]7#FMNCTSU8"#6D*5 M?$CP2S[H7W&<4#$NJ`8^.\J5=)(F27";KX&QM1P)O&%%T#AJ4#@'L1AV7SQJ MH-;($89ZW,'M(R[UU[3M8!O=(Q>C MR@["/SRB!857,HH4?$!U_-+8]C5$:C,0="$FC0 MZ0,@KX$,AJN%MMSFRE_FJF16O4["&Y#F;J]`?'!B9^P^EU5(I5DO0!IO4$GO MB^QU=`>J#I?E(OM$/8.;+,P.B.%?CW)%8I[4F*%?*58M\JMLV09$67`>M)^T M-U>D+G)',M@!RT(-/S;WZ+WG9O;^".SH6U@MIJ0_P5IXS,*(#.H8&<44%)!V[L@U, M,1^5'TFE_2D!7APWYH]-29& M)LVE96+$:O(Z1R**\FT)4D'2F&9K"%Q`Q4:K6>K)V>1XL\720*UNM2G$N`AJ MUC9N=G(]RQ.A#H/7;2\&$=2+TCAF'+MX>)G>8U1MC MN)YK]XD[-RWC:>YV0+V*_`Q4G<"E2E^DDUL,:_JQA8/##IR.012:W3X\/S$C M6XD.6$%-#/;W(%9K0C[LPC2]OK_)]IL_+O=/812?KY?ZWM`TIY/C>@;X!7.W M-'7GGMT/OSHQZ];D71,'Y`?,A^0G\#O]D3-TL3[ZYRB&5QE\2L_7"WTGE*TS MJF.];B+:N*]J[O1$!(==!S?SG3%X;9,[$<$W-1U"QCV^SD+-:3*5+; MB5ZWSAV&<%1;EFK?NU=`]3&M^,Q;YAD?2^/7>W5]?_$C2L_]]4(CXW9-*\FV M[-243-O9Q5FN5H[=+#N$73O##@!H>`KX-VX.13VOTO0`MY>'!.GFKQ!]ARW5 M[?3?5_$F@6$*+R']7R0L\]5,(_-R(Y)E:Q5+4'&\P&C+M6.[+`A3I5]*1*$% M5&QH7T`[`]KC#-#^9_E_@V((\$LQR%\-"IJ69]G3$K3&M[M7R&\@HS9_(-9<+?15;=&&6]4Y@?[E;!XS*)]S ML9Q;;GMUTV[NB$,/`4<'),44()^#NLSOB+8Y*BE#L]9ORFN^:JK"NR:3Y4:*#9X':,0]O$53J=#4@V>GYV3X0$9'Q03 M*'1(%'.]9C?D+2N,'I=#T4S((CF.3RV2W6EJ=)-NV+G00L210FE5&Z6^4*L< MZ('JQ2%[1$R#_)_?8L1'9-9KPC4X0VSZ_O7C#YALHA1^1;C@-YRKH\[T:\_$ MH8DN`O2J$"T+S*I55$R^6%F>SMS<(HSMK"BCA-%_H?.!:D)PP#/F6HG.2;*K MIVC4KY&<7A^)@7&[1:IF)Q8VGSO_J'8P[]*H.VU]/C*]+&D8^UH^[VH"+99? M!<<;\P+>FJI@\@YD)B+W^KD!LOQMA%[*1_,9U-%P')514PN_87V2[8G2@%2A M"._S?XN3,E:DW?')8%UX7FL>\;M-FA$)=]Q"HG>JJ(-6?E%2&NQ/+Z'M3'I.8>O&]L[1%N8I<0XJ93?CZ:'"]_ M,C'N\9\%QRYB86GDRL+NW#L:J#7L)ZO"?>0;'\EOF\SRR>?%9H,+\J7?X`9& M+QC'5T3?(P)Z\9!`DEH@_8!;P.0Y3++77^'3'4S.5\Z\-2ZY0RC%9I&31&64 M%>(G.*#O.RO+$^=+4J;;JY6#%Q3=0=4?%`.`:@10'P+\3@?A/(.2Y3E&5W6* MXM1T2L5&=%ST8=V9Y4F9I6DSY6[*`C4J7=N7*-TGK^_W8;*E(^1H:2%)$./"50M#9!R_PW&X7;1B\=M,PA"`H6@#2!-!?]3$@JP8?C0-;]'!7 MIUS*YW8G9&"!;TR;#F-1RI#ODVC[`#_OP[C5]/HKAUTI]HTEQY6<*`N^[.V& MG+NYY0FQF/#K5I`L(`+:".!6*NPTV_=FU)1CLV537PXOJ=V^*1-^4QJ3!8QJ M_JPEJ/T0/D=9N*,QS-]@"I,7N/VT3SX=LD,"<0HK4NEXL6K5I,HS(;/!D6-[ M!=2WY$QF',I=^G:[M*(DZ=;C@KB*/,LW-,]RWK5X&U1T!O?[!-#NH.AO2J1T M)Q>W6Z3ZTI`S#N6L%MY\M2"'Q6N[775YXHR'.$]EF%*1 M0W_:U%*?@Z0N@I&@[,7I88?KH>0I4]*OR?XE0ER0%IL_SYNUA;UVN%R#`\I* M"S_>2CR&^CJKM3^?T;O/E>TI^WF)T6]E.!$%58\BQU<*RC["_ADS@S!N(NSA MZ.9V8K`SN=#'J^[05;?[R9,(.:8V&P+8&!F<,RKB$M[#)#E):87?23R0T_)_ M1MGC5;R-T"2'W/C4PRW3]Z^W489OF*M&-.>[Y[2%*2I*6JL%LYS@F5K',LFM MGOF\I6?WD8%6NG4;-9W@`_(;?:=<_"I49$$S)VO99?V$&J&Q7],TG[M>K?S9 MSZ@3"LJ-[/3TTJ!..40)W"`I*'SPN<:43<=S20KC`.XJ=_QQN]5B[<_6=#=M M]Q.!`>3:35OO]$'QL^A&K$C%>AW#:A_C<,3]-0:0XR<6/`5/-=LZ:]?%NS"R M.G;[6\/@=7/6((*@S.V-FJCG+\:-O3D&:V[<&XWQ[I$L4BZ!=@=]LL`WM3%G MP**2WWI32W_9QR\PS>"6OC6\Q65PZK_C]-)?]ME_P:Q*/'V^6KGZTC1K@ZU& M6`RLYJG(J9]ROIC9?7>BFW13!D43_H"CU$0Y2_Z<^`R0B8Y?4^"I4,L,O,(, M5+/9IG"T;.Q_6H73V-[KFY)<&:[).3/Z"C^IZCE=!".;?F/D!$=OM39U[0)% MWFII`T[K9GS:)_F?<#L'"87&VP2SM%BJ=QC77;LR:LDS63^HA MRI3S5);*Q<$N-1B34(/3\K3>CAHTYY.UX_`<;[F8QE&.X169MK?62UN0*ZK] M"TS`]\=H\]CJOX'OT6X'[B"H_#PQ75:/$VI+*#UP_*DDBFD8RZD$5D%AR._U M\I@9N^.[AZ";,N\=\Y>66/;*IO$1.0_4]7)4]V%Z/1`+KPQ-@K&:QME<-WC3 M!^F=2%H8C#-V#>E:F(]Q%:=(T>X(U%NX>8RC313&]:_==D_=P7FLX\JQI`3Z M@E69AZ"AA#3%X=KN8`YAFG3K2U%@0:TCJ/<$M:Z".I:?AQB5KZTBT%37K&.4 M`;6TN,?:[H-.":I,*7AQB'P2P6D4VBKH?;OYK7S'V?K\1,T6NG=J.4GAI*H0 MCOYNV""O9OE;(;OS*/(1HML4<*$).LJWBFG\]EUG+5+P_6M[4F3R?_Z!H$3Q M`]U2(FVZ<)>NOB($"J'*28_F12NS(BJ=9NG[=I_UZ"!7M^1JP!QTG5"#VK"X MKF%/60):RCD?/C^:MD$OZ*DX\,;U0C-;JLIIR+&@W3&C6N@U8W#Z&<5X8X>^D3N%53-$B[O5F^N(&39$QDCJ0 M7VQI5<$-8>FO[-X"FUX*:UT/,7I4N"5T9E";&I"Y088FKZHHT?E!%)OU7'X- M?T1/AZW,'DB9T4^1XD4M=./I(&8UT):T73,A#>]_IJ^R5C: MG1=`-^G6*A(V_$%G*8:ZXGC_>E2RX4AQ@'PB4)L)X*DL40R,Y1M^"L6@;K/2 M/M.27OOY^;6?W7=/VFFW>Q/#2$50B/>F)MZ9.?&F*:WJ3YU3PL\<:;=5SCV2 M8+.M@K14%].4E_7D-=S2HY]9 M"ZR]ZFQ: M!$&SIS\1=:#.QV\PU#*/[9A3?GJC%Y8,9-OMV0\34$L4&XUFT\FOZ<4A>T2, M0YXQ(AYN"T(?^5:B"^_(PL^P?,HT0'.NY=SRVG+::+9^+]`!7,450:4VZ"2@ MFL4:Y6%7%,/DE(=Z]Z$Y%\E:3HW1VNYG._J)GX8K,41&:^9Y$OY(/V`*0M.: MHO,R7F,20[5@1](1K`LGK2"Z+K3G[AM5"KT$6^M7]*%6X51T1A8@?P-F6*5\ MVB?W,,*5+TSM409DP"X?8T+*0YUWT3I1?GNU6M-4.&_T_I&1=+L]"S8B@KP9 M>,#MQO4=_@FCAT?\UO\%)N$#)#]>AAG\%$;)/\+=`6(V=Z?B7`Q28Y,"$5EZ M/1J&`U9^A%0:U;-'(:;O`TB-;#\_,N@@FII.&OEBL#&DL$FRH%I&9=FNI$:%QG MZ:WG4SGUD:+0L&C+8`V*/PH5C^'%4$QVN7\*HQASF@F?002;60D<6A=1"3P9 MEWQSN]-=*:+02@ELQWJTN2`#@3#>@GI&E;(X9&VP,U!)+AV05W;QU4UNYA'T M?X8)L?6U_#P+CO#KOL$D98D39RDKO?V0G[*:N32EQ\KN5,1\A&C?@?.@"6AZ ME.*`#_-UT4$T6PH;-["_.MBV!O7T=:=(]M,1+NL1VY_CA)<58^"T?KA,N MOFCC8M[@V!J"(N736F?FGL9\ZKB["W\;0^=MT?K2U5U8?D@P`-VDLFV9_X0Q MQ31JH\PDKDSY#=+\;>EC]'R[_QAGZ*OD;LO<W@ MEWT&_V._0U^]]`:0-'"X+2R#RHF&*.Q"(ECZH[Z^[\X6=K\XY*3$E`O#!RLH MFX-:>UQ%`P+:0]!X\/$)VU[2-NYNJ'N6[@NZ]'9'I_`1HEN=P-W!DM/70?EP[%F7U5,$T5OY`4@6'>&QC MH6[E_>Q%FAZ>*.Z//YXAAG6)?5\8;[^%&0TE:,NT-;).8L4_DC*26%[I2`WV MN9?SVOU$66 ML<]-#"FY27(M+^UA?C'LCAT3)2LHE$EWP[#O>&#CM&G.N3-? MM"8B5:ANM`!7H&=,+>B1@M$TZ<*S_,Q1/_%&7""=%!CQ?00SG&J6%7V^SD^J M?-J]&RV3+DD-@=D$HF`UDV_.@]%+2.6S[*)["'Z)8O`*PR3]JP5;I7_L\47F M#K%6X9HY[3FAA@][WY&,LQW2.??L(J!^JE;#>B]OD6I7]\ M2G`!7+2,,,U*P;`P:24K?HLT#^/R:M$[[7,C$SN!PR`3:S`ICZF'$)W^$IX6 MX'E!,?'8[E*_1-GO+$U:8>EUE-KG)N:3AC&O?J(+?:;%F)Z3Q$)60+3./=8Z M4:%U$GZMLWF$VP,.F!\D(.VBX#:\V\%S?['2&+BH"J:D$M&W6J6N4#:%,_<7 MMB?954ZL&5E7#3LH1BP3;`\X*FFOIP)^)Z-SQCA?[(@XP&T[47A'%J?P?+[4 M&`S(AD%.B$7I+"24L?]J;O>I*P\9NCG&7DOJ/ MY\YLKN_`:VAV.:[GIZW@]\&>[G)MMZ9GI$"WDF>#$1QI\KP=(`W![T533L^& M^>-KV;M8PMB-G<90SV6N4QRJ4^Q.A\-/C)&=`C7=A+/!$@,W%: M3#5T?H//^R3#(,KD=DY;]6Z;U,@I9ANTR?`ZJE4JS?E\W\GOYNV^7#!"_S24 M3#\1RI7-&:`3`J)SQ-+B_!W&,`EW%_'V8OL4Q1'VD;+H!>9[W#P%A^O-]1U` M,D&0TPF"5!8BSM;=\]8N_=9V[TT%J-$M?OR0@KP+265YW*DXBQ3,._(-IA`M MYB,":J%!J_(1B^-AHO4+3H^8XJI-.&`HK?^$IRZ? MM>[?PPK<5?Q?R+O[A)8=IZKW.+)WFL!DX*1._:IQ'=S)3D_NFEQ2ALN;V1V3 M,2U)!A[\![6]=95##`$@#'8K*\8 MDVG_J;"ZELVDQJ)5-[P%O23S'+L?@(ZT(NQ:2RZY^#CD!43OQ/L,O,(,))7" MR?;@#M;_D"?9`/>8<6U60G[&CWF]!Q%L1('-4HI`5( M*.=V*9+K&&*)."EX/ZH>09#L5B/M:V9*B^#9J4ON4I?\Y_9AVI9CZMNN%II, M[[H0!(L5E25[KFEI*O,[+C1]X7][^?G!S^WPM"_(6]EOM5+'O]W:(Z:U6/?8 ML=F:ENHQOM5"LQ?>-]WX6YZQ<)3U>!,;K3;*\#[+M4N%W")M003":PNM&TF) M$%!VJY&N=3.E2.C\U!E?4OZR._)GG`69^HZKE2K3>RX"PFJU9 MBP`H;S]FE*??P$,^#4OR5O9?'?3Q[\`RPKQ6:R([=F'34T3&=V)D_L)#]RE/ MOH$G?^I7Y$WLQMIIP_LQWS)U\GU/A*(M"<%8RN3[WG)5TKIFQA0)FITZZ/0^ MU>("QV,MQ^1W84V:C._!ON\M5E2V[+\FI:E&V'M]WY<7(6O*R78G.QIG0=[, MOJN-.H%=%V):BW6/)3NN2:D>\[NM[_O"^\Y#1^Q^%#;*>KR-G58+97B?Y>E7 M(203Z"G6+_OLOV!6H3Q?K5PB`^MCO6$P-9,(;//*17`U930*TY0X(11AKP4- M7WU[%^BBR\"A/_`,YO2'($$BJ7T'\]1WI:F_I@4I+K;;B#+,991N=OOT@-:D M3#'JKQ;ZTKIIA2[Y(MWLJDJ7DV&:UEG.';OOS(W0K_MPQ@01*FI>71=%KJH) M06U&X9S,9F3'KDI7;T4CJ2MPQ3)M[C>OJ-_LV'TT8W@EC.R-S-(4_!-&#X_D M7/@%)N$#3J$'DTV40O`U0:Z5636#]G110OJD5S'-S8$+O;D++`>^:Z-Z:8$\ MKE)A7$-5RJ1E.G^!N6SM._FS8KL#:\PL`(/J6%/5$<,'G+A^'.7!1$Q`6L&M M6=WP:9__I1@OB<=4"VQ*JT@JML^$=[H+&5[[QLU46\B=Q M:,%`2$#:P.W?KM+T8%HQ7!^R-`OC;10_?#G03.P(7%M>&#O40@/ON$J!9?E4 MJ826N9;SY=L^@^BDV?8M1Q=PI1N.VB1G@$YCC?:H4@K^J3[DUD^C_B"&R*.& MR.Z0,?W$LVN49V++;[(PR<9Q*@:)"8XTPQU\B.(8_1/`X)A MY?'G!!6,\C/0+DXEOFY^:6_WG=4TRFNHH MXLGR<+(BFHP$DV&/?#X);Z6/"FNT"^=2:]`W_0B6\_G;#A_E7(D)N3P,Y.@[ MHK4J))5;WJP_K'E#NDWKP4X_!'),0%^)N3_-F3#7DDSQ$(B'0"N/AACEQO9; MI[>DHW3>4#'P*\W8ZMI="&6L)9GF;18/B6;ON-+!]P44:AGJ,R1#LQ&?.BLE M1K/6TKWPS+I+,9"EOYIXZ(Z6!1E]*ZF#*J8=9I:4DFX+6)T*7:;RLQV.RY"8JGK;[;3Z$;=?AO?%"( M39]XV)>N-9F*#R=$G::<&4-H6][:#HF*O[+7A^,D9V0]);_XRO04-Y2E/YMX M$+NF);'>AQ.C2ZT/UYKBPS8?3E@\[?3A?A+=J-Z'XX5"+/K$`VIUKYP=87"O8[$#QT[)R/I):LF5J28>%$M_^<8]-O[5L-Y9XR9)K9]& MI[?711.10CN]LS>M^-3[9!PHB'&>>$Y)#K[K6BZP,G0Q2)Z2 M-(P2&$5C"KYAN?Z$D/T*2;($7,NM[3U?1_V[D^YRG#R,I>#2TY8X0A:I$A(A MZ]G]=F,(NFX'=V#^@/P.<`/P.VW"^6B]\RLR5G,UPU+-*JDG3?,2E\LY31SB MV9UVISDL>RM@K#XD1WQ5-21KXJ_H:Y$) M:*UNY$9,8>?TN9Y"ORMF)1X[J)F7.JQ@V;+4WK2ZD#L!)=6'W:@-[`'2PEHB M%K#E@W(80,VLU6[^RH:%[L[?WMJ=ZG\(NCGCUPV"V#YG^6YVOI[+**Q;Q#GU MC]GV6J^/K6K]%3!6/YHCUJHWI6M#BP]X=@?G#6(W8@5[`.3*BK10SE@\MM`` M9W78PUK;4IG3+/:>W5$##.B-VL1>**V,)F(76S\MAV4TP&CMUK'6M-#OU!WU M['XB-@S>G(7L@X%LI'ONSM_YYS.I_>'M]WWM@_J\%K+HK8*Y>I`8'Y;&">EFKPP(6#0O=3;.>6%YA<@BZ0>O7"0+9/@>9O7?.^7PM MJ+!N-H]P>]C!Z_OV*`%Z47EQR![1Y_EON/TM1E^L=F_Y%>%.W[\>!0%0U.'= M#I[[.!.7MCA'K=@E;_`-KVMYUZ]WWN7"S3TONT]W3"Z#;I?%("U!,1?8WX.N M&,8S^DL*JBG!`<\)R*1YW"(@TY[A&,?CX$1`#>'O9'8ER=.%%^#B1Y2>^ZOE MS'`HMA1@'9&'BE>P/\!0;K+EPJ'GH[[=%Q?::=>N=C03T!DCK4B_X`G-J9O[3Y'T4^\Q0J&C0)%&J9= MO=`)113,G2*2\[]@-RJ/(>V+S';.G?EBYNA512.1ID!GV?-1CK3;:+`6WMSR M'9X%RV-$0XY+HT8=6OX50ZI>NZE_VS:Z;.M[[/:GPI7_*%8H7/QN:F'WB;@5 MZV/DV-T&2@,#;WP%*?HS1ZD9;+ERZ2_(G MX.1I)G]2V]QV&K1N=/&4@,PYYFG:Y_UWF.1+\!1EI&JXZ:(3:J#;I(`&%U6/ M'CJ==CE?_$2';1WD3TL/M=*@=;-(ILR5$IG41FUD,*W)SZ.-&!.7J)H6Q]@L M:*B\;W?PF]%U,+?S,D11'I&WOS]1.$@#/45Q]'1X&E'#?#G@8*[K^^;N$R_RJFP2.]P+;46%=2'8#G_F2XBAU=B4F[2(#E:/28Z>TW!U0_:+==M]CM2 M;T:WZ76O^A`0>TR3B/AV9_@9:TFFYW2Q$Q?D^JG6T@*E5"O$6I.41=N#,(N5 M4I,*"Y42TU)K54IM");SA=T95@ROQ"0=KDYR##E$(T+97_IV877K?IA=\J7@$-8;G&*/T&\9,U]/.'?9PE MX28[A+M;F#RY."C>T?Q*=7PJIZ1U>3[5.`JW!^'"FT(XGSTK];;\YB%R+7"9 M2XB@AA%@D!-7WV_`<_Y9U/?(_G(W0E+!:P*Y52Q:JC?H%0\2W72$V[7JY^@> M@E]>89BD?QWQ"NRWY^?3X.+E1((H3Z!;=-DUO*A:;K@:TR[GZPGLZ363/ZE[ M^G8:M+J&9$I+WH]T"H[]M_`3U$9Z[]L;TY(#(UI\SY_`BWY3ZS"]F_4!BOK> MCX0_5+T?J97I[:K2^_%?!\155W&:)22!=7J=/<+D]C&,<]_N8KN-**-=1NEF MMT\/>#GN4N*DG?NKN>D$F-J)TJ&61O@2S)6Z-0%REMYZBH'9QE9F'*?+%'F= M_ABH(<`9..OM\'N!2$GN`7,2;-"/ M^U.7LGV)T74I\AY6,YIJ>SZ!^Q$+EFA$E]$XL M"*LQ7<>PBR2#SF`)`40QH"`FH/W?RN;6J:LL-MYZ$^HN[Q*>8\'&VEWH9WRT6SQ0XO`9W6]HG>C,C;:EJ*\9@,6U7?X&+K5V['$/*: MVVMZICZ%:AJC+`J[RD*:X&YOG](:(#`@HR!/+\S`/?;L7FSR[([!,_D,DPS/ MX:1S&DI.Y'.9UH),&S'G3^7(M5;3W:*+$6QPETX!5C<]4]NJ?]G'+S!%<&EV M):P!5J:+(FF@PU:%/+S<^A5N`\/2GT\Q9Z3&M9BNPFPGR*!"+`$4"26MUW3. M[$]5-\YZCZ#KR&:+)G'^:8\*AQ:%7?L]$Y_G)@N3S+9M]@"10>T-\1FX*Q+G M@#N:.<=^I>7\J;3&6>]QE-9JYE'6G>)381.+PJNT/L;;*:BL&HG'*@O2-#&V MZJMO^]WNTS[!G?!CABF&5K?18KW>ZEUW@ZJKC@,_Q_I9(VKZ%N0-[#*;5(VY MU<2OFW_6*Z<3B7]Z,>C08SM(N-\3,TW+8\RE6-#>V,A,/ M5V&A,?B&6B31!E\@T.PPO\51IJ3\BE(2V.X23="Q^^O,!_O5Z2S=#W-1/XM*( M'-[^@Q!XOO`\KZTPXMTFS8@B1'11-8C_8@B5M5JN?^4,J+$Z`&+/5S2UP/RG M]?_Z5F3"._0>LNAF'+SOWXR_SS?C>;NCS7CW7ORVMA/Z\,=']:\*NP[;[#9F!(+-4ES4)S(\6^[796:G.WK6HLYZS MQ=OCL\6\I/5]KM/H9<^YW:IM^:=FDUTYLXIMF6\*:/#K%*HCC;`D4[];[B,N MR+5+F(%+N(%$YWC.&+'%M(+$!0J]NX51&EZP/?:^!E0BF/G;5&B@V1=W],3 M&GK\BP6XK;JS<17*A]M6!2J]^OK5)R=$>F,QHS+PL]9ND%RSZ9YHR!%N[#R# MS=$]O?N:NLH>_2SCY];9)L\Q^#"6%\WT9''^L]8*'%I+D6Q"-0?Z:7J7I MX:@NH6?C@_TVK",I/,9ED]9:[?,LYV]UK]]'K[7[]![0*EZGT^$!'=]X)=E^ M3K('U.#+/DZ*_T0T1^EM>+>#M_!']AZ-^,?YVG7;8MK5 MZ$?U>.44G8GU*UPM#7,MW)7=3VFTT:Q[3Z8+>%`[L@OI@ MX',-ZK^/F0H9\1 M-Z!>Q-FJL;V_UE>+4P=B18I#ZQHV5(?*V18+RX]\-5)MS,E0#KWF9IR!VNB% MS[$%^[CF<9`9SD!]#D`F`<>SJ/-$=`B$7E_DYU`JW?Z(RMF((?-HP>FEW8^I MC-!OUB/12,F12]*J=\+LR%6)07BJA]!GQ_^^B1[BZ#[:X%B?IF(2=69J>ZY_ M1MEC@\[TF-#T>%D*BE[I@<[:F2^PT/B^5LVC$K,BU:-Y&;'RT3,7YM?YFN8- M6]I[066&>`:ULZ9J)X8/80:W7V62_AJA*7A/$TNVA;8X?#J#;MQ*U)=1NMGM M,?#S^6JN[XBT6@IC#]W5V7GCD/0=7OV`_,']/>SNBFLVJAF4RU^ M\6ALVO!0>]9ZM5CZ+@U:7MOM9K(38<179(83W.ZS<`="TAX\U;P\T2NMSJDO M[M(L"3?9^6+FF=>^Q>R:V+N3N$$N+WLZCF?WV2XK":,IYV,<_4H:_%ZTYCP" M868!LVK;,'^S:_'JHQ#-0Y]=K^V.>^FKU"O##(YN5"[)H7,2(WJSY=V^_`*J--M2>0A!M40[9=V M1\?W2C8,2GA1BW&:N'PV;)K4J%05TYQ1:WLC"Y73:<02JD1<%V&\WR&'5II$ M\E=RH'7N^(NV["R&I9"",21X791SRUHQ$/Z(2^KIK.SV)F5)L\8*MN.KR\\_ M"ODIK=XK^)UV&R'F[7,4PZL,/J7GSMIOJPAD3[A;"77\2+>>55,9Y%:;QE_X M]&GKVMX;'=UD3R$@M@/[4;`*'9[$P`['K30B9>D%\N]X(D!F&BM2%O&^ZUNM M,0C,\;5%QVHI#X?%+.?0IVTKNRL8ZB)Y"AJB!;=Z[4`F$54,[U_+?_Y'!!/T M61]?/\,7)"`_(ISI;&U`ZGLQ*!)I3CH;\CK0WYOGQ=O6$XDNY:''F*1Q@#H2 MH[(Q^!VW%)>%6BC'IP3^ZP#CS6O.("L#K\BZ`2B3`G8*6T2@N[,WS_,AKNU. M/,Q/C$'F9T-4?W)U]UI_=07*7G)R0*.6B.`Y^1[7G9EP_YH3*^)[%HH:_-[2 MB6SUO=R63X33&<@PQN/#6(+_[V&/4SE]3:(-\H2B&%QLR%'*KV'R!_:5[O<) MN-HB;H\VX:YPH'XA0P+GK[*G*S6`;L4H"Z.L[^IB_4Z*^EC?/?I.^2G71)P< M!C+&8/T.+$$]1)QFCKP^#1,O.-U5R>E>Q1?Z+JM[)E;/Z9T4]7&Z=_19:$C8 M:B(G<`QDC,'I'5B"@<<0!9=[TEPN_S:D.N1S9YZ!0W.%B*UYE]6SAAK>956S MK1=+>BJ[G(C!TD:\,>'718&V%Z#R9^L*WI^18T)WYAO88RE":XUNZ5@['>\] MR4R(*6EA\Y7=TLB(YDI^/LD?93(`=5N%IYPE_R2VNET:@<,LDS(<[W^AW/]?^.)/+S M/DVOXLWNL,5IIS^&28R:H7VKOS*PD=--AGK)-+3:?>*M!\)BX4_D@,G04HRA M6#32T^GT?D=SMAY@'T][UMQ-EG.?`3P[^`7/_U=0(,`7GP4&V]6 M#?4Y`@4HJKSUU/3K-!W"MZI?S3N,G9"(,S&G%6.6\S\U+=,BO0V'DI7!7M'2/80K3FW!':\SAA)PI+29'SB;/U_.9OC*OQLFQ2N&) MK+XF1<<`9;&P/`G16$LR,<>1E2Z]#F.)X@P0'&>T=BW^SPK(5'3C%)S"MZL; M=3N!#%!\?[%P?JKM-<>B3-')8R*HZNPV">/T M'BWP%YCA`W>S(4:*@%NEHOI75),R.IITL?"G%^2DEOB).5]-"O2Z6>5\9^"+ MC0IH"I[3M!20;F_H:%)Z@T;?OOU99BBQ]-'4%#^"+(]R-\OVE35R2H_ M9K)%G93Y+OW3+9SEV_1:6,BVU5]AP"[KJ:1]K@H=UR:=XCA_*A6ERZA7JZ#M MN+MXFRX(&^'LFN69E(;[&&_-.AY,9/05A7/YU$,Q05=J<&>QU'>SU3^YG,!R M$U9(WE#'F3.S^Q"3C0#=-I8)15!KI:06!.M77[]5=E[SLC/)_9^G+K;;,G!2 MPK&_Q"7?Q-0\'Z:\N-RN]N)<186Y?A!E+21W[>N+?F7#H%,&NNED$X6J9M3, ML3RU`Q\AXVKZ$S0,&E^X$ATG?V@Y5K50#AJ'G:P?C"@OFC1C;7>PGB!%1HX@ MQ;#5Y82W]LX]3)!%P;%V,$[)KN(B21"T MQO`^RNIU#3R-B4=4(I63*+UK5I7T43B+M_3M3ONO@5K=EDP]Y*`8$M3'!+5! MZ<%@->P9.!X8%"-+9"I#(%!71%:<)='=`4/XBA;@X]/S;O\*$ZR-\(2(69+7 M>J.+I_TASLZ7*U>?XRB'35KLE:Y+3=!EQO4=RZ\)E=!G0)BE00;Y(*#>`.!A MSD`Q$#@:Z;@E'6L48=54T'+RPMI2U%)J7.*O66^)55!HQ%M6@S6H_T3NX[>Y M(&_JXOF,1N;WKOOP_1IFF\C!*9-^8OFOY M`UYIVD8VFX,`F4QF,2UD3UCXG=]ON/,WJA05N39 M8!U9@`:_AC^BI\,3>*8_@/T],HJUO>D3'@1N30GA]3WY\7SAS;VV&M!WFS0C M(H8L.Q4P_!?Y"<<2LFYZY86M&!M_ZIG=X6/JB+37()X@[;:,`X:QL(O@^IXV M&$TV'?;`B6'M\V&)?2<<[:I!B#[9P:8G2.Z?$*(1X\POW^&&T>B>C> MU3:D2&*1^&(YY1/3&S1'B#C@.H9YQ0[,@&U/BCN$KC&`G`BQX"D$HMF6K*'= MQ1JZ0>OV%#MG#HI?`/I)L/Y*SW=C],?,,5+35VHT+DRKW9'1?;!-^3$]&%3R MU>WW?>TSMH5:#+!5.8`:MNK#<\I555NR,'87'>\&;4H_-6:N^`C]I)Z/./63 M?D;JUD]EXT+([(Z'Z8-M6C^U8%#)5[_%Z3/<1/<1W.9%`?WYW-,6$=8YK1JF M9*#FE#6;79S%?"+\V8G=E,KK`E!R*"Y07#81+!EY@V^K#CMX?:_@*02MN^PO M6K<*JGA<-5Y9X="_?I54*9_+62Q7=A_DZ2-:OQQK0AX4(^-C`)7/C42*F=\@ M$TS&*;32Q8\H/??7'GLDKK^MW M_%=.'KS8_.L0I1%>VNO[JVV$1.%I']\\A@G\B'YY"7(B*(:'F^OIK$1S-)\GTOZ)*MCUJY<[N#!5K0:F?)QI0!^1/`?Q-2JQ_V M\0M,4L+C-X_[)+N%R=,EO,O*LPG/Y]"D`\/),1$_UH*QAGKB-`TKGU0K\BT_ M^N4E13=+`'6KO:*K;?=; M`7YB3)T<WL#D)<)U./:[[25\3N"& MII9$/UT\H?FB_R;_>;YT%FWZ6HU'(`1)5ER4K$(E0B+#>:[E!YHR9.FW$,+8 M`MP7VPG2FU26*?H#/,`9J`]!?J\/8E+>M+PVG9R\-6*7Q(8C^I5F6/0]NX/T MU1#(+H,2T4I*H`8-B0MKK4%4JX"\R84WQ86D>(,([[+*J.8'H^Y*WUZW94+9 MD$`&"JH(OY;&ZQFI0N%;O@T>Q*[;O@P!"(@35G/1A,[`N<[WOT%Z"@1S(?M* MTHZ?+^VBI(I(_3*G"*E(*KURO,(9!'3$ M\01:5ZJ1MR/0;4'MLH,OJ6\R=XFF]ZU_>JV>7B-NHP[D02&YM"`'N-\G@'Z@ M%#R@H3/^5"655XK^O8-MKNQJYB^TU0E@02`KCR(T5@+'T!M]IO4B=YT\N^\, MA>CA$!CQ\@$BR/(B`MO>S17\@060LXY`''3<$J^HX*.Z=5)P,# MU+0Q_G$7WU]-A\?;H.MW\WKG/SH+.`-'+50SJ287:R0F;7&'NKH0R[F@YR^^ M[?L75B(,.2Z,<([/M!*X"_-G==B9>2:;D'WV"!.TXGODL&2O1#67/]*2Y[]$ M4?17\#_^9W?T:C=HW>JY<^:@^`7D/YV1FTB%W*=%'9OEOH8.;FM-:O/9 M?9'>!]N(GNT!4#&BD._ZZWX;W4>;D,;@W<`8+?UO:)3-@>Q'\8EN%MWMX)=] M!FOA$VW/;SI"/?AGD.-()105#"LP&(U<6-/(!;M/3!10IUL!RT,,ZD.0B"@R M""A'`;5A`!Y',$9*AO$8PZ:F)$O-X"K^T4@@T'+FSN?T:]J]EU1"GZD0+!5@ MCT7KFD>T./WT:WIR^7=Z`O MQ(=]#*(!ES/RF5R[PZK$B=)M>821!7E/D',T$/D.ZB1YB8I7B[`OZ)F'Z M>(MF2T-R,/4E?(+Y.W!OT?J"3)I#A)T5S*$\\HCN^OJ'_MV;UQEZ!* MNWD1AA:0KJ#6%^2=0:WW&<#]!?,9#(-+W[_^%D?_.L!+F&Z2B'QF^O)LL=97 MK4DJ2!Q?%IEPL@EF"NY>`1T,U$83>EO( M`/QS55AUL6HK%&-,,DLDVF6QAV8.Z:M&01^9[GE]RS=3PD19(&'MR%AE2KS( M+P,T&O'L+6?ZLDZQHM`N.QVT2-+X"#&%GW:60@?#%U-!0@8XTAHUH"#Z8NHXU0!KEA2704W3AX=M\1 M*Z732+"$2L1!*9PI3BZ4@BA-#S1R;4./+4/>@BQ?=^&&A/5?/,!X\UIEHIIQ MI(9O'41.3EAQ%0+0WM[WG85C]QE[/W#=AJ5W]J#\%="?!>^(!KXEXWV0>29K MWO-T+9<[6]JM-_N!F[JKZ46ABMNJ%)TD`]O[,.U\RI2^?ZW:?`U?"322+!GFIY!3^C"V&M M"A&AABH8\+Y?P;S/%4S>[EC!'`5GIN`JSK/^@-K4).FJE=J'K9#MG]JG<9.A M==XB+PT]47?MCE[&:FT0VKQ?_P!DTV4PJ\)VCR1 MMVIM&QD;S7[*T:R%':/)PER[LZ$878<)^BC]%`6EUQ5P;.9X^Q4M2"T_BK]:ZBM0PJBAB M"\9%:W!X?MY%,"&)79`XZ,N6(H=-E?)0LRY--2$TKK-<6%X77@V!YH1=`F50 M_$TH*Q$OA`]A^OAIM__^\?X>;C)\VN:M]%4DD41G5OB&ET94_!HCK^8SWW7. MO=EZ;GE!8-6D&G;6E8`.D)5]0O8US?:;/XI7Z3C1;(RS+,,?&;+`V$D?27*M ML)IV2JZTX3P=>8E?B!&VF(HGK8!.V\QH']@C[YC].=<9P(,"/"K(A]4KS9]K M#Y:6)BX#.&&9%>">U1"5W&I([&9-):Q1D#;;)/04H*!4*GF&Q8:X<,*K`QH3 MKRQ%L)F5S*%U$17/DW$1FSA3N4^3(=`V06U%*6Q#JYVL^"E2>D7\Z]O]AS+G M$TY['Z)/N-OE%53^&>*3KJQ6!:?M^*@OTI=[%@52IX*R(W'C']!9NZ[GT[L& MRQ,7*J+0B,!)PZ02EX*K,N-9-1(M:5(;"U\+Y:.))A&29$?&G%93E+1F5BRQ M$7$]#O*-:79E9P*G/"IH9!R6!,FR MP(8,8=0N&_BF@0Y^>4BB^(&&.=-9VT,,SIW%PM'XD(D?D:1T*5F"4LQ$1ENN M;8_Q%:=*N]D1AA:0KH5HT<[E,Q_:_ZPS]^(9^`(S[*VV5;A6PYSJF'(`=,&,)\TS#(4G0GAA_ M-X_4E?-=W=R63ZF.Z7IHP,S7VI2LHD=7T5ZWD04Z`PNN*0O&\"',X):?"1E@ M!)]AFH+\1_!UG^`UXV/+RJN,']Z'.WR4?O&T/Z"Y%NO6"CQJ6+-S6CD&Y:"F MT)#=7=SERNZSA2'HNNWPP/Q!_7>0-S@#M(EJ+M42&S\:ES;"V3N[+)$NP-DX MILFH%7H.FRX>=#Z,(_@&_W6($K2')H4)[V@C7F:-T08J)7>;-S!&WX*H$HQJM$FX6B>9G(/DI^I>4X:_J9['68 MI>DR=9TH`[)/1FX[9.1<1$BR"#G\^&`L.SE$R_U\&C"ZR?_C+B7YI1&S+?0] M^9<`ID+F%*W(L0B*#>HY,[MC,N6),V.F)!`&M1'`T;D?^+UH*62>Y/A,TPYD MPI+7LHL1'I0DKIW/?(?J8]LWY@KI-+0S4H?X2#[Q^UO.Z_U+>)=5QO9S]4[) M7>D[D.J85$Z(F"DI!*2SPSJ_Z_5\JQF?";]N`\,"(L"-0,VE$W_&AD>ZBI$L M$,>TQOM?#M@)O+[_^*\#^D95D_1\Z;OZPL#X\<@SN2S]=?[G',N;K^TV!L(T MF9`3$6!4=JH_GX%:WS-`>^,]$NU?:RE@"`0Y2XLS-B'):KA>`F-1L[X@9GUM M]^F#`NJ,N%GR.(-*O%(:\X7^M:DG/R$>%T`_X1BPT@^+XFPO)WTO,,:1UP>2 M()$>FW^#&QB]P.WYRG46'$]A.(96*T%\-'3)3M\HY![![H6G,,X[CT^TS+)V,CR-0QM1"Z-J^,=CSK M$@C.XVDA9F(K[66W0`PZ4SVCY#?+=A\:"]$SBL/$@BSXFNPW$&Y3D.0_`3P/.L,-3=M'+VBJ\G)%XF].W*45^G% MM'",`@=F)%[G;ZKN[=P[<[^PT.&6:^E%TMS4UHT+ZH=D%),I`]3A](..T'D6K8O7U2.?YF)J3@Z(X.:W=A=Q!X+V[=/-LW>5#\6(01G15/ M:M2RI)8[J3%8LN%8='3`=FYE=UK?`>1&W(9^#,'%9I/@1_U1P:7/>;!;'H>S M>^5CTU_#']'3X8EF#+B^+[,/D+GW,7X;@4:]W=.KJ&]AE.*S,,=?M&7;[7"' M1>:0XUE%5!4<+30OA*U^PY("7VZE;8*D$$^2)Z6!ES?@RIY#1&C:B0< MQYW'+-#!3`H6XZ'*U"2K>>`B,AX-QY][JQG]KG;?+BFBT-3AC!JX4H+&>88C MQY)L)SI3$[2&4R8R7![+.U_1KVKWK94:`HVX>$J@-D-_HGR(,QSJ4\A6MB]N MNA(!(Y9ORQ'(3\4]V8=]BN.0O)6O[R"I:UHYB>(@II":GBX+Q^[3_R'HNMVU M@?F#XG>2^Z]H`4@3U3RJ9:L]%H\V-'MW%Z(P:'J0M=T;$&8:C.AG5C05#^,, MLCCL$JG@B)27OX]BM-CH!PAI+8Y]]HB4=58KE0-_X.P#BK)=DLK4%UCC?T(S M?MHG^*CU&\0GK9N,M"//D#V.!.6B$\D)@$KZ!G+),HQ)$BNZU*NU/&I''9&Z M+8,RI#V)9P$9#9#A`!X/YY<%Y/[A:$CCPL>:$7VRTM>2,5UT4+JM1%^F3Y#XEX1%O`9'7:XM3R6G@+HQ-VYL$%F5G(`K"YI48GKD:/+)YFVR M/]SM$*Y3OQ;_89_DT4\4[]_#*/Z\3]/K^*CE%YA=W]^&/Y"*F6E,":00J9SL MZEVR0I:5SH)V*':_!--`K6YCK!YR4`S96J5&GC`LICA^?K^P.`A`CB%UZI.J8"8%K/GAZ M+AX\U>/WG[@?E^1%SCT#2.0,ZAF"E M`4$&8[REMU]2FK?Q7`/1:]Z5F\<\K>R^KI`ES=2MNR1.0<'AO%L_!7G[&"7; MKV&2O7[:)V5<'+Z6K/$<1ZX;WO'5BH\`-5T"-#@4U7LT9^/*[J--:=I,6QQ> M@&VR0\8`9!`2EE)%(Y-(%36&AYWA!&V/K?(S;(&&QBHU(+W'M7P7HX"ZL>P0 M/U0)<>*MAK,+T_1#/EV-QSB>(;<,(2<4;)C*#K MUOX,&`+2!GP`>2O1"F5]GY:U%)E1?FLI+M9L3B1X.7-IN-C<]NI%3`28TI9, M:#K93T3=738^]6K&J>XN5;/?(*8C[KMLD]4572R[#_Q9X!M1=_T8<3J"M_#M/M[FI$2WPN6#,U#YILPCEG?2+!%F M:]R,*Q'L]6Q.1\#[U\6,NFNNW1LN89J,Q!.(HJO2Z^7OGVD,?E6:!L<.\(G* M9YAEN%K.AP1NH\)1<->.OLR/;3/*B0`;#06[M[;&GJ%#DB8CTVSWQHX)OVYE MSP(BH(TPC_Y&'O1G(4W2*^9F?XYB6$SX*=Q$._11D)Q$"7'1+L,,(L?662_U M/0EA0"#)R$(DEHS-TGLV]^UVY#FHT,[DS%`"W!0S.FT,BM9GH&H/<`>-+*_% MA[&+Y1NN"TMOI(W6OMW>"@\91AP4#D!!SO+W>3/LFA0B.=9/?6E8.*,91\.Y1N)5^U5Z3D._G!F)(?C^69E/QI M;Z*,[+[;YB%C-"7?`:BAY*.*X]4H^3RMX_M]DNR_XYQAX3/Z)7O%?#$WJ^V[ MH*B7`0ZB^X2A>YC9W)V>MS]$SA@680!3MVDH4OF6/4'1U83,&#,7-LD,DP'I M'H8<8CCTR,WNK`=2=(UF8E@1!GF)57S$>6Q]Y"6GZ^F)@ZC6>/+)CD2]W+"3 MW"N+G+Z=F6(7)& M,RD#P.A=(![N_6O5),=$ MW>&.H#XXJ(T.[EY!O5T^0Y%,*Y^D?KF3(I62VV"+=(F6Q_T_ERYI9`[0,!LM M`.3DD8&NW:_E`+Z MM$^*#<1U7(O-P\_":X'T'-5`.(>7DQ=Y6DZ>FC*/A(,5?6]!P[_LOHN3)4VW M_RN)KQ".XF$I3E]>AHXB5[([V(MY_W89Q^@QL8O>"2A/C$ MZRJ#3^FY[[0]853CU[&"D),R85(+V6(>8+5>DEI'<]_N<&XQ@G0;("%40='K MC(@#^A_2C7AH52*#:A3P.[G.(`-QFIZ+AP22'=IU7%?('"ETFB-(F/JK1-"C<]0&UGUUO)1>=6;`3[K46]EZU(B:1R19_=FB@F_WU?^(R56_@5X7P,4UA.54N+MEIQY'`1FD6.?9515B;F M$!L0GY9Z"YK8R;-[`Z2(0MTJ60W,H!H&AW$5`]4W1<50H!I+-#&-)#.RYJZ9 MH)RU9,`1&I%J2*09\WV'W3&0RF@T99)4`984.X&$/-6$^2DAW%89'^@]%SU5 M=,Z7WDI?L#X?%CFAE*6[GI"$8QSRK=WYN>>XOF=W5*4D9>QB)YF<1!PCDK1& M25`<&[4I1U0L2\4]\'627QF7[.5K#*@4AJ59PMA7@UG8.H?TYFN[/4M9TG2[ ME)+X:%AS-4"90@M)7#VQ5ADIL4^*T,7\1LNT*(YCX6P517Z[USDD5<+T_M^W M^_)`'9%V6$-6N,&7`_8EL?OYO1#(\(IYJ()QS@B*K`XLB+<-R6>L]S2T.2U4W=SU:V"J9VH.9*XS?KUJ5D_ M`^VS@FI:U3M:64E:_JEEAM=&MY)9YC8K/ZVTN^JPN46PVL_@)B?`/=X57?!W MW4#T?TL=@?[Y$F$,Z5F^B:=-LH(Q+=,<;'=!/Z?F4+;9'YH1\YB[SH,@[$X] M9FH);#T\X*3CU!MI=49Z?)$C5P0T?!%N?9+'$8:[:O:+'U%Z[CI>VXL,-4<, M'9/*23\S)87P=G58SA9V1SGT`]N[X6UQ-F)T(W3S,C"8J6 M`'](@-OB$RC2NG;[F>KC=2UGOC;Q>F-[QM(9^^0.]?:8-)_[\SY^N(7)$W:9SO$K57W*OG=N.=[G):M@^Z%^*\?N M`P4F_+H5.PN(H&I4Z7+<[AT2IR=PR5T#A/&+:]'DXS-R0W\/]"/'*?2-H.59 MMOD(,:*UN2!5C([Y/-R^($^=5TG?;![A]H#-P]&3-O(P[2+>EL_2*KMQB__/ MN;]8MX4:*\JA(09*3AR4K4293$-P0,?UYO0=@V]WN*0:`G6;#"4H@V*4>G@D M\S-.,B#G?OD&)B\1'NDB36&&D99_^1R%=SBO7P33B^Q3&"7_"'<'B-H=GNC9 MTF\IKKC],L,U.8#>$*0[4$QY5'#8EKP MC;M.@3$YTN)9_ZFB6KU[[3/C^Y.Y1PVKW3M>TTMA9(=AF*B@U"^)#?JE2$]# MH.)[8)_]CEPS'.L4QL!::5081S,3ALI?"+IV!]2;7HH)>CE]]#3=G8M.=^>B M[NXTO9W;5F^GRDYEA;/3+F",$<5_:J/V"&/-4Y?QJ#G7_G2[K8'%,!5O;)PR M8>74LA=CT4Z<$P%D'P'W"' M$X?B\`):C.S<6>!\A[I.E0?GE],+(N05DLW0=S6?V?WTD)D&W?L.5B`!:5B/ MTP*XZ3LD!N]P^`HRO:2Y-B[76Y_S MN>.W';HIDQUE2*7%3..:U012W2R./Y_GR8KM=ATU4FW`M&F"'I#V6`>TQ>RG MX'?:2:R&09X?;.[YKC;9/9I*3O@&4)\4(BB2GWFNC]/T.$N[N;\'M6[N[9ZZ MK`4@EHH/A[=5S/JY3)_NN,NUUB1%+9/*/UIDHJ3^YK"UPWI![+N_L'O7P(1? M-V.R@*!/]>K/F#Z+IM<_GBZ]N$/_##>X_.W:%+N6DZIDUQY*VMFUZN`M+"]P MW0_<+(.>S'[*FU^6SD$7;?:'9B_NC;/&YR!JHER/M6B<\?CTX;* M[>F#=PH+6AYG:7>T/SL11A0N,YR*E2%MRIFKI'QOC%\Q?MBG&9K!6[8FCU.4 MG*0YHQS+LI%0IA]I;6U[:'D/:MVJM'OJX&LMSP+^$9!?%3*@GNPX1AFPF?^F MK?5JL5IZ]"YO:?=Y/PM\(QJ2`<@1@\(4K<)W'"?'R:%%]KZ+>/LM>GA$,U8! M=/BEYMS3QJI]4RNY(F4EZN3*M*/;:C&?S?-:)W9;>RXZC+`S#Z*`1(V_%$$_ M1<)\,;:FB2AO]U?Q"_(BL+B\#^,_8/)IG^3B4U4'6W.\E^,=7PT_2U!SRN/, M0Q&MX](=\,+N\S!IV@R%&`@##,IRV MQ,$]E4W:QE$9_=.+KCT&J-:%?H'\_M3N4VAF&LS&!'4#:<3\HJ8@;ZN:'SE* M`8[!D.W%^-KZE%J!;@,F%=?;2X4I#1&X-!!R)ZJRYY M`.JI/-0%QS:=<5C)@#-A[&7X&>,( M:+F]-2V^X,_MUK"B).EV`@1Q!6Q.K=@^EIN!&+T&.[F_Z5,P#D$MH;=V'1K% M;;<.%R?*E,P>-?/]A6OYMJL5KQ$7MFWF&EMMI>K[%+5OO(61 MDCYJJ_AT@&\KW%/4DT$N/WW'M[+[9>0@=B.L-X3BN"(//R=6AZ^?8)@=$DBG M*=VN>:L!';S6:!E,U44%&\[FS4-;/_*09$UJKBQF4[E)8"'$W/T@`YKZ"7_> MO'AT)GUWU\L-W+=Q8[%MWXU92T?L5*,E]F<.76*['^;PDF+^5HL)EWHN/CX9 MNXHW"<3[J.TVHM^K]@)CB79.AEZJ]^%0>2#+1V_["6WO&-["6U@M&-RTF+WC M&@;4O$LH^IR!JI?P.S@=@UAIWZ7Z;4JWP%Q4C7#'P8,/ M6Y4LBG&@(\X?2YZ-;(BAR2*<29/?H[^$2?2"+.(+?/_ZA9BIBQ\1KHZML?A> M^YRRTL!&1\7YK>U=CR8L7%A>IHX%OG[]/X@AJ-J<@;M70)N!WW%#;O>G&.E+ M^`3+!)/KA0$VK694Q:1]-#19]*BU[U`GT[$[GI4!O3D&[8)PQ)^XD6`6TB_P M^^Z51J"?;-@\]O.0UD'D&(X55\%R[>V)$7+S#;K=-V%L!.AF/"84`6E5O%N0 MV!@.?&3&8PWSW-<\QFCMD.^M/2_?6]NM]EA),'5LP8A'&3/FSVS*M-#Q`[[I MQ5&W>&Q>6[8KOO!45),G(0(0BN+B]1 M]=CR+HS_P(+#G\`"%QW8/,+K&%[?'[\)_6>4/=Y^1Z._HO^[>X$?JL..+_L, MUA\3M26V[O!U9.>3DQ,-U-;+;4@-3;\T?9ZPLON43SFMNHV2:L!!/B!`(V)1 M/'T*_1V-"NBP@(X+:@,#,K*@EZ>.A1EW)V]%8IM['MFQ2U^>OME8V7UNJ8%: M4SLI]="9!!C+@H5RR_94YZV(;5NA.:FAESDOT.UW;?XRFDUY3BK`EQ)ZO?]2$ZS/`MSNLQ3E]AN=UET[/+(DCX@ M7-O]YDT#M:9=9770F0384D/+YR1/76P['631H8MSRS7E!;N?^ZDGUJASK`SV M"/(ZS*,+Y!&TQ==W2:1NF1-!7$H5HP_DS$@1"\=RL>&G1KL+R@TIT.1`WN'G,_@'J3M;>\HL+$7J,N6H"X(+1%#>C*V41>S?=(59CZKATO2T_ MTA<@QXQ+PP_,'%_?'.Y2^*\#:K![O4#"NX7;FA_MJO%1.B?1Q_T\=+$(1/=X M]/51?L!C=\RT&@+']'>840ZZ0/610#[4./*EP%6R4\#X'*K.`0NS[^:Q!Y9' M3RLBT0:WBP-OE\6R1\SD/38[I8S+K^L<+W=!\@)@:\N#G=50.+KWQX[5@'CE M!V/?8`JSK\G^)<(IMFK,UE87O+^"8=M0;\E7:'(E/.^MGMG4K$^'ECP7MWHOS$6+*U>%"I9AM M;S:/<'O8Y9N25?-2>1B`',L+$5@P/DOGQ=*S M.[:%G0C=VID925"TQ#=CQPG::_D$4_#[;8A]#MP=D/X:N5_+.WV;N+_AL`]W M)D5ZUDZ>5L3R6P81C8`#`&9%@1ADQT2 M]#!H]HA]P1R_*Z"GGKE&+ZQZ$>BIMJQ^\A5GCC=QD(:84!'J&5X M06-0&W(T"C@U(L9$B*/4TC1DJ+W\$M=@M"(0^HYS^AWM/E5509ZI;88"K,PB MU73,.`LU23`AVX'J=(2JX9=QCU6X#S[]CG8?HBJ@SHC7)H_SR(DC0O2AK"'` M)RWY"2O"@.<1K9]ZK9;A#3$=N];[,0--+=\K!6%OA&C&P_AIS=WNMD M-QXK:XS?.JSL^W:S0.L]S.R^B&(CP*B5'4+3R7XB5K;,`G.=?(L>'C-2"77= M>JVJ)E*T1<6V4(0BL+2%.AJKJM MD^:54M<+WRS[JBBQRT-0+PN7Y6*]-77,7;N+-+`3,0HCMR'IXV6A,KRM,W_\ M`9--E,*O2;2I);+-?TW/%TO3?#Z`2(,`<*]!KV@,C>;.O0EX*V)4C2(\3-"Z MI>D,%`,`,L)1?KFB$6?)/BDVT_)V9F*BUG[6P3L:V5+-Z8&Y.T$WBY<^"Y'[GG=1(&B_AC^BI\/3S6.84$"W2?3P`'&0:3%O!1&'#KLZ6,;W#TI1>>3[R8I6=WS)L&:DTX*9,:O3@)\GW*(':_*-)"K]%S.,7@NZ7Y3$2< M51SV"3(WQPW<&Q%G-I^7:_`E#]C%(L_WFC_+( M"FS"&-S!PB@C`;_?)PK$^18F3^7?2%0V1ZGJX1$UB-D0XEY1.NZ,OH:_GLW) MUYA"V"X?-:.8MUY(/>=`N%_M!WV<+7.&,Q)K,Y[!'/6FH?QS;TEUS11"A'GI M&?4,90!^3C99QBI7JS^?[UMSCZUP%>PG231.0[D>`KQUWI.P!@@B#' M_X)4%A+`V'T]H\6./+LUO0`UNOT8?DC!26X@O-FFO4"MFU`XX#&8+^$3+.*V MW%5;^+X.*:AF5;H+QBD?GP'<4C#T[WC* MZR1ZB-!GP'^]>-H?D)-TOO26;;4L=;!PR_0J>9F)NG:F;NOJS7V[SVI823#+ MUITXFGQ=-"59WT%*+OMWO#8>@ MF]#+/?,')W4"A#WC:HA/X092%C]?(GXWQ)#5K"K9LH^6=N:L]?!LK\$U@-PL M:YY.?\J99P"W$/8/>K^I-K=@!/YL=0):>]`;+Q(*ZJ\FRJFG-!@S^2QH@J]) M%&^B9^3<1FEZD+/P5S%"#-/L6YC!&Y*X\BM$,.,L?(#HXZ_;+@=U,'(?#I6L MS4=O.[/WCN$MEE-R'1AH,:NPAP$U57C1!^!.9X!V`U4_[0)B0--;)2`#UJ!W M#*K-2`84--I;$953JD:P&#SXJ`Q%A=PDJ+6,D/P:XG3[V>LE&@!3 MY6#_P30C%2.HX#X\E*&?"B;>2C+QT>U::^)W'2RL\J:0C99V]CVYX*)I=[TI M.=Z=%)A5O%TPFNI7XJ;P8YCL7K_!Y_`5#X7C9G%I!#S#^6JA,=:C>UXY[N6A MIRP9U=UG[JWL#F(:Q*Z;9X<`!*0!*%O0%Q*D_@9NI)Q;M3@+(W)KL\!9=Q\2 MXNOE9LWNNST.*HPX"^QX@@]A^@B>PV@+LCU(89;M(+G7XZ_A]XSG^HJ0/88I MO'A((,1_:*E],7=QB(5\'5A0D MMX!(EGVMD#T]12D>^1.$M8-%S&,<17(XAY<7%3E:N@J^#HV$\^$X2Y)"=.G: M;T9D2#-A2R3PM11,KDE+,01`8PA?&`FSF6#U<3ME9KCR^,!01>(9CSH#KOV& M1HXXD]9&"FF/")UURY`INR-6;-Q.&1HL-#XP$DWYXJQR[6?YJ9(L;6;V[)(H M@YJ`W",!>59L9/Z>[-,4N7UIA#XT41`D^5-;?F5.T6B.K$RFJ.4AIU$@2SG=E_T M2M$UMFO%`K+7JVJ1#T7^5!]WR;E2-L@'LP/5'*2PW-3MG=L=OB-#UJAN$P/` M@#+_IMX(1#&`5%[N2WG)DC!.PXTZXY'G1\R]N>O[ZT.69F&\16T^D!Q--SA% MTU6:'G!%5.*VMT6Z<N)1W&*0LVNZ/)-T/I!]%M@N7)';31/+:# M*DM`K_,J(NB*O%M1=I?S?*,]\$N5>W]BC'6!XGI(GD43UM2?!!(;W[ M^_R9X7&>TLW^!28T[7"9LC1OAWQUY:YYD7+UMSC*TMO]>WA%YB)\W/88G%." M.X;7(ZKLM`S)9-=(V"MSW1G]EG9G]I8E;2P_F1%?GT.H4Y3=+#M4MLV'W6CJ%*/R>_O9GFI0$[<6-[H]W-/C%2Y%8.LIZ< M_VB7&#%[A!TC%:Y$7G=DFM<,S+2-ZN.QHJREG3\0&*.*D:$J7>X4AQ/2\OQS7-F`XN^L9RZ7A` M]OEU]&2CC,XE(P$TE%BN>SD.E'3P;!4L=E>O;[RRU!UUURU_/ZJ(PK&=/CZX MO9[?D*`I\O[86%+.!;15T)B=P;[ABDITN?:B/@<-=Z*U:K7QLZ3?99ZAV3VJLG-Y3D.O_[UIOG/J(V=L7ZD' M6Z]C5#&X(A>HA6'D_!WS#,[LR91]BV,4>@QI>9T5`6I&]5&Z<06TBCCV/_!A ME1P#QUN<7N$;Q'EL-CCU4OSP_O4K0DIR5J]P0E5Q]Z-W<+6,S4M'%Y/WCX-M MZ(Q^B?G$XL/Y"#/MKG"A:U'M\98DL@%'(X#WKP"/(91=79#!!/T:^R1EV-_I M'8@^S%\X=!\UGUBX."]I8_E!G#B;@A.V"LX9CEJI28ZDD]2)\K8,M?(T&)E; M]<%DW)1PR\YM&34\RZ^G%M/:-G!29HVA:87';VG(,+I,S0F7J;8U(PJ,A+6Y M+2-PL:YSZ:>;UEZ$FS;K[$T'4`�P5(O<7Y',7P*H-/*6$ZB>???6-K%YX^ M*C@DIQJ&ODEV:/:D:45"!W/`0@8Z@W,2VLI<[`C"HA0L:E M'*?0:@[5:LZT@AXY*;/(L/3`%!(8]28%&ZP\-S3:-J\ELKSU#JY=9'KIX!"9 MVCC4#R!1"O/%M,)&^`BSP*YTHV/>OE#72RQWN1A_J3,M(PN*D'&I!BI]Y@7] M:-.*_>`ES2+STH>3V;XXR>#V,GJ) MMC#>XE)%YVMWH:]\!2L*.=D2I[40*N81%IYG]V-*3DIT&Q@^.`%N#DA[4.MP M!HHNH.A#:LUIE@@M908LE8C&]3SS"$BIK>9V^V#SMM+$Q.>B[/I2`JI"`1EX+WKY^C\(Z8E@^[,$WS:/=U6\8V MQ:S?-K4B?F>CJL'D[=V\^6J%BRY[2[M#R'G(,*;QA['4U?W=*RB;`])>Z.5$ M.7LQ6`337V&8'A*XO8Z_P*O[CF7KL&CD)UP596MR&I^J;VW-F:L.94#@(,+84QC6&&GIK6.0.U M*<]`,2G8QZ"<%I!Y\;/=:F9`I@;')$:TQL+%T_Z`$\5^ M3?8;"+?I)R23MTGT\``QQH\OD.0%\5N/-3K"6X0FD=,?JN@JE,)GF&4XQ=H' M]-&BC-94_?@C@_$6;GUWAD,KYG.'AB19[J+RDF+$0^4$%="OB;.55#GKGO,O M"[+RLP)8?G_0KEO)JRY_KZ3KR/II*3@`'4!6,?-W/\Y9*4)EI8 M7N"Y#[9N*](S=U`DO1>K2WZ:K)MH]O>%+KO8[?;?:8I.ER,*EVE0);S&C?N$ M"0?ZDXQ%J[QREMWGPV($&6)+E96$!\/]W-&QG)R$9NK;1_W-UQIIOYY?KHU MS0!IN4)F]L"JCM4:?LH56[7/D+$T?M;%J1?+!N8O7S9_9G1B,!;XIWY,!2U"5+ZG85"WWL9T6C,%\#6O:T0&+ MK3=?T36S^YZ4D0+=-I8-1HWYRCV-2/VI]MEN]Q5'XUT!1ZWDP0%U\&4_WGX6 MK?=U5FO?G=,$VY8_3.(G9AS&[4'4S<.X$E3931M#2]GV,3BZV^)W=B9F"Z]Z M?CAH]RMN$7),>P09KSG=A\[M?F`M0(W1 MW18[KN[M%RY0%HFI[NLD>HC0USF&\6F?O$^B[0/\O`_C_.0!7_J[[#X)\\!R MC"Z#OV!X]C'P]?ILN:;7ZW;SO3A1NGT6861!T;.AV>_W":"]`>XN>!XFP$N, M[HR]PM!T;S@_SRH/-K'[$88X4:9<'6&$_%+!Z?M\#5\Q6>GU/M$&*)2&(I2C3AMGUAH\S>$$)+G4KZS MTO<C*H6IN+3I;([`KD;M!&^:INYX"RAATK?X$.49O0I1^X'7V"- M]T#*R.',1U\A6FVD/?$!,$>A'>:!)3E-`G_)B,QCD%IZ'KT[\.V^IA$G2CLC MBR(+ZCU!WA74^I+\\R!E*?DE_3AVGVW+D&7J/$\" MXZ!(,0G?&`+PRT"!7GW=_"Y/&7\L(]?8))%=SN(#QS/ M\0,-C5N^[IEEQ82'I$HP^GJM7-M]I$'T^IVA(0A!U00?3=0:D9H"&AA7RQ'= MN(S;HM%[>N'[@06MYV!Y.#8/&?__\JZMN7$;6?\5O)RJF&59R:S M-57.>$[&V3SDB98@FR<2Z9#43+R__N!*4N(-%P)J9_UL#]DX;V-^>HPR_CW*\^V>:[O+;9/9/W^V^T3@BK'R*S>)>SC;OO,N,):FV@^E0:R^[N3OYPS+YZ#(EE04O'J/D#YP9&/[7 MC(A$<#C=M#7I'=%PV40C&%Z7P&>&(P:MYBO8'X>;PGK9PNHS\BT(L3_9X\?= MPN\(/^T++Q]$J]#.85^<;Y'6WT)W-F_XC>4`%%FTXT70]/%$&?#5[R-O&HC) MX]ZQJ?+;)[+,?<(X_Y1FC>Z"--UVI9$[;SZ3)0#'U+`$K#E3`WZE M'$]+YTOL:*(*FQ+IQA]%%TS%VB/%#E"$B'%NZ9OJW0<7O?&_9")M?`LVY M\F)/B]EZQE\[<`]]3#U]?2L<4^@>F[P11GDS;)6:WQ3'P*S:1\:W;)5-7\Z8 MZ4K0--3H^G;3*5LH7$7VS>AX3!.1 MKFU26NKA1_KPG)[R*-D]_,"'[YCV9*_=>=0HJM+#R@[4>C)*)/=1\8;U`6]8 M#_NCBHX:K@]"&K*$9"R2@Q$?C>APPZO&2AA0/*A<%ZC-HT8/&7=7R8-E1\C% M"O;'>#U%?!T6M*0**5S.@:KIVBN!0,UWORY0&[Y!#]6*/T?12`%XKRDM/;SX M`3H2M2#4:VL6Q47V[?5F:2[,1@S%FC*9K7C!`=AAV+%4]+68CR1O]?6U8G2# M1/.7^STJ;T92;JABASAFO!JC:SQ]' MS#8;4S8Q6PL3=>:KSYI-&"ZF5N8U-,/8MF6@4;=A#3*C[W*SF?+[!+!/'2-H MY]^@=$5L-2;93*&6\7%%0S)V#.%:DHI+.,2MO*XFKG'"/AN-HM_UG$%]8=L] M017+LO8"U7%HV@X3KF4U@@OZS,2E-QZ[6#QS M;.S>F2UB\M8N#SQ?[5_I@2PL#&\:>61J7$>W&C7)>RREC0%W(,0=:=B?Z`PU MNH+7IB!6NZW!^[.N:5_*X6#N7VSFM``\_U-=;IBOZ5DH`= M/E6K#=A[4;U(,O:O'J,#W^ZKPL22O?=+3J%PUZN3C M&(VKYW!I6^/,PS),>=?!Q0)V>HE;Q7UY:$ZDKW:QS^4-/38!*F=@EWOY'$A. M@N@LK*]IK9)XR3W1UYZ=;%\&_%T5ZK[]EX= MZ>%T>=#TBFF*]?:U1/5BIM&8L4YK9YP#4DC3.AO&G*C6I_#:YP;%D.SVR%47S>)V4%*_A+X M$7(#VSO0UD4=U]]Q]IB:GM9UY:K=,[HM]U]-L--4%IR]1%GQ^B4Z\IKG*S*% MJ[H;;1-:8EI%A1+&;8.#-?`ZT#U2N]ZTNZ<.ZS\A^IM187QZG8X7F:/NIB@W MAW>?$WK#CFX1_*80=U"#=ZO9>N$,G'JRV,'65F^):$T^L\4"=O:&D3ZNK3_;J$R:(8:<."YOP'8:3HT>'^%HKMD%L17PQE:VJGER M>2S%)'L0NSQJ84.TK]`+G>E3G-#6094TU4%NVE8+NN,X.<3/#OD&TDJP#Y+R M(SE/`EC"KBZ@K8OK#4)7H+`D0(*BME,81D'4L:$8&8$"Y68$98A6KA1+T2@, M=@U_`VU\15KT15-#MF9,IFR07H-&6PNM#B!?D-OA=E@6B=++D>Q)+<0:`-M] M&!+=]7HZ,']8_FZX5G:^1,6ET0^BF@O?Q=`R^,ESP8'?K1\6WM>R-BA)"\`T MEZP[G)`747^E;4&U#GB=$=N!:T@.B:SS<=S>^*(._"I\O^"N%ZK>V4/QJ^$B MU?'J%)BTUE"NL MZ%!)B.J4-^+SA%%W5?EA[3;9L0]R^=D7N=5LT9:6.HZ5]$T]3A*:HE*7*67M M9)L`>*%8%?%=@UQ!ABHMBR9?\5&H-LP%?IU\$[@V?AL!_WXR%EOF*4D;V#ZO MEAZ>0ODZ,H7_B@XGED)HEK9P>Z1>T(Y.14YI48%WWW!"WE&M6]F7M,"EPSI? MMC7%ZTH(TV%NF3%FJ4>94:;#AU_WF$]8PM1\`3LV:JF9.O8M;MG8R1@*JO!TD+,V+'5O MXMHE.>MQ,.?5:8%'9HWT<>W4F`@5,B):1DF0H?N,.SM(Y+65I"YAKAA-@8;S M9NQ%A;YL'2!JE<..%QMJY"M28R9>-^QO&K@?(W.Y$T%JSA`TW#=<'Q5R4:&? M7S>8`X]GFRGDQ=$Q$JV6I2SKI*#MB"M[6_JZF]1E&*GY:AY.G7*Z"&#?H5?4 MX"I>3$,,L8!79U?R9.4";ARD47[[3MIZ`$&VVMI^&598\[#">@H[]JBMR_56 M]!ZI+EN^ZMXVD8E`]WO6-^0B3Y?VT'%W\:1O;DN$:^I5W4;II9M-@%\G59+? M^:JM($182T&CW\4W[F:UOCZ2FRMU/QTMKA3,-GP5@1UPU-3$SRJM M)9/H!BAZCIU>".;Q7SC;QCDV+U9($_6KK/Q:0+*2C156I+[9:(D MAIT96&A;OUNBQF(&O<".KBJN5WQ->?A%K/J5JQK)33T[V:#AN#Y2G.P)8.VB ML5.HLV!QA/GZW2R8SH%O&N9*>=D_C,6K^TT&W=//Y_V(MQF.1\B#QG/<#?4N+NXHR5UC4%<3B)K`?!^QW.'DJGG]-BO@@RX*Q MDD<:M[(&&8X)7S5YV_';1DOC8L2[9&C%9O>+"]>?TWB M(O]V>LRW6?R(=^]/!?D+BW4R>&B6ZNCC9X=F`VGKY0UZ2?GV..Y,'VWIV?&$B0!V-5\#;7SYT/JB*2W3 MF@[TD!15/SD&FK9(MB'$*\YNP=ZK@2KJ:TSXWLE?R@3V5TT+K:[MHG2+IF0% M]9:@[@UB'!?FF@:A[=:DTI9Q4]\SM(OW M$:/'>?$U>HUHSL$IRXBBM\GN"WD__#\(I(*%N[K>"A+8F9"9BE51MV'JS11X M'T1U)5Q[3\J2A'(D$D,=XMI)`@`L7#?<)"5J]HU:Y*["#LJ;J./%,3(0++S= M;C-Z%(BE";R8F`"9D6Y:^?V>?1D@6P4O$IL7^;M@MG38JJ%G9CO(ZZDDH=Y/ M-5O##FTJ2.]ZT1X6(91#J,/.OY>*48@-/% M-*:S,P0%Z27BFT-7%`)"D19\31*GI+Y0>"0:NC4#1(8%J!4VG1)5'61V-%\,$ M?L2TT,J78V(NHK91Z+HGVK!2RQN`:A2-.(LJ"UD_32Q7L#/(S)7R$H,Q%D]: M0[I'>5E,(V+E`FB>)+U#1TTC3M"!F@89MJ6F\6*R7SS\2!^>TU,>);L'G+S/ MXMT3ODNC6A>\65L]C0Y[Z.=F9P7:DDKL#Q"R4])$A`I@[P&:FKAV@?3$"-?>]&DYF\TU3YRP'#Y61RE51"AN^A#`VW0`^BGY;D4>\X8]9N!WO+1U\>4,Z`JF M@F5-OX#U)+S?\]#OIS2C*1K%)XSSCSA)CW%"X<9VX;:LY@Y$J_"TP[6AU!+< M2N3LDNF4GQ@FL`M#&>GC>IDV$4JTR*3?X_BW"$+'LH8*1"E1C=0ES-=O$N:- MQJ^J;V"]YGVEUQ/8=U&,]%&'N54C6!/9JH:P.4>[N*E.$Z*C)YD,?8-V?E"O MZ*]`@WW3=U&AEU="Y_QVT`1V5K2A1K[\&#/Q&HL];^UPL>;?U!=]3>=&II=R MQI\:S6EIX]GLM*5EV9*GJM_P6N/3L\$4=L8QCDZ7O<%UN-%5;#YC:0,+X,5^ MQE#/M9\T@HQ5@ZK/U0[2."&<,3(\^UJA3W&#>5LFU=Q^#-CQH]YZ,0WX*X7] M.7([ M.0WQ85^=%TO^U1GVJ=U.,;_;DJ9T#7.1]*A($>=0NP4TQE:DC"^C30BBH0QM M/`.,9&[18LU?&NRCOZUJU]ELM.4TLQO-#>;VF))-Z]],07I1>X^S#._N:".- MV^V?ISB/Z2_T[$7!MM3(J5'G;&3J9PL[5M=#*]8YB M+EI8)Z4!`TF,JD;.8@7M[4-Q%(!M$<_]0Y\)7KM6*W:0DKPAV%,!*+U\[ MAXV0NO;A8<-0RR:";!^-C"-U)KPAQ'HRY2\(]FG>1BTO64D6`IX;!FW'\8S1 M@=E$5+.)/=8L`?8A>HF+Z,!DV-WF.2[RNSC!GPM\I`AJ,WS='WJ^\=# M_,2,IJK&TM9C9GQ0-V8>#]7#2K7!NDD53"9K]A;FL+.?-;3P">M^4)OQ$5C)VA90_*GOUYPDN-W2Y>->34$&0_SVAJWF<`0DV`# M_`"@KXQ/@U"2Z-PN\AO$B5!)1?\BJIH*0O=VXJ14)&@[:1P*M%XD.[4M^5+W M=EPB7;6\'`HL!*PJ8+_0PP$_&/!#@:AE8-4D^"LF+W,7;T69A:]9G&SCE^CP M;C5?M34*=M$6NTL&.X,QU;.]764G_6RY@/WA3DL/USN)CC#-CJMRO"QP&&GG9)VK1U1$,8K\:V@O1G\#X;.EL"[W73);*7A;LY;]BL\CX6UM9O M&FN-ZPW-H7,:((-]%ZU;:'6\65U4Z!1`GC#C?Y.EKC5&;M`E[*6>([1RV.WH M8C([$`Y*7N__51\XW\_NE=OUPM5C^:!CN(T?!C&+W(^;__IRP MI,QX6^`=+7Y'7N-DXF[G'9K>#I<&RE5MB09(-Y,)[)"$H@:NT:LF1BB'H?^6 M`_^'5DZLQK*ZHJZP[:CQ%@QLM[3<&B"E.]P2=HT%91V\G)M4I:E@3K"=5=C> M:F/[+DV>B,!'ZIX\$#%O_XKS=]/UVMU2W3:C'835=)"H;1T=+-8K_BUL!CLA M5T%ZUROQL`@A'?(/.H;USKI!=!CZG0[4="LNY_J8'J,XH2_7G4O;/N>X$.W2 MHPND8GQ`[)]G(LQA'[>4Y/<-U#8A.J#*AVJ"]9$>R?3H4"+^QS/. M,,)E'"_.R>&0L<0[LW:UG]+L*]'CF28/[N\+PI\GN[X+9JN@K4SDN#UKNZ:W MLQ`#Y2Z[U_:0SJ>P4RA457#MU2C*<=ZL5HZD%L#&BN1K5^AVVI'YVNCN[,W< M2\OZU#-S,`X$COL]OO47R@#>?(1G5/ M?B0'BN2)Y>*]?_TY^C^R>PF:#XV(,I>&C013FMQ*ZVY*ONR@4W+FMXYNZ-;'N*.2G/%'O[,9 M-%>`7[#,L*7QA^3I`6?'CHN"[X+%=.[N\H2&)';&;*>R-%D]+FO@P3$#;5P; MG+Y(845"HP+5Q[S.ZZP>;,5)W`"VK32B"1I<9/4([OW,81^SK/3R$G6PD?#B M!H9FU^WH@!G]8[3]XR&+DCS:TFG^F:5Y3C:N+<8["IGELJW.\SA6HB2#G7V8 MJEGVYE:C7Y+S`&A+T-+#]@5CXB#6,C?&389WI+S:ZZ M):G)&$H#RK@!B:.*0_N1J3KROV_W1/G?GN/M,V/Q(4K>TW]L,4VT87&+HO< MIU(FSOZ-V=*CF;[NP[#4LM[_DY<>N\.'UJ325^9QG.!O=-JW?`SPCC5V"M4N M`I0?/T])$1]$^9@M63@>V;_&]%DN9688;\L!TEP%+OFZL6D%Z8SW1IDF,Y$UV@\K.-[RV22C[;9=$[@Q`!U]ABRAFQ??N_G;F;[-K!9U MY:[E,2E+V.&K+V^5Z]-C>2&*6#0SA^#9U/*'EHG+QE8X8?*Z=M,,M/0[JH^F[J< M(368@AK,'O/[,%M_F]!73-1+BOL]HZ)H6P4.O;KSZ3S;TJ"NQI9UP3E8;^:+ M&7=`9G^SC6M`57#>8+^\QKXA$GQ9%29*?B4[=>4Z@C34$=S*<];,LR&`D(7! M_V9;XJ"R8%W.(D=U']I=ZMUI,W%TQ'4M*.]MR M]ZRH`8[&G97X@QOR&%U/YZ[8V!*'?`R*RD$LY!B+80X-^%,49_^B7MW]GLM` M1<,[`LAEFT]V!>/MD-"CX2H_HZHYX0C<9ZLU;`=Q1"U=>X[CB1I*5JC."]68 MH1^$&ZK8W2#*$#&.]#0E3)TSO:)E7W];AF_9+1V<1^#.%GW8&2BCZNDE,C*F MQ.$MK8"_]V;WO?;'E3-S5LC46R[M9=ST-"SN6[MMR`_MB@*UJ`"VU+I^%:3KW ME5NQ=WT'&9(EVKG"=98KYF8M8%\-'4$[>&YOJYRU:PHY-[?8P-S(3GS$V<-A!WM%J22D6X>S,P'L')1>N5UO"WV3A_Q')'\U M_.;6_QH5/[/Y1E?S8UK;^&#*GQ7L9(D!R7U](NL78R2P_1PE$5\\Q1N=!1MW MU>X?=XGL>H'KF#>L_FZ(M&^GQQS_>2(,?OI._G$7 M)_AS@8_YN\7$X5FP:U;+I#1E7MTA-`]?X5!,CK(8A M-@[]3DRXRC8`+[)-,KMV=LGDW>@L@Q MEE'>[X:\1G>;=MN,HV*Q0X<.*/+1]*&NN;7#WL<5I/<,RQ816L!ITN;HAG9IT@;3LMD@>\YP_9MC)@FH*^(9JJQ1-M!HWJ6R93S0' M)&]ZX1.S8S2DU-"F![>R.^)ZLA%A,]B9.:HJ7`&[;7)TH=>HM>1O$8U^%B+* M67%^2-]'!_I![]LSQL7'J,"U@$T;KCO"2+K\[?`[@C82U]JL6%@%=D4Y8YU< M(]]4L%`2BF]>J&8:18H$,6+4B)(;^LSFN%*,MKX5,VE&:75YR0`D;*?;0BM? MT5US$7U9S8?T>(P+7BPUV7U($]H>%2?;&.DT%_$(`L'1J'D@QV1F&JIK0&1?H)]/('6GJXQKZ. M,`+R8C3K;7\V'OU.*1`C<6L"3O*,X)E`(X%(B7[%ERC8SI6F)NIF8)$8I"=3 M

    D7=2[BSKZ7RC<:QN,+#$IH(\$H?_3(F^'R@.LJ0>!5D",M78NY:=+]4Q5.I/Y0USY7=SVC&GQ'L%"`5\7V=%!5D M&0%N]5FJ_8R^88V&$ZU,[%"G*E<;\*KQ[''-^?H/.\U"27Z?*UR7$"$;A,0H M"P=RX`TK+G;^H=>_Z%T\M@5_;+"3)Y3DO\:RUR6,+PRJU4GS#\'&*:-U_(H_ MM27?+6!?Q553P,N90DF4:N?5`]Q/.7EH/S[BES2/B2.U6<^N1"&EJ,6\7Q$?;Y0UUIC]KLQ"GP7SMCN`C@S@ M;ISK##KZ=`*\H@G(_V"'=X:%]P[@2PDN`3@,GRU=9JP1%: M1\@<5]6C$Z4B^3F8`$]J[!?<.SKKL[#1*$[JW$S4=VP%;2_-RNSH2>D3:PHV(&VOCY[*XM5RC^&T7"1FCUJ4-< MQ$\&K:8NIN<>OHL-92MP/E M?3R"X&VY/<.Z>+:`08%:[('1T+I*D@K1,3=($#JW#Q\^#R#[&/)XNGD0AVDS MG<[FO''('/:U5`NMKN$!:<@7BA]$2)Y:3K3;Q?QIRQ[J>E8CF[,_I+?;/T]Q MAK]FZ0O.BM>O1/;B-MF5[3+>!;/5REVD7ET0.[NQ4E@:CA:310`[A4-?&==; MB[9$H:2@MYD$#9)$-XB1W;`4]I+2O9DXV5T@FTEC?]%@PKXZPMY7#+3QLI_H MRU4W%UK(';V0*9ZC'-.'OCUO::=G)[=L8Z)?U.@EJP+O1,)\_HD@BVQZWXE< M=)?[B!]Y+G#;@;LC5TJ'MQWX+;60\-=BPX(=L`W`2!_7>X6)4"$GHKU42S)Y MM2-'E!#5*!$E]6$&BFFKT.V@F>2JPX==6MY,)["_M1EJI&X,=HFP9N(9F(5F MZSPS0*FETD(WBX9WI,-FQ=\1[+"LF4)>?"0CT<+:57%$7S_:BB\1.S(,/:<' M\BHT[P'^3`[^SX?7G_[:XCPG\D3Y\T]_T<+D.+\G0GQ.MNF1=:">!1I;@A)7 M.]`;"UZ5-R!O`&.GK*TM,+_2'#AX@N_+4!,<[?H=MSDI@<'IX))_*/ M#/$_%<]1P?YOO(U?"(\T?#P+3&5[S$SOX"8=)LS-$Y425T0.W.P4EC:A`83=MZ#'7TU MT,:+QZ0O5\BL8G](?]`'NZ.+?\I'IXFFE_0E);O'+WAWXGM%,-U,W7UY.)_, M$N!#@I<@OAP83&&?>-L%=KU0M\X:LK^B\L_C8,O-PNH!6\T%\GP@.\W`3J[O MD-C/0MYN3C^KTD1E1%M'Y?N8+&RL"UM>I-L_-#\B]80)@OELZB[Y MS%DH1$^E\KM0/Q7PUK\*TCO_0#HH0EC&[?;VX6REM^SF<^=5@=O\H-E'17,U M)NSO=91P\\G3'6!+H`=BRZT/*11@3PAJSK[X/]#5#XU1_RWYS0K'G!V M%.!8.*SRWCGO>&@?4J<-ZYX<[#*YP\)[7X-;Q;C`[/LLWCW1C-U(\P"F&1-5^_H'+Y;; M`.FW(HN3IX] M7Z("LZ^S;9=$NXKVMW*Q@Y6R9&7]_78"]L!@KW0#DKO>E/NG#\N?J\@2H@/& M!9K:>PLP?+HM[JZ-I969*K%>.R')9K:V(O&Q0) MV=BF2#5(RG;_^DWP)X_MB:':"CQGZ*UN1^I==WK7 MW7'KOUJ37WI2Z_&;^R!\[_=?Z/\VLHE:P)=N_K)13.O+U:ME[7^YN7E[>VMO M"-;;BK&[@?=TI6Y/NO*>?-\033T^2__9-L@+/-<9W+A_#!ZE1$[>^M9SGI4F MD\F-\]?@41-'/0@OE6[^]>U^K;RBG7R-=8J/@N!;)O[%=#Z\-Q39\FD#7V"?JO:_^Q:_K1M=2][DGM=U/U63P3)IK(%4#<:KD@$T-#3VC;HC^_ M/RVC`:9_O%F1%UG'?SJ23'7U5C:QN=H^$F0BW7(^!3:<=[X2M/UR16/L_2>MCSUHD8EW>PT0N\G$U\S034/#*M6^6UFCX*]?$;),)G:4 MC5D(,X\R`9A>D84566/E3!A.:Q@PM`.&8`1GLOEZIQEOC'B9AK(M@JW5'A%' MJYCY,HI@:VT9RN^OAJ:"GYRC+5:PQY,3@W%)OR!*:XT"UL?2SUK4%V M[(:HR@A+>7*T^,,&-NZP#EH/?A\8FZ.-]81,B]B*9<.S+TR,H:VLDKP9VU.L M`MX8^<@5GCL9D_^6-1M]0[)I$U>AF!C9'G9Y,K+4#S`FE/Q27^H6F)EBS=$! M*\A$#L]W( MN7I7;Z+67^[!KS'"8&AY<@`QZ!81@E28CFC68=)>=))Y*A;+Y0 MT=4">*,E6-76T&H[-4U[MW>J1]_AH6?#2;Q7[B=\G)N&;%L'HPK\_Z#8PPR0 M18"W@@70-%KTIK6SJ`>Y)3"58OG_KA.D&!`3_'GZQ.*=_LJI_*9!5SP*Y=]5 M=7!OGLY,%;!9;'WP,F[(;W*QG(?*"M.-85N>T1Y%X59_+(,4Q0KA%#VQXNO_ M=QUG'@%BVCF/0&0ADF.BV1YV^Q:(MD\3P9?;2)\@H>,I6)8*H-/5M:P=$>1C%>UE4R""8#7_@XBQTNEOZTC]Y!QQ:D/" MN&6?SO2O6')N*9M"D!_X17KIKR;K:VXA6JZ`1O\CRWMGI>8,TR_0_<8;FNB-Y&R'_YGV<#XNG`#D% M+8/X8YR(T*UM8AV9H-:F0O`^?@R>`?9;^,;O[6&W)PX.?GZ89`]K^)3X.&R) ML1.J*):1!\H&41%Q]CG3_ZY:>P+I(;B!+U?P#]L$J0WGEM M]\3-WMGM>:V\XL^.`IZ@I+SUAWM796+?Y[S,@B@%.4\&_N4FTL$P^YY.IPON M)H`:?I^M'M:K^^5\^KR8MVZG]].'V:*U_FVQ>%XS^IO4;;C<;F9JFO#UF4TH MEH$V#"9=868223&[%Z`%&[K"!#]H''2`W([JM363"?F`6<^I>;6'@\%0F$1, M+.1BZVRCY9LN-S0UMM9D)3\KI#P@RT.Q/>@/)''*GD"Y!(U@!<)3A&[3%('N MJ-`!Y0\0NRU)?6DD;.3#I$H8Z5A)O:'M-6UH(12A^Y6\M4-?IZ5^MR_.\4?2 M+&&PTV7W1KW?M%%/Q&E2@_#EY'7MP7C4+X9S\5HZ.9M\XD3UE'-0?>4T+%EC M5\[C`C5;)"8->OV.,&?%R4T);NP2O(+0=5!U'Z]0)]_-J4SP$39V<%KN]9GP@ M](0TNE1_#EY[/);$+;&GDB]-);B`:>I\Y::[BD+L2`2DWJ`O;D4ZF7AIBL&! M27UF##ZUF'OO?D('I-N!NQP-1^*T(9IF:5J0#D%]TG&^P0^?JPB4'G#J"1OZ M"(JEC7N:]/59(CF?@4)490>)U4[HF3WU'==I8";!AI=HP\]8D&>7B-KQ M9%*L*`7JP$[AMCY6+W"OZ?")'J$O4RE53 MG1]M<( M4[`!4Y_))?N:-1-^PA>R+YY<,LE)UX)[4FD"EF,+24%6.DKU*8'SQ5MW6,<6 MNL<'%.I9[>T*159[(C+*2J:=BY9P;O3U58,=E:;.H*>GV\`^(I%TCKN)JYFS M,5&FHF2`J:F3*QN"0B:SR_0@YU5*?R7L,$5M[ M,.R**T+$$"UMX!E`:&H&^43;E.I(760C"C/F>` M>$\T;JRE3J_(HNA]U^6=02QJ!O0:'MH/Q#\0->Q.QE$!1_1M0,SOK<#H9X*@ MJ:LFJ6"$]G)0/*+"C*PJD?.^%<%:$0-$C==8+J]`#9,J4.MG^/%M\?"\;JWN M6K/I^K?6W?WJ1Y;;=(Y7(JVV_AW`%]RJH_Z?;;IG'IZ-)Z3`P&+GKHVE#M31 MO6'"YY3,(S$.&-YY^T&OH%_JJSTB,CT@X=UD'3Y&TQ^+7'K*G^'L5:TY`K4` MXZ)*`;]KR+MU:NI:C/-Y>]P1>+,#"P>YN)1"-.7H@?AP;>J4Y"YG_A/K=$LU M@A%R&@Q-Q!U2/B=8/^5)`:VI)54G?+^537H1\XYNK7:M1!J*W&T>3;1^.L,` MGN]C.DU3')%`][O-#P*^REBG)%;;T.W5)'F@B$(I%XY>WPB(EO MB!Q@^@99X1+5Q#5(';TX322939*B8%(8$`"Q>*<@VMA\=3,ZFIX!$MW!0*Q: M)3)04]7B`-57KPH'"I>HEV=D01NK8\)/C^L]$F3)[]3>W$Y6PIU7(A\U539^ MB'V=J_#*75:=.\*_VOZ0"9$!A:_T_TB],\@:D0-6D-D>B+Q'AHV'RFM;Q/Y7 M7FQ]1:MCK2[MIJH#-H%Q$'QNV!MK:VM^>^^VU!\)O#J9S`S$W`$^;P#S9`T]@3>2IZ1J_HI8![PUWA% M(GDR#=5!W=C57YJ!J&*'[5U[,!)8)4PE7S]MXT*TJ7LCG(/-='&/7F?JFU.O M/Q"W52:"8OUT)PVVIFZPHEM%Z#[XU=;9/P(>V@\^0U'GBLPT&>_H73H#@4VB MN7BIGXIEA]H/SQJW-B82_W'SJ]9.176YV\N84)9F$&V]T!QQ[#:*%H-`),W* M6^/X+%A(Q2U( MS"8IYA=77F'.W'5VX;IER` M+4&RB>;(_1E",[+?^+`K[B`;'R_9`\ES.I\N1VM+G?%`7-D]E7XNYG3IR`:) M'!=:3=VK=H["IRM8*0H=<;-^*OV*ZTP26DW="QN)PJ=;."D0`OL>L;!0?HI)3^!VL$3B%5:76(BJ[TWSTY,T((O.<<2Y M4YK:0JZ+"%#QBG;=2>2.CYA")\,K2])VIG0E2?J?)V'Q;C'PL[?(VPP<;U!H M-,'"584]*3^HU>]_E-7%/B`KJCSGG>>.+,_U>D-Q.3,_/]F=+A!1$%+-.]"W MT-*WTZ#BNPXC#JH#0X,/5#>BSVX]:K)NPF.:K0)SSJKYRM$$NGMQ(/`.`J&\ MYV*[>6A6:)MH02-5_:`[V]1RP6B(F56*-/0G\/\0CDFS92I(X+)$3*CLM$'C@6FDZD,E*U&2=D#$V:! MZHP&%56=/%*(<-+]A`!#K-`=L[2]8K1I13;_S-]1+I?^0.@M MW6D,5%Z34C`+5*>RB6NN:4/2J3V`5%SC#7Y^+HIVCJ<7Z60\$M?CZ(262&/@ M&KE0S!*#1/7C_%2]+Q)(P<=DZQ,D%N:%BDP_1'DA1EJ.88XK('39_HLUYTK# ML/H;6E)SKB*=6Z8#`,$6L_K&W!7!..6H9@!TPR+4T.5CP055X4O'Q)4*DBCG MX@+Y1.-W=E'J]A,$=+G"RIA<-B`R*Q16QA7`ZF]0%NC4A$1Y%SNU2'GHJZ:Z MLP!+%XP.LD93H$<$PZ5^GM+:P\%X(DP^'DZ*<^)G$6M6P!H0LF8W"*E3=XN8 M@C,DY`/\GG-_.HRLVUE5C&1,/!1G!$EOC7(3CZY:W?0Z8LKYC,R46($G`&FIO989S,\J;%^4XAD5?.;TH5^ M4ZK1:0+7;RYTKNXA[KVL]*96$+;7%]DAY$@J'P7(ZO&/!:,8X1N0Z,>,-EU) M>9;?Z2DT*G-G-!"W??83M:J,>3P$-2Y$_'IS!M\]?.#^+?)//@_8HOQW.OW6 M=2MPJ?#[;/6P7MTOY]/GQ;RU?H8?WQ8/S^O6ZJZU>EP\39^7\(`OR1D(&X+U M-B#M\CLS=-/0L$IW$P8TS-76J[N==5-`[Q;25:1>L:IT\-)C=7<@B3L'%4,T M^\SM=1PUV])@,!)7E?7)Y&**S,@?S]-'"-E45TL/<-#]]6XGV9$T$K?OXX14 M.4,;*VV-7>I%;D=(?2YWM_.5&*;Y2(PMIC?N]@;B%LA#E`K1T+.B89RH]:F2 M\Q4%@R4MKW-7:(E@T!.W5RN6;#E^B0F%^M2%.>^0\X4/[T_K=<;B.@U$4"S' MVM-$KTTIE/?$@*$;IZ+[C?L"O>\/Q*7XJ>3+\0);D`%\^,;Y&.W+AN*/`T>`S5\%?_XCO^'<]1 M.^Y%;>PM.Y:)%]<;X!I<]\YGWPN9Z.#3Z)8.OT\I5MKCX43<%4V1),LQ[53I MCY<15G[<^0S[L^1SK-D64D'VL;A:;@S1:HQ]!`+'ZP`;-OH_$'YY!6&G!XB" M7M"#O=L@XCQP^1K4N()'#"2>$9TA M0T$9"[Q=DH^;2FD1$V2^'M6@BL*;*M-]ZQ1`%\]C"V$X)?=XGZ@K4D[(%:S547>>)(A?_77+ MK#V:OLI8IYGD2I\C@@\R;=JPU`$MV]F4`=GF(T&6_-Z6.M)`G+-C9:-LYY<) MKOHL*O(YP^G.(!;^T\%YM0W.(;G-*@=>84*,]T@B7;HK8<:E^NM.E[@5DQH* MQ(OZ:2]3__:,3E?@@=-4^E5P).P`U:=TS^=!0NX4FWO#Q*[)!/>)21-Q5T8D MTJZ">K`!T]2ROM,_.Q;!MM3K]\6%(\G$RU8.#FCJLR8@*@\3LPXD+@U+&-?N M>"*P9TU%M/U\P8L)$+_@T*F^IO.M?AUG`K>WWK$A(R0;-$CHB5L,2:1=MA=D M!Z:I._J6NFHK],I&_0!?=`($]W<+;S3DWB+@%S,ZPY'(6@XC(Z6G9ADA"W:! M5;;U4M9$C8K\A#3Z)7H-#G8*NW<(F5-=I7\[O<1NU!?9YYZ+E])5*3MRU;_U M):LV_0`QP!5O:0KKTOF,1%L:];L";PY(YZ!TQ>$%J;DWO7Q%.F"H@<%,U1W6 M,86.5E0#']SICOOBHIMDZKGH"<>YBR"NX0"EJD":X=R@$B`PZ`IL\I](NRQ]8`>D MJ+V"72!A M>@\M$[;'G;ZX2">!<%ENC!&+II9NG(6P@L&X)VY--)IF M60J0CD"-^UU?WG]EP-Y_9?V\FOWSM]7]?/&T_O?6?'&WG"V??:$RMF)Q+D-^ M-308`1.R5*Q\/MG$T9.%]M6R/F;&;F_H\/:YL9.!!6DT<@*5H9!=_%$DL\_3 MH0NBOR&Z)9;V#!#'_1FY7&R4<1B./3P29"XQ[V1QKJJ*7>JTI]-2G\E[#!.U M)T9_*`D;N43*98PB*Q0EIH],2:`%4B+5/P_CL]]W^W8(&U\/&9B+U;*RW_196BDSFT"X^;>H>%TP'Y`;\Y?S#N#T$:[[6&OTXEJKK)1 M3,MA5NIZK-)/N-XM6GG/E]BR"M[4%9880%S#CD0D:IL^GRI$O[PJNL`@>E-+ MU4G6L48Z"!G:0?=@6&A!2X-T;YT#3]3NU`Q.(IE25=2$%Y3ZK'3EZ$`8\(GJ M2)K%G=1#:[AA:6I3PB2KWE55(-!]*:>#4PT ME@A(NI/(AF!9W$9EU8%%^*8>"$RR$+?P<+P)4U=O"59?T+TANYXS:L=@!C^1 M1*:\T/'(&:UY2N+. MJE_$6U44+0.2C>UNF&B+3!@)W"AV&7-54;+P;S4M5=(FK[) M1'U`UFI[9Y`MPI9-W"A,8#^G2]FKBHIEP]/7NI^KR,,,D[B^\1?S5Q6]RXBH MO]?GIZH5W1+C=Z=[NM,5Q*2IY_^W]VW-C>-8FG_%+QO1';&C$757Q+[83KO& M,\;4X)L3DJDBZ2J,*8"-!%[+LM:S(71D.6"6F61Z0Q_JH`3 M$4@[\^_UYG\.0;B'H21M,@!%=-'.%IV*"7E&ON4R-OAP#MW]7K^;-LG_@$^# M"X$#<84N&B=%71@B?FAG<2X&)MC`F<@(>'U6Z4,QAG``$5'DHNS*U^N_#U90 M&8&:G9A!*/#VX_0P5#G\%N,3L>6R[,%G<$P!$P=RCT,5OI0@%,6Y:6?'Y3FO M46Q^F!Y-\TRR6U%%/*,`*_2"W$]KC0(;-I*W0*DEL!W/,"].B5/#[+ M4D?$:>V,T#D%XD$8>-)7XW3)ES12KH9VY/R8?`-F*VLH00;0Z!M/D&$PM]P" MJ2.NJF^U#C(BW-D"&=[YTD*`Z+[5_!@9%G`#$=%!?1MT!3IP;?#)$?6TA,9T M!IA(H\[(U#PG<<"8F`VZEV*U>LX"\MF*BN7=_4;NVL)G27K=:<<5ECD>52Z& MG(@E#V>70:0P8C\'E]D8+I6W^(!4H1(O9@F7E*UW(W]1"JV[*4B(8T/]-!CL MQE6A!(?HR5OJ9;#AQ-A_BLF09;"LXL.A+!]XA$\(L=1KJ^$YU*5CF9B5L7+H M(-*VDJ=9IN")65J[4THM.&'G*DNG1YZ@QH#P<8X#F^4)D$V0CHWZAR)#? MG\C]X(E$R4()Z;_OG><<-'GV#R-![.PQZ+ M*FJKS-20^`9F$P7+06#*4L?'JP2_JB^_``6$VH=@/KE\(RK_[CZXJP/836\^)^FO;FZL_'7CE MD%'?[\RW@3$I6^AYE7/2K@K:R1-4[=I3D=!/D2O$%[R"D[KLDN?02?LJJ*M, M<+4KT@42/Z,WBPAJ^]_,/1[\HJQ0&*_66,VKH+02L5LL8,&MLUO`S;H M]W^C(QY]605(,:6=M:^.UO(%;[&&!(\#X,$E3=Q;WMK<_0N9;KQ63*>2-)?7 MA0K*XQ"_Q6(.`CM<(L$]_HLW&`UEK98Y/:B@O7+A6RR^(*R\8*^.))"U;N;V MH9X"V0"T6"^!>]N[MW;(O<7KQIOCDK5?UM+):%T%M14+W6+)`OYS2I&[M[&4 M=<;;,&B MDJIM`F\X'&VGE;P4R,THT'3U%QV.3EXQ'#?XNS^I``*!!B)M2YEJ]91Q^DA: M`9+.U*_/^A;4GL>&P9K''_3E-8928+Y^!'?QLQ\*3\]'?#Q!7N@H$NM^M&36 M&I;C!L'LLOH$#1L*6GVP0TA(T&;H`>"MMH_(\Q!*T$_1F,3JRPL+WJFC\YG^KUIN5?4>?3J*X86_Y%BR3G;R:_ICUF_%9[P<6O)"+V8 M&,82T+^NJ.?JTY_5:D+)Y0@P9U!AUU*FKYBRHEG,#/AR\,_.>=MTMZ#';46-H;;>MA8E>=PTC)N M"1^_KC>?)"H/4,K"`L"@:/61K(*+7J.FYVL4R;?N73V91^*8R[D.T=^<_43< M%1/?\)*1)'O0:`&7^I'=9PWGS)/V$KK-Q\SX7P@AY,YB7J7$3[CE`%ST=,L< MW%^L-]O:6FL3GPFNUVOG8).GF:LG9V>M4^5Y2R9@JI6DD?,VA&=DMJF8`&-F M5F=)43*YW5:?F(4`I;:%V60&F&B6:Q!2YJV`ZN*0#'&(+GDJ&\/,5":/Y?]! MDYU>I;.=\LYA\O-,JM3*DY>^VM^<-Y=$YBQF/CQVUIYF[ MJUO3>[^ZWSF_*D0_I1LB[9!F9`1`E;0;4VG?P_//3W@9C[[CX%S/')[TY_5F%RGS:44CJS MOJFLV`G)[^H8$`/VV!83T;3$=Q>6M!Q':-WIM$4]X:S"5PQGZ*N)1FJ!325 MF*`Y`;GHR3@^GXRA8<&[>D9K9'T*F)BC7V9_*#PUDR:2)7\0LORW3M2S3:?7Y?(9&Y/U$:'KJXBB0 M0):G38G.7QPJB*:@L+07/>.6YS/N*1H2]<@.8K0"NS/GW(L;P(M?*L2K^@TS MD_N)J#*5_RD(?(=+T9?;=XW;)K-=YM8PF\V!ZQ+RC$/.;510D_D%DWC0NN1I M;62.Q4$96>H7]K0S>4W"R:_2/Q*>PBPC: MIV>_)PK78D"T#D@!]H*7AE9WI6S)2>!N+&K?WQ!OFGM/%Z_T72S6&&TT=4VW6388/68 M+!HR%R8W7+*2YU6/#@Q:K6/,.O>4_8KV/Y`[F(U'S#0W.:?LO';DQ%$5`)@8 MH3@$43MCWB-Z,W>!K#1MIC&6%4EZUK*DZT[Q:$\#1L^5I[8F;@Z>9>/+6*JL M-)5Q;@Q+-%)]U\OIL_K49C5(_NDB%&IC;I0M1G+%.>E="@EY%1614003Q2EJ M?4/^+\?]Z<7KW'3(6B]R%NSSWX.IHYARL6**Q%%<$UFA'^-,XO,)W)V_J&.I MR\83TLJ-.=?(PNY3"#4YAXB>7W!.3V@OE- M;&V3K#LN#-3.^%PN`LC:74^-7)*L?MEX%7JW/I)%]N;X1`'#8DV7<%NPP$A` M6%N@PSSF\H*EZPY$_,:LC66ZQY4;V.B_(O_=V02AD0C='O:''5;`)_IV("?1 MU?:LD-#U;O?JFK9GKHGXI)[0'-"%2?9PVZ(A*.PM+KR@7$W;)F^QT,[.VD2& MRK2%).37=J3R@>PT!3EE6Y5R-0';,P M:IW]==\K1\*Q[%?_B/[%^TY9&)+?QK<1CR[\?^2@^6GNR/I-VS^F_.JF M]H-1V. M`2,VA,?3%HOJ`==B83G8;6C_85HNK33MXMO&A^.9N]7VT;'?'JU/M$GCD8[` MG`(&'E094FO;5UWX6BQX!WR\"2-XL\+/`5,4YW7;WO&&`X86Z^:!'CO?-F!RXKYRA,IP;.H#V*B('38AU`4))\]]!J>^?YUIZD'1X8\Q%@!JG3SMI2 M?8'(H9:')(>-3EIF)]9;?81/:7@7Q4/#!RIR`XQ/Y[,Q9'2H^(C:XDM=\.(C MJ&:DNG6HY&Z0:M'R?M[BCBR?_&LP6P+FU"GHN#4+/1\6;=8;!>7"G>G:&"_O M";ETNIR?MQ9SP(QM)9VWQ0D!3-HL70K*B^O-)W)]R\,XT"RLYQA,(>VN)9VW MQ0L!3-HL@0KK)K?=WI@[4O;BY1TA/U@M\>F;OL4'@&2N;./A$(XKX@-JBSXU MH6NS.BLHI;ZA7RDT7>RAQ?G.($ZCE(_HRBF/:,#@S M`&^]$H?:VG48"FY=G982Y\SS&P')7+(F%DAK=_#1)H/-?`:8YKK:J-IF71T0 M.^SJ5#\]SRB;SK9TN_H+66_O&-.K:WQC,=_051#@\T_AC#V%.UG42]A)T$?= M##[E%`/Q](;[PX8E7L\OXB%\A#%1)S/ ME-#U>[J$B]R6.]:&%IN"N!#9B+?N-R]DQ4O2ILWF<&ET\GIM2_L\**@=Z%*3 MM8]QP,=T"N>&)&N0U1?6FB/`IUO,K,%T8<"]H$L9HIR)!,6IV"PJ6QNZWB?8 M0'TS]U'&IND4+DE86>8X&\1JTU[0.NY4J M-&?,`$OK\HVA^MKZ#?F!I^RCXWG7G_AF3:TD3BJ'?I@#/;"FQ$?D\1SN`%AQ M4%)F3%6E)Z\FM0'5]7AR9LXYS0VS.OB>;]H;C'UHKTLL4O1XF%21&\_@LA/* M&:,23)0/=X?-I#(7^D47%WJF<7RP"*LK-B(2[;*-J;$XGQJE8'0F[A7/[1]. M':Z'LQ\+OU@VQH2P4R6YP`"D,Q&MM=F0L6@V3 M2F*PZ7I8KPOK4H&EJDF[372>P0O+9*D``#+/?M*X(+Y:LV#MS*W!=WQSQYQR M_/D$85Q.)+WY<1JNU;8_RWY85?$%1.RQ7A-VLC2CMO^/9%LBB)&A0=-M+8S" M<_Y\/(G3YY@19^3?!AW]9_ON]XVZ113__8GU:&V1O/'QW&`*6/I`Y5!7YRLH_!*,; M7>]U7(`%%U^/[JJG'B\$(U"30:W1Z4-93@UTYRK4ZALVR%U@F;M_(=--R#HR%G!E$($'7WWG+1@88TC? ML+Y>?Z'=)_KJV/Z[-U@N1ZV`QC$V*0MAXZ2+5DAY>M'U]B>&T+.SPPV\$?1? M?SD8GS&NU!!S[YV# M2[8CN.PCM89VH;P]UXJN)3/$`*+(X.\.E@O`JN'5QG1)1&7I(69H]Z[Z56L$ M)5?[!.#Q'.X$(#04*7RL*3P'NV33^O)N4]\]M#WL'JTMF8X+.-]MGA%T@W1L MQ#KC5%"]*M4V,_LH1CN"$:FDM(2+PN0Q8Z+J04ZB\9@.I\! M)@\J[%LEQO"C%/-D/NT:3V0\C!C"#R/?R/,2<O2:G(S`-'U],FNH!4#,(%D>''?;5&"'Q%=;>5:9EV]PRW[ MQ[^L#0KK"MX:.C^,+)B-X9)221A@ M0Q.E(+^J%&Q;M-]S$.FKZ?Y$9/QX64B5?@E-&@E6HQ'<<9EO#&VMF^((Z6KZ M3B9&;DWVB/W+<0,K2_$HVE\^^%&*3V'-7\(Y3]??;XG`Y?_@&4?U87MS!$W))&4[S#6'J`+ZZ\8Y" MRARIK-@X\U$%S'1=YJ>])BF&MW/)[`U?3( M[58*NWD4$N?MX`%`\6P/F?L-J?<)Y]>:[4^2UJI=:ADU4!DPZ+KX1*1=V2A, MW3X;CZ83QLS]L?9\JE)C%"J4_"7;@!1E"JPK\8&]4!*UIV#NI3'92B>&`7=X M*.^_^A:1VW;*O\&8S`!3*W.,0`IIJV@Q8J\H2KJN1\^F_8;HECL)O:5`#A!Q M-]5Y39L(5QH\5KA$1ZF.I-"T`.+X,LN63>U%]*ME6_O#/ASV>#2!4\E)5_*4 MDL>FV"J=)Z'BBC%_GP[;`+S;_&Y%,7D2JIUD(\!90V+<TUM?$^N[U8ZS;K7A@[MW]8S6R/HDN`B[ MST9M)$W4=96]=6SR"N%229XM[^0_F6].DUJ/*9KYW*2P>\&V>OWO>G^C+>#)9P#=%GO MU5?&[/$FMDF!.[%G.H5A>JFFXI?:`Z37J6!65LH!0QBQ1]8;0 MC#+EVIYJZY()0XMQ3?Z-DX=,=J)59"H@@L(.\;B2R^L78[M,$;,VTGU?1@%N[B M(#+D=@O.WXP%E@L!73-L?+=_G(B?FL4#8VZ,X!R["WING@.\,.B:VOEZMW-^ MF?AP?N_@$\?AA[\][++K>KRHST=PJYO04)IG2F6D=,TQ480>C$M]Q>VO#@TX M;K+G1I!0WS,UC]Y?#H@4'+[;?^R<(T)>1-C%;&:`3>V<3IN?Q!S2QRM]][)L MUG?SFF7=O!YHS5'B^G9EV:1N%"(07WU!G]8:>?\;_V5]]8^'+P_BN1.3EA_L MJ-VP6=SHP\:JZPL6/+&'%^EEF1N*A]:#-^?S/S?("IB-_W%.:/RGDU:K'[^S M`J=N\2RWB!Q[1%X[4N96$8!).3<.073U=7E$;^8N0"DP@([+MC]>EIVU7)UH M#!U*&)[P)"BC6AF2IVXSY^*H;>Y*%CH\/8)`=W*0]%Z=Z^W6VEFFC[S$]3CU M[20K\`+P7%5[>-7)F33[OR']W-D%W"$5^UW.X9VS! MP4BA/0`ULMG-A+%59CKQ.^Q7Y$\$5O[RHPP6[`E4(O9C_%H^'1IPSN_XQY<=+W96`'P]$R*^WFPXW'0 MBO/CQ00P887H>.3,A>KZCH.Y:@'9G=<=P12JOK/^^>!Y![3YD%GF])R;?GY+RFB> M3U9=G]3*$+P][`\[6@_DVX%82#!0%+!@KMP[[O5N]^J:MH>/]>'\F(\`%Q;) MPU6&A9!JT/4=D!^T)#)I]9[E1A3R$.+3Y,MG%2IQF[S\Z;LR$<*7B'H0I7*L'6X1J$=5]' MQ\/Y^=OHZ@,11P#[[>H1F1XI)4<-3MPOH/'O@Y^_,ASA!)X[@T;B-A,+\=*` M8WU.IS*>!(+RO6'ZO&>BF%UDJL"G-!9VKQBM&]S(SX$QG2_G<%-=QA@E/9MQ MZCS[*B`+W@[?W.L[3,RS#A/914'0+^(,^KI>$&44`7D0`%P63N'9!/5/(T/_ M$"XPDF<$C3HXAT0$$WV.3V@\AT4!.7\"YFN1U&!NQX)CZ>3#,N!4]?W<'Y4 M,)50@@M<5$&%$765:&Q(=7U(Y<;EWCFX,2R`0:OB`^HHT=B`ZOKHR0\+OOY$ ML!A#!3;.>$!=Y1D34%U?)ZOB"Y)#0K4;#V&`T;JXKXKZE30WR^!)6JOF&Z)5UWI1,9WT#3(-RC>6PO@`570\D MURXR5]MG9.[N/(POBJI0#*;C.=RI(Z_75LG``X6N5VT*%::^%609^(+%QU<^ M8V;`W:597;:J_U(,=#TLGKW^O2)W3XS[(];\SWFK8#31OBX+1+H0N^Q7Q_;? M=\?P`$<18)GX0.WIV3O]CTR:_!E22/G0Q+4QH` ME&,3+.U4N01UD:`Q<4I>C]5^G`]&'PN<#!^NI@*S2U7T6("$VJ_ZN;*GTD-/ M#`.N.#C'`&"57"1H:=U$-D.4F;O\$?DBWGFEJ+`A50:5.O8JF*6MOKT*5M/\ MX+2^VM4/%UAD4ZFMG3VZ>C5_BX<*!+^E/ZT9)A"WE(PM<3&=`@:<%G0LPR_X M;KM%:^*H&/?S;/KH&:T=>TVCH;":LF[L<[B$IG6&)F6N"FDZZTQ<$U!=C;0) M0%_"7C`RP4J&]ZY'R_R!P?$M1LS$8@@8S5UM5"KPK#J,';8GU`\]6;!R=:8W M&.%TG/$.4S?D)*/1;\B/&6&,@URKDQ'$/"CJNOHNDVF51$D&\R%*"SV8S\>C M!N7*CD#*7!9471QX+`B0^D\WRV!6V.@-;WH;@5!T'@!AHM*;H?X?KN-Y:8G@ M-K7BOIOC>S;.GAL47=\V4@BD]NH4`@NX@W5QWVK0H@24#L?1UU_]0!R]&EK] M4GHE7BGSV7C:G$BGG3='](R#F@`LW3FCB_FE92!(;%MX*[@U7?>X==Q?IKOQ M,!QSN%2;`@.!84S)@2"7,WR`7<`&&IE.?]_B_[;\$RC^0#9&:7=S\"P;>1B9 M^;!!*G&-22U6"<.H_E5$'L&BOX5^E;?.GOQ_H!1[O%_43$NG>]7KL'<^<5U=0B>T`C5PA)XU6=G#7@U]62SWE= M`S?H5;W$"@B5^\2.%Z?)I&DIQ+QJ;7X^LX'G?K'U*H&S.W?HPVQ*[U@I1VP1H\GKE(#8S@'=/F1.E:Y!`68UQD^2]>0^D=XJ9PF MB"#B:H5UO4LY_Q!,)G"6%\'1=)V77"CK:H+.P>3VW;3?T(/-XS2$83+@DB'4 M'V#7^5E5%[K>;P%4`>(;T/#15`0KS)/98M&TY*I.Q(SO!`]JW;$89)PFZCLV M+[..S4_1H*Y,>W-UZ^SWCGU%"Y@(NSG'3>%-.6B(ME/7Y?EV9WJD]!UIZS$. M:%K.9F#S@-ECC4":HK*-P;\QW6_DKBV/EE0=,HU+>>5CA5I7C2'% MXNMZ&2F$)*K-/9B-EDN!1$)NUR[M5B,8W](M^1(]D([@W?;Y!J,85-CJZ!GL5 M[]A1.?47Y'Z2PF'TU@M8DU-H,*H1IQBM^,:C&8'2`(;9KY;S"5AZI&QWU:T# M*=-AF*K-&(['<$,_[TXZ@7/PC]A;**_:&;F23"-T^#='*G:8J6H^A$O'5=!Q M';.4B9<9#$E:>4&*M.4,4):\;J4044A%R8+*@83:U"S<0<#70#$C*8@.RP!H M/0TV;U59NW=,SOS@Z/T2/Q$/[QF^,GSHB3Y0+X9I#;=_6%-7X8 MI!V$=[^#_XYA_S>Q%4R,$9R%I;AS.?-34&=)=DYN7'2US*<./QGY9XLY7*QL M0<>M&>AG,Z584/>4#H:G_/B+XZ^)YOVB1;/Y9_!G>F*.I9+3;D0**U@;T< M-Z![?.W3LR1:9._S?!?(D!7S[F8&-X;G_HU4X/_X07*B7Z6SB(AF":?MT&;2 MK=1,&'Y-XA3C1/SC"9R!]J2G&B8RLJCB6A*+(=R\DS5,*9---I$8&ZL\9:@] M)TL%S9,S,4)/%E.XTF+UQR?;9B][FG+O#4*:Z,Y[`#RR>7OSQ%9F8F M]ZZ9[B+MQ9C$9WK>81_\+5N-!3#KBMS!REG.`+A5M(E*TDUW0H"J5LJYVW_L MG"-"H7=3CIYV5.TT"H0$5;[9Y#TA\)*B9Y^3(C`SP"4`:MP=(CFDQG0U]2;H M?;?=&`XV=&'P[]FJ,!N/A6)ZZG;8(4+*@%1;@W+)83.]-UV3DFY8YNQ^Q"PQ MW\P]NWR`'6*J%!WHZDI1"M.9.\%W&^.0PHX8"?&%*8KA>7+QYO1,U)>&<3EN MXG``)4#WJ2Y7A[IZD93!^(P\'T/CAYY7WVW+]P*C>>[R,1FVQGO!T7:>Y'6T MHZN_2WJ/"Z,$)LLYI%/Z>7_-T$K*^^%)7%`N:&H;\\*P_'#8T_$$3MS1\(T"0LM+_%,[=Q'9OB!NLF\.I=W3H'1UZ1X=\ MND4Y(G-D_\ORWQ_L#3[\;`[F+@,#AN:5+!BK;?(E"K8Q-N`")V'&7'W*9IHC M(Z`/_&3_?[<^7IT[&R^LQY`<4\.8@X$C.!@Y3@X-D2B:LC4`5WLV]BXVTK;) MWAFDR\X@;1B&6IF?K=AU&IB?P%L":`'!%LX5S<_CW"I8-5_W$+5$.Z^C.FXE9OS0_+#X\V7EA: MF:1ONS_X!Q>1Z&9:,66V6!A@M!4>CO*TK`6P!B=&N:OI5_.WM3_L2?$2$A^$ M#]FOR-U3ASA6T'F>CZ'<[I7G("3]-RZ4I1,AF,U+PZ%1-&GUGA`3M:NLJSL04BSZ:`*9Q9W;: M4?Z=8*6M8[?4J4=81M_Z M[Y[H`\,*_\=N:_OIIV[JPT!WZX;$D/Y MV="*/J/9T5O<(C3I__R)5YRXNH=!KBESN`+F,H>J+\O+]*)K/`[8)AF`>.^X MX9_(]PR\JO^Z](G<'XZ$F1EG%%[,C*:=LZ4F3!84[Y+S.O81QI<58.?M$PLTF5B@C;+#`$[^D8-Y`D<3+]E5QB:90W)B(*IZ]N?#KJN7KR2$@"\C M8,1D8O+=]M#Z0`.^;'Q[\RU\:2!%7?Z+5GF)=Q<\:/ZMEZ?-5J92F4*CJ20, MBMHG[>OUVCG@O>D9K9'U2:Z%3P=W_8YQNWYS4;!OW9)O(!=WYA]#`1?&=,** M'L_1>K5>E.:!!.!:SP%4R(P;U]J\H4?'M)EB3!8LZTN._HO:4EK+W""H?7N* MW@W25P)6@I$<]9W]7(K&:J=$.7\38Y=<37V$R>H_FS[-'V`HF"R*=_RJ^:G*"\.HI$']GYDEH$A*WQ''KC\=<@7= M87AB')M(A0@FP67-!0XM]AF$!'#\0HPS^%X>H3AJ.K6*Q/%?YDS(U:"N$7L4 MHHQI*HOB#Q$421XR8V!,9\R\;Q(G`,C`N\%\>)VUZ,[9QM+?!_?TP3U]<$_G M@WMDO!R-9;\<16$133T=1?WU;T?]VU'_=M2_'?5O1XI8J!5XX>C?COJWH_[M MJ'\[ZM^.^K>C_NVH?SOJWXZ4F`W]VU'79T+_=M2_'76#^8V]'5U*IM[SQY4F MEVV1MZ.&C%@:U(V6],J6G7\08.MZ[>B3,DE,RM3E![EYQ0>Y'=4=_D[P_9O, M]P$>Y*(^V5^L^R*7;HO&_Y'F/=^+5QYC.)V#)<$MZ[WZ)I3`QIPVY*1A>V@P MG8_@4OSRC4'*XB"NQMC(+`Q49W8'X32]7#G)0\#POU;;\ZSC%//DU&S,C99+ MY_`/MOI4X^8>5!'A^DM(V?0")T:J@#`WEIV9AQ!%'TK!?D8?CNL3R,.C#L:< M%7ZOTF0\'W/U.?D'LI%K[O"![WJSMVR+L,>W/E&XG(?'NM%X"N>(PC4$A69G M.6&B22H,;NMGYK(,U0A_]QW+\P5]HIWS06X.I\),QLP<:=+R5)<-H),\$016 M&=>'$JN.'!AOC@F00<;7F<'*XR;;V`,S>LG..DU!+%2,I];,4'L)E(U\9%$S MX)+[@PQ921KG@)FU@,+/&K59#'5+4?C$+'9]58RY@/I2_"S11TPUL9)EZ-?Z M\B7#=K^H9KO_;KLQ1J=?"P_D\DWWZ2X9-M6ZIGL=WXZK5(5,?T1X'WL1.#%EJB+ MAZ0U=<\AU]4+"1Q'S%*Z"(Q9.U);Y"6#TIN^&=AU]:"&1O+>.=`DU..1.OPE M8]*:OAG0M?9[+E?`4O>#/%=Y]\%B,1J"P0$V["9GZE+&3!561HMY^05G)Y'L M9';*,$M,JIDE@L0G5Z:]B9)Z7%VO?>L3`R??(!%TEI15C7KJTWJ`^-+V:3WZ MM!Y]6H\^K4>?UD.=]R@%D.W3>G1X9LK%)DQ[MSKXGH^/@);]]NSL=O>.2SXD MY_F9>G@5CKD;\:J@JM+U?:,N;C17(G5R3O/3==:HLUPN'KCWEN16GZ_-( M[Z[2)_AMBSTU_(>GLG!LQ/Y)IOZ.XW6AYY<:TT3J$QGZJ++ M*4:[FTU%%@.FD/C=$DCA%W;5 MY,?S[O>'Y=(?\8/:HE%6LC@7/97JJ%Y7Q\#:H-X[[A99/E$A+Z@3A7C[54?V%N2J*+%(!9+R0CH:BYU)UM7?'K;#9Y[22ATCEK9RBC\;0 M('X[T'PLF'JS92<`#`:LQ*K"S44`PPM+;^&:,52^TF@K-M_3*_^DM\F>8Z\]:AUEXY&:E(>M7V2H9Y@5:E4!A"QI"[L&XD8,I: M.$IUI[X]=1FL'#9Z(TE1FUL[&%8``EV0#UU-VC.&?)FT+]6=^F;/RK0GH6`/ MGG=`FR\'%R,>B$_A\M(EMZ.;-T$&0P/(:N$1=92T-9%7WW38UE)<=LU4W8]" MB6-.NX^^.#ZAW/PPS0+7CK/@B<_OT*J7]IM M].@6)USP:N=\+(FY"$Z9UP?_'2O[WVCS';?KII8"0BO,OY/GMF="S"@08SYK M+;R\WMAEGZ@JCR;(&;V8`\;IRQ]P(U'ILLE9?+22ID"U]\H:PF=%?TQ%$\Z; M#FJK.^9+Y3"G&EL_$/0QEOSB\<98RJ/C!:URR9D:\`XI?\"`1)1\V`%9U+): MNR#*9E?T!ATU&MF8&\#0^87<<&1[RZ?VLZ9]7N0,O>V50(B?,"><`EU>EA=, M10"_?WR<`SAO.FY!SM#[R5"D2_4=.Q28#,&#RFJ;>F,)37=T89ET8U[D2]%/ M$4X-J^\/4F.V9`W7U;#,8E@4S'&#WBS;QM^],7%S:X25/9U"AYPJ(FIWYYTB M`)YPI3-/W"IL9>$GQ,J36N@:#TV5+D5WIU3#&NY,FA&EM[)G1(Q.^.-;QZ:F MVH.Y>T7N?H17IIG!J@;3Q5TL5\KNSK;VL3MAB/I.G0K,QNR*5G18((>#V1#8 M%MJ2:/V\J\.%<++-M9QL0,\IZI\)!1[!F.@%R[F-0EEWMY<$[]R\G)3++DE>D\/C7'54X6WI=;<*!R*3H94IHU@M?H7YNM+\ZG@%ZX` MLA=6FN_N[P,6XL'&IX\#A6WEOR/W]=VTH\BUDG21TZ&"J?+J2=7"`EDZX+@T M]YD-E.8#^V+ZZ-ZTW#_-W8$FH9VJ6$1(HHSMQO]+GS.U5W4P^G3&,-AL&D5) M#%`KTZ)^BV9A98D-LB,#IO!6YJ(I?BNMG_2,R4Q5GL4;)9O:>/34&S<_21LC!5:^Z.V M>9%4*VF??O>(2K?GCBGETHPO\K(S@M&G,]$N$&5"*Z.=ROC,A?>RBS=^$2&U MF*\-GG`J$TA7[ZH&5L;3!+K34:>?+]I-\LP_SCB)\&AA=!IP%9)"R^)Z@\<1 MEO[[!Q\`[2XZ.J\47\A.[?*T9.2P@W"?BM'E56S1W")6H/O./+G@0^4/IP,' ML8[=C;JR?(7WC.1!@][^NXAX1I(N+V+-WS1S&-!?)\_P#()G@KI*Z95_JF#9 M4M98^UG!I<7^I598<_0B%SR[T1.EGZ[Y\SN>*QU#K'/LJ-C`.`J4%6YYP..F,SS]^<]50< M]]-R9TR&7[U%9T,EP`4:$PJZ;V5:DUMODAK)U M1M3-GS(V1N?94XCGRQ5U?;GZBDSR1XKOU3_H?.!.AQ([T*0;"9JHG.R**>JU_3XE:O/0_Y'F;HHV7^L'9X2T->B-MF93^C]<$E1>;Q%_!) MQ8W^$W/="B!]Q2#>X!9_#I:C$2M21C(*TL8K97$0HT4TR6'!U^#$6$S98K`H M.M]MYX>'W$\"TH/]"Z<&8^V'MQ%]TZ6(0*>;1;,C*?RHI&5A9[]5WQMRF!]/%%&Z#R^U63JHN M86W%*6MXX-!^R[DYIN;.O8O^/B![?:19?(S%8@YVO>$8@(0S(*OI\*)B+(T& MI,L?@-SM3D2-F5V/#Z76[V6\A([_^5\6 MMJ=8=>-F"9X[%-E4%U)P$=NYP.L,[Z/#Z_%V9WI>A$8C2WBV:PDLKW\8/Q]8 MK-P17#9%\.'+GDT\M`&X*)7KIB,3+[V>Q`B$9DUC.9PUNP:?C4`N642.4X7K M;@%.'=%Z70,7(7H#)Y&ZPY3+'_F@95C&=Q!6AF1J0<=YL%(F\2W8%'V,W]^- MY:2!LX*,H79NJLK63XN>_QRT_()ZRA('EVMC5"(T;")`T:V8[`CIX"I([/6%./3 MD0TM)<0H$:*!"T:V8]65S,!'[>V!)<0X$6+4J)+'W5`R`Y\6HZ!:.YHJZY:B MWM&T`+S29T'&@Z*NKX,I8(N`&"TG<-YA?&/H$K/$4>VPWTA]GT/8W:ZJSZ$4 M!R20.W'FVMV1JXL$GRLJ^6@(6*-/]FA5X!H`\!VY2-67/%GN1\,@W'@R49QW M8JOORS_/=.S=]JU]WRV5X;&FR`9Y-*8SAI`4.:853.(%=&QZ"%.KO+4 M/PXO@^.*C=Y,'VV>JB3#`]6:ZL[:+:XA.2S\P[3L1\?S'NSU[K`AN5'N3-?& M7_,&R\F"5;:^W65%6`SUEYI\=_HF5:S]70D*3!K^2R(`7?2.;,_ZQ,VMG3TB M`0P-!'\U+58_GZI10->\:I+!?3JXZW?30]Z+N0OR=9GV&H5%F*CM>["<#N%2 MKS4N3C^?Q%2N:YXVR:"^NJ;MX=%ZWY!/MOD&`G#E#[R?&WEJ[$Q6H_9">;/* M@DD'IL?UD,]*`8S@99F8LBG2X)77F8R.Q=G0&M1;SN,(P_NW.!#D8EZ3LD17 M_44)R,^B.>X!*4WMURANIU16B/K"&,*EO*\S,BD4K.I_(NSO6P*M^@\:C?CW M+!7W[ZD@(SY,S.;3EH1K8XXLS^>(`#[=,:T[OKF3G+YFG$U?\XQ\*SC<7I'L M=\)I:Y+?DY_7S5=SDKS/WB2-,]A@#*=P[N("`ZD^K9,DE%]"9N0D+R3WC@=[ M8WU:FX.Y>W)PQ_&`;I"-ME:8.F\PF8WA0)$_7BFK1RW29!."0NA"[0N'!(F3 M,ZLQ-N#LFS)'6GW>XE'@1O`@;-^U?AS((,CB=[?_V#E'Y!+:D7ZQ.MUC^DO7 M>^=@^X/Y8@3W%EEO;%+F(RR=DG.Q+"7H^HJ1@]!7\[>U/^RO;1O#G_[0>T)N M"!_"_USC@0]FX^F8]<"74TI&0I?=IV!E@'6]HI5,U:^FCX=EOYU\'L"SVM(/ M*4J+VC3D[[#[)*P(;G>N1TU1$.\4<]`#3<5Q701%T^#KZK3S@@4UL2S?;>\# MK:VMA391_OGI=`QXF$-5K/0RX-2>?2`[*E#>G(9M*2JQ#$I-RBQ*I6#SK4_G2W'AZMWZS*S_0C++ MOI"\'#X^`M]7D8,)3XI*<:!\=&JCX50('<2P];I6Q$ MNCTE@6S$U:#QA5>#+L2"R6VE'K1P2Z?OH]<-/?(4#U'P+[[H) M@$^NM4:$V4M(%VS.8;0W[X51TO4QBH;+Q)-EY3Y;;^_^W6_DKBT/41B2F11^ MZ@UF\QE<-F:ZL4@YB1[ M1>X^_AL]1+)<>7..Q>4M*K2[YI;RS[;6#, MQU.X2LE%7;?#"6XP0C;,=6/#@XU_@#S_R3P20^7MP25C"9(5KX/_&!B&,87; M-CA&T`XW1*$)*;+0C2)/IH4WR/^V[$V$R,`83P$3S64[;(<`)8+'2X)F)X)( MV+O?Y,D4$=@PST=S.(4S>FQWRN>)'JI\J=L4+P-JT0F#_XOOK'\&1_BN?]U7O_2MHZ>8=<#AN2`.!EMDP=;(,W6WRUGV%3SW3;EW?'I9=5 M(E;L)CZ>L*J,Y=W+BYL#6'J*O`'B6[F`D&JKZZNSL;;6FF)#[),V'MQW?(I8 M'Z@';OS@\LWQ44HX5NQ+C@;%>VA)J36A4-OCA4,0EH]=CDX;TA_?1A#I3T!$ MM>?DC6MMWM"C8]ID^.%-/B4%RWDP1U$%3;6D)5[AU)Y.I7(W\%HO>$QARO'Z M"S=TQ/^[^T1GT\9+*87E<)3#N/(6FR%>YIHL*&K(/]R6XM<#P5OSW=\'DGK3 MV7\X-AY$A-I\#A?.RNRR.F=Q0WO'IC>\J([V<`PW^DQW4OC+J8;DP%D@L]J[ M&2WZ\&*]V?1PA>>J8Z]-[YUF[#;7_NGA;#Q;P)4@%AE)#8-.ZC'VU<$KC7?8 M^;BW>\=]0>ZGM3Y9;D1B?WD;ED+0>FH["681!D-M0A?(=$LJ,NQVX14B?*=+ M"-%:[11&RRNG^:.Q*L%8JU,*;, ME2U'^R)M*Z3SRI"TZ+,I90M+11QC<%CID)K:PF0DT2OOA:9Q76W)K+:PYBBM M_K`^D6T,C/%H"??P7F=H#4V4(BY$$T4:PKKZQU_O'7P_^W>X19#;'@G\)K$> M3R[:6X?]8#H'?,TO[5XA+@E!I:MS?"4H07)R-[-$?T$8SK45YB3XV-%TFM?V M)DV&P6(8F#-`Y.0907NS)).'7!2P[GC\9Y*1EUA//'^U_<-Q-L1_,+J$O3B[ M31JA[0Q MTP(1ES9CVI(O('-$[U?;E\,.S-I;I'BD$+DU+,YH*.$+E MMZ22[OG$C;4]&^FE[:(E-(Z?FXV6RZ6`XGD:58D#PB#$=!A=SAZ2`#$>#EE% M1\38<-*F^F3(AR#FPEBOC8`#SKPDB^/9$B[8JOJXFF(9-RS\C^%LWQ.UW<0X MD`K2K([G0SCO5=Y1-$6.')'YJ,*R$\1,7Q MIBT:-45*\YSYQWM1"0RXC;6P:T78SPU/K.7F3^A"Q;43*WST?(Y!06$=SN@E M/0505#IF#AU MSQVB2>2)1A%1-M94XMW,NX:,V:",4%7'(/:<.4L;3G=)S7 M;YH5TV4#<[#J^,`FHR1"<5=7$M*$,O-3`63SJEMU95.LS0<8#YQF9J9<;,+$ M6W\$11WLP(3\A^MXY`UQ-`?T5Y(_8CD+&P#+:J]HG%KJ3#D5<2\H>5J!\25H M<>X+%6%]1H&70'2N#:A$/$S@(K0D#%"UJJ!%UCO^2N@"=506@XNLC; M/]Q0E&=K4VKH3F16FS2^=6S?-=<^7AE(] M?C2!JT<%&)'0/-M.L-(U$JSN1$M5OGC`D\RR/6M-?94P>N,IRTU+C8MF[K@[ M2E;9&M,UWB&]/Z`-2844Y$7":&3S84T-_H1!W`TW0[":->K/?#XJ@=85NV/5 MYR'@=0WB,4X*$O_W@&F`]9BNIA<6CL4K"&#V57D#E3P':S.HZILEIRHZ8T&L M?'CA@^O6]-[O=\ZON^T6K7UB91TOX+(@U!R=+APM`EW7Y%FB&$7^+,E&W,13 MKJM3,AUWMLPL^MZWI*>_Z#=GK8Y+.<3CC/[`R&VE%O67LCRNK ME8JMC-I*(1)SLXT0*$U:K0P`[&61*)J*;>ZB;>'!WCKN/@#JAT?-=/C.R:QO M(FG]XQN$G)E056`!;_N,QW*+YOF&T0%QJE%F"H'#=UJA)P#"&"W._(;:,`$I MP*.*/J@Q>YK/[A"`]G_^,X,9/M3_##YC?A2U9/ED%)/A=&A<_<<526&Z<[R# MB_!_T!H=5V&MF*M_1'A=.=O3C_YY]8\OR#>MG??/:(`9V7ZX>,M:._O@8$U_ M'OXZ44/ZKV&#IP*CWSZR-_@B+UHI)KG@&*/@F`&4FY/9:74C31H1/.KER``; M>[HK*;L@MP:B^9@K;'<,&6(Y0&[WAV\E&'GW!"@%+9>^C8[\1]X"SU6>T,,!D8'79"'TS3JRE MPG?&=ZUFM=[X&-Q4L=N:D2T=J34L1M@<)0@&6+=]@:NT5C:@-+&U$E!S3.F5 M">G)55]R-8JOEEA@.(L5NT]IRN,1AZV_C+*[-/7ZTN:=*VVN2]'7ZSTU7ES; MFV?DD9>`35#LFETW>6%,9@+YSH0:!R`A3RG8Z@!TYA@J^&+\79\,7?H^LU%]*4@M;0(U`3E;+8EU541 M6IG'0J8:^^KH&E9'E_%"-2E[H:+'B:O98#3]7U:(3+'4]?I^BD;Z M2'`@1[?5-O#<3+[BD949KH23^'BZPC11;'5-5I"+2N+11S,W&(/Y>`E9ZI-S M&!WD5Q&2NJ8-N-V9GK?:_F42UUE_Y3Y;;^]^--&2(+-;<[=#FYMC^#TO_*(W MF,UG<*M:S<&I2T&)J.N:J(`)T4F.FOC#$UP`+\051M0Q"@K@JVL-W,+B3-_0 M+_H1++'-TS%TCDT%$(9D6NJV M.#$7;>+&&?^-/AJP+!DY[R/E+:K+"T$T(GOH4#=61-LT<:^@^W0JY<_`F(^G M<"M+4=?J$H<;L(@RVMG0"S=HXJ.##X#$2X=\C89-?D/^:GOON%MD^09F`X)+G1B(>T$QBGGTU\B]Y0SQN!9,95^E"74K41B[BDG2T_S$>` M0;FW;-->8R1N'8_D2AHO`+.UYG6K+H6X@(HO>YI9#NY,=W=\1A\!!L0N3!R1 MR.O%8#%;P%G=\_M5ERA\6$5^#MK=``O>$V[QM$'D&8$LK7.!A.0\;:I+"&%$ MHLU&NX>4HI,=F2#T='=8^_0S6FF>M;3D9:T7:5Q=ME3'**+-9;V#,#`9+9<" M04MBK7>..#PH1<]($?WQ/1FV.C!_O10H?5EN1K"D]U=/D5,%7SMJLP M6ZH@$_%$N\>,4S^<+VCM(M-#&)8WZQ/9R/.(_TU3[KR,[M7ED1!RT:%7.QOV MJ^L<,(2;S#)+_N"X(;1AE3W3LA\=?"*T3[Y)3:NOYN^!,1\NX*@F<:3JDA)* M'1%_M;-P1S[43Z:UP;".)W`FZW17ZC(H%Y"(`MH9E6.+!3X4I""E=@MC.@*L MIU/0L[H$X84KXHMVAF.R;GIDX<2G2/ON-S&A'RSO/;!Y!3`,1U,XTV!I_^IR M1PRZB$'Z7U*71)+0B]BEW94N M.==]P\H3&%.V_S#D-=HE4",@JVT^YYXS1Q>0@X MVB2`!!,PF)@D;`?P=4QL+.HRK#JFR>E*LP?74TA6KO5F81G(7X/@>H+"'-8@ M5=A]5\A4@ES$G^E@U'C.?&#^1$OUHV7^L'9!#%>8&GHQ!-SPBGI6F35\>$7[ MFG86(&+H>+#_V[(WD>EC8(RG@(D(LAVJRXX2<))=:+'0BA1%;]'E5PR6JW^% MMWN][F>"V"77L^XEV^+T.R0`G!I!(K^Z&>`[2&G_ZC)+#+KHS5:[=`%1V8#` M8#8:#>&\5=-=J,MA` M$-F9V:\AJ=,UMIR`%!%$N[U&!J`@57P4R(P9G&NM=7@LB6](\\D43FZN(2@S MES(ECX01C`-+FJ_MV&@)I%OG$]DFOAP=:`3T*^:,]^[L-H/%R)@)Y%KF:U49 M@I0F!N-`)7'.U-`6GHM%8-1]1FMD?:(`$`'?;X&F.\J5`GP2PJB^J`COUE$= M9OOMQMR1&)LP)?%L.80S*>1VJRYUN)!*>+(@1-&')WWUO;[Z7K,5I)*'R<=4 M_;G`5@>F-$:G[6BN1'JU*^_0U-)$T"!'`%DY'9N882D+)\LIW,PK[+IY57(C M$<_'Y@^DPO/QYOC=MOXF(9;>VK7HL*+EA553"6)VY@RA[;G*@4RLZ.8/DAR* MOC"B*/]DRR50RV- M+]6IR(&OR"1WN0U)*D'.>_1YQ;.\[[;SPT/N)SD4/M@?!_(PAT^$^%<4R/-K M>83:3-<_WCMNG/26A"VD1&,]77&2 MI*Q]W7@BA**_VUZP;$@N%!^W*[M" M/"N5;:B[9=/U[FJ?LTFC9MAF:@H*7!$93! M7-.[7E@[Z,9Q7><7J?IB?N!/_",6?PD862HR M%'4=S"L#JNMI]?2))PKU>L9W:'J1WCPA=TVT](8&\PE@^A7^<:A+KFI8MKBS M-L@L/-FB4([Y9`07Q9S7:U=8P\8I/@IK%DI74(J(>#=@#(/$5R:I271SC"R8 MX1>]P6P^@]OQ:@Y.7<9)1#TDIGX!]GTU\3+"E%83UZY<&!.&N]]X5[<\].1: M:Q1_>#)9&K9#EXRH8S03P#?DG7;UQOIL']QIVNF'*ZIE+V+.AE9AAD-!?$#* M3,%,(I":X(8S4/W2`,)I02@"-Z9'GC"C&'6B%[P8O='GYIMC\I4P<0JM!A[C M]6&Y]#?>@QV`BI$;CV9PM)0_8H5Y"ZR>.-^-?L0NFO'?T"_Z$2UD/UJ`G6/X M!J$,_<2*7[!!C`R*VE4D*,0BSB5%RGTN^6]/7(UVE!],3")Z:&=P[A-[UT[L M;6@7)!'=ZDC<"+W6K0Z^YYLT8]3`F(^GK-S=H_H"7`H4X-(O[?OI\]U7DQ1-\(]?3)\\\DZ:JM&=[E==YO!A%3^( M:_;8>;UW,*#_II`'M1*(*SYYZL7S96\=]H/I'/`<7-J]NKP10D[;HN[G>55C MH*.[PMUO8ODBQ@= MI%41DO%>IUG*XSC,\=KS#OO`QOYL>3_O7832CG&#Y6@(=[?G'86ZI*J"8W+4 MUNP`Q0*#K-5K'VV(-PH&P6#9E.'(E.Z]6R3*PRTBSTRW"J1%(/SI[+!&B"]X M,)>&@,=P_G%TDU#Y6$;4(DZM6N5M+X+CB_5I;9"]"1?I&5PV*]Y1=)-6>3A& MI%H,AC/,*GU(1=\&Z8%Q8,Q&2S@?PJ0C=9F1`T92"6(XQFN*/LI_9(0I/=B6 M'R3^(`8S@T0GS9L-]SH;@;IT$84O#OO6[,#,PB'Q=$IP@+O7%@:&C%D+Z` M&D@!M:%NYYV^,B-L94:\L(RT(DQNB7J`HTNJ*W49D@M(=$72SH]0M.B\?&9P MC$!=PHC"%_%(._="CG+T35&G:VPY`2DBB.:.@H^I(CYSN$?+G$ZE,(1;H+XJ M45_^%WCP??E?T41[9;.W`:5!+D="FF-*KTPN6*F"\V255+M.;E_XN'KAX\5" M087V]7"KU\-=&$U[TO3U<+6OA]N7QNQP:5520CE(BCV!2J;%K;6D(`$1E3E_,W75EW44?TSMRSKV M91W[LHZ75-;Q/E/YEY0%=@]KGV9!2M49&?%O;!6ZD$N.MDOWB:/:"<[$PD6O M1"L[MVPT\R99S!?>YC7A2B4TE3ES]54>:U1YG)94>;Q>T]P)WE7@[$/_^'1P MU^^FAZZNWUQ$D?7JE7R,.DGZB+I(>JA;_C'J@_9[;6\>'=-.=9B8]2<&7-P5 M[R"JG]1?77.#DA:]_T([,K%?S%WDW&?,EG,X"4O[E[)D5E9F-+G%8-+U%?D% M[R06*>1[[7F()HB+_Y+:BZY]5K#==X_4!;[S?&N/E]?X&U&R%1I[9\P,P.A8 MX-&K0=0F5=1B$<6NT?PDGP(Y%;&<0?/RT\(.1UO>YF*N:U6L9_01A/AXJ^W* M?T?NJEAOISA=>UI!"A M=9(?:N5:;Q:6@?PU.+*29%%SV&1NA=VK00LAE'2M`J1+XO3:;.!+DJY^#9I: M2T5HRT.;Y/TUK"9`[7YD1BS@0E;$QJ(&;:KCUYGB+[(9E11;"\ODQ.!,1DUM M2@+#Z@C/>%#5MCI,572N;=_:6+N#3]-H8MVLR;]20&&T6T& MBF"L;7T:C>M*2""66`T)[;(E7V(-B=JLJ54O0CO#-5Y8UPAMO'L,,'F:"NU< MJ7>K@3&9`EH!RP>@!FT$@6HQ:*G/`PGRVE":\U$O15]@RO3:'*F3'ET[6_(% MI$<'(4Q9*O2Y;EO*A:9"!R5/>=KSA6YY&R\P[3DHA8S6=P9^`J(U*#6'6Q3.QYFFUV63_DT.]]8DS!HIWR.JWN M`QP[3:_LM./^C#\,(MN"5.:6XAL7\RN6I'4/?#XUO/YR4H-G!5>7J2%NH64U ML"51)A(D]Q6I0QDFV(:=]3O:'(A=ZV3QIRL_W@'N+=NTB6MEHM$@E<1DMES` M9;BI-B@I%!;-LR$!0+47F]-WO)OC=]OZ^X"^(&_M6G1842X+N(V,:PC5Y\!I M\R<)!!9P),_K51J+*RB-_7;+1D1MUJ8<];8\06"IS8>E\IQMM%HO`!HN(NUI MXLM:D*BM\TZG\"J6J$^WP!R^E)G4IUN0%#H?+AC3T&$>A%(G7*8U=V?YS$8&8.:>G$ZKKZVO&'IOBS?$=`39:LOHQWO%C7OLCT(53PUF M4BQID<_21BIGRO`2(!44#8*UVO-$U)P*:@24DAB@-"&&+&M";!\2AU`9FU'C M8`E?^N+IT_R;8,M0B>>XG5\<1.6+O#++;QDXL'O]^6)58/UN'3$9F7UF)9E] M;EQK\X:N"/7J9>\)&B+MU,W1T[FR)QQ2>"GC]+(I*3SI2:V%BK=P(*!K2IV^ M,$M?F*4OS-*&YIC2*W/-T/_13KIJJUV2VKX!,!4=Y)*,3_?X?$L$/,G$>G-\ MVIF!6.0MAS5]]+T>A:BJ9YYU3]'(7Z4C2]:&. MEQ=*#$,)$1-W%:8.:$U+U5=AW7K*%50IBF`B<-3 M/8A7.+55="KWO;F.TE//)R.XL/^\7@%466`>92^$;`PNPYR8#E.F50TV3\A= M$[#?$$8#,/R2?QPJ<(07IQ:M0\T'RWT[D+5OM7TAOE)!-AYSMT.;FR,KU@LN M'V#-P;7#+XF(ZIIEG0D1B9./_T;W7=8:E>>W7=JB0F3(ES1>932+ENQ#3CHFM<^8O[=[P_+#4"E M)_[5-IWHZ]6UWMX0>3^X^T0DJ:#!/@&7E`84ZJ0=-M3'0]^<^-IFX*RP9@AE MW-0NZ?TE)MP4)DF=!)O:I&OU!@8^1BS`.)';;SMXUN'0_?QHSQ#+!J1D'/[3"!%XKXI*F9M2.1/WCU"^2>-T*!N,>V M5<\6/59Y\[YW?<&M5DP3H@6V9BVX\#5BH;BV-X%Q;G7P/=^T-WAO'!CS\10N MZW)1U^V:)TK!B-FPG&C%!G*I\LBM"N%[U=UO'\M]L+QWFKAN&U2C'(ZF<#M% M:?_MW37Y84G(,=>*'-$K831+@OHY](6(E>DVQUK);J4=O7)(I&N%!1:+0V^4 MY7`*9RK([[<="O#AD$SIF58L^`L+@5;;+9$[Z.7\3H2WOKQ@DKO;A*'-;K#*\$^NBU3TO;IZ7M M0(A3]()P:DVZ=]PD@BL56\:NMHF\T<]30\YW(_V)_( M\\E1X\:T?R(7SZ_P83PE&BN],"?)RMK7C4=">+88-"4GO0])IF*Q+(_),#B]I[4T6Y^![ZY*N;*6G!$7--44'0OACM.;73N:+Q1:UTP*T?/WDVEM M!H81%AP"#35T#3&:>&B=0X*E-F5))$XEF`G3@;!9@ MCO,42ZDBM/IJ[%TR>Y?,WB6S=\GLO$OFJ,0EDQ#@BE8A09NK8-OV+?()_5X] M7TRLHO^'7&=EDW^%?:2ZH%^MZX[)K(80DF?9=+V(VM,8M[5^1QBP\PQ)?UG^ M.Z:Y[1\#LI_#F"(^RPLU;Z[7[$_*@B"BP7CRRP2JPRL$#YOPW*L,TG0HD&>L M;G]MLTD.4+KZD$8@80I4GW33H4"5C?H]MLXH26#IZJW*A)9>0Y8SN&?>W%ZK M;]P<'&E.%(EW1WX%%5:GRB"A]HU0RQ`?_>J_%BBFK_]Z(?70A#E04@]-NV/; MJ?076@58F"6"58"U.YB=HI$ZH28/.S09%HF>6\*%&'$/0P7.<**D:_E-36KX MS3>W%0:S'9#R"BWDK MZ+D=/O!"H6MQSC`9V&J;?F:F[D69XG,SN"L/YRA:HD@%B'0MV'E^]UN[B/@Q M;396($TJ:G0^`X[O#C%^XUFD9,74S^^H=U%Y.)+.'%PHD8))T.[RH`75\.I(D%*:C@9VB7G MZ(LXU2=+:1$G0[LT<1=?Q:DF94JJ.!D3W0C3IXGIT\2HXU[7IXE1)7N(5,%Y M?$E;K/TM9/&[.7XC?F0HF'BA/Q`0;UE]MD';,MECW35?294G!;9IOP5#GAB` M>T/<3?,:8DH8*V6Q4%`I?=*:;B>MZ1.<=#C!2:D$#;QQ"BJ0*0='+!5QQQ,* M@6\DL(Q?`4G,NY"HND8V%,'P1I&G`NI8KLH52)#;B8*\ MX`-$U_"';^C7[AC$71)84Y(+U/1D-M*,JC/[3KE`JB<9C>X1:6G#=!W`-RCI MQP6^ZV#V"L467>WC0N)?>H^HL$$QA10!!0J8%C8F63E%/,OF*RL33FTEA<:5 MTSJ[*2D$$E45--6"@G@%4\9TEF^$"$>-+^EPN3U3'4E15H'UY,3\D)5-[?GR MU?QM[0_[<-CCT03.D'?2E3REY+$I4DNNA*TKIFYVJ_%P6I+;BEI4JF6NHK\\ M';I@C=`"0Q#8Q;JB78OMGK9^1YO#+MP)4VYZKQB(&_R-GP-CN@`L'5,^@":, M=EEO-C%<.GP'KS]!)^<3-$C^=Q7''-#RO_X[NB)87ITD`12=OAQY!6O.:HX> M8OK,1DNF$:UZFLCZ,YH7H83(Y&0E4`Q8N`,I$[B>6@2RFQ:`<\&S?#*<#(U: M\YRFH!3XA7A22A[EIG-53*)6&G*7#G`-)?DL`RP1/G1].T=363[:"352Z MAB'4U!CQZXN_Y9;T5U%TM0^;"2F)23^TZ*?00N::LG_@U$MJK`Z`VFMI'%9W)L0C=J3[S3&A.OSJFG#%YG M[JAM.IW^>K5--A-&S44!!TFIGGN^254J+^?!HO9"4K5POOJX4WX]K%@>-CG(J(;"`"P7PB;3>[1N4=$P06*38J+=;0:`FJ MHNPR[9^&&X-!((E5^P'8C:$B[%_48DVL%B$J3=C71E$X=9?>G'.F,N?#QK#B M?AV+IY62Z?.J[;;23LYB9Q`N"1)GF?W>\H+T`2A5*90(4>/X7])\4V>I(J7D M36<19'3-/9.'26CU#=%8;5<'W_/QQ01_A\#EV$D9IFA=$+B1R>FU"]RJ@:.N M=7OSH(J*2.*#F>^].C%JDF-0(\"QIO@LDXD%&UY*]>9@0+()Z+00%5MU$ M07[$#7:!$6SI=:WBFX<"73LCK^!GHHM[QXW*&Q-@6`5)!&E1U$<7F,*-D:[5 M>#M;\UL2,:I5`M>NX!43AO!TEA3_>G6MMS=$H+W[C8]LEH?BGU",1P+Y,NKW MJ#R-JN.G:YG62-B[WQ^6&^B$5K=>;=/UCE,P?2*Z#D^8E9%*7%F%.E&)3/51 MTK9(9Q::HDD6XC(=U6)/60]J4T<('VTK=3)P"?S#7EV36!O^=':'/;TNC`02 M3/.UJC@_RG!(2O-IQHGT8AI53%]M4W:G@3&93."J-I;VKQ)QQ,"*.*/?7=MT M=\=G]&$>]]1@&83\$40'B]D"+I-B?K\JD80/G8@$9^T.^8^!2NO%V2VO?OM8\D/EO<>O.-ZOCF>W.-@A5X,)^,6`^+$,F)DEY5(@@/,A$MM#OI MG@K_8..?8_Q(/>47FNPBY0DR9YOG((A2-`YUJ<.+7D0F[9X73N%(Q\UC\9EU MW2#(D^Y77;+DH1.18Z$;.9AO)Y%3QPN)UJ<1_+?F;H&->@N0=^$GA(7RC]1$RBH% MDG/_XFY8)<940R-:J#2T[T3UKE*)16X/KDN?4893R'TLOV>5",.+4.2\J9U! MYP_3LA\=O,S:"12I`C/?2!HAY)N_!\;0`.0+[S!4XDXEZ"(B:6?)86[6D=<( M?<=-7$?2.W3#92=*1J02O^HB&E)-N^-WGFOD'RZ>C+>.[5E8;JHP\_,0C9,J%M[U;N?\"GSM1P)A4ER-JD0*<12BG4D[C^'X?=FAS1^.L_$P MFM\<&^T_=LX1H1?D?EIKY+UBA#QS3>3[OWBZ^%CN](M8N%T;LS&S(+2D+4K: M0%5B(1#\$5VUNSK%>8*NL=![*H+W;'D_[UV$TEXD@^5HR'I]E%QQI&04*C&M M"G*1C6;40K:EQFET]_L#K7V\!2!WCT%@1O_#T2?=N^JTR4,JHC%T^=/9 M81V0?&7![!D"^OKQCZ,K%,I'+R+3>#`F;+H,,GVQ/JT-LC?A0CR#.T[QCJ(K M1,I#+J)1&PD#X0_N01(?8S9:PKUK)QVIQ(4<\2-U=]'&\W_^,P,@1N)G\!GS MHV@,ED_&/QE.AJ.K_[CZ8GGKG4.J.>'_"."^BO&^,NW-E?^.K@CJ5R>P7_WC M9?V.-H<=NG*VP>=)!-H_K_[Q!?FFM?/^&8F>0>T';F6P=O:!@!R*COH+(DR2 MSL*>3C%&M*88OKYQ.(>0*`3D8GWY1U*JDB81G<_A2A"R.N2:+7DOB-E:M:<= MA-G@)^,98!$GWF%(61>X=)9Z0A1'2)FLNOP.3:$0RZ;=ENJ67Z"-FF&;20V" MN4`B1D83U]RWAP@CRU- M*J?W1\0093IB;10%KM9%[;6D*R$QU=[1@^O^K;/_<&S<5"3Y?,XJ7RDIZ1.K MRQH'Q"195XB^,1S#C3[3G43S6JD:XA-(D9 M,G0YGKVF3^4]6Y.#FE:3Y13NHEO8M12U"@IW&CQ6L#VIO<;UU3?MCE5O;R/PH2WB%/M?Q3M*VX!(W%$6[>PH'(_,85H,M$D2?`61S4&L%TG^ M'U#U3`2(I^>RL;3H%;PHGNS.;!?@G"I;+>56*/ M"%*=J>@NS),29IZ\0%AOD8 M`B$!@*]K9XJMMFRF5H($Z!((*9+^![^ET(RLTGINDI$10;"V5<.Z; MXZ/$0CD3B$T0:AR`A$5JB1_-*P/0F:.P8#3#=]LC.3/0A@T!R38F8&@L;JT9 MI6?6'P$1U79A23\G(#MQ:4TY@0@4=RMNK:4)*B!B9XZ1HC',=$4B!(V*<#S?'J&3&D=II@H/X8@EW+RKLNCH! MXV93)4"^(I/248$:OI0)(DB;3(:1)G2C]L0[S8OX='!)HDS_U?G+M/#),O;E M39U6!#P%A1J72XCF9MVYM5`<2;49\K0SUW3D@7]V+$@D;TH@@7L57ZM=YT0% M[-1V=C\E^7W&SG!B(4V,#HM1U46#JXNNTZ0NJFI?)IY)I;S`9<<`M&_'W50_ ML]$FHKN:`1CUG>I("G<+((YSZ;!E4WOO^6K9I-Y,..SQ:`*GDI.NY"DECTUQ M19T\"1573%`(*!FV`:>8=%<-*B9/0K4MJGTT6A^-UD>C]=%H:O.UCT;KH]$Z M1ME.1:,A^R0N:SIF9;GG>D7M0!Q:KK"Z>CCT<8=E<8?J^^OV<8>*18GT<8?% M<8?MWW<;@XII35,F,JK1:+I\C]@8#U*B]2+P$`U'-09+XT*@X7Z'CZ&9CYJN M]@*V MNMX<\N"@/F-/80*W9X+'O>.&KY(478'[8Y4^ND`9;HPTN(,(D8>X'5H>B<2] M1^@)N6NBI+=@NZAA)BEIO@N4X4%&6Z?OON!YLP7/M:M9W/UL#_1(O-H&RL.[ M!?$"\_%2X'U!MK/'G>.&J,62E>0A9^0\;;9(Z$P0M3`&(9VGRM-9..3^R3R2 M7<$+ZJ!%->EO'<_'$WH\6[`V2SGK8$'/*BU^O`"%%-&N['4`XW?;\KV7PP^2 MM>@'VMP(1X?RU385;3PP)I,)RT0LZ?92UK]* M+!(#*^*,=B\-WP[$-R>9,(%)BZ[,K/Q".3L3NQ65U,TA9Z1C[1X$3@]D]^8: M7>])>MG!?#)B74,@DD@EO:K$"AYD(EIH9_F_,]W=\1E]!,:;><=&;@X&T'RUTP.=KTWL/ M7P_HS!&P?O"VJQ0_JF`1,4-SL^@7M':1Z2$,RYOUB6SD>8/YF!D4`7$@972O M$G.$L(H8H]U+RBD*#Z0B!@;RV?01=?+=I'QUYI,E:S&!H$[1.-3E$"]ZD5N< M=N:Q"(`GT]H,#&,\8:4LE<.7=%$FHQ)]9$E M'"&XAZ$26RIA%S%).RL:=SF2YAYMU*C'P7=OSD$JHHMVUK4_3,M^=#`.]A=\ M)_S$F'^B9#)YWY#_Y"+?_#TPAL84[M#+.PR5^%,)NHA(VME>8AND1YZGXC68 M6B*-Z0APS2GH626Z\`*4&/*;#PUMPSI'/7H91JCQ<"@0[B'4N$JTJ(Y*8IK3 MC"C)\?](`D5O#RX9"P;XFV.O@__`MP)C"O?VPS$"E3@D"EARC=*,.P55EY1U%5XB4AUQ$HV4'UZ3:1;H-8VBPBG1_$`-GJNIVE2@F<>B(*$!!F(& MYQW`-8;VJ"(.D:ZIM?*0B"93E!B#SAR!M`^\[:K'@4+)M[M7ZG3=R:]@U*QZ1, M9R+Q%V`CZ0C?JJ/;F218DLBYLM&KM4?WB+BBAY#$:5EG`AE-A#M0CTI\6.B: M`^O4.33PK;#6X0QZPG?/M?5A[@;SR1PN;23?&-ICCCA&NJ;$NMX[KF_]F\)+ MLL:%/1$TK]?XONE9?I!]-3A`"J0QYF^Y/1Y4E%[;1"5I$+T'>^WL49RT/WK8 M(E9"VT.#&61(F,!`VF-/1;1T3:B4=O=\=.PW\J25AFCU8V>]!28MXOXY@=M^ M!$;2'GNJPJ5K;K[HC(_/;%&2^-5VY;\C-T!T8(SGS'H1^O#R2@-MHX#;!YL^>5GDO8K$:P\,8SB$,^:4==\>.X2`B=G1O0>\VD]> M"^ASBKPGKVSRYODDR,T*(@1,2FLAG9Q^-,T%JFF7-BC-@Z(0[+AFII!\ M:M=T)"=,O*CNR01[Q;\,"X:.%@LXHK'[K,ZWG--QK(LYF"2%/4LA):]^6'?/ M(BRZQ4I:[0[+#*=)5H\@"F2+$JFO7-V**X[:/$(27O_`!TYS[0]&RR&K$KTD MS;&ZK+Z8/+G.!W+]X\OAQ_^@M?_JK-SK3]/:D7`R?--:?="R=O8;[?;F^-7\ M'WS]"G]#X^B#DHZ386#7`1%9SACET)M/X:DDOI+157L^\!QVP7>F2A>0,L5# MS1/61E:`G#)%E`L7$U+JE42AQN?$FV.\%TP,P`,*QP`ZP09!()59%-K&K>ST MH4SQ;;'IDSH:8='A5E&.`4B=/D*"IBOXY-Q;.S=U+8+\-WJ;+O3P%\'?:@KQ_6,L^&M9#Z8.CO`XEKN?LD M+T_"02U)"T$#M4-:6(G+PAF_#.K'P)RN\_NM?O,\K7210/7JW)@[PMB7=X3\ M+Z:/(FO.R)BQK'0Y4UVT?3G6?@$-17.X%A!JK^Y,..CNMIP!FBGS>H53,5.F MPGR#&5*HKWFRQ5>;?*^_<`-'_+^[3Y3*H/?-\5%DZB>%DE@6R+PGMM(6`=14Q+SXL4U, M5+7U%GF2WCI[XOX7PH07P3?J'/B7Y;\_V!L29GTP=S3OS`TQ?T6>/O@R1(YG MJVWRI8#I8V,,.&TAQESC=?F\.3*"9Q2(96!UPM6?C^6TD?KZ8#H=P=X>\7JO/B+,6`Y,@EF'1E`SRGI/X51)? M^$N$[Q0%4P:K:9C>M!']27#".&LRW)JQ%'#666:7$#0L4DL.#[/R=XJ(C_%3 M&Y8`+IPCKU=95YO("?9ZL[$";&\4MZ@2!?)%U34I2&(>S+$FWAPS M%L3K7Z:[26?!?["#3!D#8S8&+$4B=:PMT0X.;UW#O\6MW2%*))85\N)6<5BM M'=DEP*AKLALA<.(,R?@H>HH3J#FI_@B[P#P.<'5-DU)AAEX?_'_$!;*?@Z6,Y-6>M)K@K]B3%J@&F0"T:!^#%+W8'3!^OF@[ZDFNT#R. MN+$5OOD:=;#ZAO:)BH&;C9I.,L-3\,9Q]\C]8KEHC9>5E%L\RX\IQU;':D/* MJE7;8R\N3E,FI=H;TMG`C>D8SC=&937FXZ!V-/=7TS:#]20<^=A8POG8G?>F ME@Z+L&CQI5=.])MA3,YCWQ[1F[F["FNGI-UV2B+>Z.\8/Q,/=7/V>\L/LMW; M>)^S25@XLM<6\I*!QNZ2QG`$^*@L,I3JKEP4NJ^F3VZMY_V\8N1N\)=^#@QC M!B@JUQBDS,R:^HT#_H5!Z[!+5_UY/LW,<^OO@[7!XO/.[_/O"T_LN(58N8O1 M9"E0M2S30/4I]X>#R8(YLT:NG;"%C$>@-A*S$2ESA`>J:"*4BW+!Q)\8DVQX M=V:+$P[O/M_L:H=W5UH384)H&]KS',\[7;/IO1=?0PW`U'>L/EO?A,?SZ@CXFZQ[QGZCCWNW!=2GA1V,#KNX._T!4V59X ML>IPP%)]J]24896*;'[BUJCHEW7-4"I9:+\AGU1OPAO-I[4AP6_?/1(0$"<* MOE[[UB>-CL/#FP.6]U2=R@P*5 M)/'I6""PBZO1QC4O+JJN._5?COMSZ[AK](PV!YH!]YG$\!/H!`K-LUMI7*T< MPG1XVRQ>[TF>NUALDB9O!'?E.NVL^74[7U9=(V[#QS+O'@.6RJ-`W%<'QF0\ M@MN_"WIN7/&\*.@:A9N6_^7=<6D@'-D550) M``,'_%51!_Q5475X"P`!!"4.```$.0$``.U=;7/;.)+^?E7['WBNNKILU3JR M[$EVDAK/GJR7&=4YELM2)GOW90HB(0D7"E``T+;VUQ\`OH@D0(F4J1">X9=$ M)M%@/\##1J/1`'_ZQ_/:=QXA98C@Z[/NVXLS!V*7>`@OK\\^3\][T_YX?.8P M#K`'?(+A]1DF9__X^2__]M._GY_W*00<>LY\ZTR'_<\/PW\Z(^0+6>;GI[9PB_-8EZXZHZ;)[>=45&OMP#3$?$;H>P`4( M?'Y]]BT`/EH@Z)TY`B)F'^$+D71BZL.PK(Y7!B7 MQP3C8&T6\#CM\.T&=D2A%L@*R@+<#D=;J72>\F11E7J;NIZNX M9+?SST^W4]7.9Z+9'4X M<)[5%4I\N*?!Y.V."WPW\-4C;G<5G$4UK"A<7)_)/CJ/N^-W(?%6H(F+R!:Y M/F-HO?%A?`U05WMV!+7[X<.'CBK5$?S;0,H19)U8]Z2=Y(7]XG%1K606Y*[F M3BWMY<$%PJA"4= M^>/SP]@\'JA6ZKDN"3!G#]"%Z!',)5+D10T#:%55$D5B57:O]\_=BROGW!D@ MYOJ$!12*/^*G.[O'_]3)R^6K#!CT)OAG]3MG;2/AJ,0^P:S9*2^79U5YR>3- M+2\B*`JI\%-@L5AT->[Q.HDP@!P@GV7XX-5)B!\NKBZZ)2CAO(E4^6M+CF;( MT2>8$1]YT@N^`;[T"J"?8,ADY_=[T5V=T._G2 M6AC+N#(1_K5"FR,+J98B MGB4-J]6MO;AX5YXUT]FD_]^_3FX'PX?I?SJ#X6C<'\]:`C5#H`%Q`]EE/>P- M,4=\.\8+0M<*:(HQ'H"H6R]CU#0H>GKZ)\">$ZKBI'1I^=$,/X;?`K11(7B$ MA:^+\#+%"KBHE1/=KC8U3A[O),]OF=`<$_@VZ09A,`9PSA\@XS1P>4#SU`!> MS:&T'TSD$%8B44F9#C'5<:1B3D:SEC36DF;V1/X74C+!4/PJ45Z/T2FNJ7]J MCM7]H,?J*G#.>2.C[%4D_MJ&_5X58>5_+V5LK2.HI*RVXE"5LAY"0Z;T(=6Q99,]DT&:B:+5.W:_;R.ZWFB$-F!)#1RE@I/6H26$1830+8;@1=TFXU(W&07<:,V&E2S1G!%! MDII=D=+FHW4[&F;(6$PD&)=],<9CS"$%+A_`1^1"-L;NV$,IGB"$/(3J#6R^ MSQ-EIY"#L!.KY$0ZB0ON6^?->#!N&6,K8_11*"1.S0'*]_HXM)\[?Y/D";G3 MCDS-LTC\A#/PG!F)$*_7NORH,T0^UE'/;;N^\:XWF`I>LYGXT60F=B1H+8%% M=-`\4\1K-0A7^PU"ZXPV3(5;]"T0G@+?IBC@UQO7>)`/H!M2=V?'N`%^<-Z8-KK&^SD[A-B1E%<=N*/*6\)8` M0YH0WLS]^GFD!<)S/`HULXDJ2,)&8(>Q-@;^S1B8*P0U@)[!&?S_` MHEUR1V*#9$Z05'=GC%I^6<6O3)+X%+JB8[TP`9`C<5L5-5&,N;CF6.H[/8\Q MQR^5]1WIZ*24#,NUQ+**6%.($:%3]"QX-4*/,$>J(D[5;K2TV7B.5*&>SONW ME^_^0R-5RRF[.)5D6Z>O&JE$\*9^+FE3^3R74JG4F5LMCZSBD;84A#=UITL? MFKFUBT'6L.$S9D:_QV17@E,,4=K&HAQ7$@7;\U01^3T@JI^9=220Y)::5:NMA*%]WL*-;4/-LZFCBMQ6F< M0N%Q17AY"T4_9XA2;SZ#'O!)'NV$SVXI8`4%#":CYNR&B[\;[$6.#*UEL(P6 MVC2'^#5GO!TT$.U$IV%*W*N'B;F#<#;Z9+TF6)U@EB+%!KBU'K;:O?B09T6B MA'(K0C4SM.:\ M.2T,LGNR(Q_=$L`&`N@F@M:=,V?0::O$*56HG"<\&H+L@C%UIQ883A4X0!KG M3:)A&V.WFTIFHU.OU;FL;'6<-_&OEC56L@9PF1DKIC]C@1TOY9*:(8XFF03J MWEQ^%)M"?=7\**5Q:YSLIID6@A.$JCO5H#J9VIBX04+.%T M!6B!87H"=4=F+O54A(-6$0TQ(MALPN_^`C_^0)+YLQ3,7=3[68IN5]N#DM;&D>HX M4I_VVQ36\\0P&@FZU'T4H.$(IL.,:4>=QKEC''7VQ7MJ3ZGL7ABH4S`4M8$> M^\FS2_OO^3YQPT]RF0J:R,4(8'6?N2X(IF4^%!,LO2L@`1"5O]'*MRRTGX6, M!>N-O,8^BT(SHHX>G817"C@8\$=2/POUJ7\Y%NX`.!*!PTET?&H$HB7A*R7A M%SF8&8\HB%GX5#\+]:#!"UD8HVAI:#T-4[YW;TX"'AF0'O;V4Q$!`DY`16W; M53DJIF<0"D9L"%6\O:7CJZ%CV&T[]O5SWT M^XPI=,D2HW]E2PR?Y4]CU(61P(7U,U`[!+<<`],`LL4B""T)+26AOL3MUOW! MC](+2^W2=M,4">8,?@L$MN%C[BM2#-:\H*2'X)*'.^'36Q;8P0+#\%/[R&/8 MH*CQH1U":F7&3YUGYGT$FPT2TV=U+;J",0EU#R_*:VB](90[&*PAVP`7[NEP MA!D'0ITSAPD'80UN9<1<5+9'1/YU'LN=RTOGW>;9^4575%*HAU%&_CC?"5?4($+T3OWE\=)-$`M( M[.^.;'R/TPX7).M@@L]QL(9B8E).@;3D72@H%?D@.Z'[_L7J'*?*"_18`#97 MM07L?`G`IC09C((=Z',67SF*&NEJ)3A6DT*JKJ,TRO/O0SC^8+B4:VSENLJG M-".UKZM@F'V@-+D^*W-6<%^6@'0#*-]^@NLYI+M1\/=C*\#(]V7IZS-.`V&@ MP%Q,WX'+X[\E-O1Q(XA'/&FOK\^\@$8I/DP,BASQ0/[U"R7!YOHL+(XX7)\Y M7!47+Y`@[D>/K`'"8W%#UK*W);X%B*F!;K(8>RC:4BHS`>6AH(_`EU`,^*N( MV8?:^[\@_"(8FY&>YRD@P+\'R!OC/M@@#GSUG3#(>!IU);$\ZE#M.?#E4'=] MYE+HJ0];O11\>$4TO_"0Z+84^D?$"-W>$$"]L(_T#BXN8U]O+H4/9'A',YJ]`9SS+/0*8K:"OT%WD#\1^E4?S_5;UG%V=_9^V.!,5*[CV%/(:D1[ M?,W]Q2Q&)4U@=!3F'E"&4M9AZON`,1`M[FI8C'?MQ'"S%T/^KIT8^GLQY._: MB6&P%T/^KIT8)HM(S0E]D#O)/H%GM`[6:A)X3Y$+9Q0MET(IO!P^0^HB!A,1 MEH?\PLK,0^Y+6D0TAQ!7SS^V0>X"V7U].>K[O@QJ[(>L%:\=5'B%J6U^QX*: M0;I.KAV"E"M\(D"Q4!E(NQ.SPH-IO$$@.76O=`@W0$;J#I_=%<#+C`M\G'CC M_;A7ZW3V:77,!=+6QCZ$6\@"7^Z$G4*JOO\N7/E'Y`E74;?%A\O:9YD3MW<$ M`0\HE#.UN6&M'H6/ MH#?&0J]`EHO?IPF-DMG'C`4RW,B1AWREC!B).'15%M=*>`$K=6QTT@HG>T+3 M?K8$MD/1)X\0"QBC`,O/\891NM"HPWQSE)8Z-GH7)C'P4SDN>S$4<:",P*O` M.X)0^)LNS$PYBHN:G35DE/XN+ M:BE`3`404ZY4/Z!T7^?L$WD5!#0`N"/8K0X[+64M\@7"ZJ-*G*)Y.!@(E8;K MC4^VD`IBNBMA0S+WPW=CLE`W,^WQXKH:?YF-"*(`54\,_T6;5 M4%O3+4)+;S%;"T+E*0RY5_.1>6A0TX3)V40)DW.@F)]-PSSHG M,]8Q"ETH!^M&.]Q#>H9,GEGV!*C'TK?ZA'&Y@4-N+9J1&_B0;/(8X_^!@(Y( M8&J2TS[.4H-Y:O""9]^QJ=73_J0M+?WB[]G6T?/^K*W]1+YG6\NG6=[2>F!. MNV/?2!.'"T<(RU;`>)<^+<$W`()*['R;8DX-+$>VHVF@3X95Q4HBK1*%4KM)0081J"W)B.9)K[#0Q#PR4:H%"RZ07P M(H55A\0VZT$J,")43VTX3OQ443OHHC7P7X!:=H]*J2D!,56VZ=!_7D7LR5B; M.O\B<+E*23`$'RI)61>#.*S\S5:&CWK/B%4#G98[`6R/?_200,*B^/*I&V!V MP$8?$CQ-$ZRVTAP'].VK07Q%V M!I_YC9_Y&F@9['G9^DUZB)?'CZ@)\I%H3PCT*#XKOT@>;>!2-(?>32"'5[-S MM:^H'=Y4L8:[G-T*L-)"C7L:S]`-Y+G2D\5"9OWI\]V"`M;9$^&/KB$=(`I= M3O1-GN;;UJ'XA80KA"ZDV&0+"N[;8-W&V*5R@]P`AO^/L313@C8JDUU&+-.# M=JG2MLZSU<9G09,!5*FR`HO&M^(BUG%NK,+,Q)`5K-VQ3O?P`^[)!]UE/E]* M?^/=YE-,;N6.6D-SYZ[;U]A(C&R>&-L,DT_#/=L\[7S0*K,/C,E#[Y\R[DG) M\@W'MM*[A]ADD0F\R>P*T38JC3GT2AX`8B:0%<6;]LL^$4]][TO6&6$/6,`.Z5'E; M1]P[^.1OPQBK,;.[X+YUW78G($>KG#)U#OCA@6TSZ*XP[L$V1ZH#Y:S=O)?36[P5PFY#-2:9YH7EBMLP38PV M8?PBB06]D3I()K?U4#.!%62LLX$3BI8(`S_[+@D,NV,A=+SE9:S#>^\#5_T= MGDF5+*\5;LHW4]3'GA(/]^JJ(!U2![DEFR9/JM!T.[8 MJ;LI`SM_PT[-57:G6??,+4NU-YSJEK]AG^9PB:0*LM+(H>E)D[D,-RY#NKZ' M8A#);,&J(--P7$,FU2EG9@[W(/,-?,C""QV6.._>PL.Z9<5 MJBC[`-]!T.,DI'W(B#[G\5*4(7!Y'B?;01:Q%)RSE#*WA"$+I)X;=D<_U M.T+6VHE"92Q)/%-)O:15\C4U;3%$.2">91I$#?>LL^>QCJ;!R'#/0OU-'_HQ M[VV(8H^%&1XUU&7#9#>)#EQ_$Q72#G?I)3;_=ZGO0I5@P]R>)?M.8B#U;*3@.3=4)]UG)D!?9-;8J!%"Y: M59"Q%&^4#B04ADN"Q7S@%L$@S!W1%UK+BS2]=)QH*NI&'@)TJ[[I0'7WOZ!0 MXP#B)"W3F;QRL4D>$,9$'VC[!-(`7U")U0UP0\E7Y3WNMB>SLKC-LE;#/;J/ M7UN_ZMM@=JOA93'OK\-J^(9O=)4L;S6L._BD;C'E$[!567BZG-4PC=],&C[S M<-MH6="':K&Z"8I2;"NW0HF*K&Z(.+$E]O:]LL`-@I8"#2/,+_-$RM1A[ZK< M'DS'.2A[1%]E*QS+B#\*"U[FSI2HXE6V2GDO)U?\5:*M[OP4B+U*]"_UB4I5 M\BI;I@97J6P]K[)]CO"@BN3LQA]%B?=]S>1`.>M"BS/QIRN\EP!'6_!8LKM' MPU:BK'WX1/.[*YFPF]\_\P7QU>Q)E-R*?_U'F'LI]:Y]>56VMHY*":ZK?5Y4 MF;4M]$1J:Y_CJ[*O=2KA_Z,AE(L1\%L@"OC;WEI]E[L2Z#WR%K8#F:U(P`#V M9A#OV2QUJ*#ER-0G$?9C2A>Q&HTBW4%`6BGK,!7YS;\2WX/ZYJ)RQ5\-RM+X MK$46I8J%45,Q24ZBB`.(R1IAP$D:7[GBULX4HJ$]V20:!T4F^%#'5I:TKJS[8/;!MC@LW'3:E4%GA*7.PI^7)VS_1OP@<[9+60';+5CR948OVM*A M;)(\C$A]/R%[@%P%&=N9G=C?G-7-+',4&;5JTM8:NQ#%?4!ES_$9^0*0`%/\ M'8:*CC@V54OBS`7R$5;([2!0^@+R-J M/?JL7Z),&1>3\_BKF+(G)XO=Q+8P%%QSO=:W6[CV,PWG)GOF9Q7EK,<]6R'J MW0/*MX+LR?+OR/1)I>JB]J$G].N"4%<,:-$I)+FMCT4%OM^.Q9\Z4FWFKN`: MB#__'U!+`0(>`Q0````(`/*$?4)-<.PUQ5,!`-/E$0`1`!@```````$```"D M@0````!B8W-T+3(P,3(Q,C,Q+GAM;%54!0`#!_Q5475X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`/*$?4*U#.NS1!@``)Q%`0`5`!@```````$```"D@1!4 M`0!B8W-T+3(P,3(Q,C,Q7V-A;"YX;6Q55`4``P?\55%U>`L``00E#@``!#D! M``!02P$"'@,4````"`#RA'U"[&^?;]5O``"G)@@`%0`8```````!````I(&C M;`$`8F-S="TR,#$R,3(S,5]D968N>&UL550%``,'_%51=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`\H1]0L*CE_*`$P$`#281`!4`&````````0```*2! MQ]P!`&)C`Q0````(`/*$?4)R.?5&_8T``,`5"@`5`!@```````$```"D M@9;P`@!B8W-T+3(P,3(Q,C,Q7W!R92YX;6Q55`4``P?\55%U>`L``00E#@`` M!#D!``!02P$"'@,4````"`#RA'U"\:_5FY@6``!],0$`$0`8```````!```` MI('B?@,`8F-S="TR,#$R,3(S,2YX`L``00E#@``!#D! 8``!02P4&``````8`!@`:`@``Q94#```` ` end XML 17 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Notes Payable (Equipment Purchase and Sale Agreement) (Details) (USD $)
    		 12 Months Ended 0 Months Ended 1 Months Ended 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Dec. 31, 2012
    2012 Plan [Member]
    Mar. 26, 2012
    Conversion of Equipment Purchase and Sale Agreement to Common Stock and Warrants [Member]
    Oct. 31, 2011
    Equipment Purchase and Sale Agreement [Member]
    Dec. 31, 2012
    Equipment Purchase and Sale Agreement [Member]
    Dec. 31, 2011
    Equipment Purchase and Sale Agreement [Member]
    Debt Instrument [Line Items]              
    Fee percent         3.00%    
    Amount of debt converted       $ 500,000      
    Long-term debt             700,000
    Accrued interest payable             42,000
    Repayment of debt 4,017,649 1,526,834   200,000      
    Interest paid 347,902 357,246   105,000      
    Interest expense           63,000 42,000
    Fair value of warrants     757,469        
    (Loss) gain on extinguishment of debt $ 1,578,914 $ (954,017)   $ (278,032)      

    XML 18 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Significant Accounting Policies (Narrative) (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Cash and Cash Equivalents    
    Cash in excess of amounts insured $ 38,847 $ 909,182
    Restricted cash 140,700   
    Research and Development    
    Research and development 1,754,163 2,410,249
    Advertising Expenses    
    Advertising expense $ 35,168 $ 68,703
    Customer One [Member]
    		    
    Revenue, Major Customer [Line Items]    
    Percentage of revenues from major customer 85.00% 89.00%
    Minimum [Member]
    		    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 3 years  
    Maximum [Member]
    		    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 5 years  
    XML 19 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 20 R57.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Stock-based Compensation (Schedule of Allocated Stock-Based Compensation) (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Stock-based compensation    
    Total $ 283,692 $ 2,262,540
    General and Administrative Expense [Member]
    		    
    Stock-based compensation    
    Total 185,478 2,043,386
    Research and Development Expense [Member]
    		    
    Stock-based compensation    
    Total $ 98,214 $ 219,154
    XML 21 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Significant Accounting Policies (Tables)
    		 12 Months Ended
    Dec. 31, 2012
    Significant Accounting Policies [Abstract]  
    Schedule of Future Patent Amortization
    Year ending
    December 31:
    		        
    2013
    		     $ 11,343  
    2014
    		       10,121  
    2015
    		       10,121  
    2016
    		       10,121  
    2017
    		       10,121  
    Schedule of Computation of Basic and Diluted Earnings per Common Share
       
    For the Year
    Ended 2011
    		    
    For the year
    Ended 2012
    		  
    Numerator
    		            
    Net income
    		   $ 1,304,446     $ 1,602,824  
    Denominator
    		                
    Basic weighted average shares outstanding
    		     75,416,916       100,798,223  
    Effect of dilutive securities:
    		                
    Stock options and warrants
    		     131,250       2,510,488  
    Restricted stock units
    		     2,550,000       3,225,133  
    Diluted weighted average shares outstanding
    		     78,098,166       106,533,844  
                     
    Net income per common share
    		                
    Basic
    		   $ 0.02     $ 0.02  
    Diluted
    		   $ 0.02     $ 0.02  
    XML 22 R50.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Preferred and Common Stock (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Preferred and Common Stock [Abstract]    
    Preferred stock, shares authorized 20,000,000 20,000,000
    Common stock, shares authorized 180,000,000 180,000,000
    Common stock, par value per share $ 0.05 $ 0.05
    Common stock, shares issued 107,473,820 75,975,656
    Common stock, shares outstanding 107,473,820  
    Class of Stock [Line Items]    
    Common stock issued for option exercises, shares    455,098
    Common Stock [Member]
    		    
    Class of Stock [Line Items]    
    Stock issued during period 31,498,164 1,897,503
    Shares of common stock issued 24,816,000  
    Common stock issued on debt conversion, shares 5,600,000 1,307,153
    Common stock issued for services rendered, shares 1,082,164  
    Common stock issued for warrant exercises, shares   372,272
    Common stock issued for interest, shares   135,369
    Common stock issued for option exercises, shares   55,098
    Common stock issued in exchange for IDI shares   27,611
    XML 23 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Notes Payable (Unsecured Convertible Note) (Details) (USD $)
    		 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 3 Months Ended 12 Months Ended 0 Months Ended 3 Months Ended 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Dec. 31, 2012
    Common Stock [Member]
    Dec. 31, 2011
    Common Stock [Member]
    Dec. 03, 2008
    Class A Warrant [Member]
    Nov. 02, 2006
    Class A Warrant [Member]
    Dec. 31, 2012
    Class A Warrant [Member]
    Dec. 31, 2008
    Class A Warrant [Member]
    Dec. 31, 2007
    Class A Warrant [Member]
    Nov. 02, 2006
    Class B Warrant [Member]
    Dec. 31, 2008
    Class B Warrant [Member]
    Dec. 31, 2007
    Class B Warrant [Member]
    Dec. 31, 2012
    Class B Warrant [Member]
    Nov. 02, 2006
    Class C Warrant [Member]
    Dec. 31, 2007
    Class C Warrant [Member]
    Nov. 02, 2006
    Class D Warrant [Member]
    Dec. 31, 2012
    Letter of Understanding [Member]
    Dec. 23, 2009
    Unsecured Convertible Note [Member]
    Mar. 31, 2011
    Unsecured Convertible Note [Member]
    Dec. 31, 2012
    Unsecured Convertible Note [Member]
    Dec. 31, 2011
    Unsecured Convertible Note [Member]
    Dec. 31, 2010
    Unsecured Convertible Note [Member]
    Nov. 02, 2006
    Unsecured Convertible Note [Member]
    Dec. 23, 2010
    Unsecured Convertible Note [Member]
    Common Stock [Member]
    Dec. 23, 2010
    Unsecured Convertible Note [Member]
    Warrants Issued for Convertible Note Restructuring [Member]
    Mar. 31, 2011
    Unsecured Convertible Note [Member]
    Warrant Issued for Interest on Convertible Note [Member]
    Dec. 31, 2011
    Unsecured Convertible Note [Member]
    Warrant Issued for Interest on Convertible Note [Member]
    Convertible notes                                                      
    Amount of credit facility                                 $ 1,000,000     $ 1,000,000              
    Credit facility initiation date                                 Sep. 25, 2006                    
    Credit facility expiration date                                 Oct. 30, 2006                    
    Principal issued                                             1,000,000        
    Debt interest rate                                   8.00%   8.00%     5.00%        
    Debt maturity date                                   Dec. 22, 2010   Dec. 31, 2013              
    Conversion price                                       $ 0.25     $ 1.5        
    Number of shares of common stock warrants can be exercised for           750,000       750,000       2,000,000   2,000,000             5,500,000   75,000 221,758  
    Warrant term length           1 year       1 year       18 months   24 months                 5 years 5 years  
    Exercise price of warrants           1.6       1.75       2.1   3.0                 0.9 0.96  
    Warrants and options exercised    455,098   55,098 231,600     64,400 454,000                                    
    Warrants expired 252,669 302,054                 750,000 650,000     650,000                        
    Shares of common stock issued     25,402,164                                         150,000      
    Common stock issued for interest, shares       135,369                             135,369                
    Common stock issued for interest    19,634                                 81,221               157,400
    Derivative valuation 1,191,269 3,760,200         698,838           58,631             46,400 300,000            
    Gain on derivative valuation 8,829,748 11,724,400                                   253,600 1,101,900            
    Risk-free interest rate             0.72%                         0.16%              
    Expected life             5 years 2 months 12 days                         1 year 0 months              
    Expected volatility             85.49%                         112.04%              
    Dividend yield             0.00%                         0.00%              
    Stock trading price             $ 0.08                         $ 0.08              
    Accretion of discount on convertible notes payable 941,225 340,377                                   333,336 333,336            
    Interest expense of convertible debt                                         $ 80,000 $ 80,000          
    XML 24 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Equity Financing and the Debt Restructuring (2012 Equity Financing and the Debt Restructuring) (Details) (USD $)
    		 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 0 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Dec. 28, 2011
    Warrants Issued to Reset Provision and Extend Maturity Date of Bridge Loan Warrants [Member]
    Dec. 28, 2011
    Original Warrants Issued for Bridge Loan [Member]
    Mar. 26, 2012
    Amended and Restated Senior Convertible Note [Member]
    Dec. 23, 2010
    Amended and Restated Senior Convertible Note [Member]
    Jul. 30, 2010
    Amended and Restated Senior Convertible Note [Member]
    Mar. 26, 2010
    Amended and Restated Senior Convertible Note [Member]
    Dec. 24, 2007
    Amended and Restated Senior Convertible Note [Member]
    Dec. 31, 2012
    Amended and Restated Senior Convertible Note [Member]
    Dec. 31, 2011
    Amended and Restated Senior Convertible Note [Member]
    Mar. 31, 2011
    Amended and Restated Senior Convertible Note [Member]
    Dec. 23, 2009
    Amended and Restated Senior Convertible Note [Member]
    Dec. 28, 2011
    Bridge Loan Note Payable [Member]
    Dec. 28, 2011
    Bridge Loan Note Payable [Member]
    Warrants Issued to Reset Provision and Extend Maturity Date of Bridge Loan Warrants [Member]
    Dec. 31, 2012
    Bridge Loan Note Payable [Member]
    Warrants Issued to Reset Provision and Extend Maturity Date of Bridge Loan Warrants [Member]
    Dec. 28, 2011
    Bridge Loan Note Payable [Member]
    Original Warrants Issued for Bridge Loan [Member]
    Dec. 31, 2012
    Bridge Loan Note Payable [Member]
    Original Warrants Issued for Bridge Loan [Member]
    Nov. 02, 2006
    Class A Warrant [Member]
    Dec. 31, 2012
    Class A Warrant [Member]
    Nov. 02, 2006
    Class B Warrant [Member]
    Dec. 31, 2012
    Class B Warrant [Member]
    Apr. 05, 2012
    2012 Plan [Member]
    Mar. 26, 2012
    2012 Plan [Member]
    Dec. 31, 2012
    2012 Plan [Member]
    Dec. 31, 2012
    2012 Plan [Member]
    Equipment Purchase Agreement Conversion [Member]
    Mar. 26, 2012
    2012 Plan [Member]
    Bridge Loan Note Payable [Member]
    Bridge Loan Conversion [Member]
    Mar. 26, 2012
    2012 Plan [Member]
    Class A Warrant [Member]
    Mar. 26, 2012
    2012 Plan [Member]
    Class B Warrant [Member]
    Mar. 26, 2012
    2012 Plan [Member]
    Maximum [Member]
    Mar. 26, 2012
    2012 Plan [Member]
    Minimum [Member]
    Equity Financing and Debt Restructuring [Line Items]                                                              
    Gross consideration in equity financing transaction                                               $ 6,000,000           $ 10,000,000 $ 3,000,000
    Commission fee percentage                                               10.00%              
    Percent of issued common stock covered by warrants issued in transaction                                               10.00%              
    Number of units to be issued in financing transaction                                               27,800,000              
    Price per unit                                               $ 0.25              
    Shares of stock issued per warrant exercised                                               0.5              
    Warrant term length     6 years 5 years                     6 years   5 years   1 year   1 year     6 years              
    Exercise price of warrants     0.35 0.65                     0.35   0.65   1.6   1.75             0.35 0.05    
    Maximum share price triggering exercisability of warrant                                               $ 0.25              
    Amount of financing proceeds triggering expiration of warrants                           12,000,000                   5,000,000              
    Maximum share price triggering expiration of warrants                                               $ 0.5              
    Minimum trading volume                                               500,000              
    Number of shares of common stock warrants can be exercised for                             247,500   357,500   750,000   750,000                    
    Proceeds from equity financing 6,150,000                                            154,000                
    Repayments of convertible debt           2,500,000                                                  
    Shares of common stock issued             2,000,000 1,000,000 1,000,000 2,000,000                         616,000                
    Common stock issued for debt restructuring         760,000                                                    
    Cash paid to settle debt         2,750,000 2,750,000       2,750,000                                          
    Amount of debt converted                                                   500,000 400,000        
    Number of shares issued for agent fees         586,164                                                    
    Payments for debt extinguishment costs 275,041                                                             
    Number of warrants issued     247,500 357,500                                     400,400                
    Number of warrants issued to investors                                             308,000                
    Principal issued                 15,000,000 5,500,000     15,000,000 1,300,000                                  
    Warrants issued to investment banker                                             92,400                
    Debt interest rate                 6.25%       6.25% 18.00%                                  
    Debt maturity date             Jun. 21, 2012 Dec. 21, 2011 Dec. 21, 2010         Feb. 28, 2012                                  
    Derivative valuation 1,191,269 3,760,200                 285,200 81,500       7,200   7,400   698,838   58,631     757,469            
    Gain on derivative valuation $ 8,829,748 $ 11,724,400               $ 203,700 $ 2,322,200         $ 89,325   $ 136,300             $ 4,365,323            
    Risk-free interest rate                               0.54%   0.54%   0.72%                      
    Expected life                               4 years 0 months   4 years 0 months   5 years 2 months 12 days                      
    Expected volatility                               82.55%   82.55%   85.49%                      
    Dividend yield                               0.00%   0.00%   0.00%                      
    Stock trading price                               $ 0.08   $ 0.08   $ 0.08                      
    XML 25 R52.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Stock-based Compensation (Schedule of Assumptions Used to Value Options) (Details) (Stock Options [Member])
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Stock Options [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Risk free interest rate 1.65% 1.91%
    Expected life (in years) 10 years 6 years 2 months 12 days
    Expected volatility 78.97% 80.89%
    Expected dividend yield 0.00% 0.00%
    XML 26 R61.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Retirement Plan (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]    
    Maximum percent of compensation which may be contributed to plan 60.00%  
    Contributions to defined contribution plans $ 99,761 $ 90,453
    Scenario One [Member]
    		    
    Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]    
    Percent of match 100.00%  
    Maximum percent of compensation matched 3.00%  
    Scenario Two [Member]
    		    
    Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]    
    Percent of match 50.00%  
    Maximum percent of compensation matched 2.00%  
    XML 27 R47.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Investment in Interact Devices, Inc (IDI) (Details) (USD $)
    		 1 Months Ended 12 Months Ended
    May 31, 2004
    Dec. 31, 2012
    Dec. 31, 2011
    Subsidiary or Equity Method Investee [Line Items]      
    Common stock issued in exchange for IDI shares     $ 10,760
    Interact Devices Inc. [Member]
    		      
    Subsidiary or Equity Method Investee [Line Items]      
    Common stock issued in exchange for IDI shares     27,611
    Number of shares of subsidiary acquired 50,127,218   414,172
    Number of shares owned   55,897,169 55,897,169
    Percent ownership   94.00%  
    Advances to subsidiary   $ 3,347,255 $ 3,126,772
    XML 28 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Accounts Receivable
    		 12 Months Ended
    Dec. 31, 2012
    Accounts Receivable [Abstract]  
    Accounts Receivable
    Note 3 - Accounts Receivable
    Included in our $821,608 and $1,239,903 net accounts receivable for the years ending December 2012 and 2011, respectively, were (i) $856,462 and $1,269,579 for billed trade receivables, respectively; (ii) $44,478 and $23,814 of unbilled trade receivables, respectively; (iii) $1,808 and $0 for employee travel advances and other receivables, respectively; less (iv) $81,140 and $53,490 for allowance for uncollectible accounts, respectively.
    Included in the numbers above is our single largest customer for each year ended December 31, 2012 and, 2011, which provided 85% and 89% of total revenue and represented 71% and 79% of our trade receivables on December 31, 2012 and 2011, respectively.
    Our largest customer initially signed a three-year agreement which has now expired, although we did receive a contract extension through May 31, 2013 to continue to provide services. Unless we can replace that customer with another similarly large customer or customers, revenues will decline substantially, which will harm our business.
    XML 29 R62.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Legal Proceedings (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Loss Contingencies [Line Items]  
    Maximum amount of additional payment $ 130,000
    Payments toward purchase price of equipment 424,500
    Escrowed amount 425,100
    Current accrual for litigation $ 141,700
    EXCEL 30 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=?83,Y9%\S-#=A M93@Q,3`X9#@B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=OF%T:6]N7V%N9%]"87-I#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/D5Q=6ET>5]&:6YA;F-I M;F=?86YD7W1H95]$96)T7SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5S7U!A>6%B;&4\+W@Z3F%M93X-"B`@("`\>#I7;W)K M#I7;W)K#I% M>&-E;%=O&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D5Q=6EP;65N=%]&:6YA;F-I;F<\+W@Z3F%M93X-"B`@("`\>#I7;W)K M#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQE M9V%L7U!R;V-E961I;F=S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U M#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5Q=6ET>5]&:6YA;F-I;F=?86YD7W1H95]$96)T7S$\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D]P97)A=&EN9U],96%S97-?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O&5S7U1A8FQE#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K8F%S961?0V]M M<&5N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9A:7)?5F%L=65?365A#I. M86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-I9VYI9FEC86YT7T%C8V]U;G1I;F=?4&]L M:6-I934\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D5Q=6ET>5]&:6YA;F-I;F=?86YD M7W1H95]$96)T7S0\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O&5S7T1E=&%I;',\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-T;V-K8F%S961?0V]M<&5N#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DQE9V%L7U!R;V-E961I;F=S7T1E=&%I;',\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I. M86UE/E-U<'!L96UE;G1A;%]#87-H7T9L;W=?26YF;W)M83$\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I%>&-E M;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I% M>&-E;%=O7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA2!);F9O2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^,C`Q,CQS<&%N/CPO'0^1ED\2!& M:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M4VUA;&QE3QS<&%N/CPO'0^665S/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^3F\\2!0 M=6)L:6,@1FQO870\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT+"!N M970\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$7)O;&P@86YD(')E;&%T960@ M97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4@*&YE="!O9B!D M:7-C;W5N="!O9B`D-C4Y+#0Y-B!A;F0@)#`L(')E2D\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)FYB'0^)FYBF5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PP,#`L,#`P/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W M-6-D,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W M864X,3$P.&0X+U=O'0O:'1M;#L@8VAA'0^)FYB'0^)FYB&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XQ+#8P,BPX,C0\&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S M<#L\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$&5R8VES97,\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^)FYB&5R8VES97,L('-H87)E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S&-H86YG92!F;W(@241)('-H87)E&-H86YG92!F M;W(@241)('-H87)E'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^)FYB'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES97,L('-H87)E M'0^)FYB'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^ M)FYB'0^)FYB'0^)FYB'1087)T7SAD M8C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ+#`R-"PW-30\'0^)FYB'0^)FYB M'0^)FYB'0^ M)FYB'0^)FYB'1I;F=U:7-H;65N="!O9B!D96)T/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M/B@Q+#4W."PY,30I/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB'!E;G-E'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&5R8VES92!O9B!O<'1I;VYS(&%N9"!W M87)R86YT'0^)FYB2!F:6YA;F-I;F<\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)FYB'0^)FYB3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=?83,Y9%\S M-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&1B M-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@8VAAF%T:6]N(&%N9"!"87-I'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.;W1E M(#$@+2!/6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,S9P="<^($)R;V%D8V%S="!);G1E2D@:7,@=&AE(&-O;G-O;&ED871E9"!P87)E M;G0@8V]M<&%N>2!O9B!"22!!8W%U:7-I=&EO;G,L($EN8RX@*$))*2P@82!W M:&]L;'DM;W=N960@2P@86YD($EN=&5R86-T($1E=FEC97,L M($EN8RX@*$E$22DL(&$@.30E(&]W;F5D('-U8G-I9&EA'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`S-G!T)SX@0DD@=V%S(&EN8V]R<&]R871E9"!I;B!5=&%H(&EN M($1E8V5M8F5R(#$Y.3D@86YD(&)E9V%N(&]P97)A=&EO;G,@:6X@2F%N=6%R M>2`R,#`P+B!)="!I2P@571A:"X@5&AE($-O;7!A;GD@;W!E2!K;F]W;B!A2!C:&%N9V5D(&ETF%T:6]N M(&9O2!T:&4@56YI=&5D(%-T871E65A&EM871E;'D@-34L.#DW+#$V.2!C;VUM;VX@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@5&AE M(&%U9&ET960@8V]N28C,SD[7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@36%N86=E;65N="!%'!E;G-E2!L:7%U:60@:6YV97-T;65N=',@=VET:"!M871U2!O9B!C87-H(&UA;F%G96UE;G0@:6YV97-T;65N=',@ M86YD(&AA=F4@:6YC2!T;R!M965T(&]U M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U19 M3$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@06-C;W5N="!296-E:79A8FQE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,S9P="<^(%1R861E(&%C8V]U;G0@2!I9&5N=&EF>6EN9R!T'!E'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`S-G!T)SX@02!T7,N($%F=&5R('1H92!R96-E:79A8FQE(&)E8V]M97,@<&%S M="!D=64L(&ET(&ES(&]N(&YO;BUA8V-R=6%L('-T871U'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!) M;G9E;G1O6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^($EN=F5N=&]R:65S M(&-O;G-I'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B!02!A;F0@17%U:7!M96YT/"]D:78^ M(#QD:78@'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`S-G!T)SX@4')O<&5R='D@86YD(&5Q=6EP;65N="!A65A'!E;G-E9"!A&-E<'0@=VAE;B!S M=6-H(')E<&%I2!A9&0@=&\@=&AE('5S969U;"!L M:69E(&]R('!R;V1U8W1I=F4@8V%P86-I='D@;V8@=&AE(&%S'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`S-G!T)SX@4&%T96YT2!F;W(@56YI=&5D(%-T871E2!I;B!O'!E;G-E9"!F'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`S-G!T)SX@06UOF%T:6]N(&5X<&5N'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@17-T:6UA=&5D(&%M;W)T M:7IA=&EO;B!E>'!E;G-E+"!I9B!A;&P@<&%T96YT6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S4E M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B!996%R(&5N9&EN9SPO9&EV/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$ M14Y4.B`P<'0G/B!$96-E;6)E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XF;F)S<#L\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E(&-O;'-P86X],T0R(&YO M=W)A<#TS1&YO=W)A<#X@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B`R,#$S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB M6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R M,#$U/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R,#$V M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,34E/C$P+#$R,3PO=&0^(#QT9"!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z M(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3&]N9RU,:79E M9"!!6EN9R!A;6]U;G0@;V8@86X@87-S970@;6%Y(&YO M="!B92!R96-O=F5R86)L92X@4F5C;W9E6EN9R!A;6]U;G0@;V8@86X@87-S970@=&\@9G5T=7)E('5N+61I M2!T:&4@86UO=6YT(&)Y('=H:6-H M('1H92!C87)R>6EN9R!A;6]U;G0@;V8@=&AE(&%S&-E961S('1H M92!E6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D]. M5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M4W1O8VLM8F%S960@0V]M<&5N'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T M)SX@26X@86-C;W)D86YC92!W:71H($%30R!4;W!I8R`W,3@L('-T;V-K+6)A MF5D(&%S(&5X<&5N2!O=F5R('1H92!R97%U:7-I=&4@6EN9R!A;6]U;G1S(&]F(&5X:7-T:6YG(&%S&%B;&4@:6YC;VUE(&EN('1H92!Y96%R6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O M;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4F5V96YU92!296-O M9VYI=&EO;CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^(%=E(')E8V]G;FEZ92!R M979E;G5E('=H96X@979I9&5N8V4@97AI2!I65T('!R;W9I9&5D+CPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`S-G!T)SX@5VAE;B!W92!E;G1E65A7!I8V%L;'D@<')O=FED92!F;W(@861D:71I;VYA;"!F M965S+"!A2!W:71H:6X@=&AE:7(@ M<')O9'5C="!O9F9E2!B87-E(&]R('!R M97!A:60@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^(%)E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z M(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@0V]N8V5N=')A=&EO;B!O9B!#6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,S9P="<^($9I;F%N8VEA;"!I;G-T2!O9B!TF5D M+"!H879E(&)E96X@=VET:&EN('1H92!R86YG92!O9B!M86YA9V5M96YT)B,S M.3MS(&5X<&5C=&%T:6]N2!L87)G M92!C=7-T;VUE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@2!S=&]C:R!M971H;V0@86YD('1H92!A=F5R86=E M(&UA6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0V-"4^)FYB6QE/3-$)T)/ M4D1%4BU43U`Z(&)L86-K(#`N-7!T('-O;&ED.R!$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@1F]R('1H92!996%R/"]D:78^ M(#QD:78@6QE/3-$)T)/4D1%4BU43U`Z(&)L86-K(#`N M-7!T('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@ M0D]21$52+51/4#H@8FQA8VL@,"XU<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)T)/4D1%4BU4 M3U`Z(&)L86-K(#`N-7!T('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@3G5M97)A=&]R/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3F5T(&EN8V]M93PO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D M/B`\=&0@#L@ M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!$96YO;6EN871O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M169F96-T(&]F(&1I;'5T:79E('-E8W5R:71I97,Z/"]D:78^(#PO=&0^(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4W1O8VL@;W!T M:6]N6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@4F5S=')I8W1E9"!S=&]C:R!U;FET M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y' M+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@ M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3XS+#(R-2PQ,S,\+W1D/B`\=&0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1&EL M=71E9"!W96EG:'1E9"!A=F5R86=E('-H87)E6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/ M5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@3F5T(&EN8V]M92!P97(@8V]M;6]N('-H87)E/"]D M:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XP M,CPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M,"XP,CPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XP,CPO=&0^(#QT9"!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XP,CPO=&0^(#QT9"!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`S-G!T)SX@4&]T96YT:6%L;'D@9&EL=71I=F4@65A M2!D:6QU M=&EV92!S96-U&-L=61E9"!F6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O M;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@061V97)T:7-I;F<@ M17AP96YS97,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#,V<'0G/B!792!F;VQL;W<@=&AE M('!O;&EC>2!O9B!C:&%R9VEN9R!T:&4@8V]S=',@;V8@861V97)T:7-I;F<@ M=&\@97AP96YS92!A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z M(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@3V9F+4)A;&%N8V4@4VAE970@07)R86YG96UE;G1S/"]D M:78^(#QD:78@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`S-G!T)SX@5V4@:&%V92!N;R!O9F8M8F%L86YC92!S M:&5E="!A'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!296-E;G0@06-C M;W5N=&EN9R!06QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^ M($EN($%U9W5S="`R,#$R+"!T:&4@1D%30B!I6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q! M63H@:6YL:6YE)SY496-H;FEC86P@06UE;F1M96YT'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T M)SX@26X@2G5L>2`R,#$R+"!T:&4@1D%30B!I6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@ M:6YL:6YE)SY);G1A;F=I8FQE7!A&%M<&QE2!A;F0@;6%R:V5T(&-O;F1I=&EO;G,L(&%N9"`V*2!M86-R;V5C;VYO M;6EC(&-O;F1I=&EO;G,N(%1H92!5<&1A=&4@:7,@969F96-T:79E(&9O2!A9&]P=&EO;B!I2`R-RP@ M,C`Q,B!I9B!T:&4@9FEN86YC:6%L('-T871E;65N=',@:&%V92!N;W0@8F5E M;B!I6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@26X@2G5N92`R,#$Q M+"!T:&4@1D%30B!I6QE/3-$ M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;VUP65A2!A9&]P=&EO;B!I65A M'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@26X@4V5P=&5M8F5R(#(P,3$L('1H M92!&05-"(&ES2!H;W<@96YT:71I97,@=&5S M="!G;V]D=VEL;"!F;W(@:6UP86ER;65N="X@5&AI2!T M:&%N(&YO="!T:&%T('1H92!F86ER('9A;'5E(&]F(&$@6EN9R!A;6]U;G0@87,@82!B87-I M2!T:&%N(&YO="!T:')E2!S<&5C:69I8R!E=F5N=',@86YD(#8I('-UF4@=&AE('%U86QI=&%T:79E(&%S7!I8V%L;'D@9&]N92!D=7)I M;F<@=&AE(#0\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@-S`E.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`G/G1H/"]F;VYT M/B!Q=6%R=&5R+CPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S M-G!T)SX@26X@36%Y(#(P,3$L('1H92!&05-"(&ES2!O9B!F86ER M('9A;'5E(&UE87-UF%T:6]N(&)Y(&QE=F5L(&9O7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^($EN8VQU M9&5D(&EN(&]U3L@*&EI*2`D-#0L-#65E('1R879E;"!A9'9A;F-E3L@;&5S6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,S9P="<^($EN8VQU9&5D(&EN('1H92!N=6UB97)S(&%B;W9E(&ES(&]U M'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`S-G!T)SX@3W5R(&QA'1E;G-I;VX@=&AR;W5G:"!-87D@,S$L(#(P,3,@=&\@8V]N=&EN=64@=&\@ M<')O=FED92!S97)V:6-E2!L87)G92!C=7-T;VUE M3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=? M83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@ M8VAA2!&:6YA;F-I;F<@86YD('1H92!$96)T(%)E2!&:6YA;F-I;F<@86YD('1H92!$ M96)T(%)E&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^ M(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B!.;W1E(#0@+2!%<75I='D@1FEN86YC:6YG(&%N M9"!T:&4@1&5B="!297-T'0M86QI9VXZ(&IU2!V97)B86QL M>2!I;F-R96%S960@=&\@)#$P+#`P,"PP,#`L(&]F('1H92!#;VUP86YY)B,S M.3MS('-E8W5R:71I97,L('-U8FIE8W0@=&\@82!M:6YI;75M(&=R;W-S(&-O M;G-I9&5R871I;VX@;V8@)#,L,#`P+#`P,"X@5&AE($-O;7!A;GD@86=R965D M('1O('!A>2!T;R!-1$(@82!C;VUM:7-S:6]N(&]F(#$P)2!O9B!T:&4@9W)O M'!E;G-E'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@4'5R&-E M960@=&AE(&YU;6)EF5D('-H87)EF5D M('-H87)E&-E'1I;F=U:7-H('1H M92!"(%=A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@ M+SX@/"]D:78^(#QD:78@'0M86QI9VXZ M(&IU'!E;G-E2`D-BXQ(&UI;&QI M;VXN($-O:6YC:61E;G0@=&\@=&AE(&-L;W-I;F<@;V8@=&AE(#(P,3(@17%U M:71Y($9I;F%N8VEN9RP@=V4@86QS;R!C;&]S960@;VX@=&AE(#(P,3(@1&5B M="!297-T'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S M-G!T)SX@26X@1&5C96UB97(@,C`Q,2P@=V4@96YT97)E9"!I;G1O(&$@;&]A M;B!W:71H(#<@86-C2!D871E(&]F($9E M8G)U87)Y(#(X+"`R,#$R+"!W:&EC:"!W87,@65A'1E;G-I;VX@;V8@=&AE(&UA='5R:71Y(&1A=&4@;V8@=&AE M($)R:61G92!,;V%N+"!W92!G3L@ M5$585"U)3D1%3E0Z(#,V<'0G/B!);B!C;VYN96-T:6]N('=I=&@@=&AE(#(P M,3(@17%U:71Y($9I;F%N8VEN9R!A;F0@=6YD97(@=&AE('1E2!& M:6YA;F-I;F2!&:6YA;F-I;F2!F:6QE9"!T:&4@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,S9P="<^($]N($%P2!&:6YA;F-I;F6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,S9P="<^($%L M;"!W87)R86YT2!W:71H(&$@ M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\ M8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0T,"4^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!#;VUM;VX\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4VAA'0M86QI9VXZ(&-E;G1E M#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5. M5#H@,'!T)SX@5F%L=64@;V8@03PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!7 M87)R86YT'0M86QI M9VXZ(&-E;G1E6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$ M14Y4.B`P<'0G/B!4;W1A;#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!787)R M86YT/"]D:78^(#QD:78@'0M86QI9VXZ M(&-E;G1E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^,3(L-#`X+#`P,#PO=&0^(#QT9"!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^-#8Y+#0V-#PO=&0^(#QT9"!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,SDL,S@W/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!"6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M.#`P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,BPU,SD\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S(L.#`W/"]T9#X@/'1D M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^,S6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB M6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@06=E;F-Y/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`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`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R<'@@#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ,RPU,S$\+W1D/B`\=&0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4 M;W1A;#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0 M041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/ M5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS M1')I9VAT/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3@L-#6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0 M041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#XF;F)S<#L\ M+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB2!O9B`D-S4W+#0V.2!W87,@8V%L8W5L M871E9"!A65A2!O9B`X-2XT.24[("AI=BD@97AP96-T960@9&EV:61E M;F0@>6EE;&0@;V8@,"XP,"4[(&%N9"`H=BD@'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@3VX@1&5C96UB97(@,C0L(#(P,3`L M('=E(&-L;W-E9"!O;B!A;B!E<75I='D@9FEN86YC:6YG("AT:&4@(D5Q=6ET M>2!&:6YA;F-I;F2`D,3@P+#`P,"!U<&]N M('1H92!C;&]S:6YG(&]F('1H92!%<75I='D@1FEN86YC:6YG(&%N9"!T:&4@ M2!! M9W)E96UE;G0L('=E(&5N=&5R960@:6YT;R!3=6)S8W)I<'1I;VX@06=R965M M96YT65A&5R8VES92!P M2!&:6YA;F-I;F'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`S-G!T)SX@3F5T('!R;V-E961S(&9R;VT@=&AE($5Q M=6ET>2!&:6YA;F-I;F6%B;&4@=&\@4$)# M(&%N9"!T:&4@97-T:6UA=&5D(&QE9V%L+"!P2!&:6YA M;F-I;F<@=&\@<&%Y(&1O=VX@9&5B="!A;F0@=&AE(')E;6%I;F1E6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P M="<^($]N($YO=F5M8F5R(#(Y+"`R,#$P+"!W92!E;G1E2!&:6YA;F-I;F<@86YD('5N M9&5R('1H92!T97)M'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`S-G!T)SX@3VX@1&5C96UB97(@,C0L(#(P,3`L('=E(&%L6%B;&4@2X@5V4@<&%I9"!T:&4@9FER65A2!T:6UE('5P;VX@;F]T:6-E(&)Y($-A2!T97)M M6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^5&AE($EN=F5S=&]R M(%)I9VAT2!#87-T M;&5R:6=G+B!4:&5S92!R96=I2!T;R!I'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@1'5R:6YG('1H92!T:')E M92!M;VYT:',@96YD960@36%R8V@@,S$L(#(P,3$L('=E(&ES'0M86QI9VXZ M(&IU2!& M:6YA;F-I;F<@=V%S('5S960@=&\@8VQO6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,S9P="<^($EN=F5S=&]R('=A&5R8VES92!P6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`S-G!T)SX@5V4@2!!9W)E96UE;G0N($$@ M9&5R:79A=&EV92!V86QU871I;VX@9V%I;B!O9B`D,BPW-C4L-C`P(&%N9"`D M-RPX-S4L,#`P+"!R97-P96-T:79E;'DL('=E'!E8W1E9"!L:69E("AI;B!Y96%R'!E8W1E9"!V;VQA=&EL:71Y(&]F(#@U+C$P)3L@ M*&EV*2!E>'!E8W1E9"!D:79I9&5N9"!Y:65L9"!O9B`P+C`P)3L@86YD("AV M*2!S=&]C:R!T3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=?83,Y9%\S M-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&1B M-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@8VAA6%B;&4\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@ M/'1H(&-L87-S/3-$=&@@8V]L6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^ M/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!.;W1E(#4@+2!.;W1E'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`S-G!T)SX@5&AE(')E8V]R9&5D('9A;'5E(&]F(&]U6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X M)R!V86QI9VX],T1B;W1T;VT^)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX] M,T1B;W1T;VT^)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X] M,T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@1&5C96UB M97(@,S$L/"]D:78^(#QD:78@'0M86QI M9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/ M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M;F]W"<@=F%L:6=N/3-$ M8F]T=&]M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R<'@@'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R,#$R/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,B!396-U6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@06UE;F1E9"!A;F0@4F5S=&%T960@4V5N:6]R(#8N M,C4E($-O;G9E6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!"6%B;&4\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@ M6QE M/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!%<75I<&UE M;G0@4'5R8VAA6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@ M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3XW,#`L,#`P/"]T9#X@/'1D('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO=&0^(#QT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$ M24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4 M;W1A;#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1R:6=H="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M."PT,36QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)U!!1$1) M3D'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!,97-S($-U6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R<'@@#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B9N8G-P.SPO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^(%1O=&%L($QO;F6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^-BPS-#DL-#0U/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0 M041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S M-G!T)SX@5V4@96YG86=E9"!0:&EL861E;'!H:6$@0G)O:V5R86=E($-O2!N;W1E'!L86EN960@ M8F5L;W2!A;&P@;V8@;W5R(&%S&-E<'1I;VX@;V8@=&AE(&5Q=6EP;65N="!A;F0@2!T:&4@97%U:7!M96YT(&QE2!I'1I;F=U:7-H960@=&AE($)R:61G92!,;V%N+B!/ M9B!T:&4@)#$L,#`P+#`P,"!N;VXM8V]N=F5R=&5D('!R:6YC:7!A;"!A;6]U M;G0L('=E(')E86QI>F5D("0Y,C,L,32!IF5D(&-A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,S9P="<^(%1H92!N M;W1E'!E8W1E9"!V;VQA=&EL:71Y M(&]F(#$R.2XP."4L("AI=BD@97AP96-T960@9&EV:61E;F0@>6EE;&0@;V8@ M,"XP,"4[(&%N9"`H=BD@2!O9B`D,3@S M+#`P,"!A'!E8W1E9"!V;VQA=&EL:71Y(&]F(#@U+C'!E M8W1E9"!D:79I9&5N9"!Y:65L9"!O9B`P+C`P)3L@86YD("AV*2!S=&]C:R!T M6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!5;G-E8W5R960@0V]N=F5R=&EB;&4@3F]T93PO9&EV/B`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@3VX@4V5P=&5M8F5R M(#(Y+"`R,#`V+"!W92!E;G1E2!A(&-O;G9E6EN9R!W M87)R86YT2!U6%B;&4@ M2!I;B!C87-H(&]R('-H87)E65A M2!F;W5R(&UO;G1H&5R8VES92!P&5R8VES M92!P&5R8VES960@-#4T+#`P,"!!(%=A'1E;F1E9"!F&5R8VES960@86YD M(&5X<&ER960N/"]D:78^(#QD:78@'1E;F1E9"!T:&4@;F]T92!M871U2!D871E('1O($1E8V5M8F5R(#(R+"`R,#$P(&%N9"`H:6DI(&EN8W)E87-E M9"!T:&4@86YN=6%L(')A=&4@;V8@:6YT97)E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@3VX@1&5C M96UB97(@,C0L(#(P,3`@=V4@8VQO2!D871E M(&]F('1H92!N;W1E('=A'1E;F1E9"!T;R!$96-E;6)E'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@ M5V4@2!S:6YC92!$96-E;6)E2X@5&AE(&%G9W)E9V%T92!D97)I=F%T:79E(&QI M86)I;&ET>2!O9B`D-#8L-#`P(&9O65A2!O9B`Q,3(N,#0E.R`H:78I(&5X<&5C=&5D(&1I M=FED96YD('EI96QD(&]F(#`N,#`E.R!A;F0@*'8I('-T;V-K('1R861I;F<@ M<')I8V4@;V8@)#`N,#@N/"]D:78^(#QD:78@65AF%T:6]N(&%N9"!D979E;&]P;65N="!A;F0@9F]R(&=E;F5R86P@ M=V]R:VEN9R!C87!I=&%L('!U'1E;F1E9"!T;R!$96-E;6)E65A2!A;F0@8V]M;65N8V5D(&EN($%P M6UE;G1S(&UA>2!B92!M861E('1H2!T:6UE(&1U2!I;G1E6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P M="<^($9R;VT@36%R8V@@,C8L(#(P,3`@=&AR;W5G:"!/8W1O8F5R(#(Y+"`R M,#$P+"!W92!E;G1E2!A;65N9&5D M('1H92!M871U2!D871E(&]F('1H92!N;W1E('1O($1E8V5M8F5R(#(Q M+"`R,#$Q+B!)9B!W92!A2!F:6YA;F-I;F<@8F5F;W)E M(%-E<'1E;6)E6UE;G1S(&]N(&]U6EN9R!T:&4@)#$N,"!M:6QL:6]N('5N M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@ M3VX@2G5L>2`S,"P@,C`Q,"P@=V4@96YT97)E9"!I;G1O(&$@9G5R=&AE2!D871E(&]F('1H92!N;W1E('=I;&P@875T;VUA=&EC86QL>2!B M92!R97-T;W)E9"!T;R!I=',@;W)I9VEN86P@9&%T92!O9B!$96-E;6)E2!B971W965N(&YO=R!A;F0@4V5P=&5M8F5R(#,P+"`R,#$P(&%N9"!R961U M8V5D('1H92!R97%U:7)E9"!C87-H(&)A;&%N8V4@2!G2!T M:6UE(&9O'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`S-G!T)SX@3VX@4V5P=&5M8F5R(#(W+"`R,#$P+"!W92!E;G1E2!F:6YA M;F-I;F<@=V%S(&5X=&5N9&5D('1O($]C=&]B97(@,S$L(#(P,3`N/"]D:78^ M(#QD:78@'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`S-G!T)SX@3VX@3V-T;V)E&EM871E;'D@)#(N-2!M:6QL:6]N(&]F('=H:6-H(&AA9"!B M965N(')A:7-E9"!O2!C;VUM;VX@65A6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^86P@=&\@,34P)2!O9B!T:&4@ M;&]W97-T('!R:6-E(&%T('=H:6-H($-O;7!A;GD@8V]M;6]N('-T;V-K(&ES M('-O;&0@9'5R:6YG(&-A;&5N9&%R('EE87(@,C`Q,#L@*'9I*2!P'!I2!D871E('=I;&P@2!S96-U&5R8VES92!P&EM871E;'D@)#65A'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@5&AE M($%M96YD960@86YD(%)E6%B;&4@ M2X@5V4@<&%I9"!T:&4@9FER65A2!T:6UE('5P;VX@ M;F]T:6-E(&)Y($-A'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`S-G!T)SX@/&9O;G0@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,S9P="<^($$@<&]R=&EO;B!O9B!T:&4@;F5T('!R;V-E961S(&9R M;VT@=&AE(#(P,3(@17%U:71Y($9I;F%N8VEN9R!W87,@=7-E9"!T;R!C;&]S M92!O;B!T:&4@,C`Q,B!$96)T(%)E'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`S-G!T)SX@5VET:"!T:&4@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^(%1H92`D-BPQ.#`L.#$V M('9A;'5E(&]F('1H92!!;65N9&5D(&%N9"!297-T871E9"!.;W1E(&%T($1E M8V5M8F5R(#,Q+"`R,#$Q(&-O;G-I6%B;&4@:6X@,C`Q,B!A;F0@:&%S(&)E96X@:6YC;'5D960@ M:6X@8W5R'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!!8V-O M=6YT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^($1U65A M2!I2P@ M=V%S(')E8V]R9&5D('1O(')E9FQE8W0@=&AE(&-H86YG92!I;B!V86QU92!O M9B!T:&4@86=G'!E8W1E9"!V;VQA M=&EL:71Y(&]F(#@S+C$V)3L@*&EV*2!E>'!E8W1E9"!D:79I9&5N9"!Y:65L M9"!O9B`P+C`P)3L@86YD("AV*2!S=&]C:R!T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,S9P="<^(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^26X@8V]N;F5C=&EO;B!W:71H('1H92!"6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,S9P="<^($]N($UA6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@06QL('=A'!E;G-E(')E;&%T960@=&\@=6YR96-O9VYI>F5D(&]F9F5R:6YG(&-O2!O9B`D-RPT,#`@65A M2!O9B`X,BXU M-24[("AI=BD@97AP96-T960@9&EV:61E;F0@>6EE;&0@;V8@,"XP,"4[(&%N M9"`H=BD@2!D M871E+B!!(&1E'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S M-G!T)SX@5&AE('!R:6YC:7!A;"!V86QU92!O9B!T:&4@;F]T92!W87,@8F5I M;F<@86-C6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($5Q=6EP M;65N="!0=7)C:&%S92!A;F0@4V%L92!!9W)E96UE;G0\+V1I=CX@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:R<^/&)R M("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@26X@3V-T;V)E'!E;G-E(&9O65A3L@5$585"U)3D1%3E0Z(#,V<'0G M/B!/;B!-87)C:"`R-BP@,C`Q,BP@=V4@8VQO2!&:6YA;F-I;F<@86YD('5N9&5R('1H92!T97)M6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD M:78@'0M86QI9VXZ(&IU65A M'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT M;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I M=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z(#!P="<^($YO=&4@-B`M($EN=F5S=&UE;G0@:6X@26YT97)A8W0@ M1&5V:6-E'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@5V4@ M8F5G86X@:6YV97-T:6YG(&EN(&%N9"!A9'9A;F-I;F<@;6]N:65S('1O($E$ M22!I;B`R,#`Q+B!)1$D@=V%S(&1E=F5L;W!I;F<@=&5C:&YO;&]G>2!W:&EC M:"!B96-A;64@86X@:6YI=&EA;"!P87)T(&]F('1H92!#;V1E8U-Y6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^($]N($]C=&]B97(@,C,L M(#(P,#,L($E$22!F:6QE9"!F;W(@0VAA<'1EF%T:6]N+"!W:&5R96)Y('=E('=O=6QD('-A=&ES9GD@=&AE(&1E M8G1S(&]F('1H92!C2!#;W5R="X@07,@82!R97-U;'0@;V8@=&AI&-H86YG92!F;W(@87!P M2`U,"PQ,C&EM871E;'D@ M.30E(&]F('1H92!T;W1A;"!O=71S=&%N9&EN9R!)1$D@6UE;G0@;V8@;W!E7,@=&5C:&YO;&]G>2X@07,@;V8@1&5C96UB97(@,S$L(#(P,3(@86YD M(#(P,3$L('=E(&AA=F4@861V86YC960@86X@86=G2P@<'5R M2!O9B!)1$DN/"]D:78^(#PA+2U%;F1& M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I M=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^($YO=&4@-R`M($]P97)A=&EN9R!,96%S97,\ M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#,V<'0G/B!/=7(@97AE8W5T:79E(&]F9FEC97,@ M87)E(&QO8V%T960@870@-S`U,"!5;FEO;B!087)K($%V96YU92P@4W5I=&4@ M-C`P+"!386QT($QA:V4@0VET>2P@571A:"`X-#`T-RX@5V4@;V-C=7!Y('1H M92!S<&%C92!A="!T:&4@97AE8W5T:79E(&]F9FEC97,@=6YD97(@82`S.2UM M;VYT:"!L96%S92P@=&AE('1E&EM871E;'D@,3,L.#@P M('-Q=6%R92!F965T(&]F(&]F9FEC92!S<&%C92!L96%S960@870@82!R871E M(&]F("0R,RPP-#D@<&5R(&UO;G1H+B!792!O8V-U<'D@82!PF5D(')E;G0@97AP96YS92!O9B!A<'!R;WAI;6%T M96QY("0S-3(L-S@Y(&%N9"`D-#8S+#8Y-"P@:6X@,C`Q,B!A;F0@,C`Q,2P@ M6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^(%=E(&%L2!M86-H:6YE6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`S-G!T)SX@1G5T=7)E(&UI;FEM=6T@<&%Y;65N=',@=6YD97(@;F]N+6-A M;F-E;&%B;&4@;W!E6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@ M6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8P)3X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^(#(P,30\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-C`E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q-3PO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B9N8G-P.SPO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C`E/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&5S(%M!8G-T&5S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O M5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O M=W=W+G&5S/"]D:78^(#QD:78@'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@1&5F97)R960@=&%X97,@ M87)E('!R;W9I9&5D(&]N(&$@;&EA8FEL:71Y(&UE=&AO9"!W:&5R96)Y(&1E M9F5R"!A2UF;W)W87)DF5D(&9O2!D:69F97)E;F-E"!A"!L87=S(&%N9"!R871E'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@3F5T(&1E9F5R"!L M:6%B:6QI=&EE6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9#L@4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M/B9N M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#)P>"<@ M=F%L:6=N/3-$8F]T=&]M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3D],(&-A6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,C4L.#@Q+#DP,#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1V5N97)A;"!B=7-I M;F5S6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,2PQ-#6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2PQ-3@L.3`P/"]T M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^,C$L,#`P/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^,S$L-C`P/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB"!L:6%B:6QI=&EE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^)FYB'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!$97!R96-I871I;VX\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$ M;&5F="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#$W,RPP,#`\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-C$L-S`P M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@5F%L=6%T:6]N(&%L;&]W86YC93PO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3XH,C0L.30Q+#`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3F5T(&1E9F5R"!A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/ M33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^ M(%1H92!I;F-O;64@=&%X('!R;W9I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G M/B`\=&%B;&4@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O M;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$ M1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF;F)S M<#L\+W1D/B`\+W1R/B`\='(^(#QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M;F]W'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!&961E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2PY,#(L-3`P/"]T9#X@ M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB M6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@0VAA;F=E(&EN('9A;'5A=&EO;B!A;&QO=V%N8V4\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/ M5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS M1')I9VAT/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W-B4^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@ M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#QB2UF;W)W87)D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@1'5E('1O(&-H M86YG92!I;B!O=VYE2!B92!L:6UI=&5D(&%S('1O('5S92!I;B!F M=71U65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO M+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L M+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($YO=&4@.2`M(%!R969E M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@ M5V4@:&%V92!A=71H;W)I>F5D('1W;R!C;&%S'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T M)SX@1'5R:6YG('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$R+"!W M92!I2!&:6YA;F-I;F<@86YD($1E8G0@4F5S=')U8W1U'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@1'5R:6YG('1H92!Y96%R(&5N M9&5D($1E8V5M8F5R(#,Q+"`R,#$Q+"!W92!I'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^/"$M M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z(#!P="<^($YO=&4@,3`@+2!3=&]C:RUB87-E9"!#;VUP96YS871I;VX\ M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#,V<'0G/B!);B!A8V-O'!E8W1E9"!T M;R!V97-T+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!3=&]C:R!);F-E;G1I=F4@4&QA;G,\+V1I=CX@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#,V M<'0G/B`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/E5N9&5R('1H M92!"2X\+V9O;G0^($]P=&EO;G,@9V5N97)A;&QY(&UA>2!N;W0@8F4@97AE2!T:&4@8F]A'!E8W1E9"!L:69E+B!/=7(@8V]M<'5T871I M;VX@;V8@97AP96-T960@=F]L871I;&ET>2!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,S9P="<^(%1H92!"2!);F-E;G1I=F4@4&QA;B`H=&AE("(R M,#`X(%!L86XB*2!H87,@8F5C;VUE(&]U6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!3=&]C:R!/<'1I;VYS/"]D:78^(#QD M:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`S-G!T)SX@/&9O;G0@'!E M8W1E9"!V;VQA=&EL:71Y(&ES(&)A2X@/&9O;G0@2!E<75A;"!T;R!T:&4@97AP96-T960@=&5R;2!O9B!T:&4@ M&5R8VES92!P871T97)N6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^ M(%1H92!F86ER('9A;'5E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M'0M86QI9VXZ(&-E;G1E M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ M(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@17AP96-T960@;&EF92`H:6X@>65A'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!%>'!E8W1E9"!V;VQA=&EL:71Y/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1T;W`@=VED=&@],T0Q-B4^(#QD:78@'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M M24Y$14Y4.B`P<'0G/B`X,"XX.24\+V1I=CX@/"]T9#X@/"]T'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!%>'!E8W1E9"!D:79I9&5N M9"!Y:65L9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$ M,38E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT M97([(%1%6%0M24Y$14Y4.B`P<'0G/B`P+C`P)3PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$=&]P('=I9'1H/3-$,38E/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`P M+C`P)3PO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:R<^/&)R M("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^(%1H92!W96EG:'1E9"!A=F5R M86=E(&9A:7(@=F%L=64@;V8@;W!T:6]N65A2X\+V1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5V%R'!E8W1E9"!V;VQA=&EL:71Y M(&ES(&)A2X@/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`S-G!T)SX@5&AE(&9A:7(@=F%L=65S(&9O6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E'0M M86QI9VXZ(&-E;G1E'0M86QI M9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`S-G!T)SX@5&AE('=E:6=H=&5D(&%V97)A9V4@9F%I65A2X\+V1I=CX@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:R<^/&)R("\^(#PO9&EV/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,S9P="<^(%)E'!E;G-E+B!2 M97-T2X@06QL(&]T:&5R(')E2!A6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`S-G!T)SX@1F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$R M('=E(')E8V]G;FEZ960@)#(X,RPV.3(@;V8@2`Q M+"`R,#$R+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^($9O65AF5D("0R+#(V,BPU M-#`@;V8@65E'!I2P@=V4@:7-S=65D("AI*2`R,C$L-S4X('=A&5R8VES960@:6X@=&AE('EE87(@ M96YD:6YG($1E8V5M8F5R(#,Q+"`R,#$Q+CPO9&EV/B`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`S-G!T)SX@5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM M87)I>F5S(&]P=&EO;B!A;F0@=V%R2!D=7)I;F<@=&AE M('EE87)S(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$R(&%N9"`R,#$Q+CPO9&EV M/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE'0M86QI9VXZ(&-E;G1E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$ M1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E(&-O;'-P M86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E&5R8VES93PO9&EV/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4')I8V4\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@.7!T)SX@3W!T:6]N M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3XF;F)S<#L\+W1D/B`\=&0@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!787)R86YT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^)FYB'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!%>'!I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@.7!T M)SX@1F]R9F5I=&5D/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`Y<'0G/B!%>&5R8VES960\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^)FYB'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/=71S=&%N9&EN9R!A="!$96-E M;6)E6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E/C(P+#0T,"PU-3$\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E/C4P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M/C`N,S<\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/C(T+#@Q-RPY M,#`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!&;W)F M96ET960\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/C$N M,S$\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@.7!T)SX@17AE"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#XF;F)S<#L\+W1D M/B`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`R<'@@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\ M+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-S`E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^($]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/ M33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`S-G!T)SX@5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S(&EN9F]R M;6%T:6]N(&%B;W5T('-T;V-K(&]P=&EO;G,@86YD('=A6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W"<@=F%L:6=N/3-$8F]T=&]M/B9N M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M<'@@'0M86QI9VXZ M(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0U(&YO=W)A<#TS1&YO=W)A<#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4 M15A4+4E.1$5.5#H@,'!T)SX@17AE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@ M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B!296UA:6YI;F<\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B!286YG92!O9CPO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!%>&5R8VES92!06QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('9A M;&EG;CTS1&)O='1O;3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!.=6UB97(\+V1I=CX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4 M15A4+4E.1$5.5#H@,'!T)SX@3W5T6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0G('9A;&EG;CTS1&)O='1O;3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!#;VYT M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!,:69E("AY96%R6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0 M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@;F]W"<@ M=F%L:6=N/3-$8F]T=&]M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R<'@@'0M86QI9VXZ(&-E;G1E'0M M86QI9VXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@ M,'!T)SX@3G5M8F5R/"]D:78^(#QD:78@'0M86QI9VXZ(&-E;G1E#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!%>&5R8VES93PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!06QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!C M96YT97(G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C0N,S8\+W1D/B`\ M=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!C96YT97(G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE/C`N-#<\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/ M33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@ M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!C96YT97(G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C`N M,3#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@;F]W#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@;F]W#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,S9P="<^(%1H97)E('=E&5R8VES M960@:6X@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,3(@86YD(#4U M+#`Y."!O<'1I;VYS('=E6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@2X@5&AE(&-OF5D(&EN(&%C8V]R9&%N8V4@ M=VET:"!T:&4@=F5S=&EN9R!S8VAE9'5L92X@06QL(&]F('1H92!R97-T2!W M97)E(&%W87)D960N/"]D:78^(#QD:78@2!O9B!R97-T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^.CPO M9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G M/B`\=&%B;&4@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-S8E/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@1W)A;G0\+V1I=CX@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@1&%T92!&86ER/"]D:78^ M(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,2PV,#`L,#`P/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@.7!T)SX@0V%N8V5L960O1F]R9F5I=&5D/"]D:78^(#PO=&0^ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@.7!T)SX@4V5T M=&QE9"!B>2!I6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B9N8G-P.SPO=&0^(#QT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S M<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,2XR-3PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@.7!T)SX@07=A6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@.7!T)SX@0V%N M8V5L960O1F]R9F5I=&5D/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@.7!T)SX@4V5T=&QE9"!B>2!I6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@ M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/ M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N M/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($]U='-T86YD:6YG(&%T($1E8V5M M8F5R(#,Q+"`R,#$R/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB M6QE M/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!697-T960@ M870@1&5C96UB97(@,S$L(#(P,3(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U M8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^,BPY-#`L,3,S/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^($EN8VQU9&5D(&EN('-T;V-K M(&)A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^($EN8VQU9&5D M(&EN('-T;V-K(&)A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,S9P="<^(%1H92!I;7!A8W0@;VX@;W5R(')E'0M86QI9VXZ(&-E;G1E M65A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5. M5#H@,'!T)SX@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$ M1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P M86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E. M1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!' M96YE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^,3@U+#0W.#PO=&0^(#QT9"!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%)E6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3XY."PR,30\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR,3DL,34T/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5&]T86P\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,C@S+#8Y,CPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^(%1O=&%L('5N'!E8W0@=&\@'0@=&AR964@>65A6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`R M,#$S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1')I9VAT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S`E/C$Q."PQ M,C<\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q-3PO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B9N M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M<'@@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@5&]T86P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U M8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@ M+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($YO=&4@,3$@+2!%<75I<&UE;G0@ M1FEN86YC:6YG/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@3VX@075G=7-T(#(W M+"`R,#`Y+"!W92!C;VUP;&5T960@86X@97%U:7!M96YT(&QE87-E(&9I;F%N M8VEN9R!T6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,S9P="<^(%=E(&5N=&5R960@:6YT;R!A($UA2`R."P@,C`P.2!W:71H M('1H92!F:6YA;F-I86P@:6YS=&ET=71I;VX@<'5R&EM871E;'D@,BPQ,#`@;&]C871I;VYS*2!O M9B!O=7(@8W5S=&]M97(F(S,Y.W,@&-H M86YG92!F;W(@82!O;F4M=&EM92!P87EM96YT(&]F("0T+#$P,"PV-S`@8GD@ M=&AE(&9I;F%N8VEA;"!I;G-T:71U=&EO;BX@5V4@<&%I9"!T;R!T:&4@9FEN M86YC:6%L(&EN2`D,30T+#`P,"!P;'5S(&%P<&QI8V%B;&4@2`Q,"4@;V8@ M=&AE(&]R:6=I;F%L(&5Q=6EP;65N="!V86QU92`H87!P2`D M-#$P+#`P,"D@;W(@=&AE('1H96X@(FEN+7!L86-E(&9A:7(@;6%R:V5T('9A M;'5E(B!A9G1E&-E961S('1H92`Q,"4@;V8@=&AE(&]R:6=I M;F%L(&QE87-E('9A;'5E(&%N9"!B>2!W:&%T(&%M;W5N="X@5V4@8V]N=&5N M9"!T:&%T('1H92!T:')E92!P87EM96YT&5R8VES:6YG(&]U'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@1'5R:6YG(#(P,3(@=V4@:&%D(&UA M9&4@;&5A2`D,2PQ M,C4L-3@X(&]F('=H:6-H("0Q+#`V-RPV-#D@=V%S(&%P<&QI960@=&]W87)D M('1H92!O=71S=&%N9&EN9R!L96%S92!A;F0@)#4W+#DS.2!W87,@:6YC;'5D M960@:6X@:6YT97)E2`D-#(R+#$P,"!P86ED('1O=V%R9"!T M:&4@:6X@<&QA8V4@9F%I2!D M=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,3(@=V4@;6%D M92!P87EM96YT6UE;G1S('1O=&%L M:6YG(&%P<')O>&EM871E;'D@)#$L-C@X+#,X,B!O9B!W:&EC:"`D,2PT,C,L M-3(X('=A'!E;G-E M+B!!9&1I=&EO;F%L;'DL('=E(&5X<&5NF5D(&]V97(@=&AE(&QI9F4@;V8@=&AE(&QE87-E(&EN8VQU M9&5D(&EN(&EN=&5R97-T(&5X<&5N3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W M7V$S.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R&AT;6PQ+71R86YS:71I;VYA;"YD=&0B M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.;W1E(#$R("T@1F%I2`Q+"`R,#`X(&9O2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T M871E2!W:&EC:"!P6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@/&)R M("\^(#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y M;6)O;"P@'0M M86QI9VXZ(&QE9G0G/B!,979E;"`Q+"!D969I;F5D(&%S(&]B6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!3>6UB;VPL('-E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)SX@3&5V96P@,BP@9&5F:6YE M9"!A2!O6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@/&)R("\^(#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@9F]N="UF86UI;'DZ(%-Y;6)O;"P@'0M86QI9VXZ(&QE9G0G/B!,979E;"`S+"!D M969I;F5D(&%S('5N;V)S97)V86)L92!I;G!U=',@:6X@=VAI8V@@;&ET=&QE M(&]R(&YO(&UA6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,3AP="<^(%=E(&UE87-U6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0G/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@ M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M(%-I9VYI9FEC86YT/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@;F]W'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@475O=&5D(%!R:6-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@06-T:79E($UA6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^($]B M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W M'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M56YO8G-E6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^($EN<'5T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/ M33H@,G!X)R!V86QI9VX],T1B;W1T;VT^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@ M'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@5&]T86P\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/ M33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W M"<@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^("A,979E;"`Q*3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@*$QE=F5L(#(I/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@;F]W'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!!6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)U!!1$1)3D'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.;VYE/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R M:6=H=#XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM+3PO=&0^(#QT9"!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`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`\=&0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM+3PO M=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&]T86P@87-S971S(&UE87-U6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$ M24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/ M33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I M9VAT/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/ M33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@ M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\ M+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB#L@4$%$1$E.1RU,1494.B`S M)2<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E(&%L:6=N/3-$;&5F=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z(#!P="<^($1E6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\ M+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@;F]W"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#XF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\ M=&0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ+#$Y,2PR-CD\ M+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E(&%L:6=N M/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%1O=&%L(&QI86)I;&ET:65S(&UE M87-U6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U M8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B`\=&%B;&4@6QE/3-$)U=)1%1(.B`Q.'!T)R!A;&EG M;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@*#$I/"]D:78^(#PO=&0^(#QT M9"!A;&EG;CTS1&QE9G0^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!3964@3F]T97,@-"`F M86UP.R`U(&9O2!F:6YA;F-I86P@:6YS=')U M;65N=',@:6X@3&5V96P@,R!O9B!T:&4@9F%I6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^($1E6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(%9A;'5A=&EO;CPO M9&EV/B`\+W1D/B`\=&0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@3&EA8FEL:71Y/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!"86QA;F-E(&%T($1E8V5M8F5R(#,Q M+"`R,#$Q/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1')I9VAT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/B@S M+#'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4;W1A;"!G86ENF5D(&%N9"!U;G)E86QI>F5D*3PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@26YC;'5D960@:6X@;F5T(&EN8V]M93PO9&EV M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1R:6=H="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/C@L.#(Y+#6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@5F%L=6%T:6]N(&%D:G5S=&UE;G0\+V1I=CX@/"]T9#X@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!0 M=7)C:&%S97,L(&ES6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#QT6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@5')A;G-F97)S('1O($QE=F5L(#,\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!" M86QA;F-E(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#XF M;F)S<#L\+W1D/B`\=&0@#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!-;VYE>2!-87)K970@1G5N M9',@86YD(%1R96%S=7)Y(%-E8W5R:71I97,\+V1I=CX@/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:R<^/&)R("\^(#PO M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,S9P="<^(%1H92!M;VYE>2!M87)K970@9G5N9',@ M86YD('1R96%S=7)Y(&-A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!&86ER(%9A;'5E(&]F($]T:&5R($9I M;F%N8VEA;"!);G-T6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^(%1H M92!C87)R>6EN9R!A;6]U;G1S(&]F(&]U&EM871E('1H96ER(&9A:7(@=F%L=65S(&1U92!T;R!T:&5I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT M;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z M(#,V<'0G/B!792!H879E(&EM<&QE;65N=&5D(&$@-#`Q*&LI(&5M<&QO>65E M(')E=&ER96UE;G0@<&QA;BX@56YD97(@=&AE('1E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W M7V$S.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!.;W1E(#$T("T@3&5G86P@4')O8V5E9&EN M9W,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@ M5V4@:&%V92!P96YD:6YG(&QE9V%L(&UA='1E&EM871E M;'D@)#$S,"PP,#`N/"]D:78^(#QD:78@2P@86YD('-E96MI;F<@:6YJ=6YC=&EV92!R96QI968@86YD(&-O;G-T2!R96QI968@87,@=&\@=&AE('!R:6-E('1O M(&)E('!A:60@8GD@=7,@9F]R('1H92!L96%S960@97%U:7!M96YT(&%N9"!S M<&5C:69I8R!P97)F;W)M86YC92!A9V%I;G-T($%#0RX@3VX@2F%N=6%R>2`W M+"`R,#$S(&EN(&$@:&5A2!I M;FIU;F-T:6]N('!R979I;W5S;'D@9W)A;G1E9"!B>2!T:&4@0V]U2!E M;&EC:71E9"!A="!T:&4@:&5A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D M,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X M,3$P.&0X+U=O'0O:'1M;#L@8VAA3QB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^ M(#QD:78@'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.;W1E(#$U("T@3&EQ=6ED M:71Y/"]D:78^(#QD:78@65A2`D,S`P M+#`P,"!P97(@;6]N=&@N($1U65E2!A<'!R;WAI;6%T96QY(#0P)2P@=VET:"!M;W)E(')E9'5C=&EO;G,@6%B;&4@=&AR;W5G:"!T:&4@:7-S=6%N8V4@ M;V8@8V]M;6]N('-T;V-K+"!W:&EC:"!W:6QL(&9U2!C87-H M(')E'!E;F1I='5R97,@7,@<')O9'5C=',@=&\@;6%R:V5T+"!C;VYT:6YU92!O M=7(@9&5V96QO<&UE;G0@;V8@0V]D96-3>7,@;W(@=6YT:6P@=V4@8F5G:6X@ M=&\@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W M7V$S.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD M:78@'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.;W1E(#$V("T@4W5P<&QE;65N M=&%L($-A6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@/&)R M("\^(#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y M;6)O;"P@'0M M86QI9VXZ(&QE9G0G/B!$=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(@ M,S$L(#(P,3(@=V4@:7-S=65D(#4X-BPQ-C0@6QE/3-$)U=)1%1(.B`R-W!T)SX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!3 M>6UB;VPL('-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT M+6%L:6=N.B!L969T)SX@1'5R:6YG('1H92!Y96%R(&5N9&5D($1E8V5M8F5R M(#,Q+"`R,#$R+"!W92!I3L@5$585"U)3D1%3E0Z(#!P="<^(#QB M6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)U=)1%1(.B`U,RXY.3EP="<^(#QD:78@3H@4WEM8F]L+"!S97)I9CL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^("9M:61D M;W0[/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE65AF%T:6]N(&5X<&5N2!B>2!O MF%T:6]N+CPO9&EV/B`\+W1D M/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV/B`\=&%B;&4@6QE/3-$)U=)1%1(.B`R-W!T)SX@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!3>6UB;VPL('-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)SX@ M1F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$R+"!A;B!A9V=R M96=A=&4@;F]N+6-A3L@5$585"U)3D1%3E0Z(#!P="<^(#QB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`R,#$Q/"]D:78^ M(#QD:78@6QE/3-$)U=) M1%1(.B`U,RXY.3EP="<^(#QD:78@3H@4WEM8F]L+"!S97)I9CL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^("9M:61D;W0[/"]D M:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE65A2!T:&4@8V]N65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@/&)R("\^(#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@9F]N="UF86UI;'DZ(%-Y;6)O;"P@'0M86QI9VXZ(&QE9G0G/B!$=7)I;F<@=&AE('EE M87(@96YD960@1&5C96UB97(@,S$L(#(P,3$@=V4@:7-S=65D(#$S-2PS-CD@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@/&)R M("\^(#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y M;6)O;"P@'0M M86QI9VXZ(&QE9G0G/B!$=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(@ M,S$L(#(P,3$@=V4@86-Q=6ER960@-#$T+#$W,B!)1$D@8V]M;6]N('-H87)E M(&5Q=6EV86QE;G1S(&EN(&5X8VAA;F=E(&9O3L@ M5$585"U)3D1%3E0Z(#!P="<^(#QB6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U=)1%1(.B`U,RXY.3EP="<^(#QD M:78@3H@4WEM8F]L+"!S97)I M9CL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58 M5"U)3D1%3E0Z(#!P="<^("9M:61D;W0[/"]D:78^(#PO=&0^(#QT9#X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE MF%T:6]N(&5X<&5N2!B>2!OF%T:6]N+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U714E'2%0Z(&)O M;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@/&)R("\^(#PO M9&EV/B`\9&EV/B`\=&%B;&4@6QE/3-$)U=)1%1(.B`R M-W!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!3>6UB;VPL('-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!T97AT+6%L:6=N.B!L969T)SX@1F]R('1H92!Y96%R(&5N9&5D($1E8V5M M8F5R(#,Q+"`R,#$Q+"!A;B!A9V=R96=A=&4@;F]N+6-A6QE/3-$)U=)1%1(.B`R-W!T)SX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!3>6UB;VPL('-E M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!L M969T)SX@3VX@36%R8V@@,C$L(#(P,3$L('1H92!#;VUP86YY+"!C;VYV97)T M960@)#2!T:')O=6=H('1H92!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@/&)R M("\^(#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y M;6)O;"P@'0M M86QI9VXZ(&QE9G0G/B!);B!-87)C:"`R,#$Q+"!W92!G65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+5=%24=(5#H@ M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E M>'0M86QI9VXZ(&IU&5S(&1U65A M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(#PA+2U3=&%R=$9R86=M96YT M+2T^(#QD:78@3L@ M5$585"U)3D1%3E0Z(#!P="<^(#QB'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!$=7)I;F<@2F%N=6%R>2`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`P<'0[('1E>'0M86QI9VXZ(&IU2!W M97)E('1E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`S-G!T)SX@5&AE('!R97!A&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^ M/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($9/3E0M5T5)1TA4.B!B;VQD M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($-A2!L M:7%U:60@:6YV97-T;65N=',@=VET:"!M871U2!I;B!E>&-E M2!O9B!C87-H(&UA;F%G96UE;G0@:6YV97-T;65N=',@86YD(&AA=F4@ M:6YC2!T;R!M965T(&]U'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!!8V-O=6YT(%)E8V5I=F%B;&5S/"]D M:78^(#QD:78@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`S-G!T)SX@5')A9&4@86-C;W5N="!R96-E:79A8FQE M2!B87-I2!U2!W'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S M-G!T)SX@26YV96YT;W)I97,@8V]N'0^/"$M+41/0U194$4@:'1M;"!054),24,@ M(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO M;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@4')O<&5R='D@86YD($5Q=6EP;65N=#PO9&EV/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,S9P="<^(%!R;W!E'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!0871E;G1S(&%N9"!);G1A;F=I8FQE M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,S9P="<^(%!A=&5N=',@7,@=&5C:&YO;&]G>2P@86YD(&%R92!A;6]R=&EZ960@;VX@82!S=')A M:6=H="UL:6YE(&)A2`R,"!Y96%R2P@96QE=F5N(&9O'!E;G-E'!E;G-E(')E M8V]G;FEZ960@;VX@86QL('!A=&5N=',@=&]T86QE9"`D,3`L,34Q(&9O6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^($5S M=&EM871E9"!A;6]R=&EZ871I;VX@97AP96YS92P@:68@86QL('!A=&5N=',@ M=V5R92!I'0M86QI9VXZ M(&QE9G0G/B`\=&%B;&4@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y' M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S M<#L\+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/C$Q M+#,T,SPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/C$P+#$R M,3PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\ M+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B`R,#$W/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`S-G!T)SX@5V4@2!N;W0@8F4@2!T:&4@87-S970N M($EF('-U8V@@87-S971S(&%R92!C;VYS:61E2!W:&EC:"!T:&4@8V%R7-E'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!3=&]C:RUB87-E9"!#;VUP96YS871I;VX\+V1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z M(#,V<'0G/B!);B!A8V-O'!E8W1E9"!T;R!V97-T+CPO9&EV/B`\ M(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&%B;&4@:6YC;VUE(&EN('1H92!Y96%R'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!2979E;G5E(%)E8V]G;FET:6]N/"]D:78^ M(#QD:78@'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`S-G!T)SX@5V4@&ES=',@=&AA="!T:&5R92!I2!O9B!E<75I M<&UE;G0@6UE;G1S(&UA9&4@:6X@861V86YC M92!B>2!C=7-T;VUEF4@=&AI2!PF5D(&EN('1H92!P97)I;V0@=&AE('=O6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,S9P="<^($EN(&ENF4@86YY(&)A2!P97(@ M;V-C=7)R96YC92!O'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B!297-E87)C:"!A;F0@1&5V96QO<&UE;G0\+V1I M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@0V]N8V5N=')A=&EO;B!O M9B!#6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`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`S-G!T)SX@0F%S:6,@ M96%R;FEN9W,@<&5R(&-O;6UO;B!S:&%R92!I2!D:79I M9&EN9R!N970@:6YC;VUE(&]R(&QO6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S M-G!T)SX@5&AE(&9O;&QO=VEN9R!T86)L92!S971S(&9O65A"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M5$]0.B!B;&%C:R`P+C5P="!S M;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0 M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XF;F)S<#L\+W1D/B`\=&0@'0M86QI9VXZ(&-E;G1E#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E. M1$5.5#H@,'!T)SX@1F]R('1H92!Y96%R/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-C0E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^($YE="!I;F-O;64\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ M+#,P-"PT-#8\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D M/B`\=&0@#L@ M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1&5N;VUI;F%T;W(\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!" M87-I8R!W96EG:'1E9"!A=F5R86=E('-H87)E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-S4L-#$V+#DQ M-CPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3`P+#DW."PR M,C,\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\ M=&0@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-C0E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M(%)E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@ M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E(&%L:6=N/3-$;&5F M=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^($1I;'5T960@=V5I9VAT960@879E6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO=&0^ M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^-S@L,#DX+#$V-CPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U!3$E'3CH@ M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\ M+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^)FYB'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!"87-I8SPO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@1&EL=71E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@86QI9VX],T1R:6=H="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^(%!O=&5N M=&EA;&QY(&1I;'5T:79E('-E8W5R:71I97,@6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S M-G!T)SX@4&]T96YT:6%L;'D@9&EL=71I=F4@65A'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!!9'9E'!E;G-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,S9P="<^(%=E(&9O;&QO=R!T:&4@<&]L:6-Y(&]F(&-H87)G:6YG('1H M92!C;W-T'!E;G-E(&%S(&EN8W5R'!E;G-E(&9O65A'0^/"$M+41/0U194$4@:'1M M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@5V4@:&%V92!N;R!O9F8M8F%L M86YC92!S:&5E="!A'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!296-E;G0@06-C;W5N=&EN9R!0 M6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,S9P="<^($EN($%U9W5S M="`R,#$R+"!T:&4@1D%30B!I6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE M)SY496-H;FEC86P@06UE;F1M96YT'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@26X@2G5L M>2`R,#$R+"!T:&4@1D%30B!I6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY) M;G1A;F=I8FQE7!A&%M<&QE2!A;F0@ M;6%R:V5T(&-O;F1I=&EO;G,L(&%N9"`V*2!M86-R;V5C;VYO;6EC(&-O;F1I M=&EO;G,N(%1H92!5<&1A=&4@:7,@969F96-T:79E(&9O2!A9&]P=&EO;B!I2`R-RP@,C`Q,B!I9B!T M:&4@9FEN86YC:6%L('-T871E;65N=',@:&%V92!N;W0@8F5E;B!I6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@26X@2G5N92`R,#$Q+"!T:&4@1D%3 M0B!I6QE/3-$)T9/3E0M4U19 M3$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;VUP65A2!A M9&]P=&EO;B!I65A'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`S-G!T)SX@26X@4V5P=&5M8F5R(#(P,3$L('1H92!&05-"(&ES M2!H;W<@96YT:71I97,@=&5S="!G;V]D=VEL M;"!F;W(@:6UP86ER;65N="X@5&AI2!T:&%N(&YO="!T M:&%T('1H92!F86ER('9A;'5E(&]F(&$@6EN9R!A;6]U;G0@87,@82!B87-I2!S<&5C:69I8R!E=F5N=',@86YD(#8I('-UF4@=&AE('%U86QI=&%T:79E(&%S7!I8V%L;'D@9&]N92!D=7)I;F<@=&AE(#0\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@-S`E M.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`G/G1H/"]F;VYT/B!Q=6%R=&5R M+CPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`S-G!T)SX@26X@ M36%Y(#(P,3$L('1H92!&05-"(&ES2!O9B!F86ER('9A;'5E(&UE M87-UF%T:6]N M(&)Y(&QE=F5L(&9O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO M+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L M+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)TU!4D=)3BU,1494.B`V,W!T.R!T97AT+6%L:6=N.B!L969T M)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ M(&-E;G1E'0M86QI9VXZ(&-E;G1E"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B`R,#$T/"]D:78^(#PO=&0^(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B`R,#$U/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,34E/C$P+#$R,3PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,34E/C$P+#$R,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)FYB6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@0D]21$52+51/ M4#H@8FQA8VL@,"XU<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)T)/4D1%4BU43U`Z(&)L86-K M(#`N-7!T('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE'0M M86QI9VXZ(&-E;G1E65A M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@ M16YD960@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!.=6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.970@:6YC;VUE/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/B9N8G-P.SPO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ M+#8P,BPX,C0\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\ M+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@0F%S:6,@=V5I9VAT960@879E6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!% M9F9E8W0@;V8@9&EL=71I=F4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!3=&]C:R!O<'1I M;VYS(&%N9"!W87)R86YT6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^,3,Q+#(U,#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,BPU,3`L-#@X/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!297-T"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR+#4U,"PP,#`\ M+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!$:6QU M=&5D('=E:6=H=&5D(&%V97)A9V4@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1R:6=H=#XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,3`V+#4S,RPX-#0\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D M/B`\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M0F%S:6,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T M)SX@0V]M;6]N/"]D:78^(#QD:78@'0M M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B!)6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B!.=6UB97(@;V8\+V1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5. M5#H@,'!T)SX@02!787)R86YT"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!686QU92!O9CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!"/"]D:78^ M(#QD:78@'0M86QI9VXZ(&-E;G1E6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A M<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R M.R!415A4+4E.1$5.5#H@,'!T)SX@5&]T86P\+V1I=CX@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@ M,'!T)SX@5V%R6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!686QU93PO M9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@26YV97-T;W)S/"]D:78^(#PO M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I M9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^,SDL,S@W/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2PV,#`L,#`P/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^.#`P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,S(L.#`W/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,BPP,#`L,#`P/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^,2PP,#`L,#`P/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RPQ-S0\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-#`E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($%G96YC M>3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&]T86P\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C@L-#$V+#`P M,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y' M+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-CDX+#@S.#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/ M33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-S4W+#0V M.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y' M+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/&9O;G0@3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=? M83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@ M8VAA6%B;&4@*%1A8FQE6%B;&4\+W1D/@T* M("`@("`@("`\=&0@8VQA6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4 M15A4+4E.1$5.5#H@,'!T)SX@1&5C96UB97(@,S$L/"]D:78^(#QD:78@'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,B!396-U6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,BPT,C@L,38V/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!5;G-E8W5R M960@0V]N=F5R=&EB;&4@3F]T93PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!! M;65N9&5D(&%N9"!297-T871E9"!396YI;W(@-BXR-24@0V]N=F5R=&EB;&4@ M3F]T93PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^-BPQ.#`L.#$V/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!"6%B;&4\+V1I=CX@/"]T M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2PQ.38L,30Q/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^+2T\+W1D/B`\=&0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@17%U M:7!M96YT(%!U"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM+3PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@ M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@5&]T86P\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^."PT,36QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RPQ,#(L,#`V M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E M(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($QE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH M,BPP-C@L,#$V/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^ M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH,RPQ,#(L,#`V/"]T9#X@/'1D M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@ M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#QT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@5&]T86P@3&]N9RUT97)M/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^+2T\+W1D/B`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@;F]W6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1% M3E0Z(#!P="<^(#PA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,S,E/C(X-"PT-#<\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S,R4^("9N8G-P.SPO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S M,R4^,C,L,#0Y/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C`E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S,E/C4X-BPP M-#@\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA&5S(%M!8G-T'0^/"$M+41/0U194$4@:'1M M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@1&5F97)R960@=&%X(&%S6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M2UF;W)W87)D)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!'96YE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^,2PQ-3@L.3`P/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-S@L-3`P/"]T9#X@/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!!;&QO=V%N8V4@9F]R(&1O M=6)T9G5L(&%C8V]U;G1S)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,C$L,#`P/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1&5F M97)R960@=&%X(&QI86)I;&ET:65S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B!$97!R96-I871I;VXF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M($YE="!D969E6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB"!0&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM M/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z(#!P="<^($-H86YG92!I;B!V86QU871I;VX@86QL;W=A;F-E)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3XH,BPQ.#(L-3`P/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M*3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH,BPQ,#`L.3`P/"]T M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/ M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#QT6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@'0M M86QI9VXZ(&-E;G1E"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E(&-O;'-P86X] M,T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E&5R8VES93PO9&EV/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4')I8V4\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!/<'1I;VYS(&=R86YT M960F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3(E/C$L-38W+#DP,#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!787)R86YT6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(E/C$L-CDW+#@S-#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@.7!T)SX@17AP:7)E9"9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G M/B!&;W)F96ET960F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E/B@R+#4Q,"PR,#$\+W1D/B`\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!% M>&5R8VES960F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U!!1$1)3D#L@ M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/=71S=&%N9&EN9R!A="!$96-E;6)E M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!/<'1I;VYS(&=R86YT960F;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E/C4P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@.7!T)SX@5V%R6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/B@R M-3(L-C8Y/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@.7!T)SX@1F]R9F5I=&5D)FYB M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U!! M1$1)3D'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!%>&5R8VES960F;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^ M+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y' M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@3W5T6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M/C0S+#,Y-BPX-C,\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M(&-O;'-P86X],T0X(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T M)SX@3W5T6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!%>&5R M8VES86)L93PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!286YG92!O9CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!%>&5R8VES M92!06QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT M97([(%1%6%0M24Y$14Y4.B`P<'0G/B!.=6UB97(\+V1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5. M5#H@,'!T)SX@3W5T6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!#;VYT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C M96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!,:69E("AY96%R6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D'0M86QI9VXZ(&-E;G1E'0M86QI M9VXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@ M,'!T)SX@3G5M8F5R/"]D:78^(#QD:78@'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B!%>&5R8VES93PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`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`Q M,'!T.R!415A4+4%,24=..B!C96YT97(G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#DE/C$N,#0\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!C96YT97(G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE/B9N8G-P.R`S+#(T."PQ-#8\+W1D/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[(%1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!C96YT97(G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M/C0S+#,Y-BPX-C,\+W1D/B`\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!C96YT97(G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C0N,C8\+W1D/B`\=&0@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!C96YT97(G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#DE/C`N-30\+W1D/B`\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!C96YT97(G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C0R+#DV,2PV-C,\+W1D/B`\ M=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!C96YT97(G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE/C`N-30\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@4F5S=')I8W1E M9#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B`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`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^.34P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`Y<'0G/B!3971T;&5D(&)Y(&ES6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM+3PO M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@;F]W6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M3W5T6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,BPU-3`L,#`P/"]T9#X@/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^,2XR-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@.7!T)SX@07=A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!3971T;&5D(&)Y(&ES6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM M+3PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^,BPY-#`L,3,S/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N M/3-$"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E M(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%9E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^,2XQ,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R M.R!415A4+4E.1$5.5#H@,'!T)SX@1F]R('1H92!Y96%R6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&-E;G1E"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q M,CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO M=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!'96YE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,BPP M-#,L,S@V/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!297-E87)C:"!A M;F0@9&5V96QO<&UE;G0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%1O=&%L/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYBF5D($-O;7!E;G-A=&EO;B!%>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$ M5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B`R,#$T/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q-3PO M9&EV/B`\+W1D/B`\=&0@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&]T86P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD M:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=T97AT+6%L M:6=N.B!C96YT97(G/B`\=&%B;&4@'0M86QI9VXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$=&]P('=I9'1H/3-$,38E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R,#$R M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R<'@@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4FES:R!F'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!%>'!E8W1E9"!L:69E("AI;B!Y96%R6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C M96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`V+C(\+V1I=CX@/"]T9#X@/"]T M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6UE M;G0@07=A6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!996%R($5N9&5D($1E8V5M8F5R(#,Q+#PO9&EV/B`\+W1D/B`\+W1R M/B`\='(^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0R."4^/&9O;G0@'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W M-6-D,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W M864X,3$P.&0X+U=O'0O:'1M;#L@8VAA&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T M)SX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@/'1A8FQE('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(%%U;W1E M9"!06QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(%-I9VYI9FEC86YT/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^($%C=&EV92!-87)K971S(&9O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z M(#!P="<^($]B6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@261E;G1I8V%L($%S6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^($EN<'5T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^($EN<'5T"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$"<@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@*$QE=F5L(#$I/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS M1&YO=W)A<"!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("A,979E M;"`S*3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U!!1$1)3D'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.;VYE/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM+3PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM+3PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM+3PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM+3PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@ M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&]T M86P@87-S971S(&UE87-U6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!,:6%B:6QI=&EE6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE#L@4$%$ M1$E.1RU,1494.B`S)2<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E(&%L M:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($1E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@ M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@ M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ+#$Y,2PR-CD\ M+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-3(E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^(%1O=&%L(&QI86)I;&ET:65S(&UE87-U6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`\ M=&%B;&4@6QE/3-$)U=)1%1(.B`Q.'!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@*#$I/"]D:78^(#PO=&0^(#QT9"!A;&EG;CTS1&QE9G0^(#QD:78@ M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!3964@3F]T97,@-"`F86UP.R`U(&9O'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I M=CX@/&1I=CX\(2TM4W1A6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T)SX@1&5R:79A=&EV93PO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(%9A M;'5A=&EO;CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M3&EA8FEL:71Y/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!"86QA;F-E M(&%T($1E8V5M8F5R(#,Q+"`R,#$Q/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E/C@L.#(Y+#6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M5F%L=6%T:6]N(&%D:G5S=&UE;G0\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E/BTM/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.#4E(&%L:6=N/3-$;&5F=#X@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z(#!P="<^(%1R86YS9F5R6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^+2T\+W1D/B`\=&0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@0F%L86YC92!A="!$ M96-E;6)E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/B@Q+#$Y,2PR-CD\+W1D/B`\ M=&0@'1087)T7SAD8C'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!I;G1E'1087)T7SAD8C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$65A&EM=6T@6TUE;6)E2P@4&QA M;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D M,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X M,3$P.&0X+U=O'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D,5\W9C$Q7S0X M8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X,3$P.&0X+U=O M'0O:'1M M;#L@8VAA&-L=61E M9"!F7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!&:6YA;F-I M;F<@86YD('1H92!$96)T(%)E2!$871E(&]F($)R:61G92!,;V%N(%=A2!$871E(&]F($)R:61G92!,;V%N(%=A6%B;&4@ M6TUE;6)E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!F:6YA;F-I;F<@=')A;G-A8W1I;VX\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^-2!Y96%R M65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^-B!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S&EM=6T@ M&5R8VES86)I;&ET>2!O9B!W87)R M86YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S&5R8VES960@9F]R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!F:6YA;F-I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S M(&9O'0^)FYB'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-"!Y96%R65A7,\6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D M,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X M,3$P.&0X+U=O'0O:'1M;#L@8VAA2!&:6YA;F-I;F<@86YD($1E8G0@4F5S=')U8W1U'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6YA M;F-I;F<@86YD($1E8G0@4F5S=')U8W1U'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6YA;F-I;F<@86YD($1E8G0@4F5S=')U8W1U'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!&:6YA;F-I;F<@86YD($1E8G0@4F5S=')U8W1U M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!&:6YA;F-I;F<@86YD($1E8G0@4F5S=')U8W1U M2!;365M M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6YA;F-I;F<@86YD($1E8G0@4F5S=')U8W1U2!;365M8F5R72!\($-L87-S($$@ M5V%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!&:6YA;F-I;F<@86YD($1E8G0@4F5S=')U M8W1U2!;365M8F5R72!\($-L87-S($(@5V%R'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6YA;F-I;F<@86YD($1E8G0@4F5S=')U8W1U2!;365M8F5R72!\($-O;6UO;B!3=&]C M:R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!&:6YA;F-I;F<@86YD($1E8G0@4F5S=')U8W1U7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA2!&:6YA;F-I;F<@86YD('1H92!$96)T(%)E M2!!9W)E96UE;G0@5V%R2!&:6YA;F-I;F<@ M86YD($1E8G0@4F5S=')U8W1U'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^-2!Y96%R65A'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&5R8VES92!P'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S(&]F(&-O M;G9E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!W M87)R86YT'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65A65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^)FYB M6%B;&4@ M6TUE;6)E'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4@*#(P,3(@4V5C M=7)E9"!#;VYV97)T:6)L92!.;W1E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^-2!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E8W1E9"!L:69E/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\65A'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'1087)T7SAD8C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!E>'!I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^-2!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S65A65A3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4@*%-E;FEO M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)FYB'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'1I;F=U:7-H;65N="!O9B!D96)T/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES960@9F]R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&5R8VES92!P'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,R!Y96%R M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^2G5N(#(Q+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^1&5C(#(Q+`T*"0DR,#$Q/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^1&5C(#(Q+`T*"0DR M,#$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6UE;G0\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B M;&4@8W5R'10 M87)T7SAD8C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!P'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S65A3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA6%B;&4@*$)R:61G92!,;V%N*2`H M1&5T86EL6UE;G0@6TUE;6)E6UE;G0@6TUE;6)E M6%B;&4@6TUE;6)E6%B;&4@6TUE;6)E6%B;&4@6TUE;6)E6%B;&4@6TUE;6)E6%B;&4@6TUE;6)E6%B;&4@6TUE;6)E2!$871E M(&]F($)R:61G92!,;V%N(%=A2!$871E M(&]F($)R:61G92!,;V%N(%=A'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65A'0^-B!Y96%R65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^1F5B(#(X+`T*"0DR M,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S6UE;G1S(&]F(&5S8W)O=R!F965S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-"!Y96%R65A6EE;&0\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^ M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W M-6-D,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W M864X,3$P.&0X+U=O'0O:'1M;#L@8VAA6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'1I;F=U:7-H;65N="!O9B!D96)T/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-3'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\X9&(W-6-D,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S M.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@8VAA2!-971H M;V0@26YV97-T964@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\2!-971H;V0@26YV97-T964@6TQI;F4@ M271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA6UE;G1S M('5N9&5R(&YO;BUC86YC96QA8FQE(&]P97)A=&EN9R!L96%S97,Z/"]S=')O M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5C=71I M=F4@3V9F:6-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!P87EM96YT/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,RPP-#D\'0^2F%N(#,Q M+`T*"0DR,#$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!P87EM96YT M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#`P,#QS<&%N/CPO M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$6UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'!I7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA"!A2!A<'!L>6EN M9R!T:&4@52Y3+B!F961E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!P7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PP,#`L,#`P M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5R M8VES97,L('-H87)E'0^ M)FYB'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&-H86YG92!F;W(@241)('-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=? M83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@ M8VAA6UE;G0@07=A MF5D/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XS('EE87)S/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&EM=6T@8V]N=')A8W1U86P@=&5R;3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^,3`@>65A'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65E($EN'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M, M:6YE($ET96US73PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6UE;G0@07=A6UE;G0@ M07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!3:&%R92UB87-E M9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6UE;G0@07=A'!E8W1E9"!L:69E("AI;B!Y96%R'0^-B!Y96%R'!E8W1E9"!V;VQA=&EL:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XW."XY-R4\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W M-6-D,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W M864X,3$P.&0X+U=O'0O:'1M;#L@8VAA'0^-2!Y96%R'0^-2!Y96%R3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'!E M8W1E9"!D:79I9&5N9"!Y:65L9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)FYB&5R M8VES92!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'!I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES M960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S&5R8VES92!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D,5\W9C$Q M7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X,3$P.&0X M+U=O'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0&5R8VES92!0F5D('5N9&5R(%-T;V-K($]P M=&EO;B!0;&%N&5R8VES92!0 M&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA&5R8VES92!0F5D('5N9&5R M(%-T;V-K($]P=&EO;B!0;&%N&5R M8VES92!0&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^,R!Y96%R&5R8VES M86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5R8VES92!0&5R8VES92!07!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D M,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X M,3$P.&0X+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'!E;G-E(%M-96UB97)= M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAAF5D($-O;7!E;G-A=&EO;B!%>'!E;G-E*2`H1&5T86EL M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W M7V$S.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\2!R96YT86P@<&%Y;65N=#PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S6UE;G1S('5N=&EL(&QE87-E(&-A;B!B92!C86YC96QL960\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\6UE;G1S('1O=V%R9"!I;B!P;&%C92!F M86ER(&UA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S6UE;G1S(&%P<&QI960@=&\@<')I;F-I<&%L/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D M,5\W9C$Q7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X M,3$P.&0X+U=O'0O:'1M;#L@8VAA2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D,5\W9C$Q M7S0X8S=?83,Y9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X,3$P.&0X M+U=O'0O M:'1M;#L@8VAA&EM=6T@<&5R8V5N="!O9B!C;VUP96YS871I;VX@=VAI8V@@ M;6%Y(&)E(&-O;G1R:6)U=&5D('1O('!L86X\+W1D/@T*("`@("`@("`\=&0@ M8VQA&EM=6T@<&5R8V5N="!O9B!C;VUP96YS871I;VX@;6%T8VAE9#PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$&EM=6T@<&5R8V5N="!O9B!C;VUP96YS871I M;VX@;6%T8VAE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'1087)T7SAD M8C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&EM=6T@86UO=6YT(&]F(&%D9&ET:6]N86P@<&%Y;65N=#PO M=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X9&(W-6-D,5\W9C$Q7S0X8S=?83,Y M9%\S-#=A93@Q,3`X9#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M.&1B-S5C9#%?-V8Q,5\T.&,W7V$S.61?,S0W864X,3$P.&0X+U=O'0O:'1M;#L@8VAA M2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'!E;G-E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'1E;G-I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-2!Y96%R65A M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&5R8VES960\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!A8W%U:7)E9#PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S&-H86YG92!F;W(@241)('-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!4=V5L=F4@0V]N M=F5R=&EB;&4@3F]T97,@6TUE;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^2G5L(#$S M+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^2G5L(#$S+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES960@9F]R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M M;6EC'1087)T7SAD8C XML 31 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Notes Payable (Senior 6.25% Convertible Note) (Details) (USD $)
    		 0 Months Ended 12 Months Ended
    Mar. 26, 2012
    Dec. 23, 2010
    Jul. 30, 2010
    Mar. 26, 2010
    Dec. 24, 2007
    Dec. 31, 2012
    Dec. 31, 2011
    Mar. 31, 2011
    Oct. 29, 2010
    Dec. 23, 2009
    Convertible notes                    
    Value of shares of common stock issued           $ 2,107,834        
    Payments for debt extinguishment costs           275,041         
    Interest paid           347,902 357,246      
    Common stock issued for interest              19,634      
    (Loss) gain on extinguishment of debt           1,578,914 (954,017)      
    Gain on derivative valuation           8,829,748 11,724,400      
    Derivative valuation           1,191,269 3,760,200      
    Warrants Issued to Senior Secured Note Holder [Member]
    		                    
    Convertible notes                    
    Number of shares of common stock warrants can be exercised for     5,208,333   1,875,000          
    Exercise price of warrants     1.8   5.0          
    Warrant term length         5 years          
    Fair value of warrants         3,750,000          
    Warrants Issued to Third Party For Financing Fees [Member]
    		                    
    Convertible notes                    
    Number of shares of common stock warrants can be exercised for         112,500          
    Exercise price of warrants         3.75          
    Warrant term length         3 years          
    Fair value of warrants         252,000          
    Common Stock [Member]
    		                    
    Convertible notes                    
    Shares of common stock issued           25,402,164        
    Value of shares of common stock issued           1,270,108        
    Amended and Restated Senior 6.25% Convertible Note [Member]
    		                    
    Convertible notes                    
    Principal issued         15,000,000 5,500,000       15,000,000
    Debt maturity date     Jun. 21, 2012 Dec. 21, 2011 Dec. 21, 2010          
    Debt interest rate         6.25%         6.25%
    Number of shares of common stock notes are convertible into         2,752,294          
    Conversion price     $ 1.8   $ 5.45         $ 1.35
    Shares of common stock issued     2,000,000 1,000,000 1,000,000 2,000,000        
    Value of shares of common stock issued       990,000 3,750,000          
    Payments for commissions, finders fees and other transaction expenses 275,041       1,377,000          
    Debt Instrument, periodic interest payment         234,375          
    Number of shares issuable, contingent to equity raised     800,000              
    Number of warrants cancelled   5,208,333                
    Common stock issued for debt restructuring 760,000                  
    Common stock issued for debt restructuring, shares 2,000,000 800,000                
    Shares of stock issuable, but forgone in lieu of cash payment   3,500,000                
    Funding threshold     6,000,000 6,000,000         8,000,000  
    Proceeds received from equity financing                 2,500,000  
    Required cash balance     950,000 1,250,000            
    Cash paid to settle debt 2,750,000 2,750,000       2,750,000        
    Debt forgiveness   7,200,000                
    Gain on troubled debt restructuring   3,062,457                
    Interest paid 680,816 350,434     937,000          
    Repayments of convertible debt   2,500,000                
    (Loss) gain on extinguishment of debt 2,173,033                  
    Number of shares issued for agent fees 586,164                  
    Value of shares issued for agent fees 222,742                  
    Gain on derivative valuation           203,700 2,322,200      
    Derivative valuation             285,200 81,500    
    Long-term debt             6,180,816      
    Accrued interest payable           680,816 680,816      
    Accrued interest payable currently             $ 171,875      
    XML 32 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Income Taxes (Tables)
    		 12 Months Ended
    Dec. 31, 2012
    Income Taxes [Abstract]  
    Schedule of Deferred Tax Assets
       
    2011
    		    
    2012
    		  
                 
    Deferred tax assets
    		            
    NOL carry-forward                                                             
    		   $ 23,862,500     $ 25,881,900  
    General business credit carry-forwards                                                                      
    		     1,147,000       1,158,900  
    Deferred compensation                                                             
    		     83,500       78,500  
    Allowance for doubtful accounts                                                             
    		     21,000       31,600  
    Deferred tax liabilities
    		                
    Depreciation                                                             
    		     (173,000 )     61,700  
                     
    Valuation allowance                                                                   
    		     (24,941,000 )     (27,212,600 )
    Net deferred tax asset                                                                   
    		   $ -     $ -  
    Schedule of Income Tax Provision
       
    2011
    		    
    2012
    		  
                 
    Federal income tax (expense) benefit at statutory rates
    		   $ 1,902,500     $ 1,831,600  
    State income tax (expense) benefit at statutory rates
    		     280,000       269,300  
    Change in valuation allowance                                                                      
    		     (2,182,500 )     (2,100,900 )
        $ -     $ -  
    XML 33 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Operating Leases (Tables)
    		 12 Months Ended
    Dec. 31, 2012
    Operating Leases [Abstract]  
    Schedule of Future Minimum Payments under Operating Leases
    2013
    		   $ 284,447  
             
    2014
    		     278,552  
    2015
    		     23,049  
        $ 586,048  
    XML 34 R56.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Stock-based Compensation (Schedule of Restricted Stock Unit Activity) (Details) (Restricted Stock Units [Member], USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Restricted Stock Units [Member]
    		    
    Restricted Stock Units    
    Outstanding, beginning balance 2,550,000 950,000
    Awarded at fair value 390,133 1,600,000
    Canceled/Forfeited      
    Settled by issuance of stock      
    Outstanding, ending balance 2,940,133 2,550,000
    Vested at December 31, 2012 2,940,133  
    Weighted Average Grant Date Fair Value    
    Outstanding, beginning balance $ 1.25 $ 1.61
    Awarded at fair value $ 0.17 $ 1.04
    Canceled/Forfeited      
    Settled by issuance of stock      
    Outstanding, ending balance $ 1.11 $ 1.25
    Vested at December 31, 2012 $ 1.11  
    XML 35 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Notes Payable (Accounts Receivable Purchase Agreements) (Details) (USD $)
    		 12 Months Ended 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Dec. 31, 2011
    Conversion of Accounts Receivable Purchase Agreements [Member]
    Dec. 31, 2012
    Conversion of Accounts Receivable Purchase Agreements [Member]
    Dec. 31, 2012
    Conversion of Accounts Receivable Purchase Agreements [Member]
    Warrant [Member]
    Dec. 31, 2011
    Conversion of Accounts Receivable Purchase Agreements [Member]
    Warrant [Member]
    Dec. 31, 2011
    Accounts Receivable [Member]
    Dec. 31, 2010
    Accounts Receivable [Member]
    Accounts, Notes, Loans and Financing Receivable [Line Items]                
    Value of accounts receivable purchase agreements               $ 775,000
    Repayment of advances             100,000  
    Interest paid 347,902 357,246         8,360  
    Amount of debt converted     675,000          
    Common stock issued for interest    19,634 109,292          
    Common stock issued in conversion     1,307,153          
    Number of warrants issued in conversion     653,576          
    Anti-dilution price protection provisions, stock price threshold     $ 1.0          
    Exercise price of warrants       0.725        
    Derivative valuation 1,191,269 3,760,200     5,900 156,300    
    Gain on derivative valuation $ 8,829,748 $ 11,724,400     $ 253,600 $ 293,800    
    Risk-free interest rate         0.36%      
    Expected life         3 years 2 months 12 days      
    Expected volatility         83.16%      
    Dividend yield         0.00%      
    Stock trading price         $ 0.08      
    XML 36 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Stock-based Compensation (Tables)
    		 12 Months Ended
    Dec. 31, 2012
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
    Schedule of Option and Warrant Activity
       
    Options
    and
    Warrants
    Outstanding
    		    
    Weighted
    Average
    Exercise
    Price
    		  
                 
    Outstanding at December 31, 2010
    		     20,442,170       1.13  
    Options granted                                                        
    		     1,567,900       0.91  
    Warrants issued                                                        
    		     1,697,834       0.68  
    Expired                                                        
    		     (302,054 )     18.67  
    Forfeited                                                        
    		     (2,510,201 )     0.08  
    Exercised                                                        
    		     (455,098 )     -  
                     
    Outstanding at December 31, 2011
    		     20,440,551       1.10  
    Options granted                                                        
    		     50,000       0.37  
    Warrants issued                                                        
    		     24,817,900       0.33  
    Expired                                                        
    		     (252,669 )     1.31  
    Forfeited                                                        
    		     (1,658,919 )     1.31  
    Exercised                                                        
    		     -       -  
                     
    Outstanding at December 31, 2012
    		     43,396,863     $ 0.54  
    Schedule of Information About Stock Options and Warrants
         
    Outstanding
    		    
    Exercisable
    		  
               
    Weighted
    Average
    Remaining
    		    
    Weighted
    Average
    		          
    Weighted
    Average
    		  
    Range of
    Exercise Prices
    		    
    Number
    Outstanding
    		    
    Contractual
    Life (years)
    		    
    Exercise
    Price
    		    
    Number
    Exercisable
    		    
    Exercise
    Price
    		  
    $ 0.17-0.95     39,583,684     4.36     $ 0.47     39,207,017     $ 0.47  
      1.00-1.59       3,306,679     3.20       1.04       3,248,146       1.04  
      2.25-4.00          506,500     3.34       2.62          506,500       2.62  
    $ 0.17-4.00     43,396,863     4.26     $ 0.54     42,961,663     $ 0.54  
    Schedule of Restricted Stock Unit Activity
       
    Restricted
    Stock Units
    		    
    Weighted
    Average
    Grant
    Date Fair
    Value
    		  
                 
    Outstanding at December 31, 2010
    		     950,000       1.61  
    Awarded at fair value
    		     1,600,000       1.04  
    Canceled/Forfeited
    		     --       --  
    Settled by issuance of stock
    		     --       --  
    Outstanding at December 31, 2011
    		     2,550,000       1.25  
    Awarded at fair value
    		     390,133       0.17  
    Canceled/Forfeited
    		     --       --  
    Settled by issuance of stock
    		     --       --  
    Outstanding at December 31, 2012
    		     2,940,133     $ 1.11  
    Vested at December 31, 2012
    		     2,940,133     $ 1.11  
    Schedule of Allocated Stock-based Compensation
       
    For the years ended
    		  
       
    December 31,
    		  
       
    2012
    		    
    2011
    		  
    General and administrative
    		   $ 185,478     $ 2,043,386  
    Research and development
    		     98,214       219,154  
                     
    Total
    		   $ 283,692     $ 2,262,540  
    Schedule of Unrecognized Compensation Expense
    2013
    		   $ 118,127  
    2014
    		     62,038  
    2015
    		     567  
    Total
    		   $ 180,732  
    Stock Options [Member]
    		  
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
    Schedule of Assumptions Used to Value Awards
     
    Year Ended December 31,
     
    2012
    2011
    Risk free interest rate
    1.65%
    1.91%
    Expected life (in years)
    10.0
    6.2
    Expected volatility
    78.97%
    80.89%
    Expected dividend yield
    0.00%
    0.00%
    Warrant [Member]
    		  
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
    Schedule of Assumptions Used to Value Awards
     
    Year Ended December 31,
     
    2012
    2011
    Risk free interest rate
    1.16%
    2.07%
    Expected life (in years)
    5.7
    5.0
    Expected volatility
    82.79%
    85.37%
    Expected dividend yield
    0.00%
    0.00%
    XML 37 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Fair Value Measurements (Tables)
    		 12 Months Ended
    Dec. 31, 2012
    Fair Value Measurements [Abstract]  
    Schedule of Fair Value of Financial Instruments
                   
    Significant
    		        
             
    Quoted Prices in
    		    
    Other
    		    
    Significant
    		  
             
    Active Markets for
    		    
    Observable
    		    
    Unobservable
    		  
             
    Identical Assets
    		    
    Inputs
    		    
    Inputs
    		  
       
    Total
    		    
    (Level 1)
    		    
    (Level 2)
    		    
    (Level 3)
    		  
    Assets
    		                        
    None
    		     --       --       --       --  
    Total assets measured at fair value
    		   $ --     $ --     $ --     $ --  
                                     
    Liabilities
    		                                
    Derivative valuation (1)
    		   $ 1,191,269     $ --     $ --     $ 1,191,269  
    Total liabilities measured at fair value
    		   $ 1,191,269     $ --     $ --     $ 1,191,269  
     
     
    (1)
    See Notes 4 & 5 for additional discussion.
    Schedule of Liabilities Measured at Fair Value on a Recurring Basis using Significant Unobservable Inputs
       
    Derivative
    		  
       
    Valuation
    		  
       
    Liability
    		  
    Balance at December 31, 2011
    		   $ (3,760,200 )
    Total gains or losses (realized and unrealized)
    		        
    Included in net income
    		     8,829,748  
    Valuation adjustment
    		     --  
    Purchases, issuances, and settlements, net
    		     (6,260,817 )
    Transfers to Level 3
    		     --  
    Balance at December 31, 2012
    		   $ (1,191,269 )
    XML 38 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Significant Accounting Policies
    		 12 Months Ended
    Dec. 31, 2012
    Significant Accounting Policies [Abstract]  
    Significant Accounting Policies
    Note 2 - Significant Accounting Policies
    Management Estimates
    The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
    Cash and Cash Equivalents
    We consider all cash on hand and in banks, and highly liquid investments with maturities of three months or less, to be cash equivalents. At December 31, 2012 and 2011, we had bank balances of $38,847 and $909,182, respectively in excess of amounts insured by the Federal Deposit Insurance Corporation. In addition we have restricted cash of $140,700, which represents a deposit to the Utah District Court, which is held pending the outcome of our litigation with our equipment lessor. We have not experienced any losses in such accounts, and believe we are not exposed to any significant credit risk on cash and cash equivalents.
    Current financial market conditions have had the effect of restricting liquidity of cash management investments and have increased the risk of even the most liquid investments and the viability of some financial institutions. We do not believe, however, that these conditions will materially affect our business or our ability to meet our obligations or pursue our business plans.
    Account Receivables
    Trade account receivables are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.
    A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than 90 days. After the receivable becomes past due, it is on non-accrual status and accrual of interest is suspended.
    Inventories
    Inventories consisting of electrical and computer parts are stated at the lower of cost or market determined using the first-in, first-out method.
    Property and Equipment
    Property and equipment are stated at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the property, generally from three to five years. Repairs and maintenance costs are expensed as incurred except when such repairs significantly add to the useful life or productive capacity of the asset, in which case the repairs are capitalized.
    Patents and Intangibles
    Patents represent initial legal costs incurred to apply for United States and international patents on the CodecSys technology, and are amortized on a straight-line basis over their useful life of approximately 20 years. We have filed several patents in the United States and foreign countries. As of December 31, 2012, the United States Patent and Trademark Office had approved four patents. Additionally, eleven foreign countries had approved patent rights. While we are unsure whether we can develop the technology in order to obtain the full benefits, the patents themselves hold value and could be sold to companies with more resources to complete the development. On-going legal expenses incurred for patent follow-up have been expensed from July 2005 forward. For the year ended December 31, 2011 we recorded a $26,180 valuation impairment related to two patent applications for areas outside the United States.
    Amortization expense recognized on all patents totaled $10,151 for each of the years ended December 31, 2012 and 2011, respectively.
    Estimated amortization expense, if all patents were issued at the beginning of 2013, for each of the next five years is as follows:
    Year ending
    December 31:
    		        
    2013
    		     $ 11,343  
    2014
    		       10,121  
    2015
    		       10,121  
    2016
    		       10,121  
    2017
    		       10,121  
    Long-Lived Assets
    We review our long-lived assets, including patents, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by a comparison of the carrying amount of an asset to future un-discounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, then the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. Fair value is determined by using cash flow analyses and other market valuations. After our review at December 31, 2012 it was determined that no adjustment was required.
    Stock-based Compensation
    In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.
    Income Taxes
    We account for income taxes in accordance with the asset and liability method of accounting for income taxes prescribed by ASC Topic 740. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income in the years in which those temporary differences are expected to be recovered or settled.
    Revenue Recognition
    We recognize revenue when evidence exists that there is an arrangement between us and our customers, delivery of equipment sold or service has occurred, the selling price to our customers is fixed and determinable with required documentation, and collectability is reasonably assured. We recognize as deferred revenue, payments made in advance by customers for services not yet provided.

    When we enter into a multi-year contract with a customer to provide installation, network management, and satellite transponder and help desk, or combination of these services, we recognize this revenue as services are performed and as equipment is sold. These agreements typically provide for additional fees, as needed, to be charged if on-site visits are required by the customer in order to ensure that each customer location is able to receive network communication. As these on-site visits are performed the associated revenue and cost are recognized in the period the work is completed. If we install, for an additional fee, new or replacement equipment to an immaterial number of new customer locations, and the equipment immediately becomes the property of the customer, the associated revenue and cost are recorded in the period in which the work is completed.

    In instances where we have entered into license agreements with a third parties to use our technology within their product offering, we recognize any base or prepaid revenues over the term of the agreement and any per occurrence or periodic usage revenues in the period they are earned.

    Research and Development
    Research and development costs are expensed when incurred. We expensed $1,754,163 and $2,410,249 of research and development costs for the years ended December 31, 2012 and 2011, respectively.
    Concentration of Credit Risk
    Financial instruments, which potentially subject us to concentration of credit risk, consist primarily of trade accounts receivable. In the normal course of business, we provide credit terms to our customers. Accordingly, we perform ongoing credit evaluations of our customers and maintain allowances for possible losses which, when realized, have been within the range of management's expectations.
    For the years ended December 31, 2012 and 2011, we had the same customer that individually constituted 85% and 89%, of our total revenues, respectively. Although the initial contract for this customer has expired, we received a contract extension through May 31, 2013 to continue to provide services. Unless we can replace that customer with another similarly large customer or customers, revenues will decline substantially, which will harm our business.

    Weighted Average Shares
    Basic earnings per common share is computed by dividing net income or loss applicable to common shareholders by the weighted average number of shares outstanding during each period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year, plus the dilutive common stock equivalents that would rise from the exercise of stock options, warrants and restricted stock units outstanding during the period, using the treasury stock method and the average market price per share during the period, plus the effect of assuming conversion of the convertible debt. The computation of diluted earnings per share does not assume conversion or exercise of securities that would have an anti-dilutive effect on earnings.

    The following table sets forth the computation of basic and diluted earnings per common share for the years ended December 31, 2011 and 2012:

       
    For the Year
    Ended 2011
    		    
    For the year
    Ended 2012
    		  
    Numerator
    		            
    Net income
    		   $ 1,304,446     $ 1,602,824  
    Denominator
    		                
    Basic weighted average shares outstanding
    		     75,416,916       100,978,223  
    Effect of dilutive securities:
    		                
    Stock options and warrants
    		     131,250       2,510,488  
    Restricted stock units
    		     2,550,000       3,225,133  
    Diluted weighted average shares outstanding
    		     78,098,166       106,533,844  
                     
    Net income per common share
    		                
    Basic
    		   $ 0.02     $ 0.02  
    Diluted
    		   $ 0.02     $ 0.02  

    Potentially dilutive securities representing 18,568,963 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2012, because their effect would have been anti-dilutive.

    Potentially dilutive securities representing 24,597,134 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2011, because their effect would have been anti-dilutive.

    Advertising Expenses
    We follow the policy of charging the costs of advertising to expense as incurred. Advertising expense for the years ended December 31, 2012 and 2011 were $35,168 and $68,703, respectively.
    Off-Balance Sheet Arrangements
    We have no off-balance sheet arrangements.
    Recent Accounting Pronouncements
    In August 2012, the FASB issued ASU No 2012-03, Technical Amendments and Corrections to SEC Sections. This Update makes changes to several of the SEC guidance literature sections within the Codification. The main focus is to update the SEC guidance as per SAB 114 to reference the codification sections rather than the old standards prior to the codification. The changes were mainly references and were not intended to change guidance. The amendments in this Update are effective immediately. This guidance didn't have a significant impact on the Company's financials since it was an update of SEC referenced guidance and didn't change existing guidance.

    In July 2012, the FASB issued ASU 2012-02, Intangibles - Goodwill and Other (Topic 350) - Testing Indefinite-Lived Intangible Assets for Impairment. The objective of this Update is to simplify how entities test indefinite-lived intangible assets for impairment and to have the testing be in-line with the updated guidance issued in 2011 related to impairment testing for goodwill. This Update allows entities to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative analysis. The more likely than not threshold is defined as having a likelihood of more than 50%. The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the quantitative impairment test and still be able to resume performing the qualitative assessment in subsequent years. Some examples of circumstances to consider are 1) cost factors that have a negative impact on earnings, 2) financial performance such as negative or declining cash flows, 3) legal, regulatory, contractual, political or business conditions, 4) other relevant entity specific events 5) industry and market conditions, and 6) macroeconomic conditions. The Update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before July 27, 2012 if the financial statements have not been issued. The Company doesn't expect this Update to impact the Company's financials since it currently has no indefinite-lived intangibles other than goodwill, but the Company will plan on utilizing the qualitative assessment options if any are acquired.

    In June 2011, the FASB issued ASU 2011-05, Comprehensive Income (Topic 220) - Presentation of Comprehensive Income. This Update eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders' equity in order to increase the prominence of other comprehensive income items and to facilitate convergence with IFRS. The Update requires that all non-owner changes in stockholders' equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements (a statement of income and statement of other comprehensive income). Additionally, adjustments for items reclassified from other comprehensive income to net income must be presented on the face of the financial statements. This Update should be applied retrospectively. For public entities, the Update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. For nonpublic entities, the Update is effective for fiscal years ending after December 15, 2012, and interim and annual periods thereafter. Early adoption is permitted, because compliance with the amendments is already permitted. The amendments do not require any transition disclosures. This impacts how items for Other Comprehensive Income are presented and the Company will follow the guidance starting in Q1 2012.

    In December 2011, the FASB issued ASU 2011-11, Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities. This Update is applicable to all entities that have financial instruments and derivative instruments that are either 1) offset in accordance with current guidance or 2) subject to an enforceable master netting arrangement. The Update requires an entity with these types of instruments to disclose information about offsetting and related arrangements. Both net and gross information for these assets and liabilities is required to be disclosed. This Update is effective for fiscal years beginning on or after January 1, 2013. The Company doesn't expect this Update to impact the Company's financials since it does not currently have any financial instruments or derivative instruments that are offset.
    In September 2011, the FASB issued ASU 2011-08, Intangibles - Goodwill and Other (Topic 350)- Testing Goodwill for Impairment. The objective of this Update is to simplify how entities test goodwill for impairment. This Update now allows entities to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step process of (1) comparing the fair value of the reporting unit to its carrying value and (2) test to measure the amount of the impairment loss if the fair value is less than the carrying value. The more likely than not threshold is defined as having a likelihood of more than 50%. The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the first step of the two-step goodwill impairment test. Some examples of circumstances to consider are 1) macroeconomic conditions, 2) industry and market conditions, 3) cost factors that have a negative impact on earnings, 4) overall financial performance such as negative or declining cash flows 5) other relevant entity specific events and 6) sustained decrease in stock price. The Update is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before September 15, 2011 if the financial statements have not been issued. If necessary, the Company will evaluate whether or not it will utilize the qualitative assessment option prior to performing the first goodwill impairment test in 2012, typically done during the 4th quarter.

    In May 2011, the FASB issued ASU 2011-04, Fair Value Measurement (Topic 820) - Amendments to Achieve Common Fair Value Measurements and Disclosure Requirements in US GAAP and IFRSs. The Amendments in this Update will improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with US GAAP and IFRSs. The Boards of both organizations worked together to ensure fair value has the same meaning and the measurement and disclosures would be the same other than minor differences in wording. The Amendments explain how to measure fair value and do not require any additional fair value measurements. A couple of the more significant changes are 1) Clarification that quantitative information about unobservable inputs categorized as Level 3 should be disclosed, 2) Specifies that premiums and discounts should be applied in the absence of Level 1 input if market participants would do so, but that premiums or discounts related to size/quantity should not be considered, 3) Additional disclosure requirements for fair value measurements categorized as Level 3, an entity's us of a nonfinancial asset in a way that differs from the asset's highest and best use and the categorization by level for items not measured at fair value in the statement of financial position, but for which fair value disclosure is required. The amendments in this Update are to be applied prospectively. The Update is effective during interim and annual periods beginning after December 15, 2011. The Company doesn't expect this guidance to have a significant impact on its financials since the amount of items disclosed at fair value is minimal, but will ensure the guidance is followed for items disclosed at fair value.
    XML 39 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Organization and Basis of Presentation (Details)
    		 12 Months Ended
    Oct. 01, 2003
    BI Networks [Member]
    Dec. 31, 2012
    Interact Devices Inc [Member]
    Dec. 31, 2011
    Interact Devices Inc [Member]
    Noncontrolling Interest [Line Items]      
    Percent ownership   94.00% 94.00%
    Number of shares owned   55,897,169 55,897,169
    Business Acquisition [Line Items]      
    Percentage of equity interests exchanged 98.00%    
    XML 40 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Notes Payable (Schedule of Notes Payable) (Details) (USD $)
    Dec. 31, 2012
    Dec. 31, 2011
    Debt Instrument [Line Items]    
    Total $ 3,102,006 $ 8,417,461
    Less Current Portion (3,102,006) (2,068,016)
    Total Long-term    6,349,445
    2012 Convertible Notes [Member]
    		    
    Debt Instrument [Line Items]    
    Total 2,428,166   
    Unsecured Convertible Note [Member]
    		    
    Debt Instrument [Line Items]    
    Total 673,840 340,504
    Amended and Restated Senior 6.25% Convertible Note [Member]
    		    
    Debt Instrument [Line Items]    
    Total    6,180,816
    Bridge Loan Note Payable [Member]
    		    
    Debt Instrument [Line Items]    
    Total    1,196,141
    Equipment Purchase and Sale Agreement [Member]
    		    
    Debt Instrument [Line Items]    
    Total    $ 700,000
    XML 41 R53.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Stock-based Compensation (Schedule of Assumptions Used to Value Warrants) (Details) (Warrant [Member])
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Warrant [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Risk free interest rate 1.16% 2.07%
    Expected life (in years) 5 years 8 months 12 days 5 years 0 months
    Expected volatility 82.79% 85.37%
    Expected dividend yield 0.00% 0.00%
    XML 42 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
    CONSOLIDATED BALANCE SHEETS (USD $)
    Dec. 31, 2012
    Dec. 31, 2011
    Current Assets    
    Cash and cash equivalents $ 394,342 $ 961,265
    Restricted cash 140,700   
    Trade accounts receivable, net 821,608 1,239,903
    Inventory 306,296 60,851
    Prepaid expenses 90,067 203,973
    Total current assets 1,753,013 2,465,992
    Property and equipment, net 572,107 1,417,134
    Other Assets, non current    
    Debt offering costs 42,176 123,278
    Patents, net 120,928 131,079
    Deposits and other assets 196,292 406,004
    Total other assets, non current 359,396 660,361
    Total assets 2,684,516 4,543,487
    Current Liabilities    
    Accounts payable 2,293,470 1,252,538
    Payroll and related expenses 363,568 390,206
    Other accrued expenses 299,728 175,008
    Unearned revenue 51,335 10,449
    Current portion of notes payable (net of discount of $103,859 and $947,994, respectively) 3,102,006 2,068,016
    Other current obligations    1,067,649
    Derivative valuation 1,191,269 3,760,200
    Total current liabilities 7,301,376 8,724,066
    Long-term Liabilities    
    Long-term portion of notes payable (net of discount of $659,496 and $0, respectively)    6,349,445
    Total long-term liabilities    6,349,445
    Total liabilities 7,301,376 15,073,511
    Commitments and contingencies      
    STOCKHOLDERS' DEFICIT:    
    Preferred stock, no par value, 20,000,000 shares authorized; none issued      
    Common stock, $.05 par value, 180,000,000 shares authorized; 75,975,656 and 107,473,820 shares issued as of December 31, 2011 and December 31, 2012, respectively 5,373,691 3,798,783
    Additional paid-in capital 99,594,490 96,859,058
    Accumulated deficit (109,585,041) (111,187,865)
    Total stockholders' deficit (4,616,860) (10,530,024)
    Total liabilities and stockholders' deficit $ 2,684,516 $ 4,543,487
    XML 43 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Notes Payable (Bridge Loan) (Details) (USD $)
    		 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 1 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Apr. 05, 2012
    2012 Plan [Member]
    Mar. 26, 2012
    2012 Plan [Member]
    Dec. 31, 2012
    2012 Plan [Member]
    Mar. 26, 2012
    Bridge Loan Conversion [Member]
    Dec. 31, 2012
    Bridge Loan Conversion [Member]
    2012 Plan [Member]
    Dec. 28, 2011
    Original Warrants Issued for Bridge Loan [Member]
    Dec. 28, 2011
    Warrants Issued to Reset Provision and Extend Maturity Date of Bridge Loan Warrants [Member]
    Dec. 28, 2011
    Warrants Issued to Investment Banker for Payment [Member]
    Dec. 31, 2012
    Warrants Issued to Investment Banker for Payment [Member]
    Dec. 28, 2011
    Bridge Loan Note Payable [Member]
    Jul. 31, 2012
    Bridge Loan Note Payable [Member]
    Dec. 31, 2012
    Bridge Loan Note Payable [Member]
    Dec. 31, 2011
    Bridge Loan Note Payable [Member]
    Mar. 26, 2012
    Bridge Loan Note Payable [Member]
    Bridge Loan Conversion [Member]
    2012 Plan [Member]
    Dec. 28, 2011
    Bridge Loan Note Payable [Member]
    Original Warrants Issued for Bridge Loan [Member]
    Dec. 31, 2012
    Bridge Loan Note Payable [Member]
    Original Warrants Issued for Bridge Loan [Member]
    Dec. 28, 2011
    Bridge Loan Note Payable [Member]
    Warrants Issued to Reset Provision and Extend Maturity Date of Bridge Loan Warrants [Member]
    Dec. 31, 2012
    Bridge Loan Note Payable [Member]
    Warrants Issued to Reset Provision and Extend Maturity Date of Bridge Loan Warrants [Member]
    Debt                                        
    Principal issued                       $ 1,300,000                
    Number of warrants issued     400,400         357,500 247,500 65,000                    
    Debt interest rate                       18.00%                
    Warrant term length       6 years       5 years 6 years               5 years   6 years  
    Number of shares of common stock warrants can be exercised for                                 357,500   247,500  
    Exercise price of warrants               0.65 0.35 0.65 0.53           0.65   0.35  
    Debt maturity date                       Feb. 28, 2012                
    Amount of financing proceeds triggering expiration of warrants       5,000,000               12,000,000                
    Payments for placement fees                       84,500                
    Payments of escrow fees                       3,000                
    Amount of debt converted                               400,000        
    Fair value of warrants         757,469   32,807                          
    Principale amount retired           400,000             900,000              
    (Loss) gain on extinguishment of debt 1,578,914 (954,017)       (222,426)             (93,661)              
    Retirement of debt offering costs 53,150                                       
    Derivative valuation 1,191,269 3,760,200     757,469                         7,400   7,200
    Gain on derivative valuation 8,829,748 11,724,400     4,365,323                         136,300   89,325
    Risk-free interest rate                                   0.54%   0.54%
    Expected life                                   4 years 0 months   4 years 0 months
    Expected volatility                                   82.55%   82.55%
    Dividend yield                                   0.00%   0.00%
    Stock trading price                                   $ 0.08   $ 0.08
    Accretion of discount on convertible notes payable 941,225 340,377                     53,160 106,723 7,041          
    Interest expense                           $ 100,899 $ 2,564          
    XML 44 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
    CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Cash flows from operating activities:    
    Net Income $ 1,602,824 $ 1,304,446
    Adjustments to reconcile net loss to net cash used in operating activities:    
    Depreciation and amortization 1,024,754 1,483,868
    Common stock issued for services 177,313   
    Common stock issued for interest    19,634
    Common stock issued for in process research and development    10,760
    Accretion of discount on convertible notes payable 941,225 340,377
    Stock based compensation 283,693 2,262,540
    Warrants issued for interest    157,400
    Warrants issued for debt extinguishment costs    404,000
    Warrants issued and expensed for issuance costs 1,095,309   
    Loss (gain) on extinguishment of debt (1,578,914) 954,017
    Expensed note conversion costs 47,348   
    Gain on derivative liability valuation (8,829,748) (11,724,400)
    Loss (gain) on sale of assets (512) 362
    Retirement of debt offering costs 53,150   
    Loss on impairment of assets    26,180
    Allowance for dousbtful accounts 31,982 10,149
    Changes in assets    
    Decrease (increase) in accounts receivable 386,313 (124,997)
    Increase in inventories (245,445) (8,676)
    Decrease (increase) in debt offering costs 105,805 (102,978)
    Decrease in prepaid and other assets 323,618 205,498
    Changes in liabilities    
    Increase (decrease) in accounts payable 1,040,932 (267,452)
    Increase in accrued expenses 136,682 13,823
    Increase (decrease) in deferred revenues 40,886 (128,988)
    Net cash used in operating activities (3,362,785) (5,164,437)
    Cash flows from investing activities:    
    Purchase of equipment (172,825) (472,505)
    Proceeds from sale of assets 3,761 1,183
    Net cash used by investing activities (169,064) (471,322)
    Cash flows from financing activities:    
    Proceeds from the exercise of options and warrants    18,304
    Proceeds from equity financing 6,150,000   
    Payments on principal on debt (4,017,649) (1,526,834)
    Equity issuance costs (776,483) (24,078)
    Proceeds from equipment financing    700,000
    Payments for debt extinguishment costs (275,041)   
    Increase in restricted cash (140,700)   
    Proceeds from notes payable 2,024,799 1,300,000
    Net cash provided by financing activities 2,964,926 467,392
    Net decrease in cash and cash equivalents (566,923) (5,168,367)
    Cash and cash equivalents, beginning of period 961,265 6,129,632
    Cash and cash equivalents, end of period 394,342 961,265
    Supplemental disclosure of cash flow information:    
    Interest paid 347,902 357,246
    Income taxes paid      
    XML 45 R59.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Equipment Financing (Details) (Telecommunications Equipment [Member], USD $)
    		 0 Months Ended 12 Months Ended
    Jul. 28, 2009
    Dec. 31, 2012
    Dec. 31, 2011
    Capital Leased Assets [Line Items]      
    Number of customers locations where equipment is installed 1,981 2,100  
    Proceeds from sale of equipment to financing institution $ 4,100,670    
    Number of payments   36  
    Monthly rental payment   144,000  
    Number of payments until lease can be cancelled   33  
    One time fee for cancellation   410,000  
    Cancellation fee as a percentage of equipment value   10.00%  
    Lease payments   1,125,588 1,688,382
    Interest portion of lease payments   57,939 264,854
    Payments toward in place fair market value   422,100  
    Increase in restricted cash   (140,700)  
    Capitalized lease acquisition fees   150,792 150,792
    Amortization of the lease acquisition fee   33,512 50,268
    Capital Lease Obligations [Member]
    		      
    Capital Leased Assets [Line Items]      
    Lease payments applied to principal   $ 1,067,649 $ 1,423,528
    XML 46 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Significant Accounting Policies (Weighted Average Shares) (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Numerator    
    Net income $ 1,602,824 $ 1,304,446
    Denominator    
    Basic weighted average shares outstanding 100,798,223 75,416,916
    Stock options and warrants 2,510,488 131,250
    Restricted stock units 3,225,133 2,550,000
    Diluted weighted average shares outstanding 106,533,844 78,098,166
    Basic $ 0.02 $ 0.02
    Diluted $ 0.02 $ 0.02
    Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
    Anti-dilutive securities 18,568,963 24,597,134
    XML 47 R65.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Subsequent Events (Details) (USD $)
    		 1 Months Ended 12 Months Ended 1 Months Ended 1 Months Ended
    Aug. 31, 2012
    Twenty Twelve Convertible Notes [Member]
    Jul. 31, 2012
    Twenty Twelve Convertible Notes [Member]
    Dec. 31, 2012
    Twenty Twelve Convertible Notes [Member]
    Mar. 29, 2013
    Subsequent Event [Member]
    Former Director [Member]
    Mar. 29, 2013
    Subsequent Event [Member]
    Directors [Member]
    Jan. 06, 2013
    Subsequent Event [Member]
    Management [Member]
    Jan. 31, 2013
    Subsequent Event [Member]
    Warrants Issued Subsequent to Balance Sheet Date [Member]
    Jan. 31, 2013
    Subsequent Event [Member]
    Twenty Twelve Convertible Notes [Member]
    Subsequent Event [Line Items]                
    Continued sales of convertible debt $ 900,000 $ 1,900,000           $ 425,000
    Debt maturity date     Jul. 13, 2013         Jul. 13, 2013
    Conversion price     $ 0.25         $ 0.25
    Number of shares of common stock warrants can be exercised for     200,000       850,000  
    Exercise price of warrants             0.25  
    Warrant term length     5 years       5 years  
    Settled by issuance of stock       258,553        
    Number of shares issued       200,000        
    Awards issued for fees       $ 15,000 $ 51,500      
    Shares authorized for issuance         686,667 529,100    
    XML 48 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Supplemental Cash Flow Information
    		 12 Months Ended
    Dec. 31, 2012
    Supplemental Cash Flow Information [Abstract]  
    Supplemental Cash Flow Information
    Note 16 - Supplemental Cash Flow Information

    2012
    ·
    During the year ended December 31, 2012 we issued 586,164 shares our common stock, valued at $222,742 to a placement agency for services rendered related to our 2012 Equity Financing and Debt Restructuring agreement


    ·
    During the year ended December 31, 2012, we issued 496,000 shares of our common stock valued at $177,313 to two consultants and one corporation of which (i) 250,000 shares was in consideration for cancellation of a warrant issued for consulting services rendered and (ii) 246,000 was for consulting services rendered.


    ·
    During the year ended December 31, 2012, we recognized $1,024,754 in depreciation and amortization expense from the following: (i) $466,606 related to cost of sales for equipment used directly by or for customers, (ii) $547,997 related to equipment other property and equipment, and (iii) $10,151 for patent amortization.


    ·
    For the year ended December 31, 2012, an aggregate non-cash expense of $941,225 was recorded for the accretion of our convertible notes of which (i) $501,166 was for the accretion of our 2012 Secured Convertible Note (ii) $333,336 was related to our unsecured convertible note and (iii) $106,723 was for our bridge loan.

    2011
    ·
    During the year ended December 31, 2011, we granted options to acquire up to 600,000 shares of our common stock valued at $389,000 to two consultants in consideration of consulting services to be rendered by the consultants over a one-year period pursuant to a written consulting agreement. For the year ended December 31, 2011, the value of options is being recognized over the contract period and $364,000 was included in stock based compensation.


    ·
    During the year ended December 31, 2011 we issued 135,369 shares our common stock to an individual for interest owed on a debt obligation, valued at $81,221 which was accrued at December 31, 2010.


    ·
    During the year ended December 31, 2011 we acquired 414,172 IDI common share equivalents in exchange for 27,611 shares of our common stock valued at $10,760 which was expensed to research and development.


    ·
    During the year ended December 31, 2011, we recognized $1,483,868 in depreciation and amortization expense from the following: (i) $798,677 related to cost of sales for equipment used directly by or for customers, (ii) $675,040 related to equipment other property and equipment, and (iii) $10,151 for patent amortization.


    ·
    For the year ended December 31, 2011, an aggregate non-cash expense of $340,377 was recorded for the accretion of our convertible notes of which (i) $333,336 was related to our unsecured convertible note and (ii) $7,041 was for our bridge loan.


    ·
    On March 21, 2011, the Company, converted $784,292 of its short-term debt into equity through the issuance of common stock and warrants to two lenders at the same unit pricing as the Equity Financing. In consideration of converting the short- term loans on the basis of $1.20 for two shares of common stock plus one warrant at an exercise price of $1.00, the Company issued 1,307,153 shares of common stock and warrants to acquire up to 653,576 shares of common stock, which warrants have a five year term and are exercisable at $1.00 per share. The $784,292 above is net of expense and includes $109,292 of interest of which $89,658 was accrued in the year ended December 31, 2010 and $19,634 which was included as interest expense for the year ended December 31, 2011. The Company's objective for converting the short-term debt into equity is to conserve cash for further market development.


    ·
    In March 2011, we granted to the holder of our senior unsecured convertible note a warrant to acquire 400,000 shares of our common stock at an exercise price of $.05 per share in consideration of a waiver of the holder's reset provision that allowed us to convert certain short terms loans to equity without causing an adjustment in the conversion price of our senior note. The warrants had a 5-year life from the date of grant, contained full-ratchet anti-dilution price protection provisions and were valued at $404,000 using a Black Scholes pricing model on the date of grant. During the year ended December 31, 2011, the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock

    We paid no cash for income taxes during the years ended December 31 2012 and 2011.
    XML 49 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Accounts Receivable (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Accounts Receivable [Abstract]    
    Net accounts receivable 821,608 1,239,903
    Billed trade receivables 856,462 1,269,579
    Unbilled trade receivables 44,478 23,814
    Employee travel advances and other receivables 1,808 0
    Allowance for uncollectible accounts 81,140 53,490
    Customer One [Member]
    		    
    Concentration Risk [Line Items]    
    Percentage of revenues from major customer 85.00% 89.00%
    Accounts Receivable [Member] | Credit Concentration Risk [Member] | Customer One [Member]
    		    
    Concentration Risk [Line Items]    
    Percentage of accounts receivable 71.00% 79.00%
    XML 50 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Significant Accounting Policies (Policies)
    		 12 Months Ended
    Dec. 31, 2012
    Significant Accounting Policies [Abstract]  
    Management Estimates
    Management Estimates
    The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
    Cash and Cash Equivalents
    Cash and Cash Equivalents
    We consider all cash on hand and in banks, and highly liquid investments with maturities of three months or less, to be cash equivalents. At December 31, 2012 and 2011, we had bank balances of $38,847 and $909,182, respectively in excess of amounts insured by the Federal Deposit Insurance Corporation. In addition we have restricted cash of $140,700, which represents a deposit to the Utah District Court, which is held pending the outcome of our litigation with our equipment lessor. We have not experienced any losses in such accounts, and believe we are not exposed to any significant credit risk on cash and cash equivalents.
    Current financial market conditions have had the effect of restricting liquidity of cash management investments and have increased the risk of even the most liquid investments and the viability of some financial institutions. We do not believe, however, that these conditions will materially affect our business or our ability to meet our obligations or pursue our business plans.
    Accounts Receivable
    Account Receivables
    Trade account receivables are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.
    A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than 90 days. After the receivable becomes past due, it is on non-accrual status and accrual of interest is suspended.
    Inventories
    Inventories
    Inventories consisting of electrical and computer parts are stated at the lower of cost or market determined using the first-in, first-out method.
    Property and Equipment
    Property and Equipment
    Property and equipment are stated at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the property, generally from three to five years. Repairs and maintenance costs are expensed as incurred except when such repairs significantly add to the useful life or productive capacity of the asset, in which case the repairs are capitalized.
    Patents and Intangibles
    Patents and Intangibles
    Patents represent initial legal costs incurred to apply for United States and international patents on the CodecSys technology, and are amortized on a straight-line basis over their useful life of approximately 20 years. We have filed several patents in the United States and foreign countries. As of December 31, 2012, the United States Patent and Trademark Office had approved four patents. Additionally, eleven foreign countries had approved patent rights. While we are unsure whether we can develop the technology in order to obtain the full benefits, the patents themselves hold value and could be sold to companies with more resources to complete the development. On-going legal expenses incurred for patent follow-up have been expensed from July 2005 forward. For the year ended December 31, 2011 we recorded a $26,180 valuation impairment related to two patent applications for areas outside the United States.
    Amortization expense recognized on all patents totaled $10,151 for each of the years ended December 31, 2012 and 2011, respectively.
    Estimated amortization expense, if all patents were issued at the beginning of 2013, for each of the next five years is as follows:
    Year ending
    December 31:
    		        
    2013
    		     $ 11,343  
    2014
    		       10,121  
    2015
    		       10,121  
    2016
    		       10,121  
    2017
    		       10,121  
    Long-Lived Assets
    Long-Lived Assets
    We review our long-lived assets, including patents, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by a comparison of the carrying amount of an asset to future un-discounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, then the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. Fair value is determined by using cash flow analyses and other market valuations. After our review at December 31, 2012 it was determined that no adjustment was required.
    Stock-based Compensation
    Stock-based Compensation
    In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.
    Income Taxes
    Income Taxes
    We account for income taxes in accordance with the asset and liability method of accounting for income taxes prescribed by ASC Topic 740. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income in the years in which those temporary differences are expected to be recovered or settled.
    Revenue Recognition
    Revenue Recognition
    We recognize revenue when evidence exists that there is an arrangement between us and our customers, delivery of equipment sold or service has occurred, the selling price to our customers is fixed and determinable with required documentation, and collectability is reasonably assured. We recognize as deferred revenue, payments made in advance by customers for services not yet provided.

    When we enter into a multi-year contract with a customer to provide installation, network management, and satellite transponder and help desk, or combination of these services, we recognize this revenue as services are performed and as equipment is sold. These agreements typically provide for additional fees, as needed, to be charged if on-site visits are required by the customer in order to ensure that each customer location is able to receive network communication. As these on-site visits are performed the associated revenue and cost are recognized in the period the work is completed. If we install, for an additional fee, new or replacement equipment to an immaterial number of new customer locations, and the equipment immediately becomes the property of the customer, the associated revenue and cost are recorded in the period in which the work is completed.

    In instances where we have entered into license agreements with a third parties to use our technology within their product offering, we recognize any base or prepaid revenues over the term of the agreement and any per occurrence or periodic usage revenues in the period they are earned.
    Research and Development
    Research and Development
    Research and development costs are expensed when incurred. We expensed $1,754,163 and $2,410,249 of research and development costs for the years ended December 31, 2012 and 2011, respectively.
    Concentration of Credit Risk
    Concentration of Credit Risk
    Financial instruments, which potentially subject us to concentration of credit risk, consist primarily of trade accounts receivable. In the normal course of business, we provide credit terms to our customers. Accordingly, we perform ongoing credit evaluations of our customers and maintain allowances for possible losses which, when realized, have been within the range of management's expectations.
    For the years ended December 31, 2012 and 2011, we had the same customer that individually constituted 85% and 89%, of our total revenues, respectively. Although the initial contract for this customer has expired, we received a contract extension through May 31, 2013 to continue to provide services. Unless we can replace that customer with another similarly large customer or customers, revenues will decline substantially, which will harm our business.
    Weighted Average Shares
    Weighted Average Shares
    Basic earnings per common share is computed by dividing net income or loss applicable to common shareholders by the weighted average number of shares outstanding during each period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year, plus the dilutive common stock equivalents that would rise from the exercise of stock options, warrants and restricted stock units outstanding during the period, using the treasury stock method and the average market price per share during the period, plus the effect of assuming conversion of the convertible debt. The computation of diluted earnings per share does not assume conversion or exercise of securities that would have an anti-dilutive effect on earnings.

    The following table sets forth the computation of basic and diluted earnings per common share for the years ended December 31, 2011 and 2012:

       
    For the Year
    Ended 2011
    		    
    For the year
    Ended 2012
    		  
    Numerator
    		            
    Net income
    		   $ 1,304,446     $ 1,602,824  
    Denominator
    		                
    Basic weighted average shares outstanding
    		     75,416,916       100,978,223  
    Effect of dilutive securities:
    		                
    Stock options and warrants
    		     131,250       2,510,488  
    Restricted stock units
    		     2,550,000       3,225,133  
    Diluted weighted average shares outstanding
    		     78,098,166       106,533,844  
                     
    Net income per common share
    		                
    Basic
    		   $ 0.02     $ 0.02  
    Diluted
    		   $ 0.02     $ 0.02  

    Potentially dilutive securities representing 18,568,963 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2012, because their effect would have been anti-dilutive.

    Potentially dilutive securities representing 24,597,134 shares of common stock were excluded from the computation of diluted earnings per common share for the year ended December 31, 2011, because their effect would have been anti-dilutive.
    Advertising Expenses
    Advertising Expenses
    We follow the policy of charging the costs of advertising to expense as incurred. Advertising expense for the years ended December 31, 2012 and 2011 were $35,168 and $68,703, respectively.
    Off-Balance Sheet Arrangements
    Off-Balance Sheet Arrangements
    We have no off-balance sheet arrangements.
    Recent Accounting Pronouncements
    Recent Accounting Pronouncements
    In August 2012, the FASB issued ASU No 2012-03, Technical Amendments and Corrections to SEC Sections. This Update makes changes to several of the SEC guidance literature sections within the Codification. The main focus is to update the SEC guidance as per SAB 114 to reference the codification sections rather than the old standards prior to the codification. The changes were mainly references and were not intended to change guidance. The amendments in this Update are effective immediately. This guidance didn't have a significant impact on the Company's financials since it was an update of SEC referenced guidance and didn't change existing guidance.

    In July 2012, the FASB issued ASU 2012-02, Intangibles - Goodwill and Other (Topic 350) - Testing Indefinite-Lived Intangible Assets for Impairment. The objective of this Update is to simplify how entities test indefinite-lived intangible assets for impairment and to have the testing be in-line with the updated guidance issued in 2011 related to impairment testing for goodwill. This Update allows entities to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative analysis. The more likely than not threshold is defined as having a likelihood of more than 50%. The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the quantitative impairment test and still be able to resume performing the qualitative assessment in subsequent years. Some examples of circumstances to consider are 1) cost factors that have a negative impact on earnings, 2) financial performance such as negative or declining cash flows, 3) legal, regulatory, contractual, political or business conditions, 4) other relevant entity specific events 5) industry and market conditions, and 6) macroeconomic conditions. The Update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before July 27, 2012 if the financial statements have not been issued. The Company doesn't expect this Update to impact the Company's financials since it currently has no indefinite-lived intangibles other than goodwill, but the Company will plan on utilizing the qualitative assessment options if any are acquired.

    In June 2011, the FASB issued ASU 2011-05, Comprehensive Income (Topic 220) - Presentation of Comprehensive Income. This Update eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders' equity in order to increase the prominence of other comprehensive income items and to facilitate convergence with IFRS. The Update requires that all non-owner changes in stockholders' equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements (a statement of income and statement of other comprehensive income). Additionally, adjustments for items reclassified from other comprehensive income to net income must be presented on the face of the financial statements. This Update should be applied retrospectively. For public entities, the Update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. For nonpublic entities, the Update is effective for fiscal years ending after December 15, 2012, and interim and annual periods thereafter. Early adoption is permitted, because compliance with the amendments is already permitted. The amendments do not require any transition disclosures. This impacts how items for Other Comprehensive Income are presented and the Company will follow the guidance starting in Q1 2012.

    In December 2011, the FASB issued ASU 2011-11, Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities. This Update is applicable to all entities that have financial instruments and derivative instruments that are either 1) offset in accordance with current guidance or 2) subject to an enforceable master netting arrangement. The Update requires an entity with these types of instruments to disclose information about offsetting and related arrangements. Both net and gross information for these assets and liabilities is required to be disclosed. This Update is effective for fiscal years beginning on or after January 1, 2013. The Company doesn't expect this Update to impact the Company's financials since it does not currently have any financial instruments or derivative instruments that are offset.
    In September 2011, the FASB issued ASU 2011-08, Intangibles - Goodwill and Other (Topic 350)- Testing Goodwill for Impairment. The objective of this Update is to simplify how entities test goodwill for impairment. This Update now allows entities to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step process of (1) comparing the fair value of the reporting unit to its carrying value and (2) test to measure the amount of the impairment loss if the fair value is less than the carrying value. The more likely than not threshold is defined as having a likelihood of more than 50%. The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the first step of the two-step goodwill impairment test. Some examples of circumstances to consider are 1) macroeconomic conditions, 2) industry and market conditions, 3) cost factors that have a negative impact on earnings, 4) overall financial performance such as negative or declining cash flows 5) other relevant entity specific events and 6) sustained decrease in stock price. The Update is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before September 15, 2011 if the financial statements have not been issued. If necessary, the Company will evaluate whether or not it will utilize the qualitative assessment option prior to performing the first goodwill impairment test in 2012, typically done during the 4th quarter.

    In May 2011, the FASB issued ASU 2011-04, Fair Value Measurement (Topic 820) - Amendments to Achieve Common Fair Value Measurements and Disclosure Requirements in US GAAP and IFRSs. The Amendments in this Update will improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with US GAAP and IFRSs. The Boards of both organizations worked together to ensure fair value has the same meaning and the measurement and disclosures would be the same other than minor differences in wording. The Amendments explain how to measure fair value and do not require any additional fair value measurements. A couple of the more significant changes are 1) Clarification that quantitative information about unobservable inputs categorized as Level 3 should be disclosed, 2) Specifies that premiums and discounts should be applied in the absence of Level 1 input if market participants would do so, but that premiums or discounts related to size/quantity should not be considered, 3) Additional disclosure requirements for fair value measurements categorized as Level 3, an entity's us of a nonfinancial asset in a way that differs from the asset's highest and best use and the categorization by level for items not measured at fair value in the statement of financial position, but for which fair value disclosure is required. The amendments in this Update are to be applied prospectively. The Update is effective during interim and annual periods beginning after December 15, 2011. The Company doesn't expect this guidance to have a significant impact on its financials since the amount of items disclosed at fair value is minimal, but will ensure the guidance is followed for items disclosed at fair value.
    XML 51 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

    "+ text.join( "

    \n" ) +"

    "; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

    " + text[p] + "

    \n"; } } }else{ formatted = '

    ' + raw + '

    '; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
    '+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
    '+ "\n"+' '+ "\n"+'
    '+ "\n"+' '+ "\n"+'
    '+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }     XML 52 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Organization and Basis of Presentation
    		 12 Months Ended
    Dec. 31, 2012
    Organization and Basis of Presentation [Abstract]  
    Organization and Basis of Presentation
    Note 1 - Organization and Basis of Presentation
    Broadcast International, Inc. (the Company) is the consolidated parent company of BI Acquisitions, Inc. (BI), a wholly-owned subsidiary, and Interact Devices, Inc. (IDI), a 94% owned subsidiary.
    BI was incorporated in Utah in December 1999 and began operations in January 2000. It is a communications services and technology company headquartered in Salt Lake City, Utah. The Company operates two divisions - BI Networks and CodecSys.
    On October 1, 2003, the Company (formerly known as Laser Corporation) acquired BI by issuing shares of its common stock representing 98% of the total equity ownership in exchange for all of the issued and outstanding BI common stock. The transaction was accounted for as a reverse acquisition, or recapitalization of BI, with BI being treated as the accounting acquirer. Effective January 13, 2004, the company changed its name from Laser Corporation to Broadcast International, Inc.
    On May 18, 2004, the Debtor-in-Possession's Plan of Reorganization for IDI was confirmed by the United States Bankruptcy Court. As a result of this confirmation and subsequent share acquisitions, for the years ended December 31, 2012 and 2011, the Company owned, on a fully diluted basis, approximately 55,897,169 common share equivalents of IDI, representing approximately 94% of the equity of IDI.
    The audited consolidated financial statements herein include operations from January 1, 2011 to December 31, 2012. IDI produced losses from operations during the period; therefore, 100% of the results from operations have been included in the Company's consolidated statements.
    XML 53 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
    CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
    Dec. 31, 2012
    Dec. 31, 2011
    CONSOLIDATED BALANCE SHEETS [Abstract]    
    Current portion of notes payable, discount $ 947,994 $ 103,859
    Long-term portion of notes payable, discount $ 0 $ 659,496
    Preferred stock, no par value      
    Preferred stock, shares authorized 20,000,000 20,000,000
    Preferred stock, shares issued 0 0
    Common stock, par value per share $ 0.05 $ 0.05
    Common stock, shares authorized 180,000,000 180,000,000
    Common stock, shares issued 107,473,820 75,975,656
    XML 54 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Equipment Financing
    		 12 Months Ended
    Dec. 31, 2012
    Equipment Financing [Abstract]  
    Equipment Financing
    Note 11 - Equipment Financing
    On August 27, 2009, we completed an equipment lease financing transaction with a financial institution. Pursuant to the financing, we entered into various material agreements with the financial institution. These agreements are identified and summarized below.

    We entered into a Master Lease Agreement dated as of July 28, 2009 with the financial institution pursuant to which we sold to the financing institution certain telecommunications equipment to be installed at 1,981 (subsequent additional locations have increased the customer's network to an aggregate of approximately 2,100 locations) of our customer's retail locations in exchange for a one-time payment of $4,100,670 by the financial institution. We paid to the financial institution 36 monthly lease payments of approximately $144,000 plus applicable sales taxes. We had the right to terminate the lease after making 33 payments for a termination fee of the higher of approximately 10% of the original equipment value (approximately $410,000) or the then "in-place fair market value" after which payment we would own all of the equipment. We gave timely notice of exercise of this option. We are currently a party to a lawsuit to determine if the "in-place fair market value" exceeds the 10% of the original lease value and by what amount. We contend that the three payments made subsequent to the notice exercising our right to purchase constitute full payment for the equipment. The equipment broker contends that we owe an additional amount. Our accounting records reflect that the capital lease has been retired and the equipment has been fully depreciated.

    We also entered into a security agreement with the financial institution pursuant to which we granted a first priority security interest in the equipment, whether now owned or hereafter acquired, and in our customer service agreement and service payments thereunder during the term of the equipment lease.

    During 2012 we had made lease payments totaling approximately $1,125,588 of which $1,067,649 was applied toward the outstanding lease and $57,939 was included in interest expense. Included in the $1,125,588 is approximately $422,100 paid toward the in place fair market value. Additionally during the year ended December 31, 2012 we made payments of $140,700 into an escrow account held by the court pending resolution of our dispute. For the year ending December 31, 2012, we expensed the final $33,512 of our lease acquisition fee of $150,792 which was being recognized over the life of the lease included in interest expense.
    During 2011 we had made lease payments totaling approximately $1,688,382 of which $1,423,528 was applied toward the outstanding lease and $264,854 was included in interest expense. Additionally, we expensed $50,268 of our lease acquisition fee of $150,792 which is being recognized over the life of the lease included in interest expense for the year ended December 31, 2011.
    XML 55 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Document and Entity Information (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Mar. 15, 2013
    Jun. 30, 2012
    Document and Entity Information [Abstract]      
    Document Type 10-K    
    Amendment Flag false    
    Document Period End Date Dec. 31, 2012    
    Entity Registrant Name BROADCAST INTERNATIONAL INC    
    Entity Central Index Key 0000740726    
    Current Fiscal Year End Date --12-31    
    Document Fiscal Year Focus 2012    
    Document Fiscal Period Focus FY    
    Entity Filer Category Smaller Reporting Company    
    Entity Common Stock, Shares Outstanding   107,932,373  
    Entity Current Reporting Status Yes    
    Entity Well-known Seasoned Issuer No    
    Entity Voluntary Filers No    
    Entity Public Float     $ 26,806,955
    XML 56 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Fair Value Measurements
    		 12 Months Ended
    Dec. 31, 2012
    Fair Value Measurements [Abstract]  
    Fair Value Measurements
    Note 12 - Fair Value Measurements
    We adopted ASC Topic 820 as of January 1, 2008 for financial instruments measured at fair value on a recurring basis. ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.
    Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:
    ·
    Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

    ·
    Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

    ·
    Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
    We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2012:
                   
    Significant
    		        
             
    Quoted Prices in
    		    
    Other
    		    
    Significant
    		  
             
    Active Markets for
    		    
    Observable
    		    
    Unobservable
    		  
             
    Identical Assets
    		    
    Inputs
    		    
    Inputs
    		  
       
    Total
    		    
    (Level 1)
    		    
    (Level 2)
    		    
    (Level 3)
    		  
    Assets
    		                        
    None
    		     --       --       --       --  
    Total assets measured at fair value
    		   $ --     $ --     $ --     $ --  
                                     
    Liabilities
    		                                
    Derivative valuation (1)
    		   $ 1,191,269     $ --     $ --     $ 1,191,269  
    Total liabilities measured at fair value
    		   $ 1,191,269     $ --     $ --     $ 1,191,269  
     
    (1)
    See Notes 4 & 5 for additional discussion.
    The table below presents our assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at December 31, 2012. We classify financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model.
       
    Derivative
    		  
       
    Valuation
    		  
       
    Liability
    		  
    Balance at December 31, 2011
    		   $ (3,760,200 )
    Total gains or losses (realized and unrealized)
    		        
    Included in net income
    		     8,829,748  
    Valuation adjustment
    		     --  
    Purchases, issuances, and settlements, net
    		     (6,260,817 )
    Transfers to Level 3
    		     --  
    Balance at December 31, 2012
    		   $ (1,191,269 )
    Money Market Funds and Treasury Securities

    The money market funds and treasury cash reserve securities balances are classified as cash and cash equivalents on our consolidated balance sheet.

    Fair Value of Other Financial Instruments
    The carrying amounts of our accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their immediate or short-term maturities. The aggregate carrying amount of the notes payable approximates fair value as the individual notes bear interest at market interest rates and there hasn't been a significant change in our operations and risk profile.
    XML 57 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
    CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    CONSOLIDATED STATEMENT OF OPERATIONS [Abstract]    
    Net sales $ 7,523,624 $ 8,446,082
    Cost of sales 4,819,624 5,868,601
    Gross profit 2,704,000 2,577,481
    Operating expenses:    
    Administrative and general 4,546,612 6,172,794
    Selling and marketing 1,908,763 1,277,629
    Research and development 1,754,163 2,410,249
    Impairment of assets    26,180
    Depreciation and amortization 558,148 685,191
    Total operating expenses 8,767,686 10,572,043
    Total operating loss (6,063,686) (7,994,562)
    Other income (expense):    
    Interest income    2,327
    Interest expense (1,542,424) (1,000,072)
    Gain on derivative valuation 8,829,748 11,724,400
    Note conversion offering expense (47,348)   
    Retirement of debt offering costs (53,150)   
    Debt conversion costs (1,095,309) (476,234)
    (Loss) gain on extinguishment of debt 1,578,914 (954,017)
    (Loss) gain on sale of assets 512 (362)
    Other income, net (4,433) 2,966
    Total other income 7,666,510 9,299,008
    Income before income taxes 1,602,824 1,304,446
    Provision for income taxes      
    Net income $ 1,602,824 $ 1,304,446
    Income per share basic $ 0.02 $ 0.02
    Income per share diluted $ 0.02 $ 0.02
    Weighted average shares basic 100,798,223 75,416,916
    Weighted average shares diluted 106,533,844 78,098,166
    XML 58 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Investment in Interact Devices Inc. (IDI)
    		 12 Months Ended
    Dec. 31, 2012
    Investment in Interact Devices, Inc (IDI) [Abstract]  
    Investment in Interact Devices, Inc (IDI)
    Note 6 - Investment in Interact Devices, Inc (IDI)
    We began investing in and advancing monies to IDI in 2001. IDI was developing technology which became an initial part of the CodecSys technology.
    On October 23, 2003, IDI filed for Chapter 11 Federal Bankruptcy protection. We desired that the underlying patent process proceed and that the development of CodecSys technology continue. Therefore, we participated in IDI's plan of reorganization, whereby we would satisfy the debts of the creditors and obtained certain licensing rights. On May 18, 2004, the debtor-in-possession's plan of reorganization for IDI was confirmed by the United States Bankruptcy Court. As a result of this confirmation, we issued to the creditors of IDI shares of our common stock and cash in exchange for approximately 50,127,218 shares of the common stock of IDI. Since May 18, 2004, we have acquired additional common share equivalents IDI. During the year ended December 31, 2012 we did not acquire any IDI share equivalents. During the year ended December 31, 2011 we acquired 414,172 IDI common share equivalents in exchange for 27,611 shares of our common stock valued at $10,760. As of December 31, 2012, we owned approximately 55,897,169 IDI common share equivalents, representing approximately 94% of the total outstanding IDI share equivalents
    Since May 18, 2004, we have advanced additional cash to IDI for the payment of operating expenses, which continues development and marketing of the CodecSys technology. As of December 31, 2012 and 2011, we have advanced an aggregate amount of $3,347,255 and $3,126,772 respectively, pursuant to a promissory note that is secured by assets and technology of IDI.
    XML 59 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Notes Payable
    		 12 Months Ended
    Dec. 31, 2012
    Notes Payable [Abstract]  
    Notes Payable
    Note 5 - Notes Payable
    The recorded value of our notes payable (net of debt discount) for the years ending December 31, 2012 and 2011 was as follows:

       
    December 31,
    2011
    		    
    December 31,
    2012
    		  
    2012 Secured Convertible Notes
    		     --       2,428,166  
    Unsecured Convertible Note
    		     340,504       673,840  
    Amended and Restated Senior 6.25% Convertible Note
    		   $ 6,180,816     $ --  
    Bridge Loan Note Payable
    		     1,196,141       --  
    Equipment Purchase and Sale Agreement
    		     700,000       --  
    Total
    		     8,417,461       3,102,006  
    Less Current Portion
    		     (2,068,016 )     (3,102,006 )
    Total Long-term
    		   $ 6,349,445     $ --  
    2012 Secured Convertible Notes
    We engaged Philadelphia Brokerage Corporation to raise funds through the issuance of convertible promissory notes. We anticipated issuing promissory notes with an aggregate principal amount of up to $5,000,000 ("2012 Convertible Debt Offering"). As of December 31, 2012 we have issued notes having an aggregate principal value of $3,050,000 as explained below. The notes are due and payable on or before July 13, 2013. The notes bear interest at 12% per annum and may convertible to common stock at a $.25 per share conversion price. We also granted holders of the notes warrants with a five year life to acquire up to 200,000 shares of our common stock for each $100,000 of principal amount of the convertible notes. The notes are secured by all of our assets with the exception of the equipment and receivables secured by the equipment lessor for equipment used in providing services for our largest customer's digital signage network.
    In July 2012, we entered into a note and warrant purchase and security agreement with individual investors and broke escrow on the initial funding under the 2012 Convertible Debt Offering, the principal amount of which was $1,900,000, which included the conversion of $900,000 of previously issued short term debt (See Bridge Loan described above) to the 2012 convertible Debt Offering, which extinguished the Bridge Loan. Of the $1,000,000 non-converted principal amount, we realized $923,175 of cash in the initial closing and issued warrants to acquire 3,800,000 shares of our common stock. We paid $76,825 in investment banking fees and costs of the offering.
    In August 2012, we continued sales of convertible debt under the 2012 Convertible Debt Offering by issuing short term debt with a principal amount of $900,000, issued warrants to acquire 1,800,000 shares of our common stock, from which we realized cash of $851,624 after payment of investment banking fees of $48,376.
    In December 2012, we continued sales of convertible debt under the 2012 Convertible Debt Offering by issuing short term debt with a principal amount of $250,000, issued warrants to acquire 500,000 shares of our common stock to one member of our Board of Directors.
    The notes and warrants mentioned above were issued with price protection provisions and were accounted for as derivative liabilities and valued on the dates issued using a Black-Scholes pricing model.

    We recorded an aggregate derivative liability of $74,500 as of December 31, 2012, related to the conversion feature of the note. A derivative valuation gain of $423,500 was recorded to reflect the change in value of the aggregate derivative liability from the time the notes were issued. The aggregate derivative liability of $74,500 was calculated as follows using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.11%, (ii) expected life (in years) of 0.50; (iii) expected volatility of 129.08%, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.
    Additionally, we recorded an aggregate derivative liability of $183,000 as of December 31, 2012, related to the warrant reset provision. A derivative valuation gain of $442,000 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants were issued. The aggregate derivative liability of $183,000 was calculated as follows using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.63%, (ii) expected life (in years) of 4.50; (iii) expected volatility of 85.75%, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.

    Unsecured Convertible Note

    On September 29, 2006, we entered into a letter of understanding with Triage Capital Management, or Triage, dated September 25, 2006. The letter of understanding provided that Triage loan $1,000,000 to us in exchange for us entering into, on or prior to October 30, 2006, a convertible note securities agreement. It was intended that the funding provided by Triage be replaced by a convertible note and accompanying warrants, as described below. Effective November 2, 2006, we entered into securities purchase agreement, a 5% convertible note, a registration rights agreement, and four classes of warrants to purchase our common stock, all of which were with an individual note holder, the controlling owner of Triage, who caused our agreement with Triage to be assigned to him, which satisfied our agreement with Triage.
    Pursuant to the securities purchase agreement, (i) we sold to the convertible note holder a three-year convertible note in the principal amount of $1,000,000 representing the funding received by us on September 29, 2006; (ii) the convertible note bears an annual interest rate of 5%, payable semi-annually in cash or shares of our common stock; (iii) the convertible note is convertible into shares of our common stock at a conversion price of $1.50 per share subject to full-ratchet anti-dilution price protection provisions ; and (iv) we issued to the convertible note holder four classes of warrants (A Warrants, B Warrants, C Warrants and D Warrants), which give the convertible note holder the right to purchase a total of 5,500,000 shares of our common stock as described below. The A and B Warrants originally expired one year after the effective date of a registration statement filed under the Securities Act of 1933, as amended (the "Securities Act"), to register the subsequent sale of shares received from exercise of the A and B Warrants. The C Warrants and D Warrants originally expired eighteen months and twenty four months, respectively, after the effective date of a registration statement to be filed under the Securities Act. The A Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.60 per share, the B Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.75 per share, the C Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $2.10 per share, and the D Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $3.00 per share.

    During the year ended December 31, 2007, the convertible note holder exercised 454,000 A Warrants. We entered into an exchange agreement dated October 31, 2007 in which the convertible note holder received 650,000 shares of our common stock in exchange for cancellation of the C and the D Warrants. The expiration date of the A Warrants and the B Warrants was extended from January 11, 2008 to December 3, 2008. During the year ended December 31, 2008, the convertible note holder exercised 64,400 A Warrants. On December 3, 2008, the remaining 231,600 A Warrants and 750,000 B Warrants were unexercised and expired.

    On December 23, 2009 we entered into an amendment with the holder of our unsecured convertible note in the principal amount of $1.0 million which (i) extended the note maturity date to December 22, 2010 and (ii) increased the annual rate of interest from 5% to 8% commencing October 16, 2009. All other terms and conditions of the note remain unchanged.

    On December 24, 2010 we closed on a Debt Restructuring as mentioned above, In connection with that Debt Restructuring the Company amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013. We issued 150,000 shares to the holder of this note as consideration to extend the term of the note.
    During March 2011, we issued 135,369 shares of common stock to the holder of our unsecured convertible note in satisfaction of $81,221 of accrued interest on the unsecured convertible note. Also in connection with the satisfaction of the accrued interest we granted to the holder a warrant to acquire up to 221,758 additional shares of our common stock at an exercise price of $0.96 per share. The warrant is exercisable at any time for a five-year period. For the year ended December 31, 2011, the $157,400 value of the warrant was included in interest expense.
    We recorded an aggregate derivative liability of $46,400 and $300,000 as of December 31, 2012 and 2011, respectively, related to the conversion feature of the note. A derivative valuation gain of $253,600 and $1,101,900, respectively, was recorded to reflect the change in value of the aggregate derivative liability since December 31, 2011 and December 31, 2010, respectively. The aggregate derivative liability of $46,400 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.16%, (ii) expected life (in years) of 1.0; (iii) expected volatility of 112.04%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.

    In connection with the amendment mentioned above, the principal value of the note is being accreted due to the difference in the value of the conversion feature before and after the amendment. The principal value of $1,000,000 of the unsecured convertible note was accreted over the amended term of the obligation, for which $333,336 was included in interest expense for each the years ended December 31, 2012 and 2011. The note bears an 8% annual interest rate payable semi-annually, and for each the years ended December 31, 2011 and 2010, $80,000, was included in interest expense.
    Senior Unsecured 6.25% Convertible Note

    On December 24, 2007, we entered into a securities purchase agreement in which we raised $15,000,000 (less $937,000 of prepaid interest). We used the proceeds from this financing to support our CodecSys commercialization and development and for general working capital purposes. Pursuant to the financing, we issued a senior secured convertible note in the principal amount of $15,000,000 (which principal amount has been increased as discussed below).The senior secured convertible note was originally due December 21, 2010, but was extended to December 21, 2013 and has been subsequently retired. The senior secured convertible note bore interest at 6.25% per annum (which rate has been changed as discussed below) if paid in cash. Interest for the first year was prepaid at closing. Interest-only payments thereafter in the amount of $234,375 are due quarterly and commenced in April 2009. Interest payments may be made through issuance of common stock in certain circumstances or may be capitalized and added to the principal. The original principal of the note was convertible into 2,752,294 shares of our common stock at a conversion price of $5.45 per share, convertible any time during the term of the note. We granted a first priority security interest in all of our property and assets and of our subsidiaries to secure our obligations under the note and related transaction agreements. In August 2009 we received a waiver from the note holder releasing their security interest for the equipment purchased under our sale lease back financing.

    In connection with the 2007 financing, the senior secured convertible note holder received warrants to acquire 1,875,000 shares of our common stock exercisable at $5.00 per share. We also issued to the convertible note holder 1,000,000 shares of our common stock valued at $3,750,000 and incurred an additional $1,377,000 for commissions, finder's fees and other transaction expenses, including the grant of a three-year warrant to purchase 112,500 shares of our common stock to a third party at an exercise price of $3.75 per share, valued at $252,000. A total of $1,377,000 was included in debt offering costs and is being amortized over the term of the note.
    From March 26, 2010 through October 29, 2010, we entered into a series of amendments to the senior secured convertible note. Each of these amendments is described below.
    On March 26, 2010, we entered into an amendment and extension agreement with the holder of the senior secured convertible note. The agreement conditionally amended the maturity date of the note to December 21, 2011. If we are unsuccessful in raising at least $6.0 million in equity financing before September 30, 2010, the maturity date of the note will automatically be restored to its original date of December 21, 2010. In consideration of entering into the agreement, the note holder was issued 1,000,000 shares of our restricted common stock valued at $990,000. In addition, we agreed to the inclusion of three additional terms and conditions in the note: (i) from and after the additional funding, we will be required to maintain a cash balance of at least $1,250,000 and provide monthly certifications of the cash balance to the note holder; (ii) we will not make principal payments on our outstanding $1.0 million unsecured convertible note without the written consent of the holder of the senior secured convertible note; and (iii) we will grant board observation rights to the note holder. Given these additional terms, unless the senior secured convertible note holder provides consent, of which there can be no assurance, we will be precluded from repaying the $1.0 million unsecured convertible note when it becomes due on December 22, 2010.
    On July 30, 2010, we entered into a further amendment agreement with the holder of the senior secured convertible note regarding the note and warrant reset provisions. The July 30, 2010 amendment conditionally amended the maturity date of the note to June 21, 2012. If we are unsuccessful in raising the $6.0 million in equity financing referenced above, the maturity date of the note will automatically be restored to its original date of December 21, 2010. The holder of the note agreed to a conversion price of the note of $1.80 per share instead of the price at which we sell equity between now and September 30, 2010 and reduced the required cash balance referenced in the March 26, 2010 amendment above from $1,250,000 to $950,000. In addition, the number of warrants originally granted to the holder pursuant to the 2007 financing increased from 1,875,000 to 5,208,333 and were exercisable at $1.80 per share instead of $5.00 per share. The warrants continued to be exercisable any time for the five years from the original date of grant. In consideration of entering into the July 30, 2010 amendment the note holder was issued 2,000,000 shares of common stock and would be issued an additional 800,000 shares of our common stock contingent upon completion of the required equity raise.
    On September 27, 2010, we entered into a further amendment agreement with the holder of the senior secured convertible note regarding the note. Pursuant to this amendment, the due date for the required equity financing was extended to October 31, 2010.
    On October 29, 2010, we entered into a fourth amendment agreement with the holder of the senior secured convertible note regarding the note and warrant provisions. The fourth amendment (i) increased the amount of the required equity raise to $8.0 million, approximately $2.5 million of which had been raised or committed by investors at the time of the amendment; (ii) extended the time in which we can complete the equity financing to December 3, 2010; (iii) deleted the provision of the senior secured convertible note that granted the Company the option to redeem the note prior to its maturity date; (iv) changed the conversion price of the note upon successful completion of the required capital raise to an amount equal to 150% of the lowest price at which Company common stock is sold during calendar year 2010; (v) changed the exercised price of the warrants to an amount equal to 150% of the lowest price at which Company common stock is sold during calendar year 2010; (vi) provides that if we are successful in completing the required capital raise the number of warrants will be increased as currently provided in the 6.25% senior secured convertible promissory note; and (vii) extended the expiration date of the warrants to December 31, 2013.
    If the additional funding was not completed by December 3, 2010, certain provisions of the prior amendments became void in that the maturity date will revert back to December 21, 2010, the conversion price became the lowest price at which equity securities had been sold, the exercise price became the lowest price at which equity securities have been sold, the number of warrants then outstanding would be determined by the original purchase documents, and the Company would not have an obligation to maintain a balance of cash and marketable securities equal to $950,000.
    On December 24, 2010, we closed on the Debt Restructuring. In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the "Amended and Restated Note") to Castlerigg Master Investment Ltd. ("Castlerigg"), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents was issued (the "Loan Restructuring Agreement"), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010. As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest. The Debt Restructuring was considered a troubled-debt restructuring and a gain on debt restructuring of $3,062,457 was recorded during the year ended December 31, 2010, which was the difference between the adjusted carrying value of the original note and the carrying value of the Amended and Restated Note.
    The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bore interest at an annual rate of 6.25%, payable semi-annually. We paid the first year's interest of approximately $344,000 at the closing. The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment. The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us. The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions. Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.
    The Investor Rights Agreement provides Castlerigg with certain registration rights with respect to the Company's securities held by Castlerigg. These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions were not satisfied. The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.
    On March 26, 2012, we closed on an equity financing (the "2012 Equity Financing"), as well as a restructuring of our outstanding senior convertible indebtedness (the "2012 Debt Restructuring"), resulting in complete satisfaction of our senior indebtedness under the Amended and Restated Note.
    A portion of the net proceeds from the 2012 Equity Financing was used to close on the 2012 Debt Restructuring. The Company paid $2,750,000 and issued 2,000,000 shares of common stock valued at $760,000 in satisfaction of the Amended and Restated Note and remaining interest value of $680,816. In consideration of negotiating the 2012 Debt Restructuring and amending our agreement with our placement agent, we paid $275,041 and issued 586,164 shares of our common stock valued at $222,742 to our placement agent, and recognized a $2,173,033 gain on extinguishment of debt as a result of this retirement.
    With the retirement of the Amended and Restated Note we recorded no aggregate derivative liability at December 31, 2012, however at the date of retirement we recorded a derivative valuation gain of $203,700, related to the conversion feature of the Amended and Restated Note to reflect the change in value of the aggregate derivative from December 31, 2011 to the date of retirement. The derivative value of $81,500 at the date of retirement was recorded as additional paid in capital.
    We recorded an aggregate derivative liability of $285,200 at December 31, 2011, related to the conversion features of the Amended and Restated Note and the conversion feature and warrants related to the Original Note. A derivative valuation gain of $2,322,200 was recorded during the year ended December 31, 2011 to reflect the change in value of the aggregate derivative.

    The $6,180,816 value of the Amended and Restated Note at December 31, 2011 consists of $5,500,000 for the principal due of the note plus $680,816 for aggregate future interest due of which $171,875 is payable in 2012 and has been included in current debt obligations at December 31, 2011 and was retired pursuant to the 2012 Debt Restructuring noted above.

    Accounts Receivable Purchase Agreements

    During the year ended December 31, 2010 we entered into two Accounts Receivable Purchase Agreements with one individual for an aggregate amount of $775,000. During the year ended December 31, 2011 we remitted $100,000 of the principal balance plus accrued interest of $8,360 and converted the remaining $675,000 of principal balance plus $109,292 of accrued and unpaid interest into 1,307,153 shares of our common stock and warrants to purchase an additional 653,576 shares of our common stock. The warrants contain anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than $1.00 per share. The current exercise price has been reset to $0.725 per share due to subsequent financings.

    We recorded an aggregate derivative liability of $5,900 and $156,300 as of December 31, 2012 and 2011, respectively, related to the conversion feature of the note. A derivative valuation gain of $253,600 and $293,800, respectively, was recorded to reflect the change in value of the aggregate derivative liability since December 31, 2011 and December 31, 2010, respectively. The aggregate derivative liability of $5,900 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.36%, (ii) expected life (in years) of 3.20; (iii) expected volatility of 83.16%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.

    Bridge Loan

    On December 28, 2011 we entered into a Note and Warrant Purchase and Security Agreement with seven individuals for an aggregate of $1,300,000 ("Bridge Loan") to be used as working capital. The note bears an annual interest rate of 18%, payable monthly in cash. Additionally, we granted to the holders of the Bridge Loan warrants with a five year term to purchase an aggregate of 357,500 shares of our common stock at an exercise price of $0.65. The note was due on February 28, 2012, but the term was subsequently extended to the earlier of the date nine months from the original maturity date or the date we closed on an additional sale of our securities that resulted in gross proceeds to us of $12 million. In consideration of the extension of the maturity date of the Bridge Loan, we granted the holders of the Bridge Loan warrants with a six year term to purchase 247,500 shares of our common stock at an exercise price of $0.35 per share. This note is collateralized by a security interest in all of our accounts receivable
    In connection with the Bridge Loan, we paid an $84,500 placement fee and issued warrants to purchase 65,000 shares of our common stock at an exercise price of $0.65 per share and subsequently reset to $0.53, to our investment banker for services in completing the above transaction and paid a $3,000 escrow fee to the Escrow Agent in exchange for holding the funds prior to their disbursement to us.
    On March 26, 2012, we closed on the 2012 Equity Financing and under the terms of the associated securities purchase agreement, two of the above described bridge lenders converted the principal balance of their portion of the bridge loan in the amount of $400,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing, reducing the outstanding principal balance to $900,000. The warrants issued had a total value of $222,426 which resulted in a loss on extinguishment of debt of $222,426. The aggregate derivative liability and valuation gain or loss for the warrants issued for the converted portion of the principal balance are included in the aggregate of 2012 Equity Financing information.

    All warrants mentioned above were issued with price protection provisions and were accounted for as derivative liabilities and valued using a Black Scholes pricing model.
    On July 13, 2012 the $900,000 principal balance was retired and was included as part of the 2012 Convertible Note (as described below) and recorded a (i) $93,661 loss on extinguishment of debt related to the remaining un-accreted portion of the note and (ii) $53,160 expense related to unrecognized offering costs, at the time of retirement.
    At December 31, 2012 we recorded an aggregate derivative liability of $7,400 related to the reset provision for the original and placement warrants issued. A derivative valuation gain of $136,300 was recorded to reflect the change in value of the aggregate derivative liability from December 31, 2011. The aggregate derivative liability of $7,400 for the reset provision of the warrants was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.54%, (ii) expected life (in years) of 4.0; (iii) expected volatility of 82.55%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.
    At December 31, 2012 we recorded an aggregate derivative liability of $7,200 related to the reset provision for the warrants issued for an extension of the maturity date. A derivative valuation gain of $89,325 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants were issued. The aggregate derivative liability of $7,200 for the reset provision of the warrants was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.54%, (ii) expected life (in years) of 4.0; (iii) expected volatility of 82.55%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.
    The principal value of the note was being accreted over the amended term of the obligation, for which $106,723 and 7,041 were included in interest expense for the years ended December 31, 2012 and 2011, respectively. The note bore an 18% annual interest rate, and for the years ended December 31, 2012 and 2011, $100,899 and $2,564, respectively were included in interest expense.

    Equipment Purchase and Sale Agreement

    In October 2011, we entered into an Equipment Purchase and Sale Agreement with a Utah corporation whereby we use the funds advanced to purchase certain electronic receiving and digital signage equipment along with installation costs. A 3% fee is due each month the amount remains outstanding. At December 31, 2011 we had an outstanding amount owed of $700,000 and had accrued two months of fees totaling $42,000 which was included as interest expense for the year ended December 31, 2011.
    On March 26, 2012, we closed on the 2012 Equity Financing and under the terms of the associated securities purchase agreement the above described lender converted the principal balance of its portion of the loan in the amount of $500,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing, the remaining $200,000 principal balance plus $105,000 of interest due was paid in cash. The warrants issued had a total value of $278,032 which resulted in a loss on extinguishment of debt of $278,032. The aggregate derivative liability and valuation gain or loss for the warrants issued for the converted portion of the principal balance are included in the aggregate of 2012 Equity Financing information.

    The 3% fee mention above was recorded as interest expense and or the years ended December 31 2012 and 2011, $63,000 and $42,000 were included, respectively.
    XML 60 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Subsequent Events
    		 12 Months Ended
    Dec. 31, 2012
    Subsequent Events [Abstract]  
    Subsequent Events
    Note 17 - Subsequent Events

    During January 2013, we sold additional convertible promissory notes in the principal amount of $425,000 on our 2012 Convertible Note offering due on July 13, 2013. The notes are convertible at $.25 per share and are secured by all of our assets. In addition, we issued warrants to acquire up to 850,000 shares of our common stock to the holders of the notes. The warrants have a five year life and are exercisable at $.25 per share.

    In March 2013 we issued 258,553 shares of common stock to a former director in settlement of his Restricted Stock Units. In addition, we issued to him 200,000 shares of common stock in satisfaction of unpaid director's fees of $15,000.

    In March 2013 we granted Restricted Stock Units to four of our directors in satisfaction of unpaid director's fees of $51,500. The Restricted Stock Units may be settled by the issuance of 686,667 shares of our common stock at the time the directors retire from the board.

    On January 7, 2013 we entered into a Merger Agreement with AllDigital, Inc., a Nevada corporation. The merger is subject among other things to normal due diligence, approval of the shareholders of both companies, and the filing and effectiveness of a registration statement. The registration statement requires year-end financial statements be included with the proxy statements furnished to the shareholders and will not be effective until at least the second quarter of 2013. On February 8, 2013, All Digital notified us that we were in breach of certain covenants regarding unencumbered ownership or potential claims against our technology and intellectual property, which gave us 30 days to cure the alleged defects before the merger agreement could be terminated. On March 8, 2013 All Digital notified us that sufficient progress had been made that the cure period was extended to April 8, 2013 for the remainder of the alleged defects to be cured or waived

    Pursuant to the January 6, 2013 Amendment and Settlement Agreement with each of Mr. Tiede and Mr. Solomon, their respective employment agreements were modified and we agreed to issue each of Mr. Tiede and Mr. Solomon 529,100 shares of common stock if they were terminated by us at any time following January 6, 2013. All other termination benefits and severance benefits for Mr. Tiede and Mr. Solomon, were terminated as of January 6, 2013. We had an obligation as of March 6, 2013 to issue to each of them 529,100 shares of common stock.
    XML 61 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Retirement Plan
    		 12 Months Ended
    Dec. 31, 2012
    Retirement Plan [Abstract]  
    Retirement Plan
    Note 13 - Retirement Plan

    We have implemented a 401(k) employee retirement plan. Under the terms of the plan, participants may elect to contribute a portion of their compensation, generally up to 60%, to the plan, subject to IRS Code Section 415 limitations. We match contributions up to 100% of the first 3% of a participant's compensation contributed to the plan and 50% of the next 2%. Employees are eligible to participate in the plan after three months of service as defined by the plan. For the years ended December 31, 2012 and 2011, we made matching contributions totaling $99,761 and $90,453, respectively.
    XML 62 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Preferred and Common Stock
    		 12 Months Ended
    Dec. 31, 2012
    Preferred and Common Stock [Abstract]  
    Preferred and Common Stock
    Note 9 - Preferred and Common Stock
    We have authorized two classes of stock, 20,000,000 shares of preferred stock with no par value and 180,000,000 shares of common stock with a $0.05 par value. No preferred stock has been issued, while 107,473,820 shares of common stock were issued and outstanding at December 31, 2012. Holders of shares of common stock are entitled to receive dividends if and when declared and are entitled to one vote for each share on all matters submitted to a vote of the shareholders.
    During the year ended December 31, 2012, we issued 31,498,164 shares of our common stock as follows: (i) 24,816,000 related to our 2012 Equity Financing and Debt Restructuring, (ii) 5,600,000 for debt conversions and (iii) 1,082,164 for services rendered by consultants.
    During the year ended December 31, 2011, we issued 1,897,503 shares of our common stock as follows: (i) 1,307,153 for debt to equity conversions, (ii) 372,272 for warrant exercises, (iii) 135,369 for interest instead of cash, (iv) 55,098 for employee option exercises and (v) 27,611 shares for conversion of IDI share equivalents.
    XML 63 R60.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Fair Value Measurements (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Derivative Valuation Liability [Member]
    		  
    Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
    Balance at December 31, 2011 $ (3,760,200)
    Included in net loss 8,829,748
    Valuation adjustment   
    Purchases, issuances, and settlements, net (6,260,817)
    Transfers to Level 3   
    Balance at December 31, 2012 1,191,269
    Fair Value, Measurements, Recurring [Member]
    		  
    Assets  
    Total assets measured at fair value   
    Liabilities  
    Derivative valuation 1,191,269 [1]
    Total liabilities measured at fair value 1,191,269
    Fair Value, Measurements, Recurring [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    		  
    Assets  
    Total assets measured at fair value   
    Liabilities  
    Derivative valuation    [1]
    Total liabilities measured at fair value   
    Fair Value, Measurements, Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member]
    		  
    Assets  
    Total assets measured at fair value   
    Liabilities  
    Derivative valuation    [1]
    Total liabilities measured at fair value   
    Fair Value, Measurements, Recurring [Member] | Significant Unobservable Inputs (Level 3) [Member]
    		  
    Assets  
    Total assets measured at fair value   
    Liabilities  
    Derivative valuation 1,191,269 [1]
    Total liabilities measured at fair value $ 1,191,269
    [1] See Notes 4 & 5 for additional discussion
    XML 64 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Operating Leases
    		 12 Months Ended
    Dec. 31, 2012
    Operating Leases [Abstract]  
    Operating Leases
    Note 7 - Operating Leases
    Our executive offices are located at 7050 Union Park Avenue, Suite 600, Salt Lake City, Utah 84047. We occupy the space at the executive offices under a 39-month lease, the term of which ends January 31, 2015. The lease covers approximately 13,880 square feet of office space leased at a rate of $23,049 per month. We occupy a production studio located at 6952 South 185 West, Unit C, Salt Lake City, Utah 84047, which consists of approximately 7,500 square feet on a month to month basis, at the rate of $7,000 per month plus utilities. We have no other properties. We recognized rent expense of approximately $352,789 and $463,694, in 2012 and 2011, respectively.
    We also lease copy machines on multi-year leases that expire in March 2014 at a minimum rate of $655 per month.
    Future minimum payments under non-cancelable operating leases at December 31, 2012 are as follow:

    2013
    		   $ 284,447  
    2014
    		     278,552  
    2015
    		     23,049  
        $ 586,048  
    XML 65 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Income Taxes
    		 12 Months Ended
    Dec. 31, 2012
    Income Taxes [Abstract]  
    Income Taxes
    Note 8 - Income Taxes
    Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
    Net deferred tax liabilities consist of the following components as of December 31, 2011 and 2012:
       
    2011
    		    
    2012
    		  
    Deferred tax assets
    		            
    NOL carry-forward
    		   $ 23,862,500     $ 25,881,900  
    General business credit carry-forwards
    		     1,147,000       1,158,900  
    Deferred compensation
    		     83,500       78,500  
    Allowance for doubtful accounts
    		     21,000       31,600  
    Deferred tax liabilities
    		                
    Depreciation
    		     (173,000 )     61,700  
                     
    Valuation allowance
    		     (24,941,000 )     (27,212,600 )
    Net deferred tax asset
    		   $ -     $ -  
    The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, 2010 and 2011 due to the following:
       
    2011
    		    
    2012
    		  
                 
    Federal income tax (expense) benefit at statutory rates
    		   $ 1,902,500     $ 1,831,600  
    State income tax (expense) benefit at statutory rates
    		     280,000       269,300  
    Change in valuation allowance
    		     (2,182,500 )     (2,100,900 )
        $ -     $ -  

    At December 31, 2012, the Company had net operating loss carry-forwards of approximately $66,364,000 that may be offset against future taxable income from the year 2013 through 2032. No tax benefit has been reported in the December 31, 2011 and 2012 consolidated financial statements since the potential tax benefit is offset by a valuation allowance of the same amount.
    Due to change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years.
    XML 66 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Stock-based Compensation
    		 12 Months Ended
    Dec. 31, 2012
    Stock-based Compensation [Abstract]  
    Stock-based Compensation
    Note 10 - Stock-based Compensation
    In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.
    Stock Incentive Plans
    Under the Broadcast International, Inc. 2004 Long-term Incentive Plan (the "2004 Plan"), the board of directors may issue incentive stock options to employees and directors and non-qualified stock options to consultants of the company. Options generally may not be exercised until twelve months after the date granted and expire ten years after being granted. Options granted vest in accordance with the vesting schedule determined by the board of directors, usually ratably over a three-year vesting schedule upon anniversary date of the grant. Should an employee terminate before the vesting period is completed, the unvested portion of each grant is forfeited. We have used the Black-Scholes valuation model to estimate fair value of our stock-based awards, which requires various judgmental assumptions including estimated stock price volatility, forfeiture rates, and expected life. Our computation of expected volatility is based on a combination of historical and market-based implied volatility. The number of unissued stock options authorized under the 2004 Plan at December 31, 2012 was 3,779,508.

    The Broadcast International, Inc. 2008 Equity Incentive Plan (the "2008 Plan") has become our primary plan for providing stock-based incentive compensation to our eligible employees and non-employee directors and consultants of the company. The provisions of the 2008 Plan are similar to the 2004 Plan except that the 2008 Plan allows for the grant of share equivalents such as restricted stock awards, stock bonus awards, performance shares and restricted stock units in addition to non-qualified and incentive stock options. We continue to maintain and grant awards under our 2004 Plan which will remain in effect until it expires by its terms. The number of unissued shares of common stock reserved for issuance under the 2008 Plan was 774,867 at December 31, 2012.
    Stock Options
    We estimate the fair value of stock option awards granted beginning January 1, 2006 using the Black-Scholes option-pricing model. We then amortize the fair value of awards expected to vest on a straight-line basis over the requisite service periods of the awards, which is generally the period from the grant date to the end of the vesting period. The Black-Scholes valuation model requires various judgmental assumptions including the estimated volatility, risk-free interest rate and expected option term. Our computation of expected volatility is based on a combination of historical and market-based implied volatility. The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the stock option award was granted with a maturity equal to the expected term of the stock option award. The expected option term is derived from an analysis of historical experience of similar awards combined with expected future exercise patterns based on several factors including the strike price in relation to the current and expected stock price, the minimum vest period and the remaining contractual period.
    The fair values for the options granted in 2012 and 2011 were estimated at the date of grant using the Black Scholes option-pricing model with the following weighted average assumptions:
     
    Year Ended December 31,
     
    2012
    2011
    Risk free interest rate
    1.65%
    1.91%
    Expected life (in years)
    10.0
    6.2
    Expected volatility
    78.97%
    80.89%
    Expected dividend yield
    0.00%
    0.00%

    The weighted average fair value of options granted during the years ended December 31, 2012 and 2011, was $0.27 and $0.61, respectively.
    Warrants
    We estimate the fair value of issued warrants on the date of issuance as determined using a Black-Scholes pricing model. We amortize the fair value of issued warrants using a vesting schedule based on the terms and conditions of each associated underling contract, as earned. The Black-Scholes valuation model requires various judgmental assumptions including the estimated volatility, risk-free interest rate and warrant expected exercise term. Our computation of expected volatility is based on a combination of historical and market-based implied volatility. The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the warrant was issued with a maturity equal to the expected term of the warrant.
    The fair values for the warrants granted in 2012 and 2011 were estimated at the date of grant using the Black Scholes option-pricing model with the following weighted average assumptions:
     
    Year Ended December 31,
     
    2012
    2011
    Risk free interest rate
    1.16%
    2.07%
    Expected life (in years)
    5.7
    5.0
    Expected volatility
    82.79%
    85.37%
    Expected dividend yield
    0.00%
    0.00%

    The weighted average fair value of warrants granted during the years ended December 31, 2012 and 2011, was $0.23 and $0.67, respectively.

    Results of operations for the years ended December 31, 2012 and 2011 includes $283,692 and $2,262,540, respectively, of non-cash stock-based compensation expense. Restricted stock units and options issued to directors vest immediately. All other restricted stock units, options and warrants are subject to applicable vesting schedules. Expense is recognized proportionally as each award or grant vests.

    For the year ended December 31, 2012 we recognized $283,692 of stock based compensation as follows: (i) $65,500 for 390,133 restricted stock units issued to 5 members of the board of directors, (ii) $833 for 50,000 options granted to 4 employees and (iii) $217,359 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2012.
    For the year ended December 31, 2011 we recognized $2,262,540 of stock based compensation expense as follows: (i) $1,544,000 for 1,400,000 restricted stock units issued to all 5 members of the board of directors, (ii) $124,000 for 200,000 restricted stock units issued to one employee, (iii) $364,000 for 600,000 options issued to one individual and one corporation for consulting services, (iv) $96,489 for 909,200 options granted to 43 employees, (v) $15,000 for 50,000 options granted to one member of our advisory board, (vi) $4,263 for 8,700 options granted to 15 of our non-employee installation technicians and (vi) $114,788 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2011. Additionally, we issued (i) 221,758 warrants to our unsecured convertible note holder, (ii) 653,576 warrants related to our accounts receivable purchase agreements, (iii) 422,500 warrants related to our Bridge Loan. See Note 5. There were 400,000 warrants exercised in the year ending December 31, 2011.

    The following table summarizes option and warrant activity during the years ended December 31, 2012 and 2011.

       
    Options
    and
    Warrants
    Outstanding
    		    
    Weighted
    Average
    Exercise
    Price
    		  
                 
    Outstanding at December 31, 2010
    		     20,442,170       1.13  
    Options granted
    		     1,567,900       0.91  
    Warrants issued
    		     1,697,834       0.68  
    Expired
    		     (302,054 )     18.67  
    Forfeited
    		     (2,510,201 )     0.08  
    Exercised
    		     (455,098 )     -  
                     
    Outstanding at December 31, 2011
    		     20,440,551       1.10  
    Options granted
    		     50,000       0.37  
    Warrants issued
    		     24,817,900       0.33  
    Expired
    		     (252,669 )     1.31  
    Forfeited
    		     (1,658,919 )     1.31  
    Exercised
    		     -       -  
                     
    Outstanding at December 31, 2012
    		     43,396,863     $ 0.54  

    The following table summarizes information about stock options and warrants outstanding at December 31, 2012.
         
    Outstanding
    		    
    Exercisable
    		  
               
    Weighted
    Average
    Remaining
    		    
    Weighted
    Average
    		          
    Weighted
    Average
    		  
    Range of
    Exercise Prices
    		    
    Number
    Outstanding
    		    
    Contractual
    Life (years)
    		    
    Exercise
    Price
    		    
    Number
    Exercisable
    		    
    Exercise
    Price
    		  
    $ 0.17-0.95     39,583,684     4.36     $ 0.47     39,207,017     $ 0.47  
      1.00-1.59     3,306,679     3.20       1.04     3,248,146       1.04  
      2.25-4.00     506,500     3.34       2.62     506,500       2.62  
    $ 0.17-4.00     43,396,863     4.26     $ 0.54     42,961,663     $ 0.54  
    There were no options exercised in the year ended December 31, 2012 and 55,098 options were exercised in the year ended December 31, 2011. There was no intrinsic value of options and warrants available and exercisable for the years ended December 31, 2012 or 2011.

    Restricted Stock Units
    For the years ended December 31, 2012 and 2011, 390,133 and 1,600,000 restricted stock units were awarded, respectively. The cost of restricted stock units is determined using the fair value of our common stock on the date of the grant and compensation expense is recognized in accordance with the vesting schedule. All of the restricted stock units vested during the year they were awarded.

    The following is a summary of restricted stock unit activity for the years ended December 31, 2012 and 2011:
       
    Restricted
    Stock Units
    		    
    Weighted
    Average
    Grant
    Date Fair
    Value
    		  
                 
    Outstanding at December 31, 2010
    		     950,000       1.61  
    Awarded at fair value
    		     1,600,000       1.04  
    Canceled/Forfeited
    		     --       --  
    Settled by issuance of stock
    		     --       --  
    Outstanding at December 31, 2011
    		     2,550,000       1.25  
    Awarded at fair value
    		     390,133       0.17  
    Canceled/Forfeited
    		     --       --  
    Settled by issuance of stock
    		     --       --  
    Outstanding at December 31, 2012
    		     2,940,133     $ 1.11  
    Vested at December 31, 2012
    		     2,940,133     $ 1.11  

    Included in stock based compensation for the year ended December 31, 2012, was $65,500 for 390,133 restricted stock units issued to all 5 members of the board of directors, all of which were recorded in general and administrative expense.

    Included in stock based compensation for the year ended December 31, 2011, was $1,668,000 as follows; (i) $1,544,000 for 1,400,000 restricted stock units issued to all 5 members of the board of directors, (ii) $124,000 for 200,000 restricted stock units issued to one employee, all of which were recorded in general and administrative expense.

    The impact on our results of operations for recording stock-based compensation for the years ended December 31, 2012 and 2011 is as follows:

       
    For the years ended
    		  
       
    December 31,
    		  
       
    2012
    		    
    2011
    		  
    General and administrative
    		   $ 185,478     $ 2,043,386  
    Research and development
    		     98,214       219,154  
                     
    Total
    		   $ 283,692     $ 2,262,540  
    Total unrecognized stock-based compensation was $180,732 at December 31, 2012, which we expect to recognize over the next three years in accordance with vesting provisions as follows:
    2013
    		   $ 118,127  
    2014
    		     62,038  
    2015
    		     567  
    Total
    		   $ 180,732  
    XML 67 R64.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Supplemental Cash Flow Information (Details) (USD $)
    		 12 Months Ended 1 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Jul. 31, 2012
    2012 Convertible Notes [Member]
    Dec. 31, 2012
    2012 Convertible Notes [Member]
    Mar. 31, 2011
    Unsecured Convertible Note [Member]
    Dec. 31, 2012
    Unsecured Convertible Note [Member]
    Dec. 31, 2011
    Unsecured Convertible Note [Member]
    Nov. 02, 2006
    Unsecured Convertible Note [Member]
    Jul. 31, 2012
    Bridge Loan Note Payable [Member]
    Dec. 31, 2012
    Bridge Loan Note Payable [Member]
    Dec. 31, 2011
    Bridge Loan Note Payable [Member]
    Dec. 31, 2012
    Common Stock [Member]
    Dec. 31, 2011
    Common Stock [Member]
    Dec. 31, 2012
    Shares Issued to Consultant for Services [Member]
    Dec. 31, 2012
    Shares Issued to Consultant for Cancellation of Warrant [Member]
    Dec. 31, 2012
    Acquisition of IDI Common Share Equivalents [Member]
    Mar. 21, 2011
    Conversion of Short Term Debt [Member]
    Dec. 31, 2011
    Conversion of Short Term Debt [Member]
    Dec. 31, 2010
    Conversion of Short Term Debt [Member]
    Mar. 31, 2011
    Modification of Senior Unsecured Convertible Note [Member]
    Dec. 31, 2011
    Modification of Senior Unsecured Convertible Note [Member]
    Dec. 31, 2012
    Placement Agency [Member]
    Dec. 31, 2011
    Options Granted for Consulting Services [Member]
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                              
    Options granted                                             600,000
    Fair value of options granted                                             $ 389,000
    Service period for options granted                                             1 year
    Stock based compensation 283,693 2,262,540                                         364,000
    Share-based Goods and Nonemployee Services Transaction [Line Items]                                              
    Warrants issued to investment banker                                           586,164  
    Common stock issued for note extensions                                           222,742  
    Debt Conversion [Line Items]                                              
    Amount of debt converted     900,000                           784,292            
    Number of warrants issued                                       400,000      
    Conversion price       $ 0.25   $ 0.25   $ 1.5                 $ 1.2            
    Exercise price of warrants                                 1.0     0.05      
    Common stock issued in conversion                                 1,307,153            
    Number of shares of common stock warrants can be exercised for       200,000       5,500,000                 653,576            
    Warrant term length       5 years                         5 years     5 years      
    Fair value of warrants                                       404,000      
    Common stock issued for interest    19,634     81,221                         109,292          
    Accrued interest payable                                   19,634          
    Interest expense                                     89,658        
    Warrants and options exercised    455,098                     55,098               372,272    
    Other Significant Noncash Transactions [Line Items]                                              
    Shares issued to consultant 496,000                         246,000 250,000                
    Value of shares issued to consultant 177,313                                            
    Common stock issued for interest, shares         135,369               135,369                    
    Common stock issued for interest   81,221                     6,768                    
    Common stock issued on debt conversion, shares                       5,600,000 1,307,153                    
    Number of shares of subsidiary acquired                               414,172              
    Common stock issued in exchange for IDI shares                         27,611     27,611              
    Common stock issued in exchange for IDI shares   10,760                     1,381     10,760              
    Accretion of discount on convertible notes payable 941,225 340,377   501,166   333,336 333,336   53,160 106,723 7,041                        
    Total depreciation and amortization expense 1,024,754 1,483,868                                          
    Depreciation and amortization included in cost of sales 466,606 798,677                                          
    Depreciation related to equipment other property and equipment, and (iii) $2,538 for patent amortization. 547,997 675,040                                          
    Patent amortization $ 10,151 $ 10,151                                          
    XML 68 R63.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Liquidity (Details) (USD $)
    		 1 Months Ended 12 Months Ended
    Jan. 31, 2013
    Dec. 31, 2012
    Dec. 31, 2011
    Liquidity [Abstract]      
    Cash flow used in operations   $ (3,362,785) $ (5,164,437)
    Cash expenses over income   300,000  
    Reduction in workforce, percentage   40.00%  
    Accounts payable satisfied with stock   600,000  
    Proceeds from issuance of convertible note and warrants 400,000 3,050,000  
    Proceeds from Bridge Loan   900,000  
    Commitments from current debt holders   $ 1,550,000  
    XML 69 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Significant Accounting Policies (Patents and Intangibles) (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Intangible Assets [Abstract]    
    Patent useful life 20 years  
    Valuation impairment   $ 26,180
    Patent amortization 10,151 10,151
    Estimated future annual amortization expense related to intangible assets:    
    2013 11,343  
    2014 10,121  
    2015 10,121  
    2016 10,121  
    2017 $ 10,121  
    XML 70 R51.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Stock-based Compensation (Narrative) (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Stock based compensation $ 283,693 $ 2,262,540
    Unrecognized compensation expense 180,732  
    Period over which compensation expense will be recognized 3 years  
    Warrants and options exercised    455,098
    Stock Options [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Number of unissued stock options authorized 3,779,508  
    Number of unissued shares of common stock reserved for issuance 774,867  
    Maximum contractual term 10 years  
    Vesting period 3 years  
    Weighted average fair value of options granted $ 0.27 $ 0.61
    Warrants and options exercised   55,098
    Stock Options [Member] | Employees [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Stock based compensation 833 96,489
    Options granted 50,000 909,200
    Number of individuals 4 43
    Stock Options [Member] | Consulting Services Providers [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Stock based compensation   364,000
    Options granted   600,000
    Number of individuals   1
    Stock Options [Member] | Nonemployee Installation Technicians [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Stock based compensation   4,263
    Options granted   8,700
    Number of individuals   15
    Stock Options [Member] | Advisory Board Member [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Stock based compensation   15,000
    Options granted   50,000
    Number of individuals   1
    Warrant [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Weighted average fair value of options granted $ 0.23 $ 0.67
    Warrants and options exercised   400,000
    Warrant [Member] | Unsecured Convertible Note Holder [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Options granted   221,758
    Warrant [Member] | Accounts Receivable Purchase Agreements Counterparty [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Options granted   653,576
    Warrant [Member] | Bridge Loan Counterparty [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Options granted   422,500
    Restricted Stock Units [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Stock based compensation 65,500 1,668,000
    Restricted stock units awarded 390,133 1,600,000
    Restricted Stock Units [Member] | Directors [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Stock based compensation 65,500 1,544,000
    Number of individuals 5 5
    Restricted stock units awarded 390,133 1,400,000
    Restricted Stock Units [Member] | Employee One [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Stock based compensation   124,000
    Number of individuals   1
    Restricted stock units awarded   200,000
    Stock Options and Warrants [Member]
    		    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Stock based compensation $ 217,359 $ 114,788
    XML 71 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Liquidity
    		 12 Months Ended
    Dec. 31, 2012
    Liquidity [Abstract]  
    Liquidity
    Note 15 - Liquidity
    Broadcast experienced negative cash flow used in operations during the year of $3,362,785 compared to negative cash flow used in operations for the year ended December 31, 2011 of $5,164,437. Our current monthly excess of cash expenses over income is approximately $300,000 per month. During 2012 the decreased in negative cash flow was realized primarily through a reduction in the number of employees by approximately 40%, with more reductions scheduled, as well as additional expense reduction actions including reducing sales and general and administrative expenses. In addition, we have commenced an initiative designed to satisfy accounts payable through the issuance of common stock, which will further decrease our need for cash. We have to date received verbal and/or written commitments to accept partial payments and/or stock in full satisfaction of at least $600,000 of current payables and indebtedness.

    The negative cash flow was met by cash reserves from the completion of the 2012 Equity Financing and the issuance of the 2012 Convertible Debt in the total amount of $3,050,000, which included $900,000 of Bridge Loan indebtedness that was converted to the 2012 Convertible Debt. In addition, we received $400,000 in January, 2013. We have commitments from current debt holders to fund up to an additional $1.550 million of our 2012 Convertible debt to offset future negative cash flow. We expect to continue to experience negative operating cash flow as long as we continue our current expenditures related primarily to bringing CodecSys products to market, continue our development of CodecSys or until we begin to receive licensing revenue from sales of CodecSys proprietary software or increase sales in our network division by adding new customers. We are actively pursuing potential customers to replace lost revenues when the BofA contract expires.
    XML 72 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Equity Financing and the Debt Restructuring (Tables)
    		 12 Months Ended
    Dec. 31, 2012
    Equity Financing and the Debt Restructuring [Abstract]  
    Schedule of Debt Conversion
                                   
       
    Common
    Shares
    Issued
    		    
    Number of
    A Warrants
    		    
    Value of A
    Warrants
    		    
    Value of
    B
    Warrants
    		    
    Total
    Warrant
    Value
    		  
    Investors
    		     24,816,000       12,408,000     $ 469,464     $ 39,387     $ 508,851  
    Bridge Loan Conversion
    		     1,600,000       800,000       30,268       2,539       32,807  
    Equipment Finance Conversion
    		     2,000,000       1,000,000       37,836       3,174       41,010  
    Agency
    		     --       4,262,400       161,270       13,531       174,801  
    Total
    		     28,416,000       18,470,400     $ 698,838     $ 58,631     $ 757,469  
    XML 73 R49.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Income Taxes (Details) (USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Dec. 31, 2011
    Deferred tax assets    
    NOL carry-forward $ 25,881,900 $ 23,862,500
    General business credit carry-forwards 1,158,900 1,147,000
    Deferred compensation 78,500 83,500
    Allowance for doubtful accounts 31,600 21,000
    Deferred tax liabilities    
    Depreciation (61,700) (173,000)
    Valuation allowance (27,212,600) (24,941,000)
    Net deferred tax asset      
    The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations:    
    Federal income tax (expense) benefit at statutory rates 1,831,600 1,902,500
    State income tax (expense) benefit at statutory rates 269,300 280,000
    Change in valuation allowance (2,100,900) (2,182,500)
    Income tax provision      
    Net operating loss carry-forwards $ 66,364,000  
    Expiration of net operating loss carry-forwards 2013 through 2032  
    XML 74 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Notes Payable (2012 Secured Convertible Notes) (Details) (USD $)
    		 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended
    Jan. 31, 2013
    Dec. 31, 2012
    Dec. 31, 2011
    Dec. 31, 2012
    Conversion Feature of Debt [Member]
    Dec. 31, 2012
    Warrant Reset Provision [Member]
    Jul. 31, 2012
    Tranche One of Warrants Issued with 2012 Convertible Notes [Member]
    Aug. 31, 2012
    Tranche Two of Warrants Issued with 2012 Convertible Notes [Member]
    Dec. 31, 2012
    Tranche Three of Warrants Issued with 2012 Convertible Notes [Member]
    Dec. 31, 2012
    2012 Convertible Notes [Member]
    Aug. 31, 2012
    2012 Convertible Notes [Member]
    Jul. 31, 2012
    2012 Convertible Notes [Member]
    Dec. 31, 2012
    2012 Convertible Notes [Member]
    Dec. 31, 2012
    2012 Convertible Notes [Member]
    Maximum [Member]
    Jul. 31, 2012
    Newly Issued Debt [Member]
    Debt Instrument [Line Items]                            
    Principal issued                 $ 3,050,000     $ 3,050,000 $ 5,000,000  
    Debt maturity date                       Jul. 13, 2013    
    Debt interest rate                 12.00%     12.00%    
    Conversion price                 $ 0.25     $ 0.25    
    Warrant term length                       5 years    
    Number of shares of common stock warrants can be exercised for           3,800,000 1,800,000 500,000 200,000     200,000    
    Amount of debt converted                     900,000      
    Continued sales of convertible debt                   900,000 1,900,000     1,000,000
    Proceeds from issuance of convertible note and warrants 400,000 3,050,000             250,000 851,624 923,175      
    Payment of investment banking fees                   48,376 76,825      
    Derivative valuation   1,191,269 3,760,200 74,500 183,000                  
    Gain on derivative valuation   $ 8,829,748 $ 11,724,400 $ 423,500 $ 442,000                  
    Risk-free interest rate       0.11% 0.63%                  
    Expected life       6 months 4 years 6 months                  
    Expected volatility       129.08% 85.75%                  
    Dividend yield       0.00% 0.00%                  
    Stock trading price       $ 0.08 $ 0.08                  
    XML 75 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
    CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (USD $)
    Total
    Common Stock [Member]
    Additional Paid-in Capital [Member]
    Retained Earnings (Deficit) [Member]
    Balance at Dec. 31, 2010 $ (15,920,842) $ 3,703,908 $ 92,867,561 $ (112,492,311)
    Balance, shares at Dec. 31, 2010   74,078,153    
    Common stock issued on debt conversion 1,296,147 65,357 1,230,790   
    Common stock issued on debt conversion, shares   1,307,153    
    Common stock issued for interest 81,221 6,768 74,453   
    Common stock issued for interest, shares   135,369    
    Common stock issued for option exercises 18,304 2,755 15,549   
    Common stock issued for option exercises, shares 455,098 55,098    
    Common stock issued for warrant exercises 260,000 18,614 241,386   
    Common stock issued for warrant exercises, shares   372,272    
    Common stock issued in exchange for IDI shares 10,760 1,381 9,379   
    Common stock issued in exchange for IDI shares   27,611    
    Equity issued for interest 157,400    157,400   
    Stock based compensation 2,262,540    2,262,540   
    Net Income 1,304,446       1,304,446
    Balance at Dec. 31, 2011 (10,530,024) 3,798,783 96,859,058 (111,187,865)
    Balance, shares at Dec. 31, 2011   75,975,656    
    Common stock issued for 2012 equity financing and debt restructuring, net of issuance costs 2,107,834 1,270,108 837,726   
    Common stock issued for 2012 equity financing and debt restructuring, net of issuance costs, shares   25,402,164    
    Common stock issued on debt conversion 1,660,000 280,000 1,380,000   
    Common stock issued on debt conversion, shares   5,600,000    
    Common stock issued for services rendered 177,313 24,800 152,513   
    Common stock issued for services rendered, shares   496,000    
    Common stock issued for option exercises, shares         
    Amended and restated 6.25% note conversion feature 81,500    81,500   
    Stock based compensation 283,693    283,693   
    Net Income 1,602,824       1,602,824
    Balance at Dec. 31, 2012 $ (4,616,860) $ 5,373,691 $ 99,594,490 $ (109,585,041)
    Balance, shares at Dec. 31, 2012 107,473,820 107,473,820    
    XML 76 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Equity Financing and the Debt Restructuring
    		 12 Months Ended
    Dec. 31, 2012
    Equity Financing and the Debt Restructuring [Abstract]  
    Equity Financing and the Debt Restructuring
    Note 4 - Equity Financing and the Debt Restructuring
    2012 Equity Financing and the Debt Restructuring
    On March 26, 2012, we closed on an equity financing (the "2012 Equity Financing") as well as a restructuring of our outstanding senior convertible indebtedness (the "2012 Debt Restructuring") resulting in complete satisfaction of our senior indebtedness.
    We entered into an Engagement Agreement, dated October 28, 2011, with MDB Capital Group, LLC ("MDB"), pursuant to which MDB agreed to act as the exclusive agent of the Company on a "best efforts" basis with respect to the sale of up to a maximum gross consideration of $6,000,000, subsequently verbally increased to $10,000,000, of the Company's securities, subject to a minimum gross consideration of $3,000,000. The Company agreed to pay to MDB a commission of 10% of the gross offering proceeds received by the Company, to grant to MDB warrants to acquire up to 10% of the shares of our common stock and warrants issued in the financing, and to pay the reasonable costs and expenses of MDB related to the offering.
    Pursuant to the Engagement Agreement, we entered into a Securities Purchase Agreement ("SPA") dated March 23, 2012 with select institutional and other accredited investors for the private placement of 27,800,000 units of our securities. The SPA included a purchase price of $0.25 per unit, with each unit consisting of one share of common stock and two forms of Warrant: (1) The "A" Warrant grants the investors the right to purchase an additional share of common stock for each two shares of common stock purchased, for a term of six years and at an exercise price of $0.35 per share; and (2) The "B" Warrant will not be exercisable unless and until the occurrence of a future issuance of stock at less than $0.25 per share, but, in the event of such issuance, grants the investors the right to acquire additional shares at a price of $0.05 to reduce the impact of the dilution caused by such issuance, but in no event shall the number of shares to be issued under the B Warrant cause us to exceed the number of authorized shares of common stock. The shares in excess of our authorized shares that would have been issuable under the B Warrant shall be "net settled" by payment of cash in an amount equal to the number of shares in excess of the authorized common shares multiplied by the closing price of our common stock as of the trading day immediately prior to the applicable date of the exercise of such B Warrant. The holders of the B Warrants agreed in December 2012 to amend the terms of the B Warrant to reduce the amount of subsequent financing required to extinguish the B Warrants with the result that the B Warrants have now been extinguished.

    Net proceeds from the 2012 Equity Financing, after deducting the commissions and the estimated legal, printing and other costs and expenses related to the financing, were approximately $6.1 million. Coincident to the closing of the 2012 Equity Financing, we also closed on the 2012 Debt Restructuring. In connection therewith, the Company paid $2,750,000 to Castlerigg Master Investment Ltd. ("Castlerigg"), and issued to Castlerigg 2,000,000 shares of common stock in full and complete satisfaction of the senior convertible note and all accrued interest. In consideration of negotiating the 2012 Debt Restructuring, we issued to one of our placement agents 586,164 shares of our common stock and paid them $275,041.
    In December 2011, we entered into a loan with 7 accredited individuals and entities under the terms of which we borrowed $1,300,000 to be used as working capital ("Bridge Loan"). The Bridge Loan bears an interest rate of 18% per annum and had a maturity date of February 28, 2012, which was subsequently extended to the earlier of the date nine months from the original maturity date or the date we close on an additional sale of our securities that results in gross proceeds to us of $12 million. In consideration of the Bridge Loan we granted to the holders of the Bridge Loan warrants with a five year term to purchase 357,500 shares of our common stock at an exercise price of $0.65 per share. In consideration of the extension of the maturity date of the Bridge Loan, we granted the holders of the Bridge Loan warrants with a six year term to purchase 247,500 shares of our common stock at an exercise price of $0.35 per share.
    In connection with the 2012 Equity Financing and under the terms of the SPA, two of the above described bridge lenders converted the principal balance of their portion of the bridge loan in the amount of $400,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing. In addition, one other entity converted the amount owed by us for equipment purchases in the amount of $500,000 to common stock and warrants as part of and on the same terms as the 2012 Equity Financing. The proceeds from these conversions were treated as funds raised with respect to the financing.

    In connection with the 2012 Equity Financing and under the terms of the SPA, the Company agreed to prepare and file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the Warrants. The Company filed the registration statement on April 9, 2012 and it was declared effective on August 1, 2012.
    On April 5, 2012 we secured an additional $154,000 from 1 company and 4 individuals (three of which are members of our Board of Directors) on the same terms and conditions as the investors of the 2012 Equity Financing. As a result of this funding we issued 616,000 shares of our common stock and A warrants totaling 400,400 of which 308,000 were issued to investors and 92,400 were issued to our investment banker.
    All warrants listed below were issued with price protection provisions and were accounted for as derivative liabilities. The A Warrants were valued using the Black Scholes pricing model and the B Warrants were valued using the Geometric Brownian Motion methodology with a risk neutral Monte Carlo approach.

                                   
       
    Common
    Shares
    Issued
    		    
    Number of
    A Warrants
    		    
    Value of A
    Warrants
    		    
    Value of
    B
    Warrants
    		    
    Total
    Warrant
    Value
    		  
    Investors
    		     24,816,000       12,408,000     $ 469,464     $ 39,387     $ 508,851  
    Bridge Loan Conversion
    		     1,600,000       800,000       30,268       2,539       32,807  
    Equipment Finance Conversion
    		     2,000,000       1,000,000       37,836       3,174       41,010  
    Agency
    		     --       4,262,400       161,270       13,531       174,801  
    Total
    		     28,416,000       18,470,400     $ 698,838     $ 58,631     $ 757,469  

    We recorded an aggregate derivative liability of $757,469 as of December 31, 2012, related to the reset feature of the A warrants and the B warrants mentioned above. A derivative valuation gain of $4,365,323 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants issued. The aggregate derivative liability of $757,469 was calculated as follows: (1) $698,838 for the reset feature of the A warrants using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.72%, (ii) expected life (in years) of 5.2; (iii) expected volatility of 85.49%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08 and (2) $58,631 for the B warrants using the Geometric Brownian Motion methodology with a risk neutral Monte Carlo approach.
    2010 Equity Financing and the Debt Restructuring
    On December 24, 2010, we closed on an equity financing (the "Equity Financing") as well as a restructuring of our then outstanding convertible indebtedness (the "Debt Restructuring"). The Equity Financing and the Debt Restructuring are described as follows.
    We entered into a Placement Agency Agreement, dated December 17, 2010, with Philadelphia Brokerage Corporation ("PBC"), pursuant to which PBC agreed to act as the exclusive agent of the Company on a "best efforts" basis with respect to the sale of up to a maximum gross consideration of $15,000,000 of units of the Company's securities, subject to a minimum gross consideration of $10,000,000. The units consisted of two shares of our common stock and one warrant to purchase a share of our common stock. The Company agreed to pay PBC a commission of 8% of the gross offering proceeds received by the Company, to issue PBC 40,000 shares of its common stock for each $1,000,000 raised, and to pay the reasonable costs and expenses of PBC related to the offering. The Company also agreed to pay PBC a restructuring fee in the amount of approximately $180,000 upon the closing of the Equity Financing and the simultaneous Debt Restructuring.
    Pursuant to the Placement Agency Agreement, we entered into Subscription Agreements dated December 23, 2010 with select institutional and other accredited investors for the private placement of 12,500,000 units of our securities. The Subscription Agreements included a purchase price of $1.20 per unit, with each unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock. The warrants have a term of five years and had an exercise price of $1.00 per share which was reset to $0.78 pursuant to the 2012 Equity Financing.
    Net proceeds from the Equity Financing, after deducting the commissions and debt restructuring fees payable to PBC and the estimated legal, printing and other costs and expenses related to the financing, were approximately $13.5 million. We used a portion of the net proceeds of the Equity Financing to pay down debt and the remainder was used for working capital.
    On November 29, 2010, we entered into a bridge loan transaction with three accredited investors pursuant to which we issued unsecured notes in the aggregate principal amount of $1.0 million. Upon the closing of the Equity Financing, the lenders converted the entire principal amount plus accrued interest into the same units offered in the Equity Financing and the proceeds from the bridge loan transaction were treated as funds raised with respect to the financing.
    In connection with the Equity Financing and under the terms of the Subscription Agreements, the Company agreed to prepare and file, and did file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the warrants. The registration statement was declared effective June 16, 2011 satisfying the obligation contained in the Subscription Agreements.
    On December 24, 2010, we also closed on the Debt Restructuring. In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the "Amended and Restated Note") to Castlerigg Master Investment Ltd. ("Castlerigg"), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents were issued (the "Loan Restructuring Agreement"), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010. As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.
    The Amended and Restated Note, dated December 23, 2010, was a senior, unsecured note that matured in three years from the closing and bore interest at an annual rate of 6.25%, payable semi-annually. We paid the first year's interest of $350,434 at the closing. The Amended and Restated Note was convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment. The Amended and Restated Note was convertible in whole or in part at any time upon notice by Castlerigg to us. The Amended and Restated Note also contained various restrictions, acceleration provisions and other standard and customary terms and conditions. Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.
    The Investor Rights Agreement provides Castlerigg with certain registration rights with respect to the Company's securities held by Castlerigg. These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied. The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.
    During the three months ended March 31, 2011, we issued Castlerigg 400,000 warrants pursuant to a waiver agreement dated March 10, 2011 allowing the issuance of shares and warrants for the conversion of the AR Note Payable without adjusting the conversion price of the Amended and Restated Senior 6.25% Convertible Note. These warrants contain full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model. During the three and six months ended June 30 ,2011 the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock. A valuation gain of $144,000 was recorded to reflect the change in value of the aggregate derivative from the time of issue to the date of conversion.
    In connection with the Debt Restructuring, the Company amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013. We also issued 150,000 shares and 75,000 warrants to acquire our common stock at $.90 per share to the holder of this note as consideration to extend the term of the note.
    On March 26, 2012, we closed on an equity financing (the "2012 Equity Financing") as well as a restructuring of our outstanding senior convertible indebtedness (the "2012 Debt Restructuring") resulting in complete satisfaction our senior indebtedness.
    A portion of the net proceeds from the 2012 Equity Financing was used to close on the 2012 Debt Restructuring therewith. The Company paid $2,750,000 and issued 2,000,000 shares of common stock valued at $760,000 to Castlerigg in satisfaction of the $5,500,000 senior convertible note and $680,816 of accrued interest.
    Investor warrants totaling 12,499,980 issued under the Subscription Agreements contain price protection adjustments in the event we issue new common stock or common stock equivalents in certain transactions at a price less than $1.00 per share and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model. The exercise price has been reset to $0.7312 per share due to subsequent financings.

    We recorded an aggregate derivative liability of $109,400 and $2,785,000 as of December 31, 2012 and 2011, respectively, related to the reset feature of the warrants issued under the Placement agency Agreement. A derivative valuation gain of $2,765,600 and $7,875,000, respectively, were recorded to reflect the change in value of the aggregate derivative liability since December 31, 2011 and December 31, 2010, respectively. The aggregate derivative liability of $109,400 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.36%, (ii) expected life (in years) of 3.0; (iii) expected volatility of 85.10%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.08.
    XML 77 R58.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Stock-based Compensation (Schedule of Unrecognized Compensation Expense) (Details) (USD $)
    Dec. 31, 2012
    Stock-based Compensation [Abstract]  
    2012 $ 118,127
    2013 62,038
    2014 567
    Total $ 180,732
    XML 78 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Notes Payable (Tables)
    		 12 Months Ended
    Dec. 31, 2012
    Notes Payable [Abstract]  
    Schedule of Notes Payable
       
    December 31,
    2011
    		    
    December 31,
    2012
    		  
    2012 Secured Convertible Notes
    		     --       2,428,166  
    Unsecured Convertible Note
    		     340,504       673,840  
    Amended and Restated Senior 6.25% Convertible Note
    		   $ 6,180,816     $ --  
    Bridge Loan Note Payable
    		     1,196,141       --  
    Equipment Purchase and Sale Agreement
    		     700,000       --  
    Total
    		     8,417,461       3,102,006  
    Less Current Portion
    		     (2,068,016 )     (3,102,006 )
    Total Long-term
    		   $ 6,349,445     $ --  
    XML 79 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 265 386 1 true 90 0 false 6 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.brin.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.brin.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.brin.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.brin.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Sheet http://www.brin.com/role/ConsolidatedStatementsOfStockholdersDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT false false R6.htm 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.brin.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 101 - Disclosure - Organization and Basis of Presentation Sheet http://www.brin.com/role/OrganizationAndBasisOfPresentation Organization and Basis of Presentation false false R8.htm 102 - Disclosure - Significant Accounting Policies Sheet http://www.brin.com/role/SignificantAccountingPolicies Significant Accounting Policies false false R9.htm 103 - Disclosure - Accounts Receivable Sheet http://www.brin.com/role/AccountsReceivable Accounts Receivable false false R10.htm 104 - Disclosure - Equity Financing and the Debt Restructuring Sheet http://www.brin.com/role/EquityFinancingAndDebtRestructuring Equity Financing and the Debt Restructuring false false R11.htm 105 - Disclosure - Notes Payable Notes http://www.brin.com/role/NotesPayable Notes Payable false false R12.htm 106 - Disclosure - Investment in Interact Devices Inc. (IDI) Sheet http://www.brin.com/role/InvestmentInInteractDevicesIncIdi Investment in Interact Devices Inc. (IDI) false false R13.htm 107 - Disclosure - Operating Leases Sheet http://www.brin.com/role/OperatingLeases Operating Leases false false R14.htm 108 - Disclosure - Income Taxes Sheet http://www.brin.com/role/IncomeTaxes Income Taxes false false R15.htm 109 - Disclosure - Preferred and Common Stock Sheet http://www.brin.com/role/PreferredAndCommonStock Preferred and Common Stock false false R16.htm 110 - Disclosure - Stock-based Compensation Sheet http://www.brin.com/role/StockbasedCompensation Stock-based Compensation false false R17.htm 111 - Disclosure - Equipment Financing Sheet http://www.brin.com/role/EquipmentFinancing Equipment Financing false false R18.htm 112 - Disclosure - Fair Value Measurements Sheet http://www.brin.com/role/FairValueMeasurements Fair Value Measurements false false R19.htm 113 - Disclosure - Retirement Plan Sheet http://www.brin.com/role/RetirementPlan Retirement Plan false false R20.htm 114 - Disclosure - Legal Proceedings Sheet http://www.brin.com/role/LegalProceedings Legal Proceedings false false R21.htm 115 - Disclosure - Liquidity Sheet http://www.brin.com/role/Liquidity Liquidity false false R22.htm 116 - Disclosure - Supplemental Cash Flow Information Sheet http://www.brin.com/role/SupplementalCashFlowInformation Supplemental Cash Flow Information false false R23.htm 117 - Disclosure - Subsequent Events Sheet http://www.brin.com/role/SubsequentEvents Subsequent Events false false R24.htm 202 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.brin.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) false false R25.htm 302 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.brin.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) false false R26.htm 304 - Disclosure - Equity Financing and the Debt Restructuring (Tables) Sheet http://www.brin.com/role/EquityFinancingAndDebtRestructuringTables Equity Financing and the Debt Restructuring (Tables) false false R27.htm 305 - Disclosure - Notes Payable (Tables) Notes http://www.brin.com/role/NotesPayableTables Notes Payable (Tables) false false R28.htm 307 - Disclosure - Operating Leases (Tables) Sheet http://www.brin.com/role/OperatingLeasesTables Operating Leases (Tables) false false R29.htm 308 - Disclosure - Income Taxes (Tables) Sheet http://www.brin.com/role/IncomeTaxesTables Income Taxes (Tables) false false R30.htm 310 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.brin.com/role/StockbasedCompensationTables Stock-based Compensation (Tables) false false R31.htm 312 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.brin.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) false false R32.htm 40101 - Disclosure - Organization and Basis of Presentation (Details) Sheet http://www.brin.com/role/OrganizationAndBasisOfPresentationDetails Organization and Basis of Presentation (Details) false false R33.htm 40201 - Disclosure - Significant Accounting Policies (Narrative) (Details) Sheet http://www.brin.com/role/SignificantAccountingPoliciesNarrativeDetails Significant Accounting Policies (Narrative) (Details) false false R34.htm 40202 - Disclosure - Significant Accounting Policies (Patents and Intangibles) (Details) Sheet http://www.brin.com/role/SignificantAccountingPoliciesPatentsAndIntangiblesDetails Significant Accounting Policies (Patents and Intangibles) (Details) false false R35.htm 40203 - Disclosure - Significant Accounting Policies (Weighted Average Shares) (Details) Sheet http://www.brin.com/role/SignificantAccountingPoliciesWeightedAverageSharesDetails Significant Accounting Policies (Weighted Average Shares) (Details) false false R36.htm 40301 - Disclosure - Accounts Receivable (Details) Sheet http://www.brin.com/role/AccountsReceivableDetails Accounts Receivable (Details) false false R37.htm 40401 - Disclosure - Equity Financing and the Debt Restructuring (2012 Equity Financing and the Debt Restructuring) (Details) Sheet http://www.brin.com/role/EquityFinancingAndDebtRestructuringTwoZeroOneTwoEquityFinancingAndDebtRestructuringDetails Equity Financing and the Debt Restructuring (2012 Equity Financing and the Debt Restructuring) (Details) false false R38.htm 40402 - Disclosure - Equity Financing and the Debt Restructuring (Schedule of Debt Conversion) (Details) Sheet http://www.brin.com/role/EquityFinancingAndDebtRestructuringScheduleOfDebtConversionDetails Equity Financing and the Debt Restructuring (Schedule of Debt Conversion) (Details) false false R39.htm 40403 - Disclosure - Equity Financing and the Debt Restructuring (2010 Equity Financing and the Debt Restructuring) (Details) Sheet http://www.brin.com/role/EquityFinancingAndDebtRestructuringTwoZeroOneZeroEquityFinancingAndDebtRestructuringDetails Equity Financing and the Debt Restructuring (2010 Equity Financing and the Debt Restructuring) (Details) false false R40.htm 40501 - Disclosure - Notes Payable (Schedule of Notes Payable) (Details) Notes http://www.brin.com/role/NotesPayableScheduleOfNotesPayableDetails Notes Payable (Schedule of Notes Payable) (Details) false false R41.htm 40502 - Disclosure - Notes Payable (2012 Secured Convertible Notes) (Details) Notes http://www.brin.com/role/NotesPayableTwoZeroOneTwoSecuredConvertibleNotesDetails Notes Payable (2012 Secured Convertible Notes) (Details) false false R42.htm 40503 - Disclosure - Notes Payable (Unsecured Convertible Note) (Details) Notes http://www.brin.com/role/NotesPayableUnsecuredConvertibleNoteDetails Notes Payable (Unsecured Convertible Note) (Details) false false R43.htm 40504 - Disclosure - Notes Payable (Senior 6.25% Convertible Note) (Details) Notes http://www.brin.com/role/NotesPayableSeniorSixTwoFiveConvertibleNoteDetails Notes Payable (Senior 6.25% Convertible Note) (Details) false false R44.htm 40505 - Disclosure - Notes Payable (Accounts Receivable Purchase Agreements) (Details) Notes http://www.brin.com/role/NotesPayableAccountsReceivablePurchaseAgreementsDetails Notes Payable (Accounts Receivable Purchase Agreements) (Details) false false R45.htm 40506 - Disclosure - Notes Payable (Bridge Loan) (Details) Notes http://www.brin.com/role/NotesPayableBridgeLoanDetails Notes Payable (Bridge Loan) (Details) false false R46.htm 40507 - Disclosure - Notes Payable (Equipment Purchase and Sale Agreement) (Details) Notes http://www.brin.com/role/NotesPayableEquipmentPurchaseAndSaleAgreementDetails Notes Payable (Equipment Purchase and Sale Agreement) (Details) false false R47.htm 40601 - Disclosure - Investment in Interact Devices, Inc (IDI) (Details) Sheet http://www.brin.com/role/InvestmentInInteractDevicesIncIdiDetails Investment in Interact Devices, Inc (IDI) (Details) false false R48.htm 40701 - Disclosure - Operating Leases (Details) Sheet http://www.brin.com/role/OperatingLeasesDetails Operating Leases (Details) false false R49.htm 40801 - Disclosure - Income Taxes (Details) Sheet http://www.brin.com/role/IncomeTaxesDetails Income Taxes (Details) false false R50.htm 40901 - Disclosure - Preferred and Common Stock (Details) Sheet http://www.brin.com/role/PreferredAndCommonStockDetails Preferred and Common Stock (Details) false false R51.htm 41001 - Disclosure - Stock-based Compensation (Narrative) (Details) Sheet http://www.brin.com/role/StockbasedCompensationNarrativeDetails Stock-based Compensation (Narrative) (Details) false false R52.htm 41002 - Disclosure - Stock-based Compensation (Schedule of Assumptions Used to Value Options) (Details) Sheet http://www.brin.com/role/StockbasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails Stock-based Compensation (Schedule of Assumptions Used to Value Options) (Details) false false R53.htm 41003 - Disclosure - Stock-based Compensation (Schedule of Assumptions Used to Value Warrants) (Details) Sheet http://www.brin.com/role/StockbasedCompensationScheduleOfAssumptionsUsedToValueWarrantsDetails Stock-based Compensation (Schedule of Assumptions Used to Value Warrants) (Details) false false R54.htm 41004 - Disclosure - Stock-based Compensation (Schedule of Option and Warrant Activity) (Details) Sheet http://www.brin.com/role/StockbasedCompensationScheduleOfOptionAndWarrantActivityDetails Stock-based Compensation (Schedule of Option and Warrant Activity) (Details) false false R55.htm 41005 - Disclosure - Stock-based Compensation (Schedule of Information About Options and Warrants) (Details) Sheet http://www.brin.com/role/StockbasedCompensationScheduleOfInformationAboutOptionsAndWarrantsDetails Stock-based Compensation (Schedule of Information About Options and Warrants) (Details) false false R56.htm 41006 - Disclosure - Stock-based Compensation (Schedule of Restricted Stock Unit Activity) (Details) Sheet http://www.brin.com/role/StockbasedCompensationScheduleOfRestrictedStockUnitActivityDetails Stock-based Compensation (Schedule of Restricted Stock Unit Activity) (Details) false false R57.htm 41007 - Disclosure - Stock-based Compensation (Schedule of Allocated Stock-Based Compensation) (Details) Sheet http://www.brin.com/role/StockbasedCompensationScheduleOfAllocatedStockbasedCompensationDetails Stock-based Compensation (Schedule of Allocated Stock-Based Compensation) (Details) false false R58.htm 41008 - Disclosure - Stock-based Compensation (Schedule of Unrecognized Compensation Expense) (Details) Sheet http://www.brin.com/role/StockbasedCompensationScheduleOfUnrecognizedCompensationExpenseDetails Stock-based Compensation (Schedule of Unrecognized Compensation Expense) (Details) false false R59.htm 41101 - Disclosure - Equipment Financing (Details) Sheet http://www.brin.com/role/EquipmentFinancingDetails Equipment Financing (Details) false false R60.htm 41201 - Disclosure - Fair Value Measurements (Details) Sheet http://www.brin.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) false false R61.htm 41301 - Disclosure - Retirement Plan (Details) Sheet http://www.brin.com/role/RetirementPlanDetails Retirement Plan (Details) false false R62.htm 41401 - Disclosure - Legal Proceedings (Details) Sheet http://www.brin.com/role/LegalProceedingsDetails Legal Proceedings (Details) false false R63.htm 41501 - Disclosure - Liquidity (Details) Sheet http://www.brin.com/role/LiquidityDetails Liquidity (Details) false false R64.htm 41601 - Disclosure - Supplemental Cash Flow Information (Details) Sheet http://www.brin.com/role/SupplementalCashFlowInformationDetails Supplemental Cash Flow Information (Details) false false R65.htm 41701 - Disclosure - Subsequent Events (Details) Sheet http://www.brin.com/role/SubsequentEventsDetails Subsequent Events (Details) false false All Reports Book All Reports Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights had a mix of decimals attribute values: 1 2 3 4. Element us-gaap_DebtInstrumentConvertibleConversionPrice1 had a mix of decimals attribute values: 1 2. Element us-gaap_DebtInstrumentInterestRateStatedPercentage had a mix of decimals attribute values: 2 4. Element us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit had a mix of decimals attribute values: 0 2. Process Flow-Through: 002 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS bcst-20121231.xml bcst-20121231.xsd bcst-20121231_cal.xml bcst-20121231_def.xml bcst-20121231_lab.xml bcst-20121231_pre.xml true true XML 80 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Equity Financing and the Debt Restructuring (Schedule of Debt Conversion) (Details) (2012 Plan [Member], USD $)
    		 12 Months Ended
    Dec. 31, 2012
    Equity Financing and Debt Restructuring [Line Items]  
    Value of Warrants 757,469
    Class A Warrant [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Number of A Warrants 18,470,400
    Value of Warrants 698,838
    Class B Warrant [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Value of Warrants 58,631
    Common Stock [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Common Shares Issued 28,416,000
    Bridge Loan Conversion [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Value of Warrants 32,807
    Bridge Loan Conversion [Member] | Class A Warrant [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Number of A Warrants 800,000
    Value of Warrants 30,268
    Bridge Loan Conversion [Member] | Class B Warrant [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Value of Warrants 2,539
    Bridge Loan Conversion [Member] | Common Stock [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Common Shares Issued 1,600,000
    Equipment Finance Conversion [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Value of Warrants 41,010
    Equipment Finance Conversion [Member] | Class A Warrant [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Number of A Warrants 1,000,000
    Value of Warrants 37,836
    Equipment Finance Conversion [Member] | Class B Warrant [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Value of Warrants 3,174
    Equipment Finance Conversion [Member] | Common Stock [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Common Shares Issued 2,000,000
    Investors [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Value of Warrants 508,851
    Investors [Member] | Class A Warrant [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Number of A Warrants 12,408,000
    Value of Warrants 469,464
    Investors [Member] | Class B Warrant [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Value of Warrants 39,387
    Investors [Member] | Common Stock [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Common Shares Issued 24,816,000
    Agency [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Value of Warrants 174,801
    Agency [Member] | Class A Warrant [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Number of A Warrants 4,262,400
    Value of Warrants 161,270
    Agency [Member] | Class B Warrant [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Value of Warrants 13,531
    Agency [Member] | Common Stock [Member]
    		  
    Equity Financing and Debt Restructuring [Line Items]  
    Common Shares Issued   
    XML 81 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
    Legal Proceedings
    		 12 Months Ended
    Dec. 31, 2012
    Legal Proceedings [Abstract]  
    Legal Proceedings
    Note 14 - Legal Proceedings
    We have pending legal matters. We have a judgment rendered against us in a lawsuit, the total amount in dispute in which is approximately $130,000.
    On July 27, 2012, CTC Resources Inc. dba U.S. Media Capital ("CTC") filed a lawsuit in the Third Judicial District Court in and for Salt Lake City, State of Utah against ACC Capital Corporation ("ACC"), Loni L. Lowder and the Company (the "CTCD Lawsuit") asserting claims for relief for breach of contract against ACC, breach of fiduciary duty and fraud against ACC and Mr. Lowder and civil conspiracy against ACC, Mr. Lowder and the Company, and seeking injunctive relief and constructive trust as to all defendants as well as money damages. On October 9, 2012, we filed our answer as well as a cross claim against ACC seeking declaratory relief as to the price to be paid by us for the leased equipment and specific performance against ACC. On January 7, 2013 in a hearing relative to a temporary injunction previously granted by the Court, the Court took testimony and heard arguments from the parties on the matter and the Court and the parties agreed that a trial would be unnecessary. Both parties submitted briefs regarding the law and summarizing the testimony elicited at the hearing. The Court's judgment rendered on February 25, 2013 vacated the parties' joint appraisal and required that the parties jointly secure another appraisal for the equipment, the results of which will be binding on the parties. We have paid $424,500 toward the purchase price of the equipment, which we believe satisfies our payment obligation, but pursuant to a restraining order we sought to prevent the lessor from contacting our customer as of March 26, 2013 we have escrowed an aggregate of $425,100 with the Court and have a current obligation to continue making monthly escrow payments in the amount of $141,700 pending a decision in the matter.